Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7404708384756785,-2.9520408667327507,0.0,0.0,0.0,71/87,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A
prerank,cytoplasmic translation (GO:0002181),-0.7314301831150263,-2.9096432121184335,0.0,0.0,0.0,62/91,13.69%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;EIF4A1;RPL23;RPL17;RPL29;GSPT2;RPL22L1;RPS5;RPS14;UBA52
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7167823214655411,-2.8575926134758314,0.0,0.0,0.0,73/91,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;ARL6IP1;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;TRAM1;RPL23;RPL17;RPL29;RPS5;RPS14;SSR2;UBA52;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A
prerank,protein targeting to ER (GO:0045047),-0.6936568296763864,-2.7816704309126132,0.0,0.0,0.0,74/99,19.88%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;SPCS2;RPS26;RPS10;SPCS1;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A;SEC61G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6561177342180574,-2.649553878167701,0.0,0.0,0.0,73/110,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;RPL12;RPL9;RPL37;RPS11;RNPS1;PABPC1;RPL7;RPL31;RPL7A
prerank,peptide biosynthetic process (GO:0043043),-0.61559138419886,-2.6222111479582892,0.0,0.0,0.0,91/153,21.28%,RPS24;DMD;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;ASMT;MRPS18A;RPS10;IGHMBP2;RPL23;RPL17;GGT5;PABPC4;RPL29;GSPT2;RPS5;RPS14;SRBD1;MRPL28;COPS5;HBS1L;RPL12;RPL9;GGT7;RPL37;RPS11;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;GGT1;YARS2;FARSB;PCSK5;RPL3;MRPL52;MRPL23;MRPL9
prerank,translation (GO:0006412),-0.5644641173335884,-2.4839441760032335,0.0,0.0,0.0,107/208,23.17%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;EEF1G;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;GTPBP1;RPL18;RPS13;EEF2;RPS2;RPL14;LARS2;RPL22;RPS26;ASMT;MRPS18A;KARS1;CARS1;EEF1E1;RPS10;IGHMBP2;RPL23;RPL17;PABPC4;RPL29;GSPT2;RPL22L1;RPS5;FASTKD2;RPS14;UBA52;IARS1;MRPL57;RARS2;SRBD1;MRPL28;COPS5;HBS1L;RPL12;RPL9;RPL37;RPS11;MRPL47;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;YARS2;FARSB;RPL3;MRPS2;MRPL52;MRPL23;MRPL9;GSPT1;MRPS12;RPL23A;TUFM;MRPL11;N6AMT1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6973811290112286,-2.3292206799319612,0.0,0.0,0.0,19/37,10.98%,GRM7;GRID2;GRIA4;GRM3;PLCB1;GRIK2;GRIN3A;GRM5;GRIK4;PTK2B;HOMER1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRM8;GRIN1;KCNB1
prerank,chemical synaptic transmission (GO:0007268),-0.4998688950208299,-2.314715579671975,0.0,0.0,0.0,115/284,22.09%,GRM7;NRXN1;NLGN1;DLG2;GRID2;SLC12A7;KCND2;SYT1;RIMS1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;HSPA8;GRM5;LIN7A;PTCHD1;GRIK4;GRIA1;PTPRN2;KCNQ3;KIF1B;SLC6A1;GABRA2;RIT2;AMPH;CACNB4;PLP1;HTR2C;GABBR2;HOMER1;CALM1;CHRM2;GABRB3;SNAP25;GRIN2A;SNCA;GABRA3;GRIK1;GLRA3;DLGAP1;DLGAP2;SYN3;GRIA3;GABRA4;SLC1A1;CDH8;GRIN2B;STXBP1;EXOC4;APBA2;PRKAR1A;GABARAP;MBP;RIC3;SLC1A4;CPLX1;SDCBP;GRIA2;SLC1A2;SYN1;SLC12A5;NLGN3;LRP6;GRIN1;GABRB1;SNPH;GABRG3;MINK1;DVL1;SLC12A6;PCDHB16;GAD2;RPS6KA1;PRKAR2B;NAPA;SLC6A5;SHISA6;SYN2;GABRB2;KIF5A;HRH1;STAC3;GRIK3;RPS6KA2;HTR2B;GABRA5;HTR4;SNAPIN;CHRNA4;CAMK4;CACNA1A;HTR2A;SYPL1;AKAP5;GLRA2;GLRA1;HRH2;KCNA1;SLC17A6;CHRFAM7A;CHRNA7;CAMKK2;SLC32A1;GABRA1;APBA3;KCNMB4;PENK;SLC18A2;SNCG;ATXN3;SCN2B;DTNA
prerank,regulation of cation channel activity (GO:2001257),-0.5795084071436463,-2.3063454222108075,0.0,0.0,0.0,38/89,14.20%,PDE4D;NLGN1;DLG2;GRIA4;LRRC7;KCNAB1;MEF2C;CACNB2;DMD;FGF14;FGF12;PTK2B;GRIA1;CACNB4;NETO1;FKBP1A;HOMER1;CALM1;ANK3;GRIN2A;CALM2;OPRM1;GRIA3;GRIN2B;CAMK2D;CTSS;CAMK2A;GRIA2;SELENON;SHISA9;GRIN1;MINK1;NOS1;FGF13;CAPN1;SHISA6;STAC;RELN
prerank,zinc ion homeostasis (GO:0055069),-0.7399888782976805,-2.295989663464832,0.0,0.0,0.0,16/28,14.55%,SLC39A10;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC39A6;SLC30A1;SLC39A14;SLC39A12;MT2A;SLC39A13;SLC39A8
prerank,cellular response to copper ion (GO:0071280),-0.8502908151900308,-2.2855585041238107,0.0,0.0,0.0,9/16,4.03%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SNCA
prerank,cellular zinc ion homeostasis (GO:0006882),-0.7443512312881756,-2.2832044682394317,0.0,7.935632874055933e-05,0.001,16/26,14.55%,SLC39A10;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC39A6;SLC30A1;SLC39A14;SLC39A12;MT2A;SLC39A13;SLC39A8
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.5025193338546694,-2.271525019069146,0.0,0.0001473760390896102,0.002,94/224,22.09%,GRM7;NRXN1;NLGN1;DLG2;SLC12A7;KCND2;SYT1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;GRM5;PTCHD1;GRIK4;GRIA1;KCNQ3;SLC6A1;GABRA2;RIT2;AMPH;CACNB4;PLP1;HTR2C;GABBR2;HOMER1;CALM1;CHRM2;GABRB3;SNAP25;GRIN2A;SNCA;GABRA3;GRIK1;GLRA3;DLGAP1;GRIA3;GABRA4;SLC1A1;GRIN2B;EXOC4;APBA2;PRKAR1A;GABARAP;MBP;CPLX1;SDCBP;GRIA2;SLC1A2;SYN1;SLC12A5;NLGN3;LRP6;GRIN1;GABRB1;GABRG3;MINK1;SLC12A6;PCDHB16;GAD2;RPS6KA1;PRKAR2B;SLC6A5;SYN2;GABRB2;KIF5A;HRH1;RPS6KA2;HTR2B;GABRA5;HTR4;CHRNA4;CAMK4;CACNA1A;HTR2A;SYPL1;AKAP5;GLRA2;GLRA1;HRH2;KCNA1;CHRFAM7A;CHRNA7;CAMKK2;GABRA1;APBA3;KCNMB4;PENK;SLC18A2;SNCG;ATXN3;SCN2B;DTNA
prerank,response to copper ion (GO:0046688),-0.7866487982356911,-2.257916790468101,0.0,0.0002063264547254542,0.003,9/20,4.03%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SNCA
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.5415277683701436,-2.1955022646458633,0.0,0.00019343105130511333,0.003,32/107,8.74%,GRM7;NLGN1;GRID2;LRRC4C;NRG3;SLC12A2;SYT1;RIMS1;RIMS2;GRM3;DGKI;CDH2;MEF2C;GRIK2;GRM5;ABR;GRIK4;MCTP1;HOMER1;GRIK1;DLGAP1;DLGAP2;SYN3;BTBD9;DGKZ;CPLX1;LRP8;CAMK2A;CNTNAP4;GRM8;SYN1;NLGN3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.49971479508694927,-2.167960623723404,0.0,0.00042478975972887634,0.007,81/168,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;DIS3L2;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;ATM;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;MTPAP;RPL12;PELO;RPL9;XRN2;RPL37;CNOT2;ERI1;RPS11;RNPS1;PABPC1;EXOSC4;RPL7;RPL31;RPL7A
prerank,rRNA metabolic process (GO:0016072),-0.49003201365539206,-2.124770208288166,0.0,0.0008596935613560593,0.013,78/160,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;HELQ;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;RPS14;UBA52;NOP56;MAPT;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;DEDD2;EXOSC4;SNU13;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,rRNA processing (GO:0006364),-0.4791054958977709,-2.112230766049252,0.0,0.0012488180154435389,0.021,81/172,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;HELQ;MAK16;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;MRPL1;THUMPD1;RPS14;UBA52;NOP56;SART1;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;ERI1;EXOSC4;SNU13;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6440729662125824,-2.091956741335375,0.0,0.0015474484104409068,0.028,17/33,17.85%,NLGN1;GRID2;LRRC4C;NRG3;GRIK2;ABR;GRIK4;GRIK1;BTBD9;LRP8;NLGN3;BCR;NGF;RELN;GRIK3;NTF3;CACNA1A
prerank,positive regulation of cell junction assembly (GO:1901890),-0.5651131558361855,-2.059602593525805,0.0,0.00319314751360822,0.058,26/56,18.00%,TEK;CNTNAP2;NRXN1;NLGN1;PTPRD;GRID2;PTPRJ;CLDN5;KDR;SYNDIG1;IL1RAPL1;IL1RAP;EPHB1;MYOC;NLGN3;VEGFA;LRRC4B;ACE2;CLSTN1;CAV1;RAC1;COL16A1;SLITRK2;SRPX2;EPHB3;PPM1F
prerank,ribosome biogenesis (GO:0042254),-0.46339472849005636,-2.049116927924063,0.0,0.0038451748380652832,0.073,82/187,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;NPM1;DDX47;WDR36;BYSL;HELQ;EXOSC2;NIP7;NVL;RPL23;RPL17;XPO1;RPL29;TEX10;RPS14;UBA52;NOP56;URB2;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;EXOSC4;SNU13;NOC2L;RPL7;MALSU1;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,regulation of dendritic spine development (GO:0060998),-0.7260170228215381,-2.0402190772303377,0.0,0.004575064865651376,0.089,6/19,2.04%,NLGN1;SHANK3;MEF2C;PPFIA2;GRIN3A;TANC2
prerank,cellular response to cadmium ion (GO:0071276),-0.6881217271838895,-2.036104798159827,0.0,0.004513391197119312,0.091,13/24,12.49%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MAPK8;MAPK3;AKT1;EGFR;MT2A
prerank,neurotransmitter secretion (GO:0007269),-0.5975936527881476,-2.035206508124968,0.0,0.004415386131124721,0.092,17/44,11.31%,NRXN1;SYT1;RIMS1;RIMS2;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,ribosomal large subunit assembly (GO:0000027),-0.6716705339715756,-2.0334249839110248,0.0,0.004364598080730763,0.095,13/24,22.71%,RPL24;RPL5;RPL6;RPL11;RPLP0;TRAF7;DHX30;PPAN;FASTKD2;NLE1;MDN1;RPL3;RPL23A
prerank,action potential (GO:0001508),-0.5768831411996129,-2.022702004869424,0.0,0.005234578573590228,0.118,23/44,20.62%,KCND2;DMD;KCNMB2;AKAP6;KCNJ2;SCN1A;ANK3;SCN2A;CACNA1G;YWHAH;KCNB1;SCN8A;SCN9A;KCNQ1;SRI;KCNE4;KCNA2;GNAQ;GNA14;SCN3A;CHRNA4;KCNA1;KCNMB4
prerank,response to cadmium ion (GO:0046686),-0.6744658776799519,-2.006906993023944,0.0,0.00637401369062564,0.149,13/26,12.49%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MAPK8;MAPK3;AKT1;EGFR;MT2A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.578745415974216,-2.005083788030363,0.0,0.006403234801824443,0.154,17/46,9.60%,GRM7;NRXN1;NLGN1;SHANK3;SYT1;GRM3;DGKI;CDH2;MEF2C;GRM5;PTK2B;HOMER1;GRIK1;DGKZ;GRM8;NLGN3;ATAD1
prerank,positive regulation of synapse assembly (GO:0051965),-0.6512224850646857,-2.0019014389721566,0.0,0.006602446551214535,0.164,16/27,17.01%,NRXN1;NLGN1;PTPRD;GRID2;SYNDIG1;SEMA4D;IL1RAPL1;IL1RAP;EPHB1;NLGN3;LRRC4B;CLSTN1;AGRN;SLITRK2;SRPX2;EPHB3
prerank,cellular response to zinc ion (GO:0071294),-0.7514300936358564,-1.998874862725735,0.0,0.006755527469236647,0.174,8/15,2.74%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8336640016248392,-1.9593199884632684,0.0,0.013121072980196855,0.306,8/11,8.85%,ADIPOR2;KDR;CD34;GATA2;PRCP;NDNF;MCAM;VEGFA
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5429555543423924,-1.9580093107154655,0.0,0.013098603716661411,0.311,22/57,14.20%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;NETO1;GRIN2A;DLGAP1;DLGAP2;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;SHISA9;GRIN1;MINK1;CAPN1;SHISA6;RELN
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.7833210956198952,-1.9575519265172963,0.0,0.01280437704325613,0.312,10/13,14.47%,PDE4D;CALM1;ANK3;CALM2;SLC8A1;CALM3;CAMK2D;SRI;CAV1;CASQ2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.5292722615805848,-1.9571938704016678,0.0,0.01261538894607063,0.315,31/63,20.36%,SLC12A7;SLC12A2;SLC26A2;ANO1;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;XPR1;SLC5A5;GABRA4;SLC1A1;SLC5A6;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;SLC25A30;ANO2;GABRB2;GABRA5;SLC20A2;ANO5;GLRA2;GLRA1;GABRA1
prerank,signal release from synapse (GO:0099643),-0.5768203987285271,-1.9540644358410972,0.0,0.012752121160114881,0.328,16/43,11.31%,NRXN1;SYT1;RIMS1;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,chloride transmembrane transport (GO:1902476),-0.5588085595408443,-1.9490317007907119,0.0,0.013243927837106862,0.343,25/48,20.36%,SLC12A7;SLC12A2;ANO1;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;SLC1A1;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;ANO2;GABRB2;GABRA5;ANO5;GLRA2;GLRA1;GABRA1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.4193289747281006,-1.943962902864411,0.0,0.014089925000330362,0.365,137/306,23.29%,RPS24;THRB;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;PTMA;RPS19;RPL38;RPLP1;FUT9;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;EEF1G;RPL39;RPS17;RPS7;RPL37A;EXT1;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;MRE11;MCM9;RPL13A;RPL30;RPS20;RPS4X;GTPBP1;RPL18;RPS13;EEF2;RPS2;FAM111A;CLSPN;RPL14;RPL22;TBRG1;ALAS1;RPS26;ASMT;MRPS18A;ATM;POLA1;RPS10;IGHMBP2;BARD1;PWP1;RPL23;RPL17;PABPC4;RPL29;GCNT1;POLR3A;GSPT2;XAB2;RPS5;RPS14;ORC6;NFKBIB;ST3GAL4;POLD2;CDK2;SRBD1;MMS19;MRPL28;COPS5;HBS1L;RPL12;POLR2J;RMI2;SET;CDC45;RPL9;RRAGC;BRCA1;RPL37;RAD1;RPS11;BCL3;RNPS1;KAT7;POLE;RFC4;CHEK1;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;POLD1;YARS2;FARSB;UPF1;RPL3;MRPL52;MRPL23;ATRIP;MRPL9;ATR;HOXD3;GSPT1;MRPS12;RPL23A;TUFM;DONSON;MRPL11;POLE3
prerank,ribosome assembly (GO:0042255),-0.5502184287956637,-1.926698135189936,0.0,0.017670009199564542,0.449,23/47,24.46%,RPS15;RPL24;RPL5;RPS27;RPS19;RPL6;RPL11;RPLP0;RPS28;RRP7A;NPM1;TRAF7;RPS5;PPAN;RPS14;MTERF3;NLE1;C1QBP;MDN1;RPL3;MRPS2;RPL23A;EIF6
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7798187740816792,1.92109213387961,0.0,0.9625942457256607,0.544,6/16,3.96%,IGFBP3;IGFBP5;PHIP;GHRH;BMP2;IGFBP6
prerank,neuron cell-cell adhesion (GO:0007158),-0.7448807802873858,-1.9176751764401263,0.0,0.019343105130511337,0.49,9/14,11.02%,NRXN1;NLGN1;CNTN4;NCAM2;ASTN1;ASTN2;NINJ2;NLGN3;RET
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7860238839811275,-1.9085176419293481,0.0,0.02151330716954431,0.527,8/12,12.95%,PDE4D;CALM1;CALM2;GJD3;CALM3;CAMK2D;SRI;CAV1
prerank,response to cytokine (GO:0034097),0.50800286525294,1.8850233656301487,0.0,0.8805049902526094,0.756,47/141,16.00%,ALDH1A2;PTPN13;DPYSL3;SMAD3;COL3A1;SELP;SP100;PID1;EIF2AK2;CXCL16;NFAT5;TRIM56;AFF3;IL6ST;TIMP3;ANXA1;PTPN14;PTPN4;IKBKE;BCL2;MCL1;HAX1;HDAC4;BST2;PTPN2;PTPN9;STAT1;LGALS9;NUB1;CD274;TIMP2;IFITM1;IFNLR1;PTPN6;BCL2L1;IRAK3;ADAR;TRIM21;CRNN;PTPN18;TBK1;PML;IL23R;CXCR4;APP;TAF9;IFNAR2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7047448667032707,-1.8844630317779896,0.0020920502092050207,0.029671709203374846,0.635,7/15,12.24%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNJ8;KCNQ1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.5258037493701319,-1.88041907015349,0.0,0.030637079381907566,0.657,20/57,11.77%,RPS24;RPL26;RPS15;RPL5;RPS19;RPL38;RPS16;RPL35A;RPS6;RPS17;RPS7;RPS25;RPL11;RPS28;RPL14;NPM1;BYSL;NIP7;NVL;XPO1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.590301600398626,-1.8769740153884895,0.0,0.0315585690977797,0.675,13/34,13.61%,PDE4D;PDE4B;ATP1B1;RYR2;SMAD7;CALM1;CALM2;SLC8A1;CALM3;NOS1;KCNQ1;SRI;ATP2A2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5743101555388064,-1.876677651829063,0.0,0.030948968208818137,0.675,15/39,13.32%,RPS24;RPS15;RPS27;RPS19;RPS16;RPS6;RPS17;RPS7;RPS25;RPS28;NOL11;RRP7A;NPM1;RPS5;RPS14
prerank,epithelial structure maintenance (GO:0010669),0.8027712941962435,1.871622996223958,0.00375234521575985,0.7111144630859957,0.811,4/11,3.36%,CXADR;MUC2;PIWIL4;RBP4
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.7806773269427295,1.865215213724858,0.0,0.5763349811337142,0.829,4/14,2.43%,ENPP3;CMPK2;ENPP1;DCTPP1
prerank,retinoid metabolic process (GO:0001523),0.5619436286834353,1.8592155449517396,0.0,0.5083670321081104,0.855,11/71,5.07%,ALDH1A2;ALDH1A1;GPC6;RBP1;ABCA4;APOA2;HSPG2;RDH10;SDC2;RBP4;RDH5
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.623941847368347,-1.8577296638937983,0.0,0.03931416034062188,0.762,12/24,14.47%,PDE4D;DMD;AKAP6;FKBP1A;CALM1;CALM2;CALM3;CAMK2D;SELENON;NOS1;SRI;CASQ2
prerank,negative regulation of vascular permeability (GO:0043116),-0.7622123203327582,-1.8572849466284755,0.0,0.03871913469528737,0.765,9/12,9.24%,SLIT2;PTPRJ;CLDN5;SH3GL2;CEACAM1;PDE3A;VEGFA;RAMP2;PDE2A
prerank,regulation of stress fiber assembly (GO:0051492),0.540902652891845,1.8561972102150812,0.0,0.4433471297572332,0.869,20/74,7.17%,PHLDB2;CGNL1;ARHGAP6;LPAR1;ROCK2;CCN2;PPM1E;DLC1;TACSTD2;ARHGAP28;NRP1;S100A10;ALMS1;TPM1;CLASP1;TGFBR1;EPHA1;ASAP3;CD47;ARHGEF10L
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6751792790044956,1.8511759737263267,0.0034904013961605585,0.41030666978792113,0.893,9/26,11.57%,EYA2;EYA1;FGFR1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,ncRNA processing (GO:0034470),-0.4228314778589532,-1.8508107983512079,0.0,0.04102887521571793,0.79,85/200,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;LIN28B;RPL10A;RPL27A;INTS7;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;INTS10;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;KARS1;HELQ;SMAD1;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;RPP30;RPS14;UBA52;NOP56;INTS12;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;DICER1;EXOSC4;SNU13;ZCCHC8;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.573982641217107,-1.8435139331781423,0.0,0.04400227452818361,0.811,12/34,10.05%,GRID2;MEF2C;GABRA2;GRIN2A;GABRA3;GABRA4;RAB3GAP1;GRIN2B;AKT1;NLGN3;GRIN1;GABRG3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5915143665836072,1.838854230305463,0.0016339869281045752,0.4265709525474628,0.92,22/50,19.41%,RORA;DCDC2;GLI3;FBXL17;ZIC1;GLI1;MGRN1;CREBBP;GLIS2;IFT81;SUFU;RAB34;IHH;BTRC;TTC23;EVC;TUBD1;GAS8;DLG5;PTCH1;WDR11;GAS1
prerank,ganglioside metabolic process (GO:0001573),-0.6414070167245716,-1.8308779237796193,0.004608294930875576,0.05104516489907738,0.869,8/20,14.23%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ST6GALNAC4;ST6GALNAC5;NEU1;GM2A
prerank,positive regulation of nervous system development (GO:0051962),-0.5305950461083382,-1.8288266662598953,0.0026041666666666665,0.051622069848956786,0.878,15/42,17.01%,NRXN1;NLGN1;PTPRD;GRID2;SYNDIG1;IL1RAPL1;IL1RAP;OPRM1;EPHB1;NLGN3;LRRC4B;CLSTN1;SLITRK2;SRPX2;EPHB3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.568307905193934,-1.8230803690438848,0.0,0.054279728858542584,0.896,14/32,9.11%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;GRIN2A;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;GRIN1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6345508785117251,1.8202156938358676,0.0034542314335060447,0.49318703486587145,0.957,9/30,6.51%,TGFBR3;SMAD3;FSTL1;SMURF2;FSTL3;TWSG1;LATS2;NREP;DKK3
prerank,epithelial tube morphogenesis (GO:0060562),-0.5627674391918391,-1.8199125586000828,0.0,0.055649748496233366,0.907,15/32,13.22%,SLIT2;MEF2C;COL4A1;RYR2;PAK1;ACVRL1;SOX17;MET;RASIP1;CTNNB1;BMP4;RHOB;PRKX;ACVR1;CSF1R
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6625002991195261,1.8182351433169845,0.0017985611510791368,0.45676807152504956,0.962,5/24,4.74%,SULF1;RORA;IL6ST;IL6;ARNT
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.715914143138263,1.8148860532622442,0.003590664272890485,0.4349664445844794,0.967,7/18,4.99%,PDPN;SMAD3;DDR2;BMP2;IL6;EFEMP2;CLASP1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6542364843662645,1.8136275050689996,0.005405405405405406,0.40645582744642744,0.971,5/26,4.74%,SULF1;RORA;IL6ST;IL6;ARNT
prerank,negative regulation of cartilage development (GO:0061037),0.7733407862208865,1.8131126066463907,0.001876172607879925,0.37729484727037027,0.971,4/13,5.16%,EFEMP1;ADAMTS12;PTHLH;TGFBR1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6066093456635583,-1.8118582349442327,0.0021691973969631237,0.060866304144009,0.929,10/24,14.08%,PDE4D;PEX5L;PDE3B;PRKAR1A;PDE11A;RAPGEF2;PDE3A;PDE2A;PRKAR2B;APLNR
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5827611676015289,1.8115196828289726,0.0,0.35830284723058853,0.975,14/46,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6899787211163034,1.8107066043383078,0.0017953321364452424,0.316691063711139,0.977,8/21,11.57%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6899787211163034,1.8107066043383078,0.0017953321364452424,0.316691063711139,0.977,8/21,11.57%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,regulation of bone mineralization (GO:0030500),0.5575240246874007,1.8045523646438437,0.001597444089456869,0.3215162506027841,0.987,15/55,4.75%,BMP6;WNT4;PTN;ENPP1;DDR2;OSR1;ECM1;BMPR1A;BMP2K;NELL1;KL;ADGRV1;BMP2;BCOR;BMP7
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6302832803231274,1.8034182972871877,0.0017667844522968198,0.30810616720209383,0.988,14/29,17.60%,GHR;IL31RA;STAT2;FER;STAT5B;STAMBP;STAT1;CCL2;PIAS1;STAT4;SOCS6;PKD2;IFNAR2;STAT5A
prerank,regulation of humoral immune response (GO:0002920),0.5829443590679927,1.8009513217311774,0.0016420361247947454,0.3007367648815356,0.99,11/44,9.38%,CFH;VTN;CFHR2;GATA6;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,regulation of small molecule metabolic process (GO:0062012),0.6479694861187991,1.795606250320464,0.0035335689045936395,0.30397455851062616,0.991,5/28,6.37%,PDK1;RORA;PANK2;FMO5;PPARA
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6469045447746682,-1.7953615716131706,0.004576659038901602,0.07266442596421906,0.963,11/17,27.64%,NLGN1;RAB27A;SCAMP5;CACNA1G;SYT4;KCNB1;RAB15;SYT10;CACNA1I;DOC2B;UNC13D
prerank,excitatory postsynaptic potential (GO:0060079),-0.6376053876171554,-1.792795639361651,0.008565310492505354,0.07337484546173967,0.965,7/19,9.11%,GRID2;MEF2C;GRIN2A;RAB3GAP1;GRIN2B;AKT1;GRIN1
prerank,regulation of gastrulation (GO:0010470),0.7251248760796006,1.7874742778418162,0.005681818181818182,0.3188171707743051,0.995,5/14,5.19%,PHLDB2;OSR1;DAG1;CLASP1;PHLDB1
prerank,chloride transport (GO:0006821),-0.4705301009752509,-1.7866363694142156,0.0,0.07768010032295172,0.969,30/74,19.29%,SLC4A10;SLC12A7;SLC26A7;SLC12A2;ANO1;CLIC5;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;SLC1A1;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;TTYH3;ANO2;GABRB2;TTYH1;FXYD1;GABRA5;ANO5;GLRA2;GLRA1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6407774677291198,-1.7853565312426385,0.004464285714285714,0.07744356757539896,0.97,8/18,9.11%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1
prerank,modified amino acid transport (GO:0072337),0.7227789257730578,1.7795683916945089,0.001834862385321101,0.33524221377441443,0.997,4/15,3.91%,PDPN;SLC6A13;SLC19A1;SLC16A12
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.4685978831218207,-1.776467044973844,0.0,0.0848211552434897,0.981,25/75,15.71%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;ATP1B1;SLC24A2;ABCC9;KCNJ3;KCNJ2;SLC6A1;ATP1A1;SLC8A1;SLC39A6;HCN2;SLC39A14;SLC12A5;SLC39A12;KCNJ6;SLC12A6;KCNJ8;KCNJ15;SLC39A8;SLC9A5;ATP1A3;KCNK9
prerank,eye morphogenesis (GO:0048592),0.6924660784530285,1.7749065385006608,0.0017825311942959,0.3394892087110143,0.998,9/19,11.60%,EFEMP1;FBN1;COL5A2;SHROOM2;COL5A1;SKI;MFAP2;NKD1;MFAP5
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5857898365229,-1.7744978544265204,0.009708737864077669,0.08540195838511093,0.983,16/25,29.82%,NLGN1;SHANK3;MEF2C;NLGN3;SHISA9;MINK1;ADRB2;SHISA6;RELN;SHANK1;GSG1L;SHISA7;MAPK8IP2;CACNG5;CACNG7;SHISA8
prerank,receptor signaling pathway via STAT (GO:0097696),0.6280348096374092,1.774152737777511,0.012131715771230503,0.3281534275085914,0.998,13/25,17.60%,GHR;IL31RA;STAT2;STAT5B;STAMBP;STAT1;CCL2;PIAS1;STAT4;SOCS6;PKD2;IFNAR2;STAT5A
prerank,diterpenoid metabolic process (GO:0016101),0.5541539064354889,1.7699757254585577,0.0031746031746031746,0.33027243785324295,0.999,10/55,5.07%,ALDH1A1;GPC6;RBP1;ABCA4;APOA2;HSPG2;RDH10;SDC2;RBP4;RDH5
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.586670216092059,-1.7685143941605401,0.0022675736961451248,0.09014098390874353,0.985,6/24,7.15%,CTNNA2;BOC;CDH2;MEF2C;CTNNB1;TCF3
prerank,ribosomal small subunit assembly (GO:0000028),-0.6665928453493921,-1.7681778697537127,0.004329004329004329,0.08890340706436306,0.985,7/16,13.32%,RPS15;RPS27;RPS19;RPS28;RRP7A;RPS5;RPS14
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7377525492570209,1.7676436019718325,0.007434944237918215,0.32700390229649545,0.999,6/14,13.85%,EFEMP1;ADAMTS12;PTHLH;TGFBR1;RFLNA;ADAMTS7
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.46147761391715697,-1.7661765398281661,0.0,0.08953913130466538,0.988,22/71,13.66%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;FCER1G;VAV1;DOCK1;SYK;HSP90AA1;RAC1
prerank,cAMP-mediated signaling (GO:0019933),-0.5782512072807957,-1.7655180162039763,0.002197802197802198,0.0887687332947716,0.989,10/24,10.76%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;RAPGEF2;PDE3A;PDE2A;ADCY2
prerank,dendrite self-avoidance (GO:0070593),-0.6630628888858641,-1.7625280358633757,0.006864988558352402,0.09048208602998574,0.99,7/16,10.36%,BSG;CNTN4;CNTN6;ROBO4;NPTN;CNTN2;EMB
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.742028688840561,1.7612036458042195,0.007677543186180422,0.34131467332930926,0.999,5/12,14.32%,DPYSL3;CTPS1;DPYD;UMPS;ALDH6A1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7354591446075426,-1.76079393187695,0.006276150627615063,0.09092431720742176,0.991,6/11,12.24%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNQ1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.45559467604987275,-1.7596220950090036,0.0,0.09066046010622945,0.991,24/73,15.74%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;FCER1G;VAV1;DOCK1;SYK;HSP90AA1;RAC1;NR4A3;PLCG1
prerank,mesenchymal cell differentiation (GO:0048762),0.5571308551845362,1.7594324723830288,0.0016339869281045752,0.3363844575889745,0.999,14/51,8.47%,RANBP3L;TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;FOXC1;FBXL17;BMP2;LOXL3;BMP7;TGFBR1;GSK3B;WNT5A
prerank,negative regulation of metabolic process (GO:0009892),0.5458448295928846,1.7567672333351136,0.0,0.33523149156236204,0.999,14/54,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.48155176760569307,-1.7515677349126384,0.0,0.09759544729770935,0.994,24/54,20.89%,RPL26;RPL24;RPL5;RPL10A;RPL35A;RPL6;RPL11;RPLP0;RPL14;NPM1;TRAF7;MAK16;NIP7;NVL;MRPL1;PPAN;NLE1;SNU13;NOC2L;RPL7;MALSU1;RPL7A;MDN1;RPL3
prerank,detection of calcium ion (GO:0005513),-0.6859837309342165,-1.7509188353223852,0.0087527352297593,0.09682392179724941,0.994,6/13,6.94%,SYT1;KCNMB2;RYR2;CALM1;CALM2;CALM3
prerank,dendritic spine organization (GO:0097061),-0.5629190143738771,-1.750298006063788,0.009153318077803204,0.09617760310987959,0.994,12/26,20.27%,CTNND2;SHANK3;INSR;DOCK10;EPHB1;LGMN;ITGA3;PAK3;SHANK1;EPHB3;MTMR2;CHRNA7
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7597006099007779,1.7493957836364482,0.001841620626151013,0.3402101555549805,0.999,5/12,11.92%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7597006099007779,1.7493957836364482,0.001841620626151013,0.3402101555549805,0.999,5/12,11.92%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.4225551238489754,-1.7488293543624227,0.0,0.09629052221588628,0.995,35/107,15.20%,SLC39A10;ATP1B1;SLC24A2;RYR2;TPT1;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;HTR2C;ATP2C1;SLC8A1;CCL14;SLC39A6;NPTN;ATP2A3;SLC30A1;SLC39A14;CXCL12;CALR;SLC39A12;SLC10A7;CD40;TMCO1;MT2A;CAV1;SLC39A13;ATP2A2;SLC39A8;CCL19;ATP13A4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7166332767536108,1.74873833192129,0.007142857142857143,0.3322049557425043,0.999,2/16,0.29%,PDK1;RORA
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6771263904559416,-1.7453071443315824,0.00663716814159292,0.09887908778196942,0.996,9/13,26.33%,SYT1;SCAMP5;CACNA1G;SYT4;KCNB1;SYT10;CACNA1I;DOC2B;HYAL3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5612488645884157,-1.7450742357759201,0.00966183574879227,0.09783548260714517,0.996,10/27,10.30%,PDE4D;CACNB2;DMD;CACNB4;FKBP1A;CALM1;CALM2;CAMK2D;SELENON;NOS1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.5531269794917446,-1.7412917896116271,0.0024096385542168677,0.10040291398194065,0.996,8/31,7.15%,CTNNA2;BOC;CDH2;MEF2C;PTBP1;CTNNB1;HDAC9;TCF3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7281189127303674,1.7408545779349403,0.014056224899598393,0.3528179616543769,0.999,5/13,3.96%,FBN1;FSTL1;LTBP1;NBL1;BMP2
prerank,cartilage development (GO:0051216),0.5524009775690053,1.7405616493057365,0.003257328990228013,0.3433319876140047,0.999,9/49,4.50%,SULF1;SOX5;CREB3L2;OSR1;WNT10B;WNT2B;ITGB8;BMP2;WNT5B
prerank,dendritic spine morphogenesis (GO:0060997),-0.647053941422324,-1.7393407394036844,0.0021551724137931034,0.1009486567486739,0.996,7/15,17.01%,CTNND2;SHANK3;DOCK10;EPHB1;PAK3;SHANK1;EPHB3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.58381360244299,-1.7387615731614794,0.00904977375565611,0.10050270202547784,0.996,8/25,9.11%,GRID2;MEF2C;GRIN2A;RAB3GAP1;GRIN2B;AKT1;NLGN3;GRIN1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.5436951522767294,-1.7386816516684755,0.007159904534606206,0.09923766559424932,0.996,17/31,26.68%,SYT1;SCAMP5;RAB3GAP1;STXBP1;CACNA1G;SYT4;SYT7;KCNB1;SYT9;SYT2;SYT6;SYT10;SYT5;CACNA1I;DOC2B;CBARP;SYT17
prerank,vasodilation (GO:0042311),-0.6842306677731655,-1.7386439323320717,0.002183406113537118,0.09797861388501058,0.996,6/13,14.97%,NOS3;KCNMA1;KLF2;NOS1;ADRB2;SOD1
prerank,positive regulation of behavior (GO:0048520),-0.7313371381795322,-1.735670443035767,0.006276150627615063,0.10013362372372044,0.997,3/10,1.17%,NLGN1;SGIP1;MEF2C
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.45374489384312905,-1.7353656770024148,0.0,0.09925592012636385,0.997,21/70,13.66%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;VAV1;DOCK1;SYK;HSP90AA1;RAC1
prerank,cell junction assembly (GO:0034329),-0.431174976356692,-1.7336019337148056,0.0029585798816568047,0.10014474774729919,0.997,32/100,11.05%,DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;ITGA6;SHANK3;CLDN5;SPOCK2;CDH2;KIRREL3;CDH11;GPM6A;CDH12;ACTB;CDH1;ACTG1;SHANK2;GJC1;CDH10;TLN2;CDH8;NRCAM;CDH22;CDH7;CDH20;VMP1;NLGN3;DNER;VASP;DBNL;PCDHB16
prerank,membrane repolarization during action potential (GO:0086011),-0.6901632029762443,-1.7315512774217565,0.0041928721174004195,0.10108738193408688,0.997,6/13,13.29%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,negative regulation of transmembrane transport (GO:0034763),-0.7480288642548596,-1.731185710542399,0.0,0.10034177524087903,0.997,4/10,7.21%,PRKCB;THBS1;INPP5K;AKT1
prerank,regulation of complement activation (GO:0030449),0.5673593137113079,1.7293965852767852,0.0016556291390728477,0.3760748918253495,1.0,10/40,9.38%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,synapse assembly (GO:0007416),-0.45755650780033924,-1.7282796697715215,0.0,0.10209475107932743,0.998,23/67,11.23%,DNM3;ADGRL3;NRXN1;NLGN1;GRID2;SHANK3;SPOCK2;CDH2;KIRREL3;GPM6A;GABRA2;LRRTM3;CDH1;GABRB3;SHANK2;NRCAM;NLGN3;LGI2;DNER;DVL1;DBNL;PCDHB16;FGF13
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6456668932153373,-1.72711694993704,0.008281573498964804,0.10225296359187953,0.999,5/15,8.22%,GRM7;GRM3;GRM5;HOMER1;GRM8
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.5141681260717841,-1.7266936047490122,0.0,0.10157979177995037,0.999,15/41,13.71%,KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2;ANK3;CTSS;NOS1;ACE2;KCNJ6;KCNQ1;KCNJ15;STAC
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5956971624033874,-1.7263749790680545,0.004750593824228029,0.10077980107538137,0.999,9/21,12.95%,PDE4D;DMD;SMAD7;INPP5K;PAQR3;RASSF2;RACK1;DDIT4;CAV1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5232783951145585,1.722073939397643,0.003189792663476874,0.39543458481347143,1.0,16/65,7.92%,PDPK1;FBN1;SMAD3;LTBP1;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,regulation of T cell chemotaxis (GO:0010819),0.7624768634894662,1.7179397742741351,0.00749063670411985,0.4008586326623228,1.0,5/11,14.09%,CXCL10;STK39;OXSR1;WNT5A;WNK1
prerank,ethanol metabolic process (GO:0006067),0.7140009408933272,1.7175303474355208,0.015065913370998116,0.39185275239438666,1.0,4/12,16.54%,ALDH1A1;ALDH2;ACSS1;SULT1A1
prerank,adherens junction organization (GO:0034332),-0.49098644569648564,-1.714353531882748,0.0,0.11340921153488888,0.999,17/48,9.09%,CADM1;CADM2;CDH2;CDH11;CDH12;SMAD7;ACTB;CDH1;CDH10;CTNNB1;CDH8;CDH22;CDH4;CDH7;CDH20;JAM3;RAMP2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.501852032359606,-1.713291396444091,0.004830917874396135,0.11335204498652904,0.999,17/39,12.83%,SLIT2;TIE1;COL4A1;KDR;PAK1;SIX1;MET;RASIP1;CTNNB1;SEMA3E;BMP4;VEGFA;LRP6;NOTCH4;FGF2;PAX2;LRP5
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5095225024526078,1.7129976109837552,0.0046439628482972135,0.40037305370830684,1.0,17/74,6.94%,PHLDB2;PDPN;SMAD3;FOXC1;EPHA3;LDLRAD4;GLIPR2;DAG1;TGFB1I1;BMP2;IL6;CLASP1;TGFBR1;PHLDB1;BCL9L;USF3;TGFBR2
prerank,embryonic heart tube development (GO:0035050),-0.6424707543123068,-1.7091244308571762,0.01284796573875803,0.11697563724851448,0.999,7/14,17.72%,RYR2;SOX17;TBX2;NDRG4;SOX18;ACVR1;HES1
prerank,integrin-mediated signaling pathway (GO:0007229),0.5087348852211394,1.709124230942385,0.001524390243902439,0.4064395398957384,1.0,21/73,12.34%,TEC;PTN;COL3A1;FN1;PLPP3;MPIG6B;CCM2;ITGB8;NRP1;FBLN1;ITGA5;ADAMTS1;ITGBL1;ITGA10;PTPRA;CD47;ITGA11;PLEK;PTK2;CUL3;FYB1
prerank,response to peptide hormone (GO:0043434),0.5603419999296795,1.706146938856176,0.005253940455341506,0.408849302883057,1.0,15/43,17.60%,TGFBR3;ROCK2;IGFBP5;STAT2;ANXA1;STAT5B;CRY1;EPM2AIP1;STAT1;EIF2B3;STAT4;MEAK7;KHK;TRIM16;STAT5A
prerank,cellular response to type I interferon (GO:0071357),0.5548959522976448,1.7048369387605364,0.004918032786885246,0.39521931137219307,1.0,18/41,16.00%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;BST2;OASL;STAT1;IFITM1;OAS2;IFI27;ADAR;IFIT1;JAK1;IFIT3;IRF9;IFNAR2
prerank,type I interferon signaling pathway (GO:0060337),0.5548959522976448,1.7048369387605364,0.004918032786885246,0.39521931137219307,1.0,18/41,16.00%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;BST2;OASL;STAT1;IFITM1;OAS2;IFI27;ADAR;IFIT1;JAK1;IFIT3;IRF9;IFNAR2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.43455298227095784,1.704646786591159,0.0,0.3869922043729559,1.0,67/248,16.51%,BICC1;TCF7L2;RNF220;WLS;LRRK1;MCC;LGR4;PRICKLE1;ZEB2;RBMS3;TLE1;MLLT3;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;LYPD6;SIAH2;LRP4;PLEKHA4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;USP8;LZTS2;PSME4;USP47;LRRK2;PSMA5;PPM1B;NKD1;PTPRU;CUL3;DVL3;BTRC;NOG;FRMD8;WNK1;USP34;TLE6;NPHP3;ILK;STK4;RNF146;SOX4;DAB2;IGFBP4;TNKS2;AXIN2;WWTR1;TBL1X
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6795672237522258,1.6952345458691425,0.0076045627376425855,0.416418379284592,1.0,4/16,2.27%,SOX5;PTN;FOXC1;TACSTD2
prerank,extracellular structure organization (GO:0043062),0.439357900034311,1.6939370904624744,0.0,0.4128256760746201,1.0,42/204,6.80%,TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LAMC3;LOXL1;TGFBR1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,regulation of immune effector process (GO:0002697),0.5591068175638211,1.6925485828154174,0.003372681281618887,0.40942743908810847,1.0,10/41,9.38%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,regulation of acute inflammatory response (GO:0002673),0.6500690209709323,1.6891821146670294,0.02197802197802198,0.4142534923388329,1.0,4/18,5.96%,IL6ST;OSM;IL6;CREB3L3
prerank,regulation of neurotransmitter transport (GO:0051588),-0.6183938793246523,-1.6884109299185808,0.017429193899782137,0.14245594670769549,1.0,6/16,8.65%,RIMS1;MEF2C;MCTP1;CPLX1;CAMK2A;SYN1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.47655493436310203,1.6874647072997142,0.0014641288433382138,0.4127398304214762,1.0,22/95,8.20%,PDPK1;TGFBR3;SMAD3;ZEB2;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;LATS2;TGFBR1;NREP;BCL9L;PPARA;DKK3;CREBBP;TGFBR2;SKI;CDKN2B;RNF111
prerank,response to zinc ion (GO:0010043),-0.5515110585709074,-1.685551664371094,0.013452914798206279,0.14553864434139516,1.0,8/25,2.74%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6334457317075546,1.6838113675568815,0.010968921389396709,0.41933928004150356,1.0,8/22,12.63%,ZBTB20;APOA2;SORBS1;CREBL2;PPARA;SIRT4;DISP3;EEF1A2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5581076615674947,1.6833158390624363,0.0016556291390728477,0.41295647635381133,1.0,11/40,4.75%,BMP6;WNT4;PTN;WNT6;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,metal ion homeostasis (GO:0055065),-0.4963015064662576,-1.6826283963569668,0.004975124378109453,0.14778964281221652,1.0,12/40,12.95%,TMTC2;SLC12A7;SLC12A2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;SLC12A5;GRIN1;SLC12A6;CAV1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5471913109720264,-1.6778322243353436,0.01182033096926714,0.15307666970801254,1.0,14/26,20.27%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1;TMEM108;RELN;SHANK1;MTMR2;TMEM25;CHRNA7
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5556054894919944,1.6775222689646492,0.003246753246753247,0.4286570119241818,1.0,11/40,6.94%,TCF7L2;PDPN;SMAD3;FOXC1;GLIPR2;TGFB1I1;BMP2;IL6;TGFBR1;BCL9L;TGFBR2
prerank,external encapsulating structure organization (GO:0045229),0.43360932404164215,1.6756094146772327,0.0,0.42855311673509827,1.0,41/205,6.80%,TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LAMC3;LOXL1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,defense response to tumor cell (GO:0002357),0.7615155092831729,1.6735690723317216,0.011764705882352941,0.42910457154354464,1.0,5/10,4.87%,RBMS3;DLEC1;PRF1;DAPK1;PLK5
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6133171768163597,1.6711333795660026,0.013961605584642234,0.4313950289242882,1.0,6/24,5.17%,EFEMP1;SOX5;ADAMTS12;PTHLH;TGFBR1;MBOAT2
prerank,synapse organization (GO:0050808),-0.4016247109527134,-1.670547605274592,0.0,0.16244407559147736,1.0,34/125,11.05%,APBB2;DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;PTPRD;LRRC4C;SHANK3;SPOCK2;CDH2;CACNB2;PPFIA2;KIRREL3;GRM5;GPM6A;SLC6A1;CACNB4;CDH1;ANK3;SNCA;GPHN;SHANK2;ARHGAP39;NRCAM;SEMA3E;NLGN3;CNTN2;L1CAM;DNER;DVL1;LRRC4B;DBNL;PCDHB16
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5250181639373123,-1.6702418862549968,0.018779342723004695,0.16114955807619333,1.0,14/27,25.52%,CTNNA2;HOMER1;IL1RAPL1;CCDC88A;EFHC2;AKT1;MBOAT1;MARK1;BRSK2;NTNG1;NTNG2;CAMK2G;TREM2;FRMD7
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6154910843454495,1.6701660201171482,0.0125,0.42756565653597556,1.0,6/23,6.51%,TGFBR3;SMAD3;SMURF2;LATS2;NREP;DKK3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6005612158407335,1.6691443361144096,0.008928571428571428,0.42373348976952,1.0,11/26,20.40%,KMT2A;METTL21C;ETFBKMT;SETD4;SETD1B;TET2;SETD5;ATPSCKMT;KMT5C;SETD2;KMT5B
prerank,regulation of monooxygenase activity (GO:0032768),-0.5654454675845656,-1.6674516255712333,0.007159904534606206,0.16383809458998055,1.0,10/23,12.95%,NOS3;NOSTRIN;NOS1AP;CALM1;SNCA;AKT1;CYGB;EGFR;HSP90AA1;CAV1
prerank,regulation of stem cell proliferation (GO:0072091),0.6562736733822049,1.666980105450787,0.028021015761821366,0.4250039778432359,1.0,5/17,8.63%,EIF2AK2;GJA1;FBLN1;TERT;YAP1
prerank,secretion (GO:0046903),-0.6338604046189853,-1.6663208036533528,0.0045662100456621,0.1641137463862159,1.0,5/14,10.70%,RIMS1;TPD52;FBLN5;NPR1;SLC22A6
prerank,protein localization to synapse (GO:0035418),-0.6581309081799922,-1.6655949186151675,0.014830508474576272,0.16360228985806222,1.0,3/12,3.28%,NRXN1;NLGN1;PCLO
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6095163597869344,1.6618098966348473,0.0074211502782931356,0.43847190695775085,1.0,7/24,4.99%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.634100458849169,1.660506358573194,0.014209591474245116,0.436294620308854,1.0,2/22,0.84%,ALDH1A2;RBP1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6427946812444527,1.6592992136108997,0.015180265654648957,0.4341246379408164,1.0,5/18,10.17%,FBN1;FSTL3;TLR4;CARTPT;MAFB
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6755552737517575,1.6573488954579318,0.016666666666666666,0.43445202546154227,1.0,5/17,7.81%,BMP6;SASH1;CD55;TRIM5;LY96
prerank,gene expression (GO:0010467),-0.35457496378200204,-1.655865606722369,0.0,0.17763676119587984,1.0,142/348,23.10%,RPS24;THRB;RPS9;RPL18A;RPL19;RPS12;ADARB1;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;PTMA;RPS19;RPL38;RPLP1;RPS8;SETX;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;SORL1;RPS17;TSPAN14;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;ADARB2;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRSF2;RPS20;RPS4X;RPL18;RPS13;CPSF2;RPS2;SRSF1;APOBEC1;SYMPK;DDX54;HNRNPK;RPL14;RPL22;ZC3H11A;DDX17;THOC2;RPS26;ASMT;HHEX;MRPS18A;AAAS;RPS10;IGHMBP2;PWP1;RPL23;RPL17;PABPC4;NUP93;RPL29;POLR3A;GSPT2;XAB2;RPS5;FASTKD2;RPS14;TASP1;NFKBIB;RAE1;HNRNPF;SRBD1;MMS19;MRPL28;COPS5;HBS1L;RPL12;POLR2J;RPL9;RBM3;RRAGC;XRN2;RPL37;DEDD2;RPS11;BCL3;DUSP11;RNPS1;SRSF9;MRPL35;POLDIP3;MRPS5;NXT1;RPL7;RPL31;RPL7A;TSPAN33;MRPL34;RBM15B;HARS1;YARS2;FARSB;UPF1;ALKBH5;RPL3;MRPL52;MRPL23;MRPL9;NUP62;SRSF6;HOXD3;GSPT1;CHTOP;CPSF3;ANGPT2;NUP188;MRPS12;RPL23A;U2AF1;MRPL11
prerank,response to interferon-gamma (GO:0034341),0.5000131961400921,1.6554841963509166,0.0077279752704791345,0.43490862730497704,1.0,23/67,16.20%,GBP6;SP100;GBP2;CXCL16;DAPK1;TLR4;GBP5;BST2;CD47;GBP4;STAT1;CCL2;LGALS9;NUB1;WNT5A;IFITM1;GBP7;TLR2;TRIM21;SLC26A6;CCL25;IL23R;GBP3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5510956115027917,-1.654931080082206,0.006593406593406593,0.17769610558706572,1.0,8/22,6.43%,SLIT2;SSH2;TMSB4X;KANK3;KANK4;TMSB10;HIP1R;CYRIB
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5794752267410499,-1.6546922060992788,0.012738853503184714,0.17626752220368708,1.0,7/19,4.93%,CSGALNACT1;HS6ST3;HS6ST2;NDST3;HS3ST5;XYLT1;EXT1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6119344043866394,1.654658960698462,0.01721170395869191,0.4314877569117341,1.0,10/23,15.64%,PARP14;PARP9;NR1H3;PTPN2;STAT1;PIAS1;SUMO1;OTOP1;JAK1;TXK
prerank,ganglioside biosynthetic process (GO:0001574),-0.6271812847119302,-1.6539825751701036,0.008385744234800839,0.17569799363077276,1.0,5/15,9.05%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5521146367196018,1.6534693292854106,0.014516129032258065,0.42905918913735114,1.0,10/38,11.03%,BMP6;SASH1;DDX60;FPR2;IFI35;GBP5;OASL;LY96;ANKRD17;POLR3F
prerank,negative regulation of wound healing (GO:0061045),0.5833555243928396,1.6519300333069884,0.01263537906137184,0.42827374193768664,1.0,9/28,12.41%,PHLDB2;TFPI;VTN;CASK;CLASP1;SERPINE1;SERPINE2;EPPK1;CD109
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.44243632661716853,1.651910910630236,0.0,0.42192535413449783,1.0,29/152,10.32%,RNF220;SULF1;WLS;LRRK1;LGR4;ZEB2;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;DACT1;BMP2;TERT;WNT5B;SALL1;LYPD6;PLEKHA4;CDC73;SKI;PSMB10;PSMA3;USP8;PSME4;USP47;LRRK2;PSMA5;PPM1B
prerank,endothelial cell proliferation (GO:0001935),-0.6198766518635829,-1.6517018038372595,0.014527845036319613,0.17815495802255568,1.0,7/17,9.91%,TEK;BMPER;BMPR2;CD34;ACVRL1;BMP4;PRKX
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4370276336038205,-1.650407791379841,0.011363636363636364,0.17842325799115472,1.0,14/72,6.94%,NRXN1;NLGN1;SHANK3;SYT1;RIMS1;RIMS2;GRIK2;SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN;LGMN
prerank,sodium ion import across plasma membrane (GO:0098719),-0.6072025192698609,-1.6487670866484407,0.02242152466367713,0.17967919845006303,1.0,5/17,6.59%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;HCN2
prerank,cardiac myofibril assembly (GO:0055003),0.667833045076994,1.646821749030472,0.011049723756906077,0.4351650307640042,1.0,5/15,8.04%,PDGFRA;CSRP3;NEBL;PDGFRB;MEF2A
prerank,chondrocyte differentiation (GO:0002062),0.5703045639548089,1.6463846113195417,0.012237762237762238,0.4305295355192913,1.0,8/32,4.50%,SULF1;SOX5;CREB3L2;OSR1;WNT10B;WNT2B;BMP2;WNT5B
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.5006564849826267,-1.6445927314368982,0.01405152224824356,0.18474894978734363,1.0,13/31,15.56%,NLGN1;SHANK3;PPFIA2;TANC2;ARHGAP44;CAPRIN2;LRP8;ABI3;DBNL;LZTS3;SRCIN1;RELN;CFL1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6922291138208204,-1.6427549342868122,0.02040816326530612,0.18595171732131566,1.0,6/10,12.86%,PDE4B;CACNB2;NOS1AP;CALM1;CALM3;SRI
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5941055531644117,-1.6425921027223442,0.02178649237472767,0.184539138267748,1.0,9/18,16.24%,GRID2;GRIK2;GRIK4;GRIK1;CDH8;SLC1A4;GRIA2;NAPA;GRIK3
prerank,acylglycerol biosynthetic process (GO:0046463),0.6050000503959718,1.6420911653299952,0.015544041450777202,0.4420394721161942,1.0,7/23,17.18%,AGMO;PLA2G4A;PLCE1;MOGAT3;DGAT2;LPGAT1;LPIN2
prerank,regulation of postsynapse organization (GO:0099175),-0.5288184226190895,-1.6416370527922306,0.009345794392523364,0.18453087832627443,1.0,11/28,15.56%,SHANK3;PPFIA2;TANC2;HOMER1;IL1RAPL1;ARHGAP44;ABI3;LZTS3;SRCIN1;ABHD17A;CFL1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.66083753008027,1.6399389352806701,0.02578268876611418,0.4443610871381601,1.0,5/15,4.99%,PDPN;DPP4;DDR2;IL6;CLASP1
prerank,carbohydrate homeostasis (GO:0033500),0.4920899724697728,1.6392879744811804,0.012364760432766615,0.4407818405237003,1.0,12/67,7.53%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;CRY1;IL6;APPL2;PTPN2;NGFR
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4446185353801187,1.6387141268266845,0.0,0.4368321094815942,1.0,34/128,12.58%,TGFBR3;BMP6;SMAD3;ZMIZ1;COL3A1;RGMA;SMURF2;RGMB;BMPR1A;CDH5;TWSG1;TGFB1I1;HIVEP1;LRRC32;BMP2;PARD6A;BMP7;PRKCZ;TGFBR1;APPL2;TGFBR2;BMP8B;USP9X;SLC33A1;SKI;RNF111;SMAD6;APPL1;ZFYVE16;PTK2;TGFBRAP1;SMAD4;MAP3K7;HFE
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.611846697363215,1.638152613900162,0.017452006980802792,0.4331343952710965,1.0,4/21,5.17%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,regulation of membrane repolarization (GO:0060306),-0.624336211714313,-1.6377517242787556,0.022964509394572025,0.18938352107840453,1.0,6/13,14.47%,AKAP6;KCNJ2;NEDD4L;KCNQ1;CAV1;CASQ2
prerank,energy reserve metabolic process (GO:0006112),0.6240253553136602,1.6365301908736505,0.018484288354898338,0.43408277092527464,1.0,5/19,9.09%,LEPR;PRKAG2;PID1;GSK3B;PYGM
prerank,cellular response to metal ion (GO:0071248),-0.38975289356263493,-1.6360317409888887,0.0,0.19052958553553667,1.0,29/123,8.84%,NLGN1;DLG2;SLC12A2;SYT1;MEF2C;PLCG2;ITPKB;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;CDH1;ANK3;SNCA;MAPK8;RYR3;MAPK3;KCNH1;LGMN;AKT1;CAMK2D;SYT4;SYT7;B2M;CPNE4
prerank,histone H3-K4 trimethylation (GO:0080182),0.7081427208084249,1.6355851773933083,0.021912350597609563,0.43251162235143364,1.0,3/11,12.91%,KMT2A;SETD1B;TET2
prerank,actin cytoskeleton reorganization (GO:0031532),0.4886535707139487,1.6353707310457861,0.00946372239747634,0.4277576169548114,1.0,13/63,4.40%,MCU;CXADR;NRK;AUTS2;PARVA;INSRR;PTK7;NRP1;FER;ANXA1;ANTXR1;KIT;EFS
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4941741065848442,1.6345435114929312,0.014018691588785047,0.42529300626262595,1.0,12/63,8.05%,TCF7L2;DEPTOR;SP100;FGFR1;PHIP;WWOX;SH3RF1;CFLAR;TGFBR1;SIAH2;TNFRSF12A;ZMYND11
prerank,neuronal action potential (GO:0019228),-0.5554615237191771,-1.6326231000071603,0.013888888888888888,0.19443073036672562,1.0,11/22,20.62%,KCNMB2;SCN1A;ANK3;SCN2A;CACNA1G;SCN8A;SCN9A;KCNA2;SCN3A;KCNA1;KCNMB4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7205288844162864,1.6315449664713764,0.0162748643761302,0.4313644405667226,1.0,8/11,12.48%,PARP14;PARP9;PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16
prerank,connective tissue development (GO:0061448),0.5564629770359875,1.6302866694532456,0.015789473684210527,0.43080978761430044,1.0,4/35,2.92%,SULF1;SOX5;CREB3L2;ITGB8
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5833217485259574,-1.6295945435931467,0.03139013452914798,0.19803719891280003,1.0,4/18,2.25%,NRXN1;NLGN1;SHANK3;PTK2B
prerank,regulation of glucose import (GO:0046324),0.5736025191312107,1.628369294207107,0.023972602739726026,0.432766254235501,1.0,9/30,9.79%,PRKAG2;PID1;ENPP1;OSBPL8;SORBS1;APPL2;CREBL2;RHOQ;APPL1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6462465481510749,1.6278052860830854,0.025454545454545455,0.43001517363220615,1.0,4/16,4.70%,KMT2A;AUTS2;MYB;BCOR
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4929399493686898,-1.6277370704161185,0.016241299303944315,0.19946385742697717,1.0,12/35,10.76%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;HTR2C;RAPGEF2;GUCY1B1;PDE3A;PDE2A;ADCY2
prerank,ceramide catabolic process (GO:0046514),-0.6320562779118305,-1.6271773307133461,0.024444444444444446,0.19866925310827252,1.0,6/14,18.67%,ACER3;ACER2;HEXB;NEU1;GM2A;GLA
prerank,actin filament bundle assembly (GO:0051017),0.5527362650804332,1.6259658979704725,0.016863406408094434,0.4312982669583106,1.0,6/33,4.72%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6140831601554306,1.6259242127786313,0.01854974704890388,0.42624520153368084,1.0,9/21,17.23%,DCDC2;GLI1;RAB34;IHH;TTC23;EVC;TUBD1;GAS8;DLG5
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5706127337047863,-1.6219600456203804,0.015317286652078774,0.20663506267055642,1.0,11/20,31.13%,PLCB1;CHRM3;CHRM2;LYPD1;AGRN;GNAQ;CHRNA7;LY6H;RGS10;LY6G6D;GNA11
prerank,canonical Wnt signaling pathway (GO:0060070),0.4837635143942966,1.6208254000734623,0.006097560975609756,0.43986734245706843,1.0,17/68,12.89%,TCF7L2;WNT4;WNT6;PLPP3;WNT10B;WNT3A;WNT2B;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;PORCN
prerank,negative regulation of viral genome replication (GO:0045071),0.5340251357485387,1.619611305565172,0.01901743264659271,0.43913888119546873,1.0,19/40,20.23%,RSAD2;ZC3HAV1;EIF2AK2;BST2;PARP10;OASL;IFITM1;RESF1;OAS2;ILF3;IFIT1;SRPK1;TASOR;IFIH1;SHFL;SETDB1;TNIP1;RNASEL;MPHOSPH8
prerank,hepaticobiliary system development (GO:0061008),0.6075454325518087,1.619464591597356,0.025179856115107913,0.43468664590806483,1.0,3/20,1.07%,TGFBR3;WNT4;PRKCSH
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.6468112043405307,-1.61670556419957,0.029978586723768737,0.21429974823009892,1.0,4/12,17.04%,CEACAM1;ERLIN1;ACADVL;BRCA1
prerank,negative regulation of cell migration (GO:0030336),0.44036328775970995,1.6160784751549155,0.002758620689655172,0.44207373943063105,1.0,39/137,13.03%,PHLDB2;SULF1;IGFBP3;ROBO1;DPYSL3;PODN;MCC;COL3A1;AFDN;IGFBP5;GJA1;DLC1;TACSTD2;KANK1;BMPR1A;LDLRAD4;DAG1;DUSP10;MIA3;TPM1;CLASP1;VCL;SERPINE1;EPHA1;BST2;CLIC4;RNF20;NGFR;EPHA4;STK24;RAP2C;IFITM1;ATP1B2;PTPRU;FOXO3;EPPK1;SLURP1;NOG;ARPIN
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5460734911536751,-1.6152159595033588,0.009153318077803204,0.21511700199821096,1.0,11/22,16.45%,NTRK2;SH3GL2;STMN2;RAPGEF2;AKT1;RAB35;NGF;TMEM108;MAPT;RAP1A;NTF3
prerank,cellular response to BMP stimulus (GO:0071773),0.4853540520270187,1.6146860984196059,0.0047169811320754715,0.4420697465683579,1.0,21/66,16.33%,TGFBR3;BMP6;SMAD3;RGMA;ADAMTS12;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;BMP8B;USP9X;SLC33A1;SMAD6;ZFYVE16;SMAD4;HFE;ADAMTS7;GDF15;ACVR2B;SMAD2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6361391524189464,1.613309684265803,0.023985239852398525,0.44244588528576984,1.0,7/17,9.50%,VTN;DOCK5;IGFBP5;NRP1;ADAMTS1;PDGFRB;DOCK7
prerank,negative regulation of immune effector process (GO:0002698),0.675486999181566,1.6098544104707981,0.015296367112810707,0.45066399868218165,1.0,6/13,9.79%,ENPP3;CD55;FER;RC3H1;CD47;APPL1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.46544300092251056,-1.6091158447075935,0.020253164556962026,0.2244745858056806,1.0,15/41,15.71%,SLC12A7;SLC12A2;ATP1B1;ABCC9;KCNJ3;KCNJ2;ATP1A1;HCN2;SLC12A5;KCNJ6;SLC12A6;KCNJ8;KCNJ15;ATP1A3;KCNK9
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5707786219502444,-1.6083377449159868,0.02412280701754386,0.22401766933517814,1.0,7/18,13.59%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,actin filament bundle organization (GO:0061572),0.5459950752603167,1.6075105539868828,0.013289036544850499,0.4543483080161519,1.0,8/33,9.75%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1;LIMA1;RFLNA
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6422524188761327,1.6063596936277682,0.024208566108007448,0.453613540739974,1.0,5/17,3.00%,SULF1;FSTL1;FSTL3;CASK;TWSG1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4408240609645421,-1.6057786789598738,0.005633802816901409,0.22685762817108554,1.0,18/54,12.95%,DPP10;KCNAB1;KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2;KCNIP4;KCNIP1;DPP6;NEDD4L;CACNA1D;KCNJ6;KCNQ1;KCNJ15;CAV1
prerank,positive regulation of dendrite extension (GO:1903861),-0.5868559375157042,-1.6051756946771059,0.02727272727272727,0.22604488948397225,1.0,16/17,40.37%,SYT1;RIMS1;RIMS2;SYT4;NEDD4L;SYT2;ITSN2;PLAA;SYT17;CPNE5;CPNE9;UNC13A;SYT3;RASAL1;RNF157;CPNE6
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5740420705918493,1.6049359890986963,0.026690391459074734,0.4542043417378592,1.0,6/25,6.37%,CBLB;SNX6;SLC6A9;CNRIP1;ERRFI1;PPARA
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7242799786166811,1.60319062952776,0.026465028355387523,0.4560274165884506,1.0,4/10,14.09%,STK39;OXSR1;WNT5A;WNK1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6631669107682012,1.6007993175174973,0.026119402985074626,0.4600520489327389,1.0,3/14,3.02%,KMT2A;AUTS2;MYB
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5018817816335163,1.598032687698142,0.01932367149758454,0.4656963359089742,1.0,13/51,7.17%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;SYNPO2;SYNPO;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,positive regulation of bone mineralization (GO:0030501),0.5433338917391216,1.5972159422866836,0.011864406779661017,0.46422511054870697,1.0,10/35,4.75%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4201195044092593,1.5969983091175082,0.002642007926023778,0.460335538688104,1.0,48/186,16.40%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;RNF213;TLE1;MLLT3;GLI3;WWOX;APCDD1;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;LZTS2;PSME4;PSMA5;NKD1;PTPRU;CUL3;VGLL4;DVL3;NOG;FRMD8;HIC1;RNF43;TLE6;NPHP3;STK4;DAB2;IGFBP4;AXIN2;WWTR1
prerank,positive regulation of telomerase activity (GO:0051973),-0.4868794826810334,-1.596801475429617,0.015730337078651686,0.2402954432191651,1.0,11/33,16.15%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;NVL;KLF4;HSP90AA1;PNKP;PKIB
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.42967650377671895,-1.5963559249067196,0.002849002849002849,0.2391406140849905,1.0,22/59,11.21%,CADM1;HMCN1;BSG;PECAM1;ROBO2;CDH2;KIRREL3;TENM3;CNTN4;CNTN6;CDH1;PTPRM;ROBO4;NPTN;CDH4;CEACAM1;CNTN2;L1CAM;PTPRT;EMB;FAT2;CD84
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5654457011691354,1.5944970308027837,0.021885521885521887,0.46539721588013344,1.0,7/26,14.28%,LGR4;APPL2;BIRC3;APPL1;TLR2;IRAK3;FLOT2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5481253463665393,1.5942230732109484,0.02613240418118467,0.46186333342180924,1.0,10/33,9.57%,TCF7L2;PDPK1;NUPR1;IL11;CDH5;ANGPT1;SERPINE1;PPARA;YAP1;CAST
prerank,regulation of microtubule-based process (GO:0032886),0.5305757557382168,1.5941557366272774,0.008532423208191127,0.45760352706627855,1.0,8/36,7.66%,PHLDB2;DIAPH1;PRKAA2;EPHA3;MAP6;CLASP1;PHLDB1;GSK3B
prerank,protein ADP-ribosylation (GO:0006471),0.5638572460875061,1.5928488343329539,0.022071307300509338,0.45790472117896447,1.0,11/28,12.48%,PARP14;ZC3HAV1;PARP9;PARP3;ARF4;PARP10;PARP12;PARP11;SIRT4;TIPARP;PARP16
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.36825728072143926,-1.5914175867933944,0.0,0.24687942814827865,1.0,44/159,11.21%,CADM1;ADGRL3;NLGN1;HMCN1;PTPRD;GRID2;LRRC4C;BSG;PECAM1;ROBO2;CLDN5;CDH2;KIRREL3;CDH11;TENM2;TGFB2;CDH12;TENM3;CNTN4;CNTN6;CDH1;PTPRM;IL1RAPL1;UNC5D;ATP2C1;CDH10;ROBO4;CDH8;TENM4;CDH22;NPTN;CDH4;CEACAM1;CDH7;CDH20;CLDN14;CNTN2;L1CAM;PTPRT;LRRC4B;EMB;FAT2;PCDHB16;CD84
prerank,regulation of dendrite extension (GO:1903859),-0.5771162412340427,-1.5910067153488745,0.02771362586605081,0.2456422043660526,1.0,16/18,40.37%,SYT1;RIMS1;RIMS2;SYT4;NEDD4L;SYT2;ITSN2;PLAA;SYT17;CPNE5;CPNE9;UNC13A;SYT3;RASAL1;RNF157;CPNE6
prerank,myotube differentiation (GO:0014902),-0.579275864513571,-1.590235646435512,0.024229074889867842,0.2451819171563689,1.0,8/17,15.36%,ADGRB3;MEF2C;JAM2;KCNH1;MYEF2;NOS1;SIX4;SORT1
prerank,positive regulation of cation channel activity (GO:2001259),-0.4738656643110895,-1.5900024008184956,0.014527845036319613,0.24385707689702618,1.0,19/40,24.60%,SHANK3;TMSB4X;AKAP6;CALM1;ANK3;CALM2;CALM3;CTSS;NLGN3;ADRB2;STAC;RELN;STAC3;GSTO1;LRRC38;HAP1;LRRC55;HTT;CASQ1
prerank,neuron development (GO:0048666),-0.3679149786097611,-1.5898264603068732,0.0,0.2423700992394163,1.0,36/141,11.76%,FRY;CNTNAP2;NLGN1;MEF2C;TENM2;TGFB2;GPM6A;TENM3;CNTN4;EPHA5;MYT1L;PLP1;GPM6B;PBX3;STX3;NTRK2;PTPRM;ATP8A2;VSX1;SH3GL2;RP1;TENM4;HMGB1;MYOC;STMN2;RAPGEF2;UNK;THOC2;RAB35;L1CAM;LYN;MANF;RUNX1;MICALL2;ZFYVE27;ULK1
prerank,regulation of synapse assembly (GO:0051963),-0.4510805165364446,-1.589095897141175,0.01038961038961039,0.2417563295273557,1.0,20/46,18.07%,NRXN1;NLGN1;PTPRD;GRID2;ROBO2;MEF2C;SYNDIG1;IL1RAPL1;SNCA;IL1RAP;EPHB1;NLGN3;LRRC4B;IL1RAPL2;CLSTN1;SLITRK2;SRPX2;EPHB3;SLITRK1;LRFN5
prerank,negative regulation of hemostasis (GO:1900047),0.6726598614135858,1.588778351732362,0.04247104247104247,0.46893111322426173,1.0,4/12,8.66%,TFPI;VTN;SERPINE1;SERPINE2
prerank,regulation of hormone secretion (GO:0046883),0.6487718047179195,1.587793382134399,0.04452690166975881,0.46810420680466136,1.0,4/15,3.55%,OSM;SNX6;IL11;ANXA1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.619675969920376,-1.587451246358463,0.03296703296703297,0.2434105088039497,1.0,5/13,12.90%,SLC4A10;GRIK2;RAB3GAP1;SHISA9;SHISA6
prerank,retrograde axonal transport (GO:0008090),-0.5783419512656398,-1.5873866416522446,0.024390243902439025,0.24174324390877844,1.0,7/16,14.97%,DLG2;ACTR10;KIF1C;DYNC1H1;TMEM108;KIF5A;SOD1
prerank,regulation of actomyosin structure organization (GO:0110020),0.6650617928097604,1.5857177759247003,0.041015625,0.4718380509720677,1.0,4/13,6.18%,ROCK2;AKAP13;ALMS1;ASAP3
prerank,neural tube development (GO:0021915),0.6394511542352407,1.585530157179855,0.05152671755725191,0.4681498728346308,1.0,3/15,3.73%,ALDH1A2;ARL13B;DACT1
prerank,axon development (GO:0061564),-0.40778551783838923,-1.5855075054456425,0.0029498525073746312,0.243796262753394,1.0,29/78,21.15%,GRM7;CTNNA2;CNTN4;DCC;ACTB;PLP1;KLF7;ANK3;S100B;NRCAM;MAP1B;SHTN1;RTN4RL1;L1CAM;NEFH;PAX2;PAK3;GAP43;MAPK8IP3;BRSK2;MAPT;SLITRK2;EPHB3;SLITRK1;CCK;AMIGO1;NTNG1;NTNG2;DSCAML1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6025526693239351,1.585153919982205,0.034990791896869246,0.4652810313518845,1.0,4/19,6.79%,DDO;HYKK;PHYKPL;ASPA
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6079874308416113,1.5842022151634205,0.030575539568345324,0.46428485088160326,1.0,8/20,8.88%,IGFBP3;VTN;IGFBP5;BMPR1A;NRP1;SERPINE1;PDGFRB;PLAU
prerank,peptidyl-methionine modification (GO:0018206),0.6790319037266364,1.5835020554182628,0.03802281368821293,0.46250721211331697,1.0,5/12,15.22%,APOA2;NAA16;NAA30;NAA15;PDF
prerank,aerobic electron transport chain (GO:0019646),-0.42184471390679423,-1.5830659555816695,0.003003003003003003,0.2468657822187333,1.0,35/68,31.41%,COX6C;COX4I1;SDHC;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;COX7B;NDUFB7;SDHD;NDUFB10;UQCC3;NDUFC2;NDUFA13;NDUFA9;UQCR10;UQCRQ;NDUFA10;COX4I2;SDHAF2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5466565914492324,1.5826604892177107,0.020869565217391306,0.46157157836611523,1.0,13/29,16.38%,TCF7L2;TLE1;TERT;TLE3;BCL9L;TCF7L1;CREBBP;CDC73;TCF7;LEO1;SMARCA4;PYGO1;AXIN2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.4211321219709099,-1.5814475965711783,0.0030303030303030303,0.24833512775007063,1.0,35/69,31.41%,COX6C;COX4I1;SDHC;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;COX7B;NDUFB7;SDHD;NDUFB10;UQCC3;NDUFC2;NDUFA13;NDUFA9;UQCR10;UQCRQ;NDUFA10;COX4I2;SDHAF2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,endothelial cell development (GO:0001885),-0.5373638400582447,-1.581151642419624,0.02268041237113402,0.2471625264034155,1.0,8/25,9.94%,PDE4D;PECAM1;PPP1R16B;MET;ROBO4;RAPGEF2;PDE2A;SOX18
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.665866989298472,-1.580399482865692,0.026905829596412557,0.24491247048508144,1.0,7/11,19.53%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.665866989298472,-1.580399482865692,0.026905829596412557,0.24491247048508144,1.0,7/11,19.53%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,megakaryocyte differentiation (GO:0030219),0.6935191076351204,1.579856354609682,0.03696498054474708,0.46796459922732625,1.0,6/11,11.59%,MPIG6B;IL11;KIT;UBA5;CDKN2B;SH2B3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6975596420233732,1.5797649502100086,0.038535645472061654,0.4641692498682688,1.0,4/11,3.96%,EFNB2;WNT3A;FRS2;BMP2
prerank,retinoic acid metabolic process (GO:0042573),0.6586285679807223,1.5780877999243053,0.03525046382189239,0.4663554382043582,1.0,4/14,14.80%,ALDH1A2;SCPEP1;BCO2;ALDH8A1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5455889998799667,1.5777915780085614,0.029310344827586206,0.46341339220620126,1.0,5/30,4.20%,ROBO1;LPAR1;AKAP13;COL3A1;F2RL3
prerank,BMP signaling pathway (GO:0030509),0.47519650925539614,1.5757239381683585,0.014084507042253521,0.46696688645481926,1.0,17/62,12.69%,TGFBR3;BMP6;SMAD3;RGMA;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;BMP8B;USP9X;SLC33A1;SMAD6;ZFYVE16;SMAD4;HFE;NOG
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6460876329621609,1.5749313307230428,0.035849056603773584,0.4661747584922606,1.0,5/14,7.85%,CD55;PTPN22;TGFBR2;IL18;LGALS9
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6291968353552493,1.57421899397275,0.060784313725490195,0.4649654025447455,1.0,4/14,5.96%,IL6ST;OSM;IL6;CREB3L3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6150546380789826,1.573373077328862,0.041666666666666664,0.46407201148280586,1.0,4/16,8.23%,SELP;NFAT5;IL6;FUT4
prerank,central nervous system neuron differentiation (GO:0021953),-0.48862096475084815,-1.5730426411946985,0.017777777777777778,0.2580996572576343,1.0,15/33,27.36%,MDGA2;GRID2;NTRK2;TOX;CTNNB1;LRP6;SPOCK1;MAPT;MAP2;LHX1;CBLN1;ZC4H2;CEND1;LMX1A;CHD5
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4771896273310437,1.5725501681452971,0.0076103500761035,0.46335638577878946,1.0,8/61,4.20%,ROBO1;LPAR1;RASGRF1;AKAP13;COL3A1;AUTS2;NOTCH2;F2RL3
prerank,substantia nigra development (GO:0021762),-0.47371559705509,-1.5712887651952891,0.01694915254237288,0.2600957141501834,1.0,17/37,17.75%,GNB4;ACTB;PLP1;CALM1;CALM2;MBP;YWHAH;CALM3;INA;S100A1;BASP1;TTBK1;HSPA5;YWHAQ;SUDS3;RAD1;CKB
prerank,epithelial cell migration (GO:0010631),0.5192747750647342,1.5703132939965956,0.027777777777777776,0.46782153030509854,1.0,7/37,3.84%,DPP4;FSTL1;ZEB2;KANK2;KANK1;NRP1;KIT
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.545589180343524,-1.5698345299655407,0.046620046620046623,0.2611482655479288,1.0,4/21,4.41%,PRKCH;SLC39A10;PRKCB;RPS3
prerank,water transport (GO:0006833),0.6956628271491812,1.5697779773112768,0.033707865168539325,0.46612566990947757,1.0,1/12,0.30%,PDPN
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.42013701734782133,1.5692468195948974,0.00546448087431694,0.4644812199196719,1.0,42/161,16.40%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;TLE1;MLLT3;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;LZTS2;PSME4;PSMA5;NKD1;PTPRU;CUL3;DVL3;NOG;FRMD8;TLE6;NPHP3;STK4;DAB2;IGFBP4;AXIN2;WWTR1
prerank,wound healing (GO:0042060),0.4687718450353254,1.5686634044930376,0.018691588785046728,0.4627844825876578,1.0,16/62,12.69%,SMAD3;COL3A1;PDGFRA;FGF1;MYOF;PPL;CFLAR;MIA3;TPM1;TGFBR1;CLDN1;WNT5A;DCBLD2;FUT10;EPPK1;NOG
prerank,potassium ion homeostasis (GO:0055075),-0.5167025776337903,-1.5679365444803788,0.018140589569160998,0.2633836550899164,1.0,8/23,10.96%,SLC12A7;SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC12A5;SLC12A6
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.46013413462428393,1.5675591223115748,0.00911854103343465,0.46282704038139383,1.0,17/74,11.57%,TCF7L2;EYA2;EYA1;PHIP;SH3RF1;TERT;CFLAR;BCL2;TGFBR1;MCL1;SERPINE1;SIAH2;GSK3B;ZMYND11;BCL2L1;EYA4;MAP2K5
prerank,cation transmembrane transport (GO:0098655),0.5070228665411152,1.5659265684771186,0.0214168039538715,0.4647303570190626,1.0,5/44,2.88%,TRPM3;SLC7A2;ATP1A2;TRPM6;SLC6A9
prerank,regulation of wound healing (GO:0061041),0.5076211694729221,1.5652441293734618,0.012841091492776886,0.463548822548939,1.0,14/42,12.53%,VTN;KANK1;CASK;ANXA1;GP1BA;SERPINE1;TNFRSF12A;CLDN1;INSL3;PLAU;PTK2;EPPK1;CD109;CADM4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6530952218423466,1.5643683483567394,0.045714285714285714,0.46307288059960733,1.0,5/13,13.11%,IL6ST;OASL;STAT1;OAS2;JAK1
prerank,positive regulation of cell differentiation (GO:0045597),0.39580482735979294,1.5642916774766713,0.00125,0.45972558770599076,1.0,38/237,8.67%,TCF4;RANBP3L;MEDAG;IGFBP3;PDPN;SOX5;BMP6;WNT4;PTN;RIN2;SMAD3;CCN2;FGFR1;DDR2;FOXC1;IL6ST;GJA1;TACSTD2;BMPR1A;NBL1;GLIPR2;NELL1;TGFB1I1;KCTD11;BMP2;IL6;BMP7;TMEM64;TGFBR1;CPNE1;BCL9L;CREBL2;TGFBR2;CTNNA1;IL18;MEF2A;YAP1;ZEB1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6264954061687881,1.5617363977275827,0.04371584699453552,0.4648792717682201,1.0,4/17,6.37%,PID1;NUPR1;HDAC4;PPARA
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6105026142491462,1.5601140079463984,0.053703703703703705,0.4669329951444225,1.0,5/16,12.91%,DPYSL3;DPYD;UPP1;NT5C;TET2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5444198266199544,-1.559342589297435,0.029545454545454545,0.2800165211596911,1.0,14/22,26.74%,AKAP6;ATP1B1;RYR2;CALM1;CALM2;CALM3;VMP1;STAC;STAC3;GSTO1;HAP1;HTT;CASQ1;JPH2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.5315505974357475,-1.5585711473689494,0.034324942791762014,0.2797929020183867,1.0,5/23,10.96%,SLC12A7;SLC12A2;CLCN3;SLC12A5;SLC12A6
prerank,response to X-ray (GO:0010165),0.665831976387199,1.55796718202166,0.05045045045045045,0.47080645953262523,1.0,6/14,8.70%,PRAP1;XRRA1;ANXA1;NUCKS1;IKBIP;XRCC4
prerank,circulatory system development (GO:0072359),0.43226589699152423,1.557890855078874,0.008620689655172414,0.4675384287280927,1.0,25/118,8.79%,FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HEG1;HSPG2;FOXC2;CDH5;RBP4;ADAP2;MTHFD1;BMP2;BCOR;TGFBR1;NCOA6;SALL1;PLCE1;POPDC2;TGFBR2;MEF2A;PRICKLE4;CACNA1C
prerank,glucose homeostasis (GO:0042593),0.4560437155791874,1.557489312357821,0.017964071856287425,0.46549333673897614,1.0,15/83,9.01%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;NUCKS1;CRY1;IL6;APPL2;CARTPT;PTPN2;NGFR;HKDC1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6650523166659494,-1.5572153628776626,0.01646090534979424,0.2809996729973241,1.0,6/10,14.08%,PDE4D;PDE3B;PDE11A;PDE3A;PDE2A;APLNR
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.43315621110234725,1.5555407988017225,0.004437869822485207,0.46861093060387776,1.0,27/112,12.26%,SOX5;TGFBR3;WNT4;SMAD3;ZMIZ1;COL3A1;CLEC3B;BMPR1A;CDH5;WWOX;TWSG1;LRRC32;PARD6A;PRKCZ;TGFBR1;APPL2;TGFBR2;USP9X;PDCD5;SKI;WNT5A;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;MAP3K7
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5571862072221825,1.5552787007220839,0.02727272727272727,0.4662000005108624,1.0,7/27,4.99%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.4937705133590164,-1.554875482504513,0.016548463356973995,0.2841129317382752,1.0,7/31,5.42%,CSGALNACT1;BMPR2;NDST3;XYLT1;EXT1;B3GAT2;CHST9
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6152612322628445,-1.5544471797517707,0.03303964757709251,0.2831900295990213,1.0,5/13,12.81%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.4959799891643321,-1.5538849174857805,0.025380710659898477,0.28234182876675495,1.0,9/29,12.90%,SLC4A10;GRIK2;NETO1;MCTP1;RAB3GAP1;CAMK2A;SHISA9;ZDHHC2;SHISA6
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4519614301336977,1.5534599556208843,0.006060606060606061,0.46947378770932124,1.0,18/85,12.11%,TCF7L2;TGFBR3;BMP6;MCC;LAMC1;FGF1;OSR1;NUPR1;TGFA;DUSP10;ANGPT1;CDC73;CDKN2B;YAP1;MTSS1;FGF18;NR4A1;EPPK1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6420139137507745,1.5533713708112524,0.03985507246376811,0.4663833916666393,1.0,8/14,20.81%,MIA3;SEC23A;SEC24D;SEC24C;SEC24B;SAR1A;SEC31A;SEC23B
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4763554407099856,-1.5532488245429337,0.01699029126213592,0.28184881470346135,1.0,13/36,12.95%,NOS3;NOSTRIN;NOS1AP;CALM1;SCARB1;AKT1;CYGB;GCH1;NUS1;S100A1;EGFR;HSP90AA1;CAV1
prerank,negative regulation of blood coagulation (GO:0030195),0.520548201995229,1.552508487634832,0.017361111111111112,0.46589659921485854,1.0,9/38,9.38%,TFPI;VTN;PDGFRA;SERPING1;GP1BA;SERPINE1;SERPINE2;PLAU;CPB2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6451383198763725,-1.550701148646379,0.031185031185031187,0.28522924365341024,1.0,5/11,12.81%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.581723099591124,-1.5506273386617242,0.04824561403508772,0.28352241183227384,1.0,4/17,3.91%,KCNAB1;AKAP6;NOS1AP;ANK3
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5730224603209756,1.5505325356459725,0.03690036900369004,0.4694793414414123,1.0,3/23,4.92%,TNNC1;TGFBR3;TPM1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5412097208045552,-1.5502175961110887,0.02109704641350211,0.28247170483050504,1.0,9/22,17.86%,PDE4B;CACNB2;DMD;CACNB4;NOS1AP;SRI;STAC;STAC3;HPCA
prerank,ceramide biosynthetic process (GO:0046513),-0.4560311763672493,-1.550018665010542,0.015113350125944584,0.2810729021873574,1.0,9/40,11.79%,ST6GALNAC3;SGMS1;ST8SIA4;CERS4;ST8SIA6;DEGS2;ST6GALNAC4;ST6GALNAC5;SGMS2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6506364060480174,1.5494528531701894,0.03076923076923077,0.46996861154311553,1.0,3/13,8.36%,DDO;ASPA;GLUL
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3948339053422817,1.549446776856723,0.0012903225806451613,0.4666796196246713,1.0,39/208,12.33%,PDPK1;WLS;RORA;LPAR1;AKAP13;TLE1;ZFAND6;ECM1;GJA1;PPM1A;TRAF5;LITAF;CFLAR;IKBKE;ROR1;MTDH;GOLT1B;OPTN;CPNE1;MIER1;PELI2;TRIM5;BIRC3;BST2;JMJD8;STAT1;LGALS9;VAPA;RIPK2;ZMYND11;WNT5A;ANKRD17;BRD4;NLRX1;PPM1B;UBE2V1;RHOC;MAP3K7;TRIM21
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6415729093897531,-1.5494318603301231,0.025,0.28049083166112315,1.0,4/11,10.30%,CACNB2;NOS1AP;CAMK2D;NOS1
prerank,regulation of ossification (GO:0030278),0.5218672786309757,1.5492151882266532,0.028169014084507043,0.4642361982633904,1.0,11/36,9.65%,PTN;RBPJ;ENPP1;DDR2;ECM1;BMP2K;BMP2;CHSY1;LRP4;WNT5A;SMAD6
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6591522920472496,1.5491233636781352,0.04158790170132325,0.4613991651043162,1.0,4/13,5.14%,ENPP3;ENPP1;DCTPP1;ENTPD7
prerank,axonogenesis (GO:0007409),-0.3399409369623913,-1.5487515066730961,0.0,0.28020719678291495,1.0,71/237,12.81%,SLIT2;NRXN1;CTNNA2;UNC5C;BSG;ROBO2;SHANK3;NCAM1;SEMA6D;EFNA5;RPS6KA5;ENAH;DAB1;TNR;NRP2;CNTN4;EPHA5;DOK6;PIK3R1;NOTCH1;DCC;NTN4;ACTB;CNTN6;NOTCH3;SH3KBP1;GAB1;KLF7;SEMA4D;SEMA3C;ANK3;SEMA6A;LAMA1;LAMA3;PRKCQ;UNC5D;EPHB1;S100B;ROBO4;NRCAM;SEMA7A;MAPK3;HSP90AB1;NPTN;SPTB;SEMA3E;MAP1B;SHTN1;EPHA6;NLGN3;TUBB3;CNTN2;L1CAM;CXCL12;VASP;SEMA3G;SEMA6B;EMB;RET;NEFH;PAX2;PTPRO;ULK1;GFRA2;PAK3;LRTM1;KIF5C;VLDLR;PIK3CD;SEMA3A;HSP90AA1
prerank,extracellular matrix organization (GO:0030198),0.3867550432848794,1.547392319595535,0.0,0.46408062014477536,1.0,46/276,6.80%,FLRT2;TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LOXL3;LAMC3;BMP1;LOXL1;TGFBR1;COL20A1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.5120082624645217,-1.547241608713375,0.02050113895216401,0.28160932707543923,1.0,8/25,12.95%,TMTC2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;GRIN1;CAV1
prerank,regulation of phospholipase activity (GO:0010517),0.6922882456590653,1.5457951320955647,0.06477732793522267,0.46652453750495165,1.0,2/10,1.20%,PDPK1;FGFR1
prerank,dicarboxylic acid transport (GO:0006835),0.5561985314661437,1.5437971368888566,0.029259896729776247,0.47029804016278465,1.0,5/28,2.57%,PDPN;SLC1A3;SLC13A3;GJA1;SLC19A1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.42365830455716896,1.5431136543129873,0.006993006993006993,0.4695832924888606,1.0,22/129,10.32%,RNF220;WLS;LRRK1;LGR4;ZEB2;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;DACT1;LYPD6;PLEKHA4;PSMB10;PSMA3;USP8;PSME4;USP47;LRRK2;PSMA5;PPM1B
prerank,neuromuscular process controlling balance (GO:0050885),-0.6253126517510224,-1.5430627407829507,0.03556485355648536,0.2885175120698852,1.0,2/12,0.74%,NRXN1;PCDH15
prerank,synaptic vesicle exocytosis (GO:0016079),-0.45845395326498795,-1.5427809881299277,0.0291005291005291,0.2873128323318416,1.0,10/40,9.75%,SYT1;RIMS1;RIMS2;STX3;PCLO;SNAP25;SNCA;CPLX1;SYT7;SNPH
prerank,negative regulation of cell differentiation (GO:0045596),0.3998042338700113,1.5418297405063195,0.005089058524173028,0.47084576231662484,1.0,44/181,14.84%,RANBP3L;EFEMP1;RORA;SMAD3;COL5A2;ENPP1;OSR1;ADAMTS12;WNT10B;LDLRAD4;MYB;ADGRV1;EID2B;PTHLH;SUZ12;IL6;BMP7;TMEM64;TGFBR1;DTX1;COL5A1;NR1H3;USF3;PPARA;CRP;CDC73;SKI;WNT5A;YAP1;IGF2;NOCT;SMAD6;SUFU;LRP3;DISP3;IQCB1;NOG;EFNA1;PAF1;ADAMTS7;LEO1;RUNX1T1;ABCA1;NPHP3
prerank,epithelial to mesenchymal transition (GO:0001837),0.49861826644636864,1.5415081904055377,0.02159468438538206,0.468833889075533,1.0,11/47,8.47%,TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;BMP2;LOXL3;BMP7;TGFBR1;GSK3B;WNT5A
prerank,regulation of transforming growth factor beta production (GO:0071634),0.604959907698073,1.541269537280134,0.05474452554744526,0.46641504757425567,1.0,7/18,11.51%,SMAD3;FN1;LTBP1;ITGB8;LRRC32;LGALS9;SMAD4
prerank,negative regulation of cell development (GO:0010721),0.5629411165334182,1.541229674208097,0.04085257548845471,0.4634815427472425,1.0,7/25,9.75%,FBN1;WNT3A;PTHLH;IL6;APPL2;GSK3B;RFLNA
prerank,histone H2B ubiquitination (GO:0033523),0.6834686856658275,1.5410474634434965,0.051587301587301584,0.46112291547007955,1.0,6/10,14.20%,DTX3L;RNF20;CDC73;WAC;PAF1;LEO1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.44787856579753293,1.54039206381561,0.01171303074670571,0.4602354160821364,1.0,16/86,8.20%,SULF1;BMP6;FOXD1;RBPJ;ZEB2;BMPR1A;CDH5;TWSG1;TGFB1I1;BMP2;BMP7;TGFBR1;CREBBP;BMP8B;CDKN2B;RNF111
prerank,regulation of glucose metabolic process (GO:0010906),0.5273414230891609,1.5402885298499105,0.03814262023217247,0.45769488569974526,1.0,3/34,3.27%,PDK1;RORA;GCGR
prerank,positive regulation of neuron migration (GO:2001224),-0.6358283734130546,-1.5399072300768297,0.04106776180698152,0.2914425650014143,1.0,8/11,23.89%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2;SHTN1;SEMA3A;PLAA;NSMF
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5668629242776783,1.5391544350840145,0.045454545454545456,0.45887668289503036,1.0,6/22,8.35%,SH3D19;TIMP3;NRDC;PTPN3;SNX9;TIMP2
prerank,regulation of viral genome replication (GO:0045069),0.4729166924639497,1.539004437116712,0.0220125786163522,0.45640829301683433,1.0,19/56,15.71%,RSAD2;ZC3HAV1;EIF2AK2;PPARA;BST2;PARP10;OASL;STAU1;IFITM1;PPID;OAS2;TMEM39A;ADAR;ILF3;IFIT1;SRPK1;TARBP2;IFIH1;PKN2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5966217521933408,-1.5377865139062497,0.04139433551198257,0.29260147968287564,1.0,3/14,10.43%,ABCG2;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.5966217521933408,-1.5377865139062497,0.04139433551198257,0.29260147968287564,1.0,3/14,10.43%,ABCG2;BLVRA;HMOX2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.660749152450358,1.537531303186342,0.049019607843137254,0.45813993687043253,1.0,4/12,13.44%,MUC2;RBP4;TLR4;STRAP
prerank,chordate embryonic development (GO:0043009),0.47367317193788566,1.5368773869935621,0.01765650080256822,0.45769246685472503,1.0,11/55,9.00%,ALDH1A2;SULF1;FGFR1;ARNT2;RBP4;DACT1;BMP2;BMP7;TGFBR1;WNT5A;IGF2
prerank,heart development (GO:0007507),0.4104772046039034,1.5364427439196044,0.009722222222222222,0.45633441548795234,1.0,28/150,8.79%,FLRT2;TGFBR3;FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HEG1;CSRP3;DLC1;FOXC2;RBP4;ADAP2;MTHFD1;BMP2;BCOR;BMP7;TGFBR1;NCOA6;SALL1;PLCE1;POPDC2;TGFBR2;MEF2A;PRICKLE4;CACNA1C
prerank,regulation of response to biotic stimulus (GO:0002831),0.5475330454839941,1.5364124536981059,0.03496503496503497,0.45360322844580897,1.0,8/28,9.79%,GATA6;CD55;PTPN22;APPL2;TRIM5;BIRC3;ERAP1;APPL1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4557522942910352,1.5360601778901037,0.016975308641975308,0.45203382345808524,1.0,12/66,7.94%,SULF1;ROBO1;TGFBR3;MCC;NR2F2;NUPR1;CASK;DUSP10;KLF9;STAT1;CDC73;CDKN2B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5099491760226003,1.5333618845740944,0.03511705685618729,0.45804989177191907,1.0,15/37,21.58%,TNPO1;DYNLL1;IFT88;IFT57;DYNC2I1;IFT81;DYNC2LI1;WDR19;IFT20;TTC21B;IFT52;KIF3C;CEP131;SSX2IP;TRIP11
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.501406273151081,-1.5333532676041932,0.030379746835443037,0.30026828194907135,1.0,13/27,28.16%,SYT1;RIMS1;RIMS2;SYT4;SYT7;SYT9;SYT2;SYT6;SYT10;SYT5;DOC2B;SYT17;VAMP2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4923661492429855,1.5332737886307497,0.03431372549019608,0.4555786830674115,1.0,11/44,7.17%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,liver development (GO:0001889),0.5241948047866252,1.5321077866855968,0.02564102564102564,0.45669699857658796,1.0,17/32,23.52%,TGFBR3;WNT4;PRKCSH;ANXA1;IL6;DNAAF1;ARID5B;NPHP3;PKD2;PCK2;CEBPB;CCDC39;CITED2;XBP1;CDK5RAP3;CEBPA;CEBPG
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5260155222092109,-1.531976879864772,0.036036036036036036,0.30159517901865557,1.0,9/21,7.24%,PDE4D;DMD;AKAP6;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,bone development (GO:0060348),0.5064207002175092,1.5316931401937044,0.034013605442176874,0.4552762888703686,1.0,6/39,7.92%,RANBP3L;SULF1;AKAP13;GJA1;SBDS;SKI
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6507145538927809,-1.5304424780878711,0.022964509394572025,0.30337491624813606,1.0,7/10,20.36%,GABRA2;GABRA3;GABRA4;GABRG3;GABRB2;GABRA5;GABRA1
prerank,central nervous system neuron development (GO:0021954),-0.5956146116269565,-1.5294456121495952,0.046610169491525424,0.30390892436699285,1.0,7/15,15.98%,NTRK2;LHX6;HSP90AB1;RAPGEF2;HSP90AA1;MAPT;MAP2
prerank,negative regulation of cell projection organization (GO:0031345),0.4851463241189627,1.529143052914543,0.032362459546925564,0.46116395466672017,1.0,8/48,8.24%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;PTPN9;EPHA4
prerank,regulation of regulated secretory pathway (GO:1903305),-0.4655845073941902,-1.5285347081963914,0.030534351145038167,0.3042203268222887,1.0,18/34,27.64%,SYT1;RIMS1;RIMS2;RAB27A;SYT4;SYT7;SYN1;SYT9;SYT2;SNAPIN;RIMS4;RAB15;SYT6;VPS18;SYT10;SYT5;SYT17;UNC13D
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4834959289134529,1.5254732498171308,0.01393188854489164,0.4700412619401862,1.0,9/49,7.50%,PARP14;GHR;IL31RA;IL6ST;OSM;PARP9;KIT;IL6;IL18
prerank,positive regulation of transporter activity (GO:0032411),0.6482093358491733,1.5249222898110442,0.0497131931166348,0.4690814598460073,1.0,3/13,6.02%,KMT2A;STK39;NR1H3
prerank,regulation of biomineral tissue development (GO:0070167),0.5455583082299823,1.5246131576999145,0.04107142857142857,0.4674201296757193,1.0,5/26,2.75%,ROCK2;ENPP1;DDR2;ECM1;BMP2K
prerank,positive regulation of protein secretion (GO:0050714),0.4553369643886927,1.5244770875906626,0.026194144838212634,0.4651152983799604,1.0,13/69,11.28%,TCF7L2;WLS;BMP6;MCU;RBP4;APBB1;TLR4;UNC13B;PPID;DNM1L;HCAR2;TLR2;NLGN2
prerank,negative regulation of viral process (GO:0048525),0.4710171571702088,1.5239868977327844,0.030254777070063694,0.4640929239721604,1.0,18/57,15.00%,RSAD2;ZC3HAV1;EIF2AK2;TRIM5;BST2;PARP10;OASL;STAT1;IFITM1;OAS2;ILF3;TRIM21;IFIT1;TRIM26;SRPK1;CHMP3;IFIH1;PML
prerank,female gamete generation (GO:0007292),0.5316247691905965,1.5233385589623079,0.03436426116838488,0.46358511759612564,1.0,4/29,7.42%,DIAPH2;PTN;NANOS2;USP9X
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.516569782243279,-1.5231045621491597,0.04784688995215311,0.3148075008319981,1.0,8/23,13.59%,ELOVL5;ACSL3;FAR2;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,protein oxidation (GO:0018158),0.6781968791918793,1.522493812392838,0.058823529411764705,0.4637739648800772,1.0,4/11,11.77%,APOA2;LOXL3;LOXL1;LOXL4
prerank,positive regulation of cell aging (GO:0090343),-0.6212869502985879,-1.5221180387014004,0.04219409282700422,0.31541698941180313,1.0,4/11,10.91%,YPEL3;B2M;ABI3;EEF1E1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.38754655071998506,-1.5199417031217706,0.006557377049180328,0.3184102670424878,1.0,30/91,16.61%,ABCG2;SLC39A10;TFRC;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC40A1;ATOX1;FTH1;FTL;SLC39A6;SLC31A1;SLC30A1;SLC39A14;SLC22A17;SLC39A12;HMOX2;SLC31A2;MT2A;CYBRD1;SLC39A13;SLC39A8;SOD1;ATP6V0A2;SCARA5
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5271735286238689,1.5196554387957464,0.030612244897959183,0.4706115588936002,1.0,6/32,6.37%,ZBTB20;PID1;PRKAA2;NUPR1;ARNT;PPARA
prerank,ameboidal-type cell migration (GO:0001667),-0.4177501965153728,-1.519391164802374,0.008021390374331552,0.3177367073399268,1.0,19/51,12.74%,SEMA6D;ERBB4;PHACTR4;TBX1;ITGA4;SEMA4D;SEMA3C;SEMA6A;CCN3;PKN1;SEMA7A;SEMA3E;AKT1;AMOT;SEMA3G;SEMA6B;FAT2;PKN3;SEMA3A
prerank,positive regulation of cellular senescence (GO:2000774),-0.6404664367475235,-1.5181733521947358,0.05042016806722689,0.3187503811026029,1.0,4/10,10.91%,YPEL3;B2M;ABI3;EEF1E1
prerank,skeletal system development (GO:0001501),0.40334767392822357,1.517975806364943,0.006793478260869565,0.473573492291739,1.0,39/148,16.89%,SULF1;SOX5;BMP6;FBN1;AKAP13;FGFR1;CREB3L2;GJA1;ITGB8;WWOX;RBP4;PTHLH;BMP2;BMP1;BMP7;TGFBR1;MMP14;BMP8B;WNT5A;IGF2;COL13A1;PRELP;RFLNA;SUFU;IHH;ANKRD11;RPS6KA3;NOG;NPR3;GDF11;RAB33B;EIF2AK3;SOX4;SPEF2;EVC;INHA;SH3PXD2B;COL1A2;COL9A2
prerank,response to sterol (GO:0036314),0.6641623884254798,1.5176133750260705,0.0708502024291498,0.47216781267150065,1.0,3/11,6.94%,RORA;TGFBR1;TGFBR2
prerank,regulation of interleukin-2 production (GO:0032663),-0.4372433794711344,-1.516137217380549,0.007518796992481203,0.32168441040938234,1.0,14/43,14.81%,PDE4D;PDE4B;NAV3;PLCG2;CD34;RPS3;HDAC7;HAVCR2;MALT1;CD80;CD86;RUNX1;PNP;PTPRC
prerank,postsynaptic membrane organization (GO:0001941),-0.5635835882909089,-1.515647930521373,0.03829787234042553,0.3207309165180509,1.0,5/17,8.74%,NRXN1;NLGN1;SHANK3;GPHN;NLGN3
prerank,alanine transport (GO:0032328),-0.6246894724994043,-1.5153832617565537,0.052083333333333336,0.3195053577047113,1.0,3/10,11.13%,SLC6A6;SLC1A4;SLC36A1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5596890401757283,1.5143492564362957,0.04280821917808219,0.480610849659638,1.0,5/25,2.80%,SULF1;FOXD1;RBPJ;BMPR1A;CDH5
prerank,positive regulation of phospholipase activity (GO:0010518),0.5526812022565848,1.5137558116178682,0.05321100917431193,0.4798858384427862,1.0,6/22,6.11%,PDPK1;PDGFRA;FGFR1;KIT;ARF4;PDGFRB
prerank,synaptic vesicle cycle (GO:0099504),-0.4746063266391177,-1.5132836100618243,0.035623409669211195,0.3227485014230955,1.0,8/30,8.10%,NLGN1;RIMS1;SYNDIG1;PCLO;SNAP25;SNCA;CPLX1;SYT7
prerank,regulation of transmembrane transport (GO:0034762),-0.47388897383890705,-1.512488368650356,0.022058823529411766,0.32280181831962024,1.0,11/31,12.30%,SLC2A1;PRKCB;KCNJ3;KCNJ2;ACTB;SNCA;NEDD4L;ACE2;KCNJ6;KCNJ8;KCNJ15
prerank,calcineurin-mediated signaling (GO:0097720),0.6685099690892677,1.5122175369734816,0.0684931506849315,0.4800202148833923,1.0,6/10,19.06%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6685099690892677,1.5122175369734816,0.0684931506849315,0.4800202148833923,1.0,6/10,19.06%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,negative regulation of reproductive process (GO:2000242),0.5956021645509008,1.510609435455871,0.07393715341959335,0.4828757623911582,1.0,3/17,7.74%,SULF1;GJA1;NPPC
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.669601214552177,1.5104250732598703,0.060665362035225046,0.48085121778658785,1.0,6/10,18.50%,CPEB1;CDC73;PAF1;LEO1;CPEB3;DHX36
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.48700408925522853,-1.508510080993821,0.037037037037037035,0.3301281232476573,1.0,6/26,10.31%,ACER3;NOS3;ACER2;AKT1;NOS1;GCH1
prerank,regulation of macrophage migration (GO:1905521),-0.6501537353926117,-1.5072596716644575,0.052083333333333336,0.33132685909809045,1.0,3/10,6.40%,MTUS1;PTK2B;EMILIN1
prerank,histone H3-K4 methylation (GO:0051568),0.5359307146715934,1.5071305622721074,0.04585537918871252,0.48908859140443006,1.0,6/26,12.91%,KMT2A;WDR5B;KMT2C;SETD4;SETD1B;TET2
prerank,positive regulation of response to external stimulus (GO:0032103),0.40904031353962067,1.5070075235665112,0.0111731843575419,0.4867723811188031,1.0,24/128,11.69%,BMP6;PTN;SASH1;IL16;DDX60;FPR2;OSM;IFI35;TLR4;ZBP1;SERPINE1;OPTN;PDGFRB;GBP5;CD47;OASL;IL18;LY96;SETD4;WNT5A;ANKRD17;POLR3F;TLR2;NFKBIZ
prerank,regulation of steroid metabolic process (GO:0019218),0.5556749067406669,1.5069688626685966,0.04275092936802974,0.48430769271600865,1.0,3/23,6.21%,RORA;PANK2;FMO5
prerank,negative regulation of immune system process (GO:0002683),0.6026765916120262,1.5064481791055604,0.050387596899224806,0.4835521211908556,1.0,3/16,6.03%,COL3A1;IL17D;FOXP3
prerank,xenobiotic transport (GO:0042908),-0.5525771000526439,-1.506097762351892,0.05066079295154185,0.33203657855734625,1.0,5/17,5.48%,ABCG2;SLC47A1;SLC7A5;ABCA3;SLC15A2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.38684676394597184,1.5060962725029619,0.00655307994757536,0.482165214660196,1.0,36/199,9.65%,ROBO1;ALDH1A1;MCC;LGR4;ROCK2;RBPJ;LAMA4;WNT10B;APOA2;GJA1;TACSTD2;ACOT11;FOXC2;LDLRAD4;TWSG1;DUSP10;BMP2;NRDC;IL17D;TLE3;TLR4;PARP3;CHSY1;WWC2;NR1H3;FOXP3;ATP2B4;LRP4;USF3;NOVA1;GSK3B;TIFAB;MAP2K6;ADM;DOCK7;SMAD6
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5696594849030479,-1.5053018999238865,0.043933054393305436,0.33215709397887555,1.0,6/15,14.75%,SMAD7;RPL5;RPS7;RPL11;RPL23;PARK7
prerank,Wnt signaling pathway (GO:0016055),0.43178125548408675,1.504410694475251,0.010263929618768328,0.48534832793105503,1.0,19/92,12.89%,TCF7L2;WLS;WNT4;WNT6;PLPP3;WNT10B;WNT3A;WNT2B;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;BTRC;PORCN
prerank,cellular response to lipid (GO:0071396),0.3875546946835936,1.504384741579905,0.0013736263736263737,0.482855584291924,1.0,30/191,8.47%,RORA;TFPI;ATP1A2;ROCK2;CXCL10;WNT6;PID1;AXL;WNT10B;LDOC1;WNT3A;EPHA3;PTK7;VIM;NCOA3;IL6;ADCY5;WNT5B;TLR4;SERPINE1;ZNF35;NR1H3;ADCY1;MAP4K1;CDC73;CCL2;LY96;CD274;FAM210B;WNT5A
prerank,potassium ion transmembrane transport (GO:0071805),-0.3539529698138699,-1.503036335692715,0.0036101083032490976,0.335699943809349,1.0,38/135,15.71%,SLC12A7;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;ATP1B1;SLC24A2;ABCC9;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;ATP1A1;KCNK10;SLC9A8;HCN2;KCNH1;TMEM175;KCNH5;SLC12A5;KCND3;KCNJ6;SLC12A6;KCNB1;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1;SLC9A5;KCNA2;ATP1A3;KCNK9
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5866075730836522,1.5024205040964504,0.04063604240282685,0.4867896942758396,1.0,4/18,11.07%,KMT2A;SETD4;SETD7;SETD1B
prerank,positive regulation of response to wounding (GO:1903036),0.5506814921688528,1.5011841028226238,0.03722504230118443,0.48820915218651606,1.0,7/24,11.17%,PTN;VTN;KANK1;ANXA1;CLDN1;INSL3;PTK2
prerank,regulation of protein export from nucleus (GO:0046825),0.5564522038769497,1.5004485161312626,0.0472027972027972,0.48809485451053397,1.0,5/23,7.66%,TCF7L2;SP100;PTPN14;TPR;GSK3B
prerank,lipid translocation (GO:0034204),-0.5162728391745296,-1.4997598689825586,0.04782608695652174,0.34152101858408385,1.0,7/21,8.59%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,regulation of fat cell differentiation (GO:0045598),0.44422057574245166,1.4993819951870153,0.03268945022288262,0.4891151471935971,1.0,19/74,14.97%,MEDAG;RORA;SMAD3;ENPP1;WNT10B;BMP2;IL6;TMEM64;CREBL2;FTO;WNT5A;YAP1;NOCT;AAMDC;LRP3;RARRES2;RUNX1T1;CARM1;PTPRQ
prerank,cardiac muscle cell contraction (GO:0086003),-0.5311220259300822,-1.499347797592787,0.04212860310421286,0.3406629181825706,1.0,7/19,9.86%,FGF12;KCNJ2;SCN1A;ATP1A1;CACNA1G;CAMK2D;CACNA1D
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.41276666461090056,-1.4990361393714497,0.015060240963855422,0.3395575805714151,1.0,22/54,22.62%,SMAD7;RPL5;IVNS1ABP;RPS3;RPL11;CTNNB1;AKT1;GNL3L;CAV1;COPS9;CAMLG;PARK7;PER2;N4BP1;SIRT7;MINAR1;VPS28;UFL1;PRMT3;PRR7;SH3RF2;DCUN1D3
prerank,response to muscle stretch (GO:0035994),-0.5641932898873572,-1.4987133527648677,0.04357298474945534,0.33853623164186963,1.0,5/15,5.50%,CDH2;DMD;RYR2;CTNNB1;SLC8A1
prerank,protein modification by small protein conjugation (GO:0032446),0.3667429305803322,1.4986544048456363,0.0,0.4891176529706262,1.0,81/361,15.01%,RNF220;PDZRN3;EYA1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;FBXO11;FBXL17;NEDD4;UBA5;DTX4;EPAS1;MYCBP2;TRIM17;KLHL21;RANBP2;SPSB4;DTX1;TPR;CUL4A;TRIM5;DTX3L;FBXO9;MGRN1;ANAPC11;USP9X;RNF20;CDC73;FBXL3;WAC;FBH1;TRIM24;KLHL18;NUB1;RNF111;PIAS1;AMFR;UBE2Z;PJA2;UBE2C;SUMO1;FBXL7;FBXO4;WWP2;FBXO24;KEAP1;HUWE1;RFWD3;RTF1;CUL3;KLHL13;NSMCE2;TRIM21;EGR2;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;ASB5;ARRB1;PEX2;PAF1;CDC27;RNF39;RNF43;RNF103-CHMP3;RNF181;POM121;LEO1;BRAP;IFIH1;RCHY1;VHL;BIRC6;UBE2R2
prerank,positive regulation of developmental growth (GO:0048639),-0.42026793954555025,-1.498451742214591,0.029333333333333333,0.33737133722674945,1.0,18/49,15.43%,SYT1;RIMS1;RIMS2;PLCB1;INSR;SEMA4D;MACF1;SEMA7A;SHTN1;SYT4;L1CAM;NEDD4L;DBNL;ZFYVE27;NGF;AGRN;SYT2;MAPT
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4791745957820278,-1.4983895908517495,0.0267639902676399,0.33574143100856896,1.0,13/29,22.51%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;ACACA;HSD17B12;ACLY;SCD;ACSBG1;HSD17B8;FASN;GCDH
prerank,regulation of BMP signaling pathway (GO:0030510),0.4471917737989433,1.4981243574072667,0.02723146747352496,0.4884171093069215,1.0,11/73,3.96%,SULF1;FOXD1;RBPJ;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;CDH5;TWSG1;BMP2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.612144453539037,1.4978501797205317,0.06764168190127971,0.4868456382270198,1.0,6/14,17.65%,DDX60;OASL;ANKRD17;TLR2;PUM2;USP15
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5050165065569542,1.497803963734563,0.0415944540727903,0.48450034116501955,1.0,5/39,5.28%,TCF7L2;MCU;GHRH;RBP4;UCN
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6396074805989672,1.4961257607989937,0.06037735849056604,0.4873693509312933,1.0,5/13,7.24%,CBLB;RANBP2;KPNA6;KPNA7;KPNA4
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6534220575036959,1.495364686684533,0.06212424849699399,0.4874440444928957,1.0,2/11,3.96%,WNT4;BMP2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6622592727200544,1.4950926153865511,0.060665362035225046,0.4859038256323586,1.0,4/11,13.03%,PDPN;KANK1;ENPP2;ARPIN
prerank,fluid transport (GO:0042044),0.6566527063202301,1.494802182188342,0.048214285714285716,0.4844804520767193,1.0,2/12,5.94%,PDPN;SLC4A11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4080229193885421,-1.4939056025016701,0.010899182561307902,0.3432131981487023,1.0,30/56,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;BCS1L;NDUFAF3;NDUFA10;TIMM21;NDUFS6;NDUFV3;NDUFS1;NDUFA2;TMEM126B;NUBPL;NDUFA6;NDUFS2
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4080229193885421,-1.4939056025016701,0.010899182561307902,0.3432131981487023,1.0,30/56,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;BCS1L;NDUFAF3;NDUFA10;TIMM21;NDUFS6;NDUFV3;NDUFS1;NDUFA2;TMEM126B;NUBPL;NDUFA6;NDUFS2
prerank,histone ubiquitination (GO:0016574),0.5705023585553266,1.4938219806868165,0.04927007299270073,0.48518928583784565,1.0,8/21,14.20%,UBE2U;DTX3L;RNF20;CDC73;WAC;HUWE1;PAF1;LEO1
prerank,ganglion development (GO:0061548),-0.6117305152105142,-1.4931947563080687,0.06196581196581197,0.3431068510465905,1.0,6/11,12.74%,UNC5C;NRP2;CTNNB1;FZD3;TUBB3;SEMA3A
prerank,regulation of platelet activation (GO:0010543),0.5708450596965257,1.492206852628682,0.06909090909090909,0.4881857987131016,1.0,5/21,4.67%,TEC;SELP;PDGFRA;PLA2G4A;TLR4
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5196407921778251,1.4906081571083363,0.044169611307420496,0.4909480925321214,1.0,6/31,5.16%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR1
prerank,regulation of secretion by cell (GO:1903530),-0.4294285819573233,-1.4894436562720852,0.019830028328611898,0.3502445299812171,1.0,15/54,14.48%,SYT1;RIMS1;RIMS2;MEF2C;NSF;MCTP1;STXBP5L;RAB3C;CPLX1;SCG5;CAMK2A;SYN1;CPLANE2;RAB12;RHBDF2
prerank,cardiac conduction system development (GO:0003161),0.5514409572035323,1.4893484451622827,0.03260869565217391,0.4929719759441514,1.0,5/24,2.36%,NOTCH2;GJB6;GATA6;GJA1;BMPR1A
prerank,regulation of telomerase activity (GO:0051972),-0.4285432395536529,-1.487741394085685,0.02702702702702703,0.352476141904298,1.0,14/45,16.15%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;TERF1;ATM;NVL;KLF4;HSP90AA1;PNKP;MEN1;PKIB
prerank,regulation of cellular component movement (GO:0051270),0.47195550973589884,1.4871155608992737,0.03896103896103896,0.4977947593506712,1.0,8/49,5.16%,PDPN;TGFBR3;ROCK2;DIAPH1;SP100;ARHGAP18;MYCBP2;TGFBR1
prerank,cellular response to organic substance (GO:0071310),0.41119079044242984,1.48678516216491,0.010263929618768328,0.4964304500079023,1.0,35/116,16.19%,PTPN13;DPYSL3;SMAD3;PID1;GHR;IGFBP5;NFAT5;CLEC3B;BMPR1A;NCOA3;PTPN14;STAT5B;PTPN4;PLK5;TGFBR1;HAX1;PTPN2;PTPN9;TGFBR2;RAMP1;IL18;CCL2;LRRK2;TIPARP;PTPN6;MAP2K5;CRNN;PTPN18;ACVR1C;NCOA2;TBK1;ADRA2A;ACVR2B;CXCR4;URI1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.608795137442661,1.4862700796886203,0.05474452554744526,0.4959068220383571,1.0,3/15,6.52%,USP18;STAT2;PTPN2
prerank,positive regulation of ossification (GO:0045778),0.49345117815462164,1.4862604175600052,0.04326123128119801,0.49356397532467633,1.0,10/39,4.75%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,embryonic eye morphogenesis (GO:0048048),0.6500322543428443,1.4856544733884494,0.0690978886756238,0.4931515264615256,1.0,2/11,0.45%,EFEMP1;FBN1
prerank,negative regulation of growth (GO:0045926),-0.36314361837836634,-1.485255079926813,0.006600660066006601,0.3570404851334136,1.0,29/121,10.66%,APBB2;SLIT2;PTPRJ;SMARCA2;TGFB2;BMPR2;NOTCH1;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;CCAR2;RACK1;NPR1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.46205926061095837,-1.4847929254096648,0.023310023310023312,0.35637340110810384,1.0,10/32,9.49%,PTPRD;ADGRB3;TNIK;HECW1;SEMA4D;IL1RAPL1;CAPRIN2;YWHAH;RAPGEF2;NEDD4L
prerank,filopodium assembly (GO:0046847),-0.5615094956281089,-1.4842642534986314,0.05319148936170213,0.3557499680724165,1.0,4/16,6.47%,DNM3;FGD5;SPATA13;FGD6
prerank,sphingosine biosynthetic process (GO:0046512),-0.6057474803342102,-1.4834650649350825,0.07539682539682539,0.354136434374606,1.0,2/11,2.19%,ACER3;ACER2
prerank,sphingoid biosynthetic process (GO:0046520),-0.6057474803342102,-1.4834650649350825,0.07539682539682539,0.354136434374606,1.0,2/11,2.19%,ACER3;ACER2
prerank,positive regulation of T cell migration (GO:2000406),0.5703064456300457,1.4833664989719066,0.05545927209705372,0.4983345155081806,1.0,7/20,15.87%,CXCL10;STK39;OXSR1;TNFRSF14;WNT5A;WNK1;APP
prerank,protein K63-linked ubiquitination (GO:0070534),0.49007617473519377,1.4824933149401383,0.04833333333333333,0.49875691839729813,1.0,12/41,13.63%,RNF152;TRIM56;TRAF5;NEDD4;TRIM5;WWP2;UBE2V1;HECTD1;TRIM21;UBE2E3;PRPF19;BFAR
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5015478565231974,1.481352123839483,0.04118616144975288,0.5000978274012455,1.0,14/36,21.65%,PARP14;AXL;PARP9;ZBP1;CASP4;CPNE1;WNT5A;CSF1;TXK;CXCR4;IL7;UBE2K;HIF1A;RIPK1
prerank,response to nitric oxide (GO:0071731),-0.595019091649903,-1.480888154628856,0.05019305019305019,0.3588836132596418,1.0,5/13,15.18%,FOXO1;KCNC2;GUCY1B1;CDK2;CCL19
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6705205570818984,1.4807188990250582,0.06378600823045268,0.5000535632121962,1.0,4/10,3.41%,ATP1A2;STK39;OSR1;NEDD4
prerank,renal system development (GO:0072001),0.46367442864290553,1.4802948504350821,0.029921259842519685,0.4992722447761037,1.0,11/52,8.79%,SULF1;WNT4;FOXC1;RBP4;IFT88;ARL3;TGFBR1;SALL1;LRP4;STAT1;GREB1L
prerank,cellular response to drug (GO:0035690),-0.48932620901718565,-1.4784597500750374,0.04066985645933014,0.3630365552508049,1.0,7/25,12.24%,MEF2C;PDE4B;TFRC;ACER2;GAS6;AIM2;KCNQ1
prerank,negative regulation of proteolysis (GO:0045861),0.49676298606734753,1.4783256465036003,0.047058823529411764,0.5034564481621034,1.0,13/34,12.98%,ECM1;TIMP3;CSTB;PTPN3;SNX12;EPHA4;TIMP2;SERPINE2;LRRK2;DNAJC1;TRIM21;EFNA1;PLAT
prerank,positive regulation of protein polymerization (GO:0032273),-0.39376722593651275,-1.477585056802322,0.022922636103151862,0.36350923273458446,1.0,30/65,24.85%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;CDC42EP3;PINK1;VASP;CDC42EP1;CDC42EP5;FES;TTBK1;HSP90AA1;RAC1;EVL;MAPT;PYCARD;TPPP;ARF6;CDK5RAP2;PFN2;CARMIL1;DCTN1;PRKCE;ARL2;MAPRE1;PFN1;OCLN
prerank,defense response to virus (GO:0051607),0.41542921374294384,1.4770509761709756,0.010071942446043165,0.5053698239271753,1.0,24/100,12.44%,RSAD2;CXCL10;EIF2AK2;STAT2;TRIM56;PRF1;IFIT2;IL6;BCL2;ZBP1;TRIM5;BST2;OASL;STAT1;ZMYND11;PHB2;MOV10;IFITM1;IFNLR1;BCL2L1;TLR2;OAS2;IFI27;IFIT1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4343087060066476,-1.4759601239926103,0.0325,0.3655297857441816,1.0,20/38,31.41%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFA11;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6261172225108338,1.4749145838002984,0.07462686567164178,0.510331355344642,1.0,3/13,4.74%,CBLB;SNX6;ERRFI1
prerank,cellular response to cytokine stimulus (GO:0071345),0.35689983693560784,1.4744029464011972,0.0035211267605633804,0.5097662807809464,1.0,91/416,16.20%,PTPN13;DPYSL3;RORA;LEPR;TEC;GBP6;SMAD3;FN1;CXCL10;IL16;PID1;AXL;STK39;GHR;OXSR1;ADAMTS12;IL31RA;ZFAND6;GBP2;FOXC1;STAT2;NFAT5;IL6ST;SHMT1;GAB2;OSM;VIM;IL11;FER;IL34;ANXA1;PTPN14;KIT;DAPK1;RC3H1;STAT5B;PTPN4;IL6;GSDME;TLR4;BCL2;MCL1;HAX1;TPR;VCAM1;GBP5;NOS2;PTPN2;PTPN9;CD47;GBP4;IL18;OPRD1;STAT1;GSK3B;CCL2;LGALS9;WNT5A;ZEB1;IL13RA1;IFNLR1;PTPN6;BCL2L1;GBP7;TLR2;IRAK3;TCF7;STAT4;SH2B3;FOXO3;CSF1;IFIT1;CRNN;PTPN18;JAK1;IL22;ADAMTS7;POU2F1;RHOU;WNK1;SLC26A6;TBK1;GREM2;CCL25;IL23R;SOCS6;CXCR4;ICAM1;IFNAR2;MUC1;GBP3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.49166754571559323,-1.4738833420067952,0.05052631578947368,0.36916173212232634,1.0,9/23,15.22%,MYO10;KIF1B;KIF1C;CCDC88A;TUBA1A;KIF5C;DYNC1I2;KIF5A;TUBA1B
prerank,axon guidance (GO:0007411),-0.33120124952167795,-1.4723168130455702,0.00423728813559322,0.3711903946888006,1.0,71/201,14.99%,SLIT2;NRXN1;UNC5C;BSG;ROBO2;SHANK3;PLXNA4;NCAM1;SEMA6D;EFNA5;RPS6KA5;ENAH;DAB1;TNR;NRP2;CNTN4;EPHA5;DOK6;PIK3R1;NOTCH1;DCC;NTN4;CNTN6;NOTCH3;SH3KBP1;GAB1;KLF7;TMEFF1;PTPRM;SEMA4D;SEMA3C;SEMA6A;LAMA1;LAMA3;PRKCQ;UNC5D;EPHB1;ROBO4;SEMA7A;MAPK3;NPTN;SPTB;SEMA3E;EPHA6;VEGFA;TUBB3;CNTN2;L1CAM;CXCL12;VASP;SEMA3G;RHOG;SEMA6B;EMB;RET;PTPRO;GFRA2;LRTM1;KIF5C;VLDLR;PIK3CD;SEMA3A;GAP43;NFIB;RAC1;EVL;RELN;RHOH;GFRA1;KIF5A;LGI1
prerank,negative regulation of lipid storage (GO:0010888),0.5713585919397275,1.4704729862224204,0.06810035842293907,0.5210792811726399,1.0,6/19,6.66%,OSBPL8;IL6;NR1H3;PPARA;PTPN2;CRP
prerank,inositol phosphate metabolic process (GO:0043647),-0.4107699526293107,-1.4704542110504055,0.029490616621983913,0.37414534770556274,1.0,14/46,15.74%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;FGF2;PLCH1;PPIP5K2;PPIP5K1;PLCG1
prerank,regulation of cell morphogenesis (GO:0022604),0.5137636802661406,1.4701014572751323,0.06405693950177936,0.5200791016657894,1.0,13/30,16.76%,PDPN;SH3D19;PHIP;MYO9A;BCL9L;CAPZB;FMNL2;MOV10;ZMYM6;SPARC;PDZD8;ZMYM3;WTIP
prerank,nuclear migration (GO:0007097),0.6243470755748118,1.4696323888711527,0.082,0.5192105967964787,1.0,5/13,12.79%,SYNE3;SYNE2;CLMN;DOCK7;FBXW11
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.494976872845854,-1.4694724853572159,0.0468384074941452,0.37488314921937027,1.0,11/24,18.62%,TEK;PTPRJ;KDR;PIK3R1;MYOC;IQSEC1;VEGFA;RAC1;COL16A1;PPM1F;ARF6
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4723864213472741,1.4687690217026734,0.05647840531561462,0.5199117062063665,1.0,7/46,7.59%,TCF7L2;IGFBP3;IGFBP5;IL6;PDGFRB;IL18;STAT1
prerank,negative regulation of cholesterol transport (GO:0032375),0.6609120071642,1.468685310395029,0.10176125244618395,0.5178224982014877,1.0,1/10,2.03%,APOA2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4837351507640095,-1.4685500635840363,0.05200945626477541,0.3751104654062986,1.0,16/27,27.41%,PDE4D;PDE4B;CTNNA3;RYR2;CAMK2D;FGF13;SRI;CAV1;ATP2A2;DSG2;GJA5;STC1;PLN;PKP2;HCN4;RANGRF
prerank,kidney development (GO:0001822),0.43947719279833175,1.467796732318027,0.03576982892690513,0.5184630073334833,1.0,13/65,8.79%,SULF1;WNT4;KANK2;OSR1;FOXC1;IFT88;ARL3;BMP7;TGFBR1;SALL1;LRP4;CTSH;GREB1L
prerank,polyamine metabolic process (GO:0006595),-0.5723133705254199,-1.4670347915581983,0.05970149253731343,0.37727486614425787,1.0,6/13,26.92%,HDAC6;OAZ2;SMS;SRM;SAT2;PAOX
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6721415792943931,1.466477048753155,0.09423076923076923,0.5209705827858376,1.0,6/10,20.20%,HNMT;SARDH;COMT;DMGDH;LRTOMT;ALDH7A1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6334842542994576,-1.465603677108253,0.07597535934291581,0.3790977123402951,1.0,5/10,16.74%,KCNAB1;ANK3;CAV1;KCNE4;KCNRG
prerank,positive regulation of tissue remodeling (GO:0034105),0.632734886199786,1.4630838997651632,0.10216110019646366,0.5300740509791275,1.0,2/10,7.50%,ROCK2;IL18
prerank,aminoglycan metabolic process (GO:0006022),-0.6172103736802734,-1.4629378833484505,0.06732673267326733,0.38370334283907276,1.0,5/10,24.29%,XYLT1;B3GAT2;CHST9;B3GAT1;B3GAT3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5966989682248314,1.462294789387268,0.07142857142857142,0.5303155379694638,1.0,3/15,7.66%,TCF7L2;TPR;GSK3B
prerank,regulation of cytoskeleton organization (GO:0051493),0.40807907175479097,1.4622480878972735,0.020771513353115726,0.5281712774372973,1.0,24/108,11.97%,PHLDB2;ROCK2;DIAPH1;ARHGAP18;PRKAA2;DLC1;EPHA3;SMIM22;MAP6;CLASP1;PHLDB1;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;CLIC4;GSK3B;RHOQ;SYDE1;IQGAP2;TJP1;PTK2;RHOC
prerank,epithelium development (GO:0060429),0.40376816125124165,1.4612114694886311,0.012875536480686695,0.5293369363303748,1.0,17/107,8.12%,ALDH1A2;WNT4;KANK2;OSR1;GATA6;DAG1;DACT1;MTHFD1;BMP2;LOXL3;ERRFI1;VCL;SALL1;ANXA4;STAT1;GSTK1;ANXA7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6198003432748325,-1.460697479590741,0.07547169811320754,0.387659050764735,1.0,3/10,6.63%,SHANK3;NETO1;NPTN
prerank,myofibril assembly (GO:0030239),0.4707952027350819,1.4606915493396362,0.02823920265780731,0.5288497503790083,1.0,8/42,6.96%,PDGFRA;TMOD3;CSRP3;CFLAR;TPM1;CSRP1;PDGFRB;ACTN2
prerank,cell-cell junction assembly (GO:0007043),-0.3924586900861544,-1.4605838709724166,0.022556390977443608,0.3861224417347958,1.0,19/63,9.09%,CTNND2;CLDN5;CDH2;CDH11;CDH12;SMAD7;ACTB;ACTG1;GJC1;GJD3;CDH10;CTNNB1;TLN2;CDH8;CDH22;CDH7;CDH20;JAM3;RAMP2
prerank,negative regulation of cell motility (GO:2000146),0.410154340441529,1.4593696442594677,0.025714285714285714,0.5311055713285068,1.0,33/108,13.03%,SULF1;ROBO1;DPYSL3;PODN;AFDN;IGFBP5;DLC1;TACSTD2;KANK1;LDLRAD4;DAG1;FBLN1;DUSP10;MIA3;TPM1;VCL;SERPINE1;EPHA1;BST2;SPINT2;CLIC4;RNF20;NGFR;EPHA4;STK24;RAP2C;IFITM1;PTPRU;FOXO3;EPPK1;SLURP1;NOG;ARPIN
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6297621524398748,1.458519307249344,0.08210526315789474,0.531792706294081,1.0,3/12,4.93%,UST;DCN;DSE
prerank,fat cell differentiation (GO:0045444),0.4434174760214676,1.4581066962040146,0.04133545310015898,0.530931181054249,1.0,12/57,12.36%,TCF7L2;PID1;IL11;OSBPL8;WNT5B;FAM120B;ALOXE3;SMAD6;ERAP1;MAFB;NR4A1;EGR2
prerank,regulation of glycolytic process (GO:0006110),0.4375990171613653,1.4577441599844696,0.04704097116843703,0.5298864753507634,1.0,10/68,7.19%,ZBTB20;PRKAG2;PRKAA2;NUPR1;ARNT;RANBP2;TPR;HDAC4;PPARA;JMJD8
prerank,regulation of response to interferon-gamma (GO:0060330),0.6111851386652204,1.4567636074410968,0.07575757575757576,0.5306978826174461,1.0,6/14,13.11%,PARP9;PTPN2;STAT1;PIAS1;SUMO1;JAK1
prerank,regulation of osteoblast differentiation (GO:0045667),0.4282042046179521,1.455496304728521,0.024427480916030534,0.5327055601638809,1.0,19/82,11.17%,RANBP3L;BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7;TMEM64;SKI;YAP1;NOCT;IFITM1;SMAD6;SUFU;LRP3;PTK2
prerank,manganese ion transport (GO:0006828),-0.5575814986857117,-1.4550975000999569,0.07223476297968397,0.39899952269337197,1.0,6/14,7.83%,TRPC3;TRPC5;TRPC4;ATP2C1;TRPC6;SLC39A14
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5080016449513266,-1.4527104281791963,0.048672566371681415,0.40358033029685925,1.0,14/22,21.71%,RPS15;RPS7;RPS20;UBB;SPRED2;ATM;EEF1E1;RPL23;EIF5A;SPRED3;RPL37;SPRED1;MSX1;ATR
prerank,brain morphogenesis (GO:0048854),-0.5808117439635596,-1.4523995069769975,0.06584362139917696,0.4025093251418478,1.0,5/12,17.38%,CTNNA2;SHANK3;PAX2;VPS51;BBS2
prerank,anterior/posterior axis specification (GO:0009948),0.6011573678177902,1.4514901609726112,0.06976744186046512,0.5442931437059049,1.0,3/15,13.25%,WLS;SKI;TASOR
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.48565051577129287,1.4507670058674704,0.05593220338983051,0.5447941392242769,1.0,8/37,7.66%,PHLDB2;PRKAA2;EPHA3;SKA1;MAP6;CLASP1;PHLDB1;GSK3B
prerank,cellular protein metabolic process (GO:0044267),-0.303982690331338,-1.4507055795226058,0.0,0.40512581471370207,1.0,144/396,21.35%,ST8SIA4;CDH2;RPS24;CHRM3;ST3GAL6;CST3;SPARCL1;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;CPE;RPL38;RPLP1;SCG3;IGFBP7;RPS8;RPL10A;RPL27A;GAS6;RPL13;RPS18;ABCA3;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;GOLM1;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;DAB2IP;RPS15A;MSRA;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;MSLN;MBTPS1;RPS20;RPS4X;RPN2;RPL18;LGMN;RPS13;MSRB2;BMP4;MSRB3;FBXL2;RPS2;RPL14;RPL22;MMP15;FDXR;SPCS2;SEC11C;MSRB1;RPS26;ASMT;SPP1;SCG2;MRPS18A;SERP1;QPCT;ZDHHC2;RPS10;IGHMBP2;EVA1A;SPCS1;RPL23;RPL17;PABPC4;PIGH;RPL29;MGAT4A;RAB12;GSPT2;RPS5;RPS14;UBA52;PHEX;SEPHS1;PLOD2;ERO1A;QSOX1;SRBD1;MRPL28;COPS5;HBS1L;RPL12;MEN1;PSENEN;RPL9;FUCA2;UBE2D3;MMP1;MATN3;RPL37;RPS11;MFGE8;LGALS1;LMCD1;MRPL35;MRPS5;RABGGTA;RPL7;RPL31;RPL7A;FBXO22;MRPL34;HARS1;YARS2;FARSB;PCSK5;PENK;RPL3;MRPL52;MRPL23;MRPL9;C3;NTAQ1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6160937907494328,-1.4506743692275963,0.07172131147540983,0.40333969459360053,1.0,6/11,19.16%,PINK1;RACK1;ATF4;PARK7;NR4A3;NONO
prerank,triglyceride biosynthetic process (GO:0019432),0.5630937814821783,1.4505394322962926,0.08272058823529412,0.5433770209395286,1.0,7/18,20.04%,AGMO;MOGAT3;DGAT2;LPGAT1;LPIN2;PCK2;DGAT1
prerank,negative regulation of signal transduction (GO:0009968),0.3711062431306619,1.4503006635058666,0.006418485237483954,0.5420644937974267,1.0,60/249,15.21%,SULF1;IGFBP3;LEPROT;LGR4;KANK2;PID1;TLE1;ENPP1;ADAMTS12;IGFBP5;MPIG6B;KANK1;FSTL3;GLI3;WWOX;APCDD1;NEDD4;DACT1;DCN;BMP2;CRY1;NTN1;BCL2;PRKCZ;DLK1;MMP14;SIAH2;DKK3;PTPN2;CD47;MGRN1;GLIS2;LRRK2;APPL1;SUFU;WWP2;PLEK;NKD1;IRAK3;PALM;RPGRIP1L;VGLL4;CADM4;BTRC;PTPN1;NOG;PTPN18;ARRB1;PIP4K2B;BDNF;HIC1;RNF43;BRAP;TRIB1;LRPAP1;NCK1;NIBAN2;CSNK2A2;TNS2;GDF15
prerank,cell proliferation in forebrain (GO:0021846),0.6461180644604307,1.4498061446874664,0.08687258687258688,0.5414745956372279,1.0,3/10,9.50%,WNT3A;NUMB;DOCK7
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5529589126204776,-1.4487223996386458,0.08008658008658008,0.4066476738764452,1.0,6/16,10.30%,NOS3;KCNC2;NDNF;GUCY1B1;GUCY1A1;NOS1
prerank,embryonic skeletal system development (GO:0048706),0.4869780668112836,1.4481955046189132,0.0686106346483705,0.5444621134983442,1.0,7/35,8.47%,SULF1;PDGFRA;OSR1;RBP4;HOXC4;DYNC2I1;WNT5A
prerank,mesoderm formation (GO:0001707),-0.5250699973447907,-1.4473293520938535,0.07925407925407925,0.4087242276417526,1.0,4/17,10.15%,BMPR2;ITGB4;ITGA8;ITGA3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.43196781032448084,-1.447016371263354,0.04914004914004914,0.40755101893406087,1.0,11/38,13.29%,CACNB2;CTNNA3;KCNJ3;KCNJ2;CACNA1G;CAMK2D;KCND3;CACNA1D;KCNQ1;CAV1;KCNE4
prerank,regulation of inflammatory response (GO:0050727),0.37477497061639914,1.446828655577159,0.010738255033557046,0.5472138376985888,1.0,27/190,8.47%,ENPP3;RORA;USP18;CASP12;IL16;ADAMTS12;FPR2;OSM;SNX6;CDH5;TNFAIP8L2;ANXA1;IFI35;IL6;TLR4;LACC1;ZBP1;CASP4;SERPINE1;NR1H3;PPARA;BIRC3;PTPN2;CD47;IL18;SETD4;WNT5A
prerank,negative regulation of cell communication (GO:0010648),0.5396286376341793,1.446586748021489,0.08348457350272233,0.5458395218983831,1.0,4/21,2.68%,IGFBP3;MPIG6B;OSM;IL11
prerank,heart process (GO:0003015),-0.5486093487840821,-1.4461823257819795,0.06109979633401222,0.40774215310766915,1.0,4/14,14.97%,SGCZ;SGCD;ACE;SOD1
prerank,ceramide metabolic process (GO:0006672),-0.40717998086954243,-1.4451811988105008,0.047619047619047616,0.40861002621642317,1.0,7/49,3.39%,ST6GALNAC3;SGMS1;ACER3;ACER2;CERS4;PPP2R1A;DEGS2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3867561124060865,1.4447903597982463,0.02074688796680498,0.5496395536712817,1.0,31/140,9.99%,ARHGAP29;CGNL1;ARHGAP6;RASGRF1;TIAM2;AKAP13;ARHGAP21;ARHGAP10;ARHGAP20;ARHGAP18;DLC1;ARHGAP28;ARHGAP32;TRIP10;FGD4;ARHGAP12;PLCE1;MYO9A;RHOF;FAM13B;TAGAP;RALBP1;PLEKHG2;ARHGEF11;ARHGAP26;RHOQ;SYDE1;GMIP;ARHGEF12;SOS2;NGEF
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5232761342091384,-1.444356423276967,0.06578947368421052,0.4089704911109654,1.0,6/18,15.17%,PLCB1;CHRM3;CHRM2;OPRM1;AGRN;GNAQ
prerank,presynapse assembly (GO:0099054),-0.5391105036409356,-1.444253192533353,0.05895691609977324,0.40737961055223343,1.0,7/16,10.22%,NLGN1;PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN3;DVL1
prerank,regulation of neuron projection development (GO:0010975),-0.32918100992279575,-1.4438345193008602,0.0,0.40663276200525245,1.0,48/163,13.08%,CTNNA2;LRRC4C;ITGA6;SHANK3;CSMD3;LRRC7;CDH2;PPFIA2;TENM3;TANC2;PTK2B;DCC;RIT2;FUT9;PAK1;NTRK2;SETX;IL1RAPL1;PRAG1;SERPINI1;TOX;DAB2IP;ARHGAP44;SNX3;STMN2;NDNF;NPTN;RAPGEF2;CCDC88A;EFHC2;AKT1;PAQR3;RTN4RL1;MBOAT1;NDRG4;SPOCK1;ABI3;LYN;RET;LZTS3;PTPRO;SCARB2;PAK3;MARK1;FES;SRCIN1;SEMA3A;MFSD2A
prerank,myeloid cell development (GO:0061515),0.556297638972651,1.4427871211482763,0.08362369337979095,0.5539409124483574,1.0,8/18,18.98%,MPIG6B;ANXA2;KIT;TLR2;SH2B3;ALAS2;APP;DMTN
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6416526389453295,1.4420297124260526,0.1134020618556701,0.5543772042137555,1.0,4/10,17.50%,APOA2;BMP1;ABCA1;ABCA7
prerank,membrane lipid biosynthetic process (GO:0046467),-0.38967258495701296,-1.4412397543143793,0.027777777777777776,0.41193624455285766,1.0,11/58,4.60%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;ST8SIA6;DEGS2;ELOVL7;SPNS2
prerank,cellular defense response (GO:0006968),0.4691245077625589,1.4405397451569137,0.06514657980456026,0.5575463141607989,1.0,6/40,9.33%,DCDC2;PRF1;CCR9;ADORA2A;LY96;LSP1
prerank,regulation of potassium ion transport (GO:0043266),-0.45446572419537157,-1.4403201711391536,0.061124694376528114,0.41253929356174246,1.0,9/31,10.30%,DPP10;KCNAB1;PTK2B;KCNIP4;ANK3;KCNIP1;DPP6;CACNA1D;NOS1
prerank,response to ethanol (GO:0045471),-0.5602390834050255,-1.440253297021362,0.07515657620041753,0.4108973247045603,1.0,7/14,19.29%,GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;GLRA2;GLRA1
prerank,amino acid transport (GO:0006865),0.45099598254661244,1.4401075145504292,0.052545155993431854,0.556820094454488,1.0,5/49,4.20%,SLC7A11;PDPN;SLC7A2;SLC6A12;SLC7A14
prerank,positive regulation of cell growth (GO:0030307),-0.3528623640391217,-1.4390027453125585,0.015822784810126583,0.41252677100697155,1.0,28/96,15.43%,SYT1;RIMS1;RIMS2;AKAP6;TGFB2;SEMA4D;H3-3A;MACF1;SEMA7A;AKT1;SDCBP;DDX49;SHTN1;SYT4;L1CAM;NEDD4L;DBNL;EXOSC2;ZFYVE27;RPS6KA1;EGFR;NGF;CEP43;MFSD2A;SYT2;TAF9B;LGI1;MAPT
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6441551033995581,1.4386658825955154,0.10317460317460317,0.5592912227340514,1.0,3/10,7.09%,ENPP1;ERRFI1;MVP
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.34490200698500395,1.438359880387575,0.0,0.5580346625699343,1.0,108/476,16.62%,TCF4;CREB5;KMT2A;RORA;WNT4;SMAD3;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;ARNT2;MLLT3;IL31RA;TBL1XR1;TEAD1;FOXC1;TRIM56;PHIP;GATA6;WNT3A;RGMB;PPM1A;ZIC2;FOXC2;GLI3;MYB;PARP9;FZD2;TGFB1I1;PRDM11;ZIC1;BMP2;RFX3;APBB1;IL6;GLI1;BMP7;NIF3L1;TGFBR1;NCOA6;SALL1;LBHD1;NSD3;NR1H3;FOXP3;DTX3L;HDAC4;CREBL2;PPARA;CREBBP;GLIS2;NSD1;SFR1;RNF20;STAT1;WAC;ARHGEF11;NEK4;QRICH1;RNF111;CRLF3;TEAD2;WNT5A;YAP1;KAT6B;RLF;EPC1;NAA16;ELF4;BRD4;MAFB;ATF7IP;UBE2V1;NAA15;ELF2;SMAD4;HIVEP3;PPP3CB;FOXO3;ILF3;DVL3;EGR2;BTRC;MAP2K1;FBXW11;MED12;SERTAD3;KAT6A;KDM8;VHL;NIBAN2;HDAC2;RARA;MAP3K2;PML;ILK;SP3;SMARCA4;SOX4;DNAJC2;SMARCC1;SMAD2;TRIM16;NFATC2;TBL1X;PSRC1;ANKRD49
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6118413153935319,-1.4381463970814368,0.06147540983606557,0.41295342841757376,1.0,4/11,4.03%,THBS1;KLF2;EPN2;SEMA6A
prerank,fibrinolysis (GO:0042730),0.6194415427824019,1.438077065880804,0.07358490566037736,0.5568610981857928,1.0,5/13,12.98%,GP1BA;SERPINE1;PLAU;CPB2;PLAT
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4954388502999743,1.437926225539066,0.06890756302521009,0.5551448776871983,1.0,4/29,4.92%,TNNC1;TGFBR3;BMP2;TPM1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5675543550760872,1.4379252994286742,0.07735849056603773,0.5529801604034255,1.0,3/17,4.75%,TFPI;ATP1A2;BMP7
prerank,potassium ion transport (GO:0006813),-0.34612850266904505,-1.4379043766937087,0.013888888888888888,0.4117820510381062,1.0,28/120,12.30%,KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNMB2;KCNK5;KCNMA1;SLC24A2;ABCC9;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNK10;SLC9A8;HCN2;KCNH1;TMEM175;KCNH5;KCND3;KCNJ6;KCNB1;KCNJ8;KCNQ1;KCNJ15
prerank,regulation of vasoconstriction (GO:0019229),-0.4703260026316292,-1.437882419483076,0.06511627906976744,0.4100515953126673,1.0,8/27,12.95%,CHRM3;KCNMB2;BMPR2;ADRA1B;ECE1;ACE;ACE2;CAV1
prerank,response to calcium ion (GO:0051592),-0.3550580141514161,-1.437767753884274,0.029508196721311476,0.40865035333348765,1.0,36/102,21.52%,NLGN1;SYT1;MEF2C;KCNMB2;PLCG2;TRPC3;KCNMA1;THBS1;ITPKB;RYR2;HOMER1;CALM1;CALM2;RYR3;KCNH1;CALM3;LGMN;CAMK2D;SYT4;SYT7;CPNE4;CAV1;SYT9;SYT2;CASQ2;ADD1;ADCY8;SLC25A13;HPCA;ECT2;CPNE7;SYT6;KCNMB4;TTN;SLC25A12;TRPM2
prerank,negative regulation of ossification (GO:0030279),0.5346819756990255,1.4371138092263933,0.07321428571428572,0.5534598450112383,1.0,7/23,9.65%,RBPJ;ENPP1;ECM1;BCOR;CHSY1;LRP4;SMAD6
prerank,melanocyte differentiation (GO:0030318),0.637887287391974,1.436797900642129,0.09923664122137404,0.5524206901393846,1.0,3/11,3.84%,LRMDA;ENPP1;KIT
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5146706136370246,1.4364665992081178,0.06228373702422145,0.5514574768292604,1.0,11/29,20.34%,USP18;STAT2;ZBP1;PTPN2;WNT5A;PTPN6;PTPN1;MUL1;IFNAR2;RNASEL;UBE2K
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.425674802432974,-1.4361351990847342,0.0375,0.41120245210892825,1.0,16/41,18.17%,PLCG2;SLC24A2;RYR2;HTR2C;GRIN2A;RYR3;SLC8A1;GRIN2B;GRIN1;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;HTR2A
prerank,negative regulation of cell population proliferation (GO:0008285),0.35208556548459746,1.4355863195039238,0.0024067388688327317,0.5523622122963916,1.0,92/351,17.80%,ALDH1A2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;MCC;KANK2;EIF2AK2;TPTE;IGFBP5;NUPR1;GATA6;LDOC1;DLC1;PDS5B;OSM;NELL1;FBLN1;RBP4;ADAMTS1;TGFB1I1;DUSP10;PTHLH;PTPN14;SLC16A2;BMP2;IGFBP6;IFI35;IL6;BTG3;GSDME;BTG4;MORC3;APPL2;FOXP3;PTPN2;COL18A1;PARP10;ZBTB7C;POU1F1;CLMN;CDC73;PDCD5;SKI;CDKN2B;WNT5A;MTSS1;IFITM1;SMAD6;NUPR2;CGRRF1;IFNLR1;PTPN6;CDH13;PTPRU;SH2B3;EPPK1;VGLL4;NUDT6;SLURP1;NOG;MAP2K1;RBM5;PEX2;ACVR1C;MDM4;IFIT3;TRIB1;WDR6;FRK;ABI1;VHL;NIBAN2;PML;TNS2;KAT2B;P3H3;SOX4;KDM2B;PKD2;APP;AXIN2;NF2;S100A11;CDKN3;GAS8;OGN;DLG5;DNAJB2;PPP2R5C;TENM1
prerank,base conversion or substitution editing (GO:0016553),-0.5890213147394889,-1.4354497143879077,0.07171314741035857,0.41134032200488907,1.0,3/11,7.38%,ADARB1;ADARB2;APOBEC1
prerank,somite development (GO:0061053),0.6121304082587535,1.4345655367094887,0.11567164179104478,0.5536531626999486,1.0,5/11,19.05%,MTHFD1;LOXL3;IHH;PTCH1;MEOX2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4590983147523242,1.4344855178533955,0.03755868544600939,0.551830920617983,1.0,10/48,11.59%,ROBO1;PARP14;USP18;STAT2;IL6;NR1H3;PTPN2;OTOP1;IRAK3;SH2B3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.412939924085084,-1.4340734808677607,0.04846938775510204,0.4131337550021754,1.0,8/44,3.31%,KCNMB2;KCNMA1;AKAP6;ATP1B1;KCNJ3;KCNJ2;NOS1AP;GABBR2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3261730217173462,1.4340367034729466,0.0,0.5512153048114393,1.0,359/1668,16.51%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;SOX5;FHL2;BMP6;TSHZ2;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;KANK2;ZMIZ1;NR2F2;CXCL10;SP100;ELF1;KCNIP3;RGMA;CREB3L2;FGF1;PID1;PRDM6;AUTS2;ARNT2;OSR1;TBL1XR1;TEAD1;SMURF2;FOXC1;NFIA;LBX1;STAT2;NFYC;NFAT5;PHIP;ZNF697;GATA6;SPIB;TCF24;WNT3A;KDM7A;MAF;HIF3A;CSRP3;PPM1A;ZBTB4;BMPR1A;ZNF395;SSBP2;OSM;NR6A1;FSTL3;ZIC2;FOXC2;IL11;GLI3;NFATC4;WWOX;MYB;NCOA3;ZIC4;MBD2;TRAK1;PARP9;CDK8;TGFA;LDB2;HIVEP2;IKZF2;TNRC6B;PRRX2;HIVEP1;CRY2;NUCKS1;HOXC6;DACT1;ZBTB8A;HOXC4;KIT;ZIC1;DCN;LITAF;BMP2;STAT5B;RFX3;CRY1;BRWD1;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;MIER3;ZFP30;EPAS1;HLF;TLR4;GLI1;BCOR;ARNT;EN2;SIM2;ZNF276;AEBP1;UXT;MTDH;GLIS3;GZF1;NCOA6;SALL1;OTP;PRRX1;ZNF3;MGA;TCF12;KDM3B;SERPINE1;KLF5;HAX1;MIER1;HDGFL3;SP9;TPR;ZNF35;MLLT10;CREB3L3;WWC2;NR1H3;FOXP3;ARF4;ATP2B4;BCL9L;ANXA4;HDAC4;ZKSCAN4;PPARA;TCF7L1;TSHZ3;VGLL3;CREBBP;RARB;POGZ;GLIS2;PCGF5;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;USP9X;HOXA2;CREBRF;IL18;DPF2;STAT1;CDC73;SKI;CDKN2B;ZSCAN21;MEF2A;RIPK2;RNF111;CRLF3;PIAS1;ZNF25;VPS72;TEAD2;ATF7;BAX;BAZ1B;CUX1;TNRC6A;WNT5A;ZNF182;ZFP37;SP8;YAP1;RHOQ;ZEB1;SAP130;CCNH;CRTC1;KAT6B;MOV10;RLF;DLG1;EPC1;GLYR1;IGF2;ZNF394;ELF4;MNAT1;ZBTB3;SUMO1;GATAD2B;CREM;SMAD6;CDK7;TOX4;HDGFL2;CDK12;SP110;E4F1;EBF4;SOX21;NUPR2;BRD4;PBX1;RFXANK;TAF7;SUFU;PFKM;MAFB;MSC;MAPK14;WWP2;CUX2;TCEA1;PPID;BAZ1A;HEYL;ZNF292;MYSM1;CIR1;CBX7;CDH13;ZNF235;TLR2;FNIP1;ELF2;RFXAP;TCF7;SMAD4;STAT4;MAP2K5;HIVEP3;EGR3;RTF1;PPP3CB;ATN1;FOXO3;NR4A1;CRTC3;ACTL6A;RBBP8;LHX9;IFI27;ZNF219;KDM5B;DVL3;EGR2;ZKSCAN7;MAML2;RPS6KA3;SS18;SRCAP;THAP1;NOG;EFNA1;HOXA10;BPTF;KDM2A;TET2;NFIC;MED12;CBX4;ARRB1;MZF1;BHLHE41;NR3C1;BRD8;GMEB1;MED20;PKNOX1;WASL;PEX2;PAF1;NFE2L1;NRF1;SENP1;HIC1;ARID5B;ZNF462;POU2F1;ZNF205;KAT6A;BRWD3;GTF2H4;PRDM5;MDM4;NCOA2;SALL2;DMTF1;RFX2;TLE6;FUS;NCK1;TBK1;FRK;VHL;THAP3;ZBTB21;ZNF569;RBM14;ZBTB12;HDAC2;IFRD1;RARA;ZNF18;MAMSTR;SP3;ZFX;ZNF383;HOXB4;TEF;SMARCA4;KAT2B;ACVR2B;SOX4;PHF20L1;IRF9;PER3;KDM2B;TXK;DAB2;VEZF1;LIN9;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9;CTDSP1;ZNF260;CPEB3;MUC1;JDP2;SMARCC1;URI1;DRGX;SMAD2;WWTR1;BCL11B;ZNF483;POU6F1;NFATC2;TBL1X
prerank,nucleotide metabolic process (GO:0009117),0.5373439438187305,1.4335170488122047,0.07504363001745201,0.5509486123551163,1.0,4/23,9.45%,ENPP3;CMPK2;FHIT;AK5
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5771479722433475,1.4334680905287576,0.09714285714285714,0.5490096953861201,1.0,3/15,6.33%,EIF2AK2;TLR4;GBP5
prerank,negative regulation by host of viral transcription (GO:0043922),-0.5815204985782159,-1.4327221215551058,0.09741550695825049,0.4149077006649968,1.0,4/12,9.20%,PSMC3;INPP5K;TFAP4;HDAC1
prerank,dermatan sulfate metabolic process (GO:0030205),0.6062129180365194,1.4323987491330905,0.09202453987730061,0.5505020685012956,1.0,3/13,4.93%,UST;DCN;DSE
prerank,metal ion transport (GO:0030001),-0.3678736337986303,-1.4322233478336397,0.022535211267605635,0.4146381513892332,1.0,20/86,10.29%,CACNA1E;GRIN3A;TRPC3;RYR2;TPT1;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;CNNM4;ATP2A3;SLC30A1;NIPAL3;CAMK2A;RAMP2;NIPAL4;CACNA1D;NIPA2;NIPA1
prerank,organic anion transport (GO:0015711),-0.3697963259251106,-1.4319027602919159,0.0196078431372549,0.4136845417245358,1.0,22/76,17.23%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO1C1;SLCO2A1;CA4;CA2;LRRC8C;SLC52A3;SLC22A6;SLC25A42;SLC35B1;CYB5R1;CYB5RL;SLC35A2;SLC4A7;SLC39A8;SLC25A19;SLCO4A1;ABCC5;SLC52A2
prerank,myoblast differentiation (GO:0045445),0.5992093893670258,1.431754106824046,0.08795411089866156,0.5505924157665019,1.0,2/14,4.66%,TCF7L2;EPAS1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.4753967324896993,-1.4317434136727694,0.07191011235955057,0.41235201670443383,1.0,8/24,26.68%,AGBL4;TTLL7;TTLL5;NAA10;TTLL8;CEP41;VKORC1;TTLL3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.46406099726116457,-1.4315816890907407,0.06802721088435375,0.41106479503798016,1.0,13/26,24.85%,NAV3;PAK1;RPS3;MET;STMN2;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,carnitine shuttle (GO:0006853),0.6298009689194091,1.4313608711165646,0.10416666666666667,0.5498142297542052,1.0,2/11,1.61%,PRKAG2;PRKAA2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6335497399077961,1.430733535352459,0.10179640718562874,0.5499064623138973,1.0,4/10,7.89%,RC3H1;FOXP3;LGALS9;CD274
prerank,actin filament polymerization (GO:0030041),0.4972766969710645,1.430394633802154,0.07130730050933787,0.5490497142737671,1.0,3/29,0.81%,GAS7;ARHGAP6;DIAPH1
prerank,muscle filament sliding (GO:0030049),0.47835620789796746,1.4300950739390141,0.054187192118226604,0.5459934299051638,1.0,6/38,10.08%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,actin-myosin filament sliding (GO:0033275),0.47835620789796746,1.4300950739390141,0.054187192118226604,0.5459934299051638,1.0,6/38,10.08%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.489364428709295,1.4290819088961932,0.07692307692307693,0.5474263685013011,1.0,8/34,11.15%,RORA;SMAD3;ENPP1;WNT10B;IL6;WNT5A;YAP1;LRP3
prerank,cellular response to nitrogen compound (GO:1901699),0.5426627541358684,1.4289190587187248,0.07334525939177101,0.5459135219506506,1.0,3/20,7.18%,ROCK2;ATP2B4;SPIDR
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5225003184376961,-1.4276996735360106,0.07603686635944701,0.4192562085907789,1.0,8/18,17.70%,NLGN1;RIMS1;RIMS2;RAB3GAP1;SYN1;RAP1A;SNAPIN;RIMS4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6079701712924018,-1.427564893326266,0.08624229979466119,0.41793843282813453,1.0,7/10,28.37%,SNCA;AKT1;SLC45A3;PTH1R;PRKCE;IRS1;PMAIP1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5475913907212969,1.4274856184981726,0.08851224105461393,0.5484486213929824,1.0,6/18,10.34%,PDPK1;COL4A3;FGFR1;CCL2;IGF2;AKT3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5438191520885438,-1.4271744778690936,0.07676348547717843,0.41719378265531704,1.0,5/14,10.48%,NOS3;ECE1;ACE;ENPEP;ACE2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5512138391362439,1.4261167273428896,0.08273381294964029,0.5490256978131441,1.0,3/20,4.74%,ZBTB20;PRKAA2;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.5512138391362439,1.4261167273428896,0.08273381294964029,0.5490256978131441,1.0,3/20,4.74%,ZBTB20;PRKAA2;ARNT
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5901126785593458,-1.4257598314237692,0.08713692946058091,0.4193143064177589,1.0,5/11,15.55%,ITPKB;IP6K2;FGF2;PPIP5K2;PPIP5K1
prerank,regulation of response to external stimulus (GO:0032101),0.3896223968866155,1.4252546903073202,0.019858156028368795,0.549725927549299,1.0,21/121,10.02%,EFNB2;PDGFRA;USP18;CASP12;ADAMTS12;GATA6;CD55;ANXA1;GP1BA;LACC1;PTPN22;ZBP1;CASP4;APPL2;TRIM5;BIRC3;WNT5A;STK24;ERAP1;APPL1;BRD4
prerank,phospholipid transport (GO:0015914),-0.403528694405343,-1.4250725164260742,0.0345821325648415,0.4193585192294857,1.0,16/52,14.19%,ATP8A1;ATP10A;ATP11B;PITPNC1;PITPNA;ABCA3;ATP8A2;ATP11A;ATP8B2;SCARB1;PRELID2;PRELID1;ATP8B1;SCARB2;MFSD2A;TMEM30A
prerank,negative regulation of neuron projection development (GO:0010977),0.44050511622496147,1.4244407954355205,0.06310679611650485,0.5503440783378484,1.0,11/56,9.99%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;LRP4;PTPN9;NGFR;EPHA4;NGEF
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.46876625175554465,1.423786521623021,0.06732348111658457,0.5505424812210504,1.0,9/43,4.75%,BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7
prerank,defense response to protozoan (GO:0042832),0.6247170924966298,1.4227277063132104,0.09716599190283401,0.5520192909136792,1.0,4/12,11.05%,GBP6;GBP2;GBP4;GBP7
prerank,collagen fibril organization (GO:0030199),0.4129397537517524,1.4207663967093038,0.03576982892690513,0.5566461046996487,1.0,15/88,6.80%,COL4A3;COL23A1;COL4A6;COL4A4;COL5A2;COL3A1;COL4A5;DDR2;LOXL3;BMP1;LOXL1;TGFBR1;COL20A1;COL5A1;COL18A1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5787091745373093,1.4206922364329182,0.08163265306122448,0.5549277870822539,1.0,3/15,8.04%,ROCK2;IL6ST;MEF2A
prerank,regulation of lipid biosynthetic process (GO:0046890),0.48803669802490135,1.4206833262235294,0.08994708994708994,0.5530254314785141,1.0,7/32,9.15%,ZBTB20;PRKAG2;PRKAA2;SORBS1;CREBL2;PPARA;SIRT4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.39375611729522164,1.4203089140185152,0.03281027104136947,0.5522885556400365,1.0,22/113,12.61%,TCF7L2;BMP6;PTN;LAMC1;FGF1;NOTCH2;OSR1;ECM1;NRP1;VEGFD;TGFA;BMP2;ARNT;TGFBR1;CLDN1;WNT5A;YAP1;AKT3;CDH13;EGR3;NR4A1;CRNN
prerank,T cell differentiation (GO:0030217),0.4606104867952998,1.4200656788513792,0.06026058631921824,0.5511741322877345,1.0,7/40,6.52%,LEPR;GLI3;NHEJ1;ANXA1;KIT;PTPN22;PTPN2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4428594330142269,1.4198281270039863,0.044753086419753084,0.5500981205175813,1.0,10/57,7.50%,PARP14;GHR;IL31RA;IL6ST;OSM;PARP9;KIT;IL6;PTPN2;IL18
prerank,acylglycerol homeostasis (GO:0055090),0.5524762044750965,1.4198106075775196,0.0711743772241993,0.5482627088731092,1.0,3/20,7.50%,RORA;NR1H3;IL18
prerank,Rac protein signal transduction (GO:0016601),-0.5347203075031921,-1.419706541106448,0.09110169491525423,0.4323040424363996,1.0,9/18,15.87%,ELMO1;EPS8;TIAM1;NCKAP1;RHOG;DBNL;RAC1;RHOH;HACD3
prerank,cation transport (GO:0006812),-0.32721642296659326,-1.4192800693959262,0.011450381679389313,0.43162579170902937,1.0,36/167,12.30%,SLC6A6;SLC47A1;PIEZO2;SLC12A2;KCNB2;KCNAB1;KCNMB2;KCNK5;SLC9B2;KCNMA1;ATP1B1;ANO1;ABCC9;KCNJ3;KCNJ2;SCN1A;SLC7A1;SLC5A5;SLC38A5;SLC8A1;SLC1A1;SLC5A6;SCN2A;TRPC6;KCNH1;TMEM63C;GRIN1;KCND3;NEDD4L;KCNJ6;SLC36A1;FGF13;SCN8A;KCNJ8;SCN9A;KCNJ15
prerank,response to prostaglandin E (GO:0034695),0.6334558718771334,1.4190587523827596,0.11728395061728394,0.5487901404363338,1.0,1/10,0.37%,TGFBR3
prerank,defense response to symbiont (GO:0140546),0.40322560028877324,1.4187964512653182,0.031746031746031744,0.547655974208287,1.0,24/92,14.41%,RSAD2;EIF2AK2;STAT2;TRIM56;PRF1;IFIT2;IL6;BCL2;ZBP1;TRIM5;BST2;OASL;STAT1;ZMYND11;MOV10;IFITM1;IFNLR1;BCL2L1;TLR2;OAS2;IFI27;IFIT1;IFIT3;IFIH1
prerank,sphingolipid metabolic process (GO:0006665),-0.34736286205272854,-1.4186996926789432,0.009836065573770493,0.43133415411671316,1.0,27/108,16.97%,ST6GALNAC3;SGMS1;ACER3;SERINC1;ELOVL5;ACER2;CERS4;CERT1;PPM1L;PPP2R1A;DEGS2;ELOVL7;SPNS2;HEXB;TECR;GLTP;NEU1;SGMS2;CERK;GM2A;PLPP1;GAL3ST1;PRKD1;HACD3;SPTSSA;ORMDL3;SGPP1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5789602195480675,-1.418328663645504,0.08,0.4305372865465109,1.0,4/12,8.10%,SYT1;RIMS1;RIMS2;SYT7
prerank,response to glucose (GO:0009749),0.4564671031339387,1.4180957747294693,0.0633116883116883,0.5480374607225785,1.0,5/46,5.35%,TCF7L2;ZBTB20;PRKAA2;APOA2;UNC13B
prerank,regulation of neuron migration (GO:2001222),-0.4637846336454899,-1.4177101307908824,0.07710280373831775,0.43039205245081014,1.0,15/26,23.89%,CTNNA2;SEMA6A;ADGRG1;DAB2IP;ARHGEF2;NEXMIF;RAPGEF2;SHTN1;CAMK2A;SEMA3A;SRGAP2;NTNG1;NTNG2;PLAA;NSMF
prerank,cellular response to sterol (GO:0036315),0.6006062003553134,1.416934782654409,0.09760589318600368,0.5498219722517215,1.0,2/13,0.60%,RORA;GRAMD1C
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.40977779739182124,-1.4168844282673954,0.04922279792746114,0.43085794405733896,1.0,17/43,23.49%,MEF2C;RYR2;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;ACVR1;APLNR;VANGL2;HES1;DLL1;SRF;TBX6;BBS7
prerank,central nervous system development (GO:0007417),-0.31121155526349165,-1.416756137847272,0.0,0.4295504752292144,1.0,49/250,10.51%,ADGRL3;ADGRL2;CNTNAP2;ROBO2;SLC2A1;CDH2;MEIS2;COL4A1;CNTN4;WWP1;ZFHX3;MOG;CNTN6;PBX3;NCKAP1;SHROOM4;VIT;GRIN2A;GRIK1;SERPINI1;SNTG2;ADGRG1;S100B;APOD;SH3GL2;ADAM22;AHI1;MAL;DCLK1;RAB3GAP1;NRCAM;GRIN2B;MBP;SCYL2;EIF2B2;ALDH5A1;ZIC3;ZBTB16;SOX6;LSR;NDRG4;BAG6;GRIN1;ADAM23;SPOCK1;DNER;DHX30;SEMA6B;DDIT4
prerank,engulfment of apoptotic cell (GO:0043652),-0.5405149482310185,-1.4161861065421872,0.0899581589958159,0.4294149031251595,1.0,8/15,17.36%,THBS1;XKR4;XKR6;RHOG;MEGF10;RAC1;RHOH;RHOBTB1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3357305111474632,1.4157873555593905,0.0011185682326621924,0.5516910275185464,1.0,133/572,16.98%,TCF7L2;FHL2;BMP6;SMAD3;RBPJ;ZEB2;ZHX2;MXI1;ATXN1;KANK2;NR2F2;SP100;KCNIP3;PRDM6;OSR1;TBL1XR1;SMURF2;FOXC1;GATA6;PPM1A;ZBTB4;NR6A1;FOXC2;GLI3;NFATC4;WWOX;MYB;MBD2;PARP9;NEDD4;LDB2;HIVEP1;CRY2;DACT1;BMP2;CRY1;APBB1;MIER3;BCOR;AEBP1;UXT;MTDH;GLIS3;GZF1;SALL1;OTP;ZNF3;MIER1;TPR;WWC2;NR1H3;FOXP3;HDAC4;PPARA;CREBBP;RARB;GLIS2;NSD1;USP9X;DPF2;STAT1;CDC73;SKI;MEF2A;ZNF25;VPS72;CUX1;ZFP37;YAP1;ZEB1;SAP130;DLG1;EPC1;IGF2;SUMO1;GATAD2B;CREM;E4F1;NUPR2;TAF7;SUFU;WWP2;CUX2;PPID;CIR1;CBX7;FNIP1;SMAD4;MAP2K5;RTF1;ATN1;FOXO3;IFI27;ZNF219;THAP1;NOG;EFNA1;BPTF;NFIC;CBX4;MZF1;BHLHE41;NR3C1;PEX2;PAF1;HIC1;ARID5B;ZNF205;PRDM5;MDM4;TLE6;FRK;VHL;ZBTB21;HDAC2;RARA;SMARCA4;ACVR2B;PER3;KDM2B;DAB2;POU5F1;ELK4;CPEB3;JDP2;URI1;SMAD2;POU6F1;TBL1X;ZBTB5;DNMT3A;NIPBL;RNF2
prerank,T cell activation (GO:0042110),0.420535233126902,1.415596074981469,0.04566929133858268,0.5504859733921291,1.0,9/69,6.52%,LEPR;DPP4;CXADR;CTPS1;NHEJ1;KIT;PTPN22;FOXP3;PTPN2
prerank,neuron projection development (GO:0031175),-0.3250684892085255,-1.4154865461708224,0.011673151750972763,0.4295838155886737,1.0,53/168,17.01%,FRY;GRM7;CNTNAP2;NLGN1;CTNND2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;PLP1;GPM6B;NCKAP1;STX3;TRIO;PAK1;PTPRM;NYAP2;EPHB1;DAB2IP;SH3GL2;DCLK1;HMGB1;MYOC;STMN2;RAPGEF2;SHTN1;UBB;RAB35;L1CAM;LYN;MINK1;DBNL;MANF;NEFH;MICALL2;ZFYVE27;ALS2;ULK1;PAK3;NGF;MAPK8IP3;TMEM108;BICDL1;LGI1;MYO16;MAPT;MAP2;NTF3;STMN4;SHANK1;SNAPIN;EPHB3
prerank,glycerolipid metabolic process (GO:0046486),-0.5987210426819606,-1.4148410051108204,0.09255079006772009,0.42965066308434524,1.0,6/11,21.10%,DGKB;DGKZ;DGKG;GAL3ST1;PGP;PNPLA3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5171286263507178,-1.4140786715403553,0.07515657620041753,0.42989361223390127,1.0,12/17,25.74%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;VPS9D1;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,camera-type eye development (GO:0043010),0.5101992148475287,1.4139463741771412,0.08777969018932874,0.5540461581661371,1.0,6/25,11.37%,EFEMP1;FBN1;SHROOM2;SKI;CACNA1C;NES
prerank,eye development (GO:0001654),0.43663451672259046,1.4137168802906024,0.05405405405405406,0.5529007173246843,1.0,11/54,10.07%,EFEMP1;FBN1;COL5A2;FOXC1;SHROOM2;RBP4;COL5A1;SKI;CACNA1C;MAB21L1;PBX1
prerank,positive regulation of wound healing (GO:0090303),0.48304157036147094,1.4132824571637304,0.06429780033840947,0.5524013302600126,1.0,11/36,15.39%,VTN;PLPP3;KANK1;FOXC2;ANXA1;SERPINE1;CLDN1;INSL3;PTK2;SMOC2;ADRA2A
prerank,positive regulation of immune system process (GO:0002684),0.5689562725909212,1.4131184989136067,0.11347517730496454,0.5510690547677776,1.0,5/16,10.70%,RSAD2;ANXA1;MIA3;LGALS9;HCAR2
prerank,cardiocyte differentiation (GO:0035051),0.6226761707835883,1.413085458983313,0.11854684512428298,0.5492946509520601,1.0,3/10,3.96%,AKAP13;GATA6;BMP2
prerank,negative regulation of coagulation (GO:0050819),0.5782598499975046,1.413066648918236,0.11524163568773234,0.5475157889444251,1.0,4/14,8.66%,TFPI;VTN;SERPINE1;SERPINE2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5692567394761107,-1.4127604481615246,0.09016393442622951,0.4319780209952519,1.0,4/12,9.05%,TGFB2;MBNL1;FBXW4;LRP6
prerank,regulation of osteoclast differentiation (GO:0045670),0.4757166875499423,1.4125474609070034,0.08006814310051108,0.5474500110486853,1.0,7/33,12.04%,FBN1;FSTL3;PRXL2A;TLR4;CARTPT;MAFB;CSF1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.48410831631138096,1.4114283064150952,0.05759162303664921,0.5492000295502518,1.0,17/33,23.90%,GLI1;PLK5;APPL2;ATP2B4;CDC73;PHB2;SUSD2;APPL1;PTPN6;CRNN;PAF1;INO80;PTEN;FBXW7;PKD1;PSME3;TAF1
prerank,cellular response to interferon-gamma (GO:0071346),0.4065428736575994,1.411004551296239,0.03193033381712627,0.5486904922537286,1.0,27/88,16.20%,GBP6;SP100;GBP2;DAPK1;TLR4;TRIM5;VCAM1;GBP5;CD47;OASL;GBP4;STAT1;CCL2;LGALS9;WNT5A;GBP7;TLR2;OAS2;TRIM21;TRIM26;JAK1;SLC26A6;CCL25;PML;IRF9;ICAM1;GBP3
prerank,granulocyte differentiation (GO:0030851),-0.49754375870080203,-1.410302186318507,0.07218683651804671,0.43692614140258645,1.0,7/18,17.25%,LEF1;CBFA2T3;TAL1;CDK2;CDKN1A;CDK4;RXRA
prerank,neurotransmitter uptake (GO:0001504),0.6004323995573584,1.4096729123134368,0.11871227364185111,0.5511867885598701,1.0,6/12,18.30%,ATP1A2;SLC1A3;GLUL;SLC38A1;SLC22A2;SLC29A1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.56410238506382,1.409065733767639,0.1005586592178771,0.5515007384772834,1.0,2/16,0.16%,RANBP3L;IGFBP3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.532925531108732,-1.4085254518813846,0.083710407239819,0.4401181348280161,1.0,7/16,17.78%,PPP1R16B;THBS1;GATA2;VEGFA;FGF2;APLNR;DLL4
prerank,regulation of lipid metabolic process (GO:0019216),0.402241756811372,1.408514008290209,0.028875379939209727,0.5515443708936907,1.0,11/88,6.91%,RORA;CHD9;PRKAG2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PANK2;PPARA;CREBBP;LACTB
prerank,heterochromatin organization (GO:0070828),-0.5477085863854478,-1.4083085343693758,0.07905982905982906,0.4390089401043438,1.0,2/14,3.43%,MECOM;PRDM16
prerank,gliogenesis (GO:0042063),-0.5332237420329217,-1.4071427732920039,0.09170305676855896,0.44047941814451125,1.0,6/15,14.20%,CDH2;TGFB2;CDK6;PAX2;NFIB;RELN
prerank,cardiac muscle tissue development (GO:0048738),0.4458345267002851,1.406287843046775,0.044444444444444446,0.556741375978196,1.0,10/50,4.75%,AKAP13;NOTCH2;GJB6;GATA6;CSRP3;GJA1;BMPR1A;RBP4;BMP2;BMP7
prerank,protein ubiquitination (GO:0016567),0.3364048089054122,1.4060412899589536,0.0022988505747126436,0.5556730596881162,1.0,103/471,15.53%,RNF220;PDZRN3;SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;HERC6;RNF217;FBXO11;FBXL17;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;EPAS1;MYCBP2;BCL2;TRIM17;RNF19A;KLHL21;KLHL22;UBE2U;SPSB4;DTX1;DZIP3;SIAH2;CUL4A;PELI2;TRIM5;DTX3L;FBXO9;MGRN1;NPEPPS;ANAPC11;USP9X;RNF20;CDC73;FBXL3;WAC;FBH1;TRIM24;KLHL18;NUB1;PSMB10;RNF111;AMFR;UBE2Z;PJA2;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO4;PSMA5;WWP2;FBXO24;KEAP1;BLMH;HUWE1;UBE2V1;RFWD3;RTF1;CUL3;KLHL13;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;ASB5;ARRB1;PEX2;PAF1;CDC27;PRPF19;RNF39;BFAR;RNF43;RNF103-CHMP3;LNPEP;RNF181;FBXL4;DDA1;LEO1;BRAP;RCHY1;VHL;BIRC6;UBE2R2;FBXL13;FBXL12;RNF146;MUL1
prerank,positive regulation of histone methylation (GO:0031062),0.5189025126229736,1.4047216295495433,0.09012131715771231,0.5580873897573219,1.0,6/24,13.47%,KMT2A;AUTS2;MYB;JARID2;SMAD4;PAF1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5684472414548637,1.4042186675553172,0.10582010582010581,0.5580304011834732,1.0,7/16,17.01%,LEPROT;PARP14;PTPN2;SH2B3;VHL;NF2;PPP2CA
prerank,defense response to bacterium (GO:0042742),0.3966955182139609,1.4029021721149286,0.03770949720670391,0.5606604393861467,1.0,19/105,11.25%,GBP6;SELP;COLEC12;GBP2;FPR2;ANXA3;IL6;TLR4;SERPINE1;OPTN;NOS2;CRP;GBP4;TNFRSF14;PLA2G6;ANKRD17;GBP7;TLR2;OAS2
prerank,polyol metabolic process (GO:0019751),-0.39313644312428586,-1.4026132384135188,0.04189944134078212,0.45077623290103574,1.0,13/46,15.74%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;PLCH1;PPIP5K2;PPIP5K1;PLCG1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5936732038491928,-1.4022267856320918,0.09710743801652892,0.45015117951805733,1.0,2/10,6.40%,SLIT2;EMILIN1
prerank,positive regulation of biosynthetic process (GO:0009891),0.46100964038481496,1.399437553876474,0.06919275123558484,0.5699264563818115,1.0,8/40,9.15%,ZBTB20;WNT4;VIM;SORBS1;TLR4;CREBL2;PPARA;SIRT4
prerank,response to hexose (GO:0009746),0.5113159478099563,1.3988806867920862,0.0924956369982548,0.5698665338864033,1.0,2/25,2.03%,TCF7L2;APOA2
prerank,regulation of exocytosis (GO:0017157),-0.4097035388344379,-1.3986742682573046,0.057692307692307696,0.4577216144765044,1.0,25/46,28.16%,SYT1;RIMS2;RAB27A;NSF;CADPS;IL1RAPL1;SNCA;STXBP5L;RAB27B;RAB3C;CPLX1;STXBP6;CPLANE2;RAB12;CLASP2;EXPH5;RAB15;SYTL4;ATP6AP1;HAP1;RAB8B;RAB3B;CHMP6;UNC13D;VAMP2
prerank,myelination (GO:0042552),-0.4061330941014903,-1.39851582004801,0.04392764857881137,0.45649340276324935,1.0,21/46,22.64%,ADGRG6;ACER3;PLP1;CMTM8;MAL;MYOC;MBP;EIF2B2;SCN2A;SCN8A;NFASC;ABCD2;TNFRSF21;ACSBG1;GAL3ST1;TPPP;AMIGO1;BCAS1;PLLP;B4GALT6;MAL2
prerank,regulation of dopamine secretion (GO:0014059),-0.4635070222861369,-1.3984785539692766,0.0889423076923077,0.4548725568438867,1.0,12/25,26.68%,SYT1;SNCA;SYT4;SYT7;SYT9;SYT2;KCNA2;CHRNA4;SYT6;SYT10;SYT5;SYT17
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.531088390551017,1.3979837855314035,0.10204081632653061,0.5708931755834172,1.0,4/21,3.43%,IGFBP5;GJA1;BMPR1A;ADAMTS1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5166924419638608,-1.3973358995635485,0.10135135135135136,0.45618548177348617,1.0,7/17,21.97%,CALM1;CALM2;HSP90AB1;CALM3;PTPRC;PPP1R15B;PPP1R15A
prerank,negative regulation of histone acetylation (GO:0035067),-0.5647323194347631,-1.396227031158223,0.1125,0.4577149139680848,1.0,5/11,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,regulation of interleukin-4 production (GO:0032673),-0.49592553940600104,-1.396041533568133,0.09271523178807947,0.4566424737704299,1.0,8/21,12.61%,LEF1;SLC7A5;PRKCQ;ZFPM1;HAVCR2;FCER1G;CD86;SYK
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.45770324796552075,1.3956232788584952,0.09803921568627451,0.5767095947995634,1.0,9/39,8.63%,ROBO1;TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;CREBBP;YAP1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5557829202104183,-1.3955235906419075,0.08739837398373984,0.4563849816259272,1.0,6/13,16.14%,PDE8A;MET;RACK1;PARK7;NR4A3;GPR37
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.40245186472550243,1.3953742878591675,0.043410852713178294,0.5757288368422464,1.0,21/87,12.26%,TGFBR3;SMAD3;ZMIZ1;COL3A1;BMPR1A;CDH5;TWSG1;LRRC32;PARD6A;PRKCZ;TGFBR1;APPL2;TGFBR2;USP9X;SKI;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;MAP3K7
prerank,basement membrane organization (GO:0071711),0.5682950376998288,1.3944998645384998,0.11281070745697896,0.5766964414463255,1.0,3/14,2.53%,FLRT2;NID1;NID2
prerank,acylglycerol metabolic process (GO:0006639),-0.4115215457606661,-1.3936379204542237,0.07444168734491315,0.45992214851788155,1.0,12/37,17.57%,DGKB;DGKI;DGKH;MGLL;ABHD2;SEL1L;DGKZ;CAV1;DGKG;ABHD6;PLAAT3;LPL
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5701965151010181,-1.3932469139604464,0.11462450592885376,0.4593900082063007,1.0,5/11,25.16%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,focal adhesion assembly (GO:0048041),-0.48587260693168366,-1.3932119559852956,0.10465116279069768,0.4578376500195248,1.0,9/21,11.94%,ACTN1;PTPRK;THSD1;PEAK1;TESK2;RCC2;TRIP6;BCR;ARHGEF7
prerank,cellular amino acid catabolic process (GO:0009063),0.39410019306512506,1.3925213636150677,0.0529500756429652,0.5814778520918659,1.0,30/87,22.46%,HAL;DDO;SHMT1;HYKK;PHYKPL;NOS2;ALDH4A1;ASPA;ACADSB;HGD;GLUL;AMT;HNMT;BCKDHA;ABAT;BLMH;ACAT1;SARDH;ALDH6A1;HIBADH;ACAD8;MCCC1;CARNMT1;PRODH;DBT;ALDH7A1;HOGA1;HAAO;IVD;MCCC2
prerank,anion transmembrane transport (GO:0098656),0.41995197496000947,1.391648937879492,0.0639269406392694,0.5824611935770726,1.0,8/67,3.91%,SLC7A2;SLC1A3;SLC13A3;SLC6A13;SLC13A4;SLC19A1;SLC6A9;SLC16A12
prerank,negative regulation of signaling (GO:0023057),0.505130336510038,1.3903749554041307,0.09800362976406533,0.5849073226557697,1.0,5/25,5.68%,IGFBP3;MPIG6B;OSM;IL11;OPTN
prerank,chemokine-mediated signaling pathway (GO:0070098),0.45686696450540165,1.3896998190147671,0.0864600326264274,0.5854385042081204,1.0,10/42,14.90%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3;SH2B3;WNK1;RBM15;CCL25
prerank,hippo signaling (GO:0035329),0.4972465161011485,1.389380454583694,0.10104529616724739,0.5846188698801535,1.0,12/26,17.62%,TEAD1;AMOTL1;LATS2;DCHS1;TEAD2;STK3;YAP1;TJP1;STK4;WWTR1;YWHAE;CASP3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.44463294083489097,1.3892786120643745,0.0743801652892562,0.5831598682792741,1.0,7/47,3.38%,PDPN;DOCK5;TACSTD2;KANK1;NRP1;FBLN1;S100A10
prerank,gonad development (GO:0008406),0.46679067001374897,1.3884960352520241,0.07601351351351351,0.5840806163503072,1.0,7/41,8.47%,WNT4;NR2F2;GATA6;WNT2B;KIT;SALL1;WNT5A
prerank,protein deneddylation (GO:0000338),-0.59464532583055,-1.3882797602969752,0.10040160642570281,0.46971905543788317,1.0,6/10,30.84%,COPS6;COPS5;COPS2;GPS1;COPS4;TOR1A
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.40864794818444145,1.3864033897171428,0.055891238670694864,0.5893527433775495,1.0,10/75,3.88%,SULF1;COL4A3;WNT4;ROCK2;CXCL10;FOXC1;THBS2;HSPG2;ADAMTS1;DCN
prerank,phosphatidylserine metabolic process (GO:0006658),0.47508766261227764,1.3863992091591555,0.07679180887372014,0.5875658968374019,1.0,4/32,5.17%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4988448190872223,1.3857120514401686,0.08319467554076539,0.5880821902843876,1.0,9/26,19.51%,CBLB;SNX6;TGFA;ERRFI1;ADRA2A;SOCS4;APP;SHC1;HBEGF
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5978469594212603,-1.384154343487475,0.10080645161290322,0.47941372118734576,1.0,4/10,8.94%,PTPRJ;SNCA;APOD;NDRG4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.42083652407438665,1.384023164777331,0.07830342577487764,0.5917445931149358,1.0,20/62,17.39%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;POLR2C;IWS1;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;AFF4;GTF2H2;CDK13
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.43548399821405015,-1.3836911926260727,0.07451923076923077,0.4789157304342168,1.0,8/32,8.65%,RIMS1;RIMS2;MEF2C;MCTP1;CPLX1;SLC30A1;CAMK2A;SYN1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5865413834656633,1.383624495024335,0.12222222222222222,0.5877483223560184,1.0,5/12,13.48%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5865413834656633,1.383624495024335,0.12222222222222222,0.5877483223560184,1.0,5/12,13.48%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5865413834656633,1.383624495024335,0.12222222222222222,0.5877483223560184,1.0,5/12,13.48%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,regulation of defense response to virus by host (GO:0050691),0.48268366268856566,1.3833671312464502,0.11091854419410745,0.5867580323969841,1.0,9/30,15.53%,PARP9;PTPN22;RNF216;DTX3L;STAT1;IFNLR1;TARBP2;IL23R;MUL1
prerank,triglyceride catabolic process (GO:0019433),-0.4877073655401618,-1.3828364607571786,0.08061002178649238,0.479579125475613,1.0,9/19,42.11%,LPL;PNPLA3;LIPH;FABP3;LIPC;FABP4;FABP7;FABP12;FABP5
prerank,neuropeptide signaling pathway (GO:0007218),-0.3801270274918574,-1.3827198828705567,0.02356020942408377,0.47828542865120977,1.0,17/58,20.74%,CPE;SORCS1;SORCS3;GLRA3;OPRM1;SORL1;RAPGEF2;CYSLTR2;NXPH2;CYSLTR1;PPY;SORT1;GPR37;GLRA2;GLRA1;GRP;PENK
prerank,positive regulation of dendritic spine development (GO:0060999),-0.48475231926807055,-1.3825614625827383,0.08315098468271334,0.4769788661125461,1.0,10/20,23.47%,NLGN1;SHANK3;CAPRIN2;LRP8;DBNL;RELN;SHANK1;LLPH;CAPRIN1;FOXO6
prerank,regulation of actin filament depolymerization (GO:0030834),0.5954701112341646,1.3821737783178625,0.11131386861313869,0.5888022941454183,1.0,3/12,10.49%,PLEKHH2;LIMA1;PLEK
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5736311104360221,1.382167312284673,0.13582677165354332,0.587071598005626,1.0,4/13,10.34%,PDPK1;FGFR1;IGF2;AKT3
prerank,cellular glucan metabolic process (GO:0006073),0.5949183631117047,1.380991596945774,0.12681159420289856,0.5892806667582889,1.0,3/11,9.09%,PRKAG2;GSK3B;PYGM
prerank,calcium import into the mitochondrion (GO:0036444),0.6098165834370082,1.3806818331627835,0.1469387755102041,0.5886000885008433,1.0,2/10,1.57%,MCU;MICU1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4249179577176145,-1.38053579673781,0.06046511627906977,0.4809131901041179,1.0,16/33,28.08%,MEF2C;THBS1;NOTCH1;ACVRL1;HMGB1;FGF2;KLF4;RGCC;DLL4;CARD10;VASH1;ANGPT2;ANGPT4;HDAC5;CSNK2B;PDCD10
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4108225549893819,-1.3790371065841287,0.05808080808080808,0.4831989972687393,1.0,7/38,3.31%,KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2
prerank,negative regulation of phosphorylation (GO:0042326),0.397641796546935,1.378892657777291,0.043010752688172046,0.5927083193672422,1.0,13/85,9.30%,PTPN13;IGFBP3;PID1;PLPP3;NUPR1;DYNLL1;FBLN1;BMP7;HDAC4;PPARA;CDKN2B;MYADM;LRRK2
prerank,zinc ion transmembrane transport (GO:0071577),-0.4711762941702343,-1.37824517302303,0.0935412026726058,0.48390479786192847,1.0,7/22,14.55%,SLC39A10;SLC39A6;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8
prerank,T-helper cell differentiation (GO:0042093),-0.5345456904107295,-1.3782009022282138,0.0975609756097561,0.48234620804884093,1.0,3/14,9.13%,LEF1;HMGB1;ZFPM1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4339038013258657,1.3780191243342548,0.07006369426751592,0.5936233969938547,1.0,13/56,8.24%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;EPHA3;FER;KIT;TPST1;EPHA1;PDGFRB;TTL;EPHA4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4039544970475228,1.3774214515615137,0.05345911949685535,0.5938498636291626,1.0,15/76,11.12%,UACA;SASH1;EIF2AK2;NFAT5;PPM1A;IFI35;TLR4;BMP7;PTPN22;CPNE1;LGALS9;PHB2;DLG1;PPM1B;TLR2
prerank,intracellular pH reduction (GO:0051452),-0.4204762417713821,-1.3773627734153666,0.07512953367875648,0.48282562263174456,1.0,13/33,21.48%,ATP6V0A1;CLCN3;ATP6V1B2;ATP6V0C;RAB38;DMXL2;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5417592443962912,1.3762473126814112,0.12786259541984732,0.5961243552209675,1.0,4/16,5.23%,FOXD1;FGF1;BMP2;SALL1
prerank,phagosome acidification (GO:0090383),-0.44322737934432443,-1.3757514377254352,0.07109004739336493,0.48554530450496414,1.0,11/26,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5068383494268707,1.375452517681559,0.12181818181818181,0.597072949815353,1.0,4/25,2.25%,PHLDB2;ARHGAP6;ROCK2;DLC1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3137130539905859,1.3752830665243314,0.0,0.595918617738579,1.0,348/1646,16.65%,TCF7L2;TCF4;CREB5;KMT2A;EFEMP1;RORA;ZBTB20;SOX5;TSHZ2;WNT4;ZKSCAN2;EBF1;FOXD1;SMAD3;PRICKLE1;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;TLE1;ARNT2;MLLT3;OSR1;IL31RA;TBL1XR1;TEAD1;SMURF2;FOXC1;NFIA;LBX1;STAT2;NFYC;NFAT5;TRIM56;PHIP;ZNF697;GATA6;SPIB;TCF24;WNT3A;KDM7A;MAF;HIF3A;RGMB;SAMD13;PPM1A;ZBTB4;ZNF395;DENND4A;SSBP2;NR6A1;FSTL3;ZIC2;SNX6;FOXC2;RBFOX2;GLI3;NFATC4;MYB;ZIC4;MBD2;ZMYND15;TRAK1;PARP9;TGFA;TCEAL7;FZD2;HIVEP2;IKZF2;TGFB1I1;PRRX2;EID2B;HIVEP1;CRY2;NUCKS1;HOXC6;PRDM11;ZBTB8A;HOXC4;PERM1;KIT;ZIC1;LITAF;BMP2;STAT5B;RFX3;CRY1;LOXL3;BRWD1;APBB1;CREB3L4;IL6;ZFP30;EPAS1;HLF;GLI1;BCOR;ARNT;BMP7;EN2;SIM2;ZNF276;UXT;MTDH;GLIS3;GZF1;NIF3L1;TGFBR1;NCOA6;SALL1;CBFA2T2;PRRX1;ZNF3;LBHD1;MGA;TCF12;KDM3B;KLF5;NSD3;BAZ2A;HDGFL3;SP9;ZNF35;CREB3L3;WWC2;NR1H3;FOXP3;ATP2B4;TESMIN;ANXA4;DTX3L;HDAC4;ZKSCAN4;CREBL2;PPARA;TCF7L1;TSHZ3;DKK3;PBXIP1;VGLL3;CREBBP;GLIS2;PCGF5;NSD1;ZBTB37;ZBTB7C;POU1F1;SFR1;KLF9;HOXA2;CREBRF;RNF20;DPF2;STAT1;WAC;ARHGEF11;NEK4;ZSCAN21;QRICH1;MEF2A;ZMYND11;NFXL1;RNF111;CRLF3;PIAS1;PHB2;ZNF25;TEAD2;ATF7;BAZ1B;CUX1;WNT5A;ZNF182;ZFP37;SP8;YAP1;ZEB1;CCNH;KAT6B;RLF;EPC1;IGF2;ZNF394;NAA16;ELF4;MNAT1;ZBTB3;USP47;SCMH1;SUMO1;CREM;SMAD6;TOX4;HDGFL2;SP110;E4F1;EBF4;JARID2;SOX21;NUPR2;BRD4;PBX1;RFXANK;TAF7;SUFU;MAFB;MSC;CDK16;MAPK14;PSPC1;WWP2;CUX2;GMNN;BAZ1A;ATF7IP;HEYL;ZNF292;UBE2V1;CIR1;POLR3F;ZNF235;TGFBRAP1;RRP8;NAA15;ELF2;RFXAP;TCF7;SMAD4;STAT4;SCML4;HIVEP3;BCL7A;EGR3;PPP3CB;ZNHIT3;FOXO3;NR4A1;ACTL6A;RBBP8;LHX9;ZNF219;VGLL4;ILF3;ZFAT;KDM5B;DVL3;EGR2;ZKSCAN7;OGG1;RPS6KA3;BTRC;SRCAP;THAP1;MAP2K1;HOXA10;FBXW11;BPTF;KDM2A;NFIC;MED12;CBX4;ARRB1;MZF1;BHLHE41;NR3C1;GMEB1;SERTAD3;MED20;PKNOX1;NFE2L1;NRF1;HIC1;ARID5B;POU2F1;ZNF205;KAT6A;BRWD3;ERCC6;PRDM5;KDM8;MDM4;NCOA2;SALL2;RBM15;DMTF1;RFX2;FUS;RUNX1T1;CARM1;VHL;NIBAN2;ZBTB21;ZNF569;ZBTB12;HDAC2;IFRD1;RARA;MAP3K2;PML;ZNF18;UIMC1;MAMSTR;ILK;SP3;ZFX;SETD5;ZNF383;HOXB4;TEF;SMARCA4;ACVR2B;SOX4;PHF20L1;IRF9;KDM2B;DNAJC2;VEZF1;LIN9;ERN2;POU5F1;ELK4;CTDSP1;ZNF260;JDP2;SMARCC1;URI1;DRGX;SMAD2;TRIM16;RING1;WWTR1;BCL11B;ZNF483;POU6F1;SPINDOC;NFATC2;TBL1X;PSRC1;CCAR1;ANKRD49;ZBTB5
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.44140944743850913,1.3746427533716878,0.09152542372881356,0.5963750790333244,1.0,6/46,7.66%,TCF7L2;SMAD3;NEDD4;ZIC1;TPR;GSK3B
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.44637185633043747,1.3731496896821722,0.08739495798319327,0.5993316769758497,1.0,9/41,13.11%,AFDN;PLPP3;FSTL3;BMP7;CD47;TJP1;PTPRU;ADAM19;JAK1
prerank,embryonic organ development (GO:0048568),0.4162062368876704,1.372170569581587,0.06472491909385113,0.6008123372019164,1.0,16/61,12.67%,KMT2A;RBPJ;TEAD1;BMPR1A;GLI3;RBP4;KIT;SALL1;RARB;TGFBR2;TEAD2;COL13A1;PBX1;NES;SH2B3;RARRES2
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5802460604925892,-1.3718815649805276,0.10309278350515463,0.49482763212475184,1.0,3/10,8.85%,CTNNB1;FZD3;VEGFA
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4749383406357678,-1.371583089699416,0.10284463894967177,0.49394051773362957,1.0,5/21,9.05%,FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC5
prerank,positive regulation of protein modification process (GO:0031401),-0.30897315630360206,-1.3706546842592067,0.01639344262295082,0.4948729307604481,1.0,50/203,13.77%,TEK;PECAM1;LIMCH1;ERBB4;LIMK2;PPP1R16B;EFNA5;PDE8A;TNIK;INSR;TFRC;KDR;VEGFC;NOS1AP;PAK1;TBX1;CSNK1D;NTRK2;CAMTA1;CALM1;GAS6;SEMA4D;CALM2;PTBP1;RAB3GAP1;PIK3R3;MAPK3;NPTN;CALM3;BMP4;AKT1;ACE;SYMPK;PINK1;ACVR2A;VEGFA;CCND1;FAS;CD74;LYN;RACK1;CD40;FGF2;EGFR;HSP90AA1;CSF1R;HRAS;RAC1;KRAS;PLAUR
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5460907296402967,1.3705644840877045,0.11837455830388692,0.6042219981965125,1.0,2/18,1.49%,ATP1A2;STK39
prerank,skeletal muscle contraction (GO:0003009),0.5306985035947938,1.3703633874545036,0.10760667903525047,0.6031453691462563,1.0,1/19,0.28%,TNNC1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.40876378856947143,1.3695520318997054,0.0631911532385466,0.6039676533372863,1.0,10/72,4.20%,ROBO1;LPAR1;AKAP13;KANK2;COL3A1;HEG1;DLC1;KANK1;NRP1;F2RL3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5525206674156862,-1.3694638565171833,0.09978308026030369,0.4964712530067904,1.0,5/12,15.47%,INSR;SETX;SMCR8;ADRB2;IRGM
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5132018415754936,1.3693861841047048,0.10873440285204991,0.6027803164796468,1.0,3/23,4.74%,ZBTB20;PRKAA2;ARNT
prerank,positive regulation of cellular catabolic process (GO:0031331),0.37044850066437274,1.3692473052004257,0.04,0.6015132077061033,1.0,27/132,12.93%,ZBTB20;RNF152;SH3D19;ZC3HAV1;PRKAA2;DACT1;DAPK1;DCN;RC3H1;NRDC;ARNT;MTDH;OPTN;TRIM5;DTX3L;PPARA;PIK3C2A;GSK3B;SNX9;MOV10;LRRK2;TPCN1;FOXO3;VGLL4;TRIM21;PTPN1;SUPV3L1
prerank,Rho protein signal transduction (GO:0007266),0.42708452992892254,1.368679675981176,0.07532051282051282,0.6018041164869092,1.0,8/53,7.75%,ARHGAP29;PDPN;ARHGAP6;ROCK2;NTN1;CELSR1;NGFR;ARHGEF11
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5950892409134143,1.3677993283927499,0.1294559099437148,0.6029151533435014,1.0,2/11,8.57%,PDK1;STK24
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3940126340861624,1.367446228789964,0.05597579425113464,0.6023560736234306,1.0,19/86,10.74%,BMP6;TEC;VTN;EPHA7;GHR;OSM;IL11;NRP1;ITGA5;ANGPT1;IL6;PRKCZ;HAX1;TNFRSF14;RIPK2;IGF2;RAP2C;PTPN6;ENPP2
prerank,negative regulation of protein polymerization (GO:0032272),-0.44324898702902404,-1.367144437381819,0.08018867924528301,0.5011605772975698,1.0,14/27,20.10%,SLIT2;SSH2;KANK3;KANK4;SNCA;HIP1R;STMN2;CYRIB;TUBB4A;TWF1;MAP2;SSH3;STMN1;PFN2
prerank,cardiolipin metabolic process (GO:0032048),0.5708883324146499,1.3671297233371709,0.13127413127413126,0.601593107409968,1.0,5/13,19.81%,PLA2G4A;PLA2G6;PLA2G5;HADHA;SLC27A1
prerank,stabilization of membrane potential (GO:0030322),0.5426532887392966,1.3668962660283543,0.12939001848428835,0.6006637644186557,1.0,1/16,0.04%,KCNK2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.357137285429236,-1.366885863551476,0.05029585798816568,0.5001367394493964,1.0,25/72,18.17%,SLIT2;SHANK3;SSH2;NAV3;KANK3;HSPA8;KANK4;SNCA;HIP1R;ARHGEF2;STMN2;EMILIN1;CYRIB;PFDN5;TUBB4A;FGF13;PFDN2;CLASP2;TWF1;MAP2;SSH3;SHANK1;PFDN4;MID1IP1;STMN1
prerank,regulation of innate immune response (GO:0045088),0.42413960635608594,1.3662508607406216,0.07496012759170653,0.6010819928408287,1.0,18/57,17.01%,USP18;FPR2;PARP9;IFI35;PTPN22;APPL2;GBP5;BIRC3;ERAP1;APPL1;PTPN6;POLR3F;IRAK3;TRIM21;PTPN1;MUL1;IFNAR2;RNF135
prerank,protein import into nucleus (GO:0006606),0.41311160739436054,1.366240531345318,0.0669710806697108,0.5994338760248531,1.0,13/66,12.16%,CBLB;PRICKLE1;TNPO1;RANBP2;APPL2;TPR;KPNA6;KPNA7;KPNA4;PHB2;APPL1;IPO7;EIF4ENIF1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4588899820095069,-1.365961059621239,0.09601873536299765,0.5011901966612544,1.0,10/25,14.81%,PDE4D;PDE4B;PLCG2;RPS3;MALT1;CD80;CD86;RUNX1;PNP;PTPRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5645438227409781,1.365834523828765,0.12643678160919541,0.597360212827572,1.0,3/16,2.25%,PHLDB2;ARHGAP6;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5645438227409781,1.365834523828765,0.12643678160919541,0.597360212827572,1.0,3/16,2.25%,PHLDB2;ARHGAP6;DLC1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5859688397632579,1.3657795551172136,0.14097744360902256,0.5958718981852865,1.0,4/12,14.75%,NR1H3;PPARA;CRP;ABCA1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36008074174345195,1.3656360715313247,0.03351206434316354,0.5946408796900603,1.0,32/158,14.55%,WLS;LPAR1;AKAP13;ECM1;GJA1;PPM1A;TRAF5;LITAF;CFLAR;IKBKE;ROR1;MTDH;GOLT1B;MIER1;PELI2;TRIM5;BIRC3;BST2;JMJD8;LGALS9;VAPA;RIPK2;ANKRD17;BRD4;UBE2V1;RHOC;MAP3K7;TRIM21;TIFA;TICAM1;ZDHHC17;TBK1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5265806717038581,1.365293781868478,0.10825688073394496,0.5940699641589118,1.0,8/19,19.06%,NFAT5;NFATC4;PLCE1;NMUR1;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,myoblast fusion (GO:0007520),-0.5374254200285543,-1.3640183540390522,0.11715481171548117,0.5050190874736659,1.0,4/12,10.30%,ADGRB3;JAM2;KCNH1;NOS1
prerank,anterograde axonal transport (GO:0008089),-0.40982993756790836,-1.36392468783515,0.07474226804123711,0.5035659406966311,1.0,13/37,17.02%,DLG2;KIF1B;KIF1C;RAB27B;AP3S2;KIF5C;MAPK8IP3;KIF3B;AP3B2;KIF5A;SOD1;SNAPIN;AP3D1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4886133739764863,1.3636602579019579,0.11148648648648649,0.5977073436185194,1.0,4/27,2.51%,FN1;PDGFRA;DDR2;S100A6
prerank,regulation of ion transport (GO:0043269),-0.3579008354495092,-1.363304788073442,0.05521472392638037,0.503572474052647,1.0,23/76,14.85%,NKAIN2;SYT1;KCNJ3;KCNJ2;ANK3;SNCA;ATP1A1;NKAIN3;CA2;YWHAH;NKAIN1;SYT4;SYT7;SIK1;B2M;NEDD4L;NOS1;KCNJ6;KCNJ8;KCNJ15;SYT9;SYT2;KCNA2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4371797326434481,-1.3620117031883512,0.08872901678657075,0.5056978041096751,1.0,7/29,5.00%,DPP10;KCNAB1;FGF12;KCNIP4;HOMER1;KCNIP1;DPP6
prerank,protein kinase B signaling (GO:0043491),-0.46248261398347107,-1.3618514033305031,0.10588235294117647,0.5044854910700716,1.0,6/23,11.27%,KDR;SETX;GAS6;PIK3R3;AKT1;PAX2
prerank,ATP transport (GO:0015867),0.6127535562983433,1.3616191946359315,0.14829659318637275,0.6027100742056416,1.0,4/10,14.25%,SLC17A9;CD47;SLC25A24;SLC25A4
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.5838823515162859,1.3612354641845594,0.14465408805031446,0.6022636462450937,1.0,4/11,13.11%,IL6ST;STAT1;STAT4;JAK1
prerank,prostanoid biosynthetic process (GO:0046457),0.5473437515807934,1.3610068745688215,0.11886792452830189,0.6013337013512019,1.0,2/15,1.37%,PTGS1;PLA2G4A
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.49367443148018997,-1.3605276912555764,0.09631147540983606,0.5065935513039176,1.0,9/17,19.56%,SMAD7;CALM1;CALM2;INPP5K;CALM3;SPRED2;DDIT4;SPRED3;SPRED1
prerank,negative regulation of hormone secretion (GO:0046888),0.607027004908847,1.360166763846127,0.15247524752475247,0.6024139238412914,1.0,3/10,2.68%,GJA1;OSM;IL11
prerank,diol biosynthetic process (GO:0034312),-0.5086632855521056,-1.3601581239886724,0.1194331983805668,0.505898711889832,1.0,3/15,10.31%,ACER3;ACER2;GCH1
prerank,regulation of lamellipodium organization (GO:1902743),0.5572628559010544,1.359653864703317,0.14711359404096835,0.6024340107270483,1.0,4/14,12.29%,PDPN;FER;CAPZB;EPHA2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.45216789414752756,1.3595194292428667,0.11074380165289256,0.6012489748280251,1.0,9/41,11.00%,PTGS1;PLA2G4A;ACSL1;PLA2G4C;PTGR1;ALOXE3;SCP2;EPHX1;SCD5
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.4445725731929863,-1.3593031720504838,0.11556603773584906,0.5066376941931245,1.0,12/26,18.17%,PLCG2;RYR2;HTR2C;RYR3;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;SLC8B1;HTR2A
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.37323834157280683,1.3588182719327846,0.03486750348675035,0.6018294000028784,1.0,22/121,9.00%,BMP6;TEC;PARP14;VTN;GHR;IL31RA;IL6ST;OSM;IL11;NRP1;PARP9;ITGA5;IL34;ANGPT1;KIT;IL6;HAX1;IL18;TNFRSF14;RIPK2;EPHA4;IGF2
prerank,intracellular sterol transport (GO:0032366),0.5730321828511978,1.357786772503943,0.13188976377952755,0.6035999458714784,1.0,8/13,29.75%,NPC1;STAR;ABCA1;SERAC1;VPS4A;OSBPL2;ABCG1;STARD4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4949188274731987,1.3576374073208652,0.10035211267605634,0.6024423486737545,1.0,5/23,5.70%,UACA;PPM1A;IFI35;BMP7;CPNE1
prerank,lipid phosphorylation (GO:0046834),-0.5811523591315397,-1.356426922144025,0.11157894736842106,0.5134283521803062,1.0,4/10,6.91%,DGKB;DGKI;DGKH;DGKZ
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5267714055146743,1.354934252282708,0.13812154696132597,0.6094679202064217,1.0,7/18,13.11%,IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.526835209924844,-1.3536468409255555,0.11940298507462686,0.520010760447658,1.0,5/13,4.08%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1
prerank,cardiac muscle cell action potential (GO:0086001),-0.4347672669233582,-1.353454678691472,0.10386473429951691,0.5189110336345175,1.0,12/30,12.24%,DMD;ATP1B1;FGF12;KCNJ2;SCN1A;ATP1A1;SLC8A1;HCN2;CACNA1G;KCND3;CACNA1D;KCNQ1
prerank,regulation of lipid kinase activity (GO:0043550),-0.5674690808401974,-1.3533806167582394,0.12830957230142567,0.517459983649645,1.0,6/11,23.08%,PIK3R1;PIK3R3;WDR81;RBL1;RBL2;PPP2R5A
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6158685633835879,1.3528585834402072,0.1434108527131783,0.6146712591981677,1.0,3/10,10.74%,PLA2G4A;PLA2G6;ENPP2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5285264831253607,1.3526442209043068,0.13059701492537312,0.6137461820625159,1.0,4/17,4.73%,EFNB2;ROBO1;NRP1;MIA3
prerank,regulation of cell killing (GO:0031341),0.5530482253671016,1.3525346548856758,0.1297709923664122,0.6124803482773223,1.0,5/16,8.47%,CFH;CD55;IL11;NOXO1;WNT5A
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.45282485553808804,1.3515889940198464,0.10304054054054054,0.6138367425724693,1.0,7/38,10.32%,RORA;TLE1;PPM1A;STAT1;ZMYND11;NLRX1;PPM1B
prerank,membrane organization (GO:0061024),-0.2995999292868599,-1.3509016408725736,0.0163265306122449,0.5229094515316479,1.0,51/227,13.89%,DNM3;SGIP1;SGCZ;SYT1;RIMS1;HIP1;FNBP1L;HSPA8;TFRC;AMPH;CERT1;ACTB;SH3KBP1;REEP1;EPN2;CHRM2;ANK3;LPCAT2;ACTG1;HIP1R;ATP2C1;SH3GL2;SNX3;DYSF;FNBP1;GLTP;CCDC88A;ARPC3;ARPC4;ARPC2;NSFL1C;UBB;REPS2;LDLRAP1;VPS33B;CNTN2;M6PR;MFN2;SERP1;ARPC1A;CBL;ADRB2;SCARB2;NUP93;SYNGR2;EGFR;NAPA;FZD4;UBA52;SYT9;SYT2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5961008677557225,1.3505287306999216,0.15458015267175573,0.6156099535612417,1.0,6/10,29.21%,SETD4;SETD7;SETD2;SETD6;SMYD2;EHMT1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5343369005566376,-1.3504665246978627,0.12087912087912088,0.5224730212893868,1.0,5/13,9.50%,PLCG2;TGFB2;SEMA7A;TGFB3;CD74
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5993794006829971,1.349937810948801,0.1541501976284585,0.6159092169261039,1.0,3/10,5.69%,PID1;ENPP1;APPL2
prerank,regulation of fibroblast proliferation (GO:0048145),0.43347091556972794,1.3488658501643704,0.09951845906902086,0.6176985019679421,1.0,9/45,8.47%,FN1;PDGFRA;DDR2;S100A6;MORC3;PARP10;CDC73;SKI;WNT5A
prerank,digestive tract development (GO:0048565),0.4583809635726161,1.3487617291038205,0.1189710610932476,0.6164132569454969,1.0,8/32,7.18%,GATA6;GLI3;KIT;GLI1;SALL1;CLMP;RARB;DNAAF1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4866543894393346,1.3486464993292298,0.12369337979094076,0.6151270661924778,1.0,9/26,18.62%,KANK2;CRY2;CRY1;STRN3;HEYL;SMARCA4;DAB2;CNOT9;CLOCK
prerank,positive regulation of inflammatory response (GO:0050729),0.3842185349290038,1.3484468335237256,0.06838905775075987,0.6140925429942246,1.0,16/86,11.69%,IL16;NUPR1;IL6ST;OSM;IFI35;IL6;TLR4;ZBP1;SERPINE1;CREB3L3;CD47;IL18;SETD4;WNT5A;TLR2;NFKBIZ
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4871220139397945,1.3482057343922513,0.09818181818181818,0.6132746371106282,1.0,2/24,1.34%,LEPR;PID1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5282758403168758,-1.3473398153267588,0.09713024282560706,0.530175252258571,1.0,10/13,39.14%,NLGN1;EPS8;HRAS;FAM98A;PFN1;CARMIL2;PLEKHM1;NDEL1;EPS8L2;P2RY12
prerank,positive regulation of type 2 immune response (GO:0002830),0.5536493751015863,1.3470472657504338,0.1575875486381323,0.6154739654396153,1.0,4/14,7.50%,RSAD2;IL6;PRKCZ;IL18
prerank,protein export from nucleus (GO:0006611),0.4816360847614143,1.347010910932432,0.11072664359861592,0.613975679559127,1.0,10/27,21.85%,RANBP3L;TPR;DUSP16;EGR2;STRADB;RAN;RANBP17;STYX;XPO5;PKD1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.4032097539946444,-1.3467668856118078,0.07635467980295567,0.5301855390974277,1.0,9/37,5.85%,CADM1;NLGN1;HMCN1;PTPRD;GRID2;TENM2;TENM3;IL1RAPL1;TENM4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5171080364319748,1.3461939881087583,0.125,0.6150583172468361,1.0,8/21,21.06%,SAMD4A;TUT4;PAN3;CNOT3;CNOT9;TUT7;PARN;PAN2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5584034111656369,-1.345687907754187,0.12184873949579832,0.5317165852116713,1.0,6/12,12.97%,CSGALNACT1;FUT8;GFPT2;PARG;GFUS;GFPT1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5233696412347235,1.3456256705098468,0.14204545454545456,0.6152941307304605,1.0,2/17,0.82%,MCU;CAMK1D
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5315710425348924,1.3455708875406864,0.14232209737827714,0.6138957897054933,1.0,7/16,12.98%,PDGFRA;NRP1;FER;PDGFRB;PIK3C2A;PTPN1;PLAT
prerank,regulation of stem cell differentiation (GO:2000736),0.38702159726309554,1.3439395396900435,0.06534954407294832,0.6173658270965797,1.0,15/89,10.29%,KMT2A;PTN;PDGFRA;EIF2AK2;TACSTD2;BMPR1A;OSM;MYB;TCF12;SLC4A11;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,negative regulation of cellular protein localization (GO:1903828),0.4582754310999312,1.3437439337152572,0.11858407079646018,0.6164317234075021,1.0,6/34,7.66%,LEPROT;ROCK2;LATS2;ACTN2;CTNNA1;GSK3B
prerank,inorganic cation transmembrane transport (GO:0098662),-0.2912385460309265,-1.3435859841168833,0.0,0.5361834106402319,1.0,63/268,14.85%,SLC6A6;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;TRPC3;ATP1B1;SLC24A2;ABCC9;KCNH7;KCNJ2;KCNC2;KCNQ3;SLC6A1;SCN1A;SLC40A1;HCN1;FKBP1A;GAS6;TRPC5;ATP1A1;TRPC4;SLC25A27;RYR3;ATP2C1;SLC8A1;KCNK10;SLC9A8;SLC39A6;HCN2;SCN2A;ATP2A3;CACNA1G;TRPC6;UCP2;KCNH1;TMEM175;ATP6V0C;KCNH5;SLC30A1;SLC39A14;KCND3;ATP5PO;CACNA1D;KCNB1;SLC36A1;SCN8A;KCNJ8;TMCO1;ATP5F1B;SCN9A;KCNQ1;SLC6A5;SLC39A13;ATP2A2;KCNC1;SLC6A11;SLC39A8;SLC9A5;KCNA2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.46636065250791364,1.3435822282591916,0.11734693877551021,0.6153428340366185,1.0,12/29,21.82%,SMAD3;TUT4;SNIP1;ADAR;TARBP2;ZC3H7B;SMAD2;HNRNPA2B1;PUM2;TUT7;PUS10;SRRT
prerank,nuclear transport (GO:0051169),-0.5020885120670937,-1.3429114191444422,0.12356979405034325,0.5366471731080324,1.0,7/16,23.65%,NPM1;AAAS;XPO1;ANP32A;NXT1;RBM15B;BANF1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5603423860738032,1.3423419013979485,0.12867647058823528,0.6177830676640269,1.0,2/13,1.19%,ZMIZ1;ELOF1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5029810268073359,1.3421032238119965,0.12522045855379188,0.6169864753497998,1.0,5/20,7.50%,RSAD2;CD55;IL6;PRKCZ;IL18
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5097294195575306,1.341421556342525,0.14183123877917414,0.6175843371972558,1.0,2/20,4.06%,WNT4;CRY1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4489594961155627,1.3403712026297816,0.11754966887417219,0.6193711321135885,1.0,9/40,12.67%,GBP6;GBP2;IL6;CRP;GBP4;TNFRSF14;GBP7;TLR2;RARRES2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5046068745446259,-1.3402834215698567,0.1223175965665236,0.5426748313752606,1.0,11/16,25.74%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30846220744328157,1.339663302565189,0.0010449320794148381,0.6201052094496609,1.0,226/1082,16.62%,TCF7L2;TCF4;CREB5;KMT2A;RORA;BMP6;WNT4;SMAD3;RBPJ;ZEB2;ZMIZ1;NR2F2;CXCL10;SP100;ELF1;ELOF1;RGMA;CREB3L2;FGF1;PID1;AUTS2;ARNT2;MLLT3;OSR1;IL31RA;TBL1XR1;TEAD1;FOXC1;NFIA;NFAT5;TRIM56;PHIP;GATA6;SPIB;WNT3A;RGMB;CSRP3;PPM1A;BMPR1A;ZNF395;SSBP2;OSM;FSTL3;ZIC2;FOXC2;IL11;GLI3;WWOX;MYB;NCOA3;PARP9;CDK8;FZD2;LDB2;TGFB1I1;HIVEP1;PRDM11;HOXC4;ZIC1;DCN;LITAF;BMP2;STAT5B;RFX3;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;EPAS1;HLF;TLR4;GLI1;ARNT;BMP7;GLIS3;NIF3L1;TGFBR1;NCOA6;SALL1;LBHD1;TCF12;SERPINE1;KLF5;HAX1;NSD3;MLLT10;CREB3L3;NR1H3;FOXP3;ARF4;BCL9L;DTX3L;HDAC4;CREBL2;PPARA;CREBBP;RARB;POGZ;GLIS2;PCGF5;NSD1;POU1F1;SFR1;CREBRF;RNF20;IL18;DPF2;STAT1;WAC;ARHGEF11;SKI;CDKN2B;NEK4;ZSCAN21;QRICH1;MEF2A;RIPK2;RNF111;CRLF3;TEAD2;WNT5A;YAP1;RHOQ;CRTC1;KAT6B;RLF;EPC1;GLYR1;IGF2;NAA16;ELF4;CDK7;E4F1;UTP15;BRD4;PBX1;RFXANK;TAF7;PFKM;MAFB;TCEA1;ATF7IP;HEYL;MYSM1;UBE2V1;CDH13;TLR2;NAA15;ELF2;RFXAP;SMAD4;MAP2K5;HIVEP3;PPP3CB;FOXO3;NR4A1;CRTC3;ILF3;DVL3;EGR2;MAML2;RPS6KA3;BTRC;SS18;SERTAD2;MAP2K1;HOXA10;FBXW11;BPTF;TET2;NFIC;MED12;ARRB1;MZF1;NR3C1;BRD8;SERTAD3;WASL;NRF1;SENP1;ZNF462;POU2F1;KAT6A;THOC5;ERCC6;KDM8;NCOA2;SALL2;NCK1;TBK1;VHL;NIBAN2;THAP3;RBM14;HDAC2;RARA;MAP3K2;PML;EIF2AK3;ILK;SP3;HOXB4;SMARCA4;KAT2B;SOX4;DNAJC2;TXK;DAB2;VEZF1;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9;SMARCC1;SMAD2;TRIM16;WWTR1;BCL11B;NFATC2;TBL1X;PSRC1;ANKRD49
prerank,homeostasis of number of cells (GO:0048872),-0.5320040310794808,-1.3393517889240738,0.14435146443514643,0.5437359172635864,1.0,3/12,4.39%,NOS3;NOTCH1;CCN3
prerank,sulfur amino acid metabolic process (GO:0000096),-0.44394559292796687,-1.338642469745815,0.10565110565110565,0.5439911604644783,1.0,11/24,23.77%,MTHFR;MSRA;TXN2;GCLC;MTRR;SMS;CTH;ADO;MPST;AHCY;NOX4
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5315556716218208,1.338563041042649,0.1553030303030303,0.6221124109737426,1.0,6/17,12.69%,RBPJ;NOTCH2;BMPR1A;BMP2;HEYL;NOG
prerank,intermediate filament organization (GO:0045109),0.5304344019986872,1.338294043411361,0.14909090909090908,0.6213639356497118,1.0,7/17,19.31%,VIM;DES;EPPK1;KRT9;BFSP1;DNAJB6;DSP
prerank,axonal transport (GO:0098930),-0.40724761214492805,-1.3378936381672666,0.09198113207547169,0.5444733143386362,1.0,16/36,26.45%,SYBU;KIF1B;DYNC1H1;AP3S2;TMEM108;KIF3B;AP3B2;SOD1;MAPT;SNAPIN;AP3D1;DCTN1;KIF4A;HAP1;NEFL;BLOC1S4
prerank,oxoacid metabolic process (GO:0043436),0.48461388229711655,1.3378392986199876,0.13464991023339318,0.6212983935660367,1.0,11/27,21.01%,DDO;ENPP1;TPST1;LIPT1;THAP4;HAO1;SULT1A1;ABHD14B;GRHPR;SULT6B1;AGXT
prerank,cristae formation (GO:0042407),-0.4377178268664775,-1.3370367528278815,0.102803738317757,0.5453071515253402,1.0,15/27,31.80%,ATP5F1A;ATP5MC1;ATP5PO;SAMM50;ATP5F1B;ATP5PD;ATP5F1D;UQCC3;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF;LETM1;CHCHD3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.47160434881471014,-1.3369759326398651,0.1004566210045662,0.5437772643809106,1.0,10/20,31.32%,GATM;OPLAH;GCLC;PLOD2;PTDSS1;GGT1;MTHFS;HAGH;MGST2;GCLM
prerank,histone modification (GO:0016570),0.3720334389513627,1.3366962542011325,0.06286549707602339,0.6233509661384633,1.0,25/109,15.59%,EYA2;EYA1;TBL1XR1;MIER3;UBE2U;NSD3;BAZ2A;MIER1;HDAC4;CREBBP;NSD1;BAZ1B;KAT6B;HLCS;HUWE1;EYA4;ATXN7;BRD8;KAT6A;PRDM5;USP36;CARM1;RBM14;HDAC2;PHF20L1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4404531896793544,1.3366287441028524,0.10743801652892562,0.6220337157052064,1.0,10/37,10.27%,IL17D;IL6;ADCY7;TLR4;APPL2;GBP5;PPARA;NOS2;APPL1;MAPK14
prerank,bicarbonate transport (GO:0015701),-0.43930896192990343,-1.3364766075407817,0.10344827586206896,0.5435634876215415,1.0,8/25,14.55%,SLC4A10;SLC26A7;CA4;CA2;CYB5R1;CYB5RL;SLC4A7;SLC39A8
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4900465774704834,-1.3363373327952048,0.11416490486257928,0.542271056930465,1.0,5/16,9.05%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5586521967808761,-1.3353365172579423,0.1090146750524109,0.5435223730470957,1.0,5/11,13.77%,ANK3;PRKCQ;LYN;SYK;PLAUR
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.48552269469392445,1.3351303788109217,0.12244897959183673,0.6251606527819482,1.0,4/23,5.14%,MCU;DPP4;CAMK1D;C5AR2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3740872186928452,1.3347246088392501,0.046176046176046176,0.6248976842477222,1.0,23/108,13.86%,SULF1;WLS;DCDC2;TLE1;KANK1;PTK7;WWOX;APCDD1;DACT1;BMP2;TERT;SALL1;FOXP3;TCF7L1;CDC73;SKI;LRRK2;NKD1;TLR2;VGLL4;BTRC;HIC1;RNF43
prerank,B cell receptor signaling pathway (GO:0050853),-0.4096493770510221,-1.3346037907032355,0.08333333333333333,0.5440610750878531,1.0,12/32,14.87%,MEF2C;PRKCB;PLCG2;RFTN1;PLEKHA1;BMX;CD38;BCAR1;SYK;PIK3CD;PTPRC;LAT2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5129693090512735,1.3344993962735272,0.11977186311787072,0.6241027478491283,1.0,2/19,0.82%,MCU;CAMK1D
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.39904694262582213,1.3343737472389545,0.07535321821036106,0.6229675225044377,1.0,14/72,13.75%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;POLR2D;KL;HNRNPH1;FGF18;FLRT1;POLR2C;NOG;SHOC2;POLR2F
prerank,membrane depolarization (GO:0051899),-0.41862139783016555,-1.3343169042692744,0.09183673469387756,0.5432390306259072,1.0,13/32,17.85%,CACNA1E;CACNB4;SCN1A;SCN2A;CACNA1G;YWHAH;SCN8A;SCN9A;CAV1;P2RX7;SCN3A;CHRNA4;CACNA1A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5847166527802123,1.3336388437450508,0.16827852998065765,0.6237683706141242,1.0,2/11,2.09%,EFNB2;WNT3A
prerank,positive regulation of protein kinase activity (GO:0045860),-0.31077340177861795,-1.3335822528289174,0.029850746268656716,0.5436447357997539,1.0,42/148,16.16%,TNIK;GRM5;TGFB2;INSR;PTK2B;PAK1;CALM1;GAS6;SNCA;CALM2;EMP2;MMD;DAB2IP;HSP90AB1;RAPGEF2;PAK5;CCDC88A;CALM3;RASSF2;ACE;STK11;LRP8;CLSPN;VEGFA;MINK1;LCP2;BORA;ADRB2;ALS2;PAK3;JTB;SRCIN1;TTBK1;HSP90AA1;CSF1R;RELN;PTPRC;PAK4;CCL19;CDKN1A;IRGM;RAP1A
prerank,actin polymerization or depolymerization (GO:0008154),0.41789890617023073,1.3334809572539543,0.08907563025210084,0.6227137817209192,1.0,4/50,0.81%,GAS7;ARHGAP6;MICAL3;DIAPH1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5227073370409716,1.3334187310819519,0.14022140221402213,0.621372846389431,1.0,6/19,5.16%,TGFBR3;RBPJ;BMPR1A;RBP4;GLI1;TGFBR1
prerank,positive regulation of signal transduction (GO:0009967),0.3387080187505324,1.3328505550876157,0.0327455919395466,0.6216497279521204,1.0,48/238,12.43%,SULF1;ROBO1;WLS;BMP6;TSPAN5;DCDC2;SASH1;RBPJ;ZMIZ1;VTN;FGF1;AXL;IL6ST;PHIP;GHRH;KANK1;BMP2K;NRP1;ITGA5;DACT1;BMP2;TERT;LOXL3;SORBS1;IL6;GLI1;ARNT;PRKCZ;AAK1;TGFBR1;SALL1;CREBBP;CDC73;LY96;SKI;BAX;YAP1;IGF2;LRRK2;CUX2;RAB34;TLR2;NLGN2;IHH;DSTYK;P2RY6;CCBE1;MAML2
prerank,"phagocytosis, engulfment (GO:0006911)",-0.40591695837499453,-1.3328472838297218,0.10421836228287841,0.5440765126047236,1.0,16/36,25.32%,ELMO1;THBS1;XKR4;XKR6;RHOG;MEGF10;DOCK1;RAC1;RHOH;RHOBTB1;FCGR1A;ITGB2;AIF1;BIN2;MSR1;ADGRB1
prerank,regulation of angiogenesis (GO:0045765),0.34536409536171553,1.332699242373857,0.032214765100671144,0.6205961029132582,1.0,29/192,8.47%,SULF1;PDPK1;COL4A3;ROCK2;SASH1;CXCL10;SP100;FGF1;ECM1;FOXC1;GATA6;THBS2;CEMIP2;HSPG2;CDH5;ITGB8;VEGFD;ANXA3;ADAMTS1;DCN;IL6;MTDH;SERPINE1;EPHA1;ATP2B4;CTSH;STAT1;GLUL;WNT5A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.42254450393035603,-1.3323097967542412,0.10161662817551963,0.5440151404648399,1.0,11/30,13.29%,FGF12;RYR2;KCNJ2;SCN1A;ATP1A1;GJC1;CACNA1G;NEDD4L;CACNA1D;KCNQ1;KCNE4
prerank,protein phosphorylation (GO:0006468),0.3191688440041606,1.3319687154117685,0.008928571428571428,0.6213763840514722,1.0,114/478,15.94%,IGFBP3;PDPK1;PDK1;EFEMP1;TGFBR3;TEC;ROCK2;CAMK1D;NRK;PDGFRA;PRKAG2;FGFR1;STK32B;GRK3;FAM20C;STK39;DDR2;PRKAA2;OXSR1;EIF2AK2;TSSK3;INSRR;BMPR1A;EPHA3;BMP2K;EPHA8;FAM20A;FER;CDK8;KIT;DAPK1;BMP2;TAOK3;CRY1;IKBKE;TLR4;PRKCZ;TOP1;LATS2;MAP3K1;AAK1;TGFBR1;MORC3;MAPK6;EPHA1;PDGFRB;TGFBR2;MAP4K1;FAM20B;GSK3B;CCL2;NEK4;WNK4;MAP2K6;EPHA4;BAZ1B;STK24;STK3;SIK3;CCNH;LRRK2;PPP4R1;COQ8B;TLK2;CDK7;CDK12;MUSK;CDK16;MAPK14;AKT3;HIPK3;GRK5;PTPN6;TLR2;PTK2;IRAK3;PPP3CB;MAP3K7;ILF3;RPS6KA3;MASTL;DAPK2;MAP2K1;MAP3K13;STRADB;JAK1;SRPK1;MAPK9;GTF2H4;ACVR1C;WNK1;TRIB1;ALK;MAPKAPK5;TBK1;FRK;NUAK2;ABI1;BIRC6;RARA;CSNK2A2;EIF2AK3;RYK;ILK;LIMK1;CDKL3;STK4;ACVR2B;TXK;PKN2;PRKD2;ERN2;APP;IGF1R
prerank,regulation of GTPase activity (GO:0043087),-0.3031564653610248,-1.3319469081773123,0.021834061135371178,0.5434998469086794,1.0,46/177,15.18%,CHN2;DOCK9;PRKG1;FGD5;ITGA6;PLXNA4;EFNA5;BCAR3;EPHA5;DOCK10;NET1;LRCH1;NTRK2;SEMA4D;ADAP1;TBC1D30;CPEB2;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;CCL14;FGD6;RAPGEF2;RGS7;RCC2;ARHGAP15;RGS6;TMED2;ARHGAP27;RACK1;CAV2;CD40;DOCK8;ALS2;ARHGEF7;VAV1;RGP1;RAPGEF6;F11R;HRAS;AGRN;EVI5;SOD1;SNX18;CCL19
prerank,ether lipid metabolic process (GO:0046485),0.549683062479393,1.3312853213422045,0.1412639405204461,0.6219777855593325,1.0,2/14,8.09%,AGMO;PLA2G6
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5168281430202832,-1.3311632403152085,0.13675213675213677,0.5441199747111106,1.0,13/14,48.12%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;ERN1;CPSF7;NCBP1;CPSF4;NCBP2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.37537540468172653,1.3305042757748056,0.07112375533428165,0.6228288568073095,1.0,18/104,7.92%,PDPK1;SMAD3;SMURF2;PPM1A;BMPR1A;FSTL3;NBL1;SNX6;LDLRAD4;TGFB1I1;PMEPA1;BMP2;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,microvillus organization (GO:0032528),-0.5251090793502164,-1.330136417593508,0.14132762312633834,0.5455202478412075,1.0,7/13,20.81%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,clathrin coat assembly (GO:0048268),-0.4987889554482655,-1.3300225017980285,0.12655601659751037,0.5442110336056251,1.0,3/15,4.85%,SGIP1;HIP1;HIP1R
prerank,regulation of cellular metabolic process (GO:0031323),0.4262425530464764,1.3298557823684067,0.11320754716981132,0.6234803758988343,1.0,7/45,6.94%,PID1;TBC1D16;PANK2;ARF4;MPV17;PPARA;SSH1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4027226198045382,1.3295379646479704,0.09852216748768473,0.6230457971772738,1.0,20/64,17.39%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;POLR2C;IWS1;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;AFF4;GTF2H2;CDK13
prerank,endocrine system development (GO:0035270),0.5019640438212852,1.3291648852802136,0.14766355140186915,0.6227539147145236,1.0,4/21,6.51%,WNT4;TGFBR1;SALL1;DKK3
prerank,mesonephros development (GO:0001823),0.5736324971216531,1.328737605817091,0.16091954022988506,0.6226528008194157,1.0,3/11,4.75%,FGF1;OSR1;BMP7
prerank,establishment of endothelial barrier (GO:0061028),-0.4307778126652211,-1.3285805794290102,0.10430839002267574,0.5467744551639065,1.0,13/29,18.44%,PDE4D;PECAM1;PPP1R16B;ROBO4;RAPGEF2;PDE2A;SOX18;RAPGEF6;F11R;TJP2;RAP1A;MARVELD2;RAB1B
prerank,lung development (GO:0030324),0.4528635207955567,1.3284216963506974,0.11774461028192372,0.6221276825669457,1.0,6/33,7.18%,PDPN;FGF1;RBP4;LOXL3;ERRFI1;DNAAF1
prerank,development of primary male sexual characteristics (GO:0046546),0.46736497513642716,1.328322718674437,0.12195121951219512,0.6210000987091305,1.0,5/34,3.84%,WNT4;GATA6;WNT2B;LHFPL2;KIT
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4718305331255786,-1.328066556278394,0.13013698630136986,0.5465631288243038,1.0,8/20,7.24%,DMD;ATP1B1;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,microvillus assembly (GO:0030033),-0.5132264717631367,-1.3280277578020128,0.14285714285714285,0.5450674038634515,1.0,7/14,20.81%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4755646137031068,1.3273641236139815,0.14234234234234233,0.6226448207729303,1.0,6/26,10.17%,FBN1;FSTL3;TLR4;CARTPT;PTPN2;MAFB
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3092779987654336,1.326559469433455,0.005296610169491525,0.6236055444191931,1.0,179/807,16.51%,TCF7L2;FHL2;BMP6;WNT4;FOXD1;SMAD3;PRICKLE1;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;KANK2;NR2F2;SP100;KCNIP3;PRDM6;TLE1;OSR1;TBL1XR1;SMURF2;FOXC1;GATA6;SAMD13;PPM1A;ZBTB4;NR6A1;ZIC2;SNX6;FOXC2;RBFOX2;GLI3;WWOX;MYB;MBD2;ZMYND15;PARP9;TCEAL7;LDB2;EID2B;HIVEP1;CRY2;PRDM11;DACT1;BMP2;RFX3;CRY1;LOXL3;APBB1;MIER3;BCOR;BMP7;AEBP1;UXT;MTDH;GLIS3;GZF1;SALL1;OTP;CBFA2T2;ZNF3;MIER1;TPR;WWC2;NR1H3;FOXP3;HDAC4;PPARA;TSHZ3;DKK3;PBXIP1;CREBBP;RARB;GLIS2;NSD1;USP9X;DPF2;STAT1;CDC73;SKI;MEF2A;ZMYND11;PHB2;ZNF25;VPS72;CUX1;WNT5A;ZFP37;YAP1;ZEB1;SAP130;KAT6B;DLG1;EPC1;IGF2;USP47;SCMH1;SUMO1;GATAD2B;CREM;E4F1;JARID2;NUPR2;TAF7;SUFU;PSPC1;WWP2;CUX2;PPID;GMNN;ATF7IP;HEYL;CIR1;CBX7;FNIP1;SMAD4;MAP2K5;SCML4;BCL7A;RTF1;ATN1;FOXO3;LHX9;IFI27;ZNF219;VGLL4;ILF3;BTRC;THAP1;NOG;EFNA1;FBXW11;BPTF;KDM2A;NFIC;CBX4;MZF1;BHLHE41;NR3C1;PEX2;PAF1;HIC1;ARID5B;POU2F1;ZNF205;KAT6A;PRDM5;KDM8;MDM4;RBM15;TLE6;RUNX1T1;FRK;VHL;NIBAN2;ZBTB21;HDAC2;RARA;PML;UIMC1;SP3;SMARCA4;ACVR2B;PER3;KDM2B;DAB2;ERN2;POU5F1;ELK4;CPEB3;MUC1;JDP2;URI1;SMAD2;RING1;POU6F1;SPINDOC;TBL1X
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4129655577301396,-1.3265201042163237,0.08780487804878048,0.5476886321177069,1.0,7/33,10.02%,DNM3;NLGN1;SYT1;AMPH;SNCA;NLGN3;SNAP91
prerank,actin nucleation (GO:0045010),-0.45247677842077966,-1.3263713348987292,0.111358574610245,0.546484870583946,1.0,7/21,13.20%,LMOD1;JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.32891443375241086,-1.3261987802112265,0.04573170731707317,0.5453742436535455,1.0,28/94,21.19%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;MAPK3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;UBA52;PSMA8;NOD2;PSME1;TOLLIP;IRAK1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5624095340814167,-1.3261444717616837,0.1527777777777778,0.5423028376140423,1.0,6/10,27.44%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5624095340814167,-1.3261444717616837,0.1527777777777778,0.5423028376140423,1.0,6/10,27.44%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,actin filament network formation (GO:0051639),-0.54829317990723,-1.3253308760386673,0.13449023861171366,0.5429550648850456,1.0,7/11,30.94%,ACTN1;PLS3;LCP1;FHOD3;CARMIL1;SPIRE2;CARMIL2
prerank,phospholipid translocation (GO:0045332),-0.4267130179151508,-1.324981792178033,0.11137440758293839,0.5423685310092599,1.0,11/28,18.34%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1;MFSD2A;TMEM30A;P2RX7;ABCB4
prerank,regulation of muscle contraction (GO:0006937),0.4826839562251505,1.3246678562600342,0.11846689895470383,0.628179641151638,1.0,4/26,5.56%,TNNC1;ATP1A2;TPM1;PLCE1
prerank,receptor clustering (GO:0043113),-0.4303498215864632,-1.324326198790644,0.1354679802955665,0.5427172341071654,1.0,5/27,3.73%,NRXN1;NLGN1;DLG2;LRRC7;ITGA4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31591180093017157,1.3241773025770942,0.0068415051311288486,0.6282492441131337,1.0,80/509,11.17%,TCF7L2;PDPK1;WLS;LPAR1;ROCK2;SASH1;AKAP13;FN1;SELP;PDGFRA;FGFR1;FGF1;AXL;ECM1;EIF2AK2;KSR1;NUPR1;NFAT5;DDX60;FAM110C;GAB2;GJA1;PPM1A;OSM;IL11;EPHA8;OSBPL8;FRS2;TRAF5;TGFA;KL;NEDD4;ADGRV1;ANGPT1;KIT;DCN;LITAF;BMP2;CFLAR;IFI35;IL6;IKBKE;ROR1;GSDME;TLR4;BCL2;MTDH;TGFBR1;GOLT1B;HAX1;CPNE1;MIER1;PELI2;PDGFRB;TRIM5;BIRC3;BST2;OASL;JMJD8;IL18;LGALS9;VAPA;RIPK2;PHB2;BAX;WNT5A;IGF2;ANKRD17;PIK3R5;MST1R;BRD4;DNM1L;FGF18;PTPN6;BCL2L1;UBE2V1;CDH13;TLR2;FNIP1;PTK2
prerank,Golgi localization (GO:0051645),0.5856498964847624,1.3237970186547212,0.18093385214007782,0.6280126968148128,1.0,3/11,11.70%,ARHGAP21;UVRAG;ARCN1
prerank,regulation of lipid storage (GO:0010883),0.5072408471229263,1.3235967968004865,0.11623931623931624,0.6271762265065484,1.0,5/22,7.67%,IL6;IKBKE;PTPN2;CRP;FTO
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5859978661682264,1.3232520437025244,0.17137096774193547,0.6267487649311521,1.0,2/10,6.03%,TLR4;FOXP3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4758018542133239,1.3229026967820976,0.1261101243339254,0.626400933090701,1.0,7/25,11.85%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,negative regulation of gene expression (GO:0010629),0.32753238814880414,1.322896439483301,0.030413625304136254,0.6249521809511113,1.0,66/302,16.03%,ROBO1;WNT4;PARP14;LGR4;ROCK2;RBMS3;SAMD4A;NOTCH2;PRKAA2;EIF2AK2;IGFBP5;SHMT1;PTBP3;BMPR1A;ITGB8;TWSG1;PARP9;TNRC6B;SLC24A3;SUZ12;DAPK1;BMP2;TERT;STOX1;PTPN22;IGF2BP1;SNX12;CPNE1;FOXP3;ATP2B4;NANOS2;NOS2;PARP10;DCP2;OPRD1;LGALS9;ANXA7;MYADM;TNRC6A;YAP1;MOV10;EPC1;NOCT;JARID2;TIPARP;WWP2;IGF2BP2;LRP3;EIF4ENIF1;ILF3;SLFN14;MAP2K1;DDX6;PTBP2;ATP2B1;TASOR;METTL16;SRGN;FLOT2;VHL;GIGYF2;EIF2AK3;KAT2B;APP;CNOT9;CPEB3
prerank,regulation of fatty acid oxidation (GO:0046320),0.5468761489925276,1.3228731528722164,0.1701720841300191,0.6235783476383113,1.0,4/16,9.15%,PRKAG2;APPL2;PPARA;SIRT4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.49652538650457534,1.3221068913901004,0.161231884057971,0.6246347490536419,1.0,4/20,5.16%,TGFBR3;RBPJ;BMP2;TGFBR1
prerank,regulation of axon regeneration (GO:0048679),0.5737162298375494,1.321901977811849,0.1903807615230461,0.6237702103558925,1.0,3/12,8.57%,PTN;EPHA4;STK24
prerank,lipid homeostasis (GO:0055088),0.4137825660480123,1.321617002619281,0.09320695102685624,0.6232369205458813,1.0,20/57,24.83%,ZBTB20;RBP1;PRKAA2;ACOXL;NR1H3;DGAT2;ABCA1;ABHD5;ACOX1;ANGPTL3;RCN3;XBP1;FBXW7;NR1D2;CEBPA;PRKAA1;TM6SF2;ABHD8;THADA;IRS2
prerank,gas transport (GO:0015669),-0.5563423103113685,-1.3214084521312648,0.13953488372093023,0.5495583549797018,1.0,3/10,11.57%,CA2;CYGB;IPCEF1
prerank,negative regulation of bone mineralization (GO:0030502),0.5573122484122949,1.3214009967913372,0.1577981651376147,0.6224561456944661,1.0,5/13,13.77%,ENPP1;ECM1;BCOR;RFLNA;SRGN
prerank,positive regulation of developmental process (GO:0051094),0.34920328973245296,1.3209004110138054,0.05326231691078562,0.6227123776217218,1.0,36/164,15.53%,PHLDB2;SOX5;PTN;MCU;FOXD1;CCN2;FGFR1;SMURF2;GJA1;BMPR1A;NCOA3;DAG1;DCN;BMP2;BMP1;BMP7;CLASP1;PHLDB1;RALBP1;ADGRL1;WNT5A;SYDE1;TAPT1;DNM1L;ENPP2;DVL3;RPS6KA3;MAP3K13;RTN4;TLE6;ALK;VHL;NIBAN2;MIEF1;SHLD2;MUL1
prerank,photoreceptor cell development (GO:0042461),-0.5056258374015536,-1.3208982527685824,0.1456953642384106,0.5494148660517997,1.0,6/14,16.59%,RORB;RP1;AHI1;VEGFA;MFSD2A;CEP290
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4545208288655878,-1.3203948046427414,0.1091703056768559,0.549329191051382,1.0,5/20,12.95%,KCNB2;CHRM3;CHRM2;ADRB2;CAV1
prerank,peptidyl-lysine modification (GO:0018205),0.3722875598933538,1.3201652546899325,0.0689149560117302,0.6235905450573254,1.0,27/99,16.55%,EYA1;SENP7;LOXL3;LOXL1;LIPT1;RANBP2;TPR;HDAC4;METTL21C;ETFBKMT;PIAS1;SIRT4;SUMO1;ESCO1;LOXL4;SENP6;SENP3;NSMCE2;EGR2;SENP1;POM121;IFIH1;P3H4;KAT2B;P3H3;ATPSCKMT;NUP37
prerank,blood vessel endothelial cell migration (GO:0043534),0.49181593527812734,1.319926925125852,0.1391941391941392,0.6228612828235556,1.0,5/22,4.73%,EFNB2;ROBO1;CDH5;NRP1;MIA3
prerank,positive regulation of protein binding (GO:0032092),0.40746722639993205,1.3186947092586423,0.10393700787401575,0.6252946891537429,1.0,21/56,17.86%,TCF7L2;VTN;WNT3A;DACT1;BMP2;TERT;DTX3L;SPPL3;GSK3B;RIPK2;STK3;AMFR;LRRK2;TRIM21;HFE;BDNF;STK4;APP;RAN;PPP2CA;LRP1
prerank,transport along microtubule (GO:0010970),0.5547798816101753,1.3181083447815105,0.16633266533066132,0.6257402423782914,1.0,7/13,23.84%,ARHGAP21;SPG11;APP;BORCS5;BAG3;CLIP3;COPG1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.46906990249698877,-1.317363759346409,0.11504424778761062,0.5563996533865901,1.0,8/19,18.00%,TEK;PTPRJ;KDR;MYOC;VEGFA;RAC1;COL16A1;PPM1F
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3962684293295074,1.3171072147296115,0.11229135053110774,0.6275963452115827,1.0,11/67,6.11%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;GHR;EPHA3;FER;KIT;EPHA1;PDGFRB
prerank,calcium ion homeostasis (GO:0055074),-0.32600814665558553,-1.3168653254306484,0.05555555555555555,0.5561362617739293,1.0,27/95,18.17%,TMTC2;ATP1B1;SLC24A2;RYR2;TPT1;HTR2C;SNCA;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;SLC30A1;SELENON;GRIN1;CXCL12;CALR;SLC10A7;CD40;TMCO1;CAV1;ATP2A2;CCL19;ATP13A4;HTR2B;SLC8B1;HTR2A
prerank,regulation of signal transduction (GO:0009966),0.341346373584469,1.316673160145325,0.04467805519053877,0.627544924094534,1.0,24/190,6.75%,SULF1;IGFBP3;RORA;DCDC2;SP100;ELF1;GRK3;IGFBP5;MPIG6B;CD55;FBXL17;IGFBPL1;NUCKS1;ZIC1;IGFBP6;GLI1;PLCE1;DTX1;ZDHHC3;FOXP3;TRIM5;TCF7L1;PTPN2;CREBBP
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5567022368972083,1.3166388247889156,0.15950920245398773,0.6262091564281914,1.0,7/13,17.54%,ENTPD7;RHOQ;LRRK2;EFL1;OPA1;RAN;GNAI3
prerank,regulation of osteoblast proliferation (GO:0033688),0.5188940862457061,1.3165259700253988,0.16500994035785288,0.6251441379724452,1.0,3/17,3.96%,EIF2AK2;NELL1;BMP2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5480524208401959,-1.3161667792420102,0.14435146443514643,0.5566206121898152,1.0,8/11,33.47%,FOXO1;FAS;CAV1;ATP6V0A2;ATP6AP1;TMEM199;ATP6V1A;ATP6V1G1
prerank,long-term synaptic potentiation (GO:0060291),-0.46183974642504994,-1.3159731104979706,0.1342281879194631,0.5555458371905112,1.0,6/21,6.63%,SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5060826367435246,-1.3138212595375693,0.12958963282937366,0.5601822365124084,1.0,6/15,13.20%,JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5691858307467655,1.3130302433733956,0.18476190476190477,0.6347500615781257,1.0,7/12,16.18%,PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16;TNKS2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5542157121828548,-1.3130067286566698,0.13569937369519833,0.5608925721295838,1.0,4/10,7.81%,PDE3B;ACER2;NEXMIF;JAM3
prerank,endocardial cushion development (GO:0003197),-0.45599566782225415,-1.3128166843995823,0.1163895486935867,0.5598559601413593,1.0,9/21,14.62%,NOS3;TGFB2;BMPR2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5058255351534003,1.3126631191781588,0.16087751371115175,0.6345271056344841,1.0,7/19,19.59%,TLR4;STAT1;RIPK2;IFIH1;TBK1;DHX36;SETD2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5175464391509583,-1.3125689349680432,0.15320910973084886,0.5590157382717775,1.0,7/13,19.46%,ABHD2;ESR1;NR3C2;BMP4;CALCOCO1;PLPP1;ESR2
prerank,amino sugar metabolic process (GO:0006040),-0.5621203836353134,-1.3122503275469863,0.17330677290836655,0.5583088655913708,1.0,4/10,12.97%,CSGALNACT1;FN3K;GFPT2;GFPT1
prerank,response to iron ion (GO:0010039),0.5675715331584068,1.311581758205568,0.17748091603053434,0.6366343422801649,1.0,4/12,12.58%,BMP6;BCL2;ACO1;HFE
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.35032633932306345,1.3115139198279266,0.055944055944055944,0.6354090529837048,1.0,20/150,6.11%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;FAM110C;GAB2;OSM;OSBPL8;FRS2;TGFA;KL;ANGPT1;KIT;MTDH;TGFBR1;HAX1;CPNE1;PDGFRB
prerank,protein monoubiquitination (GO:0006513),0.44550885312506405,1.310626497762473,0.12864493996569468,0.6368177826457595,1.0,12/36,15.01%,KLHL22;DTX3L;MGRN1;RNF20;CDC73;WAC;HUWE1;CUL3;TRIM21;PAF1;LEO1;UBE2R2
prerank,positive regulation of neutrophil migration (GO:1902624),0.5023552198976589,1.3105359090284008,0.148975791433892,0.6356563084280158,1.0,2/18,0.82%,MCU;CAMK1D
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5166993432469837,-1.310176758745586,0.1673728813559322,0.5631750522902367,1.0,12/13,48.12%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;CPSF7;NCBP1;CPSF4;NCBP2
prerank,oligosaccharide metabolic process (GO:0009311),-0.37229139364774727,-1.3099632571710693,0.0979381443298969,0.5622221530884354,1.0,9/46,9.65%,ST6GALNAC3;ST8SIA4;FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC4;ST6GALNAC5;NEU1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5128055930132506,1.3097863017197922,0.163302752293578,0.63662606460119,1.0,4/16,10.86%,SLX4;TOP2B;FANCM;CENPX
prerank,second-messenger-mediated signaling (GO:0019932),0.38438450667631563,1.30972905872977,0.08490566037735849,0.6353596563731833,1.0,13/82,9.49%,PDPK1;RCAN2;MCU;FPR2;ACKR2;CCR9;DGKD;RCAN1;PLCE1;NOS2;ACKR3;LRRK2;NMUR1
prerank,inositol lipid-mediated signaling (GO:0048017),0.41228216600496004,1.3090576167501393,0.1181959564541213,0.6361074094103675,1.0,10/50,6.63%,PDGFRA;FGFR1;GAB2;ADAP2;PLCD3;PI4KA;PLCE1;PDGFRB;PLCB3;PIK3C2A
prerank,negative regulation of protein phosphorylation (GO:0001933),0.34665070103499906,1.3088050952218182,0.06391478029294274,0.6355294414311734,1.0,25/150,10.69%,PTPN13;IGFBP3;PDPK1;DEPTOR;PRKAG2;PID1;ENPP1;PLPP3;PPM1E;LDLRAD4;FBLN1;PMEPA1;ERRFI1;PRKCZ;EPHA1;MVP;PPEF2;MYADM;DTNBP1;LRRK2;SMAD6;GPD1L;TAF7;DNAJC3;PTPN6
prerank,peptidyl-asparagine modification (GO:0018196),-0.4155997424713019,-1.3086988479334223,0.13002364066193853,0.564239101117882,1.0,11/31,22.34%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;HIF1AN;DDOST
prerank,negative regulation of anoikis (GO:2000811),0.562258435800197,1.3083907787762021,0.1752767527675277,0.6354792392626551,1.0,5/14,11.17%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3051303049927706,1.3082818437660797,0.0042780748663101605,0.6344090485440219,1.0,167/834,15.90%,TCF7L2;TCF4;KMT2A;RORA;BMP6;SMAD3;RBPJ;ZEB2;ZMIZ1;NR2F2;CXCL10;ELF1;RGMA;FGF1;PID1;AUTS2;ARNT2;OSR1;TBL1XR1;TEAD1;FOXC1;NFIA;NFAT5;PHIP;GATA6;SPIB;WNT3A;CSRP3;BMPR1A;ZNF395;SSBP2;OSM;FSTL3;FOXC2;IL11;GLI3;WWOX;MYB;NCOA3;CDK8;LDB2;HIVEP1;HOXC4;DCN;LITAF;BMP2;STAT5B;RFX3;TERT;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;EPAS1;HLF;TLR4;GLI1;ARNT;GLIS3;NCOA6;SALL1;TCF12;SERPINE1;KLF5;HAX1;MLLT10;CREB3L3;NR1H3;FOXP3;ARF4;BCL9L;HDAC4;PPARA;CREBBP;RARB;POGZ;GLIS2;PCGF5;POU1F1;CREBRF;IL18;NGFR;DPF2;STAT1;CDC73;SKI;CDKN2B;ZSCAN21;MEF2A;RIPK2;RNF111;CRLF3;WNT5A;YAP1;RHOQ;CRTC1;KAT6B;RLF;EPC1;GLYR1;IGF2;ELF4;CDK7;CDK12;E4F1;BRD4;PBX1;RFXANK;TAF7;PFKM;TCEA1;HEYL;MYSM1;CDH13;TLR2;RFXAP;SMAD4;MAP2K5;PPP3CB;FOXO3;NR4A1;CRTC3;DVL3;EGR2;MAML2;RPS6KA3;SS18;HOXA10;BPTF;TET2;NFIC;MED12;ARRB1;MZF1;NR3C1;BRD8;WASL;NRF1;SENP1;ZNF462;POU2F1;KAT6A;NCOA2;LEO1;SALL2;NCK1;TBK1;THAP3;RBM14;HDAC2;RARA;SP3;HOXB4;SMARCA4;KAT2B;SOX4;TXK;DAB2;VEZF1;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3877445327261633,-1.3082493956902461,0.09420289855072464,0.5639965426909115,1.0,14/39,14.03%,EFNA5;THBS1;ACER2;NOTCH1;ADAM15;MYOC;NEXMIF;SEMA3E;RCC2;AP1AR;SPOCK1;PTPRO;FZD4;ACTN4
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5499372701122134,-1.308237786070317,0.14989733059548255,0.5624528315521378,1.0,2/10,8.00%,HMGB1;TNFRSF1B
prerank,iron ion transmembrane transport (GO:0034755),-0.5588420780696676,-1.308171382225955,0.14432989690721648,0.5611045062631225,1.0,5/10,16.61%,SLC40A1;SLC39A14;SLC39A8;ABCC5;SCARA5
prerank,glycerolipid catabolic process (GO:0046503),-0.47218355150836433,-1.3081611640610498,0.14823008849557523,0.559580270377068,1.0,5/19,5.90%,GPCPD1;MGLL;ABHD2;GDPD1;ENPP6
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5098227988358576,-1.308086327316294,0.14870689655172414,0.5582416568531661,1.0,6/13,10.95%,COL4A1;KDR;CTNNB1;SEMA3E;VEGFA;NOTCH4
prerank,regulation of protein targeting to membrane (GO:0090313),-0.4115830058796975,-1.3078503619234527,0.12557077625570776,0.5573407607335885,1.0,8/28,15.70%,ANK3;CEMIP;INPP5K;MTCL1;MFF;KCNB1;HRAS;C2CD5
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.44231705507851315,-1.3072548624590183,0.14022988505747128,0.5574793024648086,1.0,8/22,13.39%,CALM1;CALM2;MRE11;CALM3;RASSF2;ACE;VEGFA;NEK10
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5609032354904538,1.3072362497843586,0.162426614481409,0.636431756978934,1.0,3/13,5.16%,BMP6;BMPR1A;TGFBR1
prerank,regulation of blood coagulation (GO:0030193),0.4652594673268229,1.307077208641371,0.14185639229422067,0.6355031621277154,1.0,5/27,8.66%,TFPI;VTN;GP1BA;SERPINE1;SERPINE2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.34525097287266865,-1.3065626451390293,0.08187134502923976,0.5579288399834917,1.0,26/70,24.51%,PSMC3;NCF2;MFSD6;PSMD14;PSMD3;B2M;CALR;FCER1G;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;FCGR1A;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1;SEC22B;PSMD11;PSMD8
prerank,mRNA modification (GO:0016556),-0.4519393164153448,-1.3061401486734519,0.13126491646778043,0.5576071362598077,1.0,12/22,28.51%,PUS7;PUS3;VIRMA;ZC3H13;CBLL1;TRMT6;TRUB1;METTL8;TRMT10C;RPUSD2;METTL14;TRMT61A
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.40135765555827396,1.3056103221389885,0.11690363349131122,0.6388482365460066,1.0,14/59,15.77%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;WNK1;TBK1;CSNK2A2;PRKD2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3412118714524715,1.3050588643018217,0.05423280423280423,0.6393576891154529,1.0,32/182,10.31%,ROBO1;WNT4;PARP14;ROCK2;RBMS3;NOTCH2;PRKAA2;BMPR1A;ITGB8;PARP9;TNRC6B;SLC24A3;BMP2;TERT;STOX1;PTPN22;OPTN;SNX12;CPNE1;ATP2B4;NOS2;PARP10;OPRD1;LGALS9;ANXA7;MYADM;TNRC6A;YAP1;MOV10;NOCT;TIPARP;WWP2
prerank,regulation of hydrolase activity (GO:0051336),-0.3450569729174343,-1.3049558760879243,0.06442577030812324,0.5595703110855376,1.0,21/71,12.95%,CHN2;PRKG1;FGD5;PLXNA4;EFNA5;EPHA5;NTRK2;ADAP1;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;FGD6;ARHGAP15;CAMK2A;ARHGAP27;NOS1;SCARB2;VAV1;RAPGEF6;CAV1
prerank,regulation of synapse maturation (GO:0090128),-0.5416688403885339,-1.3049469086556318,0.16163793103448276,0.5580765171997729,1.0,3/10,5.14%,NRXN1;ARHGEF15;DAB2IP
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3991915631404993,-1.304751836844104,0.12470588235294118,0.5571402980786888,1.0,12/33,20.33%,H3-3A;ESR1;PKN1;HDAC6;TRIM68;CALR;RUNX1;CBFB;KDM4C;PARK7;SAFB2;UFL1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5772210136878448,1.3047456362246677,0.16455696202531644,0.6389705276945828,1.0,4/11,6.94%,TGFBR3;BMP2;TGFBR1;TGFBR2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5807604440228259,1.3045621154679048,0.1743295019157088,0.6367734281550437,1.0,3/10,6.37%,NUPR1;HDAC4;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),0.5807604440228259,1.3045621154679048,0.1743295019157088,0.6367734281550437,1.0,3/10,6.37%,NUPR1;HDAC4;PPARA
prerank,lipid catabolic process (GO:0016042),0.5115456255888612,1.3040401691434635,0.1751412429378531,0.6370444517923972,1.0,1/18,0.18%,PLA1A
prerank,regulated exocytosis (GO:0045055),-0.30317218462266327,-1.30365783880742,0.03137254901960784,0.5587840403729244,1.0,33/173,10.13%,PCDH7;ABCC4;VWF;PECAM1;SYT1;RIMS1;RIMS2;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;PCLO;SCG3;CALM1;RAB11FIP1;GAS6;SNAP25;SNCA;STXBP1;CYRIB;CDC37L1;RAB27B;CPLX1;STEAP2;A2M;SYT4;SYT7;VEGFA;TGFB3;CHID1;LYN;FAM3C
prerank,JNK cascade (GO:0007254),-0.3847214255801714,-1.3035601886571346,0.11662531017369727,0.5575163862308503,1.0,13/40,19.11%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAP3K11;UBB;MAP4K3;MINK1;UBA52;NOD2;GPS1;IRAK1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5851203606190425,1.3035134214720527,0.1782178217821782,0.6373395810099695,1.0,1/11,0.23%,ENPP3
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6026698773455995,1.3028895361220085,0.17970401691331925,0.6379171594794697,1.0,6/10,24.66%,PRKCZ;IL18;LGALS9;RARA;SPHK2;GATA3
prerank,eye photoreceptor cell development (GO:0042462),-0.4906254861995727,-1.3026295150538956,0.1422319474835886,0.5585524074696397,1.0,5/15,16.59%,RORB;RP1;VEGFA;RPGRIP1;CEP290
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5368795544224486,1.302481630234464,0.15105162523900573,0.6378547377740599,1.0,6/15,13.97%,IL17D;IL6;TLR4;GBP5;APPL1;TICAM1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5686838843071622,1.301864776541329,0.17164179104477612,0.6384559436008073,1.0,2/11,1.19%,ZMIZ1;ELOF1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5888751409348123,1.3014566988128662,0.17479674796747968,0.6383738440789816,1.0,2/10,4.24%,ADGRV1;IFT88
prerank,regulation of chemotaxis (GO:0050920),0.4606509188365009,1.3013843622821815,0.1486013986013986,0.6372294101178323,1.0,5/30,6.52%,EFNB2;PDGFRA;MYCBP2;PDGFRB;PTPN2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.47840146686567964,1.3010194673014341,0.15370705244122965,0.6370088797996557,1.0,6/22,12.11%,PPM1E;PPM1A;DUSP10;DUSP16;PPM1B;DUSP5
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5894841423756648,1.299725450984831,0.19301470588235295,0.6396069284428039,1.0,5/10,17.01%,PARP14;PTPN2;SH2B3;NF2;PPP2CA
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5006329063892901,-1.2992151129580576,0.1468682505399568,0.5670677390956399,1.0,5/13,15.87%,ELOVL5;ELOVL7;TECR;TECRL;HACD3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5905860444419643,1.2987684717826977,0.185546875,0.6411815176908158,1.0,3/10,4.74%,VTN;ITGA5;ARNT
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3460582427983599,-1.2985863159781803,0.09018567639257294,0.5672954169986876,1.0,16/64,6.95%,LIMCH1;EFNA5;PEAK1;THBS1;ACER2;PTK2B;GPM6B;ADAM15;UTRN;MACF1;EMP2;ACTG1;CDK6;MYOC;NEXMIF;SEMA3E
prerank,mRNA destabilization (GO:0061157),0.42246666396639837,1.2984068029670695,0.13764510779436154,0.6409622949742183,1.0,16/38,23.49%,ROCK2;TUT4;POLR2D;RC3H1;FTO;MOV10;METTL16;GIGYF2;CPEB3;TUT7;DHX36;ROCK1;KHSRP;ZC3H12A;ZFP36L2;YTHDF3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5292024397322994,-1.2982362335515585,0.17634408602150536,0.5652794655598178,1.0,3/12,5.12%,AKAP6;CAMTA1;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5292024397322994,-1.2982362335515585,0.17634408602150536,0.5652794655598178,1.0,3/12,5.12%,AKAP6;CAMTA1;PTBP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5868099187640827,1.297745563334567,0.16760828625235405,0.6415006467546822,1.0,2/10,1.96%,FN1;GATA6
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.41575708158164304,1.2974065207554335,0.12563667232597622,0.6412158392360768,1.0,20/44,23.49%,ROCK2;ZC3HAV1;TNRC6B;RC3H1;NANOS2;FTO;TNRC6A;MOV10;EIF4ENIF1;METTL16;GIGYF2;CPEB3;DHX36;NANOS1;ROCK1;KHSRP;ZC3H12A;PNPT1;ZFP36L2;YTHDF3
prerank,protein localization to membrane (GO:0072657),-0.29753314813969306,-1.296966571253453,0.019762845849802372,0.567466343066384,1.0,47/187,14.15%,DPP10;NRXN1;NLGN1;DLG2;BSG;KCNB2;SHANK3;LRRC7;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;RFTN1;CPE;CDH1;KCNIP4;ITGA4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;RAB38;RAB3C;TM9SF3;TMED2;LRP6;RAMP2;DVL1;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;CAV1;RAB40B;F11R;AGRN;EHD4;CLASP2;ABHD17A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.44875050539861366,-1.2967738311531734,0.13953488372093023,0.5664810480767892,1.0,7/20,9.49%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC8A1;NEDD4L
prerank,embryonic organ morphogenesis (GO:0048562),0.425809110210021,1.2967305850375974,0.13682432432432431,0.6420080279542414,1.0,6/42,6.98%,EFEMP1;FBN1;PDGFRA;RBP4;HOXC4;DYNC2I1
prerank,neural crest cell development (GO:0014032),-0.3774962311685427,-1.2965773029594232,0.10526315789473684,0.5655883002372879,1.0,12/44,10.34%,SEMA6D;CDH2;ERBB4;PHACTR4;TBX1;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.43500480603229497,-1.2963571254989503,0.14218009478672985,0.5647002634681796,1.0,11/24,18.17%,PLCG2;RYR2;HTR2C;RYR3;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;HTR2A
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5481345333842742,-1.2957933552373915,0.14814814814814814,0.5648485328504307,1.0,4/10,17.52%,SORL1;HSP90AB1;HSP90AA1;NAB2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5229088892190689,-1.2945550459814534,0.16938775510204082,0.56684267276247,1.0,5/12,11.06%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,embryonic digestive tract development (GO:0048566),0.4881283303883664,1.294356006142965,0.14795008912655971,0.6481420800003619,1.0,4/18,6.77%,PDGFRA;GLI3;SALL1;RARB
prerank,cellular response to organonitrogen compound (GO:0071417),-0.31991352262410794,-1.2942413172309004,0.05397727272727273,0.5662580938995261,1.0,29/99,20.04%,SLIT2;MEF2C;AKAP6;ACTB;HCN1;CDH1;GABRB3;RYR3;SLC5A5;CTNNB1;INPP5K;HCN2;RAPGEF2;PDE3A;GABRB1;PDE2A;RRAGB;KCNQ1;GABRB2;CPEB4;HRH1;SPAAR;RAP1A;RRAGC;BRCA1;P2RX7;GLRA2;GLRA1;LAMTOR2
prerank,brain development (GO:0007420),-0.307986893615433,-1.2938915932732424,0.036231884057971016,0.5658139390670806,1.0,24/136,9.11%,ADGRL3;ADGRL2;CNTNAP2;CTNNA2;ROBO2;SHANK3;CDH2;MEIS2;COL4A1;CNTN4;ZFHX3;PBX3;SHROOM4;GRIN2A;ADGRG1;APOD;RAB3GAP1;GRIN2B;SCYL2;RAPGEF2;SOX6;NDRG4;BAG6;GRIN1
prerank,regulation of catecholamine secretion (GO:0050433),-0.41324664913253284,-1.293779354560243,0.125,0.5646413580139013,1.0,13/29,26.68%,SYT1;SNCA;SYT4;SYT7;KCNB1;SYT9;SYT2;KCNA2;CHRNA4;SYT6;SYT10;SYT5;SYT17
prerank,cellular response to oxygen levels (GO:0071453),-0.5471378358021591,-1.2924441573085519,0.1810344827586207,0.5669181084768712,1.0,10/10,45.33%,CPEB4;ATP6V0A2;ATP6AP1;TMEM199;PICK1;ATP6V1A;ATP6V1G1;NDUFS2;ATP6V0D1;CCDC115
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48400441755912665,-1.2914780234989263,0.16198704103671707,0.5682529896855709,1.0,9/16,37.54%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,positive regulation of cell communication (GO:0010647),-0.41452344250610174,-1.291080273477662,0.12114014251781473,0.567936225221802,1.0,6/28,3.91%,SYT1;RIMS1;RIMS2;GRIK2;HOMER1;ANK3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.41761089745894797,1.2908950901105427,0.13781512605042018,0.6579550324791735,1.0,10/43,12.23%,IGFBP5;GJA1;BMPR1A;ADAMTS1;IL6;PDGFRB;IL18;STAT1;CDH13;P2RY6
prerank,cellular response to peptide (GO:1901653),0.3964608702206241,1.290559235788073,0.1262135922330097,0.65757500575403,1.0,13/56,8.24%,FPR2;LDOC1;GJA1;VIM;SNX6;TLR4;PTPN22;CASP4;VCAM1;NGFR;GSK3B;RIPK2;EPHA4
prerank,regulation of hemopoiesis (GO:1903706),0.5716470362572195,1.290056058535513,0.19438877755511022,0.6578358488381217,1.0,5/10,10.82%,PTN;IL17D;CREBBP;MAFB;MYSM1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4264343593507655,1.289762571595415,0.13926174496644295,0.6573763816045323,1.0,6/41,6.94%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR2
prerank,regulation of stem cell population maintenance (GO:2000036),0.49901763768995044,1.2895767378004945,0.19887429643527205,0.6565802290526076,1.0,2/18,3.02%,PTN;NCOA3
prerank,membrane assembly (GO:0071709),-0.39636772410873417,-1.2888163436354838,0.12709832134292565,0.5729414445427127,1.0,9/34,8.74%,NRXN1;NLGN1;PTPRD;RFTN1;ANK3;IL1RAPL1;EMP2;NSFL1C;NLGN3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.35548299095536445,1.2882239672385956,0.08759124087591241,0.6594940555417791,1.0,23/117,10.98%,ALDH1A2;PCCA;ACOT11;LDHAL6B;PANK2;PPARA;ALDH4A1;ME2;NPC1;PTGR1;GLO1;AMACR;ACADSB;ECHDC3;NAAA;PCCB;SCP2;BTD;HLCS;ACOT1;ABAT;HACL1;SCPEP1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37469332139503864,-1.2876955867824456,0.09065934065934066,0.5746987367399757,1.0,18/42,33.70%,LARS2;KARS1;CARS1;EEF1E1;EARS2;TARS3;IARS1;RARS2;VARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;PARS2;QARS1
prerank,negative regulation of cell cycle (GO:0045786),0.37589131730004005,1.287433122253504,0.11388455538221529,0.6607139162532244,1.0,18/73,13.23%,SMAD3;NR2F2;NUPR1;FOXC1;BMP2;BTG3;BMP7;PTPN3;LATS2;BTG4;NPPC;NUPR2;GMNN;IPO7;NR4A1;TSPYL2;NUDT6;HECA
prerank,metanephric mesenchyme development (GO:0072075),0.5716295013524783,1.2869689456549591,0.20192307692307693,0.6608890299734176,1.0,3/10,7.59%,WNT4;OSR1;STAT1
prerank,regulation of cell growth (GO:0001558),-0.28890004633739197,-1.2868538414224098,0.02145922746781116,0.5757195841689259,1.0,48/204,15.68%,APBB2;SLIT2;NRG3;PTPRJ;AKAP6;SMARCA2;TGFB2;BMPR2;TFRC;NET1;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;H3-3A;PRKCQ;CCN3;FAM107A;CAPRIN2;PAK5;AKT1;CAMK2D;NDRG3;CEACAM1;SDCBP;STK11;DDX49;ING1;IP6K2;SPOCK1;CCAR2;RACK1;KIF26A;NPR1;EXOSC2;RPS6KA1;BCAR1;EGFR;CEP43;MFSD2A;DCUN1D5;JADE1;TAF9B;PAK4;LGI1;CDKN1A;ENO1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3118024324115352,1.2867064570935989,0.02112676056338028,0.6603576291978229,1.0,64/423,11.72%,TCF7L2;EFNB2;TGFBR3;BMP6;PTN;DPP4;LAMC1;RBPJ;FN1;PDGFRA;FGFR1;FGF1;PID1;DDR2;OSR1;IL31RA;IL6ST;PHIP;GHRH;WNT3A;GAB2;GJA1;BMPR1A;OSM;S100A6;IL11;FER;VEGFD;TGFA;IL34;PTHLH;BMP2;TERT;GLP2R;IL6;GLI1;BCL2;STOX1;TGFBR1;EPHA1;PDGFRB;HDAC4;BST2;CD47;TGFBR2;STAMBP;CTSH;IL18;STAT1;WNT5A;YAP1;IGF2;IL13RA1;DNAJA2;MST1R;GRK5;FGF18;PTPN6;CDH13;TJP1;PTK2;NES;DISP3;CUL3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.532842228994826,1.2856869971592433,0.19516728624535315,0.6624170276519767,1.0,4/14,14.09%,STK39;OXSR1;WNT5A;WNK1
prerank,positive regulation of insulin secretion (GO:0032024),0.4334548227802871,1.2855012746448073,0.1514629948364888,0.6615882935848933,1.0,7/36,13.28%,TCF7L2;MCU;RBP4;PLA2G6;NLGN2;PPP3CB;BAIAP3
prerank,cell-substrate junction assembly (GO:0007044),-0.399913975251456,-1.2853725588557525,0.14814814814814814,0.5785715680878674,1.0,12/33,11.94%,ITGA6;ACTN1;PTPRK;THSD1;PEAK1;ITGB4;LAMA3;TESK2;RCC2;TRIP6;BCR;ARHGEF7
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5279426354077603,1.2851875463399578,0.17996289424860853,0.661238585472768,1.0,3/14,15.92%,MOXD1;SLC5A7;SLC22A2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5469972524593658,-1.2850132860456143,0.15473887814313347,0.5781719916384432,1.0,8/10,23.91%,ATP5F1A;ATP5MC1;ATP5PO;ATP5PD;ATP5F1D;VPS9D1;ATP5MG;ATP5MC3
prerank,negative regulation of GTPase activity (GO:0034260),-0.4377607085243409,-1.28487013018275,0.13073394495412843,0.5770998189004098,1.0,7/22,13.61%,LRCH1;CPEB2;DAB2IP;RCC2;TMED2;F11R;HRAS
prerank,body fluid secretion (GO:0007589),-0.49248004802650175,-1.284753777213975,0.164079822616408,0.5759728664750228,1.0,4/15,12.79%,ERBB4;VEGFA;NPR1;PRLR
prerank,osteoclast differentiation (GO:0030316),0.4724906284530766,1.2846757757972427,0.159369527145359,0.6615983145971773,1.0,6/22,12.29%,GAB2;ANXA2;GLO1;MAPK14;CSF1;EPHA2
prerank,positive regulation of growth (GO:0045927),-0.33906835233290983,-1.2839720180295846,0.0886426592797784,0.5767372872304198,1.0,19/64,18.30%,PLCB1;AKAP6;TGFB2;INSR;RFTN1;H3-3A;AKT1;SDCBP;DDX49;EXOSC2;RPS6KA1;EGFR;CEP43;MFSD2A;TAF9B;LGI1;CDKN2AIP;PPM1F;EXOSC4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5360359649154804,1.2833856602515503,0.19813084112149532,0.6644007061992322,1.0,6/13,24.31%,IDH1;D2HGDH;IDH2;PHYH;ADHFE1;OGDH
prerank,retinal metabolic process (GO:0042574),0.5462086339153799,1.2826324793382313,0.19419237749546278,0.6652908296228885,1.0,4/12,14.80%,ABCA4;RDH10;BCO2;ALDH8A1
prerank,negative regulation of transposition (GO:0010529),0.5273212993764562,1.282521979976316,0.18435754189944134,0.6643358246038316,1.0,3/16,8.81%,TUT4;PIWIL4;MOV10
prerank,regulation of neutrophil migration (GO:1902622),-0.5447701459408824,-1.2824553017679987,0.18452380952380953,0.5795350605021443,1.0,7/10,32.79%,JAM3;RHOG;RAC1;RHOH;BST1;MPP1;RAC2
prerank,lipid oxidation (GO:0034440),-0.5321442334212474,-1.2817537556492336,0.19279661016949154,0.5800761733237837,1.0,1/12,0.45%,ADIPOR2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30646160079440715,1.2817271442425486,0.01452513966480447,0.6654816257262012,1.0,109/497,16.48%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ARID4A;ATXN1;NR2F2;TLE1;SAMD4A;ENPP1;SMURF2;EIF2AK2;IGFBP5;GATA6;SHMT1;SAMD13;ZBTB4;ZIC2;SNX6;RBFOX2;GLI3;MYB;MBD2;ZMYND15;TCEAL7;EID2B;CRY2;PRDM11;DAPK1;BMP2;RFX3;CRY1;LOXL3;BCOR;BMP7;GZF1;SALL1;CBFA2T2;IGF2BP1;CDAN1;FOXP3;HDAC4;TSHZ3;NANOS2;DKK3;PBXIP1;GLIS2;DPF2;GSK3B;ZMYND11;PHB2;WNT5A;ZEB1;KAT6B;EPC1;USP47;SCMH1;SUMO1;JARID2;TAF7;PSPC1;WWP2;GMNN;ATF7IP;IGF2BP2;HEYL;CIR1;SMAD4;SCML4;BCL7A;TSPYL2;LHX9;ZNF219;EIF4ENIF1;VGLL4;ILF3;BTRC;FBXW11;DDX6;CBX4;BHLHE41;NR3C1;ARID5B;POU2F1;KAT6A;PRDM5;KDM8;RBM15;RUNX1T1;NIBAN2;ZBTB21;HDAC2;GIGYF2;RARA;PML;PDS5A;UIMC1;EIF2AK3;SP3;SMARCA4;ERN2;CNOT9;CPEB3;SMAD2;RING1;S100A11;SPINDOC
prerank,neurotransmitter transport (GO:0006836),-0.33907225867207247,-1.2816067216846854,0.10149253731343283,0.5790930389839595,1.0,18/73,11.31%,NRXN1;SYT1;RIMS1;PPFIA2;HSPA8;LIN7A;PTPRN2;GABRA2;SNAP25;SYN3;SLC1A1;STXBP1;CPLX1;SLC1A2;SYN1;SNPH;DVL1;GAD2
prerank,positive regulation of signaling (GO:0023056),-0.3869417898429808,-1.2810865735244161,0.11165048543689321,0.5790249443158058,1.0,8/37,7.01%,SYT1;RIMS1;RIMS2;GRIK2;NSF;HOMER1;SNCA;ECE1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.463797705124418,1.2810439860319802,0.18867924528301888,0.6663128403238515,1.0,7/26,13.84%,RSAD2;IFI35;PTPN22;NR1H3;PJA2;TLR2;RTN4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3692982499670247,1.280831910996666,0.0975609756097561,0.6656452696642907,1.0,17/87,13.75%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;POLR2D;KL;HNRNPH1;CCL2;FGF18;FLRT1;POLR2C;EGR3;DSTYK;NR4A1;SHOC2;POLR2F
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.41324777851350486,1.2808232085852673,0.1419031719532554,0.6643452692440946,1.0,10/46,5.98%,ATRNL1;LAMC1;FN1;RADIL;PARVA;NRP1;FER;ANTXR1;LAMC3;EPHA1
prerank,sulfation (GO:0051923),0.5610027602025347,1.2806769120398023,0.19467213114754098,0.6634920196976802,1.0,1/11,0.28%,UST
prerank,positive regulation of RNA splicing (GO:0033120),-0.4080487320479158,-1.280434959450546,0.14603960396039603,0.5794291618861772,1.0,9/29,27.91%,PIK3R1;CELF4;SETX;TRA2A;RBM3;HNRNPLL;SLC38A2;RBMXL1;RBM20
prerank,inhibitory synapse assembly (GO:1904862),-0.5298798420609667,-1.2803094219035602,0.18886679920477137,0.5783958252325467,1.0,7/11,24.44%,GABRA2;GABRB3;LGI2;FGF13;GABRB2;GABRA1;PLXNB1
prerank,smoothened signaling pathway (GO:0007224),0.445319863282259,1.2801093833393007,0.15726495726495726,0.663872079588256,1.0,8/32,11.55%,EVC2;GLI3;ARL13B;GLI1;GPC2;CC2D2A;DISP3;IHH
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3986680935767804,1.2800564420359863,0.13078149920255183,0.6626889688791987,1.0,12/51,12.67%,PTN;CXCL10;FPR2;VEGFD;IL34;IL6;SERPINE1;LGALS9;PTK2;ANO6;CSF1;RARRES2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5848198586077542,1.2787503574925365,0.21804511278195488,0.665536629624744,1.0,3/10,6.02%,IFI35;PTPN22;NR1H3
prerank,regulation of gene expression (GO:0010468),0.29773144982413124,1.2784215037687785,0.003181336161187699,0.6653516369008474,1.0,170/903,14.70%,ROBO1;EFEMP1;RORA;BMP6;WNT4;PARP14;FOXD1;ROCK2;SMAD3;RBPJ;ATXN1;RBMS3;FN1;AFDN;WNT6;FGF1;PID1;PRDM6;TLE1;NOTCH2;PRKAA2;ARNT2;OSR1;FOXC1;NFIA;NFYC;AFF3;TRIM10;WNT3A;GJA1;PTBP3;ZBTB4;BMPR1A;ZNF395;DENND4A;SSBP2;CDH5;ITGB8;NELL1;MYB;PARP9;GCGR;SLC26A9;TNRC6B;SLC24A3;PRRX2;PRDM11;AHNAK;PTHLH;PERM1;ANGPT1;RC3H1;BMP2;PKP3;RFX3;TERT;APBB1;IL6;TLR4;BMP7;TRIM17;GZF1;STOX1;PTPN22;TGFBR1;IGF2BP1;NSD3;SNX12;CPNE1;BAZ2A;ZNF35;WWC2;FOXP3;ATP2B4;TESMIN;TRIM5;HDAC4;CREBL2;TCF7L1;NOS2;CRP;CREBBP;POGZ;PARP10;NSD1;CTSH;CLK4;POU1F1;NOVA1;RNF20;OPRD1;HNRNPH1;PDCD5;GSK3B;LGALS9;ZSCAN21;ANXA7;NFXL1;TEAD2;ATF7;MYADM;TNRC6A;WNT5A;ZFP37;YAP1;DTNBP1;KAT6B;MOV10;IGF2;TAPBP;NOCT;CREM;MUSK;FUBP1;SOX21;TIPARP;RFXANK;SUFU;MAFB;MSC;MAPK14;PSPC1;WWP2;CUX2;TDRD7;FGF18;IGF2BP2;UBE2V1;TLR2;LRP3;TGFBRAP1;TCF7;IHH;NFKBIZ;ADAM19;ZNHIT3;HNRNPH3;CSF1;ZNF219;ZFAT;TRIM21;OGG1;HFE;CRNN;THAP1;NOG;MAP2K1;TRIM26;PTBP2;MZF1;NR3C1;SERTAD3;MAPK9;METTL16;RNF39;HIC1;ZNF462;ZNF205;TICAM1;AFF1;PRDM5;NCOA2;USP36;FLOT2;DMTF1;PABPN1;FUS;CARM1;VHL;ZC3H7B
prerank,pulmonary valve development (GO:0003177),-0.4625495677993585,-1.2780567677153927,0.1714922048997773,0.5833213282508629,1.0,8/18,8.00%,SLIT2;ROBO2;NOS3;TGFB2;BMPR2;NOTCH1;BMP4;TNFRSF1B
prerank,alpha-amino acid catabolic process (GO:1901606),0.45258315894305545,1.2777211729051676,0.1702127659574468,0.6663175463358465,1.0,7/29,13.19%,DDO;ALDH4A1;ACADSB;HGD;BLMH;ACAT1;SARDH
prerank,regulation of viral entry into host cell (GO:0046596),-0.39634441821243505,-1.2775143365670423,0.12679425837320574,0.5834302887821644,1.0,10/30,18.15%,LY6E;HS3ST5;SNX3;MID2;CD74;TRIM68;TRIM62;IFITM3;IFITM2;LGALS1
prerank,negative regulation of cell growth (GO:0030308),-0.31121098490189997,-1.2769087906686598,0.06907894736842106,0.5837889573376067,1.0,25/121,11.76%,APBB2;SLIT2;PTPRJ;DIP2B;SMARCA2;TGFB2;BMPR2;DCC;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;CCAR2;SEMA3G;RACK1;NPR1;FGF13;ULK1
prerank,nuclear membrane disassembly (GO:0051081),-0.4854590402670412,-1.2765942457652595,0.1853448275862069,0.583198281342678,1.0,9/14,37.68%,PRKCB;NEK9;CTDNEP1;VRK1;DCTN1;PLK1;CDK1;CCNB2;CCNB1
prerank,protein localization to cell surface (GO:0034394),-0.41474871254799406,-1.276007586149901,0.13636363636363635,0.5834312471614723,1.0,8/26,10.57%,PTPRK;EMP2;FBLN5;CTNNB1;RIC3;JAM3;PIGU;PIGK
prerank,positive regulation of phospholipase C activity (GO:0010863),0.42288840048558474,1.2758222616001271,0.14736842105263157,0.6707988971422201,1.0,12/40,15.64%,ARHGAP6;LPAR1;PDGFRA;FGFR1;KIT;PDGFRB;PHB2;NMUR1;P2RY6;BDNF;NTRK3;TXK
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.47482004377966874,-1.2755519509304554,0.16703296703296702,0.583341158360148,1.0,5/14,15.10%,DMD;ATP1B1;ANK3;ACTN4;GLRX
prerank,entry into host (GO:0044409),-0.512856976037991,-1.2751259978522096,0.17436974789915966,0.5832161120239506,1.0,6/13,15.88%,CDH1;MET;CTNNB1;CBL;PPIA;CBLL1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4531608728801317,1.274788582098266,0.17073170731707318,0.6728358162348107,1.0,12/27,23.55%,TNRC6B;IL6;EIF4ENIF1;MAP2K1;DDX6;WTIP;PUM2;DDX5;AJUBA;RIPK1;DHX9;TGFB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5130614470904741,1.2745949407495016,0.1793478260869565,0.6721164015012742,1.0,6/15,14.82%,WNT6;FOXC1;BMP2;EDA;ANKRD11;HDAC2
prerank,negative regulation of neuron death (GO:1901215),-0.3153127569068691,-1.2743693126834954,0.09427609427609428,0.5838559426353853,1.0,27/93,17.94%,MEF2C;PTK2B;CD34;NTRK2;SIX1;SNCA;SORL1;FOXQ1;NDNF;LGMN;AKT1;TNFRSF1B;PINK1;TGFB3;NGF;ATF4;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;BTBD10;SET;NTF3;TOX3;ADAM8
prerank,regulation of cell junction assembly (GO:1901888),-0.4096458815452111,-1.274047303898892,0.14874141876430205,0.5833779860311132,1.0,9/27,16.16%,PRKCH;CLDN5;MEF2C;RAPGEF2;RUNX1;CBFB;F11R;APLNR;RAP1A
prerank,peptidyl-threonine modification (GO:0018210),0.383705847837778,1.2735115812895441,0.1292834890965732,0.6740906437207668,1.0,16/66,15.77%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;GALNT2;GALNT1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;WNK1;TBK1;CSNK2A2;PRKD2
prerank,regulation of adaptive immune response (GO:0002819),0.4942335211605922,1.272891766740637,0.18716577540106952,0.6746643353765324,1.0,2/18,4.56%,IL6ST;ADCY7
prerank,nervous system development (GO:0007399),-0.26274076636830185,-1.2723158164572506,0.0072992700729927005,0.5870414346152109,1.0,84/429,12.44%,RAPGEF5;DNM3;ADGRL3;NRXN1;NLGN1;NAV2;ROBO2;LSAMP;SHANK3;SLC2A1;MERTK;ST8SIA4;SPOCK2;CDH2;ERBB4;MEF2C;ADGRG6;NAV3;CHRM3;KIRREL3;EFNA5;GPM6A;FGF12;CNTN4;WWP1;MYT1L;MBNL1;MOG;GPM6B;CNTN6;NCKAP1;CDH1;RBFOX3;RBFOX1;CHRM2;TRPC5;SEMA6A;GRIK1;SERPINI1;MET;SHANK2;SNTG2;EPHB1;S100B;PCDH1;SH3GL2;ADAM22;AHI1;MAL;DCLK1;MOBP;NRCAM;APBA2;MBP;EIF2B2;SCN2A;ALDH5A1;ZIC3;ZBTB16;SOX6;NINJ2;MBD5;NLGN3;VEGFA;L1CAM;ADAM23;SPOCK1;DNER;CNTFR;DHX30;DVL1;SEMA6B;DBNL;PCDHB16;FGF13;FGF2;SCN8A;NRSN1;NFASC;GFRA2;IL1RAPL2;NGF;NPAS2;VLDLR
prerank,negative regulation of cation channel activity (GO:2001258),-0.42702197903080485,-1.2722584229322575,0.13793103448275862,0.5857768303212715,1.0,11/26,25.23%,KCNAB1;FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1;GPR35;EPO;CBARP
prerank,histone monoubiquitination (GO:0010390),0.45313076132512964,1.2711035897183225,0.1793103448275862,0.6792215828879413,1.0,10/24,16.98%,BCOR;DTX3L;RNF20;CDC73;WAC;PAF1;LEO1;KDM2B;RING1;RNF2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.41231388522073326,-1.2707894819854582,0.1480637813211845,0.5884150724085581,1.0,11/26,29.71%,PDE8A;AKT1;PINK1;ATF4;PPIA;PARK7;GPR37;GPR37L1;PYCR1;VNN1;HSPB1
prerank,cell part morphogenesis (GO:0032990),0.534315711856262,1.2707817389799774,0.2003780718336484,0.6788670289040167,1.0,5/13,13.49%,PID1;PACSIN2;DNM1L;SUPV3L1;WASF1
prerank,prostaglandin biosynthetic process (GO:0001516),0.48821583369707333,1.2706643581987682,0.1882770870337478,0.6779248333765173,1.0,2/18,1.37%,PTGS1;PLA2G4A
prerank,maturation of 5.8S rRNA (GO:0000460),0.5082277085512061,1.2705394245331196,0.17481203007518797,0.6770531227074206,1.0,6/17,17.86%,MPHOSPH6;NSA2;WDR12;EXOSC10;RPF1;C1D
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.488043965441486,1.2704753371913031,0.17689530685920576,0.6759276386674788,1.0,5/19,11.82%,BMP6;AFDN;TJP1;PTPRU;ADAM19
prerank,cellular response to virus (GO:0098586),0.4405105159904014,1.2704572405272314,0.16457960644007155,0.6746829513598179,1.0,13/30,22.66%,CXCL10;IL6;GSDME;LGALS9;BAX;MAPK14;IFIH1;GBF1;ARF1;HIF1A;ZC3H12A;RIOK3;LGALS8
prerank,response to thyroid hormone (GO:0097066),-0.5009978147706244,-1.2699122025089313,0.17165668662674652,0.5894931209545475,1.0,5/13,11.06%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4803931017130355,1.2698967496048803,0.17958412098298676,0.6750294736000804,1.0,5/20,7.71%,TLR4;MTDH;PTPN22;IL18;CCL2
prerank,gland development (GO:0048732),0.3861336688343832,1.2697782036314342,0.12636505460218408,0.6740924815894285,1.0,7/59,6.51%,TGFBR3;WNT4;PRKCSH;ANXA1;TGFBR1;SALL1;DKK3
prerank,positive regulation of embryonic development (GO:0040019),0.4880540700610997,1.2697673801225173,0.1977818853974122,0.6728207617057022,1.0,3/19,2.09%,WNT4;OSR1;WNT3A
prerank,respiratory tube development (GO:0030323),0.4469220990801712,1.2694961190399845,0.1724137931034483,0.6722802886572762,1.0,5/28,7.18%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,cellular response to growth factor stimulus (GO:0071363),0.33851344627752833,1.269053043943679,0.08160442600276625,0.6724084640148873,1.0,30/151,11.86%,PDPK1;SOX5;BMP6;WNT4;SMAD3;ADAMTS12;FOXC1;CLEC3B;BMPR1A;NRP1;WWOX;ANXA1;BMP2;STAT5B;BMP7;PLK5;TGFBR1;APPL2;TGFBR2;PDCD5;CCL2;ACAP2;WNT5A;APPL1;MAPK14;SMAD4;MAP2K5;EGR3;DSTYK;NR4A1
prerank,protein autoubiquitination (GO:0051865),0.3885678828207771,1.2689794867257158,0.15112540192926044,0.6713202180869868,1.0,13/61,15.98%,RNF220;RNF213;SH3RF1;TRIM17;DTX3L;AMFR;WWP2;CUL3;TRIM21;BFAR;RNF181;RNF146;RNF185
prerank,endothelial cell differentiation (GO:0045446),-0.5155989109844079,-1.2689737936673722,0.17849462365591398,0.5909935421607102,1.0,6/12,9.94%,TIE1;BMPR2;KDR;ACVRL1;SCUBE1;SOX18
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5480049394306994,1.2688096753351106,0.1961904761904762,0.6705719045703279,1.0,7/11,20.23%,TPR;RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8
prerank,negative regulation of translation (GO:0017148),0.36262763800189063,1.2687370800703284,0.12291350531107739,0.6695063235382726,1.0,20/87,16.03%,ROCK2;SAMD4A;EIF2AK2;IGFBP5;SHMT1;DAPK1;IGF2BP1;TPR;NANOS2;CPEB1;FTO;IGF2BP2;EIF4ENIF1;ILF3;DDX6;METTL16;GIGYF2;EIF2AK3;CNOT9;CPEB3
prerank,protein dephosphorylation (GO:0006470),0.3444233955025339,1.2684373825665405,0.0927536231884058,0.6691548673968014,1.0,34/135,12.79%,PTPN13;EYA2;EYA1;PPP2R2B;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;DUSP16;PTPN9;SSH1;PTPN21;PPEF2;PPP4R2;CTDSP2;PPP4R1;PPM1B;PTPN6;PPP1CB;EYA4;PTPRU;PPP3CB;DUSP5;BTRC;PTPN1;PTPN18;FBXW11
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.42791049542419046,1.2682265454477435,0.16579406631762653,0.6685641694040886,1.0,6/35,7.71%,SULF1;COL4A3;NR2F2;NGFR;STAT1;CCL2
prerank,positive regulation of secretion (GO:0051047),-0.5311421136216358,-1.267839955208439,0.15757575757575756,0.5928388935121679,1.0,2/11,10.66%,ACSL3;NPR1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4749820093550108,1.2677448129193793,0.18703703703703703,0.668837565800192,1.0,4/20,10.95%,MCU;MICU1;PHB2;PMPCB
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.46887228492193245,1.2668741725527952,0.17688266199649738,0.6702989757964269,1.0,10/25,20.27%,LSM1;SF3B3;DDX23;SLU7;SRSF4;TXNL4A;SCAF11;PRPF3;SNRNP40;KHSRP
prerank,cellular copper ion homeostasis (GO:0006878),-0.4924226135271794,-1.2667797575535995,0.19126819126819128,0.5945170622060355,1.0,7/14,26.85%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.46621550468047135,1.2661335286508064,0.1733102253032929,0.6713802568849876,1.0,4/23,8.09%,PLA2G4A;MBOAT2;PLA2G4C;PLA2G6
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5272057580674873,1.2654248888306037,0.19498069498069498,0.6724167233351264,1.0,7/13,15.69%,NUPR1;LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;FEZ2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5019029983011691,-1.2653531710287567,0.17436974789915966,0.5974952518751058,1.0,6/12,16.42%,DMD;ATP1B1;ANK3;NOS1;GLRX;FXYD1
prerank,activin receptor signaling pathway (GO:0032924),0.5040479016717693,1.2652667186767936,0.20040080160320642,0.6716628748062827,1.0,5/15,16.33%,SMAD3;TGFBR1;ACVR1C;ACVR2B;SMAD2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4404222507563777,1.2651500275426948,0.16835016835016836,0.6707440784855433,1.0,5/29,8.09%,PLA2G4A;MBOAT2;NR1H3;PLA2G4C;PLA2G6
prerank,positive regulation of binding (GO:0051099),0.3679734870977034,1.2649154046838704,0.12732919254658384,0.6702170674460947,1.0,20/84,12.58%,TCF7L2;VTN;FOXC1;WNT3A;PARP9;DACT1;BMP2;TERT;DTX3L;CLN5;SPPL3;GSK3B;SKI;RIPK2;STK3;AMFR;LRRK2;GMNN;TRIM21;HFE
prerank,protein polyubiquitination (GO:0000209),0.31379104371689864,1.264761274776998,0.04791154791154791,0.6694054747292568,1.0,66/297,15.53%,SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM56;HERC6;RNF217;TRAF5;FBXO11;FBXL17;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;BCL2;RNF19A;UBE2U;RNF216;DZIP3;SIAH2;PELI2;TRIM5;DTX3L;FBXO9;NPEPPS;ANAPC11;RNF20;FBXL3;PSMB10;ANAPC1;AMFR;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO4;PSMA5;WWP2;FBXO38;BLMH;HUWE1;UBE2V1;HECTD1;CUL3;IFI27;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;CDC27;PRPF19;BFAR;LNPEP;FBXL4;DDA1;UBE2R2;FBXL13;FBXL12;RNF146;MUL1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3773555571258795,-1.2645095715873076,0.11082474226804123,0.5984969086052284,1.0,18/40,24.85%,NAV3;PAK1;SNCA;RPS3;MET;STMN2;TUBB4A;FES;PRUNE1;RAC1;MAPT;MAP2;STMN1;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,leukotriene metabolic process (GO:0006691),0.4918988218337993,1.263328128363062,0.19160583941605838,0.6724124312891064,1.0,3/19,6.87%,PLA2G4A;DPEP2;PTGR1
prerank,cardiac muscle contraction (GO:0060048),0.42964374302666486,1.2631729133118477,0.17355371900826447,0.6716821198615032,1.0,5/34,8.06%,TNNC1;ATP1A2;CSRP3;TPM1;SCN3B
prerank,peptide cross-linking (GO:0018149),0.47145284530317844,1.2630673286885283,0.18871252204585537,0.6707883142209891,1.0,3/25,3.55%,COL3A1;FN1;ANXA1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5748553407709549,1.2628050287392625,0.20321931589537223,0.6703664146306745,1.0,1/10,0.14%,KMT2A
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.503005554329141,-1.26250095851641,0.18661257606490872,0.6030332767468669,1.0,9/13,28.25%,SHANK3;LGMN;ZDHHC2;RELN;ADCY8;AKAP5;CHRNA7;SHISA7;SQSTM1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4642094869272148,-1.262321971783272,0.1774891774891775,0.6021203854529527,1.0,9/17,37.54%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,cell differentiation in spinal cord (GO:0021515),-0.5391225101418934,-1.262231245892697,0.19298245614035087,0.6009502456502938,1.0,2/10,7.13%,MDGA2;SOX6
prerank,calcium-mediated signaling (GO:0019722),0.36158691767009354,1.2620508118549583,0.13967310549777118,0.6713928576233218,1.0,15/93,9.49%,PDPK1;RCAN2;MCU;SELP;FPR2;ACKR2;CCR9;RCAN1;PLCE1;VCAM1;ADGRL1;ACKR3;CACNA1C;LRRK2;NMUR1
prerank,neutral amino acid transport (GO:0015804),-0.4141154526669784,-1.261893836132883,0.15421686746987953,0.6004733932726186,1.0,8/28,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3865350108999458,-1.2614463194596894,0.13975903614457832,0.600317525641643,1.0,11/33,17.14%,CHRM3;AKAP6;KCNJ3;KCNJ2;NEDD4L;KCNJ6;KCNJ8;KCNQ1;KCNJ15;CASQ2;P2RX7
prerank,GTP metabolic process (GO:0046039),0.5137351143164479,1.2610496421548305,0.21386138613861386,0.6733945543395753,1.0,7/15,17.54%,ENTPD7;RHOQ;LRRK2;EFL1;OPA1;RAN;GNAI3
prerank,regulation of p38MAPK cascade (GO:1900744),0.423029196359538,1.2610211341190738,0.16695059625212946,0.672226802637388,1.0,8/35,8.89%,SASH1;RELL1;DUSP10;BMP2;PTPN22;LGALS9;PJA2;DLG1
prerank,post-translational protein modification (GO:0043687),0.31202697546184616,1.2607440529042495,0.043373493975903614,0.671736594703321,1.0,48/332,12.85%,IGFBP3;CP;TNC;FBN1;LAMC1;FSTL1;FN1;PRKCSH;LTBP1;FAM20C;SPSB1;IGFBP5;APOA2;HIF3A;FSTL3;SDC2;FBXO11;RCN1;ITIH2;IL6;EPAS1;MIA3;KLHL21;KLHL22;SPSB4;APLP2;CUL4A;FBXO9;FBXL3;NUB1;PSMB10;CHM;PSMA3;FBXL20;PSME4;FBXL7;DNAJC3;FBXO4;PSMA5;KEAP1;ESCO1;CUL3;KLHL13;CSF1;ANO8;BTRC;FBXW11;ASB5
prerank,protein import into peroxisome matrix (GO:0016558),-0.5123404404632983,-1.2605941758272614,0.16632016632016633,0.6012498532903072,1.0,4/12,15.68%,PEX5L;PEX26;PEX10;PEX16
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.32652089240897064,-1.2602211963837142,0.0950920245398773,0.600904004339851,1.0,37/79,27.91%,ACTR10;SH3GL2;MFSD6;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,striated muscle tissue development (GO:0014706),-0.40193334723718455,-1.2598724417376268,0.16784869976359337,0.6005307832831125,1.0,8/29,8.44%,SGCZ;PGM5;MEF2C;SGCD;BMPR2;SIX1;MYL6;TBX2
prerank,thymus development (GO:0048538),-0.48466860915148624,-1.2597704128281304,0.1788793103448276,0.5993928131121214,1.0,8/13,29.54%,TBX1;SIX1;SOD1;EPHB3;HES1;FOXE1;FADD;FGF10
prerank,regulation of cell population proliferation (GO:0042127),0.29616430751025363,1.2585755346543914,0.015486725663716814,0.6773320959358362,1.0,138/691,16.58%,TCF7L2;ALDH1A2;IGFBP3;EFNB2;PDPN;PODN;BMP6;COL4A3;PTN;DPP4;KANK2;FN1;CXCL10;PDGFRA;FGFR1;FGF1;IL31RA;EIF2AK2;KSR1;TPTE;NUPR1;STAT2;IL6ST;PHIP;GHRH;LDOC1;WNT3A;GAB2;DLC1;PDS5B;BMPR1A;OSM;IL11;RBFOX2;FER;SMIM22;VEGFD;TGFA;ADAMTS1;IL34;TGFB1I1;PTHLH;PTPN14;KIT;BMP2;IGFBP6;STAT5B;IFI35;GLP2R;IL6;BTG3;GSDME;GLI1;BCL2;STOX1;BTG4;TGFBR1;EPHA1;FOXP3;PDGFRB;HDAC4;PTPN2;CD47;COL18A1;TGFBR2;STAMBP;CTSH;ZBTB7C;POU1F1;CLMN;STAT1;CDC73;PDCD5;SKI;CDKN2B;PIAS1;SETD4;YAP1;IGF2;IL13RA1;DNAJA2;MST1R;IFITM1;SMAD6;NUPR2;CGRRF1;GRK5;FGF18;IFNLR1;PTPN6;CDH13;TJP1;PTK2;STAT4;PTPRU;SH2B3;CUL3;CSF1;NUDT6;CADM4;SLURP1;MAP2K1;TRAPPC14;TCIRG1;RBM5;NPR3;MDM4;IFIT3;ALK;WDR6;FRK;ABI1;VHL;NIBAN2;BIRC6;HDAC2;RARA;PML;NTRK3;TNS2;RAB33B;PDF;MEAK7;ADRA2A;KAT2B;CCKBR;P3H3;SOX4;PKD2;APP;IGF1R;INHA;AXIN2;NF2;WWTR1;S100A11;NOX1;CCAR1
prerank,smooth muscle cell differentiation (GO:0051145),-0.5203662783484664,-1.2583376004317266,0.20309050772626933,0.6021702509067715,1.0,6/12,14.62%,MEF2C;MRTFB;BMP4;TMEM204;APLNR;HEY1
prerank,long-term memory (GO:0007616),0.4854020460244971,1.2581793784556579,0.19395017793594305,0.6773012674487771,1.0,3/19,8.78%,RASGRF1;NFATC4;PJA2
prerank,regulation of receptor internalization (GO:0002090),-0.38403370359441025,-1.2574863934426168,0.1315136476426799,0.60326016730007,1.0,14/35,19.10%,INSR;ANKRD13A;ATXN2;AHI1;SCYL2;SDCBP;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5;RIN3;MTMR2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.40269965623530635,-1.2571146939521545,0.18181818181818182,0.6029136662167659,1.0,10/30,22.34%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;DDOST
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.4320050022736526,-1.2569160915763462,0.18778280542986425,0.6020816096203753,1.0,7/21,4.93%,HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5;XYLT1;EXT1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3733790093249528,1.2567972760762365,0.14465408805031446,0.6804578732033342,1.0,12/73,9.63%,ROBO1;COL4A3;SMAD3;CASP12;DLC1;TNFSF15;CFLAR;CASP4;IFT57;NGFR;BAX;CASP8AP2
prerank,triglyceride homeostasis (GO:0070328),0.4615323079278566,1.2563555257981884,0.17983193277310924,0.6805435687723745,1.0,4/26,12.05%,RORA;NR1H3;IL18;DGAT2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.48719429318996665,-1.2562877595257873,0.19527896995708155,0.602542340952911,1.0,7/13,17.72%,MGAT5;DOT1L;PTPRT;PIGU;PTPRC;EGF;HES1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3939395304337365,-1.256056339673614,0.15841584158415842,0.6018528422144168,1.0,12/31,10.34%,SLIT2;ROBO2;SEMA6D;THBS1;NOTCH1;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,heart looping (GO:0001947),-0.37208287183081,-1.2555692289738785,0.13881748071979436,0.6018874703923817,1.0,14/39,23.49%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7
prerank,negative regulation of blood pressure (GO:0045776),-0.5026372552871458,-1.2552200828681968,0.19098712446351931,0.6015078671386018,1.0,4/13,10.30%,NOS3;BMPR2;PRCP;NOS1
prerank,transcription by RNA polymerase II (GO:0006366),0.31170348998132763,1.2544375554609077,0.06519065190651907,0.6852767294644064,1.0,85/305,20.50%,RORA;SOX5;RBPJ;CCN2;ELOF1;NOTCH2;MLLT3;TBL1XR1;TEAD1;MAF;NR6A1;POLR2D;PCF11;PIR;GLIS3;PRRX1;DTX1;NR1H3;RPRD2;PPARA;CREBBP;RARB;CDC73;INTS9;TRIM24;TEAD2;YAP1;CCNH;MNAT1;NABP1;NOCT;CDK7;CDK12;TAF7;TCEA1;POLR2C;IWS1;INTS14;RTF1;NR4A1;MAML2;NFIC;NR3C1;MED20;PKNOX1;PAF1;POLR2F;POU2F1;INTS3;GTF2H4;ERCC6;LEO1;PABPN1;RARA;INTS8;MLLT1;CSTF3;SNAPC3;KAT2B;IRF9;TAF9;DDX21;WWTR1;TBL1X;AFF4;GTF2H2;CDK13;SLBP;INTS13;PMF1;NFYA;ESRRA;WDR33;PGR;E2F2;SNAPC5;RPRD1B;INTS6;SETD2;DDX5;NABP2;RNGTT;MED26;POLR2K;GMEB2
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5237301966011849,-1.254049146848926,0.21593291404612158,0.6035214050740484,1.0,4/10,16.45%,RAPGEF2;NGF;RAP1A;NTF3
prerank,neuron projection regeneration (GO:0031102),0.5684201850145202,1.2535079502994806,0.2176360225140713,0.6869068671442328,1.0,2/10,5.80%,PTN;NREP
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3545978459585328,-1.2534265577417918,0.12598425196850394,0.6040136302342904,1.0,20/53,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;BCKDK;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD11;PSMD8
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40696549691051087,-1.2531376703925219,0.13734939759036144,0.6034790305161224,1.0,12/28,24.85%,NAV3;PAK1;RPS3;MET;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.43032515343674194,-1.2531248080421085,0.18013856812933027,0.6021778258290603,1.0,6/21,13.22%,MTUS1;THBS1;PTK2B;MAPK3;CMKLR1;CSF1R
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.469026662378312,-1.2528138182002835,0.2013129102844639,0.6016661885366452,1.0,7/16,7.24%,DMD;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,protein polyglutamylation (GO:0018095),-0.5221986583702397,-1.252715778604447,0.1726315789473684,0.6006433842179558,1.0,2/11,5.77%,TTLL7;TTLL5
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.47944969518208735,-1.2525284268286274,0.1702127659574468,0.5998464279232665,1.0,8/15,19.88%,RYR2;RAB3GAP1;SRP14;SPCS2;SPCS1;ZFAND2B;SEC61A1;SEC61G
prerank,aortic valve development (GO:0003176),-0.3823597207499854,-1.2524863716461967,0.15270935960591134,0.5986208912450064,1.0,10/34,8.00%,SLIT2;ROBO2;NOS3;TIE1;BMPR2;NOTCH1;ELN;EMILIN1;BMP4;TNFRSF1B
prerank,regulation of myoblast differentiation (GO:0045661),0.43924269822551903,1.2524706587084524,0.16319444444444445,0.688925876207565,1.0,3/32,3.65%,RANBP3L;IGFBP3;EID2B
prerank,regulation of cartilage development (GO:0061035),0.4983968409547809,1.2524081249330417,0.17973231357552583,0.6878773592908312,1.0,5/18,5.17%,SOX5;PTHLH;BMP2;BMP1;MBOAT2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43091536140456405,1.2522379346368098,0.171875,0.6871548530012687,1.0,8/33,11.85%,MTURN;STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.519990208426128,-1.252203286683974,0.20159680638722555,0.5981241643256865,1.0,5/11,18.56%,NOL11;DDX11;SMARCB1;PWP1;SIRT7
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.49335499995468746,-1.2520192679325566,0.17471264367816092,0.5973497825828905,1.0,6/14,16.15%,PRKAR1A;RAPGEF2;ADRB2;PRKAR2B;PKIG;PKIB
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.30808726505467804,1.2519539946686828,0.05372405372405373,0.6868614116980738,1.0,62/348,13.33%,ROBO1;BMP6;FOXD1;ROCK2;SMAD3;RBPJ;RBMS3;FN1;AFDN;WNT6;FGF1;PID1;TLE1;OSR1;WNT3A;GJA1;ANXA2;CDH5;ITGB8;GCGR;SLC26A9;TNRC6B;SLC24A3;ANGPT1;BMP2;PKP3;IL6;TLR4;BMP7;STOX1;PTPN22;TGFBR1;DTX3L;CRP;CTSH;PDCD5;GSK3B;LGALS9;TNRC6A;WNT5A;YAP1;DTNBP1;MOV10;RESF1;MUSK;FUBP1;MAPK14;CUX2;FGF18;ATF7IP;TLR2;LRP3;MAP2K5;ADAM19;CSF1;HFE;PTPN1;NOG;MAP2K1;ARRB1;TASOR;MAPK9
prerank,glucose transmembrane transport (GO:1904659),-0.45610743011807364,-1.251852689241645,0.18681318681318682,0.5964634705264574,1.0,9/18,32.84%,SLC2A1;PPARD;SLC2A9;SORT1;SLC2A4;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5187584048881178,1.2516173977863445,0.20809248554913296,0.6867020554415346,1.0,1/14,0.15%,SULF1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4349054054122023,1.2514385187955186,0.19104991394148021,0.6860086200075075,1.0,6/28,7.40%,ARHGAP18;ARHGAP28;HAX1;RASA1;PLEKHG2;DBN1
prerank,regulation of multicellular organism growth (GO:0040014),0.5162386571523406,1.2505533010397083,0.2237354085603113,0.6874665888576478,1.0,7/15,18.82%,GHR;GHRH;STAT5B;GDF15;APP;STAT5A;PTCH1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.40552176631757436,-1.2499262292184654,0.16272965879265092,0.6007162490823049,1.0,15/28,23.70%,NOTCH3;BEND6;GATA2;AKT1;LFNG;YTHDF2;EGFL7;EGFR;HEY1;EGF;DLL4;DLL1;HIF1AN;RITA1;TCIM
prerank,positive regulation of leukocyte migration (GO:0002687),0.4455095516900882,1.2495542886675184,0.17195325542570952,0.6894132127869878,1.0,3/27,4.73%,PTN;IL6;MIA3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5587445574976837,1.2494269092647579,0.2365988909426987,0.6885496023205055,1.0,1/10,0.56%,DPP4
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4793475678263329,-1.2486564731934073,0.1940928270042194,0.6029902127461351,1.0,4/13,10.31%,NOS3;AKT1;NOS1;GCH1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.36196666097173796,-1.2485454447168984,0.12931034482758622,0.6019322139837129,1.0,18/48,15.74%,PDE4D;UBASH3B;DMD;AKAP6;PTK2B;FKBP1A;CALM1;SNCA;CALM2;CEMIP;CALM3;CAMK2D;SELENON;NOS1;SRI;APLNR;CASQ2;PLCG1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.44404256772613027,1.2483916919434845,0.19047619047619047,0.6906401916334346,1.0,6/32,6.45%,PHLDB2;ARHGAP6;DLC1;CASK;SERPINE1;RASA1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5239465625325398,-1.2483403478032626,0.19334719334719336,0.6011282372065463,1.0,5/10,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5104056442487608,-1.2480184674915573,0.20043103448275862,0.6007728804446708,1.0,7/11,36.51%,UQCRH;UQCR11;UQCC3;UQCR10;UQCRQ;CYCS;UQCRB
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.33270609799796946,-1.2478102426489592,0.1282798833819242,0.6000524418229053,1.0,24/67,24.51%,PSMC3;NCF2;PSMD14;PSMD3;B2M;CALR;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;FCGR1A;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1;SEC22B;PSMD11;PSMD8
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5302853083190875,-1.247523979579111,0.20118343195266272,0.5995487748111935,1.0,3/10,5.29%,CSGALNACT1;XYLT1;B3GAT2
prerank,positive regulation of MAPK cascade (GO:0043410),0.3144874025064612,1.2471061720133219,0.06758448060075094,0.6934303353396069,1.0,38/245,9.48%,ROBO1;LPAR1;ROCK2;CCN2;PDGFRA;FGFR1;FGF1;NOTCH2;EIF2AK2;KSR1;FPR2;MTURN;OSM;IL11;GLIPR2;EPHA8;NRP1;IL34;ANGPT1;KIT;BMP2;TAOK3;IL6;ROR1;GSDME;PRKCZ;PTPN22;PELI2;PDGFRB;TRIM5;CCL2;ACKR3;LGALS9;PHB2;IGF2;LRRK2;PIK3R5;MST1R
prerank,negative regulation of cellular component movement (GO:0051271),0.5042346647144554,1.2462793133826857,0.22495274102079396,0.6947743719108044,1.0,5/15,6.82%,TGFBR3;SP100;TACSTD2;FBLN1;SPINT2
prerank,regulation of protein kinase B signaling (GO:0051896),0.32250446863518123,1.2462749316540185,0.1089238845144357,0.6935437214624656,1.0,23/193,6.37%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;TPTE;FAM110C;GAB2;OSM;OSBPL8;FRS2;DAG1;TGFA;KL;ANGPT1;KIT;MTDH;TGFBR1;HAX1;CPNE1;PDGFRB;PPARA
prerank,neuron projection extension (GO:1990138),0.424943737066077,1.245500599367957,0.1832191780821918,0.6946750891565463,1.0,11/32,15.72%,ALCAM;AUTS2;NRP1;CPNE1;USP9X;FLRT1;PPP3CB;SPG11;CDKL3;IQGAP1;FLRT3
prerank,DNA damage checkpoint signaling (GO:0000077),-0.4088314680669046,-1.2451729345546163,0.1945080091533181,0.6050511948205554,1.0,13/28,24.83%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;RAD1;CHEK1;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,response to interleukin-4 (GO:0070670),-0.5305942528902381,-1.2449796709831442,0.23481781376518218,0.6042582431138789,1.0,1/10,0.14%,LEF1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3461091519639765,1.2442811066583561,0.12160228898426323,0.6973162075770821,1.0,15/108,8.36%,UACA;ROBO1;COL4A3;SMAD3;CASP12;DLC1;DAPK1;TNFSF15;CFLAR;CASP4;IFT57;NGFR;PDCD5;LGALS9;BAX
prerank,regulation of insulin secretion (GO:0050796),0.3468619157734016,1.2439557281834848,0.12320916905444126,0.6970579011016077,1.0,15/101,11.81%,TCF7L2;MCU;DPP4;RAPGEF4;ITPR1;RBP4;RFX3;IL6;ADCY5;NOS2;CACNA1C;SIRT4;CDK16;NLGN2;PPP3CB
prerank,positive regulation of cell adhesion (GO:0045785),-0.318501233096924,-1.2437001623086827,0.11377245508982035,0.606579460283508,1.0,17/74,13.66%,FRMD5;PTPRJ;TGFB2;ZFHX3;SMAD7;STX3;VIT;ADGRG1;NDNF;VEGFA;CXCL12;ATM;RET;MEGF10;SYK;EPB41L4B;RAC1
prerank,protein O-linked glycosylation (GO:0006493),0.3557818778969765,1.2436590644385177,0.11904761904761904,0.6967050434639253,1.0,15/96,7.45%,TMTC4;GALNT18;GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;TRAK1;TMTC1;LARGE1;GALNT2;GALNT1;RXYLT1;POMT2;GCNT4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4849417331355891,1.2435909118135835,0.2159090909090909,0.6956950041942639,1.0,4/17,18.72%,PLA2G4A;SERAC1;LPGAT1;PLA2G5
prerank,negative regulation of protein modification process (GO:0031400),0.36045457832074357,1.2434058915005335,0.1536144578313253,0.6950656042901827,1.0,12/79,10.16%,PTPN13;IGFBP3;PID1;PLPP3;PRKAA2;FBLN1;SNTA1;ATP2B4;GSK3B;MYADM;LRRK2;XRCC1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.525550743842941,1.2429640712762624,0.22283609576427257,0.6952585612667506,1.0,4/13,4.69%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3723986491168363,1.2427166456820866,0.165625,0.6947631410344117,1.0,13/68,9.92%,MMAB;ENPP1;PCCA;SHMT1;SLC19A1;AOX1;MTHFD1;PANK2;PCCB;LMBRD1;BTD;PDXK;HLCS
prerank,negative regulation of synaptic transmission (GO:0050805),-0.42250972557384553,-1.242316782075814,0.1771058315334773,0.6092239070211669,1.0,8/23,19.34%,SLC24A2;SHANK2;STXBP1;SLC30A1;ATAD1;GRIK3;MTMR2;TMEM25
prerank,positive regulation of JNK cascade (GO:0046330),-0.3320028917994221,-1.2421815054381211,0.11079545454545454,0.6083281542750127,1.0,24/70,17.54%,PLCB1;PTK2B;TPD52L1;MAP3K5;DAB2IP;HMGB1;RASSF2;MAP3K11;SDCBP;MFHAS1;DUSP22;MAPK8IP1;MINK1;GADD45G;ANKRD6;SEMA3A;HRAS;SH3RF3;CCL19;NOD2;CD27;DUSP15;LTBR;PYCARD
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.49363430380986617,-1.2420892397436234,0.1970954356846473,0.6072322123301461,1.0,5/14,15.74%,THBS1;ITGA4;CD40;RGCC;PLCG1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38683095646440757,1.2417610611556285,0.16666666666666666,0.6964700050984568,1.0,15/56,13.48%,ADAMTS1;ANXA1;STOX1;CCND3;ANAPC11;KLHL18;ESPL1;PHB2;UBE2C;ANKRD17;BRD4;CUL3;NSMCE2;RAD51B;CDC27
prerank,regulation of cellular pH (GO:0030641),-0.4021842086106918,-1.241745966385641,0.17955112219451372,0.6068951683464554,1.0,8/29,14.68%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC4A7;SLC9A5
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3439188829651333,1.2412700306487903,0.12148148148148148,0.6967625260657854,1.0,16/101,8.47%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;MTDH;PTPN22;SERPINE1;NR1H3;IL18;CDC73;CCL2;LY96;CD274;WNT5A
prerank,amino acid import (GO:0043090),-0.43268252170688914,-1.241138372571144,0.1842696629213483,0.6072674350093172,1.0,6/21,5.64%,SLC6A6;SLC47A1;SLC7A5;SLC6A1;SLC7A1;SLC1A1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4753471076483904,-1.241090475137714,0.17745302713987474,0.6060873029772107,1.0,5/15,14.89%,LEF1;CTDP1;TFAP4;SMARCB1;TAF11
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.301632984170535,1.2410655799546075,0.04942528735632184,0.6961590625953644,1.0,85/417,15.24%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ARID4A;ATXN1;NR2F2;TLE1;SMURF2;GATA6;SAMD13;ZBTB4;ZIC2;SNX6;RBFOX2;GLI3;MYB;MBD2;ZMYND15;TCEAL7;EID2B;CRY2;PRDM11;BMP2;RFX3;CRY1;LOXL3;BCOR;BMP7;GZF1;NIF3L1;SALL1;CBFA2T2;FOXP3;HDAC4;TSHZ3;DKK3;PBXIP1;GLIS2;DPF2;ZMYND11;PHB2;WNT5A;ZEB1;KAT6B;EPC1;USP47;SCMH1;SUMO1;JARID2;TAF7;PSPC1;WWP2;GMNN;ATF7IP;HEYL;CIR1;SMAD4;SCML4;BCL7A;LHX9;ZNF219;VGLL4;ILF3;BTRC;FBXW11;CBX4;BHLHE41;NR3C1;ARID5B;POU2F1;KAT6A;PRDM5;KDM8;RBM15;RUNX1T1;NIBAN2;ZBTB21;HDAC2;RARA;PML;UIMC1;SP3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47921761971289956,1.2409212953340485,0.1958041958041958,0.6954019684772699,1.0,3/19,4.44%,WNT4;VIM;IL6
prerank,regulation of establishment of cell polarity (GO:2000114),0.4964755876258556,1.2407922633713768,0.21414913957934992,0.6945928500425899,1.0,3/16,2.80%,ROCK2;KANK1;CDH5
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.46657142347960445,1.2401009227521314,0.22043010752688172,0.6955926831046892,1.0,6/22,9.79%,BPIFB1;IFI35;PTPN22;APPL2;NR1H3;APPL1
prerank,regulation of epithelial cell migration (GO:0010632),0.3942047804707734,1.2400086179125693,0.1832797427652733,0.6947060326653031,1.0,13/51,11.17%,PTN;MCC;SASH1;DOCK5;TACSTD2;GLIPR2;DUSP10;CLASP1;CTSH;GLUL;INSL3;ENPP2;PTK2
prerank,neuron differentiation (GO:0030182),-0.28047701859864177,-1.2395289721848315,0.055970149253731345,0.6090521268881176,1.0,29/165,11.12%,PTPRD;MEF2C;TENM2;TGFB2;TENM3;EPHA5;ACSL3;MYT1L;RORB;PBX3;FUT9;NTRK2;IL1RAPL1;ATP8A2;VSX1;MET;LHX6;CTNNB1;TENM4;FZD3;MYEF2;THOC2;VEGFA;LRP6;SPOCK1;SNPH;DDIT4;MANF;RUNX1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.3070932462123107,-1.2394894008129118,0.10034602076124567,0.6078599212614813,1.0,28/96,17.94%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NTRK2;SIX1;CTNNB1;FOXQ1;NDNF;LGMN;PINK1;SIGMAR1;TGFB3;KCNB1;NGF;ATF4;AKT1S1;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;SET;NTF3;TOX3;ADAM8
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3695174286398975,-1.2390032564463431,0.15865384615384615,0.6079103483649113,1.0,9/36,12.95%,CACNB2;TRPC3;TRPC6;CAMK2A;MYLK;GRIN1;CXCL12;CACNA1D;CAV1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.536278055806813,1.2388882032528161,0.22328244274809161,0.6971043368758606,1.0,4/11,17.31%,GRK3;ADM;ARRB1;GTF2H2
prerank,secondary palate development (GO:0062009),0.5157701059027313,1.2388015563157404,0.21245421245421245,0.6961367029314797,1.0,6/14,11.51%,TGFBR3;WNT3A;LRRC32;TGFBR2;WNT5A;SMAD4
prerank,cytoskeleton organization (GO:0007010),0.339982995314484,1.2376569678029048,0.13105413105413105,0.6983599277248834,1.0,22/114,11.97%,MICAL3;DIAPH1;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;BRWD1;DES;TPM1;PLCE1;RHOBTB2;RHOF;PACSIN2;CAPZB;CCL2;FMNL2;CNN2;CECR2;SPRYD3;ZMYM6;RHOC
prerank,cellular response to alkaloid (GO:0071312),-0.452313395953821,-1.2370747216475768,0.20600858369098712,0.6121489423561154,1.0,6/17,16.12%,RYR2;RYR3;CASP7;SLC8A1;CASQ2;RAD51
prerank,Notch signaling involved in heart development (GO:0061314),0.5468177626345669,1.2368702474561435,0.2446601941747573,0.6995931344099673,1.0,2/11,1.51%,RBPJ;NOTCH2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4992100819547611,-1.236587769450052,0.21621621621621623,0.6123178412470859,1.0,4/12,7.21%,SLIT2;PLCB1;CCN3;AKT1
prerank,negative regulation of defense response (GO:0031348),0.36540230542190927,1.23572280559968,0.14728682170542637,0.7018887892967101,1.0,8/77,6.52%,ENPP3;RORA;FPR2;CDH5;TNFAIP8L2;NR1H3;PPARA;PTPN2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4889985051815094,-1.2357152912961975,0.20496894409937888,0.6136408321335197,1.0,10/13,37.03%,TOX;BMP4;SOD1;CAMK4;ADAM8;ZC3H8;CLPTM1;VNN1;FOXJ1;TESPA1
prerank,organonitrogen compound catabolic process (GO:1901565),0.38604339094662427,1.2355705045803496,0.14946070878274267,0.7011453587849101,1.0,13/57,14.02%,PLA2G4A;CPQ;ANPEP;GGACT;NPEPPS;CLN5;TRIM24;PLA2G6;ERAP1;ENPP2;CLPX;AMDHD2;LNPEP
prerank,presynaptic endocytosis (GO:0140238),-0.41417255074185355,-1.2351148838377928,0.1976470588235294,0.6140670385840694,1.0,5/24,8.74%,NLGN1;SYT1;AMPH;SNCA;NLGN3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.38215293697059644,-1.2344336678004937,0.15476190476190477,0.6147017042392203,1.0,9/35,7.63%,NLGN1;CDH11;CDH12;ATP2C1;CDH10;CDH8;CDH22;CDH7;CDH20
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3976483679750661,1.2341734077636497,0.18803418803418803,0.7043404118837349,1.0,10/44,12.53%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;LBR;CH25H
prerank,pancreas development (GO:0031016),0.5351398007540669,1.2339615339300463,0.21414538310412573,0.7037800278890908,1.0,2/12,7.18%,TCF7L2;DNAAF1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.42421064450012286,1.2337888905181857,0.19015280135823429,0.7019103235681601,1.0,15/31,27.64%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;RNGTT;POLR2K;POLR2H;CMTR1;GTF2F1;ERCC2;ERCC3
prerank,7-methylguanosine RNA capping (GO:0009452),0.42421064450012286,1.2337888905181857,0.19015280135823429,0.7019103235681601,1.0,15/31,27.64%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;RNGTT;POLR2K;POLR2H;CMTR1;GTF2F1;ERCC2;ERCC3
prerank,heart trabecula morphogenesis (GO:0061384),0.47608107457009957,1.2336397195659201,0.24293785310734464,0.7012133027850438,1.0,6/18,5.16%,TGFBR3;RBPJ;BMPR1A;RBP4;BMP7;TGFBR1
prerank,leukotriene biosynthetic process (GO:0019370),0.5079937813924629,1.2332329639172737,0.2326007326007326,0.7012274195175218,1.0,2/14,2.96%,PLA2G4A;GGTA1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.40913325190613836,1.233096773757935,0.1857379767827529,0.7004773328778655,1.0,3/40,2.57%,SLC7A11;SLC13A3;SLC19A1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.46016710798344873,-1.2326394508343832,0.22085889570552147,0.6185815737657692,1.0,7/16,16.37%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;HTR2B
prerank,regulation of phospholipase C activity (GO:1900274),0.4950703988476689,1.232296426000258,0.23647294589178355,0.7017241915152406,1.0,4/15,6.11%,PDGFRA;FGFR1;KIT;PDGFRB
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4470058625876433,1.232082151689644,0.21805792163543442,0.7011798867522687,1.0,6/26,7.66%,FHL2;RCAN1;ATP2B4;EFHB;SPPL3;GSK3B
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.48636797868556003,-1.2308393377132807,0.21063829787234042,0.6224603052095744,1.0,7/13,22.46%,SORL1;GCC2;INSIG1;BRSK2;TMEM30A;SAR1B;CD81
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5493100482737724,1.230377375894111,0.25742574257425743,0.7051327910803793,1.0,3/10,3.41%,STK39;OSR1;NEDD4
prerank,regulation of mononuclear cell migration (GO:0071675),-0.41387383938913375,-1.2299243678048228,0.163135593220339,0.6237980009987484,1.0,7/23,13.22%,SLIT2;THBS1;STK10;MAPK3;LYN;CMKLR1;CSF1R
prerank,transition metal ion transport (GO:0000041),-0.383800652208969,-1.229657979273152,0.16062176165803108,0.6233057041533427,1.0,10/35,7.54%,TRPC3;TFRC;ATOX1;TRPC5;FTH1;TRPC4;ATP2C1;SLC31A1;TRPC6;SLC30A1
prerank,nitric oxide metabolic process (GO:0046209),-0.4693841845010571,-1.2296177324887214,0.1925601750547046,0.6221262760698644,1.0,4/14,10.31%,NOS3;AKT1;NOS1;GCH1
prerank,lymphocyte chemotaxis (GO:0048247),0.4116439682530536,1.2295679801784576,0.19704433497536947,0.7064216642174008,1.0,6/34,7.71%,CXCL10;CXCL16;CYP7B1;CKLF;MSMP;CCL2
prerank,muscle cell differentiation (GO:0042692),-0.3858652998492388,-1.2292422749199867,0.17482517482517482,0.6218969154072289,1.0,6/32,3.45%,SYNE1;SGCZ;MEF2C;DMD;MRTFB;TBX1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4308144361118983,1.229157566385793,0.20105820105820105,0.7065721073110465,1.0,6/31,6.98%,PDGFRA;OSR1;HOXC4;TGFBR1;TGFBR2;DYNC2I1
prerank,regulation of mitochondrial fission (GO:0090140),0.456112012653008,1.2287072331918503,0.20255474452554745,0.7068324577699244,1.0,11/24,21.45%,MCU;STAT2;DCN;RALBP1;LRRK2;DNM1L;MIEF1;MUL1;MYO19;SPIRE1;VPS35
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42412034441114227,1.2284921801188318,0.19966996699669967,0.7062923609577387,1.0,7/30,14.94%,LEPROT;NPEPPS;PDCD5;HUWE1;RHOU;USP36;CSNK2A2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.39361117298547954,-1.2283922219714538,0.18160377358490565,0.6230735198731638,1.0,10/29,22.46%,MEF2C;TFRC;CD38;CD74;CD40;PTPRC;CLCF1;CD320;MIF;CD81
prerank,regulation of embryonic development (GO:0045995),0.41735663900046427,1.228366337373057,0.22413793103448276,0.7055257801470274,1.0,5/34,5.19%,PHLDB2;DAG1;TRIP12;CLASP1;PHLDB1
prerank,respiratory system development (GO:0060541),0.4197636662753953,1.2281162576408944,0.18739352640545145,0.7051700536465787,1.0,5/32,7.18%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,C4-dicarboxylate transport (GO:0015740),-0.46351090390699523,-1.228020298817627,0.227765726681128,0.6228151409599331,1.0,7/14,30.59%,SLC1A1;SLC1A2;SLC25A30;SLC25A13;SLC25A12;LRRC8E;SLC13A5
prerank,central nervous system myelination (GO:0022010),-0.5175367842134314,-1.2272760803381513,0.2292576419213974,0.6236539479162362,1.0,7/11,33.60%,PLP1;TENM4;B4GALT6;CLU;CNTNAP1;B4GALT5;ABCA2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.478291164624372,1.227208660859655,0.21660649819494585,0.7068993431840433,1.0,6/19,14.68%,ROBO1;DCN;CCBE1;CADM4;SMOC2;MYO1C
prerank,icosanoid metabolic process (GO:0006690),0.4070069362705559,1.226777297322565,0.20608108108108109,0.7070540148305932,1.0,8/40,12.95%,PTGS1;PLA2G4A;DPEP2;PLA2G4C;PTGR1;ALOXE3;EPHX1;PON3
prerank,regulation of endothelial cell migration (GO:0010594),0.35682779038164575,1.2267019005168567,0.14499252615844543,0.7061297656029817,1.0,12/85,3.88%,PTN;RIN2;ROCK2;SASH1;NR2F2;SP100;FGF1;FOXC2;NRP1;ANXA3;ANGPT1;DCN
prerank,cellular metal ion homeostasis (GO:0006875),-0.30196624763670477,-1.2264819471546555,0.07590759075907591,0.624615808282584,1.0,26/102,15.34%,SLC12A2;KCNMA1;ATP1B1;SLC24A2;RYR2;TPT1;KCNJ2;HTR2C;ATP1A1;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;SLC30A1;CXCL12;NEDD4L;CALR;SLC10A7;CD40;TMCO1;CAV1;ATP2A2;CCL19;ATP13A4;ATP1A3
prerank,cellular response to interleukin-4 (GO:0071353),-0.5272620677831417,-1.2263672677223203,0.23155737704918034,0.6236495335146505,1.0,1/10,0.14%,LEF1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.35494923193636135,1.226221451994883,0.14896755162241887,0.7063894446310885,1.0,11/84,3.83%,PDPK1;RIN2;ROCK2;SASH1;FGFR1;FGF1;PLPP3;FOXC2;NRP1;ANXA3;ANGPT1
prerank,cellular response to amyloid-beta (GO:1904646),0.41531543701411866,1.2261566083562792,0.2033898305084746,0.7053929527673897,1.0,13/35,15.95%,FPR2;GJA1;SNX6;TLR4;CASP4;VCAM1;NGFR;GSK3B;EPHA4;CACNA2D1;APP;IGF1R;ICAM1
prerank,actin filament depolymerization (GO:0030042),0.5175372641612184,1.2259148978744188,0.20491803278688525,0.7050523557647346,1.0,2/11,7.62%,MICAL3;DSTN
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.38277281593993173,-1.2258791684719887,0.15848214285714285,0.6237188921580996,1.0,7/29,6.43%,SLIT2;SHANK3;SSH2;KANK3;KANK4;HIP1R;CYRIB
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.35296806888324794,-1.225782848989279,0.13089005235602094,0.6227158339608021,1.0,19/50,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD11;PSMD8
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.41191936638084303,1.2257172848018962,0.20394736842105263,0.7045265134789129,1.0,9/34,13.48%,PHIP;TGFA;PDGFRB;ANAPC11;ESPL1;IGF2;CUL3;NSMCE2;CDC27
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.4439708329496619,-1.2256584052228323,0.19305856832971802,0.6217956139295224,1.0,10/18,31.22%,GINS3;POLA1;POLD2;POLE;LIG3;RFC4;POLE3;GINS4;PCNA;GINS2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4315353498864496,-1.2250502108639167,0.21325051759834368,0.6223013899134546,1.0,5/20,7.09%,MEIS2;PTK2B;CDK6;HOXB8;ZBTB16
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.49695805742412924,1.2245906171222445,0.24329501915708812,0.7068743066781253,1.0,6/15,13.11%,PDPK1;FGF1;ITGA5;JMJD8;TJP1;JAK1
prerank,embryonic digit morphogenesis (GO:0042733),0.4715691395488077,1.2244039276743894,0.20532319391634982,0.7062583500392198,1.0,6/18,14.82%,OSR1;GLI3;SALL1;CREBBP;NOG;HDAC2
prerank,lipid transport (GO:0006869),-0.3036299422929212,-1.2237426815218542,0.09646302250803858,0.6247603179232392,1.0,16/97,8.59%,ATP8A1;ABCC4;SLCO1C1;SLCO2A1;CERT1;PITPNC1;PITPNA;ABCA3;SPNS2;PPARD;GLTP;SCARB1;CEACAM1;PRELID2;PRELID1;ATP8B1
prerank,cholesterol efflux (GO:0033344),0.46606710781036365,1.223657677500621,0.2188679245283019,0.7074554083816825,1.0,5/20,17.50%,APOA2;NPC1;SOAT1;ABCA1;ABCA7
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3670677212301422,1.223150436035734,0.16845329249617153,0.7077662578553768,1.0,14/66,12.35%,ROBO1;SASH1;FGFR1;FGF1;IL34;KIT;TAOK3;PDGFRB;LRRK2;PIK3R5;MST1R;FGF18;MAP3K7;DVL3
prerank,androgen receptor signaling pathway (GO:0030521),0.5459055229908315,1.2229609235296008,0.24708171206225682,0.707188841905107,1.0,2/11,3.83%,ZMIZ1;PMEPA1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4094535121873808,1.2222494218721314,0.19696969696969696,0.7081361681028464,1.0,7/34,8.47%,RBP4;IL6;LACC1;PTPN22;TNFRSF14;PHB2;WNT5A
prerank,nucleoside catabolic process (GO:0009164),0.5217229137457927,1.2218497258474164,0.24853228962818003,0.7081896461966781,1.0,4/11,9.76%,DPYD;UPP1;NT5C;DERA
prerank,response to metal ion (GO:0010038),-0.32545994899212416,-1.2217532718504847,0.12574850299401197,0.6293485369266533,1.0,18/67,17.19%,TRPC3;KCNMA1;THBS1;MT1A;MT1X;HOMER1;CALM1;SNCA;CALM2;GPHN;CALM3;NEDD4L;PPP1CA;MT2A;CAV1;MAPT;ATP5F1D;SLC25A13
prerank,retinol metabolic process (GO:0042572),0.5090195434708595,1.2217476308143331,0.23238095238095238,0.7073824547447949,1.0,2/14,3.36%,RDH10;RBP4
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3170706617736894,-1.2217393051298058,0.12538226299694188,0.6268302963158651,1.0,36/78,27.91%,ACTR10;SH3GL2;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3170706617736894,-1.2217393051298058,0.12538226299694188,0.6268302963158651,1.0,36/78,27.91%,ACTR10;SH3GL2;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,regulation of tissue remodeling (GO:0034103),0.467759528740948,1.221270260193589,0.2039355992844365,0.7077180297217104,1.0,3/18,7.50%,LEPR;DDR2;IL18
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.41789491819073504,-1.2210463858834675,0.2017167381974249,0.6275118665454061,1.0,7/23,15.32%,PDE4B;RYR2;SNCA;MAPK3;KCNQ1;ATF4;NR4A3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3699060218587154,1.221028452791752,0.1592775041050903,0.7072617798071716,1.0,18/68,17.54%,AMPD3;ENPP1;ACOT11;PTHLH;TPST1;ENTPD7;RHOQ;LRRK2;ACOT9;ACOT1;ACAT1;EPHA2;EFL1;OPA1;SULT1A1;ABHD14B;RAN;GNAI3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4328344731025434,-1.2206684085792123,0.2149321266968326,0.6272932299587451,1.0,5/21,6.94%,MEF2C;CALM1;CALM2;HSP90AB1;CALM3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.41483906855579095,1.2201950801897887,0.20473773265651438,0.7085816693729744,1.0,6/36,5.68%,AFDN;SPTBN1;VAMP5;TRARG1;RAB10;OPTN
prerank,regulation of JNK cascade (GO:0046328),-0.30172633525313514,-1.220160637625313,0.0911854103343465,0.6273851792740519,1.0,33/101,17.54%,MECOM;PLCB1;PTK2B;TPD52L1;PHLPP1;MAP3K5;EPHB1;DAB2IP;HMGB1;RASSF2;MAP3K11;SDCBP;MFHAS1;PINK1;DUSP22;MAPK8IP1;MINK1;GADD45G;ANKRD6;EGFR;SEMA3A;MAPK8IP3;HRAS;SH3RF3;CCL19;CYLD;NOD2;COPS5;MEN1;CD27;DUSP15;LTBR;PYCARD
prerank,cellular response to interleukin-6 (GO:0071354),0.43985111837333196,1.2199999653875344,0.21731448763250882,0.708026979087077,1.0,8/26,13.11%,PID1;IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3807556857614899,-1.2199566528868313,0.15789473684210525,0.6267291361752105,1.0,9/33,11.27%,NET1;SETX;MAP3K5;RPS3;PLEKHA1;RHOB;HDAC6;SIGMAR1;PAX2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3488667817157654,-1.2198630195790527,0.1525,0.6257214458029976,1.0,21/47,25.74%,ATP5F1A;ATP5MC1;ATP5PO;GHITM;SAMM50;TIMM8B;ATP5F1B;ATP5PD;MAIP1;ATP5F1D;MTX3;MTX1;TIMM22;UQCC3;NDUFA13;ATP5F1E;TIMM10;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5009693026277265,1.2197472582100592,0.2437619961612284,0.7076390805168805,1.0,6/14,14.89%,MYB;ANXA1;PRKCZ;IL18;NFKBIZ;RARA
prerank,bile acid and bile salt transport (GO:0015721),-0.4174478216524923,-1.2195829642018114,0.2132701421800948,0.6252086759898984,1.0,8/24,23.42%,ABCC4;SLCO1C1;CEACAM1;ATP8B1;RXRA;STARD5;SLC10A3;SLCO1B1
prerank,sphingolipid catabolic process (GO:0030149),-0.4684512043406468,-1.2194377656948219,0.21460176991150443,0.6243679303380053,1.0,2/15,2.19%,ACER3;ACER2
prerank,cell-cell junction maintenance (GO:0045217),0.5395110553452657,1.2193027906172142,0.22813688212927757,0.707827387215969,1.0,4/11,11.28%,PARD6A;MYADM;TJP1;NLGN2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5035077150296132,1.2191860674662782,0.23388581952117865,0.7070552259385283,1.0,3/15,8.07%,SH3D19;NRDC;SNX9
prerank,androgen metabolic process (GO:0008209),-0.4382424038750266,-1.219113130325836,0.19831223628691982,0.6240815936742421,1.0,4/18,17.90%,SRD5A3;SPP1;HSD17B7;HSD17B10
prerank,positive regulation of fat cell differentiation (GO:0045600),0.39168947463328163,1.2188937069638022,0.18333333333333332,0.7068033931265422,1.0,16/47,22.02%,MEDAG;BMP2;BMP7;TMEM64;CREBL2;NOCT;AAMDC;RARRES2;CARM1;NAPEPLD;ASXL2;CEBPB;PTGS2;XBP1;CDS1;ZC3H12A
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.4053910943050447,-1.2188693279125526,0.18414918414918416,0.6235483167309044,1.0,8/24,20.39%,ANK3;CEMIP;MTCL1;MFF;KCNB1;HRAS;C2CD5;ITGB2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3850512219834111,1.2186140075591012,0.17412140575079874,0.7065334581034718,1.0,14/51,15.53%,FBN1;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;BMP2;SKI;SMAD6;SMAD4;NOG;CHRDL1;GREM2;ACVR2B
prerank,visual perception (GO:0007601),0.35632678792029676,1.2185858853579437,0.1550632911392405,0.7054807015916026,1.0,16/84,15.15%,EFEMP1;RDH10;ZIC2;ADGRV1;MYO9A;TULP2;COL18A1;CRYBB3;IMPG2;EYA4;ATXN7;CRYBA1;OPA1;EML2;PDE6C;CEP250
prerank,carbohydrate derivative transport (GO:1901264),-0.4423546359608253,-1.2173711279256019,0.20689655172413793,0.6267310490803981,1.0,6/18,15.72%,SLC15A2;SCARB1;SLC10A7;VLDLR;MFSD2A;SLC25A19
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.38778603717195914,-1.2173326277629548,0.1784841075794621,0.6255768687765658,1.0,8/29,14.75%,SMAD7;RPS2;PINK1;FEM1A;DCUN1D2;DCUN1D5;DCUN1D1;PARK7
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.4260160767829365,-1.2172732798856911,0.21678321678321677,0.6245094885754284,1.0,8/20,22.51%,ACSL3;FAR2;ACACA;ACLY;SCD;HSD17B8;FASN;GCDH
prerank,organic substance transport (GO:0071702),-0.29224670982977063,-1.2171642306860677,0.09602649006622517,0.623573511876015,1.0,36/121,23.42%,ATP8A1;ABCG2;SLC47A1;LRP1B;SLCO2A1;ABCA3;SPNS2;SCAMP5;LMAN2L;RAB38;SCAMP1;SCAMP2;VPS33B;RAMP2;SLC22A6;MFSD2A;ABCD2;SLC22A5;GM2A;SLC50A1;CHMP1A;CHMP1B;CEP290;MFSD12;PEX19;CHMP2B;CD320;SLC35F3;DISP1;SLC19A2;CHKA;SLC18A2;CENPF;ABCA13;CHMP2A;SLCO1B1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.39590597687031415,1.216822297314275,0.1967479674796748,0.7097638009243499,1.0,13/45,16.13%,BMP6;BMPR1A;TWSG1;BMP2;BMP7;TGFBR1;BMP8B;SMAD4;HFE;GDF11;GDF15;DAB2;INHA
prerank,glycogen metabolic process (GO:0005977),0.43533410791118243,1.216539784018672,0.2030716723549488,0.7094778648947637,1.0,6/27,11.44%,PRKAG2;PYGB;GYG1;GSK3B;PYGM;STBD1
prerank,apoptotic cell clearance (GO:0043277),-0.38322648284465644,-1.216296032239059,0.19148936170212766,0.6248457492879019,1.0,11/30,17.36%,THBS1;XKR4;GAS6;HMGB1;SCARB1;XKR6;RHOG;MEGF10;RAC1;RHOH;RHOBTB1
prerank,positive regulation of phosphorylation (GO:0042327),0.31116492050310035,1.2160819758779773,0.10955414012738854,0.7097754384860747,1.0,57/240,15.94%,ZBTB20;LEPR;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;PRKAA2;FPR2;WNT3A;INSRR;LMO4;EPHA3;EPHA8;FAM20A;NRP1;VEGFD;IL34;ANGPT1;KIT;BMP2;SLCO3A1;ROR1;ARNT;CCND3;RAD50;EPHA1;PELI2;PDGFRB;RALBP1;FBH1;EPHA4;IGF2;LRRK2;MST1R;MUSK;FGF18;FNIP1;PTK2;DSTYK;EPHA2;DVL3;RARRES2;EFNA1;ARRB1;KCTD20;ALK;P2RY1;NTRK3;RYK;ILK;STK4;DAB2;APP;IGF1R
prerank,maintenance of blood-brain barrier (GO:0035633),-0.39368725547604233,-1.2160612846471521,0.18072289156626506,0.6242784812412917,1.0,12/30,7.81%,PECAM1;SLC12A2;CLDN5;ESAM;DMD;ACTB;JAM2;ACTG1;SLC1A1;MBP;LSR;JAM3
prerank,O-glycan processing (GO:0016266),0.3866474233949154,1.2160366267661658,0.17713365539452497,0.7088039762954431,1.0,9/54,9.83%,GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;GALNT2;GALNT1;GCNT4;C1GALT1C1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4257917161159779,-1.215328166941487,0.21166306695464362,0.6251141102462133,1.0,5/20,14.61%,FUT8;ST3GAL6;FUT9;ST6GALNAC5;ST3GAL4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.43160856903469974,1.2151733411278296,0.20074349442379183,0.7102849948496244,1.0,6/27,13.07%,TLR4;C5AR2;PTPN22;PTPN6;IRAK3;ARRB1
prerank,ERBB2 signaling pathway (GO:0038128),-0.3913307223347321,-1.2150161978784093,0.18615751789976134,0.6247255762882432,1.0,9/31,18.67%,ERBB4;PIK3R1;GAB1;MYOC;EGFR;HSP90AA1;EGF;ERBIN;NRG2
prerank,skeletal system morphogenesis (GO:0048705),0.39468009042898056,1.2149419091309603,0.20632279534109818,0.7099143277720622,1.0,12/42,15.86%,PDGFRA;FGFR1;WWOX;HOXC4;TGFBR1;DYNC2I1;SKI;RFLNA;ANKRD11;RAB33B;HOXB4;SPEF2
prerank,negative regulation of receptor binding (GO:1900121),-0.5135288131080917,-1.2146717472441708,0.23333333333333334,0.6244847875893618,1.0,4/10,13.61%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,negative regulation of peptidase activity (GO:0010466),0.3876694892927767,1.214618710740411,0.2040133779264214,0.7097315774128384,1.0,11/47,12.46%,VTN;ECM1;TIMP3;SERPING1;CSTB;SERPINB7;SERPINE1;TIMP2;SERPINE2;SERPINB8;SERPINE3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4829566424649684,1.2143873615247123,0.22282608695652173,0.7093023759679941,1.0,3/17,7.50%,CD55;TLR4;IL18
prerank,regulation of cell migration (GO:0030334),0.29911343714128735,1.2143855617331922,0.07403055229142186,0.7081842551572619,1.0,72/382,12.69%,PLXNA2;SULF1;ROBO1;DPYSL3;SEMA3D;PDPN;PODN;ROCK2;SASH1;AFDN;PDGFRA;FGF1;SYNE2;CXCL16;IGFBP5;FAM110C;LMO4;DLC1;KANK1;CDH5;LDLRAD4;FER;DAG1;NUMB;SMIM22;LDB2;ANXA1;DUSP10;KIT;BMP2;WNT5B;MIA3;AMOTL1;TPM1;VCL;TGFBR1;FAM83H;SERPINE1;APPL2;MMP14;EPHA1;PDGFRB;SEMA4B;MGAT3;BST2;CTSH;CLIC4;CLDN1;RNF20;NGFR;EPHA4;MYADM;STK24;SERPINE2;PLAU;RAP2C;IFITM1;APPL1;FGF18;NKD1;ENPP2;CDH13;TJP1;PTK2;PTPRU;FOXO3;RHOC;CSF1;EPPK1;ARSB;SLURP1;NOG
prerank,RNA metabolic process (GO:0016070),0.3285114202234778,1.214328021217873,0.13900709219858157,0.7072214545361865,1.0,37/127,20.84%,CELF2;ATXN1;RBMS1;RBFOX2;POLR2D;RBMS2;PAPOLG;LSM1;NOVA1;HNRNPH1;FTO;HNRNPC;RBM39;SND1;POLR2C;HNRNPH3;ADAR;SUPV3L1;DHX8;RBM5;POLR2F;RBM6;TENT2;PABPN1;ALKBH1;HNRNPR;HNRNPA2B1;NUFIP1;RNASEH1;PCBP2;DHX36;RNASE3;SNRNP40;RNASEL;RNGTT;POLR2K;PARN
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.39918348043579593,1.2139973405247466,0.19292604501607716,0.7071554543251426,1.0,11/35,19.63%,ZMIZ1;RBFOX2;NEDD4;PMEPA1;YAP1;NR3C1;TMF1;PPARGC1B;PGR;UBR5;DDX5
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.48958325179825046,-1.2135872774800496,0.21271929824561403,0.6262088972216053,1.0,7/12,31.32%,OPLAH;GCLC;GGT1;HAGH;MGST2;BDH2;GCLM
prerank,intraciliary retrograde transport (GO:0035721),0.5084060615635297,1.2135720165881496,0.2547892720306513,0.7073428530069943,1.0,4/12,17.89%,DYNC2I1;DYNC2LI1;WDR19;TTC21B
prerank,skin development (GO:0043588),0.3650360886024089,1.2135595459254962,0.16797488226059654,0.7062641640795263,1.0,23/65,21.85%,COL5A2;COL3A1;GATA6;ANXA1;ERRFI1;COL5A1;CLIC4;CLDN1;ALOXE3;WNT5A;KRT9;EPHA2;DACT2;OPN3;COL1A2;TXNIP;CASP3;DSP;WNT10A;COL1A1;PIP5K1A;TGM1;PKD1
prerank,positive regulation of cellular component organization (GO:0051130),-0.298075778017377,-1.2131060368614828,0.11363636363636363,0.6263545235286079,1.0,30/107,18.34%,ATP10A;NRXN1;SHANK3;TGFB2;INSR;TFRC;SNCA;RPS3;DAB2IP;SLF1;VEGFA;TGFB3;NEDD4L;GNL3L;TAL1;RACK1;RUNX1;LMAN1;SYK;TMEM30A;RELN;MPP7;PARK7;BMF;CCL19;CBLL1;ADD1;MMP1;TPPP;ABCB4
prerank,glycoprotein biosynthetic process (GO:0009101),-0.30932403337826786,-1.212667644014534,0.14035087719298245,0.6264168070257616,1.0,17/79,15.86%,CSGALNACT1;ST8SIA4;ST3GAL6;BMPR2;XYLT1;FUT9;ST8SIA6;CHST9;ALG5;B3GNT2;SERP1;NUS1;GCNT1;BMPR1B;B3GNT9;ST3GAL4;B3GALNT2
prerank,male gonad development (GO:0008584),0.42210978961342194,1.2121178364599257,0.2235494880546075,0.7094810910735835,1.0,4/34,3.84%,WNT4;GATA6;WNT2B;KIT
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.48894969503209823,1.2116581660868897,0.21493624772313297,0.7097469234526658,1.0,2/16,2.52%,WNT4;VIM
prerank,cellular protein modification process (GO:0006464),0.28138907117830814,1.2114487908662361,0.03695881731784583,0.709318485754124,1.0,194/982,15.91%,PTPN13;IGFBP3;CP;PDPK1;PDK1;UST;TNC;FBN1;TEC;PARP14;LAMC1;ROCK2;FSTL1;NRK;ZC3HAV1;COL3A1;FN1;PRKCSH;PRKAG2;FGFR1;LTBP1;GRK3;FAM20C;SPSB1;STK39;GALNTL5;PRKAA2;OXSR1;EIF2AK2;TPTE;IGFBP5;TSSK3;APOA2;HIF3A;PPM1E;PPM1A;BMPR1A;FSTL3;SDC2;BMP2K;FAM20A;FER;MAN2A1;FBXO11;PARP9;CDK8;RCN1;ANXA1;DUSP10;ITIH2;PTPN14;DAPK1;BMP2;TAOK3;PTPN4;LARGE1;IL6;IKBKE;LOXL1;EPAS1;MIA3;PTPN3;PRKCZ;ARAF;LATS2;MAP3K1;AAK1;PTPN22;TGFBR1;LIPT1;MORC3;KLHL21;KLHL22;SPSB4;PARP3;APLP2;CUL4A;MAPK6;PTPRA;ARF4;MTMR3;DUSP16;PTPN9;FBXO9;NPC1;PARP10;TGFBR2;SSH1;PTPN21;MAP4K1;FAM20B;GSK3B;FBXL3;CCL2;NUB1;NEK4;WNK4;PPEF2;PSMB10;PPP4R2;FUT4;MANBA;CHM;CTDSP2;STK24;STK3;SIK3;PSMA3;SIRT4;FBXL20;PSME4;LRRK2;PPP4R1;COQ8B;TLK2;TRIOBP;CDK7;CDK12;HLCS;FUT10;TIPARP;FBXL7;DNAJC3;CDK16;FBXO4;PSMA5;WWP2;PPM1B;AKT3;HIPK3;GRK5;KEAP1;PTPN6;PPP1CB;IRAK3;PTPRU;CUL3;KLHL13;PPP3CB;CSF1;DUSP5;ANO8;FNTB;ILF3;PARP16;BTRC;PTPN1;PTPN18;DAPK2;MAP2K1;FBXW11;ASB5;MAP3K13;PORCN;PLAT;STRADB;JAK1;SRPK1;WDR45B;MAPK9;PPM1M;ALG1;ACVR1C;FBXL4;WNK1;DDA1;TRIB1;CHRDL1;TBK1;FRK;NUAK2;VHL;BIRC6;RARA;PTPRR;FBXL13;EIF2AK3;RYK;PDF;ILK;FBXL12;LIMK1;ASB3;CDKL3;STK4;ACVR2B;SOCS6;TXK;PKN2;PRKD2;ERN2;IGFBP4;APP;CTDSP1
prerank,positive regulation of cyclase activity (GO:0031281),-0.46654710201750854,-1.211332789081729,0.24611973392461198,0.6290599428188572,1.0,5/14,10.30%,NOS3;MAPK8;MAPK3;CACNA1D;NOS1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.42790880117838254,-1.2108061728129464,0.2052401746724891,0.6292856320171809,1.0,5/18,14.81%,NAV3;CD34;HDAC7;HAVCR2;PTPRC
prerank,cellular response to cAMP (GO:0071320),-0.3882279686470679,-1.2106990242158142,0.19457013574660634,0.6283704291730592,1.0,8/30,12.24%,AKAP6;HCN1;SLC5A5;INPP5K;HCN2;RAPGEF2;PDE2A;KCNQ1
prerank,neutrophil activation (GO:0042119),-0.48440599354061603,-1.2105807804199338,0.23553719008264462,0.6274788122093735,1.0,3/12,12.61%,PREX1;FCER1G;SYK
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4799043886054508,1.2105175235649872,0.24603174603174602,0.711086381102049,1.0,3/15,4.93%,UST;DCN;DSE
prerank,regulation of protein neddylation (GO:2000434),-0.515306450140916,-1.2104360104711172,0.24789915966386555,0.6267266026653272,1.0,6/10,14.48%,RPL5;RPL11;DCUN1D2;COPS9;DCUN1D5;DCUN1D1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.4634339007620534,1.2103496136289138,0.21968365553602812,0.7105210762627685,1.0,3/19,5.91%,ZMIZ1;AXL;MMP14
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.513663674478943,1.21020211824226,0.26750448833034113,0.7099086753490434,1.0,4/13,9.00%,SORBS1;PRKCZ;ECHDC3;IGF2
prerank,cell chemotaxis (GO:0060326),0.37347149745385655,1.2099843845287532,0.19654088050314467,0.7094750359869932,1.0,15/60,15.74%,LPAR1;PDGFRA;PARVA;ACKR2;CCR9;NRP1;KIT;PDGFRB;ACKR3;EGR3;NR4A1;EPHA2;CCL25;CCRL2;CXCR4
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.3104568594240105,-1.2095146087382647,0.17008797653958943,0.628006645425666,1.0,21/69,19.16%,MEF2C;PTK2B;NTRK2;SIX1;FOXQ1;NDNF;LGMN;PINK1;TGFB3;NGF;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;SET;NTF3;TOX3;ADAM8;NONO
prerank,urogenital system development (GO:0001655),0.5244735806154817,1.2089905192877144,0.26627218934911245,0.711485880129747,1.0,2/11,3.55%,OSR1;ANXA1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4271601455954913,-1.2086937102731017,0.22172949002217296,0.6292000916440368,1.0,6/19,14.20%,PTPRD;IL1RAPL1;CAPRIN2;LRP8;DBNL;RELN
prerank,actin crosslink formation (GO:0051764),0.5212866587165901,1.2081652959936882,0.2413127413127413,0.7128263023948124,1.0,2/12,4.72%,DPYSL3;BAIAP2L1
prerank,mRNA methylation (GO:0080009),-0.44992281902508624,-1.2079434009798846,0.2144469525959368,0.6301484234162695,1.0,8/15,28.51%,VIRMA;ZC3H13;CBLL1;TRMT6;METTL8;TRMT10C;METTL14;TRMT61A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3136352419272865,1.207805838258912,0.13509933774834437,0.712825667557462,1.0,36/190,12.71%,UACA;RORA;CGNL1;DEPTOR;ITPR1;TLE1;PRKAA2;PPM1A;DGKD;DAG1;ARHGAP12;IFI35;BMP7;BCL2;MCL1;CPNE1;WWC2;ATP2B4;PPARA;MGRN1;STAMBP;STAT1;ZMYND11;PPEF2;MYADM;GPD1L;NLRX1;MAPK14;PPM1B;PLEK;BCL2L1;FNIP1;SH2B3;VGLL4;EPHA2;NDUFS3
prerank,primary neural tube formation (GO:0014020),0.4274518340266707,1.2077075035357245,0.23275862068965517,0.7120447473765171,1.0,6/30,7.92%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,positive regulation of neuron death (GO:1901216),0.3909085306109615,1.2075003804773496,0.19131832797427653,0.7115309806361256,1.0,7/46,8.47%,EFNB2;EPHA7;NUPR1;TLR4;GSK3B;BAX;WNT5A
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4387766676105814,1.2074852269094742,0.22603978300180833,0.7104795758705722,1.0,3/25,4.20%,PDPK1;CXCL10;F2RL3
prerank,negative regulation of immune response (GO:0050777),0.32215883376161075,1.2069051241754916,0.12569060773480664,0.7111823278805336,1.0,23/154,12.33%,ENPP3;COL3A1;GHRH;ADORA2A;FER;PTHLH;RC3H1;GLP2R;IL6;ADCY5;ADCY7;MC2R;FOXP3;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;PPM1B;GPR39;IRAK3;TRIM21
prerank,phosphorylation (GO:0016310),0.29453441797562424,1.2068496261203225,0.07403055229142186,0.710258174596763,1.0,89/384,15.87%,IGFBP3;PDPK1;PDK1;TEC;ROCK2;NRK;EPHA7;PRKAG2;FGFR1;GRK3;FAM20C;STK39;PRKAA2;OXSR1;EIF2AK2;TSSK3;BMPR1A;BMP2K;FAM20A;FER;DGKD;CDK8;DAPK1;BMP2;TAOK3;IKBKE;PI4KA;PRKCZ;TOP1;LATS2;MAP3K1;AAK1;TGFBR1;MORC3;PANK2;MAPK6;TGFBR2;MAP4K1;FAM20B;GSK3B;CCL2;NEK4;WNK4;STK24;STK3;SIK3;GK5;LRRK2;PPP4R1;COQ8B;TLK2;CDK7;CDK12;CDK16;AKT3;HIPK3;GRK5;IRAK3;XYLB;PPP3CB;ILF3;DAPK2;MAP2K1;MAP3K13;STRADB;JAK1;SRPK1;MAPK9;ACVR1C;WNK1;TRIB1;ALK;TBK1;FRK;NUAK2;BIRC6;RARA;EIF2AK3;RYK;ILK;LIMK1;CDKL3;STK4;ACVR2B;TXK;PKN2;PRKD2;ERN2;APP
prerank,primary miRNA processing (GO:0031053),0.5440831575128584,1.20676375159506,0.2708333333333333,0.7094315832332576,1.0,5/10,21.82%,SMAD3;SMAD2;HNRNPA2B1;PUS10;SRRT
prerank,mRNA polyadenylation (GO:0006378),0.4384703940278427,1.2064315488218673,0.23665480427046262,0.7081817047257195,1.0,15/26,24.46%,PCF11;PAPOLG;CDC73;PAF1;LEO1;TENT2;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,RNA polyadenylation (GO:0043631),0.4384703940278427,1.2064315488218673,0.23665480427046262,0.7081817047257195,1.0,15/26,24.46%,PCF11;PAPOLG;CDC73;PAF1;LEO1;TENT2;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.43715474820916245,1.2063008669795154,0.21631205673758866,0.7074863051637352,1.0,9/27,15.61%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;PML;FBXL12;PER3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3786364618771466,-1.206202714355445,0.18138424821002386,0.6337376574138882,1.0,17/32,32.16%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;TOPBP1;PLK1;CDK1;TICRR
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4484368198120792,-1.206189945870398,0.2494802494802495,0.6325470116598446,1.0,7/15,15.27%,TMSB4X;THBS1;NOTCH1;MET;LGMN;FGF2;PRKD1
prerank,negative regulation of cellular process (GO:0048523),0.28912858479875797,1.2059811254147197,0.04844290657439446,0.7073802805931467,1.0,119/521,17.80%,ALDH1A2;PLXNA2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;SMAD3;KANK2;CCN2;SP100;ENPP1;EIF2AK2;TPTE;NUPR1;LDOC1;GJA1;DLC1;PDS5B;OSM;CASK;FBLN1;PIWIL4;ADAMTS1;TGFB1I1;PRDM11;PTHLH;SUZ12;PTPN14;ANGPT1;BMP2;IGFBP6;IFI35;APBB1;IL6;BTG3;GSDME;MIA3;BMP7;BCL2;BTG4;APPL2;NR1H3;FOXP3;RASA1;BST2;PTPN2;COL18A1;ZBTB7C;POU1F1;CLMN;CDC73;PDCD5;SKI;CDKN2B;CRLF3;IFITM1;SMAD6;SUSD2;DCBLD2;NUPR2;CGRRF1;GMNN;IFNLR1;PTPN6;CDH13;TLR2;SMAD4;PTPRU;SH2B3;NR4A1;TSPYL2;VGLL4;NUDT6;PARP16;SERTAD2;SLURP1;NDUFS3;MAP2K1;DACT2;RBM5;SERTAD3;RTN4;MDM4;IFIT3;LRPAP1;WDR6;NCK1;FRK;ABI1;VHL;NIBAN2;PML;TNS2;EIF2AK3;CHMP4B;SMARCA4;KAT2B;MUL1;P3H3;SOX4;PKD2;APP;INHA;AXIN2;NF2;S100A11;PSRC1;PPP2CA;CDKN3;GAS8;PODXL;DLG5;OSGIN2;TXNIP;DNAJB2;OSGIN1;PPP2R5C;TENM1
prerank,replicative senescence (GO:0090399),0.5142535980292461,1.205411667611405,0.2608695652173913,0.708047430258525,1.0,3/12,5.64%,PLA2R1;TERT;SERPINE1
prerank,determination of bilateral symmetry (GO:0009855),-0.3987005053754492,-1.2050777875686687,0.1883720930232558,0.6344736113511477,1.0,10/24,26.43%,NOTCH1;TBX1;ZIC3;DNAH11;KIF3B;DLL1;ODAD2;BBS7;ODAD3;STIL
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3765380398428321,1.2048777719058485,0.19329073482428116,0.7085248418407627,1.0,17/56,16.13%,BMP6;BMPR1A;LDLRAD4;TWSG1;PMEPA1;BMP2;BMP7;TGFBR1;BMP8B;SMAD6;SMAD4;HFE;NOG;GDF11;GDF15;DAB2;INHA
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5011654285933549,1.2046125902984877,0.2593283582089552,0.7082570763395339,1.0,5/14,5.64%,IGFBP3;IGFBP5;BMPR1A;TPM1;SERPINE1
prerank,regulation of sensory perception of pain (GO:0051930),-0.49909752918074224,-1.2044974838789468,0.23965141612200436,0.6350219364161536,1.0,2/11,4.39%,MGLL;CCN3
prerank,photoperiodism (GO:0009648),0.4334096668634255,1.2036364607159646,0.2204585537918871,0.7101109717411082,1.0,11/28,19.62%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;PML;FBXL12;PER3;CLOCK;BHLHE40
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3980752270170654,1.2032875859558907,0.21258503401360543,0.7100803642683449,1.0,12/43,15.07%,PID1;ENPP1;KANK1;NUCKS1;SORBS1;PRKCZ;PTPN2;IGF2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,cellular glucose homeostasis (GO:0001678),0.39662575996969057,1.2030569357347207,0.2247191011235955,0.7097107723538807,1.0,7/41,9.01%,ZBTB20;PRKAA2;NUCKS1;UNC13B;CARTPT;NGFR;HKDC1
prerank,negative regulation of protein processing (GO:0010955),0.5073389089265001,1.203055054812697,0.25346534653465347,0.7086429935941403,1.0,4/12,9.30%,SERPINE1;SNX12;SERPINE2;LRRK2
prerank,regulation of MAPK cascade (GO:0043408),0.32282279494162003,1.202528561545948,0.13765182186234817,0.709155036293126,1.0,21/157,6.19%,TGFBR3;LPAR1;ROCK2;NRK;FN1;EPHA7;FGFR1;KSR1;OSM;IL11;EPHA8;DAG1;PRDM11;KIT;BMP2;TAOK3;IL6;ROR1;GSDME;PELI2;TRIM5
prerank,positive regulation of bone resorption (GO:0045780),-0.49859121743039647,-1.2018045791606426,0.24,0.6414370537665656,1.0,5/11,22.10%,SPP1;SYK;ADAM8;ATP6AP1;TNFRSF11A
prerank,mitochondrion morphogenesis (GO:0070584),0.5315042444691335,1.2017049030350728,0.27167630057803466,0.7106118336936896,1.0,7/11,24.58%,PID1;DNM1L;SUPV3L1;WASF1;PNPT1;SLIRP;MTM1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.47845669860905427,-1.2012421630591434,0.2633832976445396,0.6417519097364893,1.0,8/12,37.68%,PRKCB;NEK9;CTDNEP1;VRK1;PLK1;CDK1;CCNB2;CCNB1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4002096510036274,1.200589561185731,0.214168039538715,0.7128560535964262,1.0,14/38,23.75%,LEPROT;HAX1;NPEPPS;LRRK2;HUWE1;RHOU;USP36;CSNK2A2;ATP5IF1;SREBF1;FBXW7;ATG13;HPS4;RNF31
prerank,regulation of actin filament bundle assembly (GO:0032231),0.42806083106550447,1.2004560697117208,0.2179930795847751,0.7121691126088115,1.0,5/26,6.18%,ROCK2;ALMS1;SYNPO2;SYNPO;ASAP3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5166944292183892,1.2004278104226942,0.26785714285714285,0.711167287574717,1.0,3/11,6.03%,ANXA1;RC3H1;FOXP3
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4835342497393953,1.1997303200119316,0.2727272727272727,0.7122826736181792,1.0,2/16,1.46%,RASGRF1;AUTS2
prerank,apical protein localization (GO:0045176),-0.5151739459775995,-1.199692399174155,0.26458333333333334,0.645127123628832,1.0,8/10,17.16%,ACTB;GOPC;MAL;JAM3;ATP8B1;SHROOM3;INSC;VANGL2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5071202442110728,-1.1995083230070078,0.2625,0.6444119381781948,1.0,7/10,33.35%,DLGAP1;DLGAP2;BEGAIN;NPTX2;CACNG5;NPTXR;NPTX1
prerank,motor neuron axon guidance (GO:0008045),-0.4590679119449999,-1.1990885213143283,0.24550898203592814,0.6443813550654311,1.0,8/15,22.31%,SLIT2;TMEFF1;RHOG;SEMA3A;RAC1;RHOH;CHN1;LHX1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2862184512409153,-1.198924240210412,0.1225296442687747,0.6436312801894484,1.0,34/137,15.18%,DOCK9;ITGA6;BCAR3;DOCK10;NET1;CALM1;SEMA4D;CALM2;MAPK8;RPS3;TBC1D30;RAB3GAP1;CCL14;RAPGEF2;CALM3;RGS7;MTCL1;RGS6;PINK1;ARHGAP27;RACK1;CAV2;CD40;DOCK8;ALS2;ARHGEF7;RGP1;RAPGEF6;F11R;HRAS;AGRN;EVI5;SNX18;CCL19
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3018571630519585,-1.1988887834356552,0.14647887323943662,0.642541456010812,1.0,39/87,33.09%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;SAMM50;COX20;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;IMMP2L;NDUFB10;UQCC3;NDUFC2;NDUFA13;COX19;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;OMA1;BCS1L;PET100;NDUFAF3;NDUFA10;TIMM21;SDHAF2;COA5;NDUFS6;NDUFV3;NDUFS1;NDUFA2;SCO2;TMEM126B;NUBPL;COA3
prerank,response to progesterone (GO:0032570),-0.43301754410478316,-1.1987545882183885,0.23623853211009174,0.6416811026270872,1.0,5/18,12.95%,TGFB2;THBS1;ABHD2;TGFB3;CAV1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4238783233055055,1.1986149419385812,0.24119718309859156,0.7145255833575596,1.0,10/28,15.07%,PID1;ENPP1;KANK1;PRKCZ;APPL2;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,regulation of focal adhesion assembly (GO:0051893),0.37636133900964486,1.1985537215429936,0.22294022617124395,0.7136445113185981,1.0,10/54,6.01%,PHLDB2;ARHGAP6;ROCK2;DLC1;EPHA3;NRP1;S100A10;CLASP1;VCL;PTPRA
prerank,sphingolipid biosynthetic process (GO:0030148),-0.31595166384599727,-1.198470072858233,0.1476923076923077,0.6412486593461665,1.0,10/71,4.60%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;SPNS2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.32176003768563743,1.1982884652968089,0.15020297699594046,0.7133553383434897,1.0,29/138,16.51%,RORA;RBPJ;CCN2;NOTCH2;TBL1XR1;TEAD1;NR6A1;POLR2D;NR1H3;PPARA;CREBBP;RARB;TEAD2;YAP1;CCNH;MNAT1;CDK7;TAF7;POLR2C;NR4A1;MAML2;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;TAF9;WWTR1;TBL1X
prerank,tube closure (GO:0060606),0.42270958493096805,1.1980934765718219,0.23195876288659795,0.7128849756750609,1.0,6/31,7.92%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3756675604112154,-1.1972131201767173,0.19082125603864733,0.6436572468944635,1.0,8/32,7.58%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;HSP90AB1;CALM3;SYMPK
prerank,regulation of lymphocyte activation (GO:0051249),-0.49291781355748937,-1.1969262401167262,0.25,0.6433270449713524,1.0,8/12,37.58%,KAT2A;PAG1;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,canonical glycolysis (GO:0061621),-0.38998707803460236,-1.1969018022354703,0.2079646017699115,0.6410035584060584,1.0,8/24,19.92%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.38998707803460236,-1.1969018022354703,0.2079646017699115,0.6410035584060584,1.0,8/24,19.92%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,positive regulation of myelination (GO:0031643),-0.496305426957396,-1.1965588156751692,0.259825327510917,0.6408050145686894,1.0,5/11,18.02%,TENM4;TNFRSF1B;TPPP;NCMAP;DICER1
prerank,ceramide transport (GO:0035627),-0.4836404206450695,-1.1962944594893288,0.2546583850931677,0.6403905276843964,1.0,8/12,37.41%,CERT1;GLTP;SGPP1;ABCB4;ABCA13;ABCA2;PLEKHA3;CPTP
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4079902668727801,1.1960015209598553,0.22148760330578512,0.7182562632140455,1.0,6/34,13.97%,LGR4;BPIFB1;TLR4;LY96;IRAK3;TICAM1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4346000304374889,1.1957524768508556,0.226691042047532,0.7179019912676662,1.0,4/24,4.74%,ROCK2;FOXC1;NCOA3;ERRFI1
prerank,pyruvate metabolic process (GO:0006090),-0.3280429062521787,-1.1950818763645377,0.14470284237726097,0.6425901540232384,1.0,14/52,15.68%,BSG;ME1;PGK1;PKM;ME3;SLC16A1;ALDOC;GPI;TPI1;PGAM1;PGAM4;VDAC1;NR4A3;ENO1
prerank,regulation of striated muscle contraction (GO:0006942),-0.39960252771945337,-1.1950507953064171,0.22811059907834103,0.6415014250537552,1.0,8/27,12.86%,DMD;RYR2;SMAD7;CALM1;CALM2;CALM3;NOS1;SRI
prerank,glial cell differentiation (GO:0010001),-0.38937954525424046,-1.1949781445381598,0.21026894865525672,0.640512065902424,1.0,13/28,29.96%,CDH2;ADGRG6;PAX2;NFIB;RELN;TPPP;SOX2;PTPRZ1;CDK5;SOX11;PICK1;FGF10;SLC8A3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.4986753802218726,-1.194473905149204,0.2571428571428571,0.6407445210932038,1.0,4/11,28.64%,PINK1;PARK7;STK26;MMP3
prerank,regulation of feeding behavior (GO:0060259),0.5244086924549048,1.1942369792567207,0.2627450980392157,0.7212736415870292,1.0,2/11,5.28%,LEPR;UCN
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.38543829477511604,1.194072926165018,0.21546052631578946,0.7207118118431536,1.0,6/45,6.63%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.42960416975155175,-1.193714387903436,0.23605150214592274,0.6418044657147752,1.0,6/19,20.27%,SLCO1C1;KLF2;MAPK8;KLF4;EGF;CHRNA7
prerank,organic acid transport (GO:0015849),0.3406595579200432,1.1931993513564434,0.18502202643171806,0.7222348124129869,1.0,9/94,5.62%,SLC7A11;PDPN;SLC7A2;SLC13A3;SLC6A13;SLC19A1;SLC6A12;SLC7A14;ACSL1
prerank,diol metabolic process (GO:0034311),-0.4269432792625733,-1.1930911642670181,0.23318385650224216,0.6423522828757305,1.0,8/19,16.97%,NOS3;DEGS2;CALM1;AKT1;GCH1;HSP90AA1;PLPP1;SGPP1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3272591856690793,-1.1928895523617387,0.17955112219451372,0.6417699193588807,1.0,19/54,15.74%,MEF2C;NOS3;TMSB4X;THBS1;KDR;ACVRL1;GATA2;HMGB1;PRCP;ATP5F1A;AKT1;VEGFA;CD40;NUS1;FGF2;ATP5F1B;RGCC;PRKD1;PLCG1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.48881985807032174,1.1928578966777126,0.25849056603773585,0.7222289721958174,1.0,5/14,14.35%,DPYD;UPP1;NT5C;UMPS;ERH
prerank,aortic valve morphogenesis (GO:0003180),-0.37709527522902925,-1.1925246505808391,0.20772946859903382,0.6415940284310235,1.0,8/30,7.09%,SLIT2;ROBO2;NOS3;TIE1;NOTCH1;ELN;EMILIN1;BMP4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35135752504761314,1.1924537211133097,0.19047619047619047,0.722312514528792,1.0,16/77,14.94%,TCF7L2;PHIP;SH3RF1;CFLAR;BCL2;TGFBR1;MCL1;SIAH2;ZMYND11;BCL2L1;NDUFS3;OPA1;TMEM14A;BDNF;BIRC6;CSNK2A2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5211538763379694,-1.1923031557450114,0.24634655532359082,0.641051014081774,1.0,7/10,41.12%,CD74;FCER1G;CD27;CD81;TLR8;FCGR2B;CARD9
prerank,positive regulation of mitochondrial fission (GO:0090141),0.46415794281520545,1.1920574150764596,0.22777777777777777,0.7224217173478907,1.0,6/18,15.53%,MCU;DCN;RALBP1;DNM1L;MIEF1;MUL1
prerank,activation of protein kinase B activity (GO:0032148),0.41639941509970746,1.1916651751030451,0.23591549295774647,0.7225923958657244,1.0,10/29,17.88%,PDPK1;FGF1;OSBPL8;IL18;WNT5A;ADRA2C;NTRK3;ADRA2A;RICTOR;MAPKAP1
prerank,regulation of defense response (GO:0031347),0.3472729668103114,1.191349933368779,0.18456883509833585,0.7224612175616515,1.0,15/76,11.10%,USP18;CASP12;ADAMTS12;ANXA1;LACC1;PTPN22;ZBP1;CASP4;APPL2;BIRC3;WNT5A;ERAP1;APPL1;BRD4;NLRP6
prerank,retina homeostasis (GO:0001895),-0.4072407110896704,-1.1911712516502762,0.2206896551724138,0.6430514114078807,1.0,6/23,16.32%,ACTB;POTEF;ACTG1;B2M;SOD1;CDH3
prerank,response to muramyl dipeptide (GO:0032495),0.5013536131618334,1.1901630581541789,0.2611111111111111,0.7249927936672982,1.0,4/12,8.04%,LDOC1;VIM;PTPN22;RIPK2
prerank,ion transport (GO:0006811),-0.287760931065531,-1.188757822960614,0.12162162162162163,0.6488140192007347,1.0,21/111,9.21%,SLC12A7;PIEZO2;SLC26A7;SLC12A2;SLC9A2;SLC26A2;SLC24A2;ANO1;ATP11B;SLC5A5;AQP11;SLC15A2;SLC8A1;SLC1A1;SLC9A8;TRPC6;TMEM63C;SLC1A2;SLC12A5;GRIN1;GABRB1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2832517610375758,-1.1886049149524867,0.11683848797250859,0.6480226262215348,1.0,46/132,24.95%,RPS15;RPL24;CELF4;RPL5;RPS27;RPS19;RPL38;SETX;LUC7L3;RPL6;RPL11;RPLP0;RPS28;PUF60;HSP90AB1;RRP7A;SRSF1;SART3;TRAF7;HSP90AA1;EIF3A;XAB2;RPS5;PPAN;RPS14;SART1;SNRPB;NLE1;LUC7L;DICER1;SNRPF;SRSF9;GCFC2;PRMT5;MDN1;LSM4;RPL3;SNRPD1;SNRPD2;SRSF6;CELF6;RPL23A;ABT1;GEMIN8;EIF6;SRPK2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4245254512243207,1.1880871154321497,0.23008849557522124,0.730360004679157,1.0,6/29,9.15%,ZBTB20;SORBS1;NR1H3;CREBL2;PPARA;SIRT4
prerank,blood vessel morphogenesis (GO:0048514),0.3786900161911105,1.188076863636976,0.21009771986970685,0.7293193728123536,1.0,10/54,8.56%,EFNB2;TGFBR3;RBPJ;CCM2;ITGB8;NRP1;TGFBR1;RASA1;TGFBR2;ADM
prerank,regulation of filopodium assembly (GO:0051489),-0.35701240772609455,-1.1880324949940473,0.21105527638190955,0.6485428371356633,1.0,7/38,2.31%,MYO10;NLGN1;PPP1R16B;FNBP1L;TENM2;GPM6A;PIK3R1
prerank,odontogenesis (GO:0042476),0.3988277999446446,1.1879506386283645,0.22750424448217318,0.7286313077468105,1.0,6/35,6.91%,WNT6;OSR1;FOXC1;BMP2;BCOR;EDA
prerank,cellular response to purine-containing compound (GO:0071415),-0.4988705989549873,-1.1874614421331913,0.2676348547717842,0.6489808005686428,1.0,5/10,21.52%,RYR2;RYR3;SLC8A1;CASQ2;TRPM2
prerank,determination of heart left/right asymmetry (GO:0061371),-0.348746975448806,-1.1873316169097037,0.18133333333333335,0.6481635509550698,1.0,14/42,23.49%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.42485335367130717,1.1872427967101848,0.2550091074681239,0.7297487506702978,1.0,6/27,6.11%,PDGFRA;FPR2;AMBRA1;EPHA8;KIT;PDGFRB
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4443117997912005,1.1869374156883066,0.2513464991023339,0.7295983437544789,1.0,2/21,1.57%,MCU;MICU1
prerank,anion transport (GO:0006820),0.408828200197659,1.1859401161801224,0.249597423510467,0.731530718484655,1.0,5/33,3.74%,SLC13A3;SLC13A4;SLC19A1;SLC26A9;VDAC2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4639064328602064,1.1856619134526134,0.27171903881700554,0.7312944783563221,1.0,6/18,17.65%,DDX60;BIRC3;OASL;ANKRD17;PUM2;USP15
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.48638504097906093,1.1855635653524788,0.2690166975881262,0.730551884447489,1.0,4/15,6.94%,PDGFRA;MTHFD1;TGFBR1;TGFBR2
prerank,aerobic respiration (GO:0009060),-0.41849658510923526,-1.1855435678186423,0.24537037037037038,0.6519599403464216,1.0,8/20,24.28%,SDHC;ME3;NDUFS7;UQCRH;ATP5F1D;MTFR1L;MDH2;UQCR10
prerank,response to cholesterol (GO:0070723),0.47424189726118915,1.1851322620776572,0.2607879924953096,0.7307575792108383,1.0,3/17,6.94%,GRAMD1C;TGFBR1;TGFBR2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5293534831650211,1.1847955154576346,0.2754491017964072,0.7307649693277786,1.0,3/10,7.85%,CD55;TGFBR2;LGALS9
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3546124351018987,1.1846821332437785,0.22390317700453857,0.7300813511178884,1.0,12/67,12.04%,PLEKHA2;DOCK5;FN1;ECM2;NRP1;S100A10;EPHA1;GSK3B;MYADM;TRIOBP;CDH13;CSF1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4949048865485889,1.1846578905136347,0.2826086956521739,0.7291180738707514,1.0,4/13,12.43%,DCTPP1;NTHL1;NT5C;OGG1
prerank,positive regulation of dendrite development (GO:1900006),0.5324747648366583,1.1836857114586314,0.2832369942196532,0.7308390385003637,1.0,2/10,4.75%,PTN;BMP7
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37105445530713155,1.1828949827329893,0.22312703583061888,0.7321380403677074,1.0,15/52,21.06%,SAMD4A;TUT4;POLR2D;RC3H1;LSM1;DCP2;PAN3;DDX6;DIS3;CNOT3;CNOT9;TUT7;PATL1;PARN;PAN2
prerank,cGMP-mediated signaling (GO:0019934),-0.4703767692519357,-1.1827355518858984,0.252,0.65878549956326,1.0,5/13,9.24%,KCNC2;HTR2C;GUCY1B1;PDE3A;PDE2A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.29263026716869994,1.1826508531179463,0.10752688172043011,0.73177044236307,1.0,74/327,17.01%,EFEMP1;RORA;ATXN1;ZMIZ1;ARNT2;FOXC1;NFIA;NFYC;ZBTB4;ZNF395;DENND4A;SSBP2;MYB;PRRX2;PERM1;BMP2;RFX3;APBB1;GZF1;NIF3L1;TGFBR1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBL2;TCF7L1;CREBBP;NSD1;POU1F1;RNF20;ZSCAN21;NFXL1;TEAD2;ATF7;ZFP37;KAT6B;IGF2;CREM;SOX21;SUFU;MAFB;MSC;PSPC1;UBE2V1;TGFBRAP1;TCF7;ZNHIT3;ZNF219;ZFAT;OGG1;THAP1;MZF1;NR3C1;SERTAD3;HIC1;ZNF205;NCOA2;DMTF1;FUS;CARM1;VHL;PML;SP3;ACVR2B;SOX4;POU5F1;WWTR1;NFATC2;CCAR1;WTIP;PPP2CA
prerank,aorta morphogenesis (GO:0035909),0.4676471030950753,1.1825451271069936,0.2608695652173913,0.731007676142542,1.0,4/17,6.11%,RBPJ;BMPR1A;EFEMP2;PDGFRB
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4351676445539189,1.1825062092706273,0.25811965811965815,0.7300821197554365,1.0,8/22,21.01%,ROCK2;IL6ST;MEF2A;SMAD4;P2RX4;ROCK1;SLC9A1;AGT
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.41740046717284435,-1.1823402358417845,0.24175824175824176,0.6587769912213831,1.0,4/19,2.23%,PTPRJ;GRM5;RYR2;KDR
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4744968969058915,-1.1820962551037777,0.252465483234714,0.6582943700512032,1.0,6/12,10.75%,PTPRJ;F3;SNCA;APOD;NDRG4;CBL
prerank,regulation of histone modification (GO:0031056),-0.46115452040146776,-1.1820337122490818,0.24675324675324675,0.657275476928899,1.0,5/13,17.30%,MTHFR;PARG;PARK7;HPF1;NNMT
prerank,positive regulation of vascular permeability (GO:0043117),0.5020077987628858,1.1818649039511822,0.2691552062868369,0.7309406005019474,1.0,2/12,3.83%,BMP6;ANGPT1
prerank,striated muscle cell differentiation (GO:0051146),0.4681297842323816,1.1807200148543702,0.27450980392156865,0.7332381150334206,1.0,4/16,7.92%,AKAP13;BMP2;POPDC2;SKI
prerank,bile acid metabolic process (GO:0008206),0.41439804879532066,1.1806359204115333,0.2508833922261484,0.7324372335052184,1.0,9/27,18.00%,CYP7B1;CYP27A1;NPC1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9;GBA2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.29297169065707535,-1.1801122277496037,0.16314199395770393,0.6617579618555758,1.0,29/88,15.23%,PTPRB;UBASH3B;ADARB1;SNCA;SORL1;DAB2IP;SLC8A1;INPP5K;AKT1;CEACAM1;SMCR8;NPM1;LRP6;SH3BP5L;PTPRT;DVL1;CEP85;PTPRO;SRCIN1;AKT1S1;LRP5;CEP43;CAV1;PRKRIP1;PPIA;PARK7;PTPRC;GNAQ;CDKN1A
prerank,magnesium ion transport (GO:0015693),-0.485068313673938,-1.1799512700895898,0.28487229862475444,0.6610552233364464,1.0,5/12,10.29%,CNNM4;NIPAL3;NIPAL4;NIPA2;NIPA1
prerank,inflammatory response (GO:0006954),0.3061485119668648,1.1799412681221544,0.14475431606905712,0.7335278009759428,1.0,27/195,8.78%,CXCL10;FPR2;HSPG2;ADORA2A;NFATC4;ANXA1;KIT;BMP2;LOXL3;IL17D;IL6;TPST1;TLR4;C5AR2;HDAC4;PLA2G4C;NOS2;CRP;ADCY1;BDKRB2;IL18;CCL2;LGALS9;SIGLEC1;RIPK2;ADM;PJA2
prerank,regulation of anoikis (GO:2000209),0.46635954219689885,1.1799395297939361,0.2759259259259259,0.7324955750815018,1.0,5/19,11.17%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.45867540577135,-1.1798187691365487,0.266384778012685,0.6602612053718326,1.0,7/14,28.08%,THBS1;NOTCH1;KLF4;DLL4;CARD10;HDAC5;PDCD10
prerank,muscle contraction (GO:0006936),0.32375254036116097,1.1796186116356808,0.17780938833570412,0.73237838032606,1.0,17/126,10.08%,TNNC1;ROCK2;MYOF;TMOD3;CALD1;VIM;DES;SORBS1;TPM1;VCL;SNTA1;ACTN2;BDKRB2;ARHGEF11;SSPN;NMUR1;TPM4
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4766551656128908,1.1794583856907657,0.24259259259259258,0.7318130331685144,1.0,2/17,2.52%,WNT4;VIM
prerank,positive regulation of cell migration (GO:0030335),0.3004976706521028,1.1793572555938534,0.12546583850931678,0.7310903261730062,1.0,36/253,9.06%,SEMA3D;PDPN;ROCK2;VTN;DOCK5;FN1;PDGFRA;FGF1;DDR2;SYNE2;SMURF2;CXCL16;FAM110C;CDH5;GLIPR2;NRP1;FER;NUMB;SMIM22;KIT;BMP2;WNT5B;MIA3;CLASP1;TGFBR1;FAM83H;MMP14;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1;MYADM;INSL3;PLAU;SYDE1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.39391761529772806,1.1791447657563738,0.24870466321243523,0.7306526224083835,1.0,7/42,7.90%,SELP;IL6;TLR4;SERPINE1;OPTN;NOS2;TNFRSF14
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43908838967225877,1.179063867961196,0.2539404553415061,0.7298853483724013,1.0,5/23,10.49%,NUPR1;CRY1;HDAC4;PPARA;PLEK
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.497552065196582,1.1790046512237682,0.2867647058823529,0.7290211339548629,1.0,2/13,2.97%,PLXNA2;NRP1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.35677150880798564,1.178574838023084,0.2202852614896989,0.7293551453809334,1.0,11/63,9.46%,LEPR;NUPR1;TIMP3;NELL1;PTPN3;BCL2;PTPN22;MCL1;KLHL22;TIMP2;TLK2
prerank,regulation of kinase activity (GO:0043549),0.3441753623231401,1.1781829429309252,0.20176730486008837,0.7295715521281184,1.0,22/89,12.29%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;LDB2;KIT;ROR1;PLCE1;RAD50;EPHA1;PDGFRB;EPHA4;MST1R;MUSK;DSTYK;TSPYL2;EPHA2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4871699606100679,-1.1781582512399547,0.27167630057803466,0.6637066808653345,1.0,6/11,20.07%,NPM1;CCNF;BRCA1;TRIM37;KAT2A;CDK5RAP2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.40850639825306656,1.1779736825728795,0.24783362218370883,0.7292048377588007,1.0,17/30,27.68%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,negative regulation of neurogenesis (GO:0050768),0.4015855174197622,1.1779558595093098,0.2367066895368782,0.7282519775547511,1.0,6/34,7.53%,PTN;WNT3A;IL6;APPL2;LRP4;NGFR
prerank,modulation by host of symbiont process (GO:0051851),-0.3741724727316112,-1.1777739073549855,0.23671497584541062,0.663656554399418,1.0,6/31,9.20%,LEF1;INPP5K;CTDP1;TFAP4;SMARCB1;HDAC1
prerank,regulation of autophagosome assembly (GO:2000785),0.399920515778795,1.1775753725173024,0.23063973063973064,0.7284239152071392,1.0,13/33,16.33%,NUPR1;IFT88;MTMR3;LRRK2;TMEM39A;IFT20;SCFD1;NPRL3;PIP4K2B;CHMP4A;CHMP4B;FEZ2;RAB5A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.4105071043829466,-1.1775050128977034,0.2540792540792541,0.6632682156680951,1.0,9/20,12.74%,SEMA6D;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,regulation of fatty acid metabolic process (GO:0019217),0.46975789092223125,1.1771357178258768,0.2600732600732601,0.728710022384902,1.0,4/17,6.37%,PRKAG2;PRKAA2;PANK2;PPARA
prerank,positive regulation of cell killing (GO:0031343),0.5060686413523449,1.176986523083546,0.2870722433460076,0.7281393832247001,1.0,4/13,8.47%,PRF1;NOS2;NOXO1;WNT5A
prerank,neuron projection morphogenesis (GO:0048812),-0.27820195770018386,-1.1767964001848188,0.10740740740740741,0.6640790405632541,1.0,34/137,12.25%,CNTNAP2;NLGN1;CTNND2;CTNNA2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;DCC;ACTB;NCKAP1;TRIO;PAK1;KLF7;ANK3;NYAP2;EPHB1;S100B;DAB2IP;CTNNB1;DCLK1;NRCAM;MAP1B;SHTN1;UBB;MINK1;DVL1;DBNL;NEFH;PAX2;ALS2;PAK3;NGF
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4208586347211768,-1.176703284874896,0.2429245283018868,0.6631846248341051,1.0,7/18,23.07%,PPP1R16B;INPP5K;MFHAS1;PPP1R26;SH3RF2;PPP1R15A;PPP1R8
prerank,diacylglycerol metabolic process (GO:0046339),-0.3931367386671607,-1.1766810447837113,0.2523148148148148,0.6620695707659829,1.0,5/23,7.28%,DGKB;DGKI;DGKH;DGKZ;LIPE
prerank,striated muscle contraction (GO:0006941),0.37134898434495994,1.1765212482139775,0.2197092084006462,0.7285258094034189,1.0,7/53,10.20%,TNNC1;ATP1A2;CSRP3;TPM1;ARHGEF11;SCN3B;RCSD1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4467734485531207,-1.1763518126290935,0.2383073496659243,0.6618393261359689,1.0,6/17,12.61%,SLC7A5;PRKCQ;HAVCR2;FCER1G;CD86;SYK
prerank,response to interferon-alpha (GO:0035455),0.47654754798174176,1.1762824166569081,0.29704797047970477,0.7282138994728641,1.0,6/16,12.15%,AXL;EIF2AK2;TPR;BST2;IFITM1;ADAR
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3181855208548132,1.1761627787023778,0.16758241758241757,0.7276083227504884,1.0,17/142,8.79%,ATP1A2;LPAR1;SMAD3;PDGFRA;FPR2;ACKR2;CCR9;CD55;ADCY5;C5AR2;PLCE1;ATP2B4;BDKRB2;SPPL3;ACKR3;WNT5A;CACNA1C
prerank,fatty acid elongation (GO:0030497),-0.4562190809220612,-1.1759827941905618,0.2591792656587473,0.6616896655293286,1.0,3/13,6.50%,ELOVL5;ELOVL7;TECR
prerank,zinc ion transport (GO:0006829),-0.40870265314104487,-1.1747308128954277,0.22247706422018348,0.6641413293058738,1.0,11/21,31.63%,SLC39A6;SLC30A1;SLC39A14;SLC39A13;SLC39A8;TRPM2;SLC30A5;SLC30A10;SLC30A9;SLC30A3;MT3
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.43589037664892166,1.17458788101096,0.2699822380106572,0.7312034964796165,1.0,4/22,8.78%,SASH1;RELL1;BMP2;PJA2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.31668895273598163,-1.174160318859958,0.18313953488372092,0.6645717291938482,1.0,18/65,15.98%,PTPRJ;HIP1;BCAR3;SH3KBP1;HIP1R;DAB2IP;SH3GL2;CCDC88A;AKT1;CEACAM1;MVB12B;CBL;ARHGEF7;EGFR;PLAUR;RNF126;RHBDF2;EGF
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2774168473247681,-1.1735660499148863,0.1292517006802721,0.6649988206341835,1.0,32/124,16.98%,FRY;CNTNAP2;NLGN1;GPM6A;CNTN4;PLP1;GPM6B;STX3;PTPRM;PLEKHA1;SH3GL2;HMGB1;MYOC;STMN2;RAPGEF2;RAB35;L1CAM;LYN;MANF;MICALL2;ZFYVE27;ULK1;CSF1R;TMEM108;RAC1;BICDL1;LGI1;MAPT;MAP2;STMN4;MNS1;SNAPIN
prerank,regulation of DNA repair (GO:0006282),0.386268297709763,1.1733201072543644,0.22295081967213115,0.7338899633293653,1.0,4/44,3.37%,EYA2;EYA1;POLH;TRIP12
prerank,negative regulation of protein binding (GO:0032091),-0.31162753077508865,-1.1732714166050406,0.19834710743801653,0.6647402673156023,1.0,22/71,15.98%,ACTB;ADAM15;ITGA4;MAPK8;SORL1;ATP2A3;AKT1;SYMPK;DDX11;B2M;ZFPM1;GNL3L;DVL1;RACK1;PPP1CA;ADRB2;TTBK1;CAV1;ATP2A2;PARK7;CDKN1A;MAP2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.38012518170483706,-1.1732292878299493,0.2399103139013453,0.6636810330085186,1.0,12/25,27.95%,CSGALNACT1;NDST3;FUT9;EXT1;B3GNT2;B3GNT9;NDST4;B3GNT3;HAS1;HAS3;B3GNT6;B4GAT1
prerank,supramolecular fiber organization (GO:0097435),0.28980599190768985,1.1722244517238616,0.1339712918660287,0.7361215979655801,1.0,45/333,10.08%,COL4A3;CGNL1;TNXB;COL23A1;TSPAN5;COL4A6;COL4A4;COL5A2;COL3A1;TMOD3;COL4A5;DDR2;SHROOM2;HSPG2;VIM;MYO1B;ARHGAP12;LOXL3;DES;BMP1;EFEMP2;LOXL1;TPM1;CLIP4;TGFBR1;COL20A1;NCKAP5L;KATNAL1;RHOBTB2;HDGFL3;COL5A1;SIAH2;RHOF;FAT1;COL18A1;DBN1;USP9X;CCDC13;DLG1;COL13A1;TUBGCP4;TRIOBP;SERF1A;FIGN;TPM4
prerank,blood vessel diameter maintenance (GO:0097746),-0.3623129839811506,-1.1717609473289308,0.23880597014925373,0.6666820405088877,1.0,12/34,17.08%,EDNRA;NOS3;KCNMB2;KLF2;ECE1;ACE;NOS1;ACE2;NPR1;GCLC;HTR2B;PER2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3351571286104206,-1.1716329658656774,0.20551378446115287,0.6658666928070717,1.0,21/46,32.11%,PIEZO2;CRADD;TMEM150C;MAPK8;MAPK3;FAS;PDE2A;CD40;F11R;LTBR;CHEK1;CASP1;BAD;TNFRSF10B;TLR7;TNFRSF1A;MYD88;FADD;TLR5;MAP3K14;BCL10
prerank,myelination in peripheral nervous system (GO:0022011),-0.47535831498308595,-1.1714062847013151,0.2556053811659193,0.6653724217778887,1.0,5/13,18.02%,ADGRG6;MYOC;SOD1;NCMAP;DICER1
prerank,cellular response to hexose stimulus (GO:0071331),0.4299957563040866,1.171036939714466,0.2651646447140381,0.7387088134661711,1.0,7/23,17.33%,ZBTB20;PRKAA2;UNC13B;SLC26A6;SOX4;IGF1R;PCK2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.41668738667325783,1.1709342782301466,0.25217391304347825,0.7379756670265837,1.0,3/26,3.98%,PDPK1;FOXC1;STAT5B
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2871258987436979,1.1708728762643401,0.12295081967213115,0.737140892224318,1.0,89/390,16.11%,SULF1;FLRT2;EFNB2;STYK1;COL4A6;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;GHR;IL31RA;FOXC1;PHIP;INSRR;EPHA3;SDC2;FOXC2;RBFOX2;EPHA8;NFATC4;FRS2;NRP1;FER;VEGFD;POLR2D;KL;SHB;ANGPT1;KIT;SORBS1;EFS;ROR1;EPHA1;PDGFRB;RASA1;PTPN2;PIK3C2A;BDKRB2;MVP;NGFR;HNRNPH1;GSK3B;EPHA4;RHOQ;IGF2;ZNF106;DNM1;MTSS1;MST1R;POLR1G;APPL1;MUSK;NGEF;MAPK14;FGF18;FLRT1;PTK2;POLR2C;CSF1;EPHA2;RARRES2;EFNA1;EFNB1;SHOC2;PLAT;TCIRG1;WASL;BDNF;ATP6V0B;POLR2F;SHC2;ALK;NCK1;FRK;ABI1;GIGYF2;NTRK3;EIF2AK3;RYK;GDF15;BAIAP2;ATP6V1E1;FLRT3;PRKD2;IGF1R;ATP6V1C1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4339554357243296,-1.1702392465465379,0.26569037656903766,0.6676213613271655,1.0,4/16,8.42%,CELF4;PUF60;SRSF1;DDX17
prerank,positive regulation of defense response (GO:0031349),0.3320689008867666,1.1697549489861139,0.20386904761904762,0.7394552493606975,1.0,16/89,11.69%,IL16;FPR2;OSM;IFI35;TLR4;ZBP1;SERPINE1;OPTN;GBP5;CD47;IL18;SETD4;WNT5A;POLR3F;TLR2;NFKBIZ
prerank,regulation of interleukin-8 production (GO:0032677),0.34485019150826324,1.1695564706155517,0.20933734939759036,0.7389737815874764,1.0,15/69,13.07%,APOA2;ANXA1;IL17D;IL6;TLR4;C5AR2;PTPN22;SERPINE1;ANXA4;NOS2;CRP;LGALS9;TLR2;MAP2K5;ARRB1
prerank,outflow tract septum morphogenesis (GO:0003148),0.43170127676105174,1.1692305001295988,0.28136200716845877,0.7389319910159924,1.0,8/24,11.51%,ROBO1;PARVA;GATA6;BMPR1A;NRP1;TGFBR2;SMAD6;SMAD4
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3507450244671191,1.1692201434146146,0.21826625386996903,0.7379505455761776,1.0,14/66,10.69%,KANK2;ADAMTS1;ANXA1;DACT1;PLK5;CCND3;APPL2;CDC73;CCL2;CDKN2B;DLG1;ANKRD17;APPL1;PTPN6
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.32483498463262683,1.168082678107311,0.19099590723055934,0.7402270673683142,1.0,40/138,15.94%,STYK1;PTN;EPHA7;PDGFRA;FGFR1;AXL;DDR2;IL31RA;IL6ST;INSRR;EPHA3;EPHA8;FRS2;FER;KIT;EFS;ROR1;EPHA1;PDGFRB;BDKRB2;NPPC;EPHA4;MTSS1;MST1R;POLR1G;MUSK;PTK2;PTPRU;CSF1;EPHA2;BDNF;SHC2;ALK;FRK;ABI1;GUCY2C;NTRK3;RYK;ACVR2B;IGF1R
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5268074904064914,1.1679938144987025,0.3013182674199623,0.739474826962102,1.0,5/10,23.89%,PCGF5;IGF2;DNMT3A;PCGF3;MECP2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5078624205676935,1.167020378366021,0.301707779886148,0.7413430905859251,1.0,4/12,11.46%,ELF1;RC3H1;PTPN22;ELF2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.40307576206973017,1.166943680833098,0.2573770491803279,0.7405714083022943,1.0,7/31,12.69%,RANBP3L;TMEM64;SKI;NOCT;SMAD6;SUFU;NOG
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5079503991790069,1.1667901716429236,0.28785046728971964,0.7400185499782642,1.0,2/11,6.96%,LEPROT;ACTN2
prerank,positive regulation of nervous system process (GO:0031646),-0.41516339756104015,-1.166456594004988,0.271889400921659,0.6771623553599526,1.0,7/18,18.02%,RIMS1;RIMS2;TENM4;TNFRSF1B;TPPP;NCMAP;DICER1
prerank,vasculogenesis (GO:0001570),0.4077148068640819,1.1662133684586966,0.2591304347826087,0.7407551497612364,1.0,7/32,8.56%,TGFBR3;CCM2;ITGB8;PDGFRB;RASA1;TGFBR2;ADM
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4406344369663245,1.1660693653648344,0.28205128205128205,0.7391475889468245,1.0,11/20,24.02%,ACADSB;BCKDHA;ACAT1;ALDH6A1;HIBADH;ACAD8;MCCC1;DBT;IVD;MCCC2;ECHS1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4406344369663245,1.1660693653648344,0.28205128205128205,0.7391475889468245,1.0,11/20,24.02%,ACADSB;BCKDHA;ACAT1;ALDH6A1;HIBADH;ACAD8;MCCC1;DBT;IVD;MCCC2;ECHS1
prerank,cholesterol homeostasis (GO:0042632),0.353803676880777,1.1659922941551781,0.24458204334365324,0.7383761643016364,1.0,10/64,12.05%,RORA;APOA2;CYP7B1;NR1H3;NPC1;IL18;LIMA1;SOAT1;DISP3;DGAT2
prerank,positive regulation of neurogenesis (GO:0050769),-0.3093416624191161,-1.165889427952263,0.17796610169491525,0.677650781724413,1.0,14/68,8.85%,SLIT2;PTPRD;ROBO2;SHANK3;PLXNA4;TIAM1;NTRK2;IL1RAPL1;OPRM1;CAPRIN2;CTNNB1;NPTN;FZD3;VEGFA
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4280978059460723,1.1653033609380958,0.2916666666666667,0.7393817274089607,1.0,5/24,5.64%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1
prerank,mitochondrion distribution (GO:0048311),0.4974064237461655,1.1652786118002625,0.29563492063492064,0.7384604034534804,1.0,5/12,11.90%,TRAK1;MEF2A;LRRK2;DNM1L;ATCAY
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4877944420999509,1.1648470139774703,0.2723735408560311,0.7386953009429191,1.0,5/13,18.79%,ENPP1;TPST1;SULT1A1;ABHD14B;SULT6B1
prerank,regulation of cell development (GO:0060284),-0.35024000180419557,-1.1647070716229568,0.21727748691099477,0.6799149173025946,1.0,14/36,20.22%,FOXO1;RPS19;CTNNB1;HDAC9;AKT1;YTHDF2;PRUNE1;GRN;HEY1;PER2;HES6;HES1;FBXO22;DLL1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.28690246391208507,1.1646824501630784,0.1276595744680851,0.7381640731765811,1.0,82/366,16.76%,EFEMP1;RORA;ATXN1;ARNT2;FOXC1;NFIA;NFYC;ZBTB4;ZNF395;DENND4A;SSBP2;ORC5;MYB;PRRX2;NUCKS1;PERM1;BMP2;PKP3;RFX3;APBB1;GZF1;TGFBR1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBL2;TCF7L1;CREBBP;NSD1;POU1F1;RNF20;ZSCAN21;NFXL1;TEAD2;ATF7;ZFP37;KAT6B;IGF2;ANKRD17;CREM;SOX21;SUFU;MAFB;MSC;PSPC1;GMNN;UBE2V1;TGFBRAP1;ESCO1;TCF7;ZNHIT3;FOXO3;ZNF219;ZFAT;OGG1;THAP1;MZF1;NR3C1;SERTAD3;HIC1;ZNF205;NCOA2;GEMIN5;DMTF1;FUS;MAPKAPK5;ORC3;CARM1;VHL;PML;SP3;ACVR2B;SOX4;POU5F1;APP;WWTR1;NFATC2;CCAR1;WTIP
prerank,regulation of phagocytosis (GO:0050764),-0.32447386127399985,-1.1646222853629358,0.1928374655647383,0.6790320614241605,1.0,13/53,10.46%,MERTK;RAB27A;GAS6;DOCK2;GATA2;SNX3;DYSF;SCARB1;SYT7;CALR;TUB;RACK1;FCER1G
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5019831765169941,-1.1645339655478268,0.2854251012145749,0.6781433865927055,1.0,2/10,2.16%,SLC2A1;ACSL3
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.47328185899515984,1.1642273189348809,0.27552986512524086,0.7385248346811639,1.0,7/16,20.13%,CREBBP;NAA16;NAA30;NAA15;KAT2B;NAA35;NAA40
prerank,peroxisome organization (GO:0007031),-0.3929680115431765,-1.1642241951852756,0.23058252427184467,0.6778901598838898,1.0,12/25,27.46%,ABCD4;TMEM135;MFF;PEX10;ABCD2;PEX16;PLAAT3;PEX19;PEX11A;PEX3;LONP2;PEX11B
prerank,oogenesis (GO:0048477),0.45881139613675115,1.1641652870824521,0.2774674115456238,0.7377053653036272,1.0,2/15,6.49%,PTN;NANOS2
prerank,vascular transport (GO:0010232),0.3364546382851879,1.1637208343709373,0.2237037037037037,0.7380212348262504,1.0,12/81,4.01%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC13A3;SLC6A13;SLC19A1;SLC6A9;SLC24A3;SLC16A2;SLC16A12;SLCO3A1
prerank,response to unfolded protein (GO:0006986),-0.33202150659730617,-1.163657469975417,0.1930835734870317,0.6783661136578533,1.0,14/48,18.94%,HSPA8;TM7SF3;DAB2IP;HSPA14;HSP90AB1;HSPE1;HSPA4;HSP90AA1;DNAJB4;TOR1B;HSPA5;HSPA4L;PACRG;STT3B
prerank,cellular component disassembly (GO:0022411),-0.3280247822401192,-1.1634992439844634,0.20105820105820105,0.6777084642586251,1.0,16/53,17.94%,BSG;TLL1;ADAM15;MMP16;SCUBE1;A2M;CTSS;MMP15;HTRA1;CTSL;CAPN1;WASHC1;CAPNS1;MMP1;LCP1;ADAM8
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.38203462727031423,-1.1634269814499187,0.22685185185185186,0.6767367117751475,1.0,7/25,16.03%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,cellular calcium ion homeostasis (GO:0006874),-0.27307530589161155,-1.1631919839480913,0.15357142857142858,0.6762963620456303,1.0,45/133,23.64%,TRPC3;ATP1B1;SLC24A2;RYR2;TPT1;HTR2C;SLC35G1;MCUB;TRPC5;TRPC4;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;TRPC6;CAMK2D;SLC30A1;CXCL12;CALR;SMDT1;SLC10A7;CAV2;CD40;TMCO1;CAV1;ATP2A2;CCDC47;CCL19;ATP13A4;MAIP1;ADCY8;HTR2B;TMEM178A;SLC8B1;HTR2A;TRPC7;CHRNA7;PTH1R;SLC24A5;ATP2B3;CLN3;CALB2;ATP13A1;STC1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4686411739422013,1.1631396986693108,0.29676258992805754,0.7388176898644959,1.0,9/16,24.80%,PARP9;PARP3;DTX3L;SHLD2;KMT5C;RIF1;KMT5B;SMCHD1;SHLD1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4683197618297778,1.1628196950907779,0.2846715328467153,0.7388215900897861,1.0,4/16,4.69%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,amino acid import across plasma membrane (GO:0089718),0.43893751766700195,1.162804819250049,0.2674825174825175,0.7378886739143594,1.0,5/24,3.88%,SLC7A2;SLC1A3;SLC6A13;SLC6A9;SLC16A2
prerank,epidermal cell differentiation (GO:0009913),0.3883319888658655,1.162492795145515,0.25042301184433163,0.7378599243215489,1.0,13/41,21.26%,GATA6;ANXA1;GLI1;CLIC4;WNT5A;EPHA2;HDAC2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.45515145436401394,-1.16219386753429,0.2729124236252546,0.678032867975373,1.0,5/13,27.01%,PIK3AP1;IRAK1;PIK3C3;TLR7;MYD88
prerank,mitochondrial genome maintenance (GO:0000002),0.5148464232142428,1.1617992087879596,0.2907662082514735,0.7388891830134252,1.0,6/11,19.98%,MPV17;MEF2A;AKT3;OPA1;SLC25A4;LONP1
prerank,sterol homeostasis (GO:0055092),0.3503820611778239,1.161764888165834,0.24617737003058104,0.7379949862365609,1.0,10/65,12.05%,RORA;APOA2;CYP7B1;NR1H3;NPC1;IL18;LIMA1;SOAT1;DISP3;DGAT2
prerank,ion homeostasis (GO:0050801),-0.36923634073052886,-1.1617018343205439,0.23167848699763594,0.6783192022612589,1.0,6/30,9.49%,SLC4A10;KLHL3;UNC80;CAMK2D;SLC12A5;NEDD4L
prerank,cellular response to osmotic stress (GO:0071470),0.43800785321057784,1.160895290570993,0.28620102214650767,0.7396196235111221,1.0,4/21,10.20%,STK39;OXSR1;SLC4A11;RCSD1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.43837718810599147,1.1599488496851416,0.2929824561403509,0.7415004658079132,1.0,10/22,23.91%,CDC73;CDK12;BRD4;THOC5;ERCC6;LEO1;CDK13;EAPP;ELL;DDX39B
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.44978245501753067,1.1599123119906585,0.2742857142857143,0.7406283678512331,1.0,3/17,5.01%,ROCK2;CDH5;VCL
prerank,transport across blood-brain barrier (GO:0150104),0.33384495837823563,1.1596205442036698,0.22023809523809523,0.7404992727895325,1.0,12/83,4.01%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC13A3;SLC6A13;SLC19A1;SLC6A9;SLC24A3;SLC16A2;SLC16A12;SLCO3A1
prerank,negative regulation of programmed cell death (GO:0043069),0.28204852187887425,1.1592412680932553,0.14761904761904762,0.7406170912298404,1.0,73/355,16.52%,PDPN;FHL2;FSTL1;ARHGAP10;KANK2;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;IL6ST;PHIP;GATA6;PRAP1;SH3RF1;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;MCL1;HAX1;SIAH2;ARF4;ANXA4;BIRC3;RASA1;CTSH;GLO1;NGFR;GSK3B;ANXA5;RIPK2;PHB2;WNT5A;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;GRK5;BCL2L1;TJP1;PTK2;NAA15;EGR3;DSTYK;RPS6KA3;API5;SUPV3L1;OPA1;CBX4;TMEM14A;BFAR;ERCC5;IFIT3;NUAK2;VHL;NIBAN2;BIRC6;HDAC2;FIGNL1;DAB2;TAF9;IGF1R;HSPA9;MGMT;OPN3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.48638773611338976,-1.1591222755692714,0.2824742268041237,0.684607585143477,1.0,3/10,9.75%,MAPK3;FAS;LYN
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.43351237789823627,1.1587801121275567,0.2743055555555556,0.74096666416957,1.0,4/23,7.09%,CBLB;SNX6;ERRFI1;MVP
prerank,negative regulation of axonogenesis (GO:0050771),-0.3849365542634823,-1.1586984036981263,0.23394495412844038,0.6847058413121732,1.0,11/27,20.76%,DIP2B;DCC;SEMA3G;FGF13;ULK1;MCF2;ARHGDIA;MAP2;EFNB3;OMG;TRIM46
prerank,response to purine-containing compound (GO:0014074),-0.42439673979863857,-1.1584943404151589,0.29017857142857145,0.6841948768938425,1.0,3/17,2.18%,TRPC3;ABCC9;RYR2
prerank,regulation of protein kinase C signaling (GO:0090036),0.48916743153436726,1.158422840399249,0.3004115226337449,0.7409934276149439,1.0,5/14,9.74%,DGKD;ADGRV1;MYADM;WNT5A;GPD1L
prerank,negative regulation of receptor internalization (GO:0002091),-0.4728543786566496,-1.1579572240674372,0.27450980392156865,0.6845557469838012,1.0,6/12,22.20%,ANKRD13A;ATXN2;SDCBP;RIN3;MTMR2;ANKRD13B
prerank,receptor-mediated endocytosis (GO:0006898),-0.27602517210047967,-1.1575963045428055,0.13442622950819672,0.6844177932036576,1.0,30/132,13.37%,DNM3;LRP1B;SGIP1;FNBP1L;INSR;TFRC;SNCA;SORL1;STAB1;HIP1R;SCARB1;AP1S1;NLGN3;LDLRAP1;ARHGAP27;LRP6;RAMP2;M6PR;CALR;SNAP91;FCER1G;CAV2;CTSL;ADRB2;SCARB2;VLDLR;SYK;HSP90AA1;CAV1;TMEM108
prerank,regulation of axon extension (GO:0030516),-0.3421897057338246,-1.1572759255785163,0.248868778280543,0.684228374556654,1.0,12/37,15.98%,DIP2B;MACF1;NRCAM;SEMA7A;SHTN1;L1CAM;SEMA3G;DBNL;ZFYVE27;SEMA3A;MAPT;MAP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.49033622072406613,-1.1571645070289258,0.29916317991631797,0.6822470598335643,1.0,4/10,13.20%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.49033622072406613,-1.1571645070289258,0.29916317991631797,0.6822470598335643,1.0,4/10,13.20%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,polyol biosynthetic process (GO:0046173),-0.43605769426052443,-1.1569942644518503,0.2811791383219955,0.6815954819931686,1.0,6/16,15.55%,ACER3;ITPKB;IP6K2;FGF2;PPIP5K2;PPIP5K1
prerank,protein autophosphorylation (GO:0046777),0.30850799509026516,1.1569932866727437,0.20135135135135135,0.7443209213632708,1.0,26/157,11.17%,PDPK1;TEC;PDGFRA;FGFR1;STK39;DDR2;OXSR1;EIF2AK2;INSRR;EPHA8;FER;KIT;DAPK1;TAOK3;AAK1;EPHA1;PDGFRB;MAP4K1;GSK3B;EPHA4;STK24;LRRK2;CDK12;MUSK;GRK5;PTK2
prerank,motile cilium assembly (GO:0044458),0.5043741528704979,1.1566122234791865,0.29245283018867924,0.7444677712224766,1.0,3/12,8.28%,SPATA6;DNAAF1;RSPH9
prerank,gene silencing by miRNA (GO:0035195),0.4019865899814077,1.1563622477142723,0.26666666666666666,0.744180755953476,1.0,12/32,21.47%,TNRC6B;SNIP1;TNRC6A;MOV10;ADAR;TARBP2;ZC3H7B;WTIP;RAN;PUM2;AJUBA;XPO5
prerank,negative regulation of developmental process (GO:0051093),-0.3070370797485403,-1.1562969915126857,0.2257142857142857,0.6824814887794893,1.0,15/69,8.44%,NOS3;GRIN3A;CST3;TFRC;NOTCH1;DCC;TBX1;KLF7;GAS6;ARHGEF15;CDK6;BMP4;BCL11A;PINK1;TBX2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.34908298139614435,-1.1562212467117794,0.22604422604422605,0.6815930920384292,1.0,8/36,5.86%,SLIT2;MEF2C;THBS1;NOTCH1;ACVRL1;PTPRM;DAB2IP;HMGB1
prerank,histone mRNA catabolic process (GO:0071044),0.474518574895499,1.1558617051167164,0.28153564899451555,0.7446283934016827,1.0,9/15,21.40%,TUT4;LSM1;DCP2;XRN1;TENT2;SSB;EXOSC10;TUT7;TENT4B
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.39901738404054443,-1.155397313310977,0.2841163310961969,0.6828343172991191,1.0,5/22,7.57%,PDE3B;APOD;ASXL3;CCDC3;CEACAM1
prerank,non-motile cilium assembly (GO:1905515),0.4064362345155585,1.1551733506731745,0.2633333333333333,0.7456504661819696,1.0,9/30,15.32%,ARL13B;IFT88;IFT57;TMEM107;CCDC13;C2CD3;RPGRIP1L;CEP250;TOGARAM1
prerank,regulation of actin filament-based process (GO:0032970),0.34491481114682127,1.1549577838734058,0.22565687789799072,0.7453004351637162,1.0,14/70,9.50%,ROCK2;ARHGAP18;DLC1;EPHA3;SMIM22;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;RHOQ;ABRACL;IQGAP2;CNN2
prerank,response to amyloid-beta (GO:1904645),0.36842968643989743,1.1545227788935317,0.2528180354267311,0.7455662475240075,1.0,9/44,8.24%,FPR2;GJA1;SNX6;TLR4;CASP4;VCAM1;NGFR;GSK3B;EPHA4
prerank,regulation of peptidase activity (GO:0052547),0.44713371193426577,1.154326157590076,0.2974910394265233,0.7451420657251219,1.0,5/19,8.89%,ECM1;CSTB;NRDC;CTSH;PSMA3
prerank,extracellular matrix disassembly (GO:0022617),-0.32724652735682846,-1.1539735704139447,0.21739130434782608,0.6857908128491524,1.0,16/53,17.94%,BSG;TLL1;ADAM15;MMP16;SCUBE1;A2M;CTSS;MMP15;HTRA1;CTSL;CAPN1;WASHC1;CAPNS1;MMP1;LCP1;ADAM8
prerank,triglyceride metabolic process (GO:0006641),0.36902124731643376,1.1538761913938946,0.2579113924050633,0.745528276241202,1.0,5/48,12.05%,AGMO;APOA2;MOGAT3;GK5;DGAT2
prerank,regulation of actin filament polymerization (GO:0030833),-0.302384363968755,-1.1535427267788576,0.20054945054945056,0.6859483539390311,1.0,26/69,21.33%,SLIT2;SSH2;ESAM;KANK3;KANK4;PTK2B;NCKAP1;HIP1R;LMOD1;CYRIB;CDC42EP3;VASP;CDC42EP1;DBNL;CDC42EP5;PAK3;EVL;TWF1;SSH3;PYCARD;ARF6;PFN2;ABITRAM;CARMIL1;HCLS1;PRKCE
prerank,pyroptosis (GO:0070269),0.46836711655010776,1.1534766550687354,0.30916030534351147,0.7457813180481376,1.0,3/15,5.51%,GSDME;ZBP1;CASP4
prerank,negative regulation of angiogenesis (GO:0016525),0.33465054327207433,1.15339592108869,0.2511415525114155,0.7450602570416627,1.0,11/84,6.08%,SULF1;COL4A3;ROCK2;CXCL10;FOXC1;THBS2;HSPG2;ADAMTS1;DCN;SERPINE1;ATP2B4
prerank,protein neddylation (GO:0045116),-0.4611404503828447,-1.15298701261622,0.2841648590021692,0.6863850233110503,1.0,8/13,36.93%,DCUN1D2;DCUN1D5;DCUN1D1;UBE2F;DCUN1D3;NEDD8;UBE2M;RBX1
prerank,sarcomere organization (GO:0045214),0.4031158453268444,1.1527078626518663,0.2651646447140381,0.7460534774630363,1.0,4/27,6.96%,CSRP3;TPM1;CSRP1;ACTN2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4504725950715742,1.1526099578146096,0.28385899814471244,0.7453896303120241,1.0,4/18,6.37%,TNFAIP8L2;MIA3;PTPN22;PPARA
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4540007877261275,1.152566448959447,0.2820976491862568,0.7445656787690453,1.0,2/17,4.00%,GJA1;TERT
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3967238487202388,1.1520825040209737,0.28205128205128205,0.7451049399930648,1.0,6/33,3.88%,MCC;NR2F2;SP100;TACSTD2;DUSP10;DCN
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.37066680298133414,-1.152000672732476,0.24475524475524477,0.6881310714156587,1.0,10/29,23.52%,RPS19;RPS8;RPS16;RPS21;RPS14;UTP6;BMS1;HEATR1;WDR46;ABT1
prerank,response to retinoic acid (GO:0032526),0.35090422083079775,1.151874839579308,0.2746031746031746,0.7447386928905129,1.0,11/59,8.47%,WNT6;WNT10B;GATA6;WNT3A;EPHA3;PTK7;RBP4;WNT5B;ZNF35;CTSH;WNT5A
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4456772022808566,-1.1518307798730476,0.2921108742004264,0.6875480694144059,1.0,5/15,13.38%,NLGN1;SYN3;STXBP1;CNTNAP4;USP46
prerank,positive regulation of heart rate (GO:0010460),-0.4182572175729583,-1.1516288830230994,0.28448275862068967,0.6870127978003086,1.0,5/17,13.61%,PDE4D;RYR2;ADRA1B;KCNQ1;ATP2A2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.44810473774255155,1.1508624540737722,0.30798479087452474,0.746805188206832,1.0,4/17,11.41%,CXCL10;FPR2;SERPINE1;ANO6
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.29440195029058613,-1.1508547145074395,0.20170454545454544,0.6882461025484795,1.0,25/75,23.01%,PTPRJ;SORL1;DAB2IP;RASIP1;SLC8A1;PRKAR1A;INPP5K;BMP4;AKT1;PAQR3;TFAP4;LRP6;HHEX;LYN;PRKAR2B;LRP5;PKIG;MEN1;PKIB;PYCARD;CDKN1C;HEXIM2;DUSP7;SPRY4;TESK1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.44379517159133897,1.1507411506147154,0.27402135231316727,0.7461748308859403,1.0,3/19,3.94%,SHMT1;SLC19A1;MTHFD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3557893307747889,-1.1504047214203927,0.2419753086419753,0.6883033617636667,1.0,11/34,11.16%,KDR;NOTCH1;MT1G;VEGFC;FLT1;GAB1;SEMA6A;DAB2IP;VEGFA;RAMP2;NUS1
prerank,response to glucagon (GO:0033762),0.44700548351898356,1.1503318134585254,0.29831144465290804,0.746407785005929,1.0,5/19,7.01%,GCGR;CRY1;ADCY5;ADCY7;ADCY1
prerank,blood circulation (GO:0008015),0.37059364378824255,1.1502060496838462,0.2677165354330709,0.7457921011744546,1.0,8/49,7.59%,COL4A3;ROCK2;CXCL10;MYOF;ADORA2A;SERPING1;BDKRB2;STAT1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3081981179501058,1.150157047323449,0.2051983584131327,0.7449700165260567,1.0,20/152,8.87%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;FPR2;AKAP12;ADORA2A;GCGR;PTHLH;GLP2R;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADGRL1;ADM;INSL3
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5207098085662885,1.149751173027526,0.31485148514851485,0.7452198851678601,1.0,5/11,18.50%,CDC73;ZC3H3;PAF1;LEO1;DHX36
prerank,negative regulation of axon extension (GO:0030517),-0.36322378071522937,-1.1496500922080202,0.25183374083129584,0.6893734930668179,1.0,10/30,12.74%,SEMA6D;DIP2B;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,response to lipopolysaccharide (GO:0032496),0.30747106420585424,1.1494461802762515,0.2188365650969529,0.7451991829730726,1.0,27/138,14.46%,SELP;CXCL10;AXL;LDOC1;VIM;FER;IL6;TLR4;PTPN22;SERPINE1;NR1H3;NOS2;CDC73;CCL2;LY96;LGALS9;CD274;WNT5A;NOCT;SMAD6;MAPK14;IRAK3;RPS6KA3;PAF1;TICAM1;TRIB1;PABPN1
prerank,vacuolar acidification (GO:0007035),-0.3906783190623458,-1.1491132925557297,0.26057906458797325,0.6896984308029721,1.0,9/21,24.53%,ATP6V0A1;DMXL2;GRN;ATP6AP2;ATP6V0A2;ATP6V0E2;ATP6V0D2;CLN3;TMEM199
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4004472790608608,-1.1488296935191842,0.25333333333333335,0.6894231875197402,1.0,6/21,11.66%,PRKCH;SLC39A10;PRKCB;LYN;RUNX1;CBFB
prerank,cell-matrix adhesion (GO:0007160),0.3335127982333985,1.148669443678038,0.23511904761904762,0.7464428469791446,1.0,18/95,9.10%,VTN;COL3A1;FN1;ADAMTS12;ECM2;DLC1;NID2;ITGB8;ITGBL1;ITGA10;SORBS1;VCL;VCAM1;THBS3;ACTN2;SIGLEC1;ITGA11;COL13A1
prerank,cardiac muscle cell development (GO:0055013),0.43703630706040164,1.148535799901533,0.2912966252220249,0.7458759188449567,1.0,4/20,6.11%,CXADR;PDGFRA;CSRP3;PDGFRB
prerank,bone morphogenesis (GO:0060349),-0.44283149975496416,-1.1482937733222716,0.2706611570247934,0.6899519681996357,1.0,5/14,13.13%,BMPR2;LRP6;SFRP4;LRP5;BMPR1B
prerank,cellular amide metabolic process (GO:0043603),0.32372964763930534,1.147862253558517,0.2325925925925926,0.7468653256214814,1.0,15/102,9.97%,SMPD3;PLPP3;PCCA;SHMT1;ACOT11;SLC19A1;MTHFD1;AEBP1;PANK2;NAAA;PCCB;BTD;ACOT9;HLCS;ACOT1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.4277622868647958,1.1477735076703737,0.3118081180811808,0.7461849166957188,1.0,4/23,10.27%,EFNB2;WNT3A;MMP14;MAPK14
prerank,glutathione biosynthetic process (GO:0006750),-0.47134050411643624,-1.1475315335260907,0.3021276595744681,0.691128202747066,1.0,6/11,31.32%,OPLAH;GCLC;GGT1;HAGH;MGST2;GCLM
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4086562433580147,1.1474928009440692,0.28622540250447226,0.7460488793035263,1.0,7/26,13.48%,ANAPC11;ESPL1;UBE2C;CUL3;NSMCE2;HECW2;CDC27
prerank,regulation of RNA metabolic process (GO:0051252),0.348019331012355,1.1473219327757334,0.23636363636363636,0.7456626730793953,1.0,19/59,18.89%,PTBP3;AHNAK;RC3H1;IGF2BP1;RASA1;OASL;CLK4;NOVA1;HNRNPH1;IGF2BP2;OAS2;HNRNPH3;PTBP2;USP36;FUS;MBNL2;AFF2;PCBP2;GRSF1
prerank,muscle tissue morphogenesis (GO:0060415),0.45480266340621434,1.147069330708786,0.2899305555555556,0.7454347476520946,1.0,3/16,4.57%,TGFBR3;BMP2;EFEMP2
prerank,histone H4-K16 acetylation (GO:0043984),0.44589427991707437,1.1467961886851252,0.27927927927927926,0.7452692507095053,1.0,1/19,0.14%,KMT2A
prerank,cellular response to calcium ion (GO:0071277),-0.30677418564508674,-1.146004451337026,0.2231638418079096,0.6943404367103783,1.0,19/67,18.71%,NLGN1;SYT1;MEF2C;PLCG2;ITPKB;RYR3;KCNH1;LGMN;CAMK2D;SYT4;SYT7;CPNE4;SYT9;SYT2;ADD1;ADCY8;HPCA;ECT2;CPNE7
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3388472424190986,1.1458483675023468,0.25675675675675674,0.7470537364383814,1.0,15/72,11.17%,FN1;SELP;PDGFRA;FGFR1;OSM;NEDD4;KIT;DCN;ROR1;HAX1;PDGFRB;IL18;PIK3R5;PTPN6;PTK2
prerank,mitotic chromosome condensation (GO:0007076),-0.3758459492530036,-1.1457981963307657,0.28672985781990523,0.6937819000880919,1.0,12/26,31.16%,MCPH1;SMC2;CHMP1A;SET;NCAPH2;NCAPH;TENT4A;TTN;CSNK2B;NCAPD2;PLK1;CDK1
prerank,regulation of interferon-alpha production (GO:0032647),0.41715762896444086,1.1457489208200744,0.2998204667863555,0.746420197015325,1.0,7/23,19.59%,TLR4;STAT1;RIPK2;IFIH1;TBK1;DHX36;SETD2
prerank,regulation of transport (GO:0051049),-0.34691773934362147,-1.1454362837871224,0.25476190476190474,0.6937560109354787,1.0,9/36,8.21%,EPB41;ICA1;ACTB;SNCA;ACTG1;MBTPS1;WWC1;REEP5;PINK1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.29714660707803275,-1.1453590947216663,0.18944099378881987,0.6928669008790953,1.0,28/75,21.15%,CTNNA2;MEF2C;CNTN4;DCC;ACTB;KLF7;ANK3;S100B;NRCAM;UNK;MAP1B;SHTN1;MINK1;DVL1;NEFH;PAX2;PAK3;MFSD2A;BRSK2;SLITRK2;MAP2;SLITRK1;CELSR2;CCK;ABITRAM;NTNG1;NTNG2;DSCAML1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.47211635537914676,1.1449548771485971,0.311787072243346,0.7476528000013511,1.0,7/15,13.47%,GLI1;CDC73;KLHL18;PHB2;CUL3;CRNN;PAF1
prerank,response to UV-B (GO:0010224),-0.45682060723465634,-1.143865736329302,0.2907949790794979,0.6959823937875287,1.0,8/12,37.30%,STK11;CDKN1A;MFAP4;HYAL3;RELA;HYAL2;CRIP1;IL12A
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.316384428189779,-1.1435042612216113,0.2346368715083799,0.6959298288248149,1.0,17/50,21.65%,SMAD7;IVNS1ABP;RPS3;AKT1;GNL3L;CAV1;CAMLG;PARK7;PER2;N4BP1;SIRT7;MINAR1;VPS28;UFL1;PRMT3;PRR7;SH3RF2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.38267240229008237,-1.1434781286079927,0.2824074074074074,0.6949071678007724,1.0,9/25,21.87%,ITGA6;THBS1;SNCA;SDCBP;EGFR;EGF;BTBD10;PTH1R;MIF
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4390691960316444,-1.1433241347103373,0.2847380410022779,0.6941891655180594,1.0,10/14,37.58%,RPS3;CD81;CARD11;RELA;BCL10;NECTIN2;IKBKG;CD226;TESPA1;LCK
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3565508775553145,-1.1432460123623676,0.2595078299776286,0.6932965660418965,1.0,13/34,15.58%,TEK;PTK2B;PIK3R1;FLT1;DAB2IP;PIK3R3;WDR81;PIK3IP1;FGF2;WASHC1;CCL19;PRKD1;NOD2
prerank,SNARE complex assembly (GO:0035493),-0.4897632759512379,-1.1431514578098136,0.301010101010101,0.6924612930681048,1.0,3/10,8.18%,SNCA;STXBP1;STXBP6
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.33939611828010174,1.1427349675119836,0.25337331334332835,0.753238089772454,1.0,14/72,13.11%,USP18;ELF1;AXL;CFLAR;ZBP1;BIRC3;PTPN2;STAT1;PIAS1;SUMO1;PTPN6;IRAK3;PTPN1;JAK1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.46562376516781534,-1.1424227454048788,0.31547619047619047,0.693489252335324,1.0,8/12,24.04%,ACTB;LAMA3;ACTG1;AHI1;ZDHHC7;VANGL2;TRAF3IP1;LAMA5
prerank,positive regulation of defense response to virus by host (GO:0002230),0.42244101726687217,1.142422542281928,0.28136200716845877,0.7531805968317771,1.0,4/24,7.59%,PARP9;PTPN22;DTX3L;STAT1
prerank,multivesicular body organization (GO:0036257),-0.36048527351631254,-1.142107334363258,0.26004728132387706,0.6932535971844684,1.0,13/31,27.49%,RAB27A;VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP7;CHMP2B;VPS28;SNF8;CHMP2A;HGS;CHMP6;CHMP4C
prerank,inositol phosphate catabolic process (GO:0071545),-0.4673883674750348,-1.1419472330818157,0.3259423503325942,0.6925915836246297,1.0,7/12,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;NUDT3;INPP5B;SYNJ1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4836996021541214,1.1418102844054776,0.28429423459244535,0.7540366607361287,1.0,1/11,1.09%,SP100
prerank,acidic amino acid transport (GO:0015800),0.4610726427781599,1.1417290726611689,0.29120879120879123,0.7533382522714058,1.0,3/17,2.24%,SLC1A3;SLC6A13;GJA1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3425274169588269,-1.1415451549855005,0.2562814070351759,0.6926959685808959,1.0,12/39,11.23%,DMD;FGF14;FGF12;HECW1;FXYD5;NETO1;UTRN;ANK3;YWHAH;CAMK2D;NEDD4L;FGF13
prerank,regulation of protein binding (GO:0043393),0.3119311219744971,1.1415085465721275,0.23994252873563218,0.7530824602375273,1.0,33/114,18.40%,TCF7L2;VTN;CFHR2;WNT3A;IFIT2;DACT1;BMP2;TERT;DTX3L;HDAC4;EFHB;SPPL3;GSK3B;RIPK2;BAX;STK3;AMFR;LRRK2;NES;TRIM21;IFIT1;HFE;LRPAP1;STK4;DAB2;APP;GOLGA2;RAN;PPP2CA;GAS8;DNAJB2;LRP1;KDM1A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2622527638445896,-1.1412895781030385,0.14615384615384616,0.6923398814120798,1.0,34/163,14.87%,PDE4D;PTPRJ;MEF2C;PDE4B;PRKCB;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;PLEKHA1;BMX;EIF2B2;CD38;PSMD14;PSMD3;LCP2;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;BCAR1;PAK3;PSMB8;SYK;PIK3CD;TNFRSF21;PSMA8;PTPRC;LAT2
prerank,protein polymerization (GO:0051258),0.34975121450929486,1.1412116780010113,0.2641509433962264,0.7530181113307048,1.0,3/55,0.81%,GAS7;ARHGAP6;DIAPH1
prerank,positive regulation of neuron differentiation (GO:0045666),0.37515116615464783,1.1411412886798733,0.26776859504132233,0.7522710677335089,1.0,6/40,5.70%,TCF4;FGFR1;NBL1;KCTD11;BMP2;CPNE1
prerank,V(D)J recombination (GO:0033151),-0.47360865957679554,-1.1411150810062143,0.3045267489711934,0.6916955426773455,1.0,4/11,18.32%,HMGB1;TCF3;DCAF1;LIG3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3197446554189358,1.1409486307504546,0.24005681818181818,0.7519407034387499,1.0,16/110,8.56%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;ADORA2A;GCGR;PTHLH;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADGRL1;ADM
prerank,regulation of neuron death (GO:1901214),-0.29039431763238704,-1.1406351833136457,0.19825072886297376,0.6920048911150704,1.0,15/82,10.51%,GRID2;MEF2C;DCC;CD34;TRIM2;MAP3K5;SNCA;SORL1;EPHB1;GRIN2B;AKT1;TNFRSF1B;UBB;SIGMAR1;DDIT4
prerank,negative regulation of inflammatory response (GO:0050728),0.3025733714548091,1.1405368712429758,0.20220082530949107,0.7521960525959055,1.0,21/182,8.87%,ENPP3;RORA;GHRH;FPR2;ADORA2A;CDH5;TNFAIP8L2;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;NR1H3;PPARA;RXFP2;PTPN2;ADCY1;RAMP1;ADM;INSL3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3873260878715089,-1.1400042416036904,0.2737556561085973,0.6927109213504091,1.0,11/23,37.54%,CADM1;PIK3R6;RAET1E;LAMP1;RASGRP1;LILRB1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.49768690479729305,1.1396644815031924,0.3062015503875969,0.7538101576047038,1.0,4/10,17.60%,GHR;STAT5B;PTPN1;STAT5A
prerank,cell-cell junction organization (GO:0045216),0.33386082220380864,1.1387319101645823,0.2514792899408284,0.7556122946663814,1.0,16/79,11.28%,SDK1;SDK2;SMAD3;CXADR;AFDN;CDH5;PKP3;PARD6A;CTNNA1;CTNND1;CLDN1;DCHS1;MYADM;CDH13;TJP1;NLGN2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3488475172801063,1.1387004503856604,0.25158227848101267,0.7547719781467326,1.0,25/61,23.89%,EYA2;EYA1;WRN;RAD50;PARP3;PDGFRB;USP9X;EYA4;SMOC2;ERCC6;PML;UIMC1;PRKD2;DHX36;BRCC3;STPG4;USP7;ERCC8;EYA3;RTEL1;SMCHD1;DHX9;CEBPG;ZCWPW1;MECP2
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4618485810732992,-1.138366959592934,0.30327868852459017,0.6964754503968239,1.0,3/12,17.72%,NOTCH1;YTHDF2;HES1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.38781123348453406,1.1380859484687706,0.29557522123893804,0.7557597307502922,1.0,8/33,15.46%,SMAD3;TEAD1;TERT;KLF5;NGFR;FOXO3;NR3C1;SMARCA4
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.32285374911713144,1.137971642983771,0.25037037037037035,0.7551259680855911,1.0,16/88,11.97%,SMAD3;SMPD3;CDH5;SYNPO2;SYNPO;BMP7;SLX4;TPR;SPIDR;GSK3B;BAX;SUMO1;SLF2;PLEK;FNIP1;RHOC
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2862033559344307,-1.13788891756579,0.1974921630094044,0.6967514406658291,1.0,27/93,15.47%,PDE4D;DMD;BCAR3;TFRC;SMAD7;PAK1;GAS6;SNCA;CAPRIN2;INPP5K;HSP90AB1;AKT1;PAQR3;RASSF2;HDAC6;PINK1;VEGFA;NOS1;RACK1;DDIT4;EGFR;NGF;HSP90AA1;CAV1;PARK7;PRKD1;IRGM
prerank,regulation of cellular localization (GO:0060341),-0.32314552507043387,-1.1376950854311687,0.2372448979591837,0.6962074210626332,1.0,19/46,20.76%,EFNA5;EPHA5;HSP90AB1;CAMK2D;WWC1;REEP5;PINK1;DYNC1H1;LYN;DVL1;FES;HSP90AA1;LRP5;BRSK2;MAP2;PPM1F;MAD1L1;SPAG5;TRIM46
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2782281531229152,1.1370723668992917,0.18331226295828065,0.7567095260855868,1.0,35/291,8.47%,RORA;ROCK2;CXCL10;PDGFRA;WNT6;PID1;AXL;IGFBP5;WNT10B;LDOC1;WNT3A;SHMT1;EPHA3;PTK7;VIM;FER;NCOA3;DAPK1;IL6;WNT5B;TLR4;TPM1;SERPINE1;ZNF35;NR1H3;ATP2B4;MPV17;CPEB1;SSH1;CDC73;CCL2;LY96;CD274;FAM210B;WNT5A
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.35507675865272625,1.1370086097672645,0.2673107890499195,0.7559638143444319,1.0,7/50,8.25%,SASH1;EIF2AK2;NFAT5;IFI35;TLR4;LGALS9;PHB2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4319854147161829,1.1369916674620668,0.3083941605839416,0.7550775786089603,1.0,6/21,16.40%,BMP6;BMPR1A;TGFBR1;SMAD4;DAB2;WWTR1
prerank,artery morphogenesis (GO:0048844),-0.35964959178690514,-1.1367187844893625,0.2602739726027397,0.6978287841231303,1.0,8/30,8.85%,TGFB2;BMPR2;NOTCH1;SMAD7;TBX1;BMP4;TBX2;VEGFA
prerank,folic acid metabolic process (GO:0046655),0.44488053056263044,1.1361724707642102,0.2885304659498208,0.7565396587094583,1.0,3/18,3.94%,SHMT1;SLC19A1;MTHFD1
prerank,regulation of protein phosphorylation (GO:0001932),0.2860657548652692,1.1361374578090973,0.20728643216080403,0.7557162758461722,1.0,43/256,13.07%,PTPN13;IGFBP3;LEPR;ROCK2;FN1;EPHA7;FGF1;PID1;PLPP3;STAT2;PHIP;FPR2;WNT3A;CDH5;FAM20A;FER;FBLN1;VEGFD;IL34;ANGPT1;BMP2;SLCO3A1;BMP7;CCND3;PLCE1;PELI2;RALBP1;NSD1;FBH1;MYADM;IGF2;LRRK2;MUSK;BRD4;FGF18;FNIP1;PTK2;TSPYL2;DVL3;CADM4;RARRES2;EFNA1;ARRB1
prerank,regulation of astrocyte differentiation (GO:0048710),0.49647105627352783,1.1358810822250862,0.2965779467680608,0.7555103595547134,1.0,5/12,12.69%,BMP2;IL6;EPHA4;SERPINE2;NOG
prerank,regulation of cellular senescence (GO:2000772),-0.3568320426862617,-1.1358152180412504,0.2751196172248804,0.6993771514444216,1.0,7/28,10.91%,YPEL3;CDK6;YBX1;RBL1;B2M;ABI3;EEF1E1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4646330470469102,1.1356931060364577,0.33663366336633666,0.755127266828935,1.0,3/14,8.39%,ACOXL;AMACR;SCP2
prerank,tyrosine metabolic process (GO:0006570),0.48967888614198696,1.1355590003678842,0.2964426877470356,0.7546324003602916,1.0,2/11,12.98%,HGD;THAP4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3116873108084544,-1.1352009994232664,0.2215909090909091,0.7000343405922168,1.0,25/60,30.49%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;ATM;NVL;FGF2;KLF4;HSP90AA1;RGCC;PNKP;PKIB;CCT5;RFC4;WRAP53;ATR;FGFR4;RFC5;RFC2;MAP3K4;CHTF18;MYC;PCNA
prerank,polarized epithelial cell differentiation (GO:0030859),0.46280088248637014,1.1350388071556117,0.3373737373737374,0.7552489349973649,1.0,2/13,5.76%,RAB10;MYO9A
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2980397167090171,1.1349587236736804,0.22015915119363394,0.7545613550306439,1.0,33/166,16.51%,RORA;RBPJ;CCN2;NOTCH2;TBL1XR1;TEAD1;NR6A1;POLR2D;NCOA6;NR1H3;PPARA;CREBBP;RARB;POLR1C;TEAD2;YAP1;CCNH;MNAT1;POLR1G;CDK7;TAF7;POLR2C;NR4A1;MAML2;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;TAF9;POLR3H;WWTR1;TBL1X
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4416580307756984,1.1343326768674493,0.31296296296296294,0.7545455451359421,1.0,7/17,19.42%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7R;IL7
prerank,cellular response to interleukin-7 (GO:0098761),0.4416580307756984,1.1343326768674493,0.31296296296296294,0.7545455451359421,1.0,7/17,19.42%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7R;IL7
prerank,cellular response to exogenous dsRNA (GO:0071360),0.49134394342490745,1.1342678017675132,0.33925049309664695,0.75381128407413,1.0,4/12,15.53%,COLEC12;IFIT1;IFIH1;MUL1
prerank,protein targeting (GO:0006605),-0.27292352022122585,-1.1339218433645244,0.1797752808988764,0.7024658178450772,1.0,39/118,23.10%,NLGN1;AKAP6;RASSF9;SORL1;AQP11;RPL11;VPS37B;GABARAP;SRP14;SDCBP;MFF;SPCS2;ZDHHC14;ZDHHC20;MFN2;ZDHHC2;GDAP1;SPCS1;TIMM8B;ZDHHC24;NACA;RABGEF1;ZFAND2B;VPS37A;PEX16;ZDHHC7;AP4S1;AIP;PEX19;SEC61A1;TOMM20;YIF1B;TIMM22;SEC61G;AP1S3;ZDHHC23;ZDHHC9;TIMM10;HAP1
prerank,actin filament organization (GO:0007015),0.305860986232267,1.133694049632653,0.2359249329758713,0.7545786154047898,1.0,29/151,14.68%,DPYSL3;CGNL1;MCU;TMOD3;SHROOM2;MYO1B;ARHGAP12;EFS;BAIAP2L1;NEBL;TPM1;RHOBTB2;RHOF;FAT1;VILL;DBN1;DSTN;DLG1;TRIOBP;RFLNA;TPM4;MYO1A;RHOC;WASL;TLE6;MYO15A;ABI1;MYO1E;MYO1C
prerank,prostanoid metabolic process (GO:0006692),0.4728028062114027,1.133401871426543,0.33271028037383177,0.7545059247685271,1.0,2/13,6.87%,PTGS1;PTGR1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4809486018642203,1.1333606459005086,0.3370165745856354,0.753701955283909,1.0,2/13,3.65%,PRICKLE1;EID2B
prerank,protein localization to cell periphery (GO:1990778),-0.2741773085197077,-1.1331391093466214,0.1827956989247312,0.7035812576674154,1.0,34/133,14.01%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;RAB3C;TMED2;LRP6;RAMP2;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;CAV1;RAB40B;F11R;EHD4;CLASP2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3300273110434923,1.1327627225966441,0.27631578947368424,0.754548458695456,1.0,11/85,7.00%,RASGRF1;AKAP13;KANK2;NOTCH2;DLC1;KANK1;DENND4A;PLCE1;SYNGAP1;STAMBP;DENND1A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.38327554396368024,1.1319465435583265,0.27666666666666667,0.755949648073802,1.0,12/34,15.07%,PTPN13;DUSP10;PTPN22;PTPN2;DUSP16;PTPN9;PTPN6;DUSP5;PTPN1;PTPN18;PTPRQ;TNS2
prerank,sprouting angiogenesis (GO:0002040),0.3610161159608289,1.1317907266103855,0.25908372827804105,0.7555254475460597,1.0,8/51,4.73%,EFNB2;ROBO1;RNF213;PARVA;NRP1;VEGFD;ANGPT1;MIA3
prerank,regulation of neuron differentiation (GO:0045664),-0.29286113686103227,-1.1313784801634255,0.22018348623853212,0.7075069112459478,1.0,16/76,7.53%,NLGN1;BRINP3;MEF2C;BRINP1;CNTN4;ZFHX3;TIAM1;BEND6;SIX1;BRINP2;MMD;NRCAM;ARHGEF2;YWHAH;TCF3;VWC2
prerank,regulation of endopeptidase activity (GO:0052548),0.34630661566070475,1.1313700106083138,0.2786377708978328,0.7558325538872498,1.0,12/59,12.46%,VTN;TIMP3;SERPING1;SERPINB7;NRDC;SERPINE1;BIRC3;TIMP2;SERPINE2;PSMA3;SERPINB8;SERPINE3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4126854216166521,1.1312945086477482,0.3049645390070922,0.7551510430686706,1.0,2/23,0.81%,ATP1A2;DIAPH1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.49167379909317127,-1.1312352413958537,0.3193612774451098,0.7068141082696731,1.0,7/10,37.07%,RNF125;GPATCH3;C1QBP;UFD1;SEC14L1;TSPAN6;TKFC
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.367832022487887,1.131024940320016,0.27526132404181186,0.7550075457066051,1.0,11/43,15.83%,SMAD3;TEAD1;NFATC4;TERT;KLF5;PPARA;NGFR;FOXO3;NR3C1;SMARCA4;POU5F1
prerank,regulation of MAP kinase activity (GO:0043405),0.31816236442244433,1.1309406697571842,0.21502209131075112,0.7543357355483463,1.0,17/92,12.68%,ROBO1;FGFR1;FGF1;KSR1;IL34;KIT;BMP7;PDGFRB;PPEF2;LRRK2;PIK3R5;MST1R;CDK12;FGF18;IRAK3;SH2B3;PTPN1
prerank,carboxylic acid transport (GO:0046942),0.35311365173785975,1.1307351884577175,0.2868217054263566,0.753997173257688,1.0,9/55,7.19%,SLC13A3;SLC6A13;SLC16A11;SLC6A9;SLC16A2;SLC16A12;SLC6A12;SLC16A5;SLC38A6
prerank,cellular response to inorganic substance (GO:0071241),-0.396958775628209,-1.1305590966239374,0.29606625258799174,0.7076100325540796,1.0,4/21,8.49%,FOXO1;KCNC2;DDX11;GUCY1B1
prerank,serine family amino acid metabolic process (GO:0009069),0.4627635909939911,1.130246172449981,0.332703213610586,0.7543994120975938,1.0,4/16,10.71%,SHMT1;MTHFD1;SEPSECS;SEPHS2
prerank,endothelial cell migration (GO:0043542),0.3769046313096027,1.1299864407572113,0.29124579124579125,0.7542281767936141,1.0,8/37,11.86%,DPP4;FSTL1;CDH5;NRP1;STAT1;CDH13;EGR3;NR4A1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4907637054881294,1.1298215526368265,0.3210633946830266,0.7538229988785298,1.0,1/10,1.09%,SP100
prerank,glucose metabolic process (GO:0006006),-0.3101110597751655,-1.1294105551981075,0.24858757062146894,0.7097566065360363,1.0,18/58,21.55%,PPARD;PGK1;APOD;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;LRP5;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.41364926791808526,1.1293781749924099,0.29313543599257885,0.7542731563838199,1.0,5/23,7.89%,AXL;TLR4;FOXP3;LGALS9;CD274
prerank,regulation of receptor binding (GO:1900120),-0.4699706146203748,-1.1291354933667817,0.32040816326530613,0.7094835373083725,1.0,4/10,13.61%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,axon extension (GO:0048675),0.4110966824511373,1.12840230242119,0.31478260869565217,0.7562313681491184,1.0,6/23,11.84%,ALCAM;AUTS2;NRP1;USP9X;PPP3CB;SPG11
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.33714313196619866,1.1283297606033265,0.25709779179810727,0.7555286873306744,1.0,11/70,10.29%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,sensory perception of light stimulus (GO:0050953),0.32583542763700646,1.1282661049068692,0.26120556414219476,0.7548031939200689,1.0,14/87,13.05%,EFEMP1;RDH10;ZIC2;ADGRV1;MYO9A;TULP2;COL18A1;CRYBB3;IMPG2;EYA4;ATXN7;CRYBA1;OPA1;EML2
prerank,cellular response to chemical stress (GO:0062197),-0.28140865435728135,-1.1281637380273788,0.22018348623853212,0.7113096554231336,1.0,22/96,15.29%,FOXO1;PRR5L;SETX;SNCA;CPEB2;MSRA;NCF2;CHCHD2;PINK1;NUDT2;FAS;ATM;ATF4;CAV1;PYROXD1;CYBB;PPIA;PARK7;SOD1;ERO1A;PRKD1;PYCR2
prerank,hemidesmosome assembly (GO:0031581),-0.4723550846279366,-1.1276427458712872,0.29411764705882354,0.7117211951453181,1.0,3/11,4.11%,ITGA6;ITGB4;LAMA3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.36759640140414634,-1.127452798042377,0.26879271070615035,0.711145931956727,1.0,8/25,19.92%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2790353616495022,1.1273668889052668,0.21105527638190955,0.7565266392778648,1.0,30/308,6.13%,PDPN;SOX5;LEPR;PTN;FOXD1;SMAD3;GHR;SMURF2;EIF2AK2;FOXC1;GHRH;GJA1;BMPR1A;GLIPR2;NCOA3;PLA2R1;ALMS1;TGFB1I1;BMP2;RFX3;TERT;IL6;BMP1;EPAS1;TGFBR1;UCN;ACSL1;SERPINE1;APPL2;BCL9L
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.43252892758741646,1.1272791206103283,0.31746031746031744,0.7558656720007687,1.0,5/20,11.93%,GRK3;CRY1;MGRN1;PLEK;RPGRIP1L
prerank,microtubule anchoring at centrosome (GO:0034454),0.5146616113994447,1.1270818301651664,0.33400402414486924,0.7555595285751868,1.0,2/10,10.29%,NINL;NIN
prerank,steroid biosynthetic process (GO:0006694),0.34634518379278545,1.126555550607387,0.2794348508634223,0.7562197590418269,1.0,12/56,15.36%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;LBR;CH25H;STAR;OSBPL9
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4897080098950258,-1.1263646074502482,0.3201581027667984,0.7131197769612883,1.0,2/10,7.57%,PRKG1;CEACAM1
prerank,organophosphate ester transport (GO:0015748),-0.3811439407777281,-1.126248226919514,0.29064039408866993,0.7123745710557741,1.0,6/24,8.19%,PITPNC1;PITPNA;ABCA3;SCARB1;PRELID2;PRELID1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.44306345993609003,-1.1259963394506343,0.3158995815899582,0.7120857591293124,1.0,10/13,54.86%,ADRA1B;CAV1;SMTNL2;ADRA1A;ADRA1D;TRPM4;OXTR;SMTNL1;AVPR1A;F2R
prerank,cyclooxygenase pathway (GO:0019371),0.49444910259050173,1.1254671111630048,0.30393996247654786,0.7583541563657623,1.0,4/10,22.64%,PTGS1;PTGES2;PTGS2;PTGES3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.39126395046429535,-1.125453776035049,0.30752688172043013,0.7124897995147979,1.0,9/23,24.81%,UBB;COPS6;UBA52;COPS5;COPS2;GPS1;COPS4;DDB2;RAD23B
prerank,icosanoid biosynthetic process (GO:0046456),0.5086655251316217,1.1253698955062248,0.3173076923076923,0.757745103171415,1.0,1/10,1.37%,PLA2G4A
prerank,cardiac muscle cell differentiation (GO:0055007),0.4251164669159786,1.1251653639363923,0.32326820603907636,0.7573965503174818,1.0,3/21,3.96%,AKAP13;CXADR;BMP2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4783735475728807,1.1251189731752573,0.31620553359683795,0.7566387448347426,1.0,3/12,7.50%,NUPR1;IL6;IL18
prerank,negative regulation of complement activation (GO:0045916),0.5108889217610677,1.125020002265964,0.32490272373540857,0.7560096447186074,1.0,2/10,2.94%,CD55;SERPING1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.31630139158064097,-1.1248514909086593,0.25831202046035806,0.7131008236607542,1.0,19/53,26.35%,PSMC3;DAB2IP;HSP90AB1;RAD23A;PSMD14;UBB;PINK1;XPO1;TMTC3;GNA12;FOXF2;PSME1;UBQLN4;PSMC6;UFL1;PSMC5;RAD23B;TREM2;F8A1
prerank,translational elongation (GO:0006414),-0.2802966691324028,-1.12462925028745,0.20064724919093851,0.7126704747549762,1.0,49/101,36.95%,EEF1G;EEF1A1;GTPBP1;MRPL4;EEF2;GFM1;MRPS18A;RACK1;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;LTN1;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;EEF1D;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;EEF1B2;MRPL37;ERAL1;EEF2K;MRPL45;MRPL30;GTPBP2;MRPS24
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3727237177468845,1.1243900159642402,0.2900505902192243,0.7568617369436517,1.0,10/40,13.40%,PID1;BCL2;STOX1;SLC4A11;OPRD1;BAX;HEBP2;LRRK2;BCL2L1;BCO2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.31860039610289076,-1.1239463211314484,0.25066666666666665,0.713537268671272,1.0,6/48,9.13%,PDE4D;PDE4B;SLC7A5;IL1R1;CYRIB;ZFPM1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.38906228581140867,-1.1235400791404544,0.2747747747747748,0.7136335880523529,1.0,6/21,4.28%,LIMCH1;EFNA5;PEAK1;GPM6B;MACF1;ACTG1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.40816183091533415,-1.12348467837099,0.30885529157667385,0.7127058215467454,1.0,8/18,14.62%,NOS3;TGFB2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,synaptic vesicle recycling (GO:0036465),-0.34872232507500783,-1.1233088688528263,0.2878411910669975,0.7121346626691367,1.0,6/31,8.74%,NLGN1;SYT1;AMPH;SNCA;SYT7;NLGN3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.44011946700093424,1.1232002539237818,0.3392857142857143,0.759364749289924,1.0,4/17,18.72%,PLA2G4A;PLA2G4C;LPGAT1;PLA2G5
prerank,relaxation of cardiac muscle (GO:0055119),-0.44027453230417474,-1.122963135158363,0.30042918454935624,0.712040410653555,1.0,5/13,7.24%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.46802641438046566,-1.1229367691369962,0.3326133909287257,0.7110365472741403,1.0,2/11,2.33%,FOXO1;NOTCH1
prerank,regulation of plasminogen activation (GO:0010755),0.4855459282470991,1.1222853429066888,0.3263598326359833,0.7610559258636365,1.0,4/12,11.00%,CLEC3B;SERPINE1;SERPINE2;PLGRKT
prerank,protein localization to cilium (GO:0061512),0.3859106369246208,1.122207107985669,0.3006872852233677,0.7604119602198642,1.0,10/32,20.39%,INVS;ARL3;ODAD4;TMEM107;TULP2;WDR19;IFT20;TTC21B;ARL6;TULP1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.400238947484436,1.1221008656110596,0.3163444639718805,0.7598016225296662,1.0,9/27,15.07%,PID1;ENPP1;KANK1;PRKCZ;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,positive regulation of gene expression (GO:0010628),0.27020492886637654,1.1220723853481258,0.18937644341801385,0.7589864960093838,1.0,56/442,11.15%,ROBO1;BMP6;FOXD1;ROCK2;SMAD3;RBPJ;RBMS3;FN1;PLD1;AFDN;WNT6;FGF1;PID1;TLE1;SAMD4A;OSR1;EIF2AK2;WNT3A;GJA1;VIM;CDH5;ITGB8;GCGR;PLA2R1;SLC26A9;TNRC6B;SLC24A3;ANGPT1;BMP2;PKP3;IL6;TLR4;BMP7;STOX1;PTPN22;TGFBR1;CRP;CTSH;POLR1C;PDCD5;GSK3B;LGALS9;BAZ1B;TNRC6A;WNT5A;YAP1;DTNBP1;MOV10;POLR1G;MUSK;FUBP1;MAPK14;CUX2;FGF18;TLR2;LRP3
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4105934896351054,1.1218296365552447,0.3142361111111111,0.7587786260604277,1.0,5/25,9.40%,CXADR;PARVA;ITGA5;VCAM1;DSC2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4775469604765361,-1.1213533072459287,0.31610337972166996,0.7145004092583223,1.0,4/10,25.23%,CALM1;CALM3;GPR35;CBARP
prerank,cell junction maintenance (GO:0034331),0.4623009509905503,1.1213057153284693,0.34074074074074073,0.7594376257550247,1.0,4/14,11.28%,PARD6A;CLDN1;MYADM;NLGN2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.426104344363865,1.1211838609494915,0.2987249544626594,0.7588837942857699,1.0,4/21,4.70%,ROCK2;ENPP1;ECM1;BCOR
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3604119887564132,-1.1202172566543798,0.30424528301886794,0.7166467767721946,1.0,16/28,30.57%,STMN2;MAP1B;PRUNE1;CLASP2;MAPT;MAP2;SKA2;STMN4;STMN1;FKBP4;GAS2L1;ARL2;MAPRE1;SKA3;STMN3;CAMSAP1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3734779508587766,-1.1200574291412144,0.3031674208144796,0.7160133907567712,1.0,5/24,8.21%,PTK2B;CTSC;PSMD14;UBB;PINK1
prerank,neuron migration (GO:0001764),-0.3167292369232802,-1.119671094896749,0.26666666666666666,0.7160846606691433,1.0,19/48,14.20%,ADGRL3;MEF2C;GPM6A;NTRK2;NRCAM;NDNF;RAPGEF2;ASTN1;ASTN2;MAP1B;VEGFA;SPOCK1;DNER;DDIT4;FGF13;MARK1;SEMA3A;RAC1;RELN
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.45060247607289033,-1.1196167506796149,0.33131313131313134,0.715167456211547,1.0,2/12,8.51%,STARD3NL;FDXR
prerank,bile acid biosynthetic process (GO:0006699),0.4034072668150972,1.1191700678563323,0.31448763250883394,0.7636234739341635,1.0,7/24,15.36%,CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9
prerank,organophosphate catabolic process (GO:0046434),0.48943751486766085,1.1190457311798427,0.34774436090225563,0.7630694718050993,1.0,2/11,10.74%,APOA2;ENPP2
prerank,positive regulation of angiogenesis (GO:0045766),0.3107006777266044,1.1183094510983667,0.24561403508771928,0.7643040290848969,1.0,20/108,11.07%,PDPK1;SASH1;FGF1;ECM1;GATA6;FOXC2;CDH5;ITGB8;ITGA5;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;JMJD8;WNT5A;ADAM12;FGF18;TJP1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.45650150858916516,1.1179736898611043,0.31640625,0.7643800567628246,1.0,6/15,19.93%,LARGE1;MGAT3;AMDHD2;EXTL2;NAGK;CHST3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.41809794248553533,1.1179641539338974,0.3212996389891697,0.7635274606972252,1.0,6/23,12.54%,ENPP1;GLI3;MGRN1;GLIS2;SUFU;BTRC
prerank,negative regulation of JUN kinase activity (GO:0043508),0.49751220199681156,1.1179284552738804,0.3448275862068966,0.7627550684042291,1.0,3/10,10.35%,DUSP10;PTPN22;HIPK3
prerank,positive regulation of viral genome replication (GO:0045070),0.3895655164185484,1.117495432099406,0.30335097001763667,0.763085149739013,1.0,10/29,15.71%,TOP2B;PPARA;STAU1;PPID;TMEM39A;ADAR;IFIT1;SRPK1;TARBP2;PKN2
prerank,peptidyl-amino acid modification (GO:0018193),0.5185223710017781,1.1174089809417251,0.35412474849094566,0.7624440004347409,1.0,4/10,21.68%,APOA2;PDF;TTLL4;METAP2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.42664459780424385,-1.117058984256758,0.32532751091703055,0.7213414138513252,1.0,6/14,20.10%,CPEB2;PKM;UNK;CNBP;CPEB4;RBM24
prerank,regulation of catabolic process (GO:0009894),-0.409166052320449,-1.1170311177658,0.315450643776824,0.7203511342974616,1.0,11/18,33.35%,FAP;NEDD4L;ZDHHC2;ZDHHC7;HPGD;SNF8;HGS;CHMP6;FAM83D;MDM2;FURIN
prerank,positive regulation of neuron projection development (GO:0010976),-0.28656182306892053,-1.116852203723938,0.22847682119205298,0.7197508700796041,1.0,25/85,12.44%,ITGA6;LRRC7;TENM3;PTK2B;RIT2;FUT9;NTRK2;SETX;SERPINI1;TOX;DAB2IP;CAPRIN2;SNX3;STMN2;NDNF;NPTN;RAPGEF2;LRP8;NDRG4;LYN;DBNL;RET;SCARB2;FES;VLDLR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.48367159598556075,1.1167819092903186,0.3373015873015873,0.7625067636148164,1.0,3/12,3.11%,TACSTD2;KANK1;FBLN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.48367159598556075,1.1167819092903186,0.3373015873015873,0.7625067636148164,1.0,3/12,3.11%,TACSTD2;KANK1;FBLN1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.3521005399522136,-1.1161214371374868,0.2553191489361702,0.7207060051043224,1.0,7/30,16.03%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,neurotrophin signaling pathway (GO:0038179),-0.3826126379989604,-1.1161187878837082,0.31666666666666665,0.7196411523301606,1.0,9/21,16.45%,NTRK2;RAPGEF2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1;RAP1A;NTF3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4593688543782376,-1.1156723851149588,0.3452631578947368,0.7198321650929453,1.0,5/11,20.91%,ST18;FAS;PLAUR;PARK7;PRR7
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.49429448951306737,1.115552060234472,0.35845213849287166,0.7650899407536857,1.0,2/12,10.29%,NINL;NIN
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.33533937354851734,-1.1154510929763095,0.2824427480916031,0.7194140544706552,1.0,11/36,19.63%,AQP11;RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;CAMLG;PARK7;N4BP1;EIF3H
prerank,sensory perception of smell (GO:0007608),0.48808827891147905,1.1152659824623652,0.36742424242424243,0.7650292581803995,1.0,1/11,2.32%,BEST2
prerank,T cell migration (GO:0072678),0.45771223849026166,1.1151803185396183,0.32947976878612717,0.764374941268006,1.0,2/13,1.76%,CXCL10;CXCL16
prerank,positive regulation of axonogenesis (GO:0050772),0.35727474841466417,1.1148772171184427,0.29079159935379645,0.7643107269159459,1.0,7/43,7.53%,PLXNA2;ROBO1;TIAM2;NTN1;MAP6;DBN1;NGFR
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.47510726179607377,1.114824021615682,0.36328125,0.7636071258763277,1.0,4/12,11.99%,NEDD4;PTPN14;TPR;IFI27
prerank,platelet degranulation (GO:0002576),-0.2719551398344869,-1.1148177390240523,0.21311475409836064,0.7201313677890213,1.0,23/118,10.88%,PCDH7;ABCC4;VWF;PECAM1;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;SCG3;CALM1;GAS6;STXBP1;CYRIB;CDC37L1;RAB27B;A2M;VEGFA;TGFB3;CHID1;LYN;FAM3C;MANF
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.45054462083194574,1.1145831478667505,0.33269961977186313,0.7633847994970024,1.0,5/15,18.00%,CD55;GLI3;IHH;IL23R;HSPH1
prerank,ether lipid biosynthetic process (GO:0008611),0.5126860939992689,1.114330156904049,0.3333333333333333,0.7632805214820527,1.0,2/10,6.30%,PLA2G4A;PLA2G4C
prerank,mitotic cytokinesis (GO:0000281),0.353945738818388,1.1141948543544138,0.30845771144278605,0.7627784247866806,1.0,9/47,8.98%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;KLHDC8B;SNX9;ESPL1;USP8
prerank,acylglycerol catabolic process (GO:0046464),-0.35235752496208567,-1.1140770956204826,0.2668213457076566,0.7211644513092802,1.0,10/30,28.38%,MGLL;ABHD2;LIPE;ABHD6;LPL;PNPLA3;FAAH;LIPH;FABP3;LIPC
prerank,protein-containing complex assembly (GO:0065003),0.28038919971067566,1.1140201727171857,0.23735408560311283,0.7624327193668947,1.0,53/259,16.53%,TCF7L2;KMT2A;MCU;LAMC1;FN1;AFDN;TLE1;TEAD1;TGFA;TERT;TLE3;SEC23A;ST13;BCL9L;TCF7L1;CREBBP;SEC24D;CLDN1;CDC73;GSK3B;SNX9;RSPH9;TEAD2;YAP1;TAPBP;MNAT1;LRRK2;TUBGCP4;FBXL7;PPID;DNM1L;PPP6R3;ANO6;TCF7;CUL3;WDR19;SEC24C;HFE;SCFD1;OPA1;TUBGCP2;WASL;WASF1;MDM4;LEO1;GEMIN5;PML;SEC24B;SMARCA4;GOLGA2;PYGO1;AXIN2;SH3PXD2B
prerank,negative chemotaxis (GO:0050919),0.3868559505030884,1.1138469962822317,0.3149078726968174,0.7620152901607525,1.0,5/33,6.28%,ROBO1;SEMA3D;EPHA7;NTN1;SEMA4B
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3228955666723231,1.1136514788823562,0.26461538461538464,0.7616890723055355,1.0,15/78,10.73%,PDPK1;PID1;SPTBN1;EPHA3;NUMB;SORBS1;MMP14;ATP2B4;PTPN9;KIF5B;RHOQ;DLG1;STX8;APPL1;BCL2L1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4448608665146065,1.1136115658143564,0.33454545454545453,0.7609295102015549,1.0,1/16,0.36%,LEPROT
prerank,positive regulation of interferon-beta production (GO:0032728),0.38980187562413926,1.1134711033169542,0.3316239316239316,0.7604607386720429,1.0,13/33,24.28%,TRIM56;TLR4;RIPK2;POLR3F;TLR2;OAS2;IFIH1;TBK1;RNF135;RIOK3;DHX9;TOMM70;POLR3B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4457127655566413,1.1134049538628898,0.3242753623188406,0.7597775926573467,1.0,6/17,15.74%,PTN;IL34;BMP2;SERPINE2;EGR2;CXCR4
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.4804421396020465,1.1133155782477517,0.3448940269749518,0.7591558972172952,1.0,3/12,4.44%,DOCK11;NOTCH2;IL6
prerank,B cell activation (GO:0042113),-0.29368493072902996,-1.1133115132114804,0.2515151515151515,0.7222829911976308,1.0,19/68,17.66%,PTPRJ;MEF2C;PRKCB;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;MALT1;CD86;CD40;PIK3CD;DCAF1;PTPRC;LAT2;CLCF1;RABL3;CHRNA4
prerank,regulation of protein modification process (GO:0031399),0.3487476487570166,1.113179390571613,0.2988691437802908,0.7586464111820225,1.0,17/50,18.72%,FN1;STAT2;PHIP;CDH5;FER;IGF2;PPP1R16A;FNIP1;PTK2;CADM4;PML;KAT2B;NDUFS4;PPP2CA;ATG10;PLXNB2;FKTN
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3022166227048788,1.1130812548946052,0.2719665271966527,0.7580340454029036,1.0,22/136,13.07%,TCF7L2;SP100;NUPR1;MTURN;TCEAL7;BMP7;FOXP3;ANXA4;HDAC4;GLIS2;PARP10;PHB2;SUMO1;SUFU;WWP2;KEAP1;HEYL;IRAK3;MAP2K5;TRIM21;BTRC;ARRB1
prerank,regulation of nuclear division (GO:0051783),-0.39080463695891543,-1.113057533979307,0.30184331797235026,0.7219460175903484,1.0,12/20,39.62%,BORA;CAV2;CCDC8;L3MBTL1;PRMT5;MKI67;KIF20B;CUL9;DAPK3;PIN1;PDXP;CDC25C
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.381367409733145,1.1127391004557519,0.3151618398637138,0.7582046464018275,1.0,3/32,4.20%,PDPK1;CXCL10;F2RL3
prerank,"wound healing, spreading of cells (GO:0044319)",0.41202877525485054,1.1125019359318011,0.3339041095890411,0.7580005242561028,1.0,3/24,5.81%,PDPN;ITGA5;COL5A1
prerank,relaxation of muscle (GO:0090075),-0.43895770253564603,-1.1124242889724418,0.31453362255965295,0.7226888393063939,1.0,5/13,7.24%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3713465322703,-1.1116362176001304,0.3161764705882353,0.7238852752178092,1.0,10/24,12.74%,SEMA6D;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;VEGFA;SEMA3G;SEMA6B;SEMA3A
prerank,positive regulation of autophagy (GO:0010508),0.3213847315686935,1.110909737529031,0.28444444444444444,0.761647416344723,1.0,19/81,14.55%,RNF152;PRKAA2;DAPK1;DCN;MTDH;OPTN;TRIM5;PIK3C2A;GSK3B;WAC;PHB2;LRRK2;TPCN1;SESN1;FOXO3;MAP3K7;TRIM21;TICAM1;TBK1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4284854533442681,1.1107150368144645,0.3288973384030418,0.7613374102548083,1.0,6/20,17.11%,SULF1;DSTYK;NOG;SMOC2;PRKD2;GPC1
prerank,DNA biosynthetic process (GO:0071897),0.4505986043995831,1.1103737376987566,0.33213644524236985,0.7614925176734832,1.0,3/16,4.22%,POLH;TERT;WRN
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.46858323582441075,-1.1102629573152984,0.3404669260700389,0.7268729289349278,1.0,5/10,20.95%,ESR1;PSMC3;HMGB1;PSMC6;PSMC5
prerank,neuromuscular junction development (GO:0007528),0.4034975519435092,1.1100821924816795,0.31141868512110726,0.7614318187806383,1.0,6/24,9.85%,PDZRN3;NEDD4;UNC13B;LRP4;LRRK2;MUSK
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.45981739886450523,1.1096950348905246,0.35445544554455444,0.7616413734225763,1.0,2/13,4.44%,NFAT5;IL6
prerank,sterol metabolic process (GO:0016125),0.3413249964536187,1.1092920085462439,0.2859399684044234,0.7619140723598165,1.0,10/60,12.77%,PRKAG2;APOA2;CYP7B1;APOF;CYP27A1;INSIG2;SOAT1;LBR;CH25H;OSBPL5
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3417540289366962,1.1088129714650654,0.28753993610223644,0.7624469067521752,1.0,8/59,12.53%,ALDH1A2;CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;ABCD3;CH25H
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3354240713538979,1.1087339927188236,0.2988871224165342,0.7618218216221517,1.0,11/70,5.98%,ATRNL1;LAMC1;FN1;RADIL;PARVA;NRP1;FER;ARL13B;ANTXR1;LAMC3;EPHA1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3120790555274255,1.108451027302627,0.2704309063893016,0.7617534419901862,1.0,16/105,12.41%,ENPP3;RORA;FPR2;CASK;CDH5;TNFAIP8L2;SERPINE1;NR1H3;PPARA;PTPN2;EPHA4;PPM1B;IRAK3;EPPK1;TRIM21;CD109
prerank,protein O-linked mannosylation (GO:0035269),0.43676260515072174,1.108034239630271,0.35687732342007433,0.7620499107102581,1.0,5/18,7.26%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3982322662460033,1.1078987630774617,0.3327338129496403,0.7615691505208675,1.0,6/25,11.72%,FBXL17;ZYG11B;POMT2;KLHL15;UGGT2;CUL3
prerank,regulation of intracellular pH (GO:0051453),-0.3496816062226078,-1.107887958495092,0.31017369727047145,0.7325573813793064,1.0,8/34,14.68%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC4A7;SLC9A5
prerank,positive regulation of vasculature development (GO:1904018),0.31237131503577614,1.1077599036100172,0.2663755458515284,0.7611406672694054,1.0,15/94,9.37%,PDPK1;SASH1;FGF1;ECM1;GATA6;CDH5;ITGB8;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;WNT5A;ADAM12
prerank,negative regulation of innate immune response (GO:0045824),0.3781654125882424,1.1076545271244842,0.29790660225442833,0.7605792829515933,1.0,9/34,17.65%,USP18;STAT2;SERPING1;PTPN2;IRAK3;TRIM21;MUL1;FAM3A;USP15
prerank,negative regulation of response to wounding (GO:1903035),0.4301462855800531,1.107355435209377,0.34150943396226413,0.7605735402574985,1.0,5/19,12.41%,CASK;SERPINE1;EPHA4;EPPK1;CD109
prerank,heart morphogenesis (GO:0003007),0.350414878246518,1.1072503867575447,0.3088235294117647,0.760002089397678,1.0,6/50,5.16%,FLRT2;TGFBR3;DLC1;BMPR1A;BMP2;TGFBR1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3749756893860671,1.106299546312384,0.3282051282051282,0.7618538893070529,1.0,6/37,4.92%,IGFBP5;GJA1;BMPR1A;ADAMTS1;EFEMP2;TPM1
prerank,cholesterol biosynthetic process (GO:0006695),-0.3506077481997985,-1.106118823316037,0.3056234718826406,0.7366202344876039,1.0,14/31,32.03%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;SC5D;HSD17B7;DHCR7;LSS;MVD;MSMO1;DHCR24;IDI1;PLPP6
prerank,lipid modification (GO:0030258),-0.3394676853960222,-1.1059081712089582,0.30606860158311344,0.7361927283023122,1.0,13/37,18.89%,DGKB;DGKI;DGKH;PLPPR1;PLPP5;DGKZ;MBOAT1;DGKG;PLPP1;PLPPR2;MBOAT7;SGPP1;PLPPR5
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2840251126427327,1.1058585758390955,0.25326370757180156,0.7622227025188049,1.0,42/214,15.95%,TGFBR3;CCN2;FN1;EPHA7;PDGFRA;NOTCH2;FPR2;MTURN;TIMP3;GLIPR2;NRP1;FBLN1;DUSP10;ANGPT1;BMP2;ROR1;TLR4;PRKCZ;PTPN22;PDGFRB;PTPN2;CCL2;ACKR3;LGALS9;PHB2;DLG1;PTPN6;SMAD4;DSTYK;P2RY6;EPHA2;PTPN1;MAP2K1;ARRB1;ZDHHC17;P2RY1;CCL25;PTPRR;NTRK3;PRKD2;APP;ICAM1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.47217045645527467,-1.1053497348514698,0.3346613545816733,0.7367377750360066,1.0,6/10,28.28%,PDE8A;PARK7;GPR37;STK26;GPR37L1;PYCR1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.32160998180325884,1.105270119317086,0.27518796992481204,0.7630030282248308,1.0,16/79,12.69%,SULF1;ADAMTS12;SMURF2;BMPR1A;FSTL3;NBL1;CASK;NEDD4;BMP2;ATP2B4;SKI;SMAD6;SMAD4;CADM4;PTPN1;NOG
prerank,dopaminergic neuron differentiation (GO:0071542),-0.3955196560544101,-1.1052629937550789,0.3150684931506849,0.7359182709651755,1.0,4/19,10.88%,CTNNB1;VEGFA;LRP6;MANF
prerank,regulation of cell adhesion (GO:0030155),-0.2630817526619111,-1.1051165562132141,0.23344947735191637,0.735277105063668,1.0,28/129,12.92%,FRMD5;PTPRJ;PLXNA4;EFNA5;PDE3B;PTK2B;ZFHX3;CYTH1;STX3;PPP2R1A;ACVRL1;SEMA4D;TGFBI;ADGRG1;ADAM22;YTHDF2;ARHGDIB;VEGFA;CXCL12;LYN;PRKX;MINK1;ATM;ZDHHC2;RET;FES;ARHGDIA;EPB41L4B
prerank,lamellipodium assembly (GO:0030032),-0.3653143470764645,-1.104988352224956,0.33489461358313816,0.7345447035447487,1.0,8/26,13.66%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,response to peptide (GO:1901652),0.37371925758310315,1.1047755971495388,0.32521739130434785,0.7635243419007101,1.0,6/33,11.53%,STAT2;ANXA1;STAT5B;STAT1;EIF2B3;STAT4
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.438606679941481,-1.1046773933225424,0.31020408163265306,0.7343632354781338,1.0,8/13,21.71%,RPL26;SPRED2;ATM;EEF1E1;SPRED3;SPRED1;MSX1;ATR
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4744361173764465,-1.1042941735399074,0.3600867678958785,0.7343679580328004,1.0,9/10,43.97%,RCC2;ECT2;KNSTRN;SPAG5;RACGAP1;CCNB1;CDC42;NEK2;APC
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4187501323055988,-1.1041029230386277,0.3411214953271028,0.733820967900398,1.0,5/17,2.33%,SLIT2;ROBO2;NOS3;TGFB2;NOTCH1
prerank,RNA biosynthetic process (GO:0032774),0.38189404679142896,1.1040017785437823,0.31683168316831684,0.7648457430123098,1.0,5/31,10.12%,TERT;NCOA6;POLA2;PRIM2;TAF7
prerank,response to chemokine (GO:1990868),0.46447919331895515,1.1037813774392804,0.3539325842696629,0.7645991121534724,1.0,3/13,1.80%,STK39;OXSR1;FOXC1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.42137342406726086,1.1037658976445237,0.3441682600382409,0.7638175292551298,1.0,6/20,18.04%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1
prerank,regulation of axon guidance (GO:1902667),0.4963057848515571,1.1035340495631143,0.3574144486692015,0.7636317688728881,1.0,2/10,4.85%,NRP1;MYCBP2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.36458999945597403,-1.1032060308666154,0.3161290322580645,0.7353224029885567,1.0,9/26,16.37%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;PARK7;CDH3;HTR2B
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2657513661293328,-1.1029573884959116,0.2222222222222222,0.734963455055267,1.0,27/119,13.42%,PIP5K1B;INPP4B;EFR3B;PLCG2;ITPKB;INPP5D;PIK3R1;PIK3R6;MTMR6;PLEKHA1;PIK3C2B;BMX;PIK3R3;INPP5K;MPPE1;MTMR12;IP6K2;PIGM;PIGU;PI4K2A;IMPA1;FGF2;PIGQ;PIGH;DPM2;PIK3CD;CDIPT
prerank,regulation of phosphorylation (GO:0042325),0.30529362704035284,1.1027125995414828,0.2838983050847458,0.7650998992479118,1.0,26/120,17.01%,FN1;PRKAG2;STAT2;PHIP;DYNLL1;CDH5;NRP1;FER;LDB2;BMP7;RANBP2;TPR;JMJD8;CDKN2B;FNIP1;PTK2;CADM4;POM121;KCTD20;PML;ILK;APP;INHA;NUP37;NDUFS4;PPP2CA
prerank,regulation of cellular component size (GO:0032535),-0.34238806560086305,-1.1021769556389367,0.33171912832929784,0.7361343833714459,1.0,12/30,27.46%,EPS8;RAP1GAP2;PPP1CA;VAV1;RAC1;RIN3;PEX11A;PPP1R15A;RAB3B;LAMTOR4;AP2M1;PEX11B
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.35762113720980837,1.1021765348863108,0.29797191887675506,0.7657239357854368,1.0,7/43,7.09%,CBLB;SNX6;TGFA;ERRFI1;PTPN3;PTPN2;MVP
prerank,cAMP biosynthetic process (GO:0006171),0.4827828245236333,1.1020849398202925,0.34782608695652173,0.7651183314827688,1.0,3/10,7.01%,ADCY5;ADCY7;ADCY1
prerank,pigment granule transport (GO:0051904),-0.3916018398647505,-1.10175652003459,0.3282275711159737,0.7351916265282371,1.0,12/18,41.98%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,melanosome transport (GO:0032402),-0.3916018398647505,-1.10175652003459,0.3282275711159737,0.7351916265282371,1.0,12/18,41.98%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.451373410999777,1.1017132853043394,0.34944237918215615,0.765302715608868,1.0,1/15,0.80%,MOXD1
prerank,renal filtration (GO:0097205),0.49849566011199503,1.101519286835847,0.36553030303030304,0.7649804081064802,1.0,1/10,0.15%,SULF1
prerank,regulation of mitochondrion organization (GO:0010821),0.35299856532601354,1.1014069797948023,0.3203252032520325,0.7644545877858293,1.0,16/47,21.76%,PID1;STAT2;STOX1;HAX1;GSK3B;LRRK2;DNM1L;USP36;CSNK2A2;MUL1;RHOT1;MYO19;RHOT2;SREBF1;VPS35;FBXW7
prerank,acute-phase response (GO:0006953),0.47342950519996896,1.100544246599034,0.3427495291902072,0.7660093831068633,1.0,4/12,18.84%,IL6;CRP;IL22;CEBPB
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4146518401019543,-1.1003273780930698,0.3424657534246575,0.7382974193411928,1.0,5/15,9.49%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.34574043553195655,-1.1002919803014937,0.32678132678132676,0.7373240151123968,1.0,8/30,18.29%,DACH1;BMPR2;ACVRL1;TERF1;GNL3L;CDKN1A;MEN1;TINF2
prerank,modulation by symbiont of host process (GO:0044003),-0.48037758139158737,-1.0999110234566607,0.3471933471933472,0.737395378163493,1.0,5/10,15.68%,PGK1;UBB;B2M;UBA52;ENO1
prerank,regulation of cholesterol esterification (GO:0010872),0.49705301217281067,1.0996533268006092,0.36344969199178645,0.7676568019902108,1.0,1/10,2.03%,APOA2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.329959966583272,-1.0995248928285175,0.30024213075060535,0.737478343978662,1.0,8/37,7.96%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;CALM3;SYMPK;MFHAS1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.34807737028183017,-1.099056227246798,0.330188679245283,0.7377349764747706,1.0,12/32,19.25%,THBS1;KDR;NOTCH1;GATA2;HDAC7;HDAC9;VEGFA;FGF2;KLF4;SRPX2;DLL4;CARD10
prerank,positive regulation of kinase activity (GO:0033674),0.3106468401955657,1.0989893395542716,0.3031609195402299,0.7685844729111252,1.0,24/107,12.63%,EPHA7;PDGFRA;PRKAG2;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;KIT;ROR1;RAD50;EPHA1;PDGFRB;SNX9;EPHA4;MST1R;MUSK;PTK2;DSTYK;CSF1;EPHA2;EEF1A2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.41881886753607783,1.0985912010818781,0.3512476007677543,0.7688447816395745,1.0,7/20,19.14%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;CSK
prerank,regulation of intracellular signal transduction (GO:1902531),0.26430021568200235,1.0981036538740654,0.24305555555555555,0.7693246450601909,1.0,60/420,10.43%,ARHGAP29;PTPN13;PDPK1;ARHGAP6;TIAM2;AKAP13;ARHGAP21;ARHGAP10;NRK;PRKAG2;ARHGAP20;ARHGAP18;FGF1;PRKAA2;ZFAND6;TPTE;AKAP12;DLC1;ARHGAP28;ARHGAP32;TRIP10;FGD4;ARHGAP12;TRAF5;PRDM11;TAOK3;WRN;NEK8;ARAF;PTPN22;RAD50;OPTN;CPNE1;MYO9A;WWC2;RHOF;BIRC3;FAM13B;TAGAP;FBXO9;RALBP1;PLEKHG2;ARHGEF11;MAP2K6;WNT5A;STK3;ARHGAP26;RHOQ;PJA2;DLG1;SYDE1;GMIP;LRRK2;ARHGEF12;SOS2;RPA3;NGEF;TAF7;MAPK14;TTC5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.4067976695557679,-1.0979639022448475,0.3495575221238938,0.7398687124176069,1.0,13/16,49.60%,SLC39A14;PRMT5;ACP3;GRP;C3;MRAP2;PDE6G;NECAB2;MRAP;PDE6H;CHGA;F2;PRKCA
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.43095307371224095,-1.0975376048763779,0.33874239350912777,0.7401006348207498,1.0,6/13,35.26%,TMSB4X;HEY1;PER2;SOX11;HEY2;DDIT3
prerank,regulation of RNA splicing (GO:0043484),-0.2904777250360794,-1.0975348783247214,0.2923076923076923,0.7390537299761889,1.0,12/69,9.53%,QKI;PIK3R1;MBNL1;KHDRBS2;SETX;PTBP1;KHDRBS3;RPS13;HNRNPK;HNRNPH2;AHNAK2;RPS26
prerank,protein destabilization (GO:0031648),0.37643490637410604,1.0974960902795983,0.3184931506849315,0.7702931540516978,1.0,12/32,15.53%,CREBBP;CTSH;CDC73;FBXL3;SERF1A;CUL3;TRIM21;BTRC;FBXW11;PEX2;KDM8;MUL1
prerank,sulfur compound transport (GO:0072348),-0.35596585598609937,-1.0969166026718948,0.3113456464379947,0.7397316287270844,1.0,3/27,0.51%,ABCG2;SLC6A6;SLC26A7
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4768079781308486,-1.0966513741357617,0.3525641025641026,0.7395515690700737,1.0,3/10,7.21%,LRCH1;APOD;AKT1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4002451639263237,1.0965159905308666,0.35793357933579334,0.7721943697874424,1.0,5/25,9.24%,AMPD3;SHMT1;MTHFD1;PAICS;PRPSAP1
prerank,maturation of SSU-rRNA (GO:0030490),-0.34765996784456044,-1.0964571252926532,0.28287841191067,0.7390826948650968,1.0,11/34,22.29%,RPS19;RPS8;RPS16;RPS28;NOL11;RPS14;SNU13;UTP6;BMS1;HEATR1;WDR46
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4320620960551433,1.096159595842485,0.3485915492957746,0.7723542404404998,1.0,3/18,4.44%,PTN;CAMK1D;IL6
prerank,positive regulation of cell projection organization (GO:0031346),0.30246135390331924,1.095750817519133,0.30601092896174864,0.7726778754273629,1.0,12/115,5.28%,PLXNA2;ROBO1;DPYSL3;PTN;TIAM2;CAMK1D;EPHA3;PTK7;ROR1;MAP6;PLK5;CBFA2T2
prerank,neural tube closure (GO:0001843),0.3815294757154942,1.0954085772179458,0.34775374376039936,0.7728241851676042,1.0,6/34,7.92%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4730338645689238,1.0954070389787316,0.36678832116788324,0.7719929255211152,1.0,4/12,12.53%,ADAMTS12;DCN;ATP2B4;CADM4
prerank,activation of GTPase activity (GO:0090630),0.31393098974420164,1.0949742455023412,0.2994011976047904,0.7723792231348028,1.0,16/89,13.71%,ARHGAP29;RASGRF1;TIAM2;ARHGAP42;TBC1D16;EPHA1;GRTP1;SYDE1;GMIP;DOCK7;NGEF;SIPA1L2;EPHA2;RAP1GAP;GPR65;TBC1D7
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4654493958101411,1.0948447685047733,0.37957610789980734,0.7719086684671524,1.0,3/12,9.94%,KDELR3;INSIG2;TAPT1
prerank,histone lysine methylation (GO:0034968),0.3789197540756438,1.0948248495795931,0.35714285714285715,0.7711232056065406,1.0,2/33,4.07%,KMT2A;WDR5B
prerank,synaptic vesicle localization (GO:0097479),-0.4340744211064527,-1.0946326291837383,0.3393939393939394,0.7432844868892815,1.0,6/13,16.98%,NLGN1;RAB27A;SYNDIG1;KIF5C;KIF5A;SNAPIN
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4258647176098397,1.0944483779195238,0.36395759717314485,0.7713345697672789,1.0,7/19,15.90%,ELF1;PARP9;WNT5A;MAP2K5;SH2B3;IFIH1;TAF9
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.358571486663721,-1.0944444168466372,0.3054892601431981,0.7427970936276019,1.0,8/25,22.20%,ANKRD13A;ATXN2;SDCBP;RAC1;ARF6;RIN3;MTMR2;ANKRD13B
prerank,protein sumoylation (GO:0016925),0.34662722145321356,1.094355722673855,0.3274760383386581,0.7707804899039081,1.0,10/49,16.55%,EYA1;RANBP2;TPR;PIAS1;SUMO1;NSMCE2;EGR2;POM121;IFIH1;NUP37
prerank,protein heterooligomerization (GO:0051291),-0.4083159849846746,-1.094018459271162,0.34120171673819744,0.7429323826894233,1.0,7/17,24.16%,KCNC2;GRIN2B;GRIN1;TMEM120B;FARSB;HSD17B8;MAT2A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.39708424089399996,1.0938483696097898,0.3552188552188552,0.771374901698881,1.0,5/24,11.85%,EPHA7;NUPR1;MCL1;BAX;FOXO3
prerank,positive regulation of peptidase activity (GO:0010952),-0.39002913984306375,-1.093731235076644,0.3577981651376147,0.7427330999187688,1.0,6/20,21.03%,PRELID1;PINK1;GRN;PSENEN;PSME1;NDUFA13
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.33401490421604085,-1.0937026417373799,0.31203931203931207,0.7417639181723692,1.0,12/37,22.20%,ANKRD13A;ATXN2;SDCBP;PINK1;SIRT5;AP1AR;PAX2;BRCA1;RIN3;MTMR2;EDNRB;ANKRD13B
prerank,regulation of immune response (GO:0050776),0.2931440687156652,1.0936823054485305,0.27310924369747897,0.7710044161026662,1.0,14/135,9.79%,CXADR;RSAD2;COL3A1;COLEC12;ICAM4;ADCY7;PTPN22;APPL2;FOXP3;VCAM1;BIRC3;IFITM1;ERAP1;APPL1
prerank,cognition (GO:0050890),-0.3197056358441394,-1.093591542805875,0.27835051546391754,0.7410553669150123,1.0,13/42,22.52%,GRM5;PTCHD1;SHROOM4;FAM107A;DOP1B;SLC1A4;MFSD2A;ST3GAL4;CHMP2B;CHRNA4;CHRNA7;TTC8;LHCGR
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4922144085413306,1.0931371614129346,0.33962264150943394,0.7717450014550251,1.0,6/10,24.62%,NCK1;VHL;CITED2;SIRT2;BAG3;DNAJB1
prerank,positive regulation of viral process (GO:0048524),0.33526051440916116,1.093010498842558,0.31715210355987056,0.7712545873488333,1.0,14/60,15.71%,AXL;POLR2D;PPARA;KPNA6;STAU1;PPID;POLR2C;TMEM39A;ADAR;IFIT1;SRPK1;POLR2F;TARBP2;PKN2
prerank,negative regulation of TOR signaling (GO:0032007),0.36961355137464763,1.0929156399298718,0.3223684210526316,0.770694149308311,1.0,8/36,14.52%,DEPTOR;RNF152;PRKAA2;FNIP1;SESN1;NPRL3;TBC1D7;MAPKAPK5
prerank,presynapse organization (GO:0099172),-0.4643729959821037,-1.0929047829128278,0.38556701030927837,0.7420431108819643,1.0,4/10,10.22%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.46509000103373904,-1.0925999911071635,0.3855932203389831,0.7419401061234607,1.0,5/10,8.00%,CST3;NOTCH1;FAP;EMILIN1;TNFRSF1B
prerank,activation of protein kinase activity (GO:0032147),0.30302084967246096,1.0925613465189663,0.2877906976744186,0.7708020719189652,1.0,16/106,8.57%,PDPK1;NRK;FGF1;GHR;OSBPL8;ANGPT1;TNFSF15;TAOK3;ADCY5;ADCY7;TGFBR2;ADCY1;IL18;PHB2;WNT5A;STK3
prerank,gluconeogenesis (GO:0006094),-0.32446040812285404,-1.0919647506771022,0.315,0.742716080475665,1.0,15/39,21.55%,PGK1;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,cellular component assembly (GO:0022607),0.27266573825156004,1.0918432362590442,0.2578616352201258,0.771996527959567,1.0,50/253,15.32%,KMT2A;DPYSL3;PAWR;LAMC1;SPTBN1;PARVA;CALD1;TEAD1;QRICH2;WNT3A;SHROOM2;MYO1B;FLNC;BAIAP2L1;CDAN1;MYO9A;ST13;CREBBP;FBLIM1;SNX9;RSPH9;TEAD2;SYCP2;WNT5A;YAP1;RHOQ;TAPBP;MNAT1;LIMA1;TUBGCP4;PPID;DNM1L;NLGN2;WDR19;EPPK1;HFE;TEX12;TUBGCP2;GORASP2;WASL;WASF1;RTN4;RHOU;MDM4;GEMIN5;P3H4;PML;ILK;BAIAP2;TOGARAM1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.33295167261272707,-1.091682268804935,0.30158730158730157,0.7424553733737228,1.0,11/35,15.18%,SGIP1;HIP1;HIP1R;HNRNPK;B2M;LDLRAP1;SNAP91;CBL;TNK2;RAC1;CCL19
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.34703384945833843,-1.091078640549315,0.33093525179856115,0.7430615617291414,1.0,19/29,44.10%,CADM1;CYRIB;RAET1E;LAMP1;STX7;RASGRP1;FADD;TYROBP;SLAMF6;NECTIN2;CD226;IL12A;CRTAM;IL12RB1;STAP1;IL23A;ITGAM;KLRD1;CD160
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2983503492068511,1.0908271789721549,0.2808219178082192,0.7739625299464788,1.0,19/124,12.35%,TCF7L2;WNT4;PRICKLE1;SMURF2;FZD2;TNRC6B;PARD6A;PLCB3;CELSR1;PSMB10;TNRC6A;WNT5A;MOV10;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;DVL3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3905112534462635,-1.0906753453956701,0.34763948497854075,0.7432206492746221,1.0,12/21,31.63%,HDAC6;PINK1;SIRT5;PAX2;ABCD2;PARK7;BRCA1;SLC18A2;SLC30A10;MMP3;TFAP2A;MT3
prerank,positive regulation of dephosphorylation (GO:0035306),-0.35249591239022493,-1.0906406385535359,0.3264367816091954,0.7422816605135437,1.0,7/27,7.58%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;CALM3;SYMPK
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.381587717239029,1.0904385614300856,0.3565217391304348,0.7741977600488681,1.0,4/33,4.92%,IGFBP3;IGFBP5;EFEMP2;TPM1
prerank,prostaglandin metabolic process (GO:0006693),0.3992404873691042,1.0899661762100732,0.3534798534798535,0.7747558148700381,1.0,3/26,6.87%,PTGS1;PLA2G4A;PTGR1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4202621077260026,1.0896793693310287,0.35753176043557167,0.7747975746666067,1.0,6/20,10.73%,BCL2;MCL1;GSK3B;BAX;APPL1;BCL2L1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.39744661834357675,-1.089395118491242,0.3295964125560538,0.7449402319636502,1.0,2/17,3.12%,CTNNA2;NCKAP1
prerank,cellular response to retinoic acid (GO:0071300),0.3511074795118725,1.0893914835259728,0.35413153456998314,0.7747998237039776,1.0,8/42,8.47%,WNT6;WNT10B;WNT3A;EPHA3;PTK7;WNT5B;ZNF35;WNT5A
prerank,metal ion export (GO:0070839),0.37945585180992747,1.0892379107505128,0.3251231527093596,0.7743979018143075,1.0,2/31,0.51%,ATP1A2;KCNT2
prerank,cGMP metabolic process (GO:0046068),-0.4503991531232468,-1.0891335091664656,0.3492063492063492,0.7446739554958286,1.0,4/12,10.66%,GUCY1B1;PDE2A;GUCY1A1;NPR1
prerank,sodium ion transport (GO:0006814),-0.2820577435126287,-1.0885119155211453,0.3079268292682927,0.7453814659134305,1.0,18/85,12.37%,SLC6A6;SLC12A2;SLC9B2;ATP1B1;SLC24A2;SLC6A1;SCN1A;HCN1;SLC5A5;SLC8A1;SLC5A6;HCN2;SCN2A;NEDD4L;FGF13;SCN8A;SCN9A;SLC6A5
prerank,transferrin transport (GO:0033572),-0.33582632966242576,-1.088404328151664,0.33176470588235296,0.7446558612670167,1.0,12/33,21.84%,ATP6V0A1;TFRC;ATP6V1B2;ATP6V0C;ATP6V1D;ARHGAP1;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,positive regulation of B cell activation (GO:0050871),-0.30572162589085206,-1.0883320257279534,0.3504043126684636,0.7438467666660105,1.0,13/50,17.70%,MEF2C;TFRC;SH3KBP1;CD38;CD74;CD40;SYK;HMCES;PTPRC;CLCF1;NOD2;CD27;CD320
prerank,calcium ion import (GO:0070509),-0.3516501896506756,-1.0879428202101176,0.3357487922705314,0.743991851623982,1.0,11/28,17.85%,CACNA1E;CACNB2;MCUB;TRPC4;SLC8A1;CACNA1G;CACNA1D;SMDT1;ATP2A2;MAIP1;CACNA1A
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.43528204784078717,-1.087685063934023,0.35353535353535354,0.7436732970625064,1.0,3/12,2.25%,UBASH3B;RYR2;PTK2B
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.43762848365716456,-1.0865200708061393,0.3596673596673597,0.7459637895822548,1.0,5/12,19.92%,MAOA;OAZ2;DDC;SMS;SRM
prerank,regulation of cellular response to heat (GO:1900034),-0.28205465990453427,-1.0865006788780511,0.28488372093023256,0.7449844605206805,1.0,27/77,26.61%,HSPA8;CD34;MAPK3;HSP90AB1;CAMK2D;BAG1;CAMK2A;HSBP1;CCAR2;ATM;AAAS;NUP93;AKT1S1;HSP90AA1;RAE1;MAPT;FKBP4;MLST8;BAG4;NUP62;ATR;NUP188;NUP54;CAMK2G;NUP210;NUP42;NUP153
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3946120543192064,-1.0862490557849407,0.33617021276595743,0.7446262315437401,1.0,6/17,16.31%,COX6C;COX4I1;COX8A;NDUFA4;COX6A1;COX7B
prerank,neutrophil activation involved in immune response (GO:0002283),-0.22525690684878988,-1.0861537257216602,0.14189189189189189,0.7438732894453454,1.0,88/428,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;SYK;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4401494350673104,1.0861506530852072,0.38104448742746616,0.7821854665780538,1.0,5/15,13.48%,TPR;ANAPC1;UBE2C;HECW2;CDC27
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2866482278226291,1.0859571688391714,0.2901907356948229,0.7819182556593568,1.0,40/170,18.37%,ROCK2;PRDM6;AFF3;TRIM10;NELL1;TBC1D16;PRDM11;PTHLH;TRIM17;STOX1;IGF2BP1;MTMR3;TRIM5;RASA1;POGZ;NOVA1;TAPBP;FUBP1;RFXANK;IGF2BP2;IHH;NFKBIZ;TRIM21;CRNN;TRIM26;RNF39;ZNF462;AFF1;PRDM5;HNRNPDL;TXK;POU5F1;APP;AFF2;ARF1;AFF4;GDNF;C1D;BMI1;PCBP2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.26973382867684303,-1.0857685704646616,0.2848297213622291,0.7439903333010923,1.0,20/88,10.31%,EXOC6;HSPA8;SORCS1;FTH1;SORL1;FTL;SH3GL2;DOP1B;CLINT1;GOPC;EXOC4;CLVS1;SCAMP1;AP1S1;STEAP2;STXBP6;AP1S2;SCAMP2;CORO7;KLHL20
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2771892975620375,-1.0853240448521668,0.2691131498470948,0.7441380627064407,1.0,27/88,16.67%,TEK;PPP1R16B;TIE1;NRP2;THBS1;BMPR2;KDR;VEGFC;F3;ACVRL1;PTPRM;ATP5F1A;BMP4;AKT1;VEGFA;EGFL7;SCG2;CAV2;FGF2;PIK3CD;CAV1;RGCC;PRKD1;KRIT1;EGF;HTR2B;EMC10
prerank,membrane raft organization (GO:0031579),0.4326724505291396,1.085262689360225,0.36,0.7830555070081295,1.0,6/15,17.50%,ANXA2;S100A10;NPC1;MYADM;FLOT2;ABCA7
prerank,hexose transmembrane transport (GO:0008645),-0.38117818750115434,-1.0852307453439287,0.3384279475982533,0.7433832385698986,1.0,10/21,32.84%,SLC2A1;PPARD;SLC2A9;SLC50A1;SLC2A4;SLC45A3;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4859512244163717,1.0851308132434478,0.3803088803088803,0.7825640093644435,1.0,4/11,16.38%,LEPROT;SH2B3;VHL;NF2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4228471620830323,1.0850586461858558,0.3550185873605948,0.7819426297155215,1.0,3/18,2.34%,HEG1;DLC1;KANK1
prerank,cellular response to alcohol (GO:0097306),0.35280818969060457,1.0843776113141352,0.33,0.7830515457628247,1.0,8/42,7.28%,GRAMD1C;ADCY5;ADCY7;CTNNA1;ADCY1;SPIDR;MAP4K1;KLF9
prerank,positive regulation of receptor internalization (GO:0002092),-0.3672238735211903,-1.0842676225443197,0.32723112128146453,0.7449888893698954,1.0,9/22,18.68%,INSR;AHI1;SCYL2;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.3939239049365851,-1.084002189353713,0.3511111111111111,0.7446756861252289,1.0,6/17,29.71%,AKT1;PPIA;SOD1;TREM2;VNN1;HSPB1
prerank,digestive tract morphogenesis (GO:0048546),0.4448972624828258,1.0838435047248856,0.36229205175600737,0.7837795702824331,1.0,2/14,4.69%,PDGFRA;GLI1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.36066154580174137,-1.0836904690975349,0.33874709976798145,0.7445932085590463,1.0,9/25,13.61%,CTNNA3;RYR2;NOS1AP;CALM1;CALM3;CAMK2D;FGF13;CAV1;ATP2A2
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3670854169956082,-1.0832144986264873,0.38004750593824227,0.7449056906350555,1.0,13/23,31.77%,HSPA4;SAMM50;TIMM8B;HSP90AA1;BMF;MAIP1;TIMM22;BAD;NDUFA13;TIMM10;PMAIP1;TIMM13;TOMM22
prerank,cellular response to organic cyclic compound (GO:0071407),0.28848936248197943,1.0830366600437447,0.3031161473087819,0.7851976423812074,1.0,28/141,16.82%,RORA;TFPI;ATP1A2;ROCK2;DIAPH1;IGFBP5;NCOA3;ADCY5;SSH1;CTNNA1;ADCY1;SPIDR;IL18;CCL2;FAM210B;LRRK2;TIPARP;P2RY6;NR3C1;CIB2;SLC26A6;P2RY1;ADCY6;PKD2;GNG2;URI1;P2RX4;RAPGEF3
prerank,regulation of melanin biosynthetic process (GO:0048021),0.48063170780703746,1.0829794747286716,0.3884462151394422,0.7845237543084097,1.0,3/10,16.52%,ZEB2;APPL1;OPN3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.4472390329952764,-1.0827740412595415,0.3643410852713178,0.7451013021922799,1.0,5/11,15.58%,MERTK;GAS6;CXCL12;CCL19;NOD2
prerank,regulation of intracellular transport (GO:0032386),-0.32457311493630564,-1.0826469242227457,0.32151898734177214,0.7444211023033898,1.0,13/38,23.10%,WWC1;REEP5;DYNC1H1;AAAS;NEFH;CAPN10;MLC1;LAMP1;MAP2;LCP1;SPAG5;ATP9A;HAP1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3056902695765717,1.0823772080521303,0.3089802130898021,0.7853525380390495,1.0,18/95,14.46%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;SERPINE1;NR1H3;CDC73;CCL2;LY96;CD274;WNT5A;MAPK14;TLR2;PAF1;TICAM1;PABPN1
prerank,cellular response to chemokine (GO:1990869),0.346720830889393,1.0821691232889257,0.32018927444794953,0.7850804306996417,1.0,6/46,7.77%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3
prerank,protein secretion (GO:0009306),0.3392392452553311,1.0820551031177181,0.34185303514376997,0.784581720260234,1.0,7/56,5.71%,WLS;ARFGAP3;STEAP3;ANXA1;RAB10;MIA3;FAM3B
prerank,insulin receptor signaling pathway (GO:0008286),-0.2877397099667134,-1.0819551765231894,0.30149253731343284,0.7453975347233823,1.0,17/69,12.91%,GRB14;BCAR3;ATP6V0A1;FOXO1;INSR;PIK3R1;GAB1;ATP6V1B2;PIK3R3;NAMPT;ATP6V0C;AKT1;SLC39A14;CAV2;ATP6V1D;BCAR1;FOXO4
prerank,cellular response to ketone (GO:1901655),0.36237244600447066,1.081569018992192,0.3498233215547703,0.7850797063513175,1.0,9/35,17.33%,ROCK2;ADCY5;ADCY1;MAP4K1;KLF9;NR3C1;ADCY6;GNG2;PCK2
prerank,regulation of JUN kinase activity (GO:0043506),0.37262640716315465,1.081247623086204,0.3548387096774194,0.785177376965548,1.0,8/33,12.35%,SASH1;DUSP10;TAOK3;PTPN22;PPEF2;HIPK3;MAP3K7;DVL3
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4174702883571362,1.0808689349034108,0.3834862385321101,0.785412556785784,1.0,3/20,6.41%,NUPR1;CFLAR;BIRC3
prerank,neutrophil mediated immunity (GO:0002446),-0.22291999605094598,-1.08084568982952,0.17123287671232876,0.7475421856012435,1.0,88/432,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;ACE;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4397121932143301,1.0808222677187331,0.36893203883495146,0.7847097353988474,1.0,4/15,18.20%,OSBPL8;PPARA;PLIN3;ABHD5
prerank,negative regulation of interleukin-8 production (GO:0032717),0.41862847103291395,1.0805575820361968,0.37030075187969924,0.7846313770369914,1.0,5/17,13.07%,ANXA1;PTPN22;ANXA4;MAP2K5;ARRB1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.30627039053955807,1.0804679758028113,0.33236994219653176,0.7840691313380314,1.0,14/100,7.50%,PTPN13;FN1;SELP;PDGFRA;FGFR1;OSM;NEDD4;KIT;DCN;ROR1;HAX1;PDGFRB;STAMBP;IL18
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40017431196950204,-1.0803711798797517,0.35913978494623655,0.7479361790597544,1.0,7/15,15.27%,TMSB4X;KDR;MET;LGMN;VEGFA;FGF2;PRKD1
prerank,activation of phospholipase C activity (GO:0007202),0.37996637460148686,1.0802454150479035,0.3532513181019332,0.7838371917480048,1.0,7/29,15.64%,ARHGAP6;LPAR1;PHB2;NMUR1;P2RY6;BDNF;TXK
prerank,T cell mediated immunity (GO:0002456),-0.4181132436373052,-1.0793572528930533,0.35320088300220753,0.7498231043345587,1.0,3/13,11.28%,CADM1;EMP2;CD46
prerank,homotypic cell-cell adhesion (GO:0034109),0.3575340451548657,1.0784967972844983,0.3481848184818482,0.7880272203618454,1.0,8/39,10.49%,FN1;PDGFRA;PLPP3;GP1BA;VCL;CSRP1;DSC2;PLEK
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.42804394817677693,-1.0783153826690082,0.3723849372384937,0.7518061792134288,1.0,5/12,15.41%,LY6E;SNX3;MID2;IFITM3;IFITM2
prerank,negative regulation of kinase activity (GO:0033673),0.3290776237371924,1.0779940877689114,0.3333333333333333,0.7886006269514351,1.0,4/62,2.17%,PDPK1;DEPTOR;PRKAG2;PPM1E
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3377368307281222,-1.0778767914204577,0.33251833740831294,0.7520363868720636,1.0,18/32,37.14%,HINT1;JMY;STK11;BAG6;PPP1R13B;DDIT4;PYCARD;BCL3;MYBBP1A;HIPK2;CDIP1;PMAIP1;TP53;TMEM109;POU4F1;BOK;AEN;PDK2
prerank,regulation of RNA export from nucleus (GO:0046831),0.4774854456873759,1.077380955483382,0.38747553816046965,0.789464501999811,1.0,5/11,23.45%,TPR;IWS1;SETD2;KHDRBS1;DHX9
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.30567160556674927,1.0771436622016013,0.34915773353751917,0.7893402306036642,1.0,16/95,9.69%,UST;GPC6;CHST15;HSPG2;SDC2;ANGPT1;DCN;NDST1;OMD;DSE;CHSY1;NDST2;B4GALT1;GLCE;PRELP;GPC2
prerank,organic hydroxy compound transport (GO:0015850),-0.32597810731900134,-1.0771251425560522,0.35572139303482586,0.7530832624373962,1.0,5/36,8.59%,ABCC4;SLCO1C1;CEACAM1;SLC16A1;ATP8B1
prerank,neutrophil degranulation (GO:0043312),-0.2235640715849921,-1.076795982793097,0.16556291390728478,0.7530197459885658,1.0,87/425,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,renal absorption (GO:0070293),-0.4581186298314176,-1.0762743936000403,0.36116910229645094,0.7534404941933995,1.0,3/10,12.24%,KLHL3;SLC15A2;KCNQ1
prerank,membrane depolarization during action potential (GO:0086010),-0.34909374186018094,-1.0762048084971787,0.3388235294117647,0.7526797332461529,1.0,10/26,11.70%,KCNJ2;SCN1A;SLC8A1;HCN2;SCN2A;CACNA1G;YWHAH;CACNA1D;SCN8A;SCN9A
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4526284574464322,1.0758444962369065,0.3915441176470588,0.7921823358560616,1.0,4/13,15.47%,AXL;IL18;TICAM1;IL23R
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4752349230821961,1.0753488422166637,0.3861003861003861,0.79273898493298,1.0,5/11,26.26%,TAF7;HDAC2;XBP1;TMEM106A;JAK2
prerank,phospholipid metabolic process (GO:0006644),0.3185864149111551,1.075304230352652,0.33987915407854985,0.7920530005815696,1.0,9/71,11.23%,SMPD3;PLA2G4A;PLPP3;APOA2;AGPAT4;PLA2G4C;PLPPR3;ENPP2;AGPAT3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4266881409689837,1.0750660956951317,0.37523452157598497,0.7918993712007695,1.0,7/17,15.47%,RBPJ;CREBBP;STAT1;PBX1;HEYL;MAML2;KAT2B
prerank,regulation of B cell proliferation (GO:0030888),-0.3126131744901156,-1.0747884367002294,0.3090909090909091,0.755881093415796,1.0,11/44,17.70%,MEF2C;TFRC;CD38;CD74;LYN;ATM;CD40;TNFRSF21;PTPRC;CLCF1;CD320
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4707396008512808,1.0741719214340326,0.3905325443786982,0.7935485919289417,1.0,3/10,8.91%,DPYD;UPP1;NT5C
prerank,regulation of interferon-beta production (GO:0032648),0.3509206916713973,1.074091409167379,0.3701923076923077,0.7929553836812564,1.0,10/46,14.55%,TRIM56;TLR4;RNF216;RIPK2;PPM1B;POLR3F;TLR2;OAS2;IFIH1;TBK1
prerank,regulation of mast cell activation (GO:0033003),-0.446615699769467,-1.074064656198815,0.3581780538302277,0.7569048902293851,1.0,8/10,48.77%,LYN;CD84;TSLP;NECTIN2;CD226;MILR1;PLSCR1;CD300LF
prerank,dendritic cell migration (GO:0036336),-0.40113248454405664,-1.074062810338526,0.34511434511434513,0.7559052270261121,1.0,12/16,45.18%,EPS8;HMGB1;CCL19;TRPM2;ALOX5;CCL5;CCR1;PIK3CG;CCR5;CCR6;CXCR2;TRPM4
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.4751825032508802,1.0738972647286409,0.3585951940850277,0.7926235268767405,1.0,2/11,6.96%,STK39;ACTN2
prerank,cell junction organization (GO:0034330),0.3131090649487491,1.0735124928077688,0.35365853658536583,0.7928321483574949,1.0,9/71,7.37%,SDK1;SDK2;SMAD3;CXADR;FLNC;MYO9A;LRP4;FBLIM1;CLDN1
prerank,protein localization to plasma membrane (GO:0072659),-0.2607678805810491,-1.0734868946353313,0.2815884476534296,0.7565508844370299,1.0,33/129,14.01%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;CCDC88A;RAB3C;TMED2;LRP6;RAMP2;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;RAB40B;F11R;EHD4;CLASP2
prerank,DNA replication initiation (GO:0006270),0.356406267661192,1.073485246977766,0.3521594684385382,0.792094160490565,1.0,10/37,17.14%,ORC5;POLA2;PRIM2;RPA3;MCM4;GMNN;MCM6;ORC3;ORC4;LRWD1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.32157560345719327,1.073475103233529,0.3470948012232416,0.7913036155657471,1.0,10/69,6.63%,PDGFRA;FGFR1;TPTE;GAB2;PLCD3;PI4KA;PLCE1;PDGFRB;PLCB3;PIK3C2A
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3608148258661967,-1.0730497248904511,0.35947712418300654,0.7568103614981984,1.0,3/22,3.31%,GRM3;CAP2;GABBR2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3694159015727402,1.0729828953507992,0.3573825503355705,0.7918430329016835,1.0,9/33,13.47%,ADAMTS1;ANXA1;GLI1;CCND3;CDC73;PHB2;ANKRD17;CRNN;PAF1
prerank,necroptotic process (GO:0070266),0.4235372802072639,1.0729301384371719,0.3829787234042553,0.7911612796873588,1.0,6/16,21.65%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,glycolipid metabolic process (GO:0006664),-0.3050072609867615,-1.072710305010171,0.36103896103896105,0.756746680717382,1.0,10/47,14.61%,ST6GALNAC3;ST3GAL6;ST8SIA6;HEXB;GLTP;ST6GALNAC4;NEU1;CERK;GM2A;ST3GAL4
prerank,ureteric bud development (GO:0001657),0.417454738426457,1.0721262880426354,0.3762575452716298,0.7925921451542142,1.0,5/17,5.23%,OSR1;FOXC1;BMP2;BMP7;SALL1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3071840866372717,1.0719663065799336,0.334855403348554,0.7922231415277645,1.0,20/88,16.03%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;NELL1;CSTB;DAPK1;IGF2BP1;NANOS2;SERPINE2;DNAJC1;IGF2BP2;EIF4ENIF1;ILF3;DDX6;PLAT;GIGYF2;EIF2AK3;CNOT9;CPEB3
prerank,I-kappaB phosphorylation (GO:0007252),0.47187474426283593,1.07165120645456,0.39517625231910947,0.7922752783607449,1.0,3/10,12.26%,TLR4;TLR2;MAP3K7
prerank,positive regulation of T cell activation (GO:0050870),0.3162928579115985,1.071592458588683,0.35572519083969467,0.791619745961482,1.0,9/62,7.89%,ZMIZ1;IL6ST;ANXA1;IL6;VCAM1;CD47;CCL2;LGALS9;CD274
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.44535647004446693,-1.0714840542813382,0.38703339882121807,0.7593632289669435,1.0,2/11,4.39%,SLIT2;CCN3
prerank,cilium assembly (GO:0060271),0.26560708897286534,1.0711306892139887,0.2921760391198044,0.7921396427652994,1.0,77/296,21.93%,DCDC2;TNPO1;NINL;PARVA;SPATA6;CYS1;ASAP1;DYNLL1;ALMS1;ARL13B;SDCCAG8;RFX3;IFT88;ARL3;CLASP1;TTC39C;HYLS1;IFT57;ARF4;TMEM107;CEP152;EXOC2;DYNC2I1;DNAAF1;NPHP1;CCDC13;HAUS8;C2CD3;RSPH9;NUDCD3;IFT81;DYNC2LI1;CC2D2A;NEDD1;CDC14A;CCDC57;RPGRIP1L;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;ACTR1A;CEP250;TOGARAM1;CPLANE1;GBF1;AVIL;TTBK2;GAS8;EXOC7;EXOC1;YWHAE;TTC21B;RPGR;IFT52;ARL6;CCDC39;WDR11;KIF3C;CEP131;CEP63;SSX2IP;CEP78;B9D2;OFD1;RP2;ACTR3;TRIP11;DZIP1L;PKD1;LZTFL1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3980945788542717,-1.0710953959543945,0.35294117647058826,0.7595266556476015,1.0,3/15,2.61%,STOX2;TGFB2;CELF4
prerank,glutamate metabolic process (GO:0006536),-0.38010247358245564,-1.0710562931465086,0.35933806146572106,0.7586212720536436,1.0,6/19,21.90%,ALDH5A1;GCLC;GLS;GLS2;GGT1;MTHFS
prerank,positive regulation of epithelial cell migration (GO:0010634),0.30963322703141116,1.0709817438237181,0.3446244477172312,0.7917229418470078,1.0,14/92,8.87%,RIN2;ROCK2;SASH1;DOCK5;FGF1;FOXC2;GLIPR2;NRP1;ANXA3;ANGPT1;CLASP1;CTSH;WNT5A;INSL3
prerank,cell cycle G2/M phase transition (GO:0044839),0.29056091697650044,1.070847201574219,0.31824611032531824,0.7912922049959407,1.0,40/129,21.56%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CLASP1;OPTN;CEP152;HAUS8;FBXL3;CDKN2B;CCNH;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;BTRC;MASTL;FBXW11;KDM8;ACTR1A;CEP250;FBXL12;YWHAE;PPP2R2A;CCNY;CEP131;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1
prerank,membrane fusion (GO:0061025),-0.34115462685885584,-1.07083476224666,0.3681710213776722,0.7583190402806755,1.0,6/33,9.06%,DNM3;RIMS1;NSF;DYSF;NSFL1C;VPS33B
prerank,erythrocyte differentiation (GO:0030218),0.3443577587040252,1.0705271213929723,0.36661211129296234,0.7913955691691599,1.0,13/44,18.98%,TGFBR3;MPIG6B;KIT;UBA5;PTPN2;ACIN1;SH2B3;ALAS2;INHA;HSPA9;CASP3;ATP5IF1;DMTN
prerank,protein K48-linked ubiquitination (GO:0070936),0.3329042474936825,1.0703783620079967,0.3556280587275693,0.7910076220588391,1.0,14/54,15.52%,RNF152;TTC3;RNF216;DTX3L;AMFR;UBE2C;FBXO38;CUL3;IFI27;UBE2E3;UBE2Q2;BFAR;UBE2R2;RNF146
prerank,regulation of erythrocyte differentiation (GO:0045646),0.36217596003359354,1.0701961128666004,0.3506944444444444,0.7906995900674741,1.0,8/35,11.85%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAFB;MAPK14;FOXO3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3399697421416789,1.0701432976080958,0.36347517730496454,0.7900661006042574,1.0,11/45,13.23%,SMAD3;FOXC1;BTG3;BMP7;PTPN3;BTG4;PRCC;ZWINT;NABP1;TOM1L2;HECA
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4016824592448216,1.0700525252112627,0.3926605504587156,0.7887359004164393,1.0,6/21,17.31%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4016824592448216,1.0700525252112627,0.3926605504587156,0.7887359004164393,1.0,6/21,17.31%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,response to ATP (GO:0033198),-0.38482852478281376,-1.0699941379822937,0.36538461538461536,0.7597007933535543,1.0,3/18,4.62%,TRPC3;ABCC9;RYR3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3363297529450853,-1.0696368084444017,0.3459715639810427,0.7597395553719134,1.0,18/32,42.94%,CDK17;CDK14;CDK15;POLA1;HINFP;CDC45;E2F7;CDK5;PCNA;CCNE1;CDC6;KLF11;E2F1;RRM2;CDK18;TYMS;BACH1;CDT1
prerank,glycolytic process (GO:0006096),-0.33926736005150976,-1.0691901974567113,0.34553775743707094,0.7599772313275251,1.0,8/28,15.68%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;PGAM4;ENO1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.29031872842530276,1.068869993627926,0.33238636363636365,0.7911661328327194,1.0,40/128,21.56%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CLASP1;OPTN;CEP152;HAUS8;FBXL3;CDKN2B;CCNH;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;BTRC;MASTL;FBXW11;KDM8;ACTR1A;CEP250;FBXL12;YWHAE;PPP2R2A;CCNY;CEP131;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1
prerank,endodermal cell fate commitment (GO:0001711),0.4839373415126411,1.0684708902717626,0.3844660194174757,0.7914676920082574,1.0,5/10,15.83%,CDC73;RTF1;PAF1;LEO1;POU5F1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.4811419002418249,1.0679799024207859,0.4106090373280943,0.7904613267412139,1.0,5/10,19.43%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,t-circle formation (GO:0090656),0.4811419002418249,1.0679799024207859,0.4106090373280943,0.7904613267412139,1.0,5/10,19.43%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.4811419002418249,1.0679799024207859,0.4106090373280943,0.7904613267412139,1.0,5/10,19.43%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3436022708993628,1.0678670173531963,0.3627287853577371,0.7900390000841303,1.0,8/49,9.65%,PPM1A;LDLRAD4;DACT1;PMEPA1;PRKCZ;OPRD1;GSK3B;SMAD6
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.31690741840824743,1.0674991072775986,0.3411949685534591,0.7902422566872598,1.0,22/72,20.65%,POLR2D;CUL4A;RFC1;CCNH;MNAT1;CDK7;RPA3;XRCC1;TCEA1;POLR2C;PRPF19;POLR2F;GTF2H4;ERCC5;ERCC6;ERCC1;GTF2H2;UVSSA;USP7;ERCC8;POLR2K;POLD3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3283268556736768,-1.0671755824682154,0.3333333333333333,0.7646436778945284,1.0,8/32,17.26%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;PKIB;CCT5
prerank,peptidyl-lysine methylation (GO:0018022),0.3859262325031912,1.0670521005737788,0.38071065989847713,0.7906544478626032,1.0,11/26,26.95%,METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;SMYD3;EHMT2;SUV39H1;SETD6;SMYD2
prerank,stress granule assembly (GO:0034063),-0.37275081066845855,-1.0669943570557545,0.38496583143507973,0.7641964600336549,1.0,4/20,8.39%,RPS23;ATXN2;YTHDF2;DYNC1H1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.398749641346657,-1.0666848351288385,0.36923076923076925,0.7640416957764745,1.0,2/16,7.92%,CLDN5;CLDN14
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.30829076643199943,1.0665223852120613,0.3499222395023328,0.7913306502298008,1.0,27/84,22.77%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;RTN1;DAPK1;IGF2BP1;NANOS2;IGF2BP2;EIF4ENIF1;ILF3;DDX6;RTN4;GIGYF2;EIF2AK3;CNOT9;CPEB3;ABCA7;FXR2;DHX36;NANOS1;ROCK1;RNF139;GGA3;EPRS1;NCL;GAPDH
prerank,negative regulation of response to stimulus (GO:0048585),0.3289808066546607,1.0663331211918075,0.34488188976377954,0.7910458214837341,1.0,8/60,6.03%,IGFBP3;COL3A1;MPIG6B;CASK;TERT;APPL2;NR1H3;FOXP3
prerank,arachidonic acid metabolic process (GO:0019369),0.35772578826960544,1.0662576766933665,0.3701188455008489,0.7904904271807792,1.0,5/35,10.27%,PTGS1;PLA2G4A;PLA2G4C;ALOXE3;EPHX1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4867099651860551,1.0660776763770599,0.3686200378071834,0.7902118757485191,1.0,1/10,0.45%,ATP1A2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.283665195841371,1.0660749621716008,0.35743519781718963,0.7894277322060644,1.0,38/153,18.60%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;PRKCZ;TOP1;LATS2;TGFBR1;MORC3;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;MAPK14;AKT3;HIPK3;RPS6KA3;MASTL;MAP3K13;MAPK9;WNK1;MAPKAPK5;TBK1;CSNK2A2;EIF2AK3;STK4;PKN2;PRKD2;TTBK2;MKNK2;RICTOR;SMG1;DMPK;MAPKAPK3;RPS6KB2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3636055750997298,1.065810020795628,0.3587140439932318,0.7893559670320763,1.0,7/33,8.89%,KANK2;DACT1;PLK5;CDC73;CCL2;CDKN2B;DLG1
prerank,regulation of protein polymerization (GO:0032271),0.35605612041345414,1.0657179805661683,0.3602693602693603,0.788818060775088,1.0,6/35,7.40%,ARHGAP18;ARHGAP28;HAX1;RASA1;PLEKHG2;DBN1
prerank,carnitine metabolic process (GO:0009437),0.4566290256401709,1.065568588406718,0.39520958083832336,0.7884694920578564,1.0,2/12,9.64%,SHMT1;TMLHE
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.46183784015893947,1.0654151718740215,0.41714285714285715,0.7881138589687039,1.0,5/11,23.45%,WTIP;PUM2;AJUBA;XPO5;DHX9
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.34183867613570446,1.0651271640965754,0.3542009884678748,0.7880833904335942,1.0,4/47,6.08%,WNT4;ROCK2;CRY1;ATP2B4
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.27441720840968936,1.0650534906868743,0.33119383825417203,0.7875043659208877,1.0,44/234,14.46%,SMAD3;CAMK1D;DDR2;PLPP3;EIF2AK2;ZIC2;FER;TRAF5;ANXA3;FZD2;KIT;SLCO3A1;CFLAR;IL6;IKBKE;ROR1;TLR4;PRKCZ;MTDH;TRIM5;HDAC4;EDA;ADCY1;IL18;OPRD1;LGALS9;RIPK2;PHB2;WNT5A;STK3;CRTC1;UBE2V1;TLR2;IRAK3;CRTC3;MAP3K7;TRIM21;CRNN;TRIM26;MAP3K13;ARID5B;TICAM1;FLOT2;ALK
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.41722097394939117,1.0648759531548493,0.37857142857142856,0.787212606442072,1.0,4/18,10.14%,LATS2;CTNNA1;GSK3B;SUFU
prerank,protein localization to kinetochore (GO:0034501),-0.4122333733055221,-1.0646489196464368,0.36886993603411516,0.7687707541729324,1.0,11/14,42.54%,RCC2;ZWILCH;CENPT;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,mesenchyme morphogenesis (GO:0072132),-0.40200274426609833,-1.0644389226123643,0.365296803652968,0.768365635496684,1.0,7/17,14.62%,NOS3;TGFB2;NOTCH1;ACVRL1;TBX2;ACVR1;HEY1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2539139944954898,1.0644204855789106,0.31138392857142855,0.7876620886645114,1.0,97/532,16.17%,RORA;LEPR;TEC;RSAD2;FN1;CXCL10;SP100;IL16;GHR;IL31RA;GBP2;FOXC1;STAT2;IL6ST;GAB2;OSM;VIM;IL11;ANXA2;FER;TRAF5;IFIT2;IL34;ANXA1;KIT;TNFSF15;STAT5B;BRWD1;IFI35;IL6;BCL2;MCL1;APPL2;PELI2;TRIM5;VCAM1;TNFRSF12A;BIRC3;BST2;NOS2;SNRPA1;EDA;OASL;IL18;OPRD1;STAT1;CCL2;ACKR3;TNFRSF14;RIPK2;PSMB10;YAP1;ZEB1;PSMA3;IL13RA1;PSME4;CNN2;IFITM1;APPL1;PSMA5;IFNLR1;PTPN6;BCL2L1;UBE2V1;OAS2;IRAK3;SMAD4;STAT4;SH2B3;FOXO3;IFI27;CSF1;ADAR;MAP3K7;TRIM21;IFIT1;BTRC;FBXW11;TRIM26;JAK1;IL22;POU2F1;RHOU;IFIT3;GREM2;CCL25;PML;ILK;SMARCA4;IL23R;SOCS6;HNRNPDL;IRF9;ICAM1;IFNAR2;MUC1;HSPA9
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3716306595385944,1.064365167211521,0.3769911504424779,0.7870195944267264,1.0,9/29,19.03%,CUL4A;CCNH;MNAT1;CDK7;RPA3;GTF2H4;ERCC5;GTF2H2;XPC
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.44948695248784,1.0639624341680665,0.38791423001949316,0.7873132150198894,1.0,3/12,15.47%,IL17D;IL18;IL23R
prerank,modification-dependent protein catabolic process (GO:0019941),0.2774531583912376,1.0638602268679365,0.3404255319148936,0.7868311942933776,1.0,37/193,15.98%,RNF213;SPSB1;SMURF2;RNF217;FBXO11;TRIP12;NEDD4;TTC3;RC3H1;RNF19A;SPSB4;SIAH2;DTX3L;ANAPC11;NTAN1;RNF20;KLHL15;NUB1;RNF111;ANAPC1;AMFR;UBR4;UBE2C;FBXL7;KEAP1;CUL3;BTRC;ARRB1;CDC27;BFAR;RNF43;FBXL4;RCHY1;BIRC6;UBE2R2;RNF146;RNF185
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.33680343125836953,-1.0638214432501256,0.36515513126491644,0.7691664860740767,1.0,3/31,1.99%,DLG2;LRRC7;LIN7A
prerank,organophosphate biosynthetic process (GO:0090407),-0.3245941944377274,-1.0636752705805936,0.33653846153846156,0.7685727514743823,1.0,10/37,15.55%,ITPKB;GPHN;MBOAT1;PCYT2;IP6K2;FGF2;TKT;TPI1;PPIP5K2;PPIP5K1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4771499959784107,1.0633392591678548,0.4015748031496063,0.7874976252595614,1.0,4/10,12.74%,ANXA2;NELL1;EPHA4;EFNA1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.3330851158162911,-1.063101735040816,0.3387096774193548,0.769282827315162,1.0,8/30,15.91%,MPPE1;PIGM;PIGU;PIGK;PIGQ;PIGH;DPM2;PIGO
prerank,sodium ion transmembrane transport (GO:0035725),-0.2723673948160777,-1.0629253403392689,0.31176470588235294,0.7687533700758031,1.0,12/84,6.69%,SLC6A6;SLC12A2;SLC9A2;ATP1B1;SLC24A2;SLC6A1;SCN1A;HCN1;ATP1A1;SLC8A1;HCN2;SCN2A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3957766450621518,-1.0627436338479987,0.37254901960784315,0.7682693827580874,1.0,2/17,1.17%,PRKG1;MEF2C
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3470257111977721,-1.0622330769167188,0.36551724137931035,0.7687382049950051,1.0,7/27,15.23%,DACH1;BMPR2;ACVRL1;ATM;FGF2;RGCC;CDKN1A
prerank,response to steroid hormone (GO:0048545),0.37026937383245995,1.0619635556207847,0.3779264214046823,0.7904180188866167,1.0,5/31,9.42%,TFPI;ATP1A2;NR1H3;YAP1;CATSPER4
prerank,protein modification process (GO:0036211),-0.2734368067046956,-1.0611364236782717,0.3235294117647059,0.7709558586670635,1.0,17/76,16.64%,ST8SIA4;CHRM3;ST3GAL6;CPE;MSRA;RPN2;FBXL2;MMP15;SERP1;QPCT;PIGH;UBA52;PHEX;SEPHS1;PLOD2;ERO1A;UBE2D3
prerank,positive regulation of immune response (GO:0050778),0.3203193493625612,1.0610699230810596,0.3768996960486322,0.7920568701961839,1.0,7/64,7.85%,RSAD2;IL6ST;FPR2;MYB;IFI35;GBP5;LGALS9
prerank,endothelial tube morphogenesis (GO:0061154),0.46909754106708634,1.06091517701135,0.3933463796477495,0.7917475891500412,1.0,2/10,2.44%,RBPJ;CCM2
prerank,regulation of myotube differentiation (GO:0010830),-0.34885672289820285,-1.0606975813519568,0.3778801843317972,0.7712509500405831,1.0,6/24,9.20%,NOTCH1;CCN3;ATP11A;HDAC9;SIK1;HDAC1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3969612065640828,-1.060450558391213,0.3920704845814978,0.770919122620771,1.0,15/16,51.13%,CYRIB;CEACAM1;PTPRC;STX7;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL12B;RIPK3;XCL1;KLRC1;AGER
prerank,maintenance of protein localization in organelle (GO:0072595),-0.37394187129407197,-1.060385777547522,0.3722943722943723,0.7701088452705345,1.0,9/19,22.69%,AKT1;TAF3;PINK1;TAF8;HSPA5;BCL3;ARL2;SKP1;CHCHD10
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.28894519137754143,1.0587445369657502,0.37,0.7967860216194315,1.0,19/118,9.30%,PHLDB2;SH3D19;SP100;PID1;STAT2;PHIP;SDC2;DAG1;NEDD4;RC3H1;IL6;CLASP1;PHLDB1;BCL9L;GSK3B;CAPZB;EPHA4;FMNL2;LRRK2
prerank,protein targeting to mitochondrion (GO:0006626),-0.29824073110072624,-1.058285459284743,0.3565459610027855,0.7750793828343956,1.0,16/52,22.68%,MFF;HSPA4;MFN2;GDAP1;SAMM50;TIMM8B;HSP90AA1;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22;IMMP2L;NDUFA13;TIMM10
prerank,DNA dealkylation (GO:0035510),0.4759703354857222,1.057887898833781,0.39344262295081966,0.7975283660688253,1.0,4/10,16.28%,ASCC3;FTO;ALKBH1;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4759703354857222,1.057887898833781,0.39344262295081966,0.7975283660688253,1.0,4/10,16.28%,ASCC3;FTO;ALKBH1;MGMT
prerank,regulation of protein localization to membrane (GO:1905475),0.3711460454458316,1.0578351092729952,0.37742504409171074,0.7968997029353588,1.0,6/28,9.79%,GPC6;SPTBN1;MMP14;GPC2;STX8;APPL1
prerank,negative regulation of apoptotic process (GO:0043066),0.25481273360175516,1.05741484579458,0.3329479768786127,0.7972294793787839,1.0,83/444,16.28%,PDPN;FHL2;FSTL1;ARHGAP10;RNF213;TLE1;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;IL6ST;PHIP;GATA6;PRAP1;SNX6;NFATC4;SH3RF1;ITGA5;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;MCL1;HAX1;SIAH2;ARF4;ANXA4;BIRC3;RASA1;CTSH;GLO1;NGFR;GSK3B;CCL2;ANXA5;RIPK2;PHB2;WNT5A;YAP1;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;GRK5;BCL2L1;TJP1;FNIP1;PTK2;NAA15;MAP2K5;EGR3;DSTYK;RPS6KA3;API5;SUPV3L1;OPA1;CBX4;TMEM14A;BDNF;BFAR;ERCC5;IFIT3;NUAK2;VHL;NIBAN2;BIRC6;HDAC2;CSNK2A2;FIGNL1;KDM2B;DAB2;TAF9;IGF1R;HSPA9;MGMT
prerank,positive regulation of transferase activity (GO:0051347),-0.2521656765166905,-1.057110973729404,0.3023255813953488,0.7775315772187569,1.0,35/142,14.70%,TEK;MERTK;ERBB4;TIE1;SERINC1;INSR;EPHA5;KDR;NTRK2;FLT1;PRKCQ;MET;NEK7;SORL1;EPHB1;PARM1;CTNNB1;SERINC5;MRE11;MAPK3;HSP90AB1;RPS2;PINK1;EPHA6;CD74;RET;DCUN1D2;NVL;EGFR;KLF4;HSP90AA1;CSF1R;DCUN1D5;DCUN1D1;PNKP
prerank,response to tumor necrosis factor (GO:0034612),0.30059573776647486,1.057041429586844,0.35260115606936415,0.797452783002232,1.0,9/91,7.87%,PID1;ADAMTS12;ZFAND6;GBP2;CXCL16;AFF3;GSDME;CCL2;NUB1
prerank,regulation of leukocyte activation (GO:0002694),-0.4142667903209665,-1.0569683964383,0.38762886597938145,0.7769540078001942,1.0,5/14,21.87%,MFHAS1;CD74;LYN;MYO18A;MIF
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3737936983910163,1.0569342713587937,0.4058219178082192,0.7969670000077383,1.0,2/27,4.20%,LPAR1;F2RL3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.45514876165941603,1.0567699381669888,0.4048059149722736,0.7966144300013033,1.0,5/11,21.65%,COLEC12;SCARA3;TICAM1;UNC93B1;RIPK1
prerank,phagosome maturation (GO:0090382),-0.3166687494040026,-1.056332048884226,0.36503856041131105,0.7777675168588312,1.0,12/35,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;RAB32;ATP6V0D2
prerank,negative regulation of cell death (GO:0060548),-0.2710070599503168,-1.0562215219177022,0.3238993710691824,0.7770974580640146,1.0,39/88,32.04%,MECOM;PDE8A;CD34;SNCA;TM7SF3;CCN3;SORL1;CCN5;BMP4;AKT1;TNFRSF1B;PINK1;FGF2;PAX2;NPAS2;PARK7;PRKD1;BTBD10;HTR2B;PACRG;BNIP3L;SRGAP2;PSMC5;NUP62;SRSF6;CHMP2A;ADNP2;CDK5;EIF4G1;SOX11;WNT16;AMIGO2;CLU;RAD18;TRAF2;DCPS;GPNMB;MT3;TMEM109
prerank,potassium ion export across plasma membrane (GO:0097623),0.44914889815152065,1.0561037464928156,0.38361266294227186,0.7976038922724479,1.0,1/13,0.51%,KCNT2
prerank,regulation of axonogenesis (GO:0050770),0.333502182619929,1.0560941458843598,0.3667205169628433,0.7968477612409167,1.0,8/51,8.24%,PLXNA2;ROBO1;TIAM2;MAP6;LRP4;NGFR;GSK3B;EPHA4
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.33073088095644754,-1.0558763766757788,0.3497536945812808,0.7770681167280729,1.0,5/31,8.06%,HSPA8;TM7SF3;DAB2IP;HSPA14;HDAC6
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.38541517876256637,1.055678565183043,0.4157509157509158,0.7972126698704062,1.0,8/24,15.77%,VTN;ITGA5;NEDD4;ARNT;CADM4;PTPN1;NIBAN2;PRKD2
prerank,fatty acid biosynthetic process (GO:0006633),-0.2831169451946865,-1.055135927132587,0.3687315634218289,0.7782283854151297,1.0,34/63,43.98%,ELOVL5;ABHD2;ELOVL7;TECR;ACACA;TECRL;ACLY;SCD;ACSBG1;HACD3;LPL;HSD17B8;HPGD;MCAT;FADS1;LIPH;LIPC;ELOVL2;ALOX5;LIAS;CYP2E1;ACOT7;OLAH;GSTM4;GPX4;CBR4;ABCD1;DEGS1;CYP1A1;LTC4S;ACSM3;ELOVL4;ELOVL6;ALOX12
prerank,cell differentiation in hindbrain (GO:0021533),-0.4466454509309475,-1.0549279695089846,0.3938144329896907,0.7778113088777538,1.0,1/11,0.38%,GRID2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4415923189699983,-1.0545502736314436,0.4168466522678186,0.7769396994608698,1.0,6/11,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4415923189699983,-1.0545502736314436,0.4168466522678186,0.7769396994608698,1.0,6/11,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,aorta development (GO:0035904),0.4279277839029997,1.0545373632669985,0.4046692607003891,0.7995768744261621,1.0,3/14,6.11%,ROBO1;EFEMP2;PDGFRB
prerank,neural crest cell migration (GO:0001755),0.3560928976399612,1.054372109258497,0.3804878048780488,0.7992348470671202,1.0,5/36,6.28%,SEMA3D;FN1;RADIL;NRP1;SEMA4B
prerank,B cell homeostasis (GO:0001782),-0.4430703123230101,-1.054300127304381,0.4269005847953216,0.7766803291720402,1.0,4/10,14.09%,MEF2C;DOCK10;LYN;CAMLG
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.39539426091632096,1.054249000891662,0.36510791366906475,0.7980159494444621,1.0,6/23,11.51%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.39539426091632096,1.054249000891662,0.36510791366906475,0.7980159494444621,1.0,6/23,11.51%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,lamellipodium organization (GO:0097581),-0.3425014194943744,-1.054126400901025,0.36650485436893204,0.7762398712463835,1.0,8/29,13.66%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,positive regulation of cartilage development (GO:0061036),0.41846672004518304,1.0541255828408167,0.38786764705882354,0.7975886104663031,1.0,3/17,4.47%,SOX5;BMP2;BMP1
prerank,TOR signaling (GO:0031929),-0.3477590568983317,-1.0532863151163747,0.3767441860465116,0.7776222081783996,1.0,5/26,8.21%,PRR5L;RPS6;CCDC88A;AKT1;PINK1
prerank,aggrephagy (GO:0035973),0.3719496530086963,1.0531863579996854,0.3844797178130511,0.7994241165374719,1.0,4/27,4.24%,DYNLL1;VIM;ARL13B;IFT88
prerank,regulation of protein secretion (GO:0050708),0.29092489873550403,1.0528733706297075,0.37604456824512533,0.7994966501493014,1.0,14/119,10.58%,BMP6;DPP4;RAPGEF4;RSAD2;ITPR1;RFX3;APBB1;IL6;UNC13B;NOS2;CACNA1C;DNAJC1;PPID;DNM1L
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4165515595346833,1.052747132622364,0.40555555555555556,0.7990634708994482,1.0,3/16,8.04%,ROCK2;IL6ST;MEF2A
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4551490747160666,1.0525068024869448,0.40974729241877256,0.7989480978415425,1.0,3/12,9.00%,SORBS1;PRKCZ;IGF2
prerank,ERBB signaling pathway (GO:0038127),0.3191669960999933,1.0524410127721553,0.38510301109350237,0.7983584151300176,1.0,7/64,7.09%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A;MVP
prerank,substrate-dependent cell migration (GO:0006929),0.43205276009130505,1.0522961637387074,0.39029126213592236,0.7979792096458157,1.0,4/14,8.07%,EPHA8;NRP1;NTN1;ITGA11
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4209114569422711,-1.0521847736912155,0.4004282655246253,0.7797614059721861,1.0,2/13,1.72%,PLCB1;IL33
prerank,regulation of apoptotic process (GO:0042981),0.2470010515359355,1.0521713971801332,0.30486486486486486,0.7975547767258581,1.0,116/676,14.82%,IGFBP3;PDPN;FHL2;PAWR;TIAM2;AKAP13;FSTL1;ARHGAP10;PHLDA1;CXCL10;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;WNT10B;IL6ST;PHIP;GATA6;PRAP1;FGD4;PNMA3;STEAP3;FBXO11;SH3RF1;IFIT2;ADAMTSL4;ANXA1;ANGPT1;DAPK1;BMP2;CFLAR;WRN;APBB1;IL6;PLK5;BCL2;ARAF;LATS2;MTDH;UNC13B;ZBP1;MCL1;HAX1;IFT57;SIAH2;ARF4;ANXA4;TNFRSF12A;BIRC3;RASA1;CREBBP;ACTN2;USP27X;CTSH;GLO1;PLEKHG2;ANP32E;NGFR;STAT1;PDCD5;GSK3B;ARHGEF11;TRIM24;ANXA5;QRICH1;RIPK2;PHB2;CHM;BAX;WNT5A;STK3;UBE2Z;NAA16;CALHM2;USP47;ARHGEF12;SMAD6;SOS2;NGEF;DNAJC3;HIPK3;PPID;GRK5;DNM1L;PTPN6;BCL2L1;TJP1;PTK2;NAA15;ANO6;EGR3;DSTYK;FOXO3;RPS6KA3;API5;DAPK2;SUPV3L1;OPA1;CBX4;TMEM14A;RBM5;BFAR;RTN4;ERCC5;ACVR1C;IFIT3;USP36;ALK;NUAK2;VHL;NIBAN2;BIRC6;HDAC2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3763663613284485,1.0515998074973578,0.3910149750415973,0.7982967404015611,1.0,5/27,11.67%,CTPS1;RRM1;NUDT13;AK5;RRM2B
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.29829933873394154,-1.0513789259575654,0.36272040302267,0.781130595508136,1.0,13/50,14.75%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;RFFL;VEGFA;PAX2;RPS6KA1;NGF;KLF4;PLAUR;PARK7
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4369954665503589,1.0511086357509167,0.40636704119850187,0.798862238324311,1.0,6/15,20.73%,GGACT;ALDH4A1;SARDH;PRODH;DPEP1;HOGA1
prerank,oligodendrocyte development (GO:0014003),-0.39792765264533236,-1.0508731978719348,0.4017467248908297,0.7816038983873643,1.0,7/15,33.41%,PLP1;EIF2B2;TPPP;B4GALT6;CNTNAP1;PRDM8;B4GALT5
prerank,epiboly involved in wound healing (GO:0090505),0.4223160432255142,1.0503078659408294,0.3929824561403509,0.8002140674097095,1.0,1/16,0.30%,PDPN
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.4474613163724747,1.0501378293887562,0.40601503759398494,0.7999273938817547,1.0,3/13,10.14%,SP100;TPR;SUFU
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.29212059098365384,-1.049985548600168,0.37566137566137564,0.7831388241810369,1.0,10/52,8.42%,NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;PUF60;KHDRBS3;DDX17
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3372335802729427,-1.0499202361789894,0.38588235294117645,0.7823496891485043,1.0,7/30,14.75%,H3-3A;PKN1;HDAC6;HDAC1;TRIM68;KDM4C;PARK7
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.42201962555062555,-1.0498866486822742,0.40080160320641284,0.7814601512522137,1.0,3/12,9.11%,PLCG2;RAB27A;GRIN1
prerank,sensory perception of sound (GO:0007605),0.3011330001344849,1.0493232550610008,0.38753799392097266,0.8014109640151635,1.0,8/88,6.55%,COL4A3;EYA1;DCDC2;ADGRV1;KIT;ROR1;GSDME;CCDC50
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3976248461878083,1.0491956911621978,0.38859180035650626,0.8009950114134919,1.0,6/20,13.26%,ROCK2;RHOQ;FMNL2;DLG1;PLEK;LLGL2
prerank,protein homotetramerization (GO:0051289),0.33200169035190263,1.0491439039544541,0.39166666666666666,0.8003441559383626,1.0,4/49,6.33%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,anterior/posterior pattern specification (GO:0009952),0.3316154407709252,1.0489329627966473,0.38225806451612904,0.8001357001323268,1.0,12/53,16.33%,WLS;HOXC6;HOXC4;BMP2;TGFBR1;TIFAB;SKI;HEYL;BHLHE41;HOXB4;ACVR2B;SMAD2
prerank,DNA metabolic process (GO:0006259),0.262112225177703,1.0489111695085327,0.34317343173431736,0.799432970580921,1.0,67/270,20.65%,TCF7L2;SP100;PDS5B;DCTPP1;ORC5;POLH;TERT;WRN;TOP1;SLX4;UBE2U;RAD50;PARP3;POLA2;TOP2B;PRIM2;RFC1;POLG;NTHL1;DDX23;MNAT1;PSME4;SUMO1;NABP1;UVRAG;RPA3;XRCC1;MCM4;GMNN;ADPRS;RBBP8;OGG1;SUPV3L1;MCM6;RAD51B;INTS3;GTF2H4;ERCC5;ORC3;RAD9A;DNASE1L1;PDS5A;ALKBH1;ERCC1;ORC4;USP45;MGMT;DDX21;AXIN2;KMT5C;RAN;LRWD1;SMARCAL1;FANCC;RNASEH1;PARP4;XPC;DFFB;DNA2;NSMCE3;USP7;LONP1;RIF1;CTC1;NABP2;KMT5B;POLD3
prerank,serine family amino acid catabolic process (GO:0009071),0.4631336941690857,1.0487963341186592,0.42971887550200805,0.7989768192253499,1.0,2/10,8.48%,SHMT1;AMT
prerank,muscle cell migration (GO:0014812),-0.4449263930246089,-1.048738857024474,0.42574257425742573,0.7837363452913529,1.0,7/10,34.44%,SIX1;CCN3;MEGF10;THBS4;DDR1;ITGB1BP1;AAMP
prerank,positive regulation of exocytosis (GO:0045921),-0.317555406268997,-1.0484992043352497,0.37185929648241206,0.783399312909459,1.0,15/35,27.64%,RAB27A;CADPS;SNCA;RAB27B;SDCBP;CLASP2;EXPH5;RAB15;SYTL4;ATP6AP1;SNF8;CHMP2A;SDC4;HGS;UNC13D
prerank,phosphatidic acid metabolic process (GO:0046473),0.3304612626602597,1.0482380860242655,0.3823038397328882,0.7997317317526146,1.0,7/48,11.23%,PLD1;PLA2G4A;AGPAT4;DGKD;PLA2G6;GPD1L;AGPAT3
prerank,actin filament-based transport (GO:0099515),0.39677996663847864,1.048026863799869,0.3957597173144876,0.7995422646137471,1.0,10/21,19.11%,SYNE2;MYO1B;MYO1A;WASL;MYO15A;MYO1E;MYO1C;MYO5A;MYO19;MYO5B
prerank,negative regulation of double-strand break repair (GO:2000780),0.3570839163216282,1.0479853433676372,0.37766830870279144,0.7989020455347303,1.0,15/30,27.81%,TRIP12;KLHL15;FBH1;OGG1;ERCC6;SHLD2;UBR5;CYREN;RIF1;SMCHD1;SHLD1;TFIP11;FANCB;CGAS;HMGA2
prerank,phospholipid biosynthetic process (GO:0008654),-0.32272997737893394,-1.047379792275844,0.3492822966507177,0.7856247742642865,1.0,15/36,28.11%,SGMS1;SRD5A3;MBOAT1;PCYT2;NUS1;SGMS2;DOLPP1;CPNE7;AGPAT5;CLN3;DHDDS;FADS1;HDHD5;MVD;SAMD8
prerank,negative regulation of DNA replication (GO:0008156),0.4424193189243327,1.0467538391022275,0.43308550185873607,0.8014835319690102,1.0,5/13,16.44%,CDAN1;GMNN;TSPYL2;PDS5A;S100A11
prerank,response to cAMP (GO:0051591),-0.3220826697954721,-1.0464750126096023,0.38929440389294406,0.787250193868049,1.0,8/37,12.24%,AKAP6;HCN1;SLC5A5;INPP5K;HCN2;RAPGEF2;PDE2A;KCNQ1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.36378260707821436,-1.0460675270074018,0.3925438596491228,0.7874161936111295,1.0,4/20,21.43%,STARD3NL;FDXR;HSD17B10;CYP46A1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3486306923779899,1.0459224068819888,0.40387722132471726,0.8029700852825569,1.0,9/36,12.26%,TCF7L2;FZD2;TNRC6B;PLCB3;TNRC6A;WNT5A;MOV10;PPP3CB;MAP3K7
prerank,regulation of autophagy (GO:0010506),0.26689106441806737,1.045025843595806,0.3588082901554404,0.8046810536637253,1.0,59/216,22.08%,LEPR;ITPR1;RNF152;PRKAG2;PRKAA2;NUPR1;SNX6;NEDD4;DAPK1;DCN;BCL2;MTDH;PTPN22;MCL1;KLHL22;HAX1;OPTN;MTMR3;TRIM5;PIK3C2A;GSK3B;LRRK2;TLK2;TPCN1;DNM1L;KEAP1;FOXO3;SLC38A9;TRIM21;EEF1A2;DAPK2;PIP4K2B;ATP6V0B;TICAM1;USP36;WDR6;CSNK2A2;ATP6V1E1;ATP6V1C1;GOLGA2;EXOC7;EXOC1;CASP3;ABL2;USP10;PIP4K2C;PLEKHF1;VPS26B;ROCK1;TRIM8;SREBF1;SIRT2;MTMR4;TRIM65;VPS35;FBXW7;ATG13;ZC3H12A;RRAGD
prerank,cellular response to light stimulus (GO:0071482),-0.2757715668745641,-1.044760970367783,0.366120218579235,0.7901955908361605,1.0,26/66,32.69%,PTPRK;RPL26;NPM1;YY1;ATF4;COPS9;CASP9;BMF;PDE6A;GPR88;N4BP1;NOC2L;POLD1;ATR;POLK;SAG;RHNO1;MYC;PDE6G;PCNA;TMEM161A;RRH;TP53;OPN1MW3;OPN1MW;RUVBL2
prerank,dephosphorylation (GO:0016311),0.28058136039280857,1.0446140812020397,0.3785310734463277,0.8050350322919035,1.0,33/147,12.79%,PTPN13;PLPP3;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;DUSP28;PTPN3;PTPN22;PTPRA;MTMR3;DUSP16;PTPN9;SSH1;PTPN21;PPEF2;PPP4R2;CTDSP2;PLPPR3;NT5C;PPP4R1;PPM1B;PTPN6;PPP1CB;PTPRU;PPP3CB;DUSP5;BTRC;PTPN1;PTPN18;FBXW11
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35726327992165063,1.044552755249571,0.4099264705882353,0.8044424358468013,1.0,10/33,13.11%,PDPK1;FGF1;CEMIP2;ITGA5;JMJD8;GLUL;FGF18;TJP1;EPN1;JAK1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3323850378153729,-1.0444946780743827,0.3898305084745763,0.7900453215394582,1.0,13/30,32.03%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;HSD17B7;DHCR7;LSS;MVD;MSMO1;DHCR24;IDI1;PLPP6
prerank,base-excision repair (GO:0006284),0.3322886355142118,1.0443270291826514,0.39389067524115756,0.8042764898239347,1.0,12/48,14.06%,WRN;RFC1;POLG;NTHL1;USP47;RPA3;XRCC1;HUWE1;ADPRS;OGG1;ERCC5;ERCC6
prerank,autonomic nervous system development (GO:0048483),0.4138903978799674,1.0441540494842687,0.4126126126126126,0.8039949110410269,1.0,2/17,2.97%,FN1;NRP1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32305355469972713,1.044038462572067,0.39546191247974066,0.8035382690658978,1.0,8/57,8.87%,LPAR1;FPR2;AKAP12;HRH3;ADCY5;ADCY7;ADCY1;INSL3
prerank,regulation of chemokine production (GO:0032642),0.3469870710618609,1.0440110084279295,0.3949579831932773,0.8028648078362115,1.0,7/36,11.12%,EIF2AK2;IL6;TLR4;IL18;LGALS9;WNT5A;TLR2
prerank,regulation of chromatin binding (GO:0035561),0.4618757360241975,1.0440039651490325,0.4077490774907749,0.8021366372045885,1.0,3/10,10.51%,PARP9;DTX3L;GMNN
prerank,regulation of cellular respiration (GO:0043457),-0.38098284880645583,-1.0436590511201225,0.4288747346072187,0.7914634044529124,1.0,4/17,8.19%,PRDM16;CBFA2T3;IFNAR1;PRELID1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.3993610224743524,1.0434099558386156,0.4169811320754717,0.8029673870781343,1.0,7/20,17.46%,STK39;OSR1;NEDD4;ACTN2;HECW2;ADRA2A;YWHAE
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3904917841147413,1.0433076047675764,0.407871198568873,0.8024914386539621,1.0,5/24,9.00%,ENPP1;SORBS1;EPM2AIP1;GSK3B;IGF2
prerank,response to axon injury (GO:0048678),0.41935787472760055,1.0432624397779906,0.43902439024390244,0.80185076091927,1.0,2/18,5.80%,DPYSL3;NREP
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.39795824333414676,1.0431424000576957,0.4115384615384615,0.8014251987759197,1.0,2/20,3.96%,WNT4;BMP2
prerank,peroxisomal membrane transport (GO:0015919),-0.3429971612020044,-1.0429262565810422,0.3886255924170616,0.7927216174244915,1.0,15/27,34.74%,ABCD4;ATAD1;PEX26;GDAP1;PEX10;ABCD2;PEX16;PEX19;PXMP4;RAB8B;PEX3;PEX11B;ALDH3A2;PEX1;PEX13
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.4243063075063066,1.0428913542888434,0.40808823529411764,0.8013575404301889,1.0,6/15,17.12%,BMP2K;DGKD;AAK1;WASL;DAB2;NEU3
prerank,cellular response to UV (GO:0034644),-0.2707101671899523,-1.0428570351536108,0.37110481586402266,0.7919428823703425,1.0,30/76,32.69%,PTPRK;RPL26;STK11;NPM1;YY1;ATF4;COPS9;CASP9;BMF;CDKN1A;MFAP4;MMP1;N4BP1;CHEK1;NOC2L;POLD1;ATR;POLK;DDB2;TIMP1;RHNO1;HYAL3;MMP2;MMP3;MYC;PCNA;TMEM161A;TP53;HYAL2;RUVBL2
prerank,regulation of cytokine production (GO:0001817),0.2817617691842393,1.042801599550771,0.37518037518037517,0.8008355994533669,1.0,25/126,15.64%,LGR4;EIF2AK2;TRIM56;TWSG1;PLA2R1;ANXA1;IL6;DTX4;C5AR2;IGF2BP1;ZBP1;FOXP3;NOS2;CD47;CRP;LGALS9;MAPK14;IGF2BP2;TRIM21;ATP2B1;SRGN;IFIH1;TBK1;ADRA2A;TXK
prerank,organelle transport along microtubule (GO:0072384),0.36022900707303396,1.0427014475961756,0.3861566484517304,0.8003574782292472,1.0,9/31,21.23%,ARHGAP21;TRAK1;UXT;KIF5B;FBXW11;RHOT1;RHOT2;BORCS5;PEX14
prerank,heart contraction (GO:0060047),0.3428332380941883,1.042608897281165,0.3833605220228385,0.7998902666285226,1.0,4/41,4.92%,TNNC1;ATP1A2;CSRP3;TPM1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.296785858459487,-1.0422222446366776,0.38419618528610355,0.792877794261045,1.0,15/51,12.25%,CNTNAP2;TNIK;GPM6A;NCKAP1;TRIO;PAK1;NYAP2;DAB2IP;DCLK1;SHTN1;UBB;MINK1;DBNL;ALS2;NGF
prerank,protein mannosylation (GO:0035268),0.39219224941547526,1.0422142534585679,0.417910447761194,0.8001973562459967,1.0,5/22,7.26%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.366787511933801,-1.042194616728659,0.4054669703872437,0.791969285901312,1.0,9/19,35.36%,BAG6;DDIT4;PYCARD;BCL3;HIPK2;CDIP1;TP53;TMEM109;AEN
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2564672902482003,1.0420178802697562,0.36848484848484847,0.7999802487183081,1.0,72/348,16.13%,LEPR;BMP6;TEC;ROCK2;VTN;PRKAG2;FGF1;DDR2;GHR;FPR2;WNT3A;BMPR1A;OSM;IL11;FAM20A;NRP1;TWSG1;ITGA5;VEGFD;IL34;ANGPT1;BMP2;SLCO3A1;IL6;BMP7;ARAF;STOX1;TGFBR1;CCND3;RAD50;HAX1;PELI2;ATP2B4;CREBL2;RALBP1;BMP8B;OPRD1;FBH1;TNFRSF14;RIPK2;SNX9;IGF2;LRRK2;RAP2C;DOCK7;MUSK;FGF18;ENPP2;FNIP1;PTK2;SMAD4;CSF1;DVL3;HFE;RARRES2;EFNA1;ARRB1;MTCP1;BDNF;TBK1;P2RY1;GDF11;NTRK3;GDF15;ILK;IQGAP1;STK4;DAB2;PRKD2;APP;CNOT9;INHA
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3029489895390614,-1.0419856328914803,0.37376237623762376,0.7915986051950312,1.0,17/49,24.83%,ACER2;INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CASP9;RAD1;BCL3;CHEK1;E2F7;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.33191399032769714,1.0416715341683218,0.38422818791946306,0.8001413674733844,1.0,7/49,8.81%,KMT2A;MTURN;TNRC6B;GP1BA;KMT2C;TNRC6A;MOV10
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4087163487898582,1.0413094987087081,0.43272727272727274,0.8003502784045808,1.0,7/18,20.83%,RFX3;ODAD4;DNAAF1;NPHP3;SPEF2;CCDC39;OFD1
prerank,vasculature development (GO:0001944),0.41425130337713834,1.0412908895231723,0.40293040293040294,0.7996586048349248,1.0,4/16,6.11%,PDGFRA;CDH5;ERRFI1;PDGFRB
prerank,regulation of trophoblast cell migration (GO:1901163),0.43262352540920895,1.041289851764162,0.4274952919020716,0.798918399689611,1.0,4/14,14.05%,SMURF2;GJA1;SYDE1;ACVR1C
prerank,secretory granule organization (GO:0033363),0.46651648802799217,1.041093922523898,0.41541353383458646,0.798698957188763,1.0,4/10,14.75%,F2RL3;DTNBP1;SRGN;ABCA1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.30764878286649683,1.0410489033947286,0.378419452887538,0.7980676844364332,1.0,11/73,10.29%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.356581210197372,-1.0409300301788993,0.3957845433255269,0.7936576332630959,1.0,7/26,16.20%,EFNA5;ANO1;EPHA5;KLF7;LRP5;BRSK2;ADCY8
prerank,ventricular septum development (GO:0003281),0.3491186263010726,1.040847701772622,0.4083044982698962,0.7978738199691999,1.0,11/37,14.12%,ROBO1;TGFBR3;BMPR1A;TGFBR1;SALL1;TGFBR2;HEYL;SMAD4;HECTD1;NOG;MDM4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3122421549312453,-1.040533122060495,0.38480392156862747,0.7938302221340818,1.0,9/39,9.86%,CHRM3;FGF12;FXYD5;HOMER1;UTRN;YWHAH;TRPC6;NEDD4L;CACNA1D
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3078518445157897,-1.040327450223836,0.38498789346246975,0.7934370209317845,1.0,15/40,16.45%,SGIP1;HIP1;INSR;AHI1;SCYL2;HNRNPK;B2M;LDLRAP1;VEGFA;ATAD1;CBL;SFRP4;CCL19;EGF;NTF3
prerank,regulation of microtubule depolymerization (GO:0031114),-0.34315241801921265,-1.0402719184177138,0.39351851851851855,0.7925930513567848,1.0,7/25,17.33%,NAV3;ARHGEF2;STMN2;MAP1B;FGF13;CLASP2;MID1IP1
prerank,toxin transport (GO:1901998),0.46408507735207416,1.0401617816732016,0.4388349514563107,0.7989409067740764,1.0,4/10,21.36%,ANTXR1;SLC22A2;ANTXR2;SLC22A3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.40780402615859757,-1.0401431404038977,0.408207343412527,0.792018568696878,1.0,3/12,11.68%,PROM1;PTPRO;BASP1
prerank,mammary gland epithelium development (GO:0061180),0.42337662471661286,1.0399607221071152,0.42857142857142855,0.7987213517362152,1.0,1/14,0.44%,WNT4
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3312464266460073,1.039803078352516,0.40947546531302875,0.7983851111819491,1.0,4/46,3.04%,PLD1;PLA2G4A;AGPAT4;DGKD
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4411965916846841,1.0397195103441736,0.44878957169459965,0.7978767158368637,1.0,6/13,25.87%,UBA5;SENP6;ATG10;ATG7;DESI1;DESI2
prerank,detection of mechanical stimulus (GO:0050982),-0.36728902269701114,-1.0395184472299381,0.3933333333333333,0.7928100351857933,1.0,3/19,5.47%,PIEZO2;CDH2;CTNNB1
prerank,cellular response to acid chemical (GO:0071229),-0.3431418249916822,-1.0393763313267792,0.40043763676148797,0.7922758865724222,1.0,11/27,26.20%,KLF2;VEGFA;RRAGB;CPEB4;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.40185306419131295,-1.0393554043381357,0.43340857787810383,0.7913680213274227,1.0,3/14,8.54%,GAS6;CCDC3;RFFL
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.33433352597266947,1.0393313186063733,0.3969335604770017,0.7981343362497134,1.0,17/42,19.51%,MBD2;ANP32E;HNRNPC;VPS72;GATAD2B;CECR2;ACTL6A;SRCAP;ERCC6;HDAC2;SMARCA4;SMARCC1;CHD8;CHD4;ARID1B;ACTR8;NASP
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.47227280650897974,1.0380462141011537,0.4305019305019305,0.8007214411739835,1.0,5/10,24.70%,MYB;JARID2;KDM1A;RIF1;ATRX
prerank,negative regulation of viral life cycle (GO:1903901),-0.38892313604151385,-1.037889238998192,0.4025695931477516,0.7945384583304099,1.0,6/15,15.41%,LY6E;SNX3;MID2;IFITM3;PPIA;IFITM2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3191815353943802,1.0376094703511052,0.38283828382838286,0.8011357108753517,1.0,10/60,13.36%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10;ATF7IP;MED12;MED20
prerank,amide transport (GO:0042886),-0.33894516338806363,-1.0375611971887968,0.39909297052154197,0.7945004478592914,1.0,6/26,6.82%,ABCG2;CERT1;SLC38A5;AQP11;SLC5A6;GLTP
prerank,cellular response to unfolded protein (GO:0034620),-0.3367685879671726,-1.0375417757778966,0.395,0.7935957073691641,1.0,4/26,5.60%,HSPA8;TM7SF3;DAB2IP;HSPA14
prerank,negative regulation of calcium ion transport (GO:0051926),0.41723485325173076,1.0373390504701447,0.405607476635514,0.8011511467329031,1.0,1/15,0.45%,ATP1A2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.45219733096931236,1.0369887947638758,0.41916167664670656,0.8013573470506669,1.0,5/11,15.67%,MLLT3;WNT5B;PLEKHA4;NKD1;DAB2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.38196260937048687,-1.0367865226857673,0.4200426439232409,0.794838111546591,1.0,3/16,7.35%,BMPR2;PRCP;ACE
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.37010468820509557,1.0366193642003412,0.39661016949152544,0.8016293938193686,1.0,10/30,18.98%,PARP14;PRKCZ;PTPN2;MVP;PTPN6;SH2B3;CADM4;NF2;PPP2CA;DMTN
prerank,double-strand break repair (GO:0006302),0.27813497826886424,1.0362718531293942,0.3900414937759336,0.8018115326304562,1.0,46/158,21.52%,EYA1;PARP9;NHEJ1;NUCKS1;WRN;APBB1;TONSL;SLX4;RAD50;PARP3;DTX3L;SPIDR;SFR1;FBH1;AP5Z1;BAZ1B;XRCC4;SUMO1;NABP1;RPA3;XRCC1;DCLRE1A;RFWD3;RBBP8;NSMCE2;KDM2A;RAD51B;PRPF19;ERCC5;UIMC1;ERCC1;SMARCAL1;ACTR8;TDP2;BRCC3;DNA2;CYREN;RIF1;SMC6;NABP2;UBXN1;EYA3;INO80;CHEK2;PALB2;NSMCE1
prerank,response to molecule of bacterial origin (GO:0002237),0.3085284157948691,1.0361222984308498,0.39906832298136646,0.8014725537077899,1.0,14/69,15.47%,SELP;FER;IL6;TLR4;PTPN22;NOS2;LY96;LGALS9;NOCT;SMAD6;IRAK3;RPS6KA3;TRIB1;IL23R
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2794725634449385,1.0360694314277303,0.3723849372384937,0.800891442484301,1.0,28/140,18.11%,LPAR1;PDGFRA;FPR2;ACKR2;CCR9;CD55;F2RL3;ADCY5;C5AR2;PLCE1;BDKRB2;SPPL3;ACKR3;CACNA1C;JPH1;GPR65;JPH3;CIB2;P2RY1;CCRL2;CACNA2D1;CCKBR;CXCR4;JPH4;P2RX4;TAC4;ABL2;GPR157
prerank,sodium ion homeostasis (GO:0055078),-0.3585307528579005,-1.0358550775511317,0.42954545454545456,0.7964376856196096,1.0,5/21,9.49%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4683591129243903,1.0353556613643664,0.4018867924528302,0.801970760213724,1.0,1/10,0.35%,SOX5
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4076015198328056,1.035127287570894,0.4028520499108734,0.8018526009905994,1.0,2/18,4.25%,ENPP3;IFI35
prerank,negative regulation of insulin secretion (GO:0046676),-0.3809456753727338,-1.0351121028100094,0.4043478260869565,0.7976786314039493,1.0,4/17,13.96%,KLF7;CCN3;KCNB1;INHBB
prerank,secondary alcohol metabolic process (GO:1902652),0.33737766885775083,1.0349500875135902,0.3976510067114094,0.8016100527808243,1.0,9/42,14.75%,APOA2;APOF;CYP27A1;IDH1;SOAT1;CH25H;OSBPL5;IDH2;ABCA1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4327195143131677,-1.0348466795857354,0.4151696606786427,0.7974454876093078,1.0,5/11,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3862612475006644,1.0347199916375445,0.3924731182795699,0.8015244487309185,1.0,4/21,6.98%,CGNL1;ARHGAP12;SYNGAP1;STAMBP
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.32610336590879513,-1.0344453436020133,0.4084507042253521,0.797664326285416,1.0,14/36,24.83%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CDC45;RAD1;CHEK1;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3416804493102752,-1.0342627818869456,0.3761467889908257,0.7972294345057623,1.0,5/24,5.63%,DACH1;BMPR2;ACVRL1;RPS3;MSH3
prerank,macrophage activation involved in immune response (GO:0002281),-0.4110295601275311,-1.0342253510358739,0.4336283185840708,0.7963777023051829,1.0,4/13,13.25%,PLCG2;DYSF;SYK;GRN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.28690893552816654,-1.0341659363876556,0.41456582633053224,0.7955803566020592,1.0,20/57,21.03%,NOD1;MAP3K5;GRIN2A;PERP;GRIN2B;HMGB1;CTSD;LGMN;SOX7;GRIN1;MALT1;AIM2;SYK;TTBK1;FOXL2;PYCARD;PPM1F;CASP1;BAD;NDUFA13
prerank,regulation of neuroinflammatory response (GO:0150077),0.3878113037841615,1.0340961473490078,0.41530054644808745,0.8024322447794895,1.0,3/19,7.50%,NUPR1;IL6;IL18
prerank,regulation of protein localization to cell periphery (GO:1904375),0.39653697059271764,1.034050859456126,0.4337121212121212,0.801818812127896,1.0,5/18,9.79%,SPTBN1;MMP14;MISP;STX8;APPL1
prerank,cellular protein localization (GO:0034613),-0.22299652946029777,-1.0336844742002278,0.3368421052631579,0.796014431137476,1.0,53/285,12.57%,CNTNAP2;GRID2;ESAM;PTPRK;DMD;TBC1D8;NSF;CPE;SYNDIG1;STX3;REEP1;ID1;EMP2;ARF5;TBC1D30;FBLN5;CTNNB1;AHI1;ARHGEF2;STXBP1;RAB6B;CEP68;YWHAH;STX16;RIC3;RAB38;HERC2;AMOT;TM9SF3;ARL1;SCG5;JAM3;CNTLN;HDAC6;NPM1;SGSM1;TMED2;VPS33B;CNTN2;RRAGB;CD74;ATG9A;HHEX;MFN2;PIGU;PIGK;TBC1D22B;TBC1D8B;TBC1D14;CPLANE2;EGFR;NAPA;RUNDC1
prerank,response to ketone (GO:1901654),-0.3503270471842245,-1.0335257268460016,0.42650602409638555,0.7955202335943424,1.0,4/24,2.48%,SLIT2;TGFB2;THBS1;ABHD2
prerank,negative regulation of cell adhesion (GO:0007162),-0.268709807318846,-1.0335079938623164,0.40816326530612246,0.7946299663370396,1.0,20/72,16.83%,PLXNA4;PDE3B;ACER2;NOTCH1;CDH1;ACVRL1;SEMA4D;SEMA6A;TGFBI;ADAM22;NEXMIF;JAM3;ARHGDIB;SPOCK1;PTPRO;ARHGDIA;FZD4;PTPRC;CBLL1;PLXND1
prerank,positive regulation of endocytosis (GO:0045807),-0.2982798611449249,-1.0334431183054733,0.3811881188118812,0.7938484742120047,1.0,9/45,10.75%,NLGN1;SGIP1;HIP1;SNCA;HNRNPK;B2M;LDLRAP1;NEDD4L;CBL
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.34669941731064247,1.0334076447961693,0.4110032362459547,0.8028178074630796,1.0,9/35,16.38%,LEPROT;GHR;KIT;IL6;CRLF3;SH2B3;VHL;OCIAD1;NF2
prerank,embryonic limb morphogenesis (GO:0030326),0.35009852572572886,1.0331582841030866,0.39168110918544197,0.8027420508275108,1.0,7/34,8.79%,OSR1;AFF3;GLI3;SALL1;CREBBP;SKI;CACNA1C
prerank,regulation of calcium ion transport (GO:0051924),-0.2841478723340295,-1.0331362870018823,0.38108882521489973,0.7937884002565103,1.0,12/54,12.86%,EPB41;CACNB2;HOMER1;CTNNB1;INPP5K;TRPC6;CAMK2A;MYLK;CACNA1D;NOS1;CD84;SRI
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4380025238491382,1.0324645633069303,0.4204322200392927,0.8038101007523494,1.0,1/12,0.67%,ROCK2
prerank,regulation of protein sumoylation (GO:0033233),0.41648253709802285,1.0320805064556091,0.43566176470588236,0.8040829180274713,1.0,3/17,8.24%,ZMIZ1;HDAC4;PIAS1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.24817360597674684,-1.0320566524385322,0.39344262295081966,0.7958535833681655,1.0,36/114,25.30%,ST18;TMSB4X;PTK2B;PSMC3;COMMD7;TNFRSF1B;PSMD14;PSMD3;PSMD4;PSMD6;CD40;PSMA6;AIM2;EIF5A;PSMA4;PSMB8;ACTN4;PSMA8;CD27;LTBR;PSME1;PYCARD;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;BAG4;PSMB1;TRAF1;TNFRSF11A;TNFRSF9;PSMD11;TNFSF13;PSMD8;TXNDC17
prerank,response to hydrogen peroxide (GO:0042542),-0.2977694616218945,-1.0316684777294884,0.369727047146402,0.7960371140368708,1.0,13/45,21.52%,NET1;SETX;MAP3K5;RPS3;PLEKHA1;RHOB;HDAC6;PAX2;PARK7;SOD1;ECT2;STK26;TRPM2
prerank,GPI anchor metabolic process (GO:0006505),-0.3311450317321465,-1.0315438136312944,0.41387024608501116,0.7954637575703237,1.0,7/26,15.91%,MPPE1;PIGM;PIGU;PIGQ;PIGH;DPM2;PIGO
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3570463445665847,1.0315204324336937,0.400679117147708,0.8047979216852009,1.0,3/32,4.20%,PDPK1;CXCL10;F2RL3
prerank,innate immune response (GO:0045087),0.26429663242299317,1.031300033204889,0.39258312020460356,0.8046067696295657,1.0,40/217,15.87%,STYK1;CXCL10;SP100;COLEC12;CXCL16;TRIM56;TRIM10;FER;BPIFB1;TLR4;TRIM17;TRIM5;BST2;NOS2;CRP;NUB1;RIPK2;PHB2;PJA2;ANKRD17;IFITM1;IFNLR1;TLR2;PTK2;IFI27;ADAR;TRIM21;IFIT1;RARRES2;TRIM26;SRPK1;ANKHD1;RNF39;TIFA;IFIH1;TBK1;FRK;PML;IL23R;APP
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.44198067900940297,1.0309500630575814,0.4367816091954023,0.8048437313186634,1.0,7/12,26.83%,PCGF5;RBM15;LRIF1;PCGF3;RLIM;SMCHD1;YTHDC1
prerank,synaptic membrane adhesion (GO:0099560),-0.4006536797928857,-1.030940378100865,0.43312101910828027,0.7962697459004893,1.0,7/14,20.67%,PTPRD;LRRC4C;LRRC4B;SLITRK2;SLITRK1;LRFN5;NTNG1
prerank,macrophage chemotaxis (GO:0048246),0.4528170393315669,1.0305142756348098,0.41386138613861384,0.8052335948164318,1.0,2/10,7.71%,CKLF;CCL2
prerank,endoderm formation (GO:0001706),-0.3149849787636295,-1.0305015821693517,0.3989769820971867,0.7965739983359614,1.0,9/35,9.60%,COL8A1;ITGA4;SOX17;LAMA3;MMP15;COL12A1;SOX7;COL6A1;ITGA7
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.29738857023412957,-1.030400847909248,0.4040920716112532,0.7958766331604641,1.0,8/44,10.04%,PTPRJ;SORL1;DAB2IP;INPP5K;BMP4;PAQR3;LYN;MAPK8IP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.43835997290646345,1.030301138839291,0.4215686274509804,0.8050548926036925,1.0,3/13,10.49%,BMP2;DKK3;PLEK
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3551297800763342,-1.0299443222506934,0.4150537634408602,0.7962113325182097,1.0,10/22,33.18%,ESR1;PSMC3;MED30;PSMC6;PSMC5;SRF;MED13;TP53;PAXIP1;SUB1
prerank,positive regulation of cell motility (GO:2000147),0.2692599354454743,1.0298953696967823,0.40797940797940796,0.8053646987999291,1.0,24/205,7.37%,SEMA3D;PDPN;ROCK2;PDGFRA;FGF1;SYNE2;CXCL16;FAM110C;CDH5;FER;NUMB;SMIM22;KIT;BMP2;NTN1;WNT5B;TGFBR1;FAM83H;MMP14;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1
prerank,regulation of macrophage activation (GO:0043030),0.35653707822164643,1.0297531324751172,0.42132867132867136,0.8049990104384805,1.0,6/30,8.78%,IL31RA;IL6;TLR4;NR1H3;WNT5A;PJA2
prerank,amino sugar biosynthetic process (GO:0046349),-0.4194488397897015,-1.0296871411416713,0.41020408163265304,0.7959834195334622,1.0,5/12,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.38679512941447247,-1.0294366258736483,0.4225352112676056,0.7957609487756316,1.0,6/15,9.68%,KDR;VEGFC;F3;VEGFA;CXCL12;SCG2
prerank,macromolecule catabolic process (GO:0009057),0.3717643612801283,1.0293702699884082,0.4263157894736842,0.805283725156384,1.0,5/26,12.19%,NEDD4;CLN5;TRIM24;UVRAG;CLPX
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.43079855429055397,1.0290904529696507,0.45489443378119004,0.8052951049323716,1.0,3/15,9.45%,CMPK2;ENTPD7;AK5
prerank,regulation of activated T cell proliferation (GO:0046006),0.3532858824007633,1.0281738847703374,0.4087719298245614,0.8069699856168098,1.0,6/30,9.00%,RC3H1;FOXP3;IL18;LGALS9;CD274;IGF2
prerank,skeletal muscle organ development (GO:0060538),0.36962750316280746,1.027906108628608,0.42070116861435725,0.8069675745661025,1.0,6/26,10.19%,CSRP3;CFLAR;LARGE1;IGSF8;POPDC2;MSC
prerank,regulation of mitochondrial fusion (GO:0010635),0.44465563243840966,1.027535051324311,0.42350746268656714,0.8072110121516708,1.0,3/11,15.53%,PID1;HUWE1;MUL1
prerank,activation of adenylate cyclase activity (GO:0007190),0.35476166190215697,1.0271171886402055,0.42150170648464164,0.8075676483241834,1.0,6/35,8.73%,LGR4;ADCY5;ADCY7;RXFP2;ADCY1;ACR
prerank,negative regulation of heart contraction (GO:0045822),0.4456413226763844,1.0268868890085459,0.4646840148698885,0.8074817435572268,1.0,1/11,0.45%,ATP1A2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.31475793643451283,1.0267812407696484,0.4042207792207792,0.8070417379641518,1.0,10/56,11.97%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;SNX9;ESPL1;USP8;CECR2;RHOC
prerank,monoacylglycerol metabolic process (GO:0046462),0.43481293314214714,1.026058224728607,0.45119705340699817,0.8082728267853543,1.0,3/13,12.05%,PLA2G4A;MOGAT3;DGAT2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4364331296539843,-1.0257982648480108,0.41020408163265304,0.8051602311337835,1.0,4/10,16.37%,DGKH;GAP43;PLPP1;HTR2B
prerank,Ras protein signal transduction (GO:0007265),0.27520325398963474,1.025796642347355,0.39568345323741005,0.8081961041211556,1.0,37/137,20.42%,ARHGAP29;PDPN;ARHGAP6;ROCK2;PLD1;KSR1;RRAS2;NTN1;PLCE1;CELSR1;NGFR;ARHGEF11;USP8;RAP2C;RALGDS;CDC42EP4;MAPK14;CDH13;SHOC2;WASF1;SHC2;BRAP;MAPKAPK5;LIMK1;ADRA2A;RIT1;RAPGEF3;COL1A2;RAP2B;SOS1;SHC1;FARP2;NRAS;SETDB1;RASSF1;ROCK1;CRKL
prerank,regulation of supramolecular fiber organization (GO:1902903),0.37826395645779703,1.025670811908511,0.4452423698384201,0.8077905762883907,1.0,3/22,4.96%,AKAP13;EFEMP2;AEBP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.38115261334693473,-1.0254996284123958,0.44666666666666666,0.8050325334866726,1.0,6/17,5.50%,ATP1B1;RYR2;ATP1A1;GJC1;GJD3;SLC8A1
prerank,aminoglycan catabolic process (GO:0006026),0.36540261098475213,1.0252672222926231,0.43127147766323026,0.8081778318865255,1.0,3/28,2.58%,GPC6;HSPG2;SDC2
prerank,nucleoside salvage (GO:0043174),-0.43077907072934774,-1.0246462367267792,0.4351297405189621,0.8065166819892445,1.0,5/10,22.06%,UCK2;UPP2;UCKL1;UCK1;HPRT1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3524180540442814,1.0246237471893995,0.4239864864864865,0.8091168727496377,1.0,7/31,9.72%,KANK2;DACT1;CDC73;CCL2;CDKN2B;DLG1;SUSD2
prerank,negative regulation of protein transport (GO:0051224),0.3705935637026019,1.024616683831101,0.43275862068965515,0.8084165223421055,1.0,3/25,10.31%,RSAD2;SNX12;WWP2
prerank,response to organophosphorus (GO:0046683),-0.38308748203996645,-1.0246100988409523,0.44155844155844154,0.8056706618451428,1.0,2/16,2.03%,TRPC3;ABCC9
prerank,selective autophagy (GO:0061912),0.3110412170402491,1.0244987635409262,0.40705128205128205,0.8080373849541576,1.0,9/56,11.44%,DYNLL1;VIM;AMBRA1;ARL13B;IFT88;UBA5;PHB2;UBE2V1;STBD1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4089463398873122,1.0244610561061704,0.4392857142857143,0.8074085420217301,1.0,8/16,21.53%,MIA3;VAPA;LRRK2;TAPT1;GBF1;ANK2;SEC16A;BCAP31
prerank,recombinational repair (GO:0000725),0.30041655293166797,1.0244182299321203,0.43797856049004597,0.8068059152310775,1.0,17/77,14.03%,NUCKS1;WRN;TONSL;SLX4;RAD50;SPIDR;SFR1;FBH1;AP5Z1;NABP1;RPA3;XRCC1;RFWD3;RBBP8;NSMCE2;RAD51B;ERCC5
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3169367185418994,1.0242384547686485,0.4094488188976378,0.8065719059591445,1.0,9/52,8.89%,PDPK1;SPTBN1;EPHA3;SORBS1;EPB41L2;ATP2B4;PTPN9;KIF5B;DLG1
prerank,embryonic hemopoiesis (GO:0035162),0.44807460255615894,1.0241916633843766,0.44597249508840864,0.8059633080033919,1.0,5/12,13.95%,KMT2A;KIT;TGFBR2;SH2B3;THOC5
prerank,double-strand break repair via homologous recombination (GO:0000724),0.289717141770121,1.0241633426043097,0.41887905604719766,0.8053229799949363,1.0,20/95,14.03%,NUCKS1;WRN;TONSL;SLX4;RAD50;SPIDR;SFR1;FBH1;AP5Z1;NABP1;RPA3;XRCC1;MCM4;FANCM;RFWD3;RBBP8;NSMCE2;MCM6;RAD51B;ERCC5
prerank,extracellular matrix assembly (GO:0085029),-0.3500890660423797,-1.0241600944695652,0.4105504587155963,0.8060336613273136,1.0,13/23,24.93%,NTN4;GPM6B;GAS6;MYH11;FBLN5;EMILIN1;RAMP2;QSOX1;MFAP4;NTNG1;NTNG2;HAS1;HAS3
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2887588206284607,-1.0239903864354483,0.4117647058823529,0.8055454379813832,1.0,14/54,14.02%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1;B3GAT2;CHST9;HS3ST2;GUSB;SGSH;AGRN;NAGLU
prerank,response to UV-A (GO:0070141),-0.394287882345431,-1.023979716567068,0.4309623430962343,0.8046245688462974,1.0,7/14,28.64%,AKT1;CCND1;EGFR;MMP1;TIMP1;MMP2;MMP3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4569747634918397,1.0237186353827954,0.4337121212121212,0.805739526107067,1.0,5/11,21.65%,NUPR1;BIRC3;SLC25A4;PELI1;RIPK1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.43240624757712753,1.0237176174085467,0.4351005484460695,0.8050333063002766,1.0,6/12,20.78%,IDH1;SIRT4;ACO1;IDH2;IREB2;ASS1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4115994462016404,1.0236061448307223,0.4358974358974359,0.8046322695447713,1.0,1/15,2.03%,APOA2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.4308954721439464,1.0233756072626305,0.4448742746615087,0.8045218457720518,1.0,3/13,8.81%,ZC3HAV1;RC3H1;MOV10
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.33383635308725773,-1.0229209801788217,0.42824074074074076,0.8065920094582183,1.0,10/26,17.54%,GRIN2B;MBP;PRELID1;GRIN1;LYN;AIM2;TTBK1;PSENEN;PSME1;PYCARD
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4451988519311737,1.022669310986929,0.4472168905950096,0.8056407031749434,1.0,1/11,2.03%,APOA2
prerank,muscle organ development (GO:0007517),-0.2856782983547725,-1.0226653134756045,0.4328767123287671,0.8063254822294523,1.0,9/54,7.13%,MEF2C;DMD;SGCD;COL6A3;TEAD4;TBX1;UTRN;MKX;SOX6
prerank,T cell receptor signaling pathway (GO:0050852),-0.24186115006950126,-1.0224862733235545,0.3665480427046263,0.8059384970512674,1.0,38/138,21.19%,PDE4D;PTPRJ;PDE4B;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;EIF2B2;PSMD14;PSMD3;LCP2;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;BCAR1;PAK3;PSMB8;PIK3CD;TNFRSF21;PSMA8;PTPRC;PLCG1;PSME1;PRAM1;PSMD7;PSMC6;IKBKB;CD276;PSMB5;CD247;PSMC5;PSMB1
prerank,positive regulation of telomere capping (GO:1904355),-0.38061115913053,-1.0222407799796989,0.4343891402714932,0.8057023868699008,1.0,5/17,16.15%,PRKCQ;NEK7;MAPK3;PNKP;PKIB
prerank,B cell mediated immunity (GO:0019724),-0.43940323087199173,-1.0219238562072213,0.4455852156057495,0.8056045416763051,1.0,7/10,43.95%,CD74;FCER1G;CD27;TLR8;FCGR2B;CARD9;SLA2
prerank,monocarboxylic acid transport (GO:0015718),-0.28826121062496474,-1.0215283390449068,0.43213296398891965,0.805885793821079,1.0,9/51,8.59%,ABCG2;ABCC4;SLCO1C1;SLCO2A1;SLC16A9;SLC5A6;CEACAM1;SLC16A1;ATP8B1
prerank,peptidyl-serine modification (GO:0018209),0.26933759228668647,1.02132471737634,0.4223433242506812,0.8083823418075546,1.0,37/166,17.20%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;PRKCZ;TOP1;LATS2;TGFBR1;MORC3;GALNT2;GALNT1;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;MAPK14;AKT3;HIPK3;RPS6KA3;MASTL;MAP3K13;MAPK9;WNK1;MAPKAPK5;TBK1;CSNK2A2;EIF2AK3;STK4;PKN2;PRKD2;TTBK2;MKNK2;RICTOR;SMG1
prerank,positive regulation of GTPase activity (GO:0043547),-0.2341351365315547,-1.0211701786742664,0.4,0.8060314089110214,1.0,49/188,16.45%,DOCK9;ITGA6;RALGAPA2;BCAR3;ABR;TBC1D8;DOCK10;NET1;TIAM1;SEMA4D;ARHGEF15;TBC1D30;RAP1GAP2;RAB3GAP1;CCL14;RAPGEF2;RGS7;RGS6;CCDC125;SGSM1;ARHGAP27;BCR;RHOG;RACK1;ARHGEF26;CAV2;CD40;TBC1D22B;DOCK8;ALS2;TBC1D8B;TBC1D14;ARHGEF7;RALGAPA1;RGP1;RUNDC1;RAPGEF6;SIPA1L3;F11R;HRAS;AGRN;ARHGAP45;EVI5;SNX18;ARHGAP24;CCL19;TBC1D12;RAP1A;NTF3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2562374793676447,-1.0211091983503153,0.4104938271604938,0.805277466779751,1.0,21/98,13.06%,SLCO1C1;THBS1;INSR;NSF;SNCA;PPARD;AHI1;SCYL2;CHCHD2;ECE1;AKT1;IFNAR1;PRELID1;VEGFA;ATAD1;GHITM;ACE2;SFRP4;ACACA;KLF4;ACLY
prerank,regulation of fibrinolysis (GO:0051917),-0.3974976849051607,-1.0209052461124548,0.4087136929460581,0.8049304803133697,1.0,3/13,12.50%,THBS1;FAP;USF1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4589117187890557,1.0207841036066823,0.44022770398481975,0.8090496892961871,1.0,2/10,3.84%,FPR2;KIT
prerank,positive regulation of lyase activity (GO:0051349),-0.39749610304690536,-1.0207260092305475,0.44017094017094016,0.8044822193762952,1.0,5/14,18.69%,NOS3;CACNA1D;NOS1;PARK7;AKAP5
prerank,pore complex assembly (GO:0046931),0.39452095371624774,1.0206236558509265,0.4166666666666667,0.8087823321734138,1.0,5/19,13.84%,AFDN;TPR;ANO6;AHCTF1;RTN4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4589998355295285,1.020574612686608,0.44529750479846447,0.8081891216812211,1.0,3/11,7.89%,TWSG1;LGALS9;CD274
prerank,positive regulation of protein import (GO:1904591),0.3556330828455888,1.020306402028663,0.4316546762589928,0.8081848422401573,1.0,4/30,7.63%,SMAD3;ZIC1;TPR;PDCD5
prerank,superoxide anion generation (GO:0042554),-0.4024527735034707,-1.0202707374039297,0.4375,0.8047583430704663,1.0,9/13,43.98%,NCF2;CYBB;TAFA4;NOX4;NCF1;NOX3;NCF4;DUOX1;ALOX12
prerank,regulation of ERBB signaling pathway (GO:1901184),0.40997428214045284,1.0202347960496214,0.44569288389513106,0.8076538967320882,1.0,4/15,12.72%,RBPJ;FER;CDH13;PTPN18
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4119591781957525,-1.0201106430077227,0.45010183299389,0.8042382343870801,1.0,7/12,31.46%,PFDN5;PFDN2;PFDN4;VBP1;TREM2;CLU;LDLR
prerank,regulation of cellular component organization (GO:0051128),-0.24270907482100726,-1.0200604523046837,0.43309859154929575,0.8034261191031467,1.0,30/135,16.16%,NRG3;HIP1;HSPA8;TFRC;NET1;RIT2;SEMA4D;PRKCQ;HIP1R;DAB2IP;FAM107A;RAPGEF2;PAK5;CAMK2D;ERMN;CEACAM1;STK11;PINK1;SSRP1;SPOCK1;ANKRA2;BCAR1;HSP90AA1;DCUN1D5;RAB5C;PARK7;PAK4;IRGM;SLITRK2;RAP1A
prerank,vasoconstriction (GO:0042310),-0.42628886084627,-1.0195589609739824,0.445859872611465,0.8038555181857477,1.0,3/11,6.29%,EDNRA;SLC8A1;ACTA2
prerank,copper ion homeostasis (GO:0055070),-0.3756374403118057,-1.0191324029366982,0.43670886075949367,0.804091686256521,1.0,9/17,34.86%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6;XIAP;ANKRD9
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4423490877324144,1.019065685486263,0.4489402697495183,0.809809616829795,1.0,1/12,0.31%,SDK2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4453777420965898,-1.0189456040357832,0.44813278008298757,0.8037202552944412,1.0,3/10,6.57%,IL33;KDR;NAMPT
prerank,endochondral bone morphogenesis (GO:0060350),-0.41863840177703804,-1.018941431049721,0.4497991967871486,0.8027969369039101,1.0,4/11,13.13%,MEF2C;BMPR2;BMP4;BMPR1B
prerank,negative regulation of endopeptidase activity (GO:0010951),0.32797828107860244,1.0186917376694746,0.4371859296482412,0.8100548611767925,1.0,12/47,16.68%,VTN;TIMP3;SERPING1;SERPINB7;SERPINE1;TIMP2;SERPINE2;SERPINB8;SERPINE3;RECK;ANXA8;ANXA8L1
prerank,microtubule depolymerization (GO:0007019),-0.37275380033875066,-1.01868914740336,0.4427645788336933,0.8025896807982204,1.0,8/17,28.05%,STMN2;KIF18A;NCKAP5;STMN4;STMN1;KIF14;STMN3;KIF19
prerank,negative regulation of mRNA processing (GO:0050686),-0.37644449829750515,-1.0185111965446951,0.42081447963800905,0.8021570841167497,1.0,6/15,21.65%,PTBP1;BARD1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,regulation of ERAD pathway (GO:1904292),-0.4163995851911668,-1.018392610153509,0.4418604651162791,0.8015616565257306,1.0,6/11,28.13%,AQP11;BAG6;USP13;ATXN3;TMEM259;HERPUD1
prerank,L-amino acid transport (GO:0015807),0.3625750625980101,1.0183511828454657,0.4227504244482173,0.8102237826534813,1.0,2/28,0.80%,SLC7A2;SLC1A3
prerank,coenzyme A biosynthetic process (GO:0015937),0.4431158701387031,1.0182201792578078,0.4408817635270541,0.8084068500769381,1.0,7/11,31.09%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4431158701387031,1.0182201792578078,0.4408817635270541,0.8084068500769381,1.0,7/11,31.09%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4431158701387031,1.0182201792578078,0.4408817635270541,0.8084068500769381,1.0,7/11,31.09%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3213354261406235,1.0180042688324153,0.4264705882352941,0.8082367029524572,1.0,18/53,23.52%,EYA2;EYA1;PLA2R1;FBH1;EYA4;HIC1;ERCC6;UIMC1;FXR2;BRCC3;DDX5;ERCC8;EYA3;NSMCE1;NACC2;SMCHD1;DHX9;CEBPG
prerank,import into nucleus (GO:0051170),0.3025729701850574,1.0177918622352962,0.445440956651719,0.8080660024319793,1.0,11/73,14.29%,PRICKLE1;TNPO1;GEMIN4;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;GEMIN5
prerank,nuclear export (GO:0051168),0.29753821533449243,1.0177489270743707,0.4217791411042945,0.8074773814702321,1.0,16/80,17.93%,RANBP3L;ATXN1;WASHC4;TPR;SLU7;SRSF4;EGR2;MAGOHB;STRADB;DDX39A;THOC5;POM121;SRSF5;RAN;LSG1;RANBP17
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4579644198055265,1.0175372141218473,0.4472168905950096,0.8073627279317237,1.0,2/10,3.94%,SHMT1;MTHFD1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.34912660856667116,1.0173582401004866,0.43074324324324326,0.8071187066217691,1.0,3/35,2.97%,PLXNA2;SEMA3D;NRP1
prerank,apical junction assembly (GO:0043297),0.3131434078391606,1.0173100250800975,0.44043887147335425,0.8065349730347571,1.0,13/53,16.05%,AFDN;CDH5;PARD6G;PARD6A;VCL;CTNNA1;CLDN1;DLG1;RHOC;FBF1;CLDN11;PKN2;PATJ
prerank,arachidonic acid secretion (GO:0050482),0.4602105694926101,1.0169360484990766,0.4365079365079365,0.8061062178750239,1.0,2/10,7.04%,ANXA1;BDKRB2
prerank,arachidonate transport (GO:1903963),0.4602105694926101,1.0169360484990766,0.4365079365079365,0.8061062178750239,1.0,2/10,7.04%,ANXA1;BDKRB2
prerank,protein-containing complex subunit organization (GO:0043933),0.2825426733054932,1.016747253015724,0.42814814814814817,0.805874251514804,1.0,22/109,15.00%,KMT2A;LAMC1;TEAD1;TPR;ST13;CREBBP;SNX9;TEAD2;YAP1;TAPBP;MNAT1;TUBGCP4;PPID;DNM1L;WDR19;HFE;TUBGCP2;WASL;WASF1;MDM4;GEMIN5;PML
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.33343279535578657,1.0165953075504577,0.42625607779578606,0.8055608963605458,1.0,5/41,7.19%,PRKAG2;LACC1;RANBP2;TPR;JMJD8
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.23395097913114324,-1.0164484783182173,0.4233576642335766,0.806041568422106,1.0,35/151,20.68%,SGMS1;ACER3;DMD;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;PCYT1B;LPCAT2;GPHN;SPNS2;SLC44A5;ALAS1;GCH1;SGMS2;GCNT1;GSTM5;MFSD2A;PLPP1;ST3GAL4;PRKD1;HACD3;SPTSSA;STARD7;SGPP1;GSTO2;LPIN3;CEPT1;GSTO1;TYW5;CHKA;PCSK5
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2928925182648284,1.016371350045621,0.4221556886227545,0.8053938269704786,1.0,14/87,9.48%,ROCK2;PDGFRA;ARHGAP18;NOTCH2;DLC1;EPHA3;SMIM22;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;RHOQ;IQGAP2
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4359310372211806,-1.016333753758005,0.4666666666666667,0.8054525236428729,1.0,3/10,14.26%,SNCA;HDAC6;AOC3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3786188741134454,1.0162286403399587,0.4515539305301645,0.8050469143314294,1.0,5/22,12.61%,NOTCH2;CASK;KLF9;EPPK1;CRNN
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3887787221959781,-1.0158326405564408,0.43612334801762115,0.8059355032870242,1.0,4/15,13.06%,HMGCS1;HMGCS2;ACACA;ACLY
prerank,regulation of macrophage differentiation (GO:0045649),0.4173088685642947,1.0153795652244715,0.43144424131627057,0.8065306354645375,1.0,4/15,16.13%,IL34;PTPN2;CSF1;INHA
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.45796228631847746,1.0153500035296612,0.44793713163064836,0.8052313191349237,1.0,2/10,8.09%,SMPD3;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.45796228631847746,1.0153500035296612,0.44793713163064836,0.8052313191349237,1.0,2/10,8.09%,SMPD3;PLA2G6
prerank,inorganic anion transport (GO:0015698),0.31976049975346804,1.0152591894748617,0.41601255886970173,0.80477836509596,1.0,10/53,12.18%,ENPP3;SLC13A4;ENPP1;SLC26A9;SLC4A11;CLIC4;ANO10;NMUR1;ANO6;ANO8
prerank,sulfur amino acid catabolic process (GO:0000098),-0.42807297148899226,-1.0148048133678742,0.4497816593886463,0.8080268646005822,1.0,5/10,23.01%,TXN2;MTRR;CTH;ADO;MPST
prerank,long-chain fatty acid metabolic process (GO:0001676),0.312058970863038,1.0147412973007246,0.4401294498381877,0.8054082065839735,1.0,11/64,10.80%,PLA2G4A;AIG1;ACSL1;PLA2G4C;ALOXE3;SCP2;SLC27A2;ACOT1;EPHX1;SLC27A3;HACL1
prerank,regulation of lymphocyte migration (GO:2000401),-0.4272705217435963,-1.0146052489475414,0.4642857142857143,0.8076677398802926,1.0,3/10,7.21%,STK10;JAM2;AKT1
prerank,error-free translesion synthesis (GO:0070987),0.3879496703496257,1.01427459802773,0.4649910233393178,0.8058979592220817,1.0,6/22,14.53%,POLH;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.43476891232498627,1.0135417749021298,0.43222003929273084,0.807133200051632,1.0,4/12,12.04%,IL34;BST2;PTK2;CSF1
prerank,negative regulation of organelle assembly (GO:1902116),0.34063139613192556,1.0134809705158607,0.4349315068493151,0.8065865399344891,1.0,13/35,16.15%,NUPR1;YAP1;LRRK2;SMAD4;TMEM39A;SCFD1;TBC1D7;RBM14;CHMP4A;CHMP4B;KAT2B;FEZ2;ODF2L
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4261804690908789,1.013380850013223,0.439453125,0.8061443863962874,1.0,7/12,20.92%,RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8;TET1
prerank,RNA processing (GO:0006396),0.2661022970126947,1.0130253141409973,0.4231292517006803,0.8063672864259657,1.0,43/176,18.58%,CELF2;ATXN1;RBMS1;TUT4;RBMS2;FASTKD5;SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPH1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RBM39;RNPC3;SRSF4;DHX16;HNRNPH3;ADAR;MAGOHB;USB1;DHX8;RBM5;SRPK1;ZMAT5;RBM6;TENT2;PABPN1;FUS;SRSF5;CSTF3;HNRNPR;HNRNPA2B1;PPP2CA;NUFIP1;WBP4;SCAF11;TUT7;USP39;PRPF3
prerank,negative regulation of catabolic process (GO:0009895),0.32868290197535077,1.012782185881451,0.4311774461028192,0.8062762846266293,1.0,12/47,15.39%,NUPR1;APOA2;SNX12;HDAC4;PPARA;AZIN2;SF3B3;HCAR2;IRAK3;MDM4;ALK;ADRA2A
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2994032425489285,1.0125801656310671,0.4250386398763524,0.8060754657788196,1.0,22/73,16.82%,WNT3A;OSM;IL11;IL6;ARAF;STOX1;HAX1;ATP2B4;CREBL2;OPRD1;RIPK2;DOCK7;FNIP1;MTCP1;BDNF;TBK1;NTRK3;STK4;PRKD2;APP;CNOT9;RAPGEF3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.3928894668293914,-1.0120710527353276,0.42535787321063395,0.8139967711662366,1.0,6/13,31.60%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.32978252568698163,-1.011929990516041,0.425,0.8134726669778367,1.0,5/27,5.42%,CSGALNACT1;CSPG4;XYLT1;B3GAT2;CHST9
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.35030762471509935,-1.011589619613001,0.42298850574712643,0.8134896886981843,1.0,4/21,8.85%,TOX;CTNNB1;FZD3;VEGFA
prerank,myeloid cell differentiation (GO:0030099),0.3206771362786659,1.0114679690812218,0.4264705882352941,0.8082307182638077,1.0,15/47,17.68%,MPIG6B;IL11;KIT;UBA5;NCOA6;PTPN2;CDKN2B;ACIN1;TET2;KAT6A;ALAS2;INHA;HSPA9;CASP3;ATP5IF1
prerank,negative regulation of cytokine production (GO:0001818),0.26417869825580226,1.0114059788265477,0.4438356164383562,0.8076950642964055,1.0,31/163,15.47%,LGR4;FN1;AXL;APOA2;TWSG1;ANXA1;IL6;IKBKE;ADCY7;TLR4;C5AR2;PTPN22;APPL2;RNF216;FOXP3;ANXA4;PPARA;LGALS9;CD274;NLRX1;PTPN6;IRAK3;MAP2K5;HOMER3;ARRB1;ATP2B1;SRGN;IFIH1;TBK1;RARA;IL23R
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.405551074332569,-1.0113802034932013,0.4524793388429752,0.8131765023179282,1.0,6/12,31.60%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,sodium ion export across plasma membrane (GO:0036376),0.42345051706621994,1.0108496331196357,0.43223443223443225,0.8084059865338606,1.0,1/13,0.45%,ATP1A2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3023168385514063,1.010811107798479,0.4197901049475262,0.8078138037472672,1.0,6/67,3.68%,SULF1;ROCK2;AXL;NRP1;VEGFD;SHB
prerank,microtubule-based transport (GO:0099111),-0.4087053294980294,-1.0107837428159463,0.4578313253012048,0.8138944871652095,1.0,7/12,34.12%,DYNC1I2;ADCY10;SPAG17;HTT;CABYR;DNAAF2;CCDC40
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.40684215163072873,-1.0106744210566758,0.46466809421841543,0.8132943367704702,1.0,3/13,6.57%,IL33;KDR;NAMPT
prerank,keratinocyte differentiation (GO:0030216),0.363124821911029,1.010650727422556,0.4601449275362319,0.8075212775484987,1.0,10/29,21.26%,ANXA1;CLIC4;WNT5A;EPHA2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2936628560867971,-1.0094586913058792,0.4143222506393862,0.8157869326903345,1.0,19/43,32.16%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;PLK1;CDK1;CDC6;TICRR
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3190336789916903,1.0094457491045339,0.4492753623188406,0.8099927434551115,1.0,6/48,7.19%,PRKAG2;GCGR;RANBP2;TPR;NOS2;JMJD8
prerank,regulation of vasculogenesis (GO:2001212),-0.3954715804577681,-1.009270877478649,0.4475374732334047,0.8154246063761897,1.0,7/14,16.16%,KDR;CD34;EMP2;RAPGEF2;CEACAM1;HEY1;RAP1A
prerank,cellular respiration (GO:0045333),-0.30046967609333314,-1.0092552357073667,0.4105263157894737,0.8145502054125614,1.0,17/41,36.51%,SDHC;ME3;NDUFS7;UQCRH;NR4A3;ATP5F1D;SLC25A13;COQ10B;MTFR1L;MDH2;UQCR10;COX4I2;NDUFS1;MTLN;CYCS;BLOC1S1;UQCRB
prerank,negative regulation of autophagy (GO:0010507),0.31476970654692094,1.0092142731587113,0.46050420168067224,0.8098711280574359,1.0,8/54,9.46%,LEPR;NUPR1;BCL2;PTPN22;MCL1;KLHL22;LRRK2;TLK2
prerank,lymphocyte differentiation (GO:0030098),0.30244840831029834,1.0091213067133258,0.45864661654135336,0.809412107062746,1.0,9/68,6.52%,LEPR;AXL;IL11;NHEJ1;KIT;PTPN22;VCAM1;HDAC4;PTPN2
prerank,positive regulation of protein metabolic process (GO:0051247),0.2768225716842214,1.0090925430098012,0.4438122332859175,0.808792640804881,1.0,19/110,12.85%,ROCK2;SMURF2;SLC6A9;NEDD4;DACT1;IL17D;NR1H3;IL18;GSK3B;WNT5A;TIPARP;SLC25A37;WWP2;HUWE1;NKD1;MAP2K5;CSF1;HECW2;ASB5
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37217778830437837,-1.0087914776597067,0.4479166666666667,0.8150011662138885,1.0,7/17,20.73%,AHI1;BMP4;SFRP4;FGF2;NKX6-1;BTG1;BAD
prerank,mitochondrial translation (GO:0032543),-0.2467103855669805,-1.008773918077851,0.4425087108013937,0.8141292197610958,1.0,45/104,35.83%,MRPL4;LARS2;GFM1;MRPS18A;EARS2;MRPL1;MRPS30;MRPS23;FASTKD2;MRPL57;RARS2;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;HARS1;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MTIF2;MRPL45;MRPL30
prerank,N-glycan processing (GO:0006491),0.4019230838134617,1.0086377481968638,0.46422018348623856,0.8092382133042174,1.0,3/18,3.00%,MAN1C1;PRKCSH;MAN2A1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2745613133494896,-1.0084883964614966,0.43609022556390975,0.8140463560508286,1.0,16/62,12.39%,MEF2C;MEIS2;PRKCB;THBS1;PTK2B;H3-3A;PRKCQ;CDK6;HOXB8;ZBTB16;ZFPM1;HDAC1;LYN;RUNX1;CBFB;FES
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.39759132814002507,1.0083127209793006,0.4425925925925926,0.809348753179615,1.0,5/18,13.46%,MORC3;PARP10;CDC73;SKI;PEX2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.29106279285695136,-1.0082909649645238,0.4223918575063613,0.813646164399998,1.0,14/47,15.73%,TGFB2;FOXO1;MID1;PHLPP1;EPHB1;DAB2IP;MAPK3;FAS;MAPK8IP1;EGFR;MAPK8IP3;PPIA;NOD2;COPS5
prerank,proteoglycan metabolic process (GO:0006029),0.3686823809194472,1.008243908085955,0.46994535519125685,0.8088298709872505,1.0,2/26,1.66%,SULF1;ADAMTS12
prerank,lysine catabolic process (GO:0006554),0.43509626609713925,1.0077857594460338,0.4881889763779528,0.8086591908372035,1.0,2/12,6.12%,HYKK;PHYKPL
prerank,lysine metabolic process (GO:0006553),0.43509626609713925,1.0077857594460338,0.4881889763779528,0.8086591908372035,1.0,2/12,6.12%,HYKK;PHYKPL
prerank,telomere maintenance via recombination (GO:0000722),0.4413810098466509,1.0075357003013687,0.44756554307116103,0.808647277985164,1.0,5/11,21.67%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.30009127851895895,-1.007433784754066,0.4585365853658537,0.8151695671142066,1.0,13/37,19.63%,RPL5;RPS7;RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;RPL23;CAMLG;PARK7;N4BP1;EIF3H
prerank,glycosaminoglycan catabolic process (GO:0006027),0.31444272338482093,1.0072587644879663,0.4473257698541329,0.8086592206115962,1.0,10/55,12.60%,GPC6;CEMIP2;HSPG2;SDC2;DCN;OMD;PRELP;GPC2;LYVE1;ARSB
prerank,positive regulation of heart contraction (GO:0045823),0.3899467369097076,1.006826940459616,0.45108695652173914,0.8090308379832862,1.0,3/19,8.56%,ATP1A2;SCN3B;ADM
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3602137460887818,1.006430746643092,0.4322469982847341,0.8093985491862872,1.0,9/27,20.27%,TLR4;MAP3K1;LY96;TLR2;IRAK3;MAP3K7;TAB1;TNIP1;CD36
prerank,response to histamine (GO:0034776),0.44771751036372115,1.0061598890794388,0.4695121951219512,0.8094311474167417,1.0,1/10,0.81%,DIAPH1
prerank,cellular response to hormone stimulus (GO:0032870),0.2999378735884698,1.0060312302196028,0.4358974358974359,0.8090655812091787,1.0,10/69,7.82%,TFPI;ATP1A2;GHR;NCOA3;STAT5B;CTSH;SFR1;KLF9;RAMP1;TRIM24
prerank,cellular response to glucagon stimulus (GO:0071377),0.4032226329705251,1.0056434289494212,0.47378640776699027,0.8093447631389309,1.0,4/17,7.01%,GCGR;ADCY5;ADCY7;ADCY1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3904034012583193,-1.0053666369311123,0.4251101321585903,0.8200942772360577,1.0,6/14,20.46%,PCYT2;ETNK1;SELENOI;LPIN3;CEPT1;CHKA
prerank,regulation of interleukin-17 production (GO:0032660),0.3428295164240846,1.0050936139796567,0.4400715563506261,0.8100160146050734,1.0,5/31,7.50%,OSM;IL6;TLR4;FOXP3;IL18
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3118960811486351,1.0050040125677733,0.45819935691318325,0.8095479215983673,1.0,7/59,8.81%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3937066957386693,1.0047988010832183,0.44508670520231214,0.8093769706468174,1.0,3/18,2.80%,ROCK2;KANK1;CDH5
prerank,neutrophil migration (GO:1990266),-0.27235740710161926,-1.0047865801429305,0.42857142857142855,0.820789819645579,1.0,10/58,15.18%,BSG;PECAM1;PDE4B;TGFB2;CCL14;FCER1G;SYK;PIK3CD;PPIA;CCL19
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.30161450849987004,-1.0045773147926644,0.4444444444444444,0.8204313274630171,1.0,7/38,13.98%,PTPRJ;PHLPP1;PLEKHA1;INPP5K;AKT1;RACK1;PPP2R5B
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36776904286484774,1.0041850627128466,0.46265938069216755,0.8102708419998246,1.0,9/24,23.55%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;DMTN;LZTFL1;TGFB1
prerank,cellular response to glucose stimulus (GO:0071333),0.35449314604389476,1.003968191771341,0.4484536082474227,0.8101411411622116,1.0,3/30,5.35%,ZBTB20;PRKAA2;UNC13B
prerank,ncRNA metabolic process (GO:0034660),0.3398966979085437,1.0039279159801155,0.44768439108061747,0.8095710782465211,1.0,11/37,21.47%,TUT4;PIWIL4;EXD1;DTD2;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3345823908982761,-1.0033373801044199,0.46017699115044247,0.8230968305132205,1.0,8/24,18.17%,STMN2;KIF18A;FGF13;NCKAP5;MAPT;STMN4;TPPP;STMN1
prerank,negative regulation of macroautophagy (GO:0016242),0.3622796478613059,1.003192084990141,0.4672566371681416,0.8107278211813934,1.0,9/26,17.20%,NUPR1;LRRK2;TMEM39A;SCFD1;USP36;CHMP4A;CHMP4B;FEZ2;SMG1
prerank,catecholamine biosynthetic process (GO:0042423),-0.4224367879236546,-1.0030702879063393,0.4665271966527197,0.8229052233087626,1.0,4/11,10.31%,TGFB2;SNCA;DDC;GCH1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3213093803627157,1.0030196438910826,0.43610223642172524,0.8104663542294984,1.0,13/45,15.95%,SP100;GBP2;TRIM5;VCAM1;OASL;STAT1;OAS2;TRIM21;TRIM26;JAK1;PML;IRF9;ICAM1
prerank,organelle disassembly (GO:1903008),0.335793686041037,1.0027478286706268,0.45797598627787306,0.8104725840228292,1.0,10/33,21.38%,UBA5;PLK5;KIF5B;KLC1;ATG2A;GBF1;GOLGA2;MCTS1;MRRF;ZFAND1
prerank,peptidyl-proline modification (GO:0018208),-0.32920873111166515,-1.0026001329411072,0.44976076555023925,0.8233579494634693,1.0,8/25,25.72%,FKBP1A;FKBP7;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,positive regulation of cellular component movement (GO:0051272),0.3690422119629737,1.0025289864269973,0.45306859205776173,0.8103887078799673,1.0,3/24,5.16%,PDPN;NTN1;TGFBR1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3586334311567126,-1.0023292364326408,0.45617977528089887,0.8231733946490678,1.0,7/20,21.34%,ENTPD1;HSP90AB1;PSTPIP1;P2RX7;PYCARD;CASP1;C3
prerank,calcium ion transmembrane transport (GO:0070588),0.2896770134833778,1.0022663604780038,0.44144144144144143,0.8103966137669459,1.0,13/86,11.41%,TRPM3;MCU;TRPM6;MICU1;NALCN;SLC24A3;ATP2B4;PHB2;CACNA1C;TMEM165;TRPC1;PMPCB;ANO6
prerank,response to estradiol (GO:0032355),0.3459538206302404,1.0020124822966932,0.45210084033613446,0.8104069375207156,1.0,5/31,8.59%,NCOA3;ANXA1;STAT5B;FAM210B;STRN3
prerank,negative regulation of transferase activity (GO:0051348),-0.3189209574497796,-1.0019100649792638,0.45351473922902497,0.8235407605586579,1.0,8/28,19.80%,SMAD7;INPP5K;TERF1;PARK7;MAPT;MEN1;CDKN1C;EIF4A2
prerank,positive regulation of macrophage activation (GO:0043032),-0.36912396776324474,-1.0018439632825276,0.43478260869565216,0.8228331217019299,1.0,4/17,12.72%,IL33;THBS1;KARS1;TTBK1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3125650640626746,1.001552014560871,0.4634551495016611,0.8108981789704686,1.0,8/51,10.22%,IL16;IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,Notch signaling pathway (GO:0007219),0.3128495009247251,1.0014936095642253,0.46825396825396826,0.810353916179509,1.0,12/59,12.43%,RBPJ;NOTCH2;GMDS;BMP2;DTX4;DTX1;DTX3L;CREBBP;STAT1;PBX1;HEYL;MAML2
prerank,histone H4-K5 acetylation (GO:0043981),-0.3843544442797614,-1.0014109211078854,0.46336206896551724,0.822208627014698,1.0,6/15,24.14%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),-0.3843544442797614,-1.0014109211078854,0.46336206896551724,0.822208627014698,1.0,6/15,24.14%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,regulation of cell division (GO:0051302),0.2935624541631179,1.0013387276864776,0.4572317262830482,0.8100692145951769,1.0,18/72,18.08%,FGF1;MLLT3;NCOA3;PLK5;KLHL21;UVRAG;SUSD2;BCL2L1;KLHL13;AHCTF1;ENTR1;FSD1;TLE6;BIRC6;POU5F1;TXNIP;NLRP5;MYO19
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3724775678270778,1.0011132746741083,0.45045045045045046,0.809968319493121,1.0,5/22,14.68%,ROCK2;CRY2;GSK3B;MASTL;BOD1L1
prerank,protein localization to cell-cell junction (GO:0150105),0.4037508931500482,1.0011043100032933,0.468503937007874,0.8093220723962296,1.0,2/15,2.80%,CGNL1;CDH5
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3048830555762808,1.0010547597576815,0.4340490797546012,0.8087728431261648,1.0,8/65,7.58%,RORA;GATA6;TERT;EPAS1;BMP7;CPEB1;NPEPPS;OPRD1
prerank,programmed necrotic cell death (GO:0097300),0.3837498988736818,1.0010000197879536,0.462406015037594,0.8082333815741504,1.0,6/18,21.65%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3624191123046382,1.0007595579220587,0.44609665427509293,0.8081890701790473,1.0,4/24,5.64%,CXCL10;FPR2;NBL1;SERPINE1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.39134191068744345,1.000713027916255,0.4679611650485437,0.8076525857481308,1.0,7/16,22.79%,RC3H1;MOV10;CPEB3;DHX36;KHSRP;ZC3H12A;ZFP36L2
prerank,positive regulation of transport (GO:0051050),0.28856306358706174,1.000684649283479,0.4434250764525994,0.807072782280691,1.0,10/85,8.36%,KMT2A;CAMK1D;FPR2;APOA2;ANXA2;ANXA1;NR1H3;CD47;GSK3B;BAX
prerank,positive regulation of protein sumoylation (GO:0033235),0.44969736252394765,1.0006720283482413,0.4706994328922495,0.8064417365447609,1.0,3/10,15.53%,HDAC4;PIAS1;MUL1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.27669620462654326,-1.0002154455603038,0.44501278772378516,0.8245825300521961,1.0,26/57,32.57%,FOXN3;MRE11;CLSPN;CCND1;BABAM1;ATM;MDC1;CDK2;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;PLK1;CDK1;TP53;PRKDC;FBXO31;NEK11;TICRR;MUS81
prerank,superoxide metabolic process (GO:0006801),-0.3190135429585058,-1.0001287544280868,0.4534313725490196,0.8239009212328484,1.0,9/29,23.77%,NOS3;SH3PXD2A;NCF2;PREX1;CYBB;SOD1;PRDX2;TAFA4;NOX4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.40537124047387557,-1.0001216173276968,0.46220302375809935,0.8230138110566406,1.0,4/12,19.83%,GNL3L;GNL3;CCT5;WRAP53
prerank,positive regulation of cytokine production (GO:0001819),0.24834902097072695,0.9994286161944358,0.4679245283018868,0.8089224084876238,1.0,31/292,8.47%,SULF1;RORA;ROCK2;IL16;SPTBN1;EIF2AK2;IL6ST;APOA2;OSM;PLA2R1;ANXA1;IL17D;IL6;TLR4;ARNT;LACC1;PRKCZ;PTPN22;ZBP1;SERPINE1;GBP5;NOS2;CREBBP;POLR1C;IL18;LGALS9;CD274;TNFRSF14;RIPK2;SETD4;WNT5A
prerank,response to lipid (GO:0033993),0.2809650195034781,0.9986813530720192,0.46449704142011833,0.8101924756961869,1.0,19/105,12.46%,SELP;GATA6;FER;RBP4;ANXA1;STAT5B;TLR4;PTPN22;PPARA;NOS2;CTSH;LY96;LGALS9;STRN3;NOCT;SMAD6;IRAK3;FOXO3;RPS6KA3
prerank,regulation of dendrite development (GO:0050773),0.3352328123931167,0.9982988015363584,0.4765886287625418,0.8104591769735212,1.0,7/37,7.66%,PTN;CAMK1D;SDC2;NEDD4;BMP7;DBN1;GSK3B
prerank,platelet aggregation (GO:0070527),0.34626683869825,0.9982980500511947,0.4938704028021016,0.8097970109858955,1.0,5/33,5.48%,FN1;PDGFRA;GP1BA;VCL;CSRP1
prerank,ephrin receptor signaling pathway (GO:0048013),0.29048211854838596,0.9979173028683453,0.4434389140271493,0.8100899900148827,1.0,16/82,13.46%,EFNB2;ROCK2;EPHA7;EPHA3;SDC2;EPHA8;EPHA1;RASA1;EPHA4;DNM1;NGEF;PTK2;EPHA2;EFNA1;EFNB1;WASL
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2906155277673455,0.9977917615158367,0.44411326378539495,0.8097624176798942,1.0,20/80,20.80%,ROCK2;PLD1;SMPD3;SAMD4A;VIM;IL6;PLA2G6;EPHA4;ZCCHC4;EFNA1;SOX4;CPEB3;UPF3A;CASP3;FXR2;PLXNB2;SIRT3;ERBB2;ELAVL1;SPHK2
prerank,cilium organization (GO:0044782),0.253761076463431,0.9977741997714461,0.4610552763819096,0.8091351786791572,1.0,54/209,22.19%,DCDC2;PARVA;CYS1;ASAP1;DYNLL1;ARL13B;RFX3;IFT88;ARL3;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;DYNC2I1;DNAAF1;NUDCD3;IFT81;CC2D2A;CDC14A;CCDC57;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;CEP250;CPLANE1;PKD2;GBF1;AVIL;TTBK2;EXOC7;EXOC1;RPGR;IFT52;ARL6;WDR11;CEP131;SSX2IP;CEP78;B9D2;OFD1;RP2;ACTR3;DZIP1L;PKD1;LZTFL1;CFAP410
prerank,cell projection organization (GO:0030030),0.3464955220872186,0.997660141904908,0.4370629370629371,0.8087634484116373,1.0,8/30,14.00%,PARVA;QRICH2;PACSIN2;NPHP1;RHOQ;PLEK;ATP1B2;RHOU
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.38365006128723955,0.9975539862885354,0.46678321678321677,0.8083763824179412,1.0,4/21,11.82%,DAG1;SPPL3;ERAP1;ADAM19
prerank,ubiquinone biosynthetic process (GO:0006744),-0.37680746094743667,-0.9975470966147189,0.455531453362256,0.8293443793528383,1.0,7/15,23.92%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5;NDUFA9
prerank,neuron projection organization (GO:0106027),-0.37688292529617373,-0.9972352247021442,0.45010615711252655,0.8293638768277224,1.0,6/15,21.20%,INSR;LGMN;ABCD2;ATP1A3;CHRNA7;DCTN1
prerank,myotube cell development (GO:0014904),-0.4228330927512608,-0.9972113934851401,0.462890625,0.8285249675655997,1.0,3/10,10.78%,SIX1;SELENON;CAV2
prerank,negative regulation of secretion by cell (GO:1903531),0.3383473147312081,0.9970133585273621,0.4694915254237288,0.8090476425618937,1.0,5/38,4.42%,RSAD2;OSM;IL11;ANXA1;HRH3
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.38104274989031783,0.9969764053848601,0.44731977818853974,0.8084739605039638,1.0,3/18,12.74%,ROCK2;EPHA4;EFNA1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3508249737373365,-0.9968747180905303,0.48394495412844035,0.8286500837888405,1.0,7/20,25.72%,FKBP1A;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,positive regulation of protein catabolic process (GO:0045732),0.2863128023632395,0.9965738451148286,0.4557522123893805,0.8088323457166049,1.0,15/84,12.85%,SH3D19;SMURF2;NEDD4;DACT1;NRDC;GSK3B;SNX9;WNT5A;TIPARP;WWP2;HUWE1;NKD1;VGLL4;HECW2;ASB5
prerank,regulation of integrin activation (GO:0033623),0.4155639525562436,0.9961487762170319,0.46107784431137727,0.8092386135837966,1.0,3/15,10.49%,SELP;FBLIM1;PLEK
prerank,negative regulation of macrophage activation (GO:0043031),0.4002332826470086,0.9961258090838275,0.48507462686567165,0.8086336258398039,1.0,2/16,6.02%,IL31RA;NR1H3
prerank,limb development (GO:0060173),0.3501222931386002,0.9959844881830614,0.45309734513274336,0.8083064556988288,1.0,9/28,20.75%,GLI3;SALL1;LRP4;NOG;IQCE;KAT2B;RSPO2;PTCH1;MEGF8
prerank,nucleic acid-templated transcription (GO:0097659),0.32747923270761314,0.9958731418231822,0.45166666666666666,0.8079251281210565,1.0,11/42,13.75%,POLR2D;TERT;BAZ2A;DTX1;CREBL2;MEF2A;EPC1;POLR2C;THAP1;MED20;POLR2F
prerank,response to exogenous dsRNA (GO:0043330),0.3916325829549829,0.9956937305135141,0.45935727788279773,0.8076917192797883,1.0,6/18,15.53%,COLEC12;IRAK3;IFIT1;TICAM1;IFIH1;MUL1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3944518564283761,0.9956753461215724,0.4703770197486535,0.8070891522582561,1.0,6/18,18.47%,BCL2;HEBP2;BCL2L1;SLC25A4;MUL1;SLC25A31
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.39551528800712266,-0.9955065585692869,0.46963562753036436,0.8316173155791684,1.0,5/13,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4086887512310069,-0.9953166115740119,0.49173553719008267,0.8312138451384489,1.0,8/11,35.94%,ARL6IP1;VCPIP1;ATL2;STX18;BNIP1;TRDN;LPCAT3;MOSPD3
prerank,positive regulation of type I interferon production (GO:0032481),0.2965221295385797,0.9950682705309835,0.45839874411302983,0.8079399986436779,1.0,29/73,27.24%,TRIM56;TLR4;PTPN22;ZBP1;CREBBP;POLR1C;STAT1;RIPK2;POLR3F;TLR2;OAS2;POLR2F;IFIH1;TBK1;POLR3H;RNF135;DHX36;SETD2;POLR2K;RIOK3;GAPDH;DHX9;TOMM70;POLR3B;POLR2H;STAT6;ISG15;CRCP;CGAS
prerank,myeloid dendritic cell activation (GO:0001773),-0.39966733083734907,-0.9950629265628705,0.46464646464646464,0.8310416489468249,1.0,4/12,17.73%,DOCK2;HMGB1;PYCARD;CAMK4
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29299650137000666,0.9949036027485959,0.4560862865947612,0.8076968736071499,1.0,16/76,15.53%,PRICKLE1;ANGPT1;CRY1;MYCBP2;HDAC4;BIRC3;RIPK2;PIAS1;LRRK2;FBXO4;HUWE1;CENPX;CUL3;TBC1D7;RCHY1;MUL1
prerank,negative regulation of telomere maintenance (GO:0032205),0.40422354669444294,0.9948122366513256,0.45623836126629425,0.8072749519710157,1.0,5/15,16.18%,SLX4;RAD50;SMG6;ERCC1;TNKS2
prerank,response to organic cyclic compound (GO:0014070),0.30919007350788685,0.9947405586579101,0.4511400651465798,0.8068016543401626,1.0,9/52,10.07%,IGFBP5;ANXA1;STAT5B;IL18;CCL2;STRN3;LRRK2;HLCS;TIPARP
prerank,negative regulation of viral release from host cell (GO:1902187),0.419276075828853,0.9946778272611857,0.4591439688715953,0.8063157222686314,1.0,7/13,24.18%,TRIM5;TRIM21;TRIM26;CHMP3;PML;TRIM8;TRIM32
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.278315575936262,0.9945163648555572,0.48125937031484256,0.8060557903856317,1.0,14/102,9.79%,PDPK1;ENPP1;FER;GCGR;TRARG1;RAB10;SORBS1;ADCY5;ADCY7;CPEB1;ADCY1;INSIG2;RHOQ;OTOP1
prerank,calcium ion transport (GO:0006816),-0.24018488210098268,-0.9944320628489274,0.4755700325732899,0.8318561170084304,1.0,25/113,13.61%,CACNA1E;CACNB2;GRIN3A;TRPC3;SLC24A2;RYR2;TPT1;FKBP1A;GAS6;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;ATP2A3;CACNA1G;TRPC6;CAMK2A;RAMP2;CACNA1D;CRACR2B;TMCO1;CAV1;SLC3A2;ATP2A2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4357145889048287,0.9941627239831793,0.47547169811320755,0.8062919851369429,1.0,3/11,7.85%,GATA6;BMPR1A;LGALS9
prerank,mesenchyme development (GO:0060485),0.40353898715911835,0.9930122059180235,0.4613861386138614,0.8084673680326607,1.0,3/15,5.16%,BMP2;BMP7;TGFBR1
prerank,negative regulation of T cell proliferation (GO:0042130),0.345388778088201,0.9928665603744712,0.4678260869565217,0.8081670547170388,1.0,5/28,7.90%,RC3H1;FOXP3;LGALS9;CD274;TNFRSF14
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3801535135202663,0.9925129938850327,0.48608534322820035,0.8083735115526614,1.0,3/20,5.16%,ZMIZ1;EPAS1;TGFBR1
prerank,protein homooligomerization (GO:0051260),0.27397802106575475,0.9924950437584381,0.4507042253521127,0.8077772855833335,1.0,8/114,6.33%,ALDH1A2;RNF213;MICU1;SHMT1;PRF1;CLYBL;APPL2;GBP5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3080149371079267,-0.9919987999763058,0.45663265306122447,0.8377284380474714,1.0,11/32,18.90%,NAV3;SNCA;ARHGEF2;STMN2;TUBB4A;FGF13;CLASP2;MAP2;MID1IP1;STMN1;FKBP4
prerank,multivesicular body assembly (GO:0036258),-0.31437518338901227,-0.9919321912115071,0.4662004662004662,0.8369852084031344,1.0,12/30,27.49%,VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP7;CHMP2B;VPS28;SNF8;CHMP2A;HGS;CHMP6;CHMP4C
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.41282518631210186,-0.9918969577867252,0.5136268343815513,0.8361735507832485,1.0,4/12,13.74%,SIX1;VEGFA;PAX2;SIX4
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.32689177574755257,0.9915301079059005,0.46037099494097805,0.8095314983228217,1.0,7/42,7.66%,PLEKHA2;RIN2;NRP1;S100A10;EFEMP2;EPHA1;GSK3B
prerank,negative regulation of platelet activation (GO:0010544),-0.3738421116419888,-0.9914401478400953,0.47071583514099785,0.8365883092816618,1.0,3/16,7.57%,PRKG1;NOS3;CEACAM1
prerank,protein transport (GO:0015031),-0.2096829374285838,-0.9912286207260496,0.4842105263157895,0.8362343562004717,1.0,83/332,19.55%,LRP1B;PRKCB;ATP6V0A1;TBC1D8;TFRC;NSF;SYNDIG1;STX3;ANK3;MACF1;SCAMP5;ARF5;TBC1D30;ATP6V1B2;SEL1L;LMAN2L;ARHGEF2;STXBP1;RAB6B;TVP23B;YWHAH;STX16;TANGO6;ATP6V0C;RAB38;SCAMP1;HERC2;RAB3C;ARL1;SCG5;HDAC6;GCC2;NPM1;SCAMP2;SGSM1;TMED2;VMP1;VPS33B;RAMP2;CD74;SCG2;SLC10A7;ATP6V1D;TBC1D22B;ARHGAP1;TBC1D8B;TBC1D14;NAPA;VLDLR;RUNDC1;RAB12;KIF3B;RAB5C;PPY;SNX8;MIA2;EVI5;CHMP1A;TBC1D12;VIPAS39;ATP6V0A2;DNAJC27;CHMP1B;CEP290;TMED7;RABL3;AP3D1;ATP6V1G2;TVP23A;BBS2;CHMP2B;NECAB3;BBS1;LRSAM1;RAB1B;RAB15;ARF6;TBC1D5;ARL4D;SAR1B;ATP6V0E2;IFT22;TBC1D1
prerank,camera-type eye morphogenesis (GO:0048593),-0.420899825693541,-0.9911804844615393,0.47435897435897434,0.8354565849304225,1.0,4/10,9.05%,TENM3;TBX2;VEGFA;LRP6
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2542133201696759,-0.9910090055409418,0.4805194805194805,0.8350236374182753,1.0,13/84,8.46%,QKI;NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;PUF60;KHDRBS3;HNRNPK;DDX17;TRA2A
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.41319916040384314,0.9909807166730268,0.4491682070240296,0.8102304734717266,1.0,4/13,16.03%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,negative regulation of developmental growth (GO:0048640),-0.3151288839510134,-0.9909533392850629,0.47368421052631576,0.8342691075885827,1.0,9/30,17.38%,DIP2B;DCC;WWC1;SEMA3G;FGF13;ULK1;CDKN1A;MAP2;BBS2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3591618005480377,0.9906786593689787,0.4740608228980322,0.8103039515211184,1.0,8/23,22.98%,PLK5;PRCC;ZWINT;NABP1;INTS3;NABP2;CDK5RAP3;WEE1
prerank,mitochondrion localization (GO:0051646),0.38434215939471184,0.9902654734134799,0.47574626865671643,0.8106149799452866,1.0,6/19,15.53%,TRAK1;MEF2A;LRRK2;ATCAY;TLE6;MUL1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.28065010523578837,0.9899931983075773,0.4890190336749634,0.8106278824976714,1.0,9/93,4.01%,SASH1;CCN2;EIF2AK2;MTURN;RELL1;TRAF5;SH3RF1;BMP2;TAOK3
prerank,apoptotic process (GO:0006915),-0.2231209687186613,-0.9899080815381145,0.4646017699115044,0.836131783697096,1.0,42/203,15.09%,HIP1;EFNA5;FOXO1;ELMO1;PTK2B;DCC;CIT;ADAM15;NCKAP1;PPP2R1A;TBX1;PLAGL1;TRPC5;SEMA6A;ARHGEF6;CASP7;PPARD;MAL;FAP;PRUNE2;SCN2A;PAK5;ZBTB16;AKT1;STK11;RHOB;RFK;NUDT2;BAG6;FAS;TRAF7;DDIT4;MRPS30;FASTKD2;TNFRSF21;CASP9;JADE1;PPIA;PAK4;AKAP1;BMF;VDAC1
prerank,amino acid transmembrane transport (GO:0003333),0.32284380316632577,0.9898634069290452,0.44112769485903813,0.8102879542355249,1.0,3/45,3.88%,SLC7A11;SLC6A13;SLC16A2
prerank,regulation of mast cell degranulation (GO:0043304),0.4236843901005526,0.9897235970593177,0.47398843930635837,0.8099938045311775,1.0,3/14,7.85%,GAB2;FER;LGALS9
prerank,regulation of cell motility (GO:2000145),0.27572625267967726,0.9896331793562084,0.492176386913229,0.8095769931991397,1.0,13/121,6.82%,PLXNA2;ROCK2;DIAPH1;ARHGAP18;FGF1;LMO4;TACSTD2;FBLN1;LDB2;NTN1;AMOTL1;MGAT3;SPINT2
prerank,response to growth factor (GO:0070848),0.32480165007000494,0.9894152187058215,0.4683954619124797,0.8094684277427955,1.0,16/41,20.47%,GATA6;BMPR1A;STAT5B;PLK5;TGFBR1;TGFBR2;MAP2K5;EPHA2;TBC1D7;ACVR1C;ACVR2B;URI1;SHC1;EMD;ERBB2;MAPK7
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3055829149106322,-0.9891665173468152,0.4730077120822622,0.8372761172941768,1.0,11/33,23.10%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR;EGF;AFAP1L2;NUP62;HAP1
prerank,copper ion transport (GO:0006825),-0.4051584452667988,-0.9891540736771657,0.4704641350210971,0.8364095873366347,1.0,4/11,10.91%,ATOX1;SLC31A1;STEAP2;SLC31A2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4161161012380729,0.988767106039544,0.4701348747591522,0.8104065362287467,1.0,5/13,19.42%,AXL;WNT5A;IFIH1;TAF9;IL7
prerank,"transcription, DNA-templated (GO:0006351)",0.2536378085080663,0.9884504250996683,0.47606382978723405,0.8105361603281515,1.0,46/207,18.57%,SOX5;MLLT3;MAF;POLR2D;PIR;GLIS3;NCOA6;BAZ2A;DTX1;CREBL2;POLR1C;CDC73;TRIM24;MEF2A;CCNH;EPC1;MNAT1;NOCT;CDK7;TAF7;HIPK3;TCEA1;POLR2C;IWS1;RTF1;FOXO3;THAP1;NFIC;MED20;PKNOX1;PAF1;POLR2F;GTF2H4;ERCC6;LEO1;MLLT1;SNAPC3;IRF9;TAF9;POLR3H;DDX21;AFF4;GTF2H2;TTF1;PMF1;NFYA
prerank,stress fiber assembly (GO:0043149),0.3963825452635051,0.9880836795008325,0.4793233082706767,0.8101427712757082,1.0,3/15,13.07%,SORBS1;CUL3;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.3963825452635051,0.9880836795008325,0.4793233082706767,0.8101427712757082,1.0,3/15,13.07%,SORBS1;CUL3;ARRB1
prerank,cellular response to fatty acid (GO:0071398),0.42652747708320693,0.9879246846000089,0.48484848484848486,0.8098945800271127,1.0,2/12,12.05%,PID1;DGAT2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.2933953577971439,-0.9878327803856671,0.47794117647058826,0.8391511743832311,1.0,12/39,16.16%,TIE1;HSPA8;NOTCH1;DAB2IP;RAPGEF2;PINK1;ANKRA2;HSP90AA1;SPTY2D1;CCL19;IRGM;RAP1A
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3532155421557358,-0.9878114205371081,0.45435684647302904,0.8382934321407648,1.0,8/18,25.75%,SLC2A1;PRKCB;INPP5K;NR4A3;C2CD5;C3;OCLN;RTN2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2940465640439697,-0.9877671565218535,0.44862155388471175,0.8374989531661929,1.0,4/39,2.04%,MYO1D;PPFIA2;FNBP1L;TANC2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.32512465404631136,0.9876911955663895,0.4717948717948718,0.8098180535720415,1.0,6/39,7.71%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1;CCL2
prerank,positive regulation of DNA repair (GO:0045739),0.32066093231652837,0.9876156321358046,0.48325358851674644,0.8093598847267379,1.0,17/46,23.82%,EYA2;EYA1;SPIDR;SLF2;XRCC1;EYA4;ERCC6;UIMC1;MGMT;BRCC3;ERCC8;EYA3;SPIRE1;SMCHD1;DHX9;CEBPG;ZCWPW1
prerank,regulation of cell communication (GO:0010646),0.3301028747751966,0.9875835826742908,0.45546218487394957,0.8088088170054943,1.0,4/35,3.55%,CXADR;GRK3;IGFBPL1;ANXA1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.41700419079015655,0.987549356598954,0.46828358208955223,0.8082447046487273,1.0,7/13,21.85%,DBN1;SUFU;KEAP1;PKD2;NFKBIE;GET4;PKD1
prerank,plasma membrane organization (GO:0007009),0.3031319044441875,0.987329824963789,0.4771986970684039,0.8081210549047976,1.0,11/61,11.41%,MYOF;SPTBN1;A4GALT;COL5A1;PACSIN2;SNX9;MICALL1;PLSCR4;STX2;PLSCR2;ANO6
prerank,positive regulation of lipid catabolic process (GO:0050996),0.380969009282795,0.9866979047976675,0.4696132596685083,0.8090088181021404,1.0,7/19,27.14%,APOA2;PPARA;ABHD5;ANGPTL3;DAGLB;IRS2;PRKCD
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3469513624190464,0.9866211572209941,0.47971781305114636,0.8085708362336698,1.0,4/27,7.71%,NFAT5;IL6;CD47;CCL2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.428947694806913,0.9862961910310389,0.4915254237288136,0.8087346945355357,1.0,5/12,9.50%,DOCK5;IGFBP5;ADAMTS1;TPM1;DOCK7
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.26201247499632074,-0.9859409855915751,0.47953216374269003,0.8415688046467172,1.0,25/72,24.51%,PSMC3;AKT1;PSMD14;PSMD3;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;DICER1;IRAK1;CARD10;PSMD7;PSMC6;PSMB5;PSMC5;TNFRSF10B;PSMB1;NFKB2;SKP1;PSMD11;PSMD8
prerank,cell cycle checkpoint signaling (GO:0000075),0.40998654993476435,0.9857288379711793,0.5,0.8094496840123425,1.0,3/12,9.40%,PRCC;ZWINT;NABP1
prerank,limb morphogenesis (GO:0035108),-0.33979439347198787,-0.9855195599299003,0.47334754797441364,0.8418353308281753,1.0,5/20,13.13%,TGFB2;MBNL1;FBXW4;LRP6;BMPR1B
prerank,tRNA aminoacylation (GO:0043039),-0.2995464528008285,-0.9853246481642292,0.47593582887700536,0.8414535905202978,1.0,14/37,33.70%,LARS2;KARS1;CARS1;EEF1E1;IARS1;RARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;QARS1
prerank,ubiquinone metabolic process (GO:0006743),-0.37743541577830153,-0.98481833648026,0.4661016949152542,0.8419420009867655,1.0,7/15,23.86%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5;AIFM2
prerank,phosphate ion homeostasis (GO:0055062),0.44423525785467277,0.9843256691340497,0.4969939879759519,0.8122342466823051,1.0,1/10,1.45%,ENPP1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3513063604806731,0.9840974119325788,0.47294938917975565,0.8121680147933361,1.0,3/27,2.88%,SLC7A2;SLC1A3;SLC6A9
prerank,positive regulation of innate immune response (GO:0045089),0.3437494428146602,0.9836992368099678,0.4581196581196581,0.8125052344063203,1.0,6/30,11.03%,FPR2;IFI35;ZBP1;GBP5;WNT5A;POLR3F
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2896398639289971,-0.983656315009217,0.49257425742574257,0.844303843592038,1.0,15/42,27.56%,PEX26;PEX10;ZFAND2B;PEX16;C2CD5;DNLZ;HSPA5;GRPEL2;TOMM40L;SEC61A1;TOMM20;SEC61G;RTN2;TIMM21;SEC61B
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.3673318920332457,0.9835315600983225,0.4840989399293286,0.8123214390929427,1.0,4/22,8.47%,APOA2;LACC1;TNFRSF14;WNT5A
prerank,cellular response to interleukin-1 (GO:0071347),-0.23284397922604588,-0.9832007577282279,0.50187265917603,0.8446594622114675,1.0,35/143,21.19%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;DAB2IP;CCL14;MAPK3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;CD40;PSMA6;PSMA4;PSMB8;PTGIS;UBA52;PSMA8;CCL19;NOD2;PSME1;PYCARD;TOLLIP;IRAK1;PSMD7;PSMC6;IKBKB;PSMB5;UPF1;PSMC5;PSMB1
prerank,positive regulation of glucose import (GO:0046326),0.376679975477857,0.9831925936333025,0.4982014388489209,0.812513798866603,1.0,5/21,9.79%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,positive chemotaxis (GO:0050918),0.40327203502615144,0.9830989278345211,0.49056603773584906,0.8120949779394792,1.0,3/17,3.83%,FPR2;NRP1;ANGPT1
prerank,microtubule anchoring (GO:0034453),0.41968791971037,0.9830448950544713,0.4655493482309125,0.8115994603702537,1.0,2/12,4.99%,DAG1;CLASP1
prerank,positive regulation of exosomal secretion (GO:1903543),0.39610843840610777,0.9830310501342063,0.484629294755877,0.8109991112547733,1.0,1/15,1.31%,SMPD3
prerank,positive regulation of locomotion (GO:0040017),-0.3217289692845535,-0.9828053033100536,0.45657015590200445,0.8447893745056713,1.0,3/27,3.24%,SPOCK2;THBS1;STX3
prerank,peptide catabolic process (GO:0043171),0.3620954169295498,0.9826445981811655,0.4915254237288136,0.811335662312093,1.0,5/23,9.70%,CPQ;ANPEP;NPEPPS;CTSH;ERAP1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.24991915283619862,-0.9822839040076613,0.5167597765363129,0.8453805859774651,1.0,26/84,24.51%,PSMC3;CDC26;PSMD14;UBB;PSMD3;PTTG1;PSMD4;PSMD6;PSMA6;UBE2E1;PSMA4;PSMB8;UBA52;PSMA8;CDK2;BUB1B;UBE2D1;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;ECRG4;PSMD11;PSMD8
prerank,import into cell (GO:0098657),0.3259454541145052,0.9821999362406759,0.47818791946308725,0.8117289927876974,1.0,5/41,3.88%,ATP1A2;SLC1A3;SLC6A13;SLC19A1;SLC16A2
prerank,peptide hormone secretion (GO:0030072),0.35083412275886167,0.9820451481139416,0.4776386404293381,0.8114666437551565,1.0,5/26,10.26%,GHRH;ANXA1;IL6;FAM3B;CDK16
prerank,membrane repolarization (GO:0086009),-0.37758036073556756,-0.9819560588250035,0.4901098901098901,0.8453845010634436,1.0,6/15,13.29%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,cellular response to superoxide (GO:0071451),-0.4226365420833149,-0.9818439717794005,0.484,0.8447632430262474,1.0,3/10,21.77%,NOS3;SOD1;PRDX2
prerank,regulation of blood circulation (GO:1903522),0.34488005893763296,0.981712879367488,0.4816112084063047,0.8115884344399162,1.0,4/34,7.04%,CELF2;DES;TPM1;BDKRB2
prerank,response to interleukin-1 (GO:0070555),0.28980619320808415,0.9816313326583982,0.47699386503067487,0.8111649993010163,1.0,14/73,16.20%,ADAMTS12;GBP2;ANXA1;RC3H1;HDAC4;CD47;CCL2;LGALS9;IRAK3;ADAMTS7;CCL25;APP;TAF9;GBP3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3196837513149937,-0.9811863641148446,0.5,0.845712277619182,1.0,12/27,28.37%,CD74;SPRED2;ATM;EEF1E1;PTTG1IP;SPRED3;SPRED1;MSX1;ATR;MIF;YJU2;PMAIP1
prerank,transcription by RNA polymerase I (GO:0006360),0.32981575447853667,0.9810920566382433,0.47627118644067795,0.8118421099625693,1.0,18/34,27.68%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;TAF1;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.31243808832323255,0.9807161153658627,0.4935897435897436,0.812103366162396,1.0,9/46,14.97%,TIMP3;FBLN1;DUSP10;TLR4;PTPN2;DLG1;SMAD4;PTPN1;PTPRR
prerank,chemical homeostasis (GO:0048878),0.29950972980818974,0.9806276003243378,0.47289156626506024,0.8116759558137263,1.0,6/61,7.96%,ZBTB20;RBP1;ACOXL;SLC4A11;NR1H3;WNK4
prerank,calcium ion transport into cytosol (GO:0060402),-0.33735358481093164,-0.9805996375493142,0.4823008849557522,0.8464300327440608,1.0,5/21,9.11%,RYR2;GRIN2A;SLC8A1;GRIN2B;GRIN1
prerank,positive regulation of blood coagulation (GO:0030194),-0.3544327435328995,-0.9805435762134657,0.4912663755458515,0.8456929424992088,1.0,4/17,14.61%,THBS1;F3;USF1;ST3GAL4
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.38732098755350725,-0.9803427229611836,0.5139442231075697,0.845372056462936,1.0,4/13,9.73%,EPN2;DAB2IP;EMILIN1;HHEX
prerank,regulation of microtubule-based movement (GO:0060632),-0.41069108593169246,-0.9802976537650946,0.5010224948875256,0.8446134925724513,1.0,6/11,26.73%,HDAC6;NEFH;LAMP1;MAP2;HAP1;CCDC65
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.35864001536531537,0.980094545650678,0.4783362218370884,0.8123419705771506,1.0,9/24,21.40%,SLX4;DCP2;HNRNPC;XRN1;TNKS2;EXOSC10;TEN1;CTC1;TENT4B
prerank,regulation of oxidative phosphorylation (GO:0002082),0.39514205180232986,0.9795563191854764,0.5192660550458715,0.8130927542326847,1.0,1/16,1.78%,NUPR1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.39763140589264523,-0.9783411251167592,0.4723404255319149,0.8492835868956559,1.0,6/12,18.17%,SNCA;STMN2;TUBB4A;ARHGEF7;MAP2;STMN1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.24600339929080922,-0.9779856377980076,0.47770700636942676,0.8493326551492296,1.0,19/91,14.81%,SYT1;RIMS2;HIP1;RIT2;NSF;HIP1R;STXBP5L;MAPK3;MBTPS1;SCARB1;RAB3C;CPLX1;SYT7;CPLANE2;FES;RAB12;SYK;RAB5C;PTPRC
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2597597816008287,-0.9779200081947765,0.5,0.8486095377452508,1.0,15/71,14.25%,CTSC;CTSB;OTUD7A;FAP;LGMN;CTSS;HDAC6;UBB;BAG6;MALT1;ZRANB1;CTSL;PSMA6;UBA52;PSMA8
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.34859922359585027,-0.9777318171206378,0.49528301886792453,0.8482052110031596,1.0,12/18,50.23%,PRELID1;XRCC6;PRKDC;IKZF3;CRTAM;PRDM1;CCR2;TBX21;ABL1;SLAMF8;NCKAP1L;CD2
prerank,glucan catabolic process (GO:0009251),0.39920892617937737,0.9770826156040174,0.5,0.8185283307578156,1.0,4/15,11.44%,PYGB;MGAM;PYGM;STBD1
prerank,regulation of cell-cell adhesion (GO:0022407),0.32154972951110433,0.976834081048529,0.5081699346405228,0.8184490430530434,1.0,7/39,8.23%,DPP4;EPHA7;AFDN;FSTL3;CD47;SPINT2;FUT4
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.40729423435047213,0.9767975732041017,0.4913294797687861,0.8179100390531648,1.0,2/14,9.45%,CMPK2;AK5
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.30581389111654733,-0.9765812275854506,0.4610091743119266,0.8504857333262301,1.0,6/30,11.92%,TPT1;RPS3;CXCL12;CD74;CCAR2;PTTG1IP
prerank,actomyosin structure organization (GO:0031032),0.28295976820533686,0.9764900061490022,0.4895330112721417,0.81801832560736,1.0,9/75,6.96%,ROCK2;TMOD3;CSRP3;SORBS1;EPB41L5;TPM1;EPB41L2;CSRP1;ACTN2
prerank,protein targeting to membrane (GO:0006612),-0.2488455425525022,-0.9762419898177771,0.4967532467532468,0.8504798297270496,1.0,29/83,24.06%,ARL6IP1;AQP11;VPS37B;SRP14;SDCBP;ZDHHC14;ZDHHC20;ATAD1;PEX26;ZDHHC2;GDAP1;TRAM1;ZDHHC24;NACA;RABGEF1;ABCD2;SSR2;VPS37A;PEX16;ZDHHC7;PEX19;SEC61A1;PXMP4;YIF1B;ZDHHC23;SGTB;ZDHHC9;TAOK2;RAB8B
prerank,female gonad development (GO:0008585),0.3765860495933504,0.9760385511463066,0.48214285714285715,0.8184819468026728,1.0,2/19,3.84%,NR2F2;KIT
prerank,positive regulation of chromatin organization (GO:1905269),-0.39370669130019886,-0.9759232154652505,0.5031055900621118,0.8504314083144727,1.0,4/12,18.29%,H3-3A;TERF1;TAL1;TINF2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.32461560481394136,0.9758831415803465,0.4878048780487805,0.8182374194372041,1.0,11/39,17.19%,BMP6;BMP2;MIA3;PPARA;SPINT2;MYADM;PTK2;MAP2K5;WNK1;NF2;PODXL
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3934929423945901,-0.975521208243534,0.4959349593495935,0.8506380014687953,1.0,2/12,11.40%,ABCC9;KCNJ8
prerank,oligodendrocyte differentiation (GO:0048709),-0.3570570066169433,-0.9753059629400863,0.504524886877828,0.8503490188100284,1.0,8/19,34.59%,EIF2B2;SOX6;TPPP;PTPRZ1;CDK5;SLC8A3;PRDM8;SOX8
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3081722820585336,0.9752807200537997,0.49185667752442996,0.8190437792705323,1.0,9/48,10.63%,PDPK1;FGFR1;FOXC2;ANXA1;ANGPT1;PIK3C2A;MAPK14;AKT3;FGF18
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3736526570361932,0.975221490243303,0.47504621072088726,0.8185501659734953,1.0,4/18,17.33%,ANXA1;KLF9;NR3C1;PCK2
prerank,regulation of protein localization to nucleus (GO:1900180),0.3175458731552713,0.9751622950172162,0.4794745484400657,0.8180550522655555,1.0,9/43,8.63%,PARP9;LATS2;TPR;DTX3L;CTNNA1;NGFR;GSK3B;GLUL;YAP1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4381923781932407,0.9751576546865981,0.467680608365019,0.8174401465304767,1.0,1/10,0.40%,BMP6
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2806926258430487,0.9751195769376426,0.5135908440629471,0.8169022302935843,1.0,15/94,12.29%,PDK1;ITPR1;IKBKE;BCL2;MCL1;CASP4;CUL4A;FHIT;QRICH1;BAX;STK24;BCL2L1;RRP8;CUL3;EPHA2
prerank,small GTPase mediated signal transduction (GO:0007264),0.2708688098865165,0.9749186168254955,0.5142045454545454,0.8167886938063081,1.0,16/103,10.27%,RIN2;TIAM2;PLD1;ARHGAP18;KSR1;RRAS2;ARHGAP32;NTN1;ARL3;PLCE1;SIAH2;RALBP1;RRAD;USP8;RALGDS;MAPK14
prerank,transepithelial transport (GO:0070633),0.39831416530879993,0.9739011453455081,0.4774436090225564,0.818526850637347,1.0,2/15,0.80%,CXADR;SLC1A3
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2715389516427013,0.973492549687219,0.507959479015919,0.8188719469816883,1.0,12/109,6.63%,PTPN13;PLEKHA2;PLA2G4A;TPTE;PI4KA;PDGFRB;MTMR11;MTMR3;PLCB3;PLEKHA4;PLA2G4C;PIK3C2A
prerank,regulation of mRNA polyadenylation (GO:1900363),0.38923155444318336,0.9730154100636115,0.47842401500938087,0.8193741346824,1.0,3/17,8.00%,CPEB1;RNF20;ZC3H3
prerank,synaptic vesicle membrane organization (GO:0048499),-0.35650205650288647,-0.9728352451394514,0.4925373134328358,0.8563417529503508,1.0,9/17,32.17%,STX3;SNAP25;SYNGR2;AP3D1;SNAP29;STX1B;TOR1A;SYNGR1;STX19
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3868650888185592,-0.9728006656926947,0.5097613882863341,0.8555369882339323,1.0,3/13,6.94%,GRIN2A;PERP;LGMN
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3591061371916415,0.9724069654289516,0.48484848484848486,0.8202115526111403,1.0,8/21,23.55%,LRRK2;BCL2L1;OPA1;NCK1;EIF2AK3;XBP1;TXNDC12;SYVN1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.38704508516214753,0.9721027082759612,0.5018181818181818,0.8203229900745135,1.0,4/17,10.73%,BCL2;BAX;DNM1L;BCL2L1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.37531483258847703,-0.9720374880766799,0.49079754601226994,0.8567429411833295,1.0,5/14,28.11%,THBS1;CMKLR1;C1QBP;JAK3;LILRB1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3746533832979283,0.9719567717009109,0.49552772808586765,0.82004709980049,1.0,5/20,19.70%,TNRC6B;TNRC6A;MOV10;WTIP;AJUBA
prerank,sensory perception (GO:0007600),-0.2813010893428721,-0.971759771524526,0.5011990407673861,0.856574463077778,1.0,13/45,20.93%,PCDH15;TMEM150C;GNAS;OPRM1;SCN9A;KCNA2;NTSR2;GNAL;P2RX7;CHRNA4;CHRNA7;PENK;TTC8
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3406730460220385,0.9715301246146859,0.4833040421792619,0.8204263765951694,1.0,3/28,5.83%,SMAD3;ZIC1;TPR
prerank,regulation of ruffle assembly (GO:1900027),-0.3230618341127632,-0.9713724643435585,0.5152941176470588,0.856712688948772,1.0,9/23,20.74%,NLGN1;EPS8;ABI3;CAV1;HRAS;EVL;ARHGAP24;PFN2;FAM98A
prerank,regulation of protein autophosphorylation (GO:0031952),0.32360949579635356,0.9710281235100261,0.49401709401709404,0.8209448942201027,1.0,6/36,9.47%,EPHA7;ENPP1;ERRFI1;RAD50;MVP;RAP2C
prerank,peripheral nervous system development (GO:0007422),-0.3273652914103994,-0.9707539289507034,0.49440715883668906,0.8574972876162931,1.0,6/23,16.45%,ADGRG6;SERPINI1;SCN8A;NFASC;NGF;NTF3
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.27978173670029666,-0.9706757230450527,0.5118733509234829,0.8568273160164177,1.0,12/46,19.73%,AKT1;MFF;PINK1;MFN2;GDAP1;TIMM8B;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3148884291547222,-0.9706007950712957,0.5156626506024097,0.8561371637656295,1.0,7/27,10.30%,FGF12;FXYD5;UTRN;YWHAH;CAMK2D;NEDD4L;NOS1
prerank,regulation of viral life cycle (GO:1903900),0.3763620274186223,0.9704047578000646,0.5,0.8218571064708625,1.0,4/21,12.33%,AXL;TRIM5;KPNA6;TRIM21
prerank,positive regulation of nuclear division (GO:0051785),0.3550431929439361,0.970360769688334,0.4981949458483754,0.8213203362375341,1.0,4/25,9.00%,PHIP;TGFA;PDGFRB;IGF2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2859511602489508,0.9702940561771546,0.5075075075075075,0.8208627149429907,1.0,27/76,24.22%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;PTK2;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180;DNAJB2;RNF139;SIRT2;PTEN;FBXW7;CDK5RAP3;CEBPA;RNF14;TAF1;COP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.37036933344000494,0.970290642630736,0.5009276437847866,0.8202417981286096,1.0,5/19,12.67%,CAMK1D;IL34;PTK2;CSF1;RARRES2
prerank,regulation of interferon-gamma production (GO:0032649),-0.2562368941447132,-0.9702001656684419,0.5112994350282486,0.8563604297050086,1.0,9/71,9.14%,PDE4D;PDE4B;SLC7A5;IL1R1;GAS6;HMGB1;CYRIB;ZFPM1;HAVCR2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.34518645846003493,0.9697649518018846,0.4878472222222222,0.8208970238755189,1.0,12/28,26.14%,PARP9;PARP3;DTX3L;ERCC6;SHLD2;KMT5C;CYREN;RIF1;KMT5B;SMCHD1;SHLD1;TFIP11
prerank,metanephros development (GO:0001656),0.34508275888642853,0.9696788600830788,0.4866785079928952,0.8204474691869293,1.0,4/26,7.04%,FOXD1;OSR1;BMP7;CTSH
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.28671510444098985,0.9694995047771715,0.5123456790123457,0.8202685704826517,1.0,10/70,11.99%,PDPK1;SMAD3;BCL2;MCL1;GSK3B;BAX;CASP8AP2;APPL1;BCL2L1;IFI27
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.27781540329264115,-0.9693283457608121,0.48157248157248156,0.8577979280794324,1.0,10/44,12.59%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;VEGFA;PAX2;RPS6KA1;NGF;KLF4
prerank,positive regulation of apoptotic process (GO:0043065),0.24167753333639924,0.9690894105995922,0.546583850931677,0.8205715103853709,1.0,38/293,10.58%,IGFBP3;PAWR;TIAM2;AKAP13;EPHA7;PHLDA1;NUPR1;WNT10B;DLC1;FGD4;PNMA3;IFIT2;ADAMTSL4;PRDM11;DAPK1;BMP2;APBB1;IL6;LATS2;TGFBR1;UNC13B;ZBP1;TNFRSF12A;USP27X;PLEKHG2;NGFR;PDCD5;ARHGEF11;QRICH1;BAX;STK3;UBE2Z;CALHM2;ARHGEF12;SOS2;NGEF;PPID;DNM1L
prerank,neural crest cell differentiation (GO:0014033),-0.3534594818582115,-0.9689455901306889,0.4847775175644028,0.8579609068040375,1.0,2/18,1.17%,CDH2;MEF2C
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.31166858910029466,0.9684967987898685,0.4948805460750853,0.8213537052918164,1.0,7/43,11.49%,TLR4;C5AR2;PTPN22;LGALS9;CD274;PTPN6;IRAK3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32674531202551904,0.9677995401207871,0.5127334465195246,0.8224433966867866,1.0,5/34,9.66%,DOCK5;NRP1;S100A10;MYADM;TRIOBP
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.38875192714340406,0.9677524164693078,0.5084745762711864,0.821935798303482,1.0,7/16,21.48%,SLX4;SMG5;SMG6;TNKS2;HNRNPA2B1;DHX36;RTEL1
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.2970914637654292,-0.9676241909350207,0.5012787723785166,0.8608767146198755,1.0,18/35,30.45%,FAR2;HMGCS2;GGT5;ACACA;ACLY;SCD;GGT7;GGT1;HSD17B8;HPGD;FASN;HMGCLL1;GCDH;BDH1;HMGCL;ALOX5AP;ALOX5;BDH2
prerank,intracellular lipid transport (GO:0032365),0.3606992214482293,0.9672589454830033,0.5008849557522124,0.8224943902690947,1.0,2/21,1.61%,PRKAG2;PRKAA2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3941797668486472,0.9671536179967966,0.4934579439252336,0.822114861375408,1.0,4/14,12.68%,GHR;STAT5B;PTK2;PTPN1
prerank,regulation of vacuole organization (GO:0044088),0.36844384223854065,0.9667325031069571,0.4972677595628415,0.822435001809397,1.0,10/20,25.01%,ANXA2;IFT88;MTMR3;IFT20;NPRL3;RAB5A;ADPRH;UBQLN2;MTM1;NPRL2
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.27976146611187724,-0.9662634491130739,0.5231958762886598,0.8636941332669692,1.0,14/44,21.33%,PTK2B;NCKAP1;LMOD1;ARPC4;CDC42EP3;VASP;CDC42EP1;CDC42EP5;EVL;PYCARD;ARF6;PFN2;CARMIL1;PRKCE
prerank,response to insulin (GO:0032868),0.2807780184415454,0.9661413023968277,0.4984375,0.8232565904538289,1.0,11/80,9.79%,PDPK1;ENPP1;FER;TRARG1;RAB10;SORBS1;EPM2AIP1;CPEB1;INSIG2;RHOQ;OTOP1
prerank,amide biosynthetic process (GO:0043604),-0.2752918053374835,-0.9653522008827556,0.5253807106598984,0.8652778161650008,1.0,4/47,3.39%,SGMS1;DMD;CERS4;DEGS2
prerank,atrial septum morphogenesis (GO:0060413),-0.4128822704513365,-0.965338248361818,0.5403846153846154,0.8644092885300027,1.0,4/10,12.80%,TGFB2;BMPR2;ZFPM1;ACVR1
prerank,ventricular septum morphogenesis (GO:0060412),0.34718536552614226,0.9652904315874941,0.508833922261484,0.8246294580836258,1.0,8/27,12.69%,ROBO1;TGFBR3;BMPR1A;TGFBR1;TGFBR2;HEYL;SMAD4;NOG
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3165122036062206,-0.9652529927298076,0.4954128440366973,0.8637255598307512,1.0,12/26,31.97%,PLCG2;RAB27A;SNCA;GRIN1;ABCD2;PARK7;SLC18A2;ADGRB1;SLC30A10;TLR6;ALOX5;SLC5A3
prerank,pinocytosis (GO:0006907),-0.4112364284024642,-0.965233361098624,0.5184381778741866,0.8628882360825078,1.0,5/10,27.58%,DOCK2;PYCARD;CARMIL1;SNX33;AHSG
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.39032424970966795,-0.9646447291138758,0.5176715176715176,0.863599026391934,1.0,5/12,17.57%,HMGB1;MBP;CD74;KLF4;LPL
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3027609717308814,0.9645812327201903,0.5088,0.8257146046694193,1.0,7/49,7.85%,APOA2;IL17D;IL6;TLR4;SERPINE1;NOS2;LGALS9
prerank,L-glutamate transmembrane transport (GO:0015813),0.4317945217190223,0.9644897857496226,0.531496062992126,0.8253075258290004,1.0,1/10,0.80%,SLC1A3
prerank,glycerophospholipid metabolic process (GO:0006650),-0.25129342374400365,-0.9644160073521402,0.5151515151515151,0.8633225883648034,1.0,24/75,22.65%,GPCPD1;PLCB1;DGKH;SERINC1;GDPD1;ABCA3;SERINC5;ENPP6;PIGM;PIGQ;PIGH;DPM2;CSF1R;PGP;GDE1;PLCG1;ABHD6;PNPLA6;CPNE7;PNPLA3;PIGB;PLA2G7;CLN3;PLA2G4F
prerank,positive regulation of viral life cycle (GO:1903902),0.3626588548499786,0.9643022369277408,0.4972170686456401,0.8251339508488726,1.0,3/22,7.85%,AXL;KPNA6;LGALS9
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3591824756542726,0.9640595356913093,0.4811320754716981,0.8251027699809831,1.0,3/20,10.75%,NR2F2;LATS2;IPO7
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2775889389547942,0.9637804634421514,0.5343283582089552,0.8251658291364579,1.0,15/80,14.53%,PRICKLE1;ANGPT1;CRY1;MYCBP2;SPSB4;BIRC3;RIPK2;LRRK2;FBXO4;FANCM;HUWE1;CENPX;CUL3;TBC1D7;RCHY1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.28934333156187414,0.9636661739047565,0.5215384615384615,0.8248361273872002,1.0,14/75,11.86%,PDPK1;FGFR1;ECM1;NRP1;VEGFD;BMP2;ARNT;TGFBR1;WNT5A;IGF2;AKT3;CDH13;EGR3;NR4A1
prerank,hemopoiesis (GO:0030097),0.27989555839978264,0.9631046599343216,0.5083459787556904,0.8255936562030921,1.0,15/87,11.60%,KMT2A;TGFBR3;NOTCH2;WNT10B;WNT2B;FSTL3;KIT;NCOA6;SBDS;TGFBR2;WNT5A;FUT10;PLEK;SH2B3;MFAP5
prerank,protein N-linked glycosylation (GO:0006487),-0.2618478115396382,-0.9630189398948246,0.5347593582887701,0.8663163989859607,1.0,21/66,20.57%,FUT8;MGAT5;ALG14;RPN2;SRD5A3;ALG5;GFPT2;LMAN1;MGAT4A;DPM2;DOLPP1;PGM3;GFPT1;SLC39A8;GAL3ST1;OSTC;ALG6;PMM2;STT3B;MOGS;UBE2J1
prerank,positive regulation of cell death (GO:0010942),0.2930581347222714,0.9627087593362438,0.509375,0.8259087777045735,1.0,7/59,9.30%,EFNB2;SLC6A13;GSK3B;RIPK2;WNT5A;HEBP2;LRRK2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.24645760287296473,-0.9626705739943873,0.5466237942122186,0.8663028215776053,1.0,18/80,13.77%,NLGN1;FNBP1L;TENM2;GPM6A;EPS8;PIK3R1;NCKAP1;CCDC88A;CDC42EP3;ARPC2;TGFB3;CDC42EP1;CDC42EP5;ANLN;WASHC1;HRAS;RAC1;AGRN
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3768266869288456,0.9624942657792779,0.5046904315196998,0.8258213729976007,1.0,5/20,17.14%,TERT;SNIP1;TARBP2;ZC3H7B;PUM2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3372078124467286,0.9624494493727273,0.5043177892918825,0.8253140199160766,1.0,2/29,1.51%,RASGRF1;NOTCH2
prerank,endodermal cell differentiation (GO:0035987),0.3348063753844453,0.9621822779476138,0.5254237288135594,0.8253583227515354,1.0,8/31,14.20%,VTN;FN1;ITGA5;MMP14;CDC73;RTF1;PAF1;LEO1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3790475574477419,0.9620314564458549,0.5009140767824497,0.8250914486969244,1.0,5/16,18.55%,PDS5B;POGZ;PDS5A;NIPBL;DSCC1
prerank,insulin secretion (GO:0030073),-0.3511666769303683,-0.9619846790028576,0.5052854122621564,0.8672847441310355,1.0,9/19,27.02%,RIMS2;PTPRN2;SNX19;PARK7;RAB11FIP5;PTPRN;SELENOT;CAMK2G;MAFA
prerank,mesoderm development (GO:0007498),-0.34888672540636323,-0.9617486616426633,0.5066666666666667,0.8670683332290475,1.0,12/18,36.94%,TIE1;TBX1;BMX;VEGFA;IKZF1;TBX6;MEST;TCF15;MESD;IKZF3;HES7;BTK
prerank,cobalamin metabolic process (GO:0009235),0.3811062519798259,0.9616675827043902,0.5147058823529411,0.8253055544299435,1.0,2/17,8.52%,MMAB;LMBRD1
prerank,piRNA metabolic process (GO:0034587),0.3706547323568401,0.961630048438824,0.5100548446069469,0.824776715285271,1.0,2/19,8.18%,PIWIL4;EXD1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.39699569324665174,-0.9615174047380375,0.5234042553191489,0.8668268952151631,1.0,3/10,18.62%,IQSEC1;EPB41L4B;ARF6
prerank,regulation of Notch signaling pathway (GO:0008593),0.28491257159742717,0.9613062804393471,0.5,0.8249038205773522,1.0,10/76,6.75%,TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;DLK1;DTX1;MMP14;CREBBP
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4212608982726114,0.9611840543551464,0.5131086142322098,0.8245899138847009,1.0,4/11,23.55%,IL34;CSF1;RIPK1;TGFB1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.23647538359904727,0.9609722962474679,0.5602923264311814,0.8244850535974304,1.0,83/336,20.40%,PRAP1;PDS5B;ZBTB4;POLH;TRIP12;TAOK3;SPATA18;CRY1;WRN;APBB1;IKBKE;PLK5;BCL2;SLX4;NCOA6;MCL1;UBE2U;RAD50;PARP3;CUL4A;DTX3L;SUSD6;SPIDR;CCDC13;WAC;FBH1;NEK4;MAP2K6;BAX;BAZ1B;YAP1;MNAT1;SIRT4;PSME4;USP47;SUMO1;SLF2;NABP1;TLK2;UVRAG;NUPR2;MAPK14;SETD7;BCL2L1;RFWD3;ADPRS;RBBP8;EPHA2;OGG1;MASTL;RAD51B;HIC1;INTS3;GTF2H4;BOD1L1;RAD9A;PML;PDS5A;ALKBH1;ERCC1;TAF9;USP45;MGMT;NFATC2;MACROD1;KMT5C;NIPBL;SMARCAL1;FANCC;SHPRH;ATF2;PARP4;USP10;XPC;UBR5;NSMCE3;RIF1;SMC6;CEP63;NABP2;ERCC8;BLK;KMT5B
prerank,amyloid fibril formation (GO:1990000),-0.26746776004094414,-0.9609204912626426,0.5372750642673522,0.8675815369350547,1.0,9/51,8.76%,CST3;FKBP1A;H3-3A;SNCA;TGFBI;SORL1;TSPAN14;UBB;B2M
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4045461621410957,0.9608839121478503,0.47735849056603774,0.8240793761695919,1.0,4/12,14.09%,MIA3;PPARA;FUT4;WNK1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2653335999346833,-0.9606527007108232,0.543010752688172,0.8674311564651679,1.0,22/61,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;SIRT5;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CAV1;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;FGFR4;PSMD11;PSMD8
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.28415248865557347,0.960566740864533,0.5395136778115501,0.8241942427256408,1.0,17/78,15.97%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;SGTA;LRRK2;SUMO1;KEAP1;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180
prerank,response to ionizing radiation (GO:0010212),0.2883450421611332,0.960352631896745,0.49850299401197606,0.8240491620971234,1.0,14/70,15.16%,EYA1;XRRA1;NHEJ1;ANXA1;IKBIP;SPIDR;XRCC4;NABP1;MAPK14;RFWD3;INTS3;RAD9A;UIMC1;FIGNL1
prerank,iron ion transport (GO:0006826),-0.27320811278107904,-0.9603202230139981,0.5466666666666666,0.8674546103068859,1.0,17/47,21.84%,ATP6V0A1;TFRC;SLC40A1;FTH1;ATP6V1B2;ATP6V0C;SLC39A14;ATP6V1D;ARHGAP1;TTYH1;ATP6V0A2;SCARA5;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4074005670187658,-0.9601398174031495,0.5060975609756098,0.8670509879741893,1.0,6/10,29.30%,INSIG1;YOD1;UBE2J1;UBAC2;SVIP;UBE2G2
prerank,positive regulation of programmed cell death (GO:0043068),0.2406899748521344,0.9600390183477993,0.5758706467661692,0.824200236341437,1.0,36/272,10.58%,IGFBP3;PAWR;TIAM2;AKAP13;PHLDA1;WNT10B;PRF1;FGD4;PNMA3;IFIT2;ADAMTSL4;DAPK1;BMP2;APBB1;IL6;LATS2;UNC13B;ZBP1;TNFRSF12A;NOS2;USP27X;PLEKHG2;NGFR;PDCD5;ARHGEF11;QRICH1;BAX;STK3;UBE2Z;CALHM2;LRRK2;ARHGEF12;SOS2;NGEF;PPID;DNM1L
prerank,regulation of receptor recycling (GO:0001919),0.3861335887152881,0.9600317262588208,0.5095419847328244,0.823599799958806,1.0,3/16,5.68%,ANXA2;TBC1D16;OPTN
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.37866835669372106,0.9594125819960201,0.5144404332129964,0.8244298331981478,1.0,5/18,15.53%,GSK3B;BAX;TMEM14A;ZNF205;MUL1
prerank,lipid droplet formation (GO:0140042),0.4324048531722229,0.9591557762608924,0.5048543689320388,0.82443881521017,1.0,2/10,6.30%,SMIM22;PLA2G4C
prerank,maintenance of protein location in nucleus (GO:0051457),-0.34311581822443826,-0.959148567169002,0.5150812064965197,0.8688951862381602,1.0,9/20,22.69%,SYNE1;TAF3;TAF8;BARD1;PARK7;BCL3;ARL2;SKP1;CHCHD10
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4301428669455685,0.9591198574964236,0.5058823529411764,0.8239258089775385,1.0,4/10,19.29%,WNT3A;WNT5A;RYK;WNT2
prerank,nucleic acid metabolic process (GO:0090304),0.2879744140333564,0.9588786795203588,0.5341614906832298,0.8238851657859609,1.0,15/69,16.84%,ENPP1;RBFOX2;POLR2D;WRN;RAD50;LSM1;POLG;HNRNPH1;HNRNPC;POLR2C;POLR2F;DNASE1L1;HNRNPR;HNRNPA2B1;RAN
prerank,negative regulation of nervous system development (GO:0051961),-0.3511580104205819,-0.958756169913573,0.5088888888888888,0.8690847905299894,1.0,4/17,8.76%,ROBO2;NOTCH1;SORL1;B2M
prerank,tight junction assembly (GO:0120192),-0.26764357728462485,-0.9586760391326524,0.5223097112860893,0.8683941168268621,1.0,10/49,14.33%,PECAM1;CLDN5;ESAM;ACTG1;LSR;CLDN14;RAMP2;MICALL2;F11R;MPP7
prerank,sympathetic nervous system development (GO:0048485),-0.3538051678358127,-0.9585394071129003,0.48444444444444446,0.8678638082469224,1.0,4/15,12.74%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3343165469616706,0.9584564776535832,0.5084175084175084,0.8242926714232545,1.0,8/33,12.74%,DPP4;FOXC2;EPHA8;SERPINE1;PLAU;PTK2;EPHA2;EFNA1
prerank,telomere maintenance (GO:0000723),0.29693431170498785,0.9583128609476379,0.5260736196319018,0.824044937228059,1.0,16/50,22.64%,SP100;TERT;WRN;RAD50;PARP3;RPA3;NSMCE2;TEN1;DNA2;RIF1;SMC6;CTC1;POLD3;RTEL1;TEP1;PTGES3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.43529557733914814,0.9582036875401028,0.481335952848723,0.8236681846704299,1.0,4/10,21.76%,TGFA;ADRA2A;HBEGF;FBXW7
prerank,homocysteine metabolic process (GO:0050667),-0.3906934248438496,-0.9579866525492854,0.5382932166301969,0.8685176453601434,1.0,5/11,23.77%,MTHFR;MTRR;CTH;MPST;NOX4
prerank,cellular response to oxidative stress (GO:0034599),-0.23063721056390235,-0.9578370342414599,0.5427631578947368,0.8680723344080212,1.0,26/118,15.43%,PTPRK;FOXO1;PRR5L;SETX;SNCA;MAPK8;RPS3;CPEB2;MSRA;NCF2;MAPK3;CHCHD2;AKT1;PINK1;NUDT2;EGFR;ATF4;PYROXD1;CYBB;PPIA;PARK7;SOD1;ERO1A;PRKD1;PYCR2;MAPT
prerank,protein localization to cell junction (GO:1902414),0.35670710596694744,0.9571576888669097,0.526595744680851,0.8255180746690041,1.0,5/22,13.11%,CGNL1;HEG1;TJP1;NLGN2;JAK1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.38783415385439507,0.9571576413671146,0.5141242937853108,0.824299597806024,1.0,6/15,22.79%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.38783415385439507,0.9571576413671146,0.5141242937853108,0.824299597806024,1.0,6/15,22.79%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.2855154699716847,-0.9571253769681656,0.5156626506024097,0.869027926889188,1.0,10/39,15.98%,PTPRJ;SH3KBP1;DAB2IP;SH3GL2;LGMN;CBL;ARHGEF7;EGFR;RNF126;EGF
prerank,glycine metabolic process (GO:0006544),0.4052556812870277,0.9567187282727689,0.5213849287169042,0.8247763428129704,1.0,2/12,8.48%,SHMT1;AMT
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.28629773197643715,-0.9562217925172579,0.509478672985782,0.8705550556190456,1.0,9/35,10.15%,TGFB2;MET;DAB2IP;ARHGAP44;RASIP1;MYOC;CCDC125;MFN2;ITGA3
prerank,cellular response to fluid shear stress (GO:0071498),-0.3882775143204281,-0.9560081967917826,0.5074309978768577,0.8702629918413608,1.0,2/12,3.29%,MEF2C;KLF2
prerank,artery development (GO:0060840),0.351317042232254,0.955733160172041,0.504424778761062,0.8264809730067424,1.0,4/23,5.16%,ROBO1;NRP1;EFEMP2;TGFBR1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.3542905638276227,-0.9550182490167843,0.5196687370600414,0.8720337387521897,1.0,7/17,20.22%,KLF7;APOLD1;CEACAM1;PRKX;CAV1;MAFF;DLL1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4282617218121969,0.9549345264451573,0.512,0.827788017648168,1.0,2/10,3.02%,FOXC1;NCOA3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.32216398062357426,-0.9548156553004602,0.5321100917431193,0.871712547692878,1.0,6/24,13.57%,PECAM1;ITGA4;SEMA4D;SYK;GFUS;F11R
prerank,positive regulation of cellular process (GO:0048522),0.22711458094242637,0.9547663711970467,0.5943820224719101,0.8275758437417475,1.0,58/565,9.48%,EFNB2;PDPN;BMP6;PTN;DPP4;CAMK1D;CCN2;FN1;PDGFRA;FGFR1;COLEC12;FGF1;PRKAA2;IL31RA;CXCL16;NUPR1;IL6ST;PHIP;GHRH;FPR2;APOA2;WNT3A;GAB2;OSM;IL11;FER;VEGFD;TGFA;IL34;PTHLH;GLP2R;IL6;TLR4;GLI1;BCL2;TPM1;STOX1;TGFBR1;KLHL22;MMP14;EPHA1;PDGFRB;HDAC4;CD47;TGFBR2;STAMBP;CTSH;NOXO1;RIPK2;ECHDC3;EPHA4;WNT5A;IGF2;IL13RA1;DNAJA2;ANKRD17;USP47;MST1R
prerank,Golgi ribbon formation (GO:0090161),-0.37728771852539483,-0.9547042377769953,0.5483193277310925,0.8711633352916577,1.0,7/13,28.15%,STX16;GCC2;VTI1A;MYO18A;PRMT5;TMED5;GOLPH3
prerank,positive regulation of immune effector process (GO:0002699),0.33585695590098197,0.9544902738318267,0.5282685512367491,0.8275896123373828,1.0,5/27,9.25%,DDX60;MYB;APPL2;LGALS9;ANKRD17
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3037694467420208,-0.953991371733321,0.5428571428571428,0.8723029797595284,1.0,8/28,17.40%,CRADD;DAB2IP;GABARAP;DDX47;DEDD;NGF;SORT1;DEDD2
prerank,thyroid hormone generation (GO:0006590),0.436699094655839,0.953730441191329,0.5471311475409836,0.8286919100097915,1.0,2/10,10.14%,CPQ;DIO2
prerank,purine nucleotide metabolic process (GO:0006163),0.35910521454253236,0.9533410755045666,0.5350553505535055,0.828951663512008,1.0,9/24,21.77%,MTHFD1;FHIT;NT5C;PRPSAP1;ITPA;PRPSAP2;NT5C1A;XDH;ADSL
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.37637958086446194,-0.9532355600352959,0.5306122448979592,0.8735539056707223,1.0,3/13,4.82%,CACNB2;KCNJ3;GJC1
prerank,negative regulation of leukocyte activation (GO:0002695),0.38979006087167134,0.9531178452180245,0.52734375,0.8288661652021246,1.0,2/15,6.02%,IL31RA;NR1H3
prerank,positive regulation of filopodium assembly (GO:0051491),0.3446733217139691,0.9528181738991213,0.5327586206896552,0.8289255174134815,1.0,3/24,2.97%,DPYSL3;DOCK11;NRP1
prerank,endoderm development (GO:0007492),0.41164333980339757,0.9526269730497834,0.5568400770712909,0.8287478077485688,1.0,1/13,0.60%,LAMC1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3547812079452398,0.952600370626269,0.5282685512367491,0.8282004901751303,1.0,9/24,20.89%,SUZ12;EPC1;JARID2;TASOR;DNMT3A;PPHLN1;BMI1;MPHOSPH8;PHF1
prerank,morphogenesis of an epithelium (GO:0002009),-0.3132836867829619,-0.9525146403273492,0.5443037974683544,0.8746596898328652,1.0,6/25,9.91%,ACTB;LAMA3;ACTG1;AHI1;LRP6;PRKX
prerank,cAMP metabolic process (GO:0046058),0.3968953620166864,0.9517918903783498,0.51171875,0.8294361912317009,1.0,6/13,15.73%,PTHLH;ADCY5;ADCY7;ADCY1;EPHA2;ADCY6
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3209985764793405,-0.9515295724371721,0.5277777777777778,0.8764298537521361,1.0,11/24,26.04%,UBB;UBA52;POLD2;POLE;LIG3;RFC4;POLD1;POLB;POLK;RFC5;RFC2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.29159355485524313,-0.9515041457286754,0.5351089588377724,0.8756043853949331,1.0,5/33,9.94%,TFRC;AKT1;PRELID1;PINK1;GHITM
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2991134545911081,0.9512445993312956,0.533011272141707,0.8301285960839927,1.0,11/48,16.30%,ZMIZ1;ELOF1;POLR1C;BAZ1B;POLR1G;SERTAD2;POLR2F;ERCC6;MYO1C;KAT2B;DDX21
prerank,positive regulation of catabolic process (GO:0009896),0.2872840358251127,0.9509738493325012,0.5594512195121951,0.83014754792339,1.0,12/65,12.85%,SMURF2;APOA2;NEDD4;DACT1;GSK3B;WNT5A;TIPARP;WWP2;HUWE1;NKD1;HECW2;ASB5
prerank,sodium-independent organic anion transport (GO:0043252),-0.39940980885021166,-0.9509691883900971,0.5229759299781181,0.8762107482346845,1.0,2/10,1.10%,SLCO1C1;SLCO2A1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.32685403234684596,-0.950047788174139,0.5314533622559653,0.8769412929026872,1.0,9/22,28.90%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.32685403234684596,-0.950047788174139,0.5314533622559653,0.8769412929026872,1.0,9/22,28.90%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,Golgi to endosome transport (GO:0006895),-0.3489666090954991,-0.94987214160261,0.5185185185185185,0.8765376916519005,1.0,6/16,15.36%,DOP1B;AP1AR;CORO7;KLHL20;KIF16B;SORT1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.26385547534758486,-0.9497576080435325,0.5571030640668524,0.8759602039765235,1.0,11/56,15.58%,PLCG2;NOD1;CTSB;HMGB1;LGMN;CTSS;UBB;CTSL;S100A1;UBA52;NOD2
prerank,regulation of multicellular organismal development (GO:2000026),0.3458170842028438,0.9493710295046149,0.5399644760213144,0.8332544490418438,1.0,4/25,11.25%,PTN;TRIP12;MYSM1;OAS2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.2892502059404242,-0.9488810274041685,0.522077922077922,0.877383111753692,1.0,7/36,9.77%,SGMS1;CRADD;TPD52L1;RPS3;DAB2IP;FAS;TRAF7
prerank,regulation of peptide hormone secretion (GO:0090276),0.28615295197827695,0.9487245138261394,0.5506134969325154,0.8341620971212452,1.0,16/67,19.78%,DPP4;RAPGEF4;ITPR1;RFX3;IL6;NOS2;CACNA1C;PPP3CB;HFE;ADRA2C;ADRA2A;RAPGEF3;CLOCK;ITPR2;UQCC2;KCNS3
prerank,positive regulation of intracellular transport (GO:0032388),-0.289718086610369,-0.9486653929716556,0.5505050505050505,0.8770844743474434,1.0,19/38,34.18%,PRR5L;SORL1;OAZ1;STK11;OAZ2;DYNC1H1;PCNT;CAPN10;MLC1;CEP290;SPAG5;B3GAT3;STX18;PDCD10;VAMP2;PGAP1;KIF20B;PLA2G4E;BCAS3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.33960794361516583,0.948656360200208,0.5219594594594594,0.8337051113687993,1.0,8/29,17.71%,TENT5A;PKP3;DHX34;NOCT;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.390130610440868,0.9484503399443156,0.5330739299610895,0.8335584089699514,1.0,6/14,23.55%,LRRK2;BCL2L1;OPA1;XBP1;TXNDC12;SYVN1
prerank,transition metal ion homeostasis (GO:0055076),0.3360929216849027,0.9484142275891697,0.533106960950764,0.833052029253692,1.0,1/28,0.17%,CP
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.31623764242189,0.9482906239728333,0.5225694444444444,0.8327254899198704,1.0,5/38,6.64%,ROCK2;SMAD3;TLR4;ATP2B4;CD47
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34185514834039327,-0.9482741884843031,0.5320088300220751,0.8772903978369151,1.0,7/18,29.71%,AKT1;PINK1;PPIA;PARK7;NONO;VNN1;HSPB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3872997083756337,-0.9481878585233698,0.546583850931677,0.8766640152145405,1.0,3/11,7.21%,PLCB1;PIK3R1;AKT1
prerank,regulation of protein kinase activity (GO:0045859),0.26934309552932817,0.9476838627445427,0.5681818181818182,0.8335485497863143,1.0,15/106,12.04%,PDPK1;DEPTOR;PRKAG2;DDR2;PPM1E;PLCE1;EPHA1;SNX9;DTNBP1;RAP2C;UVRAG;TAF7;PTK2;TSPYL2;CSF1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23283017232340356,0.9475163001981728,0.6081242532855436,0.8333094169029068,1.0,57/341,15.01%,RNF213;SPSB1;TBL1XR1;SMURF2;RNF217;FBXO11;FBXL17;TRIP12;NEDD4;TGFB1I1;TTC3;NHLRC3;RC3H1;RNF19A;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;DTX3L;ANAPC11;NTAN1;USP9X;RNF20;KLHL15;NUB1;PSMB10;RNF111;ANAPC1;AMFR;UBR4;UBE2C;PSMA3;PSME4;FBXL7;PSMA5;WWP2;KEAP1;UBXN2A;HUWE1;SPOPL;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;CDC27;BFAR;RNF43;FBXL4;RCHY1;BIRC6;KCTD5;PML;UBE2R2
prerank,mRNA catabolic process (GO:0006402),0.30454543758332714,0.9473853321665177,0.5240549828178694,0.8330146056998338,1.0,12/44,19.63%,TUT4;RC3H1;DHX34;NANOS2;DCP2;XRN1;SLFN14;SUPV3L1;METTL16;EXOSC10;TUT7;DDX5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.26517120810958184,-0.9473014343998833,0.5316804407713499,0.8782296859401931,1.0,18/55,24.51%,PSMC3;PSMD14;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;PSMD8
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3668862430271079,0.9470557542460244,0.5190562613430127,0.8332120375954556,1.0,9/19,15.56%,BMPR1A;BMP2;TGFBR2;SMAD6;HEYL;SMAD4;EFNA1;MDM4;SOX4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.34511474757892,-0.9470349173828444,0.5175438596491229,0.8781060738944574,1.0,13/17,44.93%,ZWILCH;SPDL1;CENPA;CTCF;ZW10;CDK1;MIS12;BUB3;KNL1;BOD1;AURKB;CHAMP1;HASPIN
prerank,regulation of aerobic respiration (GO:1903715),-0.35696188428317366,-0.946762997451963,0.510548523206751,0.8779539658491495,1.0,2/15,8.21%,CBFA2T3;PINK1
prerank,regulation of metal ion transport (GO:0010959),0.37758017697392415,0.9466860724501865,0.5229681978798587,0.8334884966482071,1.0,5/16,15.11%,IL16;BCL2;DLG1;GRIN3B;CACNA2D1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3081249734104865,-0.946270065638802,0.5325581395348837,0.8784000146941151,1.0,5/27,8.25%,CSNK1D;SORL1;PAQR3;ARL1;GCC2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3222761340199188,0.9462307799844724,0.5363321799307958,0.8339669408216827,1.0,17/32,27.68%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;POLR2K;UBTF;TAF1;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3535155320174404,-0.9460834331369176,0.5590909090909091,0.8780399512602715,1.0,8/17,26.80%,ALG14;SRD5A3;NUS1;DOLPP1;ALG6;DHDDS;ALG13;MVD
prerank,T cell homeostasis (GO:0043029),-0.39840877993494955,-0.946033513776192,0.5103734439834025,0.8773234200321539,1.0,6/10,28.37%,AKT1;FAS;ZC3H8;JAK3;FADD;PMAIP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.28538925547723976,-0.9459717195432596,0.538083538083538,0.8766348922743739,1.0,8/35,17.26%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;PKIB;CCT5
prerank,regulation of interleukin-6 production (GO:0032675),0.2665304927478944,0.9455503671855501,0.5647590361445783,0.8348951341261207,1.0,14/96,11.49%,IL16;IL17D;IL6;TLR4;C5AR2;PTPN22;NOS2;CD47;LGALS9;SETD4;WNT5A;PTPN6;TLR2;IRAK3
prerank,histone H3 acetylation (GO:0043966),-0.2807459282862648,-0.9449721753930983,0.5465393794749404,0.8785543869104674,1.0,12/40,23.62%,LEF1;TADA2A;JADE3;JADE1;BRCA2;TAF5L;KAT7;KAT2A;SGF29;BRPF1;POLE3;ING4
prerank,positive regulation of mitochondrion organization (GO:0010822),0.29337456290545727,0.9448159894702339,0.5481366459627329,0.836017718396462,1.0,10/57,15.53%,MCU;DCN;RALBP1;PDCD5;GSK3B;BAX;DNM1L;ZNF205;MIEF1;MUL1
prerank,mitochondrion organization (GO:0007005),0.24769613613893277,0.944213869453326,0.5806010928961749,0.8367940998830478,1.0,33/165,15.53%,CXADR;PID1;TRAK1;IFIT2;TERT;SPATA18;GABPB1;HAX1;MPV17;TIMM17A;MEF2A;PHB2;BAX;SIRT4;NIPSNAP2;LRRK2;DNM1;MTFP1;AFG1L;TMEM70;AKT3;DNM1L;BCL2L1;ATCAY;SUPV3L1;OPA1;MTFR1;WASF1;NRF1;TIMM9;SLC25A4;MIEF1;MUL1
prerank,regulation of centrosome cycle (GO:0046605),-0.3276622839247915,-0.9433638906247035,0.5202702702702703,0.881938451133581,1.0,11/21,35.00%,NPM1;CHMP1A;CHMP1B;CHMP2B;GEN1;CHMP2A;CHMP4C;FBXW5;AURKA;PKHD1;VPS4B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2970490609922124,-0.9433232883481688,0.5759036144578313,0.8811821625918679,1.0,10/30,19.63%,RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;CAMLG;PARK7;N4BP1;EIF3H
prerank,positive regulation of response to stimulus (GO:0048584),-0.2773817270920921,-0.9430557486526712,0.573170731707317,0.8810231272161522,1.0,8/40,10.91%,TGFB2;HOMER1;YPEL3;SELENON;B2M;ABI3;CD80;EEF1E1
prerank,epidermis development (GO:0008544),0.2901252762698667,0.9429893714502453,0.5402476780185759,0.8390616997230438,1.0,5/56,6.61%,CCN2;GATA6;PTHLH;GLI1;SVEP1
prerank,glutathione metabolic process (GO:0006749),-0.2818697996060133,-0.9429401524916529,0.547979797979798,0.8804564325988457,1.0,21/38,43.27%,OPLAH;GGT5;GSTM5;GCLC;PARK7;SOD1;GGT7;GGT1;HAGH;ETHE1;MGST2;GCLM;GSTA4;GSR;HPGDS;NAT8;GSTM4;GPX1;GLRX2;GSTP1;GGCT
prerank,ESCRT III complex disassembly (GO:1904903),-0.4081872916748087,-0.9429357724577012,0.5373134328358209,0.878735435278064,1.0,5/10,23.37%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),-0.4081872916748087,-0.9429357724577012,0.5373134328358209,0.878735435278064,1.0,5/10,23.37%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A
prerank,regulation of lipid catabolic process (GO:0050994),0.3622334170148559,0.9427069753616731,0.5394495412844037,0.8391536488992112,1.0,5/19,15.39%,APOA2;HCAR2;RARRES2;ALK;ADRA2A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3085801150905406,-0.9425739538339339,0.5320088300220751,0.8788167979562769,1.0,7/25,12.81%,INSR;NOS1AP;KLF2;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,regulation of protein localization to centrosome (GO:1904779),0.42230065806268924,0.9424589166414071,0.5142857142857142,0.8391602112575306,1.0,3/10,15.15%,PARD6A;GSK3B;CEP250
prerank,vesicle transport along actin filament (GO:0030050),-0.33570567895284315,-0.9422478785745964,0.5545657015590201,0.8788179428791137,1.0,2/19,1.44%,MYO1D;FNBP1L
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.36750199940610884,-0.9421394931379085,0.5444444444444444,0.8782440442089514,1.0,3/15,9.94%,AKT1;PRELID1;GHITM
prerank,antibacterial humoral response (GO:0019731),-0.34366254541145735,-0.9419097676894045,0.5157657657657657,0.8780111026380825,1.0,3/16,14.16%,RPL39;DEFA6;RNASE7
prerank,regulation of organelle organization (GO:0033043),0.27573424427459015,0.9415201955225923,0.54375,0.8407389587142712,1.0,19/80,19.72%,ZEB2;DIAPH1;STOX1;CLIC4;SYDE1;ARMH3;DNM1L;TJP1;PTK2;TMEM33;TMED9;RAB33B;MUL1;SAR1A;MYO5A;RHOT1;USP6NL;RHOT2;TBC1D25
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.34383744100427643,0.9409570635175811,0.5087108013937283,0.8414690431734217,1.0,9/25,23.09%,CDC73;ZMYND11;CDK12;BRD4;LEO1;CDK13;EAPP;ELL;HEXIM1
prerank,regulation of nervous system process (GO:0031644),-0.34093248206844107,-0.9407823829940308,0.5256124721603563,0.8801520788868924,1.0,4/18,4.33%,NOS3;HTR2C;DLGAP1;DLGAP2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3380010446946859,0.9407375440611068,0.5317604355716878,0.8413684666558051,1.0,10/27,23.42%,PCF11;NYNRIN;XRN1;SLFN14;ZC3H12B;CSTF3;RNASEH1;PARN;ZC3H12A;KHNYN
prerank,cellular response to dsRNA (GO:0071359),0.38981510066852904,0.9404922571444405,0.5324427480916031,0.8413115931156139,1.0,4/15,15.53%,COLEC12;IFIT1;IFIH1;MUL1
prerank,negative regulation of endocytosis (GO:0045806),-0.3141696073148827,-0.9403546338190919,0.5513126491646778,0.8804214292465553,1.0,11/24,28.11%,MCTP1;SCAMP5;CAV1;RAC1;PRKD1;LRSAM1;ARF6;MTMR2;SNX33;NR1H2;LILRB1
prerank,positive regulation of protein transport (GO:0051222),-0.25033636117371993,-0.940102261549292,0.5266106442577031,0.8802455317729936,1.0,27/67,28.16%,TGFB2;PRR5L;ACSL3;FRMD4A;ATP2C1;OAZ1;OAZ2;TGFB3;PCNT;RACK1;PPIA;MYOM1;MYO18A;CEP290;EXPH5;ADAM8;ARF6;SYTL4;VPS28;TTN;CLN3;B3GAT3;APBB3;TREM2;PDCD10;GOLPH3;VAMP2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3310848221351488,-0.9396792378777329,0.5528089887640449,0.8805253467824657,1.0,5/20,10.30%,RPS6KA5;DIP2B;TADA2A;MAPK3;NOS1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.24745638403946602,-0.9387464786020944,0.5888888888888889,0.8821462410024026,1.0,10/75,8.05%,PLCB1;RGS5;RGS3;MGLL;CALM1;RGS12;RGS4;RGS6;SLC39A14;CAMK2A
prerank,negative regulation of cellular senescence (GO:2000773),-0.37492137628879696,-0.9384468860459432,0.5460674157303371,0.8820465994408624,1.0,3/13,7.60%,CDK6;YBX1;RBL1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3216564306258901,-0.9379807195022987,0.5504587155963303,0.8824835605251254,1.0,4/21,8.46%,PPP1R16B;FKBP1A;MFHAS1;PPP1R11
prerank,sulfate transport (GO:0008272),-0.3536106378590386,-0.9377620806226048,0.5325301204819277,0.8821670214854694,1.0,2/14,1.62%,SLC26A7;SLC26A2
prerank,sterol transport (GO:0015918),0.36125354163300516,0.9376289075809785,0.5427046263345195,0.8473043626820013,1.0,3/19,12.77%,APOA2;NPC1;OSBPL5
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3378431355796351,-0.9375698549521057,0.5588865096359743,0.8818140030327475,1.0,6/16,22.59%,INSR;HDAC6;MTRF1;UPF1;GSPT1;CLN3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.30493175157898816,0.937123335480621,0.5295081967213114,0.8478915377141414,1.0,15/42,23.13%,SPIDR;KLHL15;FBH1;PPP4R2;ERCC6;FUS;FIGNL1;SHLD2;KDM1A;SETD2;RIF1;RTEL1;PPP4C;SMCHD1;ARID2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.39581268427656047,0.9370194265421031,0.5295275590551181,0.8475307620942569,1.0,3/12,11.01%,PLK5;WAC;RFWD3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3460535641010164,-0.9367741911239713,0.5528089887640449,0.8830401675898721,1.0,5/17,13.29%,RYR2;NEDD4L;KCNJ8;KCNQ1;KCNE4
prerank,cellular response to reactive oxygen species (GO:0034614),0.285056665294322,0.9362856924723928,0.5594855305466238,0.8485975033177138,1.0,7/59,6.20%,PDGFRA;OSER1;FER;ANXA1;IL6;TPM1;MPV17
prerank,steroid catabolic process (GO:0006706),-0.3979150597868259,-0.9355502272520809,0.5667311411992263,0.8854857023477577,1.0,3/10,15.92%,YWHAH;SPP1;HSD11B1
prerank,regulation of immunoglobulin production (GO:0002637),0.3420716690960829,0.9352030301594224,0.5429616087751371,0.8505020618149004,1.0,3/23,8.25%,RBP4;IL6;PHB2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3488567732702314,-0.93505088533102,0.550561797752809,0.885913215333743,1.0,5/16,18.02%,HMGB1;KPNB1;H1-0;FOXL2;DICER1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.26991063339820526,0.9349527991355874,0.5668693009118541,0.8504535848101066,1.0,7/85,6.55%,COL4A3;EYA1;DCDC2;ADGRV1;ROR1;GSDME;CCDC50
prerank,negative regulation of locomotion (GO:0040013),0.39447744491821723,0.9348522360299946,0.5459558823529411,0.8500724357783666,1.0,4/12,6.82%,TACSTD2;FBLN1;PTPN2;SPINT2
prerank,barbed-end actin filament capping (GO:0051016),0.3673754483212462,0.9345321237411512,0.5381750465549349,0.8495979667442737,1.0,8/18,22.17%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2
prerank,actin filament capping (GO:0051693),0.3673754483212462,0.9345321237411512,0.5381750465549349,0.8495979667442737,1.0,8/18,22.17%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2
prerank,vitamin transport (GO:0051180),0.3351095340873741,0.9345131224628396,0.5723905723905723,0.8490285138138289,1.0,2/29,2.57%,PDPN;SLC19A1
prerank,histone deacetylation (GO:0016575),0.30393642310671254,0.9344452383845866,0.5526315789473685,0.8485651265860263,1.0,11/43,17.36%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;PRDM5;RBM14;HDAC2;ELK4;TBL1X;MIDEAS
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3022678595066994,-0.9341114589273766,0.5771028037383178,0.8875173395730049,1.0,10/27,23.84%,MAP3K5;MAPK8;MAPK3;UBB;MAP3K20;UBA52;KAT7;IKBKB;SKP1;TAOK2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.36710061186869136,-0.9340807886313583,0.539714867617108,0.8867298430080673,1.0,3/13,3.09%,RYR2;NOTCH1;CPE
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3526663904437473,-0.9337378255906333,0.5277777777777778,0.8867821316945795,1.0,3/16,2.33%,TGFB2;BMPR2;NOTCH1
prerank,response to interferon-beta (GO:0035456),0.35405423925025864,0.9335341388943897,0.5585106382978723,0.8500241683785579,1.0,9/22,23.67%,IKBKE;BST2;STAT1;IFITM1;IFNAR2;SHFL;UBE2K;PNPT1;XAF1
prerank,intracellular protein transport (GO:0006886),0.23251170804511387,0.9332144072993839,0.62590799031477,0.8501558541352577,1.0,79/304,22.04%,RANBP3L;WLS;PRICKLE1;TNPO1;COPZ2;ARFGAP3;SNX6;TRAK1;TBC1D16;TRARG1;RAB22A;LAMP2;RAB43;APPL2;TPR;ARF4;GRTP1;SIL1;SRPRA;NGFR;SNX9;PHB2;SCFD2;SLU7;AP4E1;ARF3;STX8;APPL1;STX2;FUT10;STX11;IPO7;KIF13B;COX18;ARCN1;HOMER3;SNX27;EIF4ENIF1;EGR2;SCFD1;STRADB;POM121;TMED9;VPS26C;ARL4A;MYO1C;COPZ1;SAR1A;RAB5A;TRIM23;AP4M1;ARF1;RAN;SEC31A;RPGR;RANBP17;AP3B1;RAB19;ARL6;USP6NL;WDR11;SEC16A;NUP85;ARFIP2;TBC1D25;VPS26B;VPS33A;FAM91A1;SNX15;HIKESHI;UNC93B1;GGA3;RAB14;VPS35;XPO5;MYO6;PKD1;OXA1L;NAPG
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3826584980366178,-0.9329745408572425,0.5612903225806452,0.8879894289332485,1.0,4/11,12.62%,MEF2C;RAPGEF2;LYN;PIK3CD
prerank,mesonephric tubule development (GO:0072164),0.37407322984354996,0.9327852849221412,0.5364372469635628,0.8505335784721165,1.0,4/15,5.23%,OSR1;FOXC1;BMP7;SALL1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.261509493398905,0.9320962758582911,0.5941605839416059,0.8514452659242817,1.0,26/101,19.81%,ROBO1;FGFR1;FGF1;IL34;KIT;CCND3;ATP2B4;PDGFRB;WNT5A;LRRK2;PIK3R5;MST1R;FGF18;PARP16;MAP2K1;MTCP1;ADRA2A;PKD2;PSRC1;PPP2CA;TENM1;MAPRE3;DIRAS1;CCNY;ERBB2;SLC27A1
prerank,peptidyl-arginine modification (GO:0018195),-0.3627134879141064,-0.9320735085843517,0.5684210526315789,0.8895266688767529,1.0,3/15,19.68%,ART3;PARK7;PRMT5
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3810995470665526,0.9314850655835488,0.5384615384615384,0.852213966172937,1.0,3/15,4.50%,RNF213;DACT1;WNT5B
prerank,axonal transport of mitochondrion (GO:0019896),-0.3892121812637443,-0.9314679668452591,0.5484536082474227,0.8902429956785595,1.0,2/11,2.69%,SYBU;ACTR10
prerank,carbohydrate transport (GO:0008643),-0.38740112371095725,-0.9312131365745193,0.5560538116591929,0.8900186518504766,1.0,5/11,29.52%,AQP11;SLC50A1;SLC2A2;SLC23A1;SLC23A2
prerank,mitochondrial fission (GO:0000266),-0.3449316575625316,-0.9310393715856035,0.5235042735042735,0.889627099208368,1.0,3/16,10.98%,DNM3;MFF;GDAP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.36279781821195745,0.9310145391538991,0.5502742230347349,0.852719215391673,1.0,2/18,8.52%,MMAB;LMBRD1
prerank,RNA modification (GO:0009451),-0.2570231097053603,-0.9309549329830756,0.5989159891598916,0.8890073775461598,1.0,16/54,23.06%,ADARB1;PUS7;FTSJ3;THUMPD1;QTRT2;PUS3;ELP5;DTWD2;WDR4;TYW5;RBM15B;CDKAL1;TRMT6;TRMT9B;TFB1M;TRUB1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4046871656038673,0.9306981109212095,0.5493827160493827,0.8528117614131082,1.0,4/11,10.71%,IGF2BP1;RASA1;NOVA1;IGF2BP2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2187280012634037,-0.9302972273986263,0.677536231884058,0.8898650101673518,1.0,49/145,24.51%,PPP2R1A;CSNK1D;PSMC3;KCNH5;RCC2;PSMD14;DYNC1H1;PSMD3;CCND1;PCNT;PSMD4;TUBA1A;PSMD6;TUBB4A;PSMA6;PSMA4;PRKAR2B;PSMB8;HSP90AA1;CEP43;DYNC1I2;NDE1;TUBB4B;PSMA8;CEP135;PLK4;CDK2;CDK4;CEP290;PSME1;SSNA1;TUBG1;PSMD7;PSMC6;CDK5RAP2;PSMB5;CEP41;PSMC5;PSMB1;DCTN1;CENPF;SKP1;DTL;HMMR;CEP70;PSMD11;KIF14;MAPRE1;PSMD8
prerank,purine-containing compound catabolic process (GO:0072523),0.39062185440460895,0.9301815935414584,0.5436507936507936,0.8533768616772067,1.0,5/13,20.56%,DPYD;NT5C;ITPA;NT5C1A;XDH
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3732856855256843,-0.9299481031428112,0.5638766519823789,0.8898881752529378,1.0,3/12,11.10%,PIK3R1;DAB2IP;ATF6
prerank,establishment of spindle orientation (GO:0051294),0.3226341881635761,0.9296667990709654,0.5530434782608695,0.8539515498896338,1.0,6/28,13.67%,GJA1;CLASP1;MISP;FBXW11;LLGL2;MAP4
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3330493162442257,0.9295466113666955,0.5649819494584838,0.8536194579267448,1.0,5/29,6.11%,PDGFRA;AMBRA1;EPHA8;KIT;PDGFRB
prerank,regulation of cellular protein localization (GO:1903827),0.3019787629030129,0.9294714821948362,0.5608214849921012,0.853182710423616,1.0,14/45,19.59%,GPC6;PRKAA2;SPIDR;GPC2;DVL3;HFE;PTPN1;CCDC66;BDNF;GBF1;GPC1;KDM1A;GPC4;SETD2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3024732414982845,-0.9292817060823547,0.5714285714285714,0.8908263261193743,1.0,7/26,12.81%,INSR;NOS1AP;KLF2;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.38196407040044944,-0.9292682926074355,0.5797979797979798,0.890016310675974,1.0,6/11,37.89%,SORL1;MTMR2;MSN;PTPN23;EIPR1;EZR
prerank,regulation of primary metabolic process (GO:0080090),0.25360457142602433,0.9288485875352546,0.597997138769671,0.8539878440783821,1.0,13/126,10.29%,CHD9;ROCK2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PPARA;CREBBP;LACTB;PSMB10;PSMA3;PSME4;PSMA5
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.3772828869342001,-0.9286734564861686,0.5445134575569358,0.8907503611090934,1.0,2/12,3.81%,STX3;SNAP25
prerank,regulation of mitotic cell cycle (GO:0007346),-0.21451376173459735,-0.9286708518488551,0.6704980842911877,0.8899074792533913,1.0,45/171,21.28%,BRINP3;MEIS2;BRINP1;NEK7;BRINP2;PSMC3;CDC26;LGMN;SDCBP;PSMD14;SIK1;PSMD3;TFAP4;TTC28;TAL1;PSMD4;BORA;CAV2;CCDC8;PSMD6;PSMA6;UBE2E1;ANGEL2;PSMA4;PSMB8;DYNLT3;PSMA8;CYLD;BUB1B;BTG1;ASNS;UBE2D1;PSME1;L3MBTL1;MAEA;CDKN1C;PRMT5;PSMD7;PSMC6;PSMB5;USP2;MKI67;PSMC5;PSMB1;AFAP1L2
prerank,positive regulation of double-strand break repair (GO:2000781),0.30760793862866803,0.9286166226239806,0.5689102564102564,0.8539092041259753,1.0,17/39,24.80%,PARP9;PARP3;DTX3L;SPIDR;SLF2;ERCC6;FUS;SHLD2;MGMT;KMT5C;RIF1;KMT5B;SPIRE1;SMCHD1;ARID2;ZCWPW1;SHLD1
prerank,protein deacetylation (GO:0006476),0.29934862511984583,0.9281471798983343,0.5500821018062397,0.854391767565178,1.0,12/41,18.56%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;SIRT4;PRDM5;RBM14;HDAC2;TBL1X;MIDEAS;SIRT3
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3169453537515334,-0.9281029379952427,0.5671981776765376,0.8905693571739681,1.0,8/22,20.22%,CNTN4;B2M;CALR;HEY1;HES1;NEPRO;SOX2;DLL1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.24298718973501435,-0.9279424290753784,0.5914285714285714,0.8901413011739095,1.0,15/73,17.94%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;CD86;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL;ADAM8
prerank,negative regulation of phagocytosis (GO:0050765),-0.34557921946688297,-0.9278463554391781,0.5767634854771784,0.8895175591331601,1.0,4/17,10.38%,SNX3;HMGB1;DYSF;RACK1
prerank,regulation of organelle assembly (GO:1902115),0.274033644070964,0.9278389551284046,0.5737463126843658,0.8544467482524601,1.0,12/72,16.33%,DCDC2;TBC1D16;ALMS1;SDCCAG8;IFT88;MTMR3;DYNC2LI1;SENP6;IFT20;NPRL3;SPICE1;RAB5A
prerank,regulation of histone acetylation (GO:0035065),0.3126451015864712,0.927809075938426,0.5604770017035775,0.853910337493445,1.0,8/33,16.82%,KMT2A;FOXP3;GLYR1;TAF7;IWS1;ARRB1;SETD5;RAPGEF3
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3212640347932275,-0.9273843426602614,0.5536105032822757,0.8898392763990814,1.0,8/21,22.06%,PDE4D;HINT1;PDE2A;PNP;NT5C2;NUDT18;NUDT3;HPRT1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.33467168401099134,0.927288909500146,0.5704347826086956,0.8544566169031915,1.0,6/25,12.26%,CD55;KIT;LACC1;TNFRSF14;WNT5A;MAP3K7
prerank,protein-DNA complex assembly (GO:0065004),0.2556735336239485,0.9270009515962295,0.5885797950219619,0.8544928541936312,1.0,19/116,15.44%,TCF4;ORC5;CUL4A;PSMB10;CCNH;KAT6B;PSMA3;MNAT1;PSME4;CDK7;RPA3;MCM4;PSMA5;GMNN;MCM6;GTF2H4;ERCC5;ORC3;ORC4
prerank,cellular response to nutrient levels (GO:0031669),0.2826697684936,0.926625144934163,0.5928338762214984,0.8547642414246477,1.0,11/62,11.14%,PRKAA2;GCGR;WRN;LAMP2;CARTPT;PPARA;CDKN2B;STK24;LRRK2;NUPR2;FNIP1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3642195401351912,-0.9265127304437989,0.577433628318584,0.8912077045335409,1.0,8/14,42.98%,TNFRSF1B;GRN;PTPRC;TREM2;LDLR;IL4;CST7;TAFA3
prerank,generation of neurons (GO:0048699),0.2406289127053204,0.9264824128955911,0.6179183135704874,0.8545081350852177,1.0,17/190,5.24%,WNT4;DCDC2;WNT6;FGFR1;AUTS2;WNT10B;WNT3A;WNT2B;NRP1;SH3RF1;FZD2;SDCCAG8;WNT5B;EN2;BTG4;NIF3L1;OTP
prerank,stress-activated MAPK cascade (GO:0051403),-0.25427240201342977,-0.9263467923193862,0.5850746268656717,0.8907640133273939,1.0,11/61,10.09%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAPK3;MAP3K11;UBB;MAP4K3;MAP3K20;MINK1
prerank,positive regulation of proteolysis (GO:0045862),0.2888515393457072,0.9263066607264174,0.5688524590163935,0.8543196907350578,1.0,16/55,22.02%,SH3D19;NRDC;CTSH;SNX9;CCBE1;BTRC;FBXW11;HDAC2;ADRA2A;CYFIP2;ATP5IF1;ASPH;TNIP1;IST1;RCN3;ZC3H12A
prerank,carbohydrate catabolic process (GO:0016052),-0.2712871960069562,-0.9261747462110613,0.5847255369928401,0.8903886997391715,1.0,9/38,15.68%,PGK1;PKM;ALDOC;NEU1;GPI;TPI1;PGAM1;PGAM4;ENO1
prerank,dopamine metabolic process (GO:0042417),-0.3360988489948574,-0.9261195952377448,0.5555555555555556,0.8896767392246697,1.0,4/18,10.31%,TGFB2;SNCA;MAOA;GCH1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3112868055562307,-0.9257304776365635,0.5545243619489559,0.8898414514736139,1.0,7/23,18.18%,RPS6KA5;TADA2A;MAPK3;SMARCB1;NOS1;BRCA1;KAT7
prerank,regulation of interleukin-1 production (GO:0032652),0.3752414400732327,0.9256977973178379,0.5486381322957199,0.8551471953946536,1.0,2/15,4.67%,ANXA1;TLR4
prerank,neuron apoptotic process (GO:0051402),-0.33087812873853595,-0.9254122664533015,0.5720620842572062,0.889880924029538,1.0,5/19,13.40%,CIT;TRPC5;SCN2A;FAS;TNFRSF21
prerank,fatty acid transmembrane transport (GO:1902001),0.3516193447751461,0.9253709708903428,0.5378927911275416,0.8552966623271422,1.0,2/19,1.61%,PRKAG2;PRKAA2
prerank,vesicle transport along microtubule (GO:0047496),-0.3066564465122332,-0.9253077398743492,0.5754923413566739,0.8893040728217152,1.0,9/23,23.43%,KIF1C;DYNC1H1;KIF3B;NDE1;BICDL1;KIF5A;CLN3;HAP1;HTT
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3407084606092994,0.9252628628050968,0.5361010830324909,0.8549566077972284,1.0,12/24,21.89%,SEC23A;SEC24D;TAPBP;ERAP1;SEC24C;HFE;SEC24B;SEC31A;TAP2;ABCB9;BCAP31;PDIA3
prerank,positive regulation of metabolic process (GO:0009893),-0.229810285875766,-0.9252282408554295,0.6547231270358306,0.8886747324046063,1.0,20/103,13.10%,ADIPOR2;EBF2;INSR;GATM;PRDM16;KSR2;GNAS;UCP2;DYNC1H1;VEGFA;MFN2;ADRB2;CMKLR1;GADD45G;ACACA;SYK;PRLR;CAV1;ACLY;SCD
prerank,negative regulation of catalytic activity (GO:0043086),-0.3123938479752337,-0.924791290098654,0.5660377358490566,0.8889750484685114,1.0,12/24,31.64%,NOTCH1;CAMK2A;HDAC6;CCAR2;NOS1;TMBIM1;APBA3;CLN3;TIMP1;PLN;MT3;TP53
prerank,membrane protein proteolysis (GO:0033619),0.3122370737888497,0.9247155003370836,0.5742574257425742,0.8555682593524506,1.0,6/37,11.82%,DAG1;CTSH;SPPL3;NGFR;ERAP1;ADAM19
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.35856682118934535,-0.9239937066390944,0.565410199556541,0.8902208664835111,1.0,10/13,48.65%,CYRIB;MR1;STX7;FADD;NECTIN2;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3156396057892738,0.9239602061265496,0.5678571428571428,0.8567710177547696,1.0,6/31,11.12%,IL16;TLR4;LGALS9;RIPK2;MAPK14;TLR2
prerank,negative regulation of cyclase activity (GO:0031280),-0.3540537397170989,-0.9239192413071381,0.5271966527196653,0.8895487273613895,1.0,2/14,3.31%,GRM3;GABBR2
prerank,response to alcohol (GO:0097305),-0.3054084926216793,-0.9237748081894255,0.5486111111111112,0.8890670986546971,1.0,7/27,15.18%,SLIT2;GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;CCL19
prerank,negative regulation of cilium assembly (GO:1902018),-0.3782487301451267,-0.923541048774127,0.5774946921443737,0.8888210134326207,1.0,2/12,4.90%,LIMK2;TBC1D30
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.37172827495721755,-0.9232054530040729,0.5826446280991735,0.8888843956901041,1.0,4/12,15.10%,UCK2;UPP2;UCKL1;UCK1
prerank,RNA destabilization (GO:0050779),0.3623897438192183,0.9230166514675481,0.5833333333333334,0.8582668416182607,1.0,4/18,14.87%,ROCK2;FTO;METTL16;GIGYF2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.38334410659609985,0.9227330184331629,0.5525812619502868,0.8582987942207969,1.0,3/14,3.32%,FOXC1;NRP1;VEGFD
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3864419946638202,-0.9225872262935787,0.5761316872427984,0.8895525090981524,1.0,4/11,11.12%,MECOM;CD34;YTHDF2;RUNX1
prerank,establishment of spindle localization (GO:0051293),0.38302775945835255,0.9225100890840505,0.5457943925233645,0.8582118747517751,1.0,6/14,18.03%,CLASP1;ESPL1;LLGL2;MAP4;TLE6;NLRP5
prerank,mitotic DNA replication (GO:1902969),-0.3944086430032131,-0.9222652636906374,0.5679012345679012,0.8895329044733128,1.0,3/10,16.39%,GINS3;POLA1;CDC45
prerank,DNA geometric change (GO:0032392),0.33961925289258166,0.9217051415399314,0.5836236933797909,0.8594435493573472,1.0,11/24,24.40%,ANXA1;WRN;ASCC3;RAD50;SUPV3L1;HNRNPA2B1;DHX36;DNA2;RTEL1;DHX9;ZRANB3
prerank,regulation of interleukin-10 production (GO:0032653),0.29788763599439294,0.9216839275490445,0.5792163543441227,0.8589017649603876,1.0,7/44,7.89%,IL6;TLR4;PRKCZ;FOXP3;CD47;LGALS9;CD274
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3714536880714766,-0.9216568110502585,0.5802997858672377,0.8902204103667735,1.0,3/13,6.85%,STX3;HSP90AB1;RIC3
prerank,sulfur compound biosynthetic process (GO:0044272),0.2577782568203629,0.9216214456459134,0.6192592592592593,0.8584377442750503,1.0,12/104,9.21%,UST;CHST15;GGTA1;ANGPT1;DCN;OMD;DSE;CHSY1;B4GALT1;GLCE;GSTK1;PRELP
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.334152023773402,-0.921416310874113,0.5750528541226215,0.8900072087852036,1.0,6/18,11.23%,KDR;GATA2;HDAC7;HDAC9;VEGFA;FGF2
prerank,cellular response to glucose starvation (GO:0042149),0.30028184986349704,0.9208141468664416,0.5859766277128547,0.8596925650285184,1.0,8/41,15.09%,PRKAG2;PRKAA2;MTMR3;RRP8;SESN1;FOXO3;NUAK2;EIF2AK3
prerank,cellular response to insulin stimulus (GO:0032869),0.24853105354576188,0.920804887290188,0.6122159090909091,0.8591122678607523,1.0,30/124,17.33%,PDPK1;ENPP1;PHIP;FOXC2;FER;TRARG1;RAB10;SORBS1;PTPN2;PIK3C2A;CPEB1;GSK3B;INSIG2;RHOQ;IGF2;ZNF106;APPL1;OTOP1;RARRES2;TCIRG1;ATP6V0B;DENND4C;BAIAP2;KAT2B;ATP6V1E1;IGF1R;ATP6V1C1;MYO5A;LPIN2;PCK2
prerank,dendrite morphogenesis (GO:0048813),0.31151962897887275,0.9207697250748188,0.5867346938775511,0.8586075854660437,1.0,6/35,8.04%,PTN;DCDC2;SDC2;MAP6;LRP4;MEF2A
prerank,ovarian follicle development (GO:0001541),-0.35481890651779147,-0.9206736203933853,0.5567010309278351,0.8911480615170319,1.0,6/13,22.52%,EIF2B2;VEGFA;INHBB;SOD1;FOXL2;LHCGR
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2790985287388535,-0.9206680512696757,0.5971563981042654,0.8903256229187305,1.0,11/35,13.61%,TEK;ESAM;PTK2B;SEMA3E;ARHGDIB;ABI3;FES;ARHGDIA;CSF1R;F11R;HRAS
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.30167556772870746,0.9203836111176925,0.592891760904685,0.8588817376312309,1.0,11/45,17.14%,PARP9;RC3H1;PKP3;TDRD7;FOXO3;METTL16;GEMIN5;MAPKAPK5;ZC3H7B;APP;PUM2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2344002267575187,-0.9199253759129488,0.653125,0.8913928367439864,1.0,17/90,13.10%,ADIPOR2;EBF2;GATM;PRDM16;KSR2;GNAS;UCP2;DYNC1H1;VEGFA;MFN2;ADRB2;CMKLR1;GADD45G;SYK;PRLR;CAV1;SCD
prerank,nucleotide-excision repair (GO:0006289),0.2587006257994333,0.9199041227079382,0.5867269984917044,0.8593904841313559,1.0,28/101,20.65%,POLR2D;SLX4;CUL4A;RFC1;RNF111;CCNH;MNAT1;CDK7;RPA3;XRCC1;TCEA1;POLR2C;OGG1;PRPF19;POLR2F;GTF2H4;ERCC5;ERCC6;ERCC1;USP45;GTF2H2;FANCC;UVSSA;XPC;USP7;ERCC8;POLR2K;POLD3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.301377456532266,-0.9193961571889216,0.5944700460829493,0.891934072920801,1.0,7/25,13.77%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.31638660453134265,0.9182927578242743,0.5716845878136201,0.8624203798041481,1.0,5/29,11.41%,CXCL10;FPR2;SERPINE1;LGALS9;ANO6
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.34266990625391636,0.9182898039438842,0.5553505535055351,0.8618313868567329,1.0,4/23,8.04%,PRKAG2;BMP7;STOX1;RIPK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.34503365816008247,-0.918033062249468,0.5404814004376368,0.8943848380733056,1.0,4/16,9.99%,TPT1;RPS3;CXCL12;CCAR2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.38816481607003894,-0.9180091254035364,0.5882352941176471,0.8936171492586635,1.0,4/10,17.25%,TBX1;RXRB;ACTN4;RXRA
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3597758938882776,-0.9179841541212483,0.5534979423868313,0.8928547224391179,1.0,2/13,3.31%,GRM3;GABBR2
prerank,positive regulation of isotype switching (GO:0045830),-0.34703650565337923,-0.9170558799829169,0.5822784810126582,0.894402192214819,1.0,4/15,15.24%,TFRC;CD40;HMCES;CLCF1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.33246218854320886,0.916976765566167,0.5662020905923345,0.8642305418927763,1.0,10/27,21.01%,NR1H3;PPARA;CRP;IL18;CSF1;MAPK9;ABCA1;PLA2G5;CD36;AGT
prerank,histone H3-K36 demethylation (GO:0070544),0.41234393757109866,0.9169538354651596,0.5714285714285714,0.8636844540170536,1.0,4/10,15.61%,KDM7A;KDM2A;KDM8;KDM2B
prerank,tRNA 5'-end processing (GO:0099116),-0.35156269282005703,-0.9166978610670687,0.5630630630630631,0.8945113100888574,1.0,6/15,26.42%,PRORP;RPP30;HSD17B10;RPP25L;TRMT10C;POP7
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.3149062315738069,-0.9166893551218593,0.5588235294117647,0.8936985449716774,1.0,6/21,17.33%,NAV3;ARHGEF2;STMN2;FGF13;CLASP2;MID1IP1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3234531536930069,0.9165203913780139,0.585278276481149,0.8640642643984442,1.0,4/30,5.68%,SPTBN1;VAMP5;RAB10;OPTN
prerank,regulation of chromatin organization (GO:1902275),0.38025302947045647,0.9162968167795105,0.5722120658135283,0.8639329428303681,1.0,4/14,15.34%,MLLT3;IGF2;TLK2;SETD5
prerank,response to laminar fluid shear stress (GO:0034616),-0.3998527167492687,-0.9161299892818344,0.5693877551020409,0.8942541977376411,1.0,3/10,12.59%,SMAD7;KLF2;KLF4
prerank,receptor internalization (GO:0031623),-0.2705685560299729,-0.9156240044131525,0.594847775175644,0.8947124349946607,1.0,10/44,12.95%,DNM3;TFRC;SNCA;SCYL2;CEACAM1;LDLRAP1;RAMP2;FCER1G;SYK;CAV1
prerank,dendritic cell chemotaxis (GO:0002407),-0.3521635649616812,-0.9156056354158173,0.5622406639004149,0.8939093650980305,1.0,11/14,47.90%,HMGB1;CCL19;TRPM2;CCL5;CCR1;PIK3CG;CCR5;CCR6;CXCR2;TRPM4;CCR2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3610089720203987,0.9152416252083937,0.5663716814159292,0.8657779356025628,1.0,2/18,3.52%,PTN;IL34
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3827538993841074,0.9151931483675386,0.5725190839694656,0.865275511273792,1.0,5/13,19.93%,LARGE1;MGAT3;EXTL2;NAGK;CHST3
prerank,muscle cell development (GO:0055001),0.318278266562186,0.9146265738147119,0.5779334500875657,0.8659865735223388,1.0,4/30,4.79%,CXADR;MYOF;EFEMP2;NEBL
prerank,tRNA processing (GO:0008033),-0.24967878502316973,-0.9146260271392483,0.6278409090909091,0.8956035091411017,1.0,26/61,34.91%,CSTF2;KARS1;THUMPD1;QTRT2;RPP30;PUS3;ELP5;DTWD2;WDR4;TSEN54;TYW5;CDKAL1;TRMT6;TRMT9B;TRUB1;TRMT10C;CPSF1;ADAT2;POP7;CTU2;TRMT61A;TSEN34;ADAT1;TRMT10A;DDX1;THG1L
prerank,regulation of acrosome reaction (GO:0060046),-0.3829597820969258,-0.9140962441798142,0.5781584582441114,0.8960782672673999,1.0,1/10,0.97%,PLCB1
prerank,cellular response to hypoxia (GO:0071456),0.2534226529671864,0.9139359494036484,0.6401137980085349,0.8669347290759912,1.0,16/126,10.29%,RORA;GATA6;HIF3A;TERT;EPAS1;ARNT;BMP7;STOX1;CPEB1;NPEPPS;CREBBP;OPRD1;PSMB10;PSMA3;PSME4;PSMA5
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2868861344782768,-0.9137507158006664,0.5995085995085995,0.8961318908488174,1.0,7/32,15.49%,RPS19;RPL39;RPL30;DEFA6;PGLYRP1;RNASE7;HMGN2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.33916618536606336,0.9135043511606289,0.566003616636528,0.8673734052473802,1.0,5/22,14.28%,BMP7;MYADM;MAP2K5;WNK1;FLOT2
prerank,negative regulation of nuclear division (GO:0051784),0.4000188964610033,0.9133830486478681,0.548828125,0.8670362746627857,1.0,5/11,22.28%,BMP7;NANOS2;TOM1L2;TOM1L1;NME6
prerank,negative regulation of secretion (GO:0051048),0.4052339135615149,0.9133447384825696,0.5694444444444444,0.8665185608778103,1.0,5/10,23.21%,NR1H3;TIFAB;ERBB3;PTGER3;NRG1
prerank,membrane lipid metabolic process (GO:0006643),0.34248491592011165,0.9133259817230897,0.5784671532846716,0.865959859989605,1.0,1/22,0.19%,AGMO
prerank,protein localization to nucleus (GO:0034504),0.2566496335009533,0.9131692135959352,0.6160458452722063,0.865711099817215,1.0,21/102,18.29%,PRICKLE1;TNPO1;GBP2;WRN;BMP7;MORC3;APPL2;TPR;PHB2;APPL1;TOR1AIP1;IPO7;EIF4ENIF1;PAF1;POM121;PML;RAN;YWHAE;ABCA7;RANBP17;INTS13
prerank,nucleus organization (GO:0006997),-0.2582738223450953,-0.9130408644856741,0.6206896551724138,0.8970052118565491,1.0,17/47,30.84%,SYNE1;RPS19;NUP93;CTDNEP1;CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A;CEP55;NUP54;CHMP6;CHMP4C;REEP4;NDC1;PITPNB;TOR1A
prerank,fatty acid catabolic process (GO:0009062),0.27012894707362556,0.9129130377654464,0.6040688575899843,0.86567693843557,1.0,22/67,23.01%,PCCA;AIG1;PCCB;SCP2;SLC27A2;HACL1;ACAT1;ABCD3;PEX2;PECR;HAO1;PHYH;ACADS;LPIN2;ABHD3;ACOX1;HADHA;ACBD5;NUDT19;HADH;MMUT;LPIN1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.280765433189493,-0.9128404182440208,0.6161616161616161,0.8966289072140184,1.0,6/35,8.46%,FKBP1A;CALM1;CALM2;HSP90AB1;CALM3;PPP1R11
prerank,quinone biosynthetic process (GO:1901663),-0.35353204415068096,-0.9125889915238744,0.5690021231422505,0.8964391398278444,1.0,6/14,23.50%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5
prerank,negative regulation of T cell differentiation (GO:0045581),0.40924075859301123,0.9116699687949605,0.5645833333333333,0.8678154669011776,1.0,2/10,11.55%,GLI3;IHH
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.29949331704205734,-0.9116123908902769,0.562363238512035,0.8980572089089368,1.0,7/25,15.08%,SLIT2;LIMK2;TBC1D30;ARHGAP44;ABI3;EVL;ARHGAP24
prerank,long-chain fatty acid transport (GO:0015909),0.3148382242961927,0.911570175597928,0.566607460035524,0.8674458847515774,1.0,5/30,12.51%,PRKAG2;PRKAA2;ACSL1;SLC27A2;ABCD3
prerank,regulation of cell size (GO:0008361),0.335268660373855,0.9115524630715688,0.6040145985401459,0.8668918151704872,1.0,1/23,0.53%,DEPTOR
prerank,regulation of protein catabolic process (GO:0042176),-0.22661189549735494,-0.9115115895986414,0.67003367003367,0.8974765412808756,1.0,15/99,12.13%,FMN2;FOXO1;WWP1;HECW1;NSF;SORL1;EEF1A1;DAB2IP;SNX3;OAZ1;OAZ2;NEDD4L;ZDHHC2;BARD1;EGFR
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.30448538691339616,-0.9113706757048338,0.6147186147186147,0.897023646393348,1.0,2/23,7.57%,GAS6;CEACAM1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.33544158595655005,-0.9112226675197782,0.5821917808219178,0.896541350001259,1.0,3/18,9.81%,IL33;THBS1;KARS1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.368784824202256,0.911183491080519,0.5804066543438078,0.8671228528207734,1.0,4/16,11.44%,PYGB;MGAM;PYGM;STBD1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.36165054633334126,0.9111050489738317,0.5867924528301887,0.8667016257192984,1.0,3/16,6.37%,ADCY7;APPL2;PPARA
prerank,regulation of glycogen metabolic process (GO:0070873),-0.368421712117678,-0.9109353000480354,0.5921325051759835,0.8964440846504788,1.0,4/12,15.96%,PPP1R3B;INPP5K;AKT1;PPP1R3C
prerank,steroid metabolic process (GO:0008202),0.26965327483273693,0.9108550956164796,0.624405705229794,0.8666762911583015,1.0,7/72,8.39%,CYP7B1;HSD17B1;CYP27A1;RDH5;NPC1;AMACR;SCP2
prerank,positive regulation of histone modification (GO:0031058),-0.2838497705159104,-0.9106760219404914,0.6018735362997658,0.8962687288536205,1.0,8/33,17.04%,RPS6KA5;TADA2A;MAPK3;SART3;NOS1;CTBP1;APLNR;BRCA1
prerank,regulation of transposition (GO:0010528),0.3875550478997779,0.9104764574421371,0.5649819494584838,0.8669310658267475,1.0,1/13,3.26%,PIWIL4
prerank,estrogen metabolic process (GO:0008210),0.36675910846449794,0.910426041939002,0.5772811918063314,0.8664520514393258,1.0,3/15,16.54%,HSD17B1;HSD17B14;SULT1A1
prerank,N-terminal protein amino acid modification (GO:0031365),0.37263373936627897,0.910194964208528,0.5733333333333334,0.8663742049846789,1.0,6/14,21.68%,NAA16;NAA15;PDF;NAA35;NAA40;METAP2
prerank,striated muscle cell development (GO:0055002),-0.35762466528976466,-0.9096081293894568,0.5857461024498887,0.8981720319674611,1.0,2/14,6.20%,PGM5;LMOD1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.25897106972836537,-0.9095989305768956,0.6321525885558583,0.8973704160744241,1.0,7/49,4.93%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1
prerank,chromatin assembly (GO:0031497),-0.27268047247627797,-0.908750886429466,0.616580310880829,0.898607194654006,1.0,11/38,23.29%,H3-3A;LIN54;NPM1;SART3;ASF1A;H1-0;ANP32B;SPTY2D1;NOC2L;NAP1L2;POLE3
prerank,regulation of fibroblast migration (GO:0010762),-0.3187265873331162,-0.9085753673222362,0.5808510638297872,0.8982369591347583,1.0,10/20,22.74%,THBS1;PRR5L;RFFL;FGF2;ARHGEF7;RAC1;GNA12;PRKCE;CLN3;HAS1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.23218069040509548,-0.908538275355179,0.6686390532544378,0.8975153845512964,1.0,17/83,16.39%,USP29;CDK17;CDK14;CDK6;MAX;CAMK2A;CCND1;CDK15;POLA1;BCAT1;ACVR1;HINFP;USP37;CDK2;CDKN1A;CDK4;CDC45
prerank,cardiac cell development (GO:0055006),-0.3733510770420007,-0.9080094600594856,0.5964523281596452,0.8980115101569811,1.0,4/11,8.85%,NOTCH1;MYH11;SLC8A1;VEGFA
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3253582674036606,-0.9078264568221521,0.5973451327433629,0.8976437614890763,1.0,6/20,15.74%,THBS1;ITGA4;SFRP4;CD40;RGCC;PLCG1
prerank,positive regulation of DNA replication (GO:0045740),-0.3340337226505183,-0.9077649457783179,0.5897435897435898,0.8969817944283797,1.0,5/16,18.18%,BCAR3;EGFR;ATAD5;EGF;KAT7
prerank,chromosome condensation (GO:0030261),-0.27909472817469233,-0.9077357269332821,0.6096256684491979,0.8962387215599241,1.0,18/36,37.96%,MCPH1;SMC2;H1-0;CHMP1A;SET;NCAPH2;NCAPH;TENT4A;TTN;BANF1;CSNK2B;NCAPD2;PLK1;CDK1;NCAPD3;INCENP;CCNB1;BANF2
prerank,regulation of cellular response to stress (GO:0080135),-0.2200177293862391,-0.9076445268311376,0.7092651757188498,0.895642768963591,1.0,42/115,26.67%,HSPA8;OPRM1;MAPK3;CHCHD2;HSP90AB1;CAMK2D;BAG1;CAMK2A;PINK1;NPM1;HSBP1;CCAR2;ATM;AAAS;MANF;NUP93;ATF4;NPAS2;AKT1S1;HSP90AA1;CASP9;RAE1;MAPT;ARMT1;ADCY8;FKBP4;VASH1;MLST8;BAG4;NUP62;ATR;NUP188;CLN3;SLC38A2;AIFM2;NUP54;CAMK2G;NUP210;MBTPS2;NUP42;NUP153;EIF4G1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22479530672075257,-0.9071137660851011,0.6928327645051194,0.8961327427085676,1.0,34/109,21.19%,PLCG2;PIK3R1;PAK1;CALM1;MAPK8;PRKCQ;PSMC3;MAPK10;MAPK3;PSMD14;PSMD3;LYN;LCP2;MALT1;FCER1G;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;VAV1;SYK;RAC1;PSMA8;LAT2;NR4A3;PLCG1;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,cholesterol transport (GO:0030301),0.29176495289079457,0.9071051194495917,0.603648424543947,0.8726376029695835,1.0,9/45,17.50%,APOA2;NPC1;LIMA1;SOAT1;OSBPL5;STAR;ABCA1;SERAC1;ABCA7
prerank,lymphocyte mediated immunity (GO:0002449),0.3946007146945791,0.9066233477265304,0.5850467289719626,0.8731369289524759,1.0,1/12,2.47%,CD55
prerank,regulation of actin filament-based movement (GO:1903115),0.40571622871583973,0.906426140671489,0.56640625,0.8729880691084059,1.0,1/10,0.30%,PDPN
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.336733565092972,0.9061613955789283,0.583904109589041,0.873005172293616,1.0,4/22,8.20%,GHR;KIT;IL6;CRLF3
prerank,neuron projection fasciculation (GO:0106030),-0.3739335972266782,-0.906159116753112,0.6064516129032258,0.8976646558155923,1.0,4/10,19.95%,CNTN4;NRCAM;EPHB3;AMIGO1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2402259070152832,0.9059108557867146,0.6565389696169088,0.8729716931524049,1.0,41/166,20.78%,SMAD3;ZEB2;PLD1;SAMD4A;VIM;SLC6A9;SORBS1;IL6;TLR4;GLI1;ARNT;NR1H3;EPM2AIP1;PDGFRB;PTPN2;IGF2;APPL1;SLC25A37;ZCCHC4;SMOC2;ZNF205;STAR;SOX4;PRKD2;PKD2;CPEB3;OPN3;LPGAT1;P2RX4;UPF3A;FXR2;PLXNB2;DNA2;ERBB2;SLC27A1;CTC1;CD36;PTGS2;SREBF1;ELAVL1;ASS1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2825056095423792,-0.9058024568839185,0.5913461538461539,0.8977167125721988,1.0,8/30,15.87%,ELOVL5;ELOVL7;ABCD4;TECR;TECRL;ABCD2;ACSBG1;HACD3
prerank,chromatin remodeling (GO:0006338),0.25590670994901116,0.9055221308331481,0.6384266263237519,0.8732380834533225,1.0,28/100,19.06%,MYB;MBD2;TOP1;BAZ2A;FOXP3;HDAC4;HNRNPC;BAZ1B;GATAD2B;JARID2;CECR2;BAZ1A;MYSM1;ACTL6A;KDM5B;SRCAP;BPTF;ERCC6;HDAC2;SMARCA4;KAT2B;SMARCC1;CHD8;INO80C;CHD4;HCFC2;ARID1B;ACTR8
prerank,telomere organization (GO:0032200),0.2950269561598592,0.9054468119233123,0.5823817292006526,0.8728404298596745,1.0,5/43,5.63%,SP100;TERT;WRN;RAD50;PARP3
prerank,regulation of amyloid fibril formation (GO:1905906),-0.34824015658333596,-0.9046425836235269,0.5978947368421053,0.8998375263671503,1.0,8/15,31.46%,PFDN5;PFDN2;PFDN4;CHRNA7;VBP1;TREM2;CLU;LDLR
prerank,histone H4 acetylation (GO:0043967),0.2897633339679977,0.9040517246460537,0.594551282051282,0.875357150522585,1.0,10/47,17.72%,KMT2A;APBB1;EPC1;JADE2;ACTL6A;BRD8;ZZZ3;TRIM16;KANSL1;ATF2
prerank,cellular iron ion homeostasis (GO:0006879),0.2800998410293424,0.9035099252545249,0.6207430340557275,0.875986936476937,1.0,2/55,0.40%,CP;BMP6
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.27233783512483684,-0.9030773087026409,0.6206896551724138,0.9028763797974265,1.0,8/39,12.62%,EFR3B;ITPKB;PIK3R1;PIK3C2B;PIK3R3;IP6K2;PI4K2A;PIK3CD
prerank,positive regulation of chemotaxis (GO:0050921),-0.264266454912869,-0.9028541487016772,0.6178010471204188,0.9025806525871678,1.0,11/43,15.27%,TMSB4X;THBS1;KDR;F3;STX3;MET;LGMN;VEGFA;FGF2;CCL19;PRKD1
prerank,cellular senescence (GO:0090398),0.3227620052007548,0.9026332556091733,0.6173913043478261,0.8773086965536079,1.0,8/27,15.00%,CDKN2B;MAPK14;NSMCE2;MAP2K1;OPA1;KAT6A;MAPKAPK5;PML
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3901171589556318,0.9023911916635553,0.5882352941176471,0.8772525596221235,1.0,3/12,9.00%,SORBS1;EPM2AIP1;IGF2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.304291717388927,0.9023568917545626,0.6169491525423729,0.8767330318674147,1.0,7/37,10.73%,NUPR1;GSDME;BCL2;FBH1;BAX;DNM1L;BCL2L1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3504337236120421,-0.9019953738942363,0.5990888382687927,0.9039262266207614,1.0,5/13,14.47%,PTK2B;NEDD4L;NOS1;CAV1;CASQ2
prerank,AMP metabolic process (GO:0046033),0.3791643866857528,0.9017075405519104,0.591254752851711,0.8776082984347272,1.0,1/13,1.05%,AMPD3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2968549259965126,-0.901411789758807,0.6241610738255033,0.9045318376996783,1.0,10/26,27.44%,SGIP1;FNBP1L;SNAP91;AP2B1;DLL1;ITSN2;AP2A2;AP2A1;CLTA;AP2M1
prerank,neuron fate commitment (GO:0048663),-0.34501530501424305,-0.9011449452774715,0.588865096359743,0.9043800155733499,1.0,7/14,35.39%,MYT1L;POU3F2;DLL4;DLL1;POU4F1;PAX6;ASCL1
prerank,cellular response to radiation (GO:0071478),-0.26522646527625504,-0.9010615117992721,0.6322418136020151,0.9037691396198524,1.0,17/40,31.96%,NET1;INTS7;RHOB;KDM4D;CDKN1A;RAD51;RAD1;GPR88;ECT2;RHNO1;RAD51AP1;BLM;EEF1D;RRH;TP53;OPN1MW3;OPN1MW
prerank,translational termination (GO:0006415),-0.22512148992878261,-0.9010487655519892,0.6913183279742765,0.9029854160291039,1.0,38/95,34.00%,MRPL4;MRPS18A;MRPL1;MRPS30;GSPT2;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;GSPT1;MRPS31;MRPL49;MRPS12;MRPL11;N6AMT1;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1
prerank,regulation of cilium assembly (GO:1902017),0.27860645759521413,0.9004248370703649,0.624420401854714,0.8798735446135802,1.0,11/62,14.44%,DCDC2;TBC1D16;SDCCAG8;IFT88;YAP1;TAPT1;DYNC2LI1;ENTR1;IFT20;TBC1D7;CROCC
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.34375514750424496,0.9003957342367965,0.6065292096219931,0.879334136710172,1.0,3/21,7.53%,EPHA7;BIRC3;NGFR
prerank,positive regulation of protein processing (GO:0010954),0.3546886998056063,0.9002700103214787,0.6007827788649707,0.8790252442623012,1.0,3/19,12.38%,CLEC3B;PLGRKT;CCBE1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3990970726853078,0.9002287796211853,0.5838264299802761,0.8785267292006479,1.0,4/11,19.29%,WNT3A;WNT5A;RYK;WNT2
prerank,smooth muscle contraction (GO:0006939),0.36923989967943616,0.9001695546567107,0.5889908256880734,0.8780506475941146,1.0,4/14,9.49%,ROCK2;PIK3C2A;BDKRB2;NMUR1
prerank,regulation of mRNA processing (GO:0050684),-0.2780460022370544,-0.8998627493392836,0.6081424936386769,0.9050530273368985,1.0,5/32,11.59%,QKI;KHDRBS2;KHDRBS3;HNRNPK;PTCD2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.38339859359655004,-0.8997892941652116,0.6346555323590815,0.9044173294607829,1.0,4/10,7.57%,KDR;CD34;RAPGEF2;CEACAM1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3413368526141862,0.8995713856202793,0.575591985428051,0.8787857365878275,1.0,2/20,3.96%,RBPJ;BMP2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3571869939232423,-0.8993950633848262,0.6126315789473684,0.9045154307090071,1.0,3/12,19.78%,KLF2;CALR;ASXL1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.31484057228618584,0.8992445452797437,0.6309314586994728,0.8789133321657274,1.0,4/29,8.63%,KANK2;UBA5;STRN3;YAP1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3743982027256653,-0.8989949090512401,0.5856832971800434,0.9046649843297307,1.0,3/11,14.89%,C1QTNF3;SIK1;PGP
prerank,regulation of type I interferon production (GO:0032479),0.25951423434252163,0.8987394781610186,0.649016641452345,0.8794342894456938,1.0,32/84,27.24%,TRIM56;IKBKE;DTX4;PTPN22;ZBP1;RNF216;CREBBP;POLR1C;NLRX1;POLR3F;TRIM21;POLR2F;IFIH1;TBK1;POLR3H;RNF135;PCBP2;DHX36;POLR2K;NLRP4;OTUD5;GAPDH;TAX1BP1;DHX9;TRIM32;POLR3B;POLR2H;UBE2L6;STAT6;ISG15;CRCP;CGAS
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3398804092445996,0.8986694110183454,0.5826086956521739,0.8789937335305281,1.0,4/21,12.35%,WNT3A;FZD2;GSK3B;DVL3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.3716584672788331,-0.8986609057796934,0.6012145748987854,0.9046539994479073,1.0,6/11,33.67%,MFHAS1;LYN;TREM2;TLR6;TLR1;TIRAP
prerank,regulation of heart contraction (GO:0008016),0.25860369830732766,0.8982554254744073,0.6183431952662722,0.8792760304763372,1.0,9/90,7.74%,CELF2;ATP1A2;ITPR1;TMEM65;DES;TPM1;ATP2B4;CORIN;NPPC
prerank,negative regulation of myotube differentiation (GO:0010832),-0.35902429703228456,-0.8977753611076876,0.6052060737527115,0.9059903219865603,1.0,3/12,9.20%,NOTCH1;CCN3;HDAC1
prerank,regulation of superoxide anion generation (GO:0032928),0.37343955597641004,0.8976292296761444,0.5925925925925926,0.8800938609489249,1.0,2/14,6.66%,FPR2;CRP
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2766812211956897,0.8973057495694146,0.6232339089481946,0.8802116174457045,1.0,10/59,14.55%,ROCK2;TLR4;BIRC3;LY96;RIPK2;TLR2;MAP3K7;TIFA;TICAM1;TBK1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.326530796214649,0.8969393574461171,0.5709156193895871,0.880434155803975,1.0,3/22,10.75%,NR2F2;LATS2;IPO7
prerank,mesenchymal to epithelial transition (GO:0060231),-0.37305576241332317,-0.896854899194511,0.5987654320987654,0.9073812689065748,1.0,3/10,11.68%,BMP4;PAX2;BASP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3687894155429491,-0.8966982143750513,0.5921908893709328,0.9069719609260295,1.0,8/12,48.12%,CLSPN;HUS1B;TOPBP1;CDC6;TICRR;RAD17;SETMAR;HUS1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.23790920550066474,0.8962916955768034,0.6876712328767123,0.8812679161681873,1.0,17/151,8.25%,CCN2;PDGFRA;NOTCH2;FPR2;MTURN;GLIPR2;NRP1;ANGPT1;BMP2;ROR1;PRKCZ;PTPN22;PDGFRB;CCL2;ACKR3;LGALS9;PHB2
prerank,negative regulation of protein metabolic process (GO:0051248),-0.25335164632837337,-0.8956144199949025,0.6426666666666667,0.9087762508348762,1.0,17/48,28.40%,FMN2;SNX3;HSP90AB1;PFDN5;CD84;EGFR;PFDN2;INHBB;EIF2AK1;PFDN4;EDNRB;VBP1;TREM2;ADGRB1;EDN1;AZIN1;CLU
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3766561289691821,0.8951846478415213,0.5951035781544256,0.8831832661816063,1.0,3/13,12.48%,PARP9;PARP10;PARP16
prerank,regulation of defense response to virus (GO:0050688),0.3702051412605273,0.8947769831997423,0.5827067669172933,0.8834766773307811,1.0,3/14,10.66%,RNF216;PPM1B;IFNLR1
prerank,negative regulation of cell aging (GO:0090344),-0.33402066177188544,-0.8940136781100931,0.6089887640449438,0.9118629761817741,1.0,3/16,7.60%,CDK6;YBX1;RBL1
prerank,regulation of sodium ion transport (GO:0002028),0.3052139501066555,0.8936624618051665,0.6026936026936027,0.8852591235220215,1.0,10/34,14.09%,NKAIN4;NEDD4;SNTA1;ATP2B4;WNK4;SCN3B;DLG1;GPD1L;SLMAP;WNK1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.36025053430269416,-0.893434603914842,0.5805084745762712,0.9124750812550313,1.0,8/12,33.81%,EPHB1;HSP90AB1;HSP90AA1;B4GALT6;EPHB6;SPTBN4;B4GALT5;EPHB2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2496885846735945,0.8929347457328641,0.678726483357453,0.8863044477662015,1.0,15/116,10.90%,GHRH;ADORA2A;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;GPR39
prerank,pre-miRNA processing (GO:0031054),0.36949629848821386,0.8924069298504643,0.5739299610894941,0.8868924101979835,1.0,4/14,18.15%,TUT4;ADAR;TARBP2;TUT7
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.33391193568425526,-0.8923603299918976,0.6004273504273504,0.9142953158964476,1.0,6/17,9.86%,CACNB2;KCNJ2;SLC8A1;HCN2;CACNA1G;CACNA1D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2817878112875661,0.8919538662044199,0.6331058020477816,0.8873150795828164,1.0,8/48,11.27%,AMPD3;ADCY5;ADCY7;PANK2;ADCY1;NPPC;AK5;ACAT1
prerank,negative regulation of JNK cascade (GO:0046329),0.3102952766261078,0.8919522675435957,0.6086206896551725,0.8867253559063027,1.0,6/31,10.35%,DUSP10;DACT1;TAOK3;PTPN22;ZMYND11;HIPK3
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.306745848535706,-0.8918902543544277,0.631336405529954,0.914680110280964,1.0,3/24,8.69%,ABCG2;SUCLA2;ALAS1
prerank,T cell proliferation (GO:0042098),-0.35078643906821705,-0.8918781099846831,0.6064516129032258,0.9139028371645509,1.0,1/13,0.07%,CADM1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.22087748030908705,-0.8917353308581104,0.7272727272727273,0.9126069019335288,1.0,27/104,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,cellular response to lectin (GO:1990858),-0.22087748030908705,-0.8917353308581104,0.7272727272727273,0.9126069019335288,1.0,27/104,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.27822810373476,0.8917272521258816,0.6252019386106623,0.8866827419669477,1.0,8/52,8.89%,PDPK1;SPTBN1;EPHA3;SORBS1;ATP2B4;PTPN9;KIF5B;DLG1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3803487509915755,0.8917247383588754,0.608286252354049,0.886098786661273,1.0,2/13,6.66%,FPR2;CRP
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4078362055046228,0.8915835421923717,0.5969868173258004,0.8858059857640269,1.0,2/10,11.55%,EMC2;EMC9
prerank,mitochondrial translational elongation (GO:0070125),-0.22731335845756814,-0.8912623848018438,0.6815286624203821,0.9129435273480122,1.0,38/88,35.83%,MRPL4;GFM1;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MRPL45;MRPL30
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3228110213392175,0.8911991597141382,0.5775401069518716,0.8861089053292484,1.0,6/26,11.67%,LARGE1;RRM1;GBGT1;GK5;ALG11;RRM2B
prerank,response to amino acid (GO:0043200),-0.28915849663440646,-0.8910913582250544,0.6177156177156177,0.9125611491307911,1.0,11/31,26.20%,GLRA3;GRIN1;RRAGB;CPEB4;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,positive regulation of histone deacetylation (GO:0031065),-0.35951031362984187,-0.8908715442601539,0.6201716738197425,0.912270418165596,1.0,4/12,15.27%,VEGFA;CTBP1;APLNR;PRKD1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.37501000676410623,-0.8904508740384334,0.6039215686274509,0.9124728379970847,1.0,5/10,37.14%,SIRT7;ZNF692;DGKQ;GNMT;PDK2
prerank,regulation of developmental growth (GO:0048638),-0.28304367439458844,-0.8896603231831123,0.6206088992974239,0.913544887123003,1.0,9/29,16.05%,PLCB1;INSR;SIX1;NRCAM;MBD5;MFSD2A;SIX4;SOD1;SPAAR
prerank,iron ion homeostasis (GO:0055072),0.2729383606965228,0.8893134546741636,0.6307692307692307,0.8896773845668248,1.0,2/58,0.40%,CP;BMP6
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2688752121049694,0.889124544598968,0.6337386018237082,0.8894971477254718,1.0,6/67,4.24%,DCDC2;PLD1;FER;TBC1D16;SDCCAG8;IFT88
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.31895422970406895,-0.8888067105695846,0.6416861826697893,0.914700339358393,1.0,2/19,0.90%,DLG2;LRRC7
prerank,protein depolymerization (GO:0051261),0.3146486424064716,0.88843844091892,0.6132596685082873,0.890388557390367,1.0,3/27,7.62%,MICAL3;NCKAP5L;DSTN
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.30115960718491597,-0.8881752525401739,0.6070640176600441,0.915331599068229,1.0,8/23,15.98%,SIX1;BMP4;VEGFA;FGF2;PAX2;PIK3CD;SIX4;EGF
prerank,histone mRNA metabolic process (GO:0008334),0.3202523450747311,0.8880825023149627,0.6179966044142614,0.890558497138115,1.0,9/27,18.22%,TUT4;LSM1;DCP2;XRN1;TENT2;SSB;EXOSC10;TUT7;SLBP
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.30931859142109114,-0.8879826812157546,0.6589327146171694,0.915017068628098,1.0,4/21,11.52%,RPL5;RPS7;RPL11;RPL23
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.23376011135708294,-0.8876179061365594,0.7085889570552147,0.9150505871826624,1.0,24/76,21.62%,TEK;PTK2B;NCKAP1;LMOD1;CDC42EP3;DYNC1H1;VASP;CDC42EP1;CDC42EP5;PFDN2;FES;HRAS;EVL;PLK4;NTF3;P2RX7;PYCARD;ARF6;PFN2;SPAG5;CARMIL1;HCLS1;PRKCE;NUP62
prerank,endomembrane system organization (GO:0010256),0.2329480725814458,0.8875111480689482,0.733957219251337,0.8911808474654009,1.0,43/178,19.30%,ARHGAP21;MYOF;SPTBN1;A4GALT;RAB22A;MIA3;WASHC4;CLASP1;RAB43;OPTN;VAPA;GOLGA5;GOLGA8B;FAM174B;USP8;LRRK2;DNM1;DNM1L;UBXN2A;HUWE1;TMCC1;GORASP2;TJAP1;SRGN;COG2;LMAN1L;TMED9;EIF2AK3;GBF1;ATL1;GOLGA2;ANXA8;ANXA8L1;SEC31A;HOOK1;DMPK;DNAJC28;LYSMD3;PLEKHF1;USP6NL;SEC16A;ARFGEF2;PLEKHM2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.312617803789115,-0.8874053419369534,0.631236442516269,0.9147666912191266,1.0,5/19,13.57%,PRKCH;CLDN5;RUNX1;CBFB;F11R
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.21949613529431203,-0.8872750826302157,0.7212121212121212,0.9142917810260971,1.0,27/105,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,negative regulation of protein depolymerization (GO:1901880),0.33120240057352507,0.8867932527550368,0.608843537414966,0.8921873115897061,1.0,5/24,11.21%,PLEKHH2;CLASP1;HDGFL3;LIMA1;ATXN7
prerank,MAPK cascade (GO:0000165),0.2191947446947909,0.8867504778045794,0.7466007416563659,0.8916977432768508,1.0,48/295,13.11%,RASGRF1;NRK;PDGFRA;FGFR1;FGF1;SPTBN1;IL31RA;KSR1;CCM2;FRS2;TGFA;KL;ANGPT1;KIT;TAOK3;PTPN3;ARAF;PTPRA;PDGFRB;SYNGAP1;RASA1;ACTN2;CTSH;IL18;CCL2;LGALS9;MEF2A;PSMB10;PSMA3;DLG1;RGL3;PSME4;LRRK2;RALGDS;PSMA5;FGF18;BCL2L1;PPP1CB;PTK2;CUL3;DUSP5;MAP3K7;FNTB;BTRC;MAP2K1;FBXW11;SHOC2;JAK1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.38758162695104076,0.8866537939393959,0.5927342256214149,0.8913363193254334,1.0,3/11,11.07%,AFDN;RAP2C;TJP1
prerank,organelle organization (GO:0006996),0.21543385769809856,0.8866079858804967,0.765906362545018,0.8908511960119804,1.0,90/388,19.98%,MICAL3;CXADR;DIAPH1;ARHGAP21;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;TERT;BRWD1;DES;GABPB1;MIA3;TPM1;CLASP1;RAB43;PLCE1;HAX1;OPTN;PACSIN2;CAPZB;CCL2;VAPA;GOLGA5;GOLGA8B;PHB2;FMNL2;FAM174B;SIRT4;NIPSNAP2;LRRK2;CNN2;AFG1L;CECR2;ZFYVE16;SPRYD3;PPID;GEM;DNM1L;UBXN2A;HUWE1;RAB34;ATXN7;TMCC1;ZMYM6;ABCD3;OPA1;MTFR1;GORASP2;TJAP1;WASL;PEX2;NRF1;COG2;LMAN1L;CHMP3;RHOU;BRWD3;TMED9;EIF2AK3;FAF2;CHMP4A;CHMP4B;PDZD8;PKD2;GBF1;ZMYM3;ATL1;GOLGA2;SAR1A;WTIP;PYROXD2;SEC31A;RHOT1;DNAJC28;PLD2;SIRT3;ESRRA;LYSMD3;PLEKHF1;USP6NL;DMTN;SEC16A;RHOT2;PLEKHM2;AJUBA;CHMP5;COG4;LONP1
prerank,sphingoid metabolic process (GO:0046519),0.37409090727177624,0.8864795729395623,0.6085271317829457,0.8905431628618306,1.0,2/12,8.11%,PLPP3;NAAA
prerank,negative regulation of protein secretion (GO:0050709),-0.26609250044533905,-0.886286513492537,0.6610576923076923,0.9157735610844554,1.0,8/38,14.87%,RAB11FIP1;CCN3;OPRM1;RAB11FIP3;KCNB1;INHBB;RHBDF2;RAB11FIP5
prerank,regulation of cell differentiation (GO:0045595),0.2369376169052748,0.8860821486772831,0.6975476839237057,0.8908239556118567,1.0,14/148,6.75%,PHLDB2;CCN2;FGFR1;EIF2AK2;EPHA3;DAG1;PTHLH;SUZ12;CLASP1;TGFBR1;MBOAT2;PHLDB1;NREP;CREBBP
prerank,cranial nerve development (GO:0021545),0.3889598170192199,0.8860311473286455,0.6086956521739131,0.890347232243654,1.0,2/11,7.72%,SALL1;TIFAB
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3182351148177795,-0.8859355431385031,0.6192560175054704,0.9158180242656656,1.0,6/20,13.86%,HSP90AB1;AKT1;CCND1;EGFR;TTBK1;RGCC
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.26701712247716886,0.885780235956083,0.6577287066246057,0.8902994524174908,1.0,8/66,8.63%,SMAD3;PARP9;ZIC1;TERT;TPR;DTX3L;NGFR;YAP1
prerank,positive regulation of axon extension (GO:0045773),-0.29984680080375786,-0.8857455865085088,0.6383928571428571,0.915472281594611,1.0,8/22,15.43%,MACF1;SEMA7A;SHTN1;VEGFA;L1CAM;DBNL;ZFYVE27;MAPT
prerank,cytosolic calcium ion transport (GO:0060401),0.3129557359332188,0.8853618992073526,0.6305841924398625,0.8905862965280762,1.0,8/28,16.74%,MCU;MICU1;CACNA1C;JPH1;ATP2B1;JPH3;CACNA2D1;JPH4
prerank,regulation of cardiac conduction (GO:1903779),0.2710608222267421,0.8850965990905265,0.624420401854714,0.8905641901475436,1.0,9/54,13.14%,ATP1A2;ITPR1;TMEM65;ATP2B4;CORIN;NPPC;TRPC1;ATP1B2;ATP2B1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.32912118066220697,-0.8846801250368509,0.6048192771084338,0.9171057878090492,1.0,3/16,16.84%,CELF4;TRA2A;RBM3
prerank,mRNA splice site selection (GO:0006376),0.3103401158590864,0.8843675635571266,0.6345811051693404,0.891501983962932,1.0,1/30,0.13%,CELF2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.3773988254236714,-0.8842030659130011,0.6163522012578616,0.9174601717839881,1.0,4/10,24.43%,SORL1;DNAJA4;SACS;HSPA2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3088819783589263,-0.8841892673424239,0.6308724832214765,0.9166987330938385,1.0,4/20,11.45%,PDE4D;ADRA1B;RAPGEF2;ADRB2
prerank,regulation of biosynthetic process (GO:0009889),-0.3744452080039268,-0.8841730083736222,0.631578947368421,0.9159431090588226,1.0,10/11,53.07%,SNCA;MID1IP1;ALOX5;THRSP;GSTP1;CCN6;SLC25A33;PIKFYVE;UCP1;PCK1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3056848881750543,0.8841134450284657,0.6122448979591837,0.891473513690335,1.0,5/30,7.89%,IL6;TLR4;PRKCZ;LGALS9;CD274
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.25950752112981634,0.883641146859728,0.6755555555555556,0.891918277088117,1.0,21/73,20.89%,SUZ12;HDAC4;POLR1C;BAZ1B;EPC1;IGF2;POLR1G;JARID2;TASOR;POLR2F;ERCC6;MYO1C;KAT2B;DDX21;DNMT3A;PPHLN1;BMI1;MPHOSPH8;POLR2K;SPHK2;PHF1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.398823259827447,0.8830456093061364,0.61003861003861,0.8926130333585678,1.0,3/10,15.09%,CCL2;QRICH1;EIF2AK3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.28573686464597486,0.8828654160222915,0.6373983739837399,0.8924028213013206,1.0,6/47,6.94%,PID1;FPR2;TLR4;PDGFRB;CRP;TGFBR2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.32546882704976965,0.8828438162078309,0.6129032258064516,0.8918662787293459,1.0,4/23,8.20%,GHR;KIT;IL6;CRLF3
prerank,establishment of protein localization to organelle (GO:0072594),0.2627470086063298,0.8827793827124346,0.6820276497695853,0.8914330390259795,1.0,13/72,17.93%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;RAN;HK1;RANBP17
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3290943087516427,-0.8826115577701095,0.6218487394957983,0.9187196727429953,1.0,2/15,2.99%,PIEZO2;SCN1A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.22269195234419176,-0.8823053230398505,0.7075471698113207,0.9186564397209548,1.0,24/86,21.74%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;STMN2;CDC42EP3;VASP;CDC42EP1;CDC42EP5;FES;RAC1;EVL;MAPT;PYCARD;ARF6;CDK5RAP2;PFN2;CARMIL1;DCTN1;PRKCE;ARL2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.2324836786831292,0.8822883637492513,0.7281292059219381,0.8918994403038687,1.0,44/173,21.58%,SPTBN1;COPZ2;DYNLL1;CD55;ARFGAP3;TGFA;KDELR3;MIA3;SEC23A;ARF4;SEC24D;CAPZB;VAPA;DCTN5;PROS1;ERGIC1;COPE;GOSR1;ARCN1;CUL3;SEC24C;SCFD1;COG2;LMAN1L;TMED9;ACTR1A;COPZ1;SEC24B;GBF1;SPTBN2;GOLGA2;SAR1A;SEC31A;CAPZA1;ANK2;SEC16A;F5;COG4;COG1;DCTN4;VAMP7;IER3IP1;BCAP31;TRIP11
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2891479246553877,-0.8822594396708751,0.6466666666666666,0.9179816803301266,1.0,8/25,15.10%,DMD;ATP1B1;ANK3;TRPC6;CTSS;NDUFA4;STAC;GLRX
prerank,replication fork processing (GO:0031297),0.29210655855735007,0.881996821118877,0.6399317406143344,0.8919752256546706,1.0,7/38,11.01%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,regulation of neuroblast proliferation (GO:1902692),0.36390408654453493,0.8818279511939426,0.615678776290631,0.8917219608195175,1.0,1/15,0.48%,PTN
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.25497560411864467,0.8813364172417826,0.661849710982659,0.8921808616680608,1.0,18/85,15.98%,PRICKLE1;NUPR1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180;RNF185
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3248810067080984,-0.8810288662542791,0.6419491525423728,0.9200611984976095,1.0,6/17,33.21%,RFFL;CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,atrioventricular valve development (GO:0003171),-0.343003322607665,-0.8809397151173581,0.6288888888888889,0.919468635752517,1.0,6/14,14.08%,TGFB2;BMPR2;NOTCH1;ZFPM1;ACVR1;APLNR
prerank,DNA double-strand break processing (GO:0000729),-0.3190354312428293,-0.8803086022159894,0.6189427312775331,0.9201409602738075,1.0,6/18,17.04%,UBE2V2;MRE11;ATM;BARD1;EXD2;BRCA1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.27600781894008036,-0.8797381245032287,0.6363636363636364,0.9207246648886467,1.0,10/33,19.39%,PIK3R1;NYAP2;PLEKHA1;PIK3C2B;AKT1;PIK3CD;MYO16;HTR2B;HTR2A;C1QBP
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3705116963248536,-0.8794583324830337,0.6202783300198808,0.9205878036832204,1.0,5/10,33.14%,RPUSD2;RPUSD3;RPUSD1;NOP10;NHP2
prerank,mammary gland development (GO:0030879),0.33798039386130874,0.8791158617432678,0.6185185185185185,0.8964113973421935,1.0,1/21,0.44%,WNT4
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3719483483844747,-0.8789687949179503,0.6559139784946236,0.9209518501290804,1.0,4/10,19.50%,ELOVL5;ABCD2;MID1IP1;SLC45A3
prerank,DNA-dependent DNA replication (GO:0006261),-0.21090796805247936,-0.8789210191674643,0.75,0.9202836360934687,1.0,46/128,27.76%,REV3L;PSMC3;GINS3;PSMD14;UBB;PSMD3;PSMD4;POLA1;MGME1;PSMD6;PSMA6;PSMA4;PSMB8;ORC6;UBA52;PSMA8;TWNK;PNKP;POLD2;CDK2;RAD51;CDC45;PSME1;POLE;RFC4;SIRT7;PSMD7;PSMC6;POLD1;PSMB5;PSMC5;PSMB1;POLB;POLE3;PSMD11;WRNIP1;MCM10;PSMD8;SRPK2;RFC5;RFC2;RECQL;CDC34;GINS4;BLM;CDK2AP1
prerank,cGMP biosynthetic process (GO:0006182),-0.37798377776433845,-0.878822369504029,0.6076923076923076,0.9197215160547183,1.0,3/10,10.66%,GUCY1B1;GUCY1A1;NPR1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.35011798836980046,-0.8787668279722115,0.6373390557939914,0.9190448499733375,1.0,6/12,20.13%,SERINC3;SERINC5;PSPH;SEPHS1;CTH;GGT1
prerank,vesicle organization (GO:0016050),-0.25481515886859807,-0.8785578956972675,0.6950904392764858,0.918740452069701,1.0,20/46,29.48%,FNBP1L;CD34;ALS2CL;VPS33B;PI4K2A;CAV2;ALS2;CAV1;SORT1;CHMP2B;SAR1B;DNAJC13;SNX33;VPS18;LAPTM4B;PHETA2;PI4K2B;SNX10;SQSTM1;SNX11
prerank,regulation of extracellular matrix organization (GO:1903053),0.35865652789050956,0.8784067420902751,0.6163410301953819,0.8973444014827021,1.0,3/15,4.96%,DDR2;EFEMP2;AEBP1
prerank,response to glucocorticoid (GO:0051384),-0.2897120027292651,-0.8781322291029935,0.6505494505494506,0.9189235648402078,1.0,2/26,5.15%,SLIT2;FAM107A
prerank,chromosome organization (GO:0051276),0.24751929272153825,0.8780863202401877,0.6831831831831832,0.8974189360981889,1.0,10/99,11.01%,TCF7L2;NUCKS1;BRWD1;CDAN1;CUL4A;TOP2B;TCF7L1;SETD7;GEM;RFWD3
prerank,regulation of myoblast fusion (GO:1901739),0.38298555495996456,0.8778319740243996,0.6196911196911197,0.8973753630884277,1.0,2/11,10.27%,CFLAR;MAPK14
prerank,pharyngeal system development (GO:0060037),-0.32923082731981107,-0.8773625393666723,0.6332665330661322,0.9198738832150275,1.0,4/15,7.09%,TGFB2;BMPR2;TBX1;BMP4
prerank,phosphate-containing compound metabolic process (GO:0006796),0.22630987006223352,0.8772278769452485,0.7258485639686684,0.8980840704014371,1.0,28/198,12.11%,ENPP3;EPHA7;PLA2G4A;ENPP1;PLPP3;TPTE;PPM1A;ACYP2;DUSP10;PLCD3;PI4KA;DUSP28;TOP1;PLCE1;PANK2;PLCB3;PLA2G4C;DUSP16;PLPPR3;NT5C;HKDC1;GK5;LRRK2;PFKM;INPP1;XYLB;PPP3CB;DUSP5
prerank,regulation of DNA binding (GO:0051101),-0.2549188412506769,-0.8769236780866306,0.6723716381418093,0.9200495100777216,1.0,11/44,17.85%,LEF1;MAPK8;HMGB1;MDFI;DOT1L;TFAP4;NGF;PLAUR;EGF;HES1;BCL3
prerank,positive regulation of TOR signaling (GO:0032008),-0.25267540078249007,-0.8768752659279366,0.693069306930693,0.9193666167353183,1.0,16/40,32.05%,GPR137C;GAS6;SMCR8;RRAGB;RRAGC;PIP4P1;LAMTOR2;MLST8;TREM2;MIOS;LAMTOR4;HTR6;GOLPH3;WDR24;PIH1D1;SEC13
prerank,genitalia development (GO:0048806),0.37512100160301154,0.8768014166924023,0.5864661654135338,0.8984312766479358,1.0,2/12,8.47%,TIFAB;WNT5A
prerank,protein processing (GO:0016485),-0.21888604875638962,-0.8766614443245566,0.7590027700831025,0.9190941874283682,1.0,23/102,22.59%,F3;CPE;PCSK2;MMP16;LGMN;ECE1;FAM111A;CTSS;CPD;SPCS2;SEC11C;CTSL;SPCS1;PCSK7;PHEX;PSENEN;ADAMTS3;CPXM1;CASP1;GGT1;PCSK5;CPZ;CLN3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.25855522815774856,-0.8761044485945445,0.6842105263157895,0.9196065477768932,1.0,10/38,14.81%,GRM5;GAS6;ACE;LRP8;SH3BP5L;SRCIN1;CAV1;CSF1R;RELN;PTPRC
prerank,myeloid leukocyte differentiation (GO:0002573),0.26288148087987256,0.875493172336206,0.6629032258064517,0.9006402227859288,1.0,13/65,15.00%,IL31RA;GAB2;KIT;PIR;TGFBR2;GLO1;LGALS9;MAPK14;CSF1;EPHA2;THOC5;RARA;PML
prerank,regulation of transferase activity (GO:0051338),0.3542732531676488,0.8754420677619337,0.6294964028776978,0.9001582105958211,1.0,6/17,20.15%,LDB2;JMJD8;SMG6;HMBOX1;PARP4;NABP2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.3280460713398602,-0.8754255685089231,0.6494623655913978,0.9203386543595586,1.0,4/16,12.29%,PIGM;PIGQ;PIGH;DPM2
prerank,protein localization to condensed chromosome (GO:1903083),-0.35204063066306596,-0.8748741737891876,0.6302521008403361,0.92079352580136,1.0,9/12,42.54%,ZWILCH;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.22374872567538684,-0.8745646373545686,0.7404129793510325,0.9207128630561628,1.0,30/82,24.48%,PPP2R1A;CSNK1D;KCNH5;NPM1;DYNC1H1;PCNT;TUBA1A;TUBB4A;PRKAR2B;ATAD5;HSP90AA1;CEP43;NEK10;DYNC1I2;NDE1;TUBB4B;CEP135;PLK4;CDK2;CEP290;SSNA1;TUBG1;CDK5RAP2;CEP41;DCTN1;CENPF;HMMR;CEP70;KIF14;MAPRE1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.25568407776407764,-0.8745306665025486,0.6684636118598383,0.919999450925942,1.0,12/41,20.28%,GRM5;NTRK2;GAS6;DOCK3;ACE;LRP8;SRCIN1;CSF1R;RELN;EGF;FCGR1A;DLG3
prerank,T cell activation involved in immune response (GO:0002286),-0.35128108970069083,-0.8744874837020112,0.6332622601279317,0.9193277113522833,1.0,3/12,17.58%,CD74;FCER1G;LCP1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3616822519466783,0.8743756384274307,0.6046966731898239,0.9018691278207693,1.0,3/13,11.55%,GLI3;TGFBR2;IHH
prerank,autophagosome maturation (GO:0097352),-0.2724906769921701,-0.8742847951755847,0.7162790697674418,0.9190244264375033,1.0,12/32,26.99%,CALM1;GABARAP;GABARAPL1;VMP1;VPS33B;TECPR1;ATP2A2;VIPAS39;LIX1;CLN3;SNAP29;MAP1LC3B
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3190558784285266,-0.8741704747291692,0.6313559322033898,0.918502161523934,1.0,6/18,21.32%,MTHFR;MSRA;SMS;ASNS;SLC25A13;SLC25A12
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2559694219593585,0.8739285535265369,0.6637037037037037,0.9022199594905771,1.0,16/70,19.81%,PLA2G4A;APOA2;MBOAT2;NR1H3;PLA2G4C;PLA2G6;STARD10;ENPP2;CSNK2A2;PCYT1A;LPIN2;ABHD3;PEMT;PLA2G5;SLC44A2;SLC27A1
prerank,positive regulation of phagocytosis (GO:0050766),0.28091916655423643,0.8737291633797771,0.6583747927031509,0.9020604364784224,1.0,7/47,8.09%,CAMK1D;FPR2;APOA2;APPL2;CD47;CCL2;C2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.37348166097634494,0.8736014243128074,0.6216730038022814,0.9017424756647663,1.0,5/12,20.16%,CLN5;LRRK2;TMEM165;TMEM9;VPS33A
prerank,regulation of establishment of planar polarity (GO:0090175),0.2513949379004408,0.8728198449641479,0.7142857142857143,0.902865123273254,1.0,11/88,10.29%,PRICKLE1;SMURF2;FZD2;DACT1;PARD6A;CELSR1;PSMB10;WNT5A;PSMA3;PSME4;PSMA5
prerank,phospholipid dephosphorylation (GO:0046839),-0.26538929899147906,-0.8723776414993375,0.6683168316831684,0.9216783443681591,1.0,18/37,25.38%,MTMR6;PLPPR1;PLPP5;INPP5K;MTMR12;PLPP1;PLPPR2;SGPP1;PIP4P1;MTMR7;PLPPR5;MTMR2;INPP5J;INPP5B;PLPPR4;MTMR1;SYNJ1;MTMR9
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.32042640797823196,0.8719652236575303,0.6431159420289855,0.9041010247762077,1.0,4/22,10.49%,DYNLL1;BMP7;CDKN2B;PLEK
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.29321016937345484,-0.8718564034271228,0.6388261851015802,0.9213334437471289,1.0,10/23,33.92%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53;E2F1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.29321016937345484,-0.8718564034271228,0.6388261851015802,0.9213334437471289,1.0,10/23,33.92%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53;E2F1
prerank,homologous chromosome segregation (GO:0045143),-0.31056428452737955,-0.8718151751761096,0.6474820143884892,0.9206491161293389,1.0,4/20,18.56%,FMN2;PTTG1;MEI4;SIRT7
prerank,modulation by host of viral genome replication (GO:0044827),0.3596530709705422,0.8717252000887952,0.620889748549323,0.9040306313548723,1.0,3/13,11.99%,NUCKS1;VAPA;IFI27
prerank,macrophage migration (GO:1905517),0.3630424829802177,0.871617159015701,0.6374269005847953,0.9036818373173777,1.0,3/13,16.78%,CKLF;CCL2;P2RX4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.25864169224159106,0.8715310972539604,0.677710843373494,0.9032809951152511,1.0,10/74,10.29%,RBPJ;HIF3A;EPAS1;ARNT;STOX1;CREBBP;PSMB10;PSMA3;PSME4;PSMA5
prerank,cellular response to pH (GO:0071467),0.34775665930800004,0.8709515491380334,0.6358595194085028,0.9039331464436839,1.0,2/17,10.21%,INSRR;PKD1L3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2911769924366143,-0.8708377258155946,0.65,0.9220554408752816,1.0,5/23,7.34%,PAK1;MAP3K5;RPS3;DAB2IP;MAP3K11
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3019918757286274,-0.8706949964748203,0.6397379912663755,0.9215769390342994,1.0,10/22,30.64%,NOL11;DDX11;SMARCB1;PWP1;ATF4;HEATR1;RASL11A;LYAR;WDR75;PIH1D1
prerank,protein import into peroxisome membrane (GO:0045046),-0.30226137909403417,-0.870511014580334,0.6651270207852193,0.9212205640035673,1.0,10/22,27.46%,ATAD1;PEX26;GDAP1;ABCD2;PEX16;PEX19;PXMP4;RAB8B;PEX3;PEX11B
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2462458969914995,0.8704339286712799,0.6942028985507246,0.9044246324055251,1.0,22/100,15.97%,PRICKLE1;RNF217;ZYG11B;ARAF;RNF19A;FHIT;GSK3B;WAC;NUB1;PIAS1;LRRK2;SUMO1;TLK2;KEAP1;HECTD1;HFE;DDA1;TRIB1;RCHY1;DAB2;TAF9;RNF180
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.359960061879218,0.8702066314341738,0.6164383561643836,0.9043062784727781,1.0,3/14,15.47%,IL17D;IL18;IL23R
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.320377969669158,0.8701519192696519,0.6525573192239859,0.90382152860126,1.0,7/25,15.00%,QRICH2;EPHA4;SGTA;HFE;EFNA1;CSNK2A2;PML
prerank,negative regulation of binding (GO:0051100),0.2512161267801391,0.8701355142273357,0.7051851851851851,0.903266789800137,1.0,11/81,9.34%,SP100;CFHR2;ARHGAP28;IFIT2;DACT1;CPNE1;EFHB;GSK3B;BAX;LRRK2;SUMO1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.2300066714464295,-0.8699002928299322,0.7465181058495822,0.9218022426027686,1.0,13/69,17.57%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL
prerank,negative regulation of protein catabolic process (GO:0042177),0.28841996894027877,0.8698963400479176,0.6498371335504886,0.9031954070965468,1.0,8/40,11.49%,TIMP3;NELL1;PTPN3;SNX12;TIMP2;AZIN2;SF3B3;IRAK3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2891216163220754,0.8694125003215794,0.6747572815533981,0.9037122312911678,1.0,6/42,9.92%,POLH;WRN;PARP10;RFC1;REV1;RPA3
prerank,reverse cholesterol transport (GO:0043691),0.3685639819139759,0.8693981231542576,0.6153846153846154,0.9031586344821332,1.0,1/13,2.03%,APOA2
prerank,pre-replicative complex assembly (GO:0036388),-0.23523353205801897,-0.8692944312926797,0.7245179063360881,0.9223472148840498,1.0,18/64,21.19%,PSMC3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;ORC6;UBA52;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1
prerank,mononuclear cell differentiation (GO:1903131),0.31808744330021277,0.8690563175889706,0.662431941923775,0.9032798912470633,1.0,3/24,4.89%,AXL;IL31RA;PIR
prerank,histone methylation (GO:0016571),0.308804515665117,0.868586015555509,0.626970227670753,0.9036680869374223,1.0,10/26,26.95%,NSD3;CREBBP;NSD1;CARM1;SMYD3;PRMT1;EHMT2;SUV39H1;SETD6;SMYD2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3015966085372349,0.8683690408647637,0.6415770609318996,0.903536382462888,1.0,7/29,15.14%,COPZ2;GOLGA5;COPE;GOSR1;COG2;RAB33B;COPZ1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.33320906732484684,-0.868262931193401,0.6263498920086393,0.9239211585030007,1.0,1/15,0.19%,PRKCH
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.22634311474675153,0.8682105089626012,0.7590361445783133,0.9033031676583931,1.0,18/172,9.74%,PTPN13;PLEKHA2;PLD1;PLA2G4A;APOA2;AGPAT4;DGKD;PI4KA;CPNE1;MTMR3;PLEKHA4;PLA2G4C;PIK3C2A;ETNK2;STARD10;PIK3R5;ARF3;GPD1L
prerank,regulation of mRNA catabolic process (GO:0061013),0.23629277155348793,0.8681760726897708,0.7247191011235955,0.902793635676989,1.0,15/121,11.13%,TNPO1;ZC3HAV1;SAMD4A;VIM;RC3H1;PKP3;IGF2BP1;DCP2;PSMB10;MOV10;PSMA3;PSME4;PSMA5;IGF2BP2;XRN1
prerank,skeletal muscle tissue development (GO:0007519),0.30129873350354114,0.8680969552454568,0.6604414261460102,0.9023850527338004,1.0,7/32,12.36%,CSRP3;CFLAR;IGSF8;POPDC2;SKI;MSC;EGR2
prerank,cellular lipid catabolic process (GO:0044242),0.3141863467500278,0.8679944792880632,0.6388888888888888,0.9020277355997371,1.0,9/27,23.01%,APOA2;ENPP2;LPIN2;ACOX1;ANGPTL3;SIRT2;ACBD5;NUDT19;LPIN1
prerank,positive regulation of protein acetylation (GO:1901985),0.3635047856927442,0.8679649922125122,0.6196911196911197,0.9015137394912283,1.0,1/12,1.61%,PRKAA2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3384842318033112,0.8679470993712302,0.6101083032490975,0.9009672424742851,1.0,2/19,4.00%,AMPD3;TERT
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24245183473109455,0.8675014417297454,0.7322720694645442,0.901311789171296,1.0,15/117,10.90%,GHRH;ADORA2A;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;GPR39
prerank,COPII vesicle coating (GO:0048208),-0.2319293657148408,-0.86665908453778,0.7362637362637363,0.9251596602419906,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,vesicle coating (GO:0006901),-0.2319293657148408,-0.86665908453778,0.7362637362637363,0.9251596602419906,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2319293657148408,-0.86665908453778,0.7362637362637363,0.9251596602419906,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,stem cell development (GO:0048864),-0.32434787453840946,-0.8663508519541014,0.6322869955156951,0.9250435759396656,1.0,9/16,42.24%,CDH2;PTPRC;SOX11;KBTBD8;SOX8;CYP26C1;NOLC1;KLHL12;SNAI2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.22001920400608763,-0.866088268083742,0.7816455696202531,0.9248401280314316,1.0,30/98,23.39%,DPP10;PRKCH;PIK3R1;STX3;ANK3;MAPK8;CEMIP;YWHAH;AKT1;MTCL1;MFF;PPP1R13B;ITGA3;RHOG;KCNB1;EGFR;HRAS;STAC;STAC3;C2CD5;YWHAQ;ARF6;AKAP5;ITGB2;BAD;PRKCE;NKD2;CD81;YWHAZ;CNPY4
prerank,B cell differentiation (GO:0030183),-0.24964720066437496,-0.8660774879216421,0.7220779220779221,0.9240843925541318,1.0,11/46,16.85%,PTPRJ;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;DCAF1;PTPRC;CLCF1;RABL3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2556368853354976,0.8659272322260947,0.7117117117117117,0.9040534144017148,1.0,16/80,15.81%,PLPP3;COPZ2;ARFGAP3;KDELR3;ARF4;TAPBP;ERGIC1;ARF3;COPE;UVRAG;ARCN1;SCFD1;KLC1;TMED9;COPZ1;GBF1
prerank,mucosal immune response (GO:0002385),0.3472876926097862,0.8657325327261691,0.6098003629764065,0.903886627875711,1.0,3/15,10.66%,BPIFB1;NOS2;IFNLR1
prerank,regulation of water loss via skin (GO:0033561),-0.3303812868476606,-0.8650605130193075,0.6484210526315789,0.9246858181026669,1.0,6/15,24.09%,MET;LSR;HRNR;STMN1;UGCG;FA2H
prerank,establishment of skin barrier (GO:0061436),-0.3303812868476606,-0.8650605130193075,0.6484210526315789,0.9246858181026669,1.0,6/15,24.09%,MET;LSR;HRNR;STMN1;UGCG;FA2H
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.27685903632591485,-0.8650347628792768,0.6995798319327731,0.9239709913093485,1.0,5/30,6.60%,CSGALNACT1;CSPG4;HEXB;CHST9;NDNF
prerank,cellular response to leucine starvation (GO:1990253),-0.35884795924023527,-0.8645573295951315,0.6435643564356436,0.9242311526819196,1.0,2/10,9.32%,SESN3;RRAGB
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3821573999212137,0.8641952296996077,0.621832358674464,0.9064933062850794,1.0,7/11,26.52%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,regulation of intracellular protein transport (GO:0033157),-0.2710742094425638,-0.8640603087681015,0.7057416267942583,0.92451934377212,1.0,10/32,20.44%,PRR5L;OAZ1;BMP4;GCC2;OAZ2;PCNT;CEP290;LCP1;SIRT7;UHMK1
prerank,granulocyte chemotaxis (GO:0071621),0.2661392476817341,0.8635278286325444,0.6816074188562596,0.9073005576900477,1.0,5/55,7.71%,CXADR;CXCL10;ANXA1;CKLF;CCL2
prerank,mitotic cell cycle phase transition (GO:0044772),0.22139357082412395,0.8632367217664475,0.7722371967654986,0.9073295890405719,1.0,59/203,23.03%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CLASP1;LATS2;CCND3;OPTN;CUL4A;CEP152;HAUS8;FBXL3;CDKN2B;CRLF3;ANAPC1;CCNH;UBE2C;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;CUL3;BTRC;MASTL;FBXW11;CDC27;KDM8;ACTR1A;CEP250;CHMP4B;FBXL12;CDKN3;YWHAE;PPP2R2A;CCNY;CEP131;NASP;CCNG2;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1;USP26;CUL2;FBXL6;SPAST;PHF8;WEE1;UBE2S
prerank,muscle tissue development (GO:0060537),0.3614091834944077,0.863029551266753,0.64376130198915,0.9071841851366171,1.0,2/13,5.48%,CSRP3;CSRP1
prerank,protein deacylation (GO:0035601),-0.28719839568192007,-0.8628456817175365,0.6635730858468677,0.9264195712881984,1.0,6/23,18.56%,HDAC7;HDAC6;SIRT5;HDAC1;ABHD17A;SIRT7
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.281531280142187,0.862574921643221,0.6748681898066784,0.9075748994978894,1.0,7/41,14.89%,TLR4;C5AR2;PTPN22;LGALS9;PTPN6;IRAK3;RARA
prerank,monocyte differentiation (GO:0030224),0.38062459806338356,0.8623710066273608,0.6215686274509804,0.9074127289900098,1.0,2/10,4.89%,IL31RA;PIR
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3429849346872671,-0.8622738788454885,0.6381156316916489,0.9268923194757197,1.0,2/12,2.18%,CTNNA3;RYR2
prerank,sensory perception of taste (GO:0050909),0.3881496359527995,0.8622584196130811,0.624,0.9070735910675196,1.0,10/10,61.21%,PKD1L3;CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;ASIC1;PKD2L1;TAS1R1;ASIC3
prerank,regulation of translation (GO:0006417),0.22668587820332328,0.8619948817052953,0.7771812080536913,0.907054836865397,1.0,38/173,19.46%,PLD1;SAMD4A;EIF2AK2;IGFBP5;SHMT1;VIM;DAPK1;PKP3;IL6;IGF2BP1;NANOS2;IGF2BP2;CTIF;TRAP1;FOXO3;ZCCHC4;EIF4ENIF1;ILF3;RPS6KA3;DDX6;GEMIN5;MAPKAPK5;GIGYF2;EIF2AK3;ALKBH1;SOX4;APP;CNOT9;CPEB3;UPF3A;OGFOD1;FXR2;SHFL;PLXNB2;DHX36;EIF4H;NANOS1;ERBB2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.30782595701081567,-0.8615997818942778,0.6743215031315241,0.9276198210317917,1.0,2/19,2.90%,CYTH3;CYTH1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.31355729796765025,0.8615534573481427,0.6637478108581436,0.9073757236556634,1.0,6/26,11.56%,STK39;NEDD4;ACTN2;DLG1;WWP2;ATP1B2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3716371011480162,-0.8615456577580267,0.6511156186612576,0.926967161612855,1.0,4/10,18.37%,GALNT13;GALNT3;GALNT4;POGLUT3
prerank,protein deubiquitination (GO:0016579),-0.19019217028048727,-0.8614062976265696,0.9156118143459916,0.9264994102916654,1.0,72/242,25.03%,USP29;IL33;SMAD7;ACTB;ESR1;PSMC3;OTUD7A;SNX3;USP31;NFRKB;CLSPN;RAD23A;PSMD14;UBB;MBD5;PSMD3;YY1;BABAM1;EIF3F;USP13;PSMD4;SMAD1;ZRANB1;PSMD6;BARD1;ADRB2;PSMA6;PSMA4;PSMB8;USP3;FOXO4;TFPT;USP46;USP37;UBA52;PSMA8;TAF9B;VCPIP1;OTUD1;MINDY2;CYLD;COPS5;YOD1;USP38;SUDS3;BRCA1;UBE2D1;PSME1;TOMM20;KAT2A;PSMD7;PSMC6;ASXL1;MINDY1;USP42;PSMB5;USP2;PSMC5;PSMB1;POLB;ATXN3;OTUB2;SHMT2;USP22;KDM1B;PSMD11;DDB2;MCRS1;PSMD8;USP11;RAD23B;JOSD2
prerank,establishment of vesicle localization (GO:0051650),-0.31222570867455995,-0.8609657506179303,0.678714859437751,0.9266452371285557,1.0,9/18,26.35%,LIMK2;RAB27A;KIF5C;KIF5A;SNAPIN;TESK1;CDK5;SYNJ1;F8A1
prerank,spliceosomal complex assembly (GO:0000245),0.2741918915069111,0.8608462057512005,0.7062600321027287,0.9082540128018596,1.0,10/46,18.43%,CELF2;ZRSR2;DDX23;RBM5;SRPK1;PRPF19;SRSF5;TXNL4A;SCAF11;USP39
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.31037125350341604,0.8606205085932791,0.6505016722408027,0.9081657159305,1.0,5/28,8.36%,ITPR1;BCL2;CASP4;QRICH1;BAX
prerank,response to UV (GO:0009411),-0.213199308765883,-0.8594946293767639,0.7837837837837838,0.929083909390222,1.0,26/95,23.75%,PTPRK;RPL26;MAPK8;AKT1;NPM1;MAP4K3;YY1;CCND1;CCAR2;EGFR;ATF4;USF1;COPS9;CASP9;BMF;MEN1;MFAP4;BCL3;N4BP1;NOC2L;POLD1;ATR;DCUN1D3;DTL;POLK;DDB2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3539216964756009,0.8594179270990536,0.6521739130434783,0.9100611626096101,1.0,3/13,6.49%,PID1;PPARA;NOS2
prerank,positive regulation of cell cycle (GO:0045787),-0.23293681198237154,-0.8593752010231072,0.7131147540983607,0.9285770077815515,1.0,15/62,18.55%,MEIS2;TGFB2;RPS15A;LGMN;AKT1;RAD23A;CCND1;LRP6;CALR;TAL1;EGFR;RGCC;CDK4;ASNS;CHEK1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3078815559628585,0.8593614056773774,0.6363636363636364,0.9095928217475227,1.0,1/25,0.36%,LEPROT
prerank,rRNA 3'-end processing (GO:0031125),-0.3619379264641241,-0.8591564550471675,0.6600397614314115,0.9282909719799678,1.0,3/10,17.35%,RPS21;EXOSC2;ERI1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.33388053946063884,-0.8584821473395257,0.6607538802660754,0.9289506457421992,1.0,5/15,13.74%,SIX1;BMP4;VEGFA;PAX2;SIX4
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3152451377845292,0.8581156036474156,0.6313799621928167,0.9115938913120676,1.0,3/22,12.74%,ROCK2;EPHA4;EFNA1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.28331692035198897,-0.8579155787682609,0.6604215456674473,0.9293630705878366,1.0,3/27,5.90%,GPCPD1;GDPD1;ENPP6
prerank,negative regulation of hydrolase activity (GO:0051346),-0.24340770796000893,-0.8577827339295482,0.728494623655914,0.9288678643703255,1.0,11/49,13.61%,CST3;LRCH1;CPEB2;DAB2IP;RCC2;SLC39A14;CAMK2A;TMED2;NOS1;F11R;HRAS
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2757962534184993,0.8576062733343667,0.6891025641025641,0.9120381007297576,1.0,11/49,16.19%,NUPR1;GSDME;BCL2;MCL1;BAX;DNM1L;BCL2L1;NDUFS3;DAPK2;EIF2AK3;URI1
prerank,spindle assembly (GO:0051225),0.2585312406872977,0.8570854111643441,0.7004341534008683,0.9125095637641617,1.0,22/67,23.81%,MAP9;STAG1;CLASP1;HAUS8;GOLGA8B;MISP;TUBGCP4;TUBGCP2;TUBGCP5;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;MAPRE3;CEP63;OFD1;INO80;CHEK2;STAG2;MAPRE2;NEK6
prerank,regulation of protein localization (GO:0032880),0.26881189098425945,0.8570074571354639,0.6898638426626323,0.9120841006992852,1.0,11/58,12.35%,AFDN;TRIM17;AAK1;TPR;TRIM5;DLG1;USP8;SUMO1;ATCAY;TRIM21;DVL3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2730598809891347,0.8568133599309323,0.6786885245901639,0.9118993213736465,1.0,7/45,10.22%,IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.33676201099398134,-0.855944351796682,0.6645833333333333,0.9320358145885821,1.0,3/13,11.77%,RPS15;NPM1;XPO1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.3572594594144597,-0.8559308453052747,0.6734279918864098,0.9312868517722616,1.0,1/11,0.95%,AGBL4
prerank,Golgi to plasma membrane transport (GO:0006893),0.276863603956268,0.8555242882056723,0.6892561983471074,0.9139240828937849,1.0,7/47,7.15%,SPTBN1;VAMP5;RAB10;ARL3;OPTN;EXOC2;VPS35L
prerank,leukocyte tethering or rolling (GO:0050901),0.34081700234083334,0.8550998737559815,0.6505576208178439,0.914203881248066,1.0,2/17,6.20%,SELP;VCAM1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.33927348626083526,0.8550031343383012,0.6407079646017699,0.9138147772400717,1.0,8/16,27.24%,KLHL15;FBH1;SHLD2;RIF1;SMCHD1;SHLD1;FANCB;CGAS
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3342128421071927,0.8549676548510685,0.6261682242990654,0.913307932604527,1.0,8/18,24.03%,TERT;IL6;MAP2K1;DDX5;RIPK1;ZC3H12A;TGFB1;ZC3H10
prerank,protein localization to organelle (GO:0033365),-0.20163964948516197,-0.8547351922368688,0.8350515463917526,0.9331092617843193,1.0,40/133,22.17%,CSNK1D;SCG3;SIX1;SORL1;RPL11;YBX1;CEP68;BMP4;PAQR3;ARL1;CNTLN;GCC2;RAB35;CALR;HHEX;TUB;SERP1;DVL1;TRAM1;ATP6V1D;SIX4;DCP1A;TMEM30A;LAMP5;CCDC47;TOR1B;CTDNEP1;LAMP1;WDR83OS;BBS2;BBS1;TOLLIP;ARF6;SEC61G;MSX1;MTCH2;UBAC2;CYB5A;PPP1R15A;CD68
prerank,positive regulation of chemokine production (GO:0032722),0.2773828707098947,0.8546236754252076,0.6617405582922824,0.9134454332904679,1.0,7/44,11.12%,EIF2AK2;IL6;TLR4;IL18;LGALS9;WNT5A;TLR2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.30669490959592227,0.8544679651170793,0.6538461538461539,0.9132026838940149,1.0,6/29,14.55%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,snRNA metabolic process (GO:0016073),-0.3194827123406552,-0.8540144165094752,0.6790393013100436,0.933878306247136,1.0,9/17,31.31%,INTS7;INTS10;INTS12;ZCCHC8;INTS11;INTS1;INTS5;INTS2;RBM7
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.26400038550023835,0.8539339610603163,0.6788990825688074,0.9137100817989675,1.0,9/55,10.73%,NUPR1;WWOX;GSDME;BCL2;TGFBR1;TNFRSF12A;BAX;DNM1L;BCL2L1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.3308899196079811,-0.8539288504097852,0.6789366053169734,0.9333048757021737,1.0,2/14,5.50%,SLC24A2;SLC8A1
prerank,neurogenesis (GO:0022008),0.27443627457058484,0.8538611550749395,0.6878980891719745,0.9132948702690553,1.0,5/43,7.99%,LPAR1;TRAK1;ANXA1;CLN5;DCHS1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.32529940328769236,-0.8538045702201839,0.669683257918552,0.9328241660358289,1.0,5/14,21.65%,PTBP1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.29498219519254615,-0.8535813326051016,0.6750572082379863,0.9325166109134174,1.0,11/23,36.75%,SEL1L;LMAN1;TECPR2;PREB;RANGRF;SEC61B;HERPUD1;UFD1;SEC13;AUP1;DERL1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.32532454865273835,-0.8535178475676872,0.698237885462555,0.9318948119889742,1.0,6/15,15.36%,NTRK2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2598341398220273,-0.8533533544758436,0.7298578199052133,0.9314579824985703,1.0,11/37,16.48%,SMAD7;CALM1;CALM2;CEMIP;INPP5K;CALM3;SPRED2;DDIT4;IRGM;EGF;SPRED3
prerank,ear morphogenesis (GO:0042471),0.3296354231382177,0.8532891486645346,0.6474820143884892,0.9138353347161493,1.0,4/20,12.69%,OSR1;ZIC1;TIFAB;NOG
prerank,protein import (GO:0017038),0.2465772127390775,0.8532621388054593,0.7002923976608187,0.9133224111231656,1.0,13/84,14.16%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;PXMP2;APPL1;IPO7;EIF4ENIF1;ABCD3;PEX2;POM121
prerank,protein insertion into membrane (GO:0051205),-0.2663369960667232,-0.8531758055571844,0.7047146401985112,0.9310608317795682,1.0,14/32,28.16%,REEP1;SERP1;TRAM1;EGFR;CCDC47;MAIP1;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;GET1;SEC61B;VAMP2
prerank,glycoprotein catabolic process (GO:0006516),0.3360213218383719,0.8531451930123025,0.6672727272727272,0.9130007996650908,1.0,2/17,8.25%,ADAMTS12;MANBA
prerank,negative regulation of lyase activity (GO:0051350),-0.3193094471198121,-0.8530938137510683,0.6587473002159827,0.9304696850626202,1.0,2/16,3.31%,GRM3;GABBR2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.32307733437385994,-0.8530728827053614,0.6452328159645233,0.9297560498059053,1.0,4/16,17.04%,CEACAM1;ERLIN1;ACADVL;BRCA1
prerank,regulation of synapse organization (GO:0050807),-0.2788669059342845,-0.8528100674286512,0.6810933940774487,0.929565736429301,1.0,3/26,3.96%,CTNNA2;MEF2C;IL1RAPL1
prerank,mitochondrial gene expression (GO:0140053),-0.25094616591280927,-0.8527191009209976,0.7182044887780549,0.9289882392664105,1.0,14/42,24.76%,LARS2;MRPS18A;FASTKD2;TWNK;MRPL57;RARS2;MRPL47;HARS1;MRPS2;TFB2M;MRPL23;MRPS12;POLRMT;MRPS16
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.37657507760430414,0.8525418148801133,0.6278118609406953,0.9136470413576122,1.0,3/10,13.97%,TLR4;MIA3;TICAM1
prerank,respiratory electron transport chain (GO:0022904),-0.3288914176637199,-0.8524422434543758,0.6708074534161491,0.9287971778707919,1.0,3/14,21.32%,GPD2;SLC25A13;SLC25A12
prerank,macrophage differentiation (GO:0030225),0.3592203633396862,0.8524210211610402,0.6530973451327433,0.9133219556353982,1.0,2/13,12.04%,IL31RA;CSF1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.31745166890392873,-0.8522084524338425,0.6876456876456877,0.928559229804804,1.0,5/16,16.46%,HS3ST5;TRIM68;TRIM62;CAV1;FUCA2
prerank,nuclear pore complex assembly (GO:0051292),0.3826095468180678,0.8521701615945203,0.6578411405295316,0.9132677503237783,1.0,3/10,13.84%,TPR;AHCTF1;RTN4
prerank,regulation of interleukin-12 production (GO:0032655),0.26917918299271415,0.8520717348340413,0.7091222030981067,0.9128907157285495,1.0,8/47,11.49%,IL16;TLR4;CD47;LGALS9;RIPK2;MAPK14;TLR2;IRAK3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.3811204164412321,0.8519448953480699,0.6363636363636364,0.9125746580690827,1.0,3/10,11.69%,RC3H1;FOXP3;NFKBIZ
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.34787998315261187,0.8518921133789443,0.62756052141527,0.9121105751760359,1.0,4/15,16.03%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.335740153086516,0.8517259984418101,0.6672862453531598,0.9118832974627435,1.0,2/16,6.37%,PID1;PPARA
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36277764036072874,0.8514754423486708,0.6672760511882998,0.9118142988338053,1.0,4/13,19.24%,VDAC2;BAX;RHOT1;RHOT2
prerank,bicellular tight junction assembly (GO:0070830),0.2696311061227562,0.8513047996076981,0.695024077046549,0.9115996823136482,1.0,6/46,8.89%,AFDN;CDH5;PARD6G;PARD6A;CLDN1;DLG1
prerank,sphingosine metabolic process (GO:0006670),-0.30892485958322347,-0.851032807130427,0.6666666666666666,0.9302906141076915,1.0,2/17,2.19%,ACER3;ACER2
prerank,establishment of protein localization to membrane (GO:0090150),0.2570347885134844,0.8506971110556372,0.7070552147239264,0.9122443899963202,1.0,13/66,14.72%,SYNE3;AFDN;RAB10;ZDHHC3;NPC1;CHM;MICALL1;COX18;GRIN3B;RAB3IP;GORASP2;MYO1C;SEC63
prerank,mitochondrial translational termination (GO:0070126),-0.214835160416969,-0.8505532282402042,0.7875,0.930565127825397,1.0,37/88,35.83%,MRPL4;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MRPL45;MRPL30
prerank,negative regulation of DNA recombination (GO:0045910),0.2747871099479364,0.8503808956366298,0.698019801980198,0.9123305598589061,1.0,18/43,27.24%,POLR2D;PARP3;KLHL15;FBH1;POLR2C;POLR2F;SHLD2;RIF1;POLR2K;RTEL1;MSH2;SMCHD1;ZRANB3;ATRX;SHLD1;POLR2H;FANCB;CGAS
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23912686156174634,0.8503490323254719,0.7337278106508875,0.9118294186849889,1.0,24/94,20.83%,NINL;DYNLL1;ALMS1;SDCCAG8;CLASP1;CEP152;NPHP1;HAUS8;C2CD3;CC2D2A;NEDD1;RPGRIP1L;RAB3IP;IQCB1;FBF1;ACTR1A;CEP250;TTBK2;YWHAE;CEP131;CEP63;CEP78;B9D2;OFD1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3471095831515485,-0.8503283617235333,0.6694915254237288,0.9302758741015652,1.0,1/12,0.98%,TMEFF2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.35367018721054255,0.8493687928377691,0.6347305389221557,0.913262123000049,1.0,6/12,24.03%,TERT;POU5F1;ELAVL1;ZC3H12A;TGFB1;ZC3H10
prerank,protein glycosylation (GO:0006486),0.23297770194317677,0.8492731089460422,0.774468085106383,0.9128995915354811,1.0,22/125,13.88%,MAN1C1;GALNT18;GALNTL5;TRAK1;LARGE1;GALNT2;ALG9;MGAT3;NPC1;GALNT1;POMT2;B4GALT1;GCNT4;FUT4;C1GALT1C1;FUT10;TMEM165;ALG11;TET2;TUSC3;MGAT4C;ALG1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3842550554090681,0.8492167975859299,0.6615678776290631,0.9124421541264991,1.0,3/10,13.95%,CRY1;RFWD3;THOC5
prerank,proteasomal protein catabolic process (GO:0010498),0.21831434499787677,0.849088795073084,0.7973684210526316,0.9121315694242145,1.0,51/201,22.39%,SPSB1;TBL1XR1;SMURF2;FBXL17;NEDD4;NHLRC3;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;PSMB10;PSMA3;PSME4;PSMA5;WWP2;ERLEC1;UBXN2A;HUWE1;SPOPL;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;PRPF19;BFAR;KCTD5;PML;SOCS6;RNF185;TBL1X;UBE4B;PPP2R5C;TRIM3;PCBP2;CLOCK;PSMC2;ERCC8;RNF139;UBE2K;SIRT2;RCN3;UBXN1;PELI1;RMND5B;FBXW7;PSMD1;RMND5A
prerank,regulation of response to oxidative stress (GO:1902882),-0.3578754960463628,-0.8490524148375067,0.655241935483871,0.9322427369592784,1.0,7/11,29.93%,MCTP1;PINK1;SELENON;GGT7;AIFM2;ACOX2;ALOX5
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28730412860755183,-0.8488000940467614,0.7028985507246377,0.9319777711658963,1.0,8/23,22.71%,OTUD7A;USP37;VCPIP1;MINDY2;YOD1;MINDY1;ATXN3;OTUB2
prerank,spermatid development (GO:0007286),0.2886723744294984,0.8484218427392698,0.6579378068739771,0.9129114533033714,1.0,2/32,3.09%,GALNTL5;ZMYND15
prerank,nitrogen compound transport (GO:0071705),0.22968303595211834,0.8480805166324983,0.7450424929178471,0.913010172368541,1.0,7/141,4.73%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC6A12;SLC7A14;MIA3
prerank,regulation of telomere capping (GO:1904353),-0.2849085867243668,-0.8474998306614867,0.6919642857142857,0.9339266326096599,1.0,6/23,16.15%,PRKCQ;NEK7;MAPK3;ATM;PNKP;PKIB
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3191569321723426,-0.8471300316584642,0.6680942184154176,0.9339481785187888,1.0,5/16,14.75%,ASXL3;EMILIN1;CEACAM1;ABCD2;PARK7
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3798187904485991,0.8470401543048358,0.6550308008213552,0.9144761962546573,1.0,2/10,11.41%,APPL2;ANO6
prerank,keratan sulfate metabolic process (GO:0042339),-0.2642236760171016,-0.8466014750413411,0.7114427860696517,0.9342552305265281,1.0,13/31,29.51%,ST3GAL6;HEXB;B3GNT2;B4GALT4;ST3GAL4;LUM;B3GNT3;B4GALT6;CHST5;B4GALT2;B4GAT1;GALNS;ST3GAL2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3078797016893528,0.8465060223630473,0.6666666666666666,0.9149237939299978,1.0,5/26,9.79%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,regulation of cell death (GO:0010941),-0.21386386422208473,-0.8463151390652636,0.8012618296529969,0.9341258717325036,1.0,23/94,21.65%,ACER3;PDE8A;ACER2;DCC;SNCA;CCN3;EPHB1;CCN5;BMP4;TNFRSF1B;UBB;FGF2;NPAS2;PARK7;PRKD1;HTR2B;PACRG;BNIP3L;SRGAP2;CHRNA7;PRR7;SNCG;SRSF6
prerank,protein targeting to lysosome (GO:0006622),-0.295968736434184,-0.8460767273854112,0.6597701149425287,0.9338370453155657,1.0,5/20,11.75%,HSPA8;SORL1;GCC2;M6PR;SCARB2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.35838552988673555,0.8459681469492922,0.6459510357815442,0.9154392147621937,1.0,3/13,9.00%,SORBS1;EPM2AIP1;IGF2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.21517896614989596,-0.8458533077742602,0.7950310559006211,0.9335578752612544,1.0,28/86,25.13%,KLF2;PSMC3;PSMD14;UBB;PSMD3;ELOB;VEGFA;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;ATF4;UBA52;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;HIGD1A;PSMB1;HIF1AN;PSMD11;EPO;PSMD8;HMOX1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3834085242247119,0.8457972567630202,0.6532258064516129,0.9152150105583815,1.0,1/10,1.62%,MLLT3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.2959721133881279,-0.8454122285750852,0.702355460385439,0.9336831294468658,1.0,6/21,23.30%,NOS1AP;CACNA1D;KCNQ1;KCNE4;GJA5;SCN1B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.2988105431176925,0.8452591839743238,0.6745362563237775,0.9156885171882866,1.0,5/30,10.49%,MLLT3;FSTL3;KIT;SBDS;PLEK
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3522315606434606,-0.845231870597756,0.6530172413793104,0.9332694305547612,1.0,3/11,19.83%,TERF1;CCT5;WRAP53
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.34350364222592156,-0.8451874225219809,0.6860706860706861,0.9326122414700972,1.0,2/12,13.08%,ACSL3;MFSD2A
prerank,negative regulation of viral transcription (GO:0032897),-0.33469201879574706,-0.8447822492399558,0.665938864628821,0.932663018631179,1.0,3/13,13.64%,MID2;TRIM62;IFITM3
prerank,positive regulation of secretion by cell (GO:1903532),-0.22403871194982905,-0.8444536466147574,0.749271137026239,0.9325889196669652,1.0,18/70,18.92%,SLC12A2;TGFB2;RAB27A;CADPS;FRMD4A;SNCA;RAB27B;TGFB3;KCNB1;RGCC;CLASP2;PPIA;MYOM1;MYO18A;EXPH5;ADAM8;ARF6;SYTL4
prerank,heterocycle biosynthetic process (GO:0018130),-0.3271926493471745,-0.8441902529487398,0.6714876033057852,0.9323786083780566,1.0,7/14,33.05%,GPHN;GCH1;PYCR2;PYCR1;ALOX5;LIAS;MOCS2
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.29285032911716086,-0.8440307905210077,0.6807095343680709,0.9319634721704618,1.0,3/22,4.35%,SLC7A5;RFTN1;PRKCQ
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.29979926305412363,0.8437846906039631,0.6620689655172414,0.917536784005894,1.0,4/29,11.27%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.29979926305412363,0.8437846906039631,0.6620689655172414,0.917536784005894,1.0,4/29,11.27%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,regulation of DNA metabolic process (GO:0051052),0.274610051402571,0.8434305264608376,0.6968698517298187,0.9176707679546573,1.0,12/44,21.26%,POLH;NUCKS1;STOX1;MPV17;UBE2V1;SMG5;SMG6;SMG1;IL7R;MPHOSPH8;WDR70;TOM1L1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.28003238631210514,0.8433892137035276,0.6782006920415224,0.9171926730601984,1.0,6/36,8.89%,DUSP10;DACT1;TAOK3;PTPN22;ZMYND11;DLG1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.32823365740942634,-0.8433242842131288,0.6638115631691649,0.9326462025261419,1.0,9/14,32.11%,PLCG2;SEMA7A;CD74;NR4A3;CAMK4;LILRB1;LAPTM5;GPRC5B;BCL10
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.33179105001273357,0.8427907170638127,0.6527050610820244,0.9177767705508442,1.0,5/18,13.62%,FRS2;BMP2;HDAC4;BHLHE41;BDNF
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.31884552387885734,0.8427377580776653,0.6914285714285714,0.9173100377894332,1.0,6/21,15.73%,ADCY5;ADCY7;ADCY1;NPPC;GUCY2C;ADCY6
prerank,DNA duplex unwinding (GO:0032508),0.2634210238812548,0.84214959381831,0.7184466019417476,0.917902370031255,1.0,9/50,14.03%,ANXA1;WRN;ASCC3;RAD50;CUL4A;MCM4;SUPV3L1;MCM6;GTF2H4
prerank,stem cell differentiation (GO:0048863),0.27646761562478633,0.8419735122743596,0.7109634551495017,0.9176748848535095,1.0,6/39,9.97%,MLLT3;OSR1;FBXL17;KIT;JARID2;SOX21
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3046001230170524,-0.841603388125131,0.6651884700665188,0.935339684035446,1.0,3/17,7.57%,PTPRJ;DGKZ;CEACAM1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3363259668508287,0.8414526964633505,0.6506986027944112,0.9181280303111634,1.0,14/14,66.40%,MYO9A;PATJ;FSCN1;RAP2A;SH3BP1;SCRIB;CAMSAP3;RHOA;OPHN1;CDC42;EZR;SYNE4;FOXJ1;MSN
prerank,regulation of microtubule nucleation (GO:0010968),-0.3569608114026115,-0.8412476640577241,0.6694736842105263,0.9352960489170863,1.0,4/10,27.41%,PAK1;ARHGEF7;DCTN1;RANGRF
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.32108391596249675,0.8410698745370431,0.6721311475409836,0.9183043210116356,1.0,6/19,18.89%,ENPP1;TPST1;SULT1A1;ABHD14B;SULT6B1;PAPSS1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3286804406134278,0.8409128599949729,0.6622390891840607,0.9180421919936904,1.0,5/18,11.87%,CAMK1D;ADCY1;OPRD1;CRTC1;CRTC3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2634235550143012,-0.8402909562071051,0.7232558139534884,0.936450535123105,1.0,12/31,27.37%,DIS3L2;EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EXOSC1;EDC3;LSM2;POLR2G;LSM3
prerank,regulation of cell cycle phase transition (GO:1901987),-0.21159187220638623,-0.8400305790187881,0.7964071856287425,0.9362315207019496,1.0,26/91,24.51%,PSMC3;CDC26;PSMD14;PSMD3;TFAP4;PSMD4;PSMD6;PSMA6;UBE2E1;PSMA4;PSMB8;NEK10;PSMA8;CDKN1A;BUB1B;UBE2D1;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;TCIM;PSMD8
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2833100752110443,-0.8397717875100311,0.715311004784689,0.936002937724351,1.0,11/23,41.51%,CALM1;PDE6A;SAG;NMT2;PDE6G;GUCA1B;PDE6B;GUCY2D;GUCY2F;FNTA;GRK4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.30513771248436206,0.8396412274122944,0.6795096322241682,0.9199628566052432,1.0,3/26,6.02%,PRKAG2;PRKAA2;NR1H3
prerank,microtubule nucleation (GO:0007020),0.3277984172341393,0.8393197610338484,0.6678635547576302,0.9200387727963795,1.0,7/19,16.24%,CLASP1;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,DNA catabolic process (GO:0006308),0.37204535203175076,0.8390220650243481,0.6723809523809524,0.9200516826100029,1.0,3/11,19.29%,FBH1;DNASE1L1;DFFB
prerank,icosanoid secretion (GO:0032309),0.36096816414149485,0.8382063191203096,0.6500956022944551,0.9210490153282495,1.0,3/12,7.04%,ANXA1;NOS2;BDKRB2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.35260762106189847,0.8381818197563463,0.669921875,0.9205286788044834,1.0,2/15,8.09%,SMPD3;PLA2G6
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2988063923074704,0.8377073080088687,0.6845753899480069,0.9208851576899091,1.0,6/30,14.55%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,glycolipid biosynthetic process (GO:0009247),-0.24645181628572213,-0.8373402375642005,0.7383863080684596,0.9400358824213706,1.0,13/38,22.26%,ST8SIA6;MPPE1;ST6GALNAC5;PIGM;PIGU;PIGQ;PIGH;DPM2;ST3GAL4;PIGO;ST8SIA5;B4GALT6;PIGB
prerank,innate immune response in mucosa (GO:0002227),0.378638074996362,0.837256517976567,0.6539196940726577,0.9211479580235177,1.0,2/10,6.49%,BPIFB1;NOS2
prerank,regulation of presynapse assembly (GO:1905606),0.32970156551308516,0.8368981546551387,0.6702898550724637,0.9206989242909567,1.0,2/18,2.09%,GPC6;WNT3A
prerank,regulation of presynapse organization (GO:0099174),0.32970156551308516,0.8368981546551387,0.6702898550724637,0.9206989242909567,1.0,2/18,2.09%,GPC6;WNT3A
prerank,lipoprotein localization (GO:0044872),0.3606023770937863,0.8363417401337759,0.6883629191321499,0.9211844904791817,1.0,5/11,20.27%,MIA3;ZDHHC3;ZDHHC17;LRP1;CD36
prerank,renal water homeostasis (GO:0003091),0.3038209775432162,0.8362505757764289,0.6857142857142857,0.9208084797765707,1.0,7/23,21.44%,ADCY5;ADCY7;ADCY1;ADCY6;MYO5B;RAB11FIP2;PRKAR1B
prerank,regulation of exosomal secretion (GO:1903541),0.31704674995171267,0.8355684197970017,0.6666666666666666,0.9215305496371087,1.0,1/19,1.31%,SMPD3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.20887269780431938,0.8349247036825557,0.8615196078431373,0.9222088618141014,1.0,72/259,22.55%,DCDC2;PARVA;CYS1;ASAP1;DYNLL1;FGD4;NRP1;ARL13B;KIT;RFX3;IFT88;NTN1;ARL3;VCL;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;ACTN2;DYNC2I1;DNAAF1;PMP22;MTSS1;RAP2C;NUDCD3;IFT81;CC2D2A;CDH13;ANO6;CDC14A;CCDC57;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;CEP250;CPLANE1;GBF1;AVIL;TTBK2;RAP2B;EXOC7;EXOC1;RPGR;IFT52;ARL6;WDR11;DMTN;CEP131;ARFIP2;SSX2IP;B9D2;PIP5K1A;OFD1;RP2;ACTR3;DZIP1L;FGD1;PKD1;LZTFL1;CFAP410;FSCN1;CYFIP1;RAP2A;RHOD
prerank,cortical cytoskeleton organization (GO:0030865),0.272443563595622,0.8348191016801554,0.7081967213114754,0.9218555303297269,1.0,9/41,13.26%,ROCK2;RHOBTB2;RHOF;RHOQ;FMNL2;DLG1;PLEK;RHOC;LLGL2
prerank,negative regulation by host of viral process (GO:0044793),0.36988150248570406,0.8341945639476755,0.6566265060240963,0.9225256814345694,1.0,2/10,7.87%,CRP;VAPA
prerank,regulation of secretion (GO:0051046),-0.3301351825660362,-0.8340905749008068,0.6990740740740741,0.9457757092869151,1.0,7/13,32.56%,ACSL3;KCNQ1;EGF;SGK1;POFUT2;FGF10;SCIN
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.2929947735313475,0.8340866177764115,0.6886120996441281,0.9221422708372018,1.0,4/28,8.24%,PTN;ADCY1;GSK3B;EPHA4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3066004661962447,-0.8339818449120299,0.7044967880085653,0.9452316275803088,1.0,6/15,22.27%,REEP1;ARL6IP1;ZFYVE27;ATL2;RTN3;RAB18
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3357105348106622,0.8337918534550243,0.6897196261682244,0.9221531979830605,1.0,1/17,0.72%,AKAP13
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.3335637605852537,-0.8332890220399036,0.6997885835095138,0.9458452933781638,1.0,1/12,1.77%,IL1R1
prerank,proteolysis (GO:0006508),0.21075446050431268,0.8332594749725695,0.8582474226804123,0.9226224589646588,1.0,37/252,14.02%,DPP4;ADAMTS12;CPQ;ADGRV1;PRSS57;ANPEP;BMP1;AEBP1;CASP4;CPNE1;MMP14;DPP8;NPEPPS;LACTB;CTSH;SPPL3;PLAU;CPB2;ERAP1;SUFU;CTSW;CAPN15;NLN;ADAM19;SENP6;ENDOU;CLPX;DPP7;CELA1;PLAT;SENP1;FBXO3;SRGN;RNPEP;ADAMTS7;CPXM2;LNPEP
prerank,cellular response to amino acid starvation (GO:0034198),-0.2160534289420601,-0.8332149585471013,0.830028328611898,0.945239451517149,1.0,25/71,27.31%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;FAS;RRAGB;ATP6V1D;ATF4;CDKN1A;PRKD1;RRAGC;ATP6V1G2;ATP6V0E2;LAMTOR2;ATP6V1F;MLST8;ATP6V0D2;DEPDC5;SH3GLB1;MIOS;LAMTOR4;ITFG2
prerank,cellular response to heat (GO:0034605),0.2801924619222745,0.8331886512942023,0.7065026362038664,0.922210020317622,1.0,5/35,9.34%,FGF1;POLR2D;TPR;SLU7;SUMO1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.37985129558393427,0.8330187440931331,0.654296875,0.9219664923144179,1.0,2/10,14.33%,TERT;TARBP2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.273846028884594,0.8329467058103225,0.6945812807881774,0.9215478400879076,1.0,4/41,7.19%,PRKAG2;RANBP2;TPR;JMJD8
prerank,positive regulation of T cell differentiation (GO:0045582),0.27956561908266764,0.832597033042508,0.714759535655058,0.921666296079526,1.0,3/36,3.59%,ZMIZ1;GLI3;DUSP10
prerank,negative regulation of cell activation (GO:0050866),0.350210418994217,0.8323567681329862,0.6608187134502924,0.9215898682658228,1.0,1/14,1.10%,PDGFRA
prerank,DNA repair (GO:0006281),0.20875420630969443,0.8319997937690337,0.8516209476309227,0.9217211696731484,1.0,69/284,21.52%,EYA1;PDS5B;PARP9;POLH;NUCKS1;WRN;APBB1;SLX4;ASCC3;UBE2U;RAD50;PARP3;DTX3L;FTO;FBH1;BAZ1B;XRCC4;MNAT1;PSME4;USP47;SUMO1;NABP1;UVRAG;RPA3;XRCC1;FANCM;HUWE1;DCLRE1A;CENPX;UBE2V1;RFWD3;ADPRS;RBBP8;FANCE;OGG1;RAD51B;INTS3;GTF2H4;ERCC5;ERCC6;RAD9A;PDS5A;UIMC1;ALKBH1;ERCC1;USP45;MGMT;KMT5C;SMARCAL1;GTF2H2;FANCC;PARP4;WDR33;XPC;ACTR8;TDP2;BRCC3;DNA2;SETD2;NSMCE3;NABP2;ERCC8;KMT5B;POLD3;UBXN1;EYA3;INO80;CHEK2;NSMCE1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.3604453458131797,0.8315939974017321,0.689108910891089,0.9219717345478289,1.0,2/12,4.44%,TERT;IL6
prerank,lipid biosynthetic process (GO:0008610),0.24579999241054787,0.8315503307670231,0.7563527653213752,0.9214905337665626,1.0,11/77,16.00%,PRKAA2;AGPAT4;HSD17B1;PAM;ACSL1;SCP2;SCD5;AGPAT3;ABCD3;STAR;PDSS1
prerank,cardiac ventricle development (GO:0003231),0.31356847527706894,0.8315347264639604,0.6991150442477876,0.9209597232529994,1.0,5/20,14.12%,TMEM65;SALL1;HEYL;HECTD1;MDM4
prerank,regulation of programmed cell death (GO:0043067),0.22074428977207897,0.8310064590270365,0.8002610966057441,0.9214073969849293,1.0,18/161,8.36%,IGFBP3;KANK2;CXCL10;STEAP3;FBXO11;DAPK1;WRN;PLK5;HAX1;IFT57;BIRC3;CREBBP;ACTN2;ANP32E;STAT1;TRIM24;CHM;BAX
prerank,dorsal/ventral pattern formation (GO:0009953),0.31606484707685595,0.8309372094631735,0.712430426716141,0.920997001151633,1.0,2/20,2.59%,BMPR1A;NBL1
prerank,regulation of protein processing (GO:0070613),0.31439919390411175,0.8306437513481493,0.6904315196998124,0.9210103016243393,1.0,6/21,20.29%,SNX12;SERPINE2;LRRK2;CCBE1;GAS1;RNF139
prerank,mitochondrial fusion (GO:0008053),-0.3014648437004204,-0.8305968983896544,0.7076566125290024,0.9495648567849779,1.0,4/18,11.20%,MFF;MFN2;GDAP1;MFN1
prerank,phospholipid catabolic process (GO:0009395),0.298964383036252,0.8304876367064026,0.6888111888111889,0.9207373021699572,1.0,4/24,10.74%,PLA2G4A;APOA2;PLA2G4C;ENPP2
prerank,regulation of cell cycle (GO:0051726),0.20815402126992372,0.8304430313226115,0.8616352201257862,0.9202638826624487,1.0,50/271,16.38%,TCF7L2;SMAD3;NOTCH2;NUPR1;GATA6;SMIM22;FBXL17;PRDM11;BMP2;APBB1;BMP7;BTG4;TGFBR1;PRCC;BIRC3;RNF20;FBXL3;CDKN2B;MAP2K6;CRLF3;ANKRD17;CDK7;E4F1;NUPR2;SND1;GMNN;GRK5;RRP8;CDC14A;NR4A1;TSPYL2;TRIM21;NUDT6;MASTL;THAP1;MAP2K1;WDR6;RARA;CSNK2A2;PML;FIGNL1;FBXL12;IQGAP1;KAT2B;WDR12;LIN9;PKD2;GBF1;INHA;NF2
prerank,purine-containing compound salvage (GO:0043101),0.3553628338790605,0.8299599858017545,0.6871401151631478,0.9206064893766863,1.0,1/12,1.05%,AMPD3
prerank,cellular response to misfolded protein (GO:0071218),0.31498730378589435,0.8299156244292454,0.6666666666666666,0.9201384222615598,1.0,5/20,15.98%,POMT2;KLHL15;UGGT2;CUL3;RNF185
prerank,regulation of protein metabolic process (GO:0051246),-0.24462725818642023,-0.8298273373411325,0.7493857493857494,0.9502911514183155,1.0,10/44,13.77%,KLF2;FKBP1A;MAPK8;HSP90AB1;ACE;SPOP;NEDD4L;ZDHHC2;KLF4;PLAUR
prerank,negative regulation of defense response to virus (GO:0050687),0.3706244288579076,0.829752162268677,0.6666666666666666,0.9198930477404557,1.0,4/10,18.37%,PPM1B;TARBP2;MUL1;PCBP2
prerank,epithelial cell-cell adhesion (GO:0090136),0.37336408032586665,0.829433673387512,0.6733870967741935,0.9199386774287915,1.0,3/11,11.09%,KIT;VCL;SERPINB8
prerank,in utero embryonic development (GO:0001701),0.2983641329913509,0.8286801137534593,0.6971326164874552,0.920839422085214,1.0,4/25,9.00%,ARNT2;BMP2;TGFBR1;IGF2
prerank,regulation of cholesterol transport (GO:0032374),0.31432316344300976,0.8285903118209325,0.6900175131348512,0.9204644330392612,1.0,2/20,6.02%,APOA2;NR1H3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3196633800163287,0.8283698267304088,0.7083333333333334,0.9203366986474766,1.0,19/19,68.07%,ZC3H12A;CARD16;CD33;MEFV;GHSR;FFAR1;GHRL;NLRP2B;IGF1;TNFAIP3;CX3CL1;FFAR4;PYDC1;APOA1;GSTP1;GIT1;CPTP;CX3CR1;NLRP3
prerank,regulation of mRNA stability (GO:0043488),0.22177491408080902,0.8282635395777708,0.8100407055630936,0.9199917547775411,1.0,21/145,14.96%,ROCK2;TNPO1;SAMD4A;TENT5A;VIM;RC3H1;IGF2BP1;DCP2;FTO;PSMB10;PSMA3;PSME4;NOCT;PSMA5;IGF2BP2;XRN1;EIF4ENIF1;METTL16;FUS;GIGYF2;DIS3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2568591626331223,0.8281715945888487,0.7532051282051282,0.9196033093555618,1.0,15/52,22.31%,SHMT1;SLC19A1;MTHFD1;IDH1;ME2;MDH1B;D2HGDH;IDH2;PHYH;ADHFE1;HOGA1;ASS1;MTHFD2L;HAAO;MTHFD1L
prerank,UV protection (GO:0009650),0.36767937487204505,0.8280820066488214,0.6488095238095238,0.9192311290371515,1.0,2/10,14.03%,SCARA3;ERCC5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24894212045494624,-0.8276694679297277,0.7487437185929648,0.9537966042180237,1.0,12/40,20.33%,PTK2B;RPL5;RPS7;RPL11;RAD23A;RPL23;XPO1;GNA12;FOXF2;UBQLN4;CCDC22;UFL1
prerank,regulation of necroptotic process (GO:0060544),0.31058107245552613,0.8276638250462465,0.6872852233676976,0.919498614747962,1.0,5/23,14.28%,CFLAR;ZBP1;BIRC3;SLC25A4;FLOT2
prerank,hexose biosynthetic process (GO:0019319),-0.24229072264800058,-0.8271557123219414,0.7786259541984732,0.9540842211986575,1.0,15/42,21.55%,PGK1;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.3183728368381094,0.8269867398928049,0.6947565543071161,0.9202397949833598,1.0,1/20,1.80%,FOXC1
prerank,snRNA 3'-end processing (GO:0034472),-0.29895230381476506,-0.8269131874671104,0.6947608200455581,0.9537817596111681,1.0,9/19,30.92%,INTS7;INTS6L;EXOSC2;INTS12;EXOSC4;TOE1;INTS1;INTS5;INTS2
prerank,response to amino acid starvation (GO:1990928),-0.213125286513857,-0.8268680448333966,0.851123595505618,0.953105309917346,1.0,25/72,27.31%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;FAS;RRAGB;ATP6V1D;ATF4;CDKN1A;PRKD1;RRAGC;ATP6V1G2;ATP6V0E2;LAMTOR2;ATP6V1F;MLST8;ATP6V0D2;DEPDC5;SH3GLB1;MIOS;LAMTOR4;ITFG2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1948468304919648,-0.8266619545622228,0.8737201365187713,0.9527361486121939,1.0,48/125,30.94%,RPS27;KPNB1;EFHC2;RCC2;DYNC1H1;PCNT;KIF18A;XPO1;KIF3B;DYNC1I2;NDE1;CLASP2;PPP1CC;NEK9;CENPU;SKA2;BUB1B;DYNLL2;ZWILCH;CENPT;CENPQ;CENPL;STMN1;TUBG1;MAD1L1;NSL1;CENPN;CENPF;KIF4A;DSN1;KNTC1;SPDL1;TUBG2;DCTN6;CENPA;BCCIP;MAPRE1;SGO1;STIL;BIRC5;ITGB3BP;CLIP1;TBCE;PLK1;ZW10;DLGAP5;NUF2;AURKA
prerank,activation of protein kinase A activity (GO:0034199),0.3342290461211869,0.8266614893718724,0.6729678638941399,0.9202896450003825,1.0,3/16,7.01%,ADCY5;ADCY7;ADCY1
prerank,regulation of T cell cytokine production (GO:0002724),0.33129185408448675,0.8263047025902043,0.6685185185185185,0.9203662894856656,1.0,4/15,12.58%,CD55;FOXP3;MAP3K7;HFE
prerank,mRNA 3'-end processing (GO:0031124),0.24462158365334663,0.8260317856197231,0.7541478129713424,0.920329072698093,1.0,29/78,24.64%,POLR2D;PCF11;RPRD2;PAPOLG;CDC73;SLU7;SRSF4;MAGOHB;PAF1;DDX39A;THOC5;LEO1;TENT2;PABPN1;SRSF5;CSTF3;APP;PAPOLB;SLBP;GRSF1;WDR33;RPRD1B;TENT4B;SRSF3;SRSF11;CLP1;DDX39B;PAPOLA;SRSF7
prerank,positive regulation of calcium ion import (GO:0090280),0.35369210700444775,0.8256124381797888,0.6412371134020619,0.9205869421112938,1.0,2/12,7.71%,PDGFRB;CCL2
prerank,histone H2A monoubiquitination (GO:0035518),0.33088936696982924,0.8256028516293007,0.6908396946564885,0.9200548928543395,1.0,8/17,21.94%,BCOR;PCGF5;KDM2B;RING1;RNF2;BMI1;PCGF3;PCGF2
prerank,midbody abscission (GO:0061952),-0.30196423717295706,-0.8254987453686206,0.6791666666666667,0.9542819419802361,1.0,9/17,30.19%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,regulation of spindle organization (GO:0090224),0.3156929234954083,0.8253128557978693,0.6702508960573477,0.9200464653671364,1.0,5/18,16.56%,MAP9;PARP3;SENP6;FSD1;PSRC1
prerank,cellular response to leucine (GO:0071233),0.37425502012781364,0.8252170862120325,0.6773547094188377,0.919132080108282,1.0,4/10,22.08%,KLHL22;SESN1;LARS1;RRAGD
prerank,response to leucine (GO:0043201),0.37425502012781364,0.8252170862120325,0.6773547094188377,0.919132080108282,1.0,4/10,22.08%,KLHL22;SESN1;LARS1;RRAGD
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2723311305991785,0.8251829854668237,0.72508038585209,0.918644019713914,1.0,6/40,11.01%,POLH;CRY1;MCL1;NEK4;UBE2V1;RFWD3
prerank,Fc receptor signaling pathway (GO:0038093),0.22913047833543787,0.8250647279092612,0.7982954545454546,0.9183192214909882,1.0,15/110,13.33%,PDPK1;TEC;GAB2;FER;KIT;MAP3K1;PSMB10;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;BTRC;FBXW11;MAPK9
prerank,regulation of protein kinase A signaling (GO:0010738),0.31777159410208883,0.8243808912058,0.6758747697974218,0.9190388383392363,1.0,4/20,9.30%,AKAP12;ADGRV1;PJA2;LRRK2
prerank,regulation of amyloid-beta formation (GO:1902003),0.28146533323544365,0.8241526022332094,0.7117117117117117,0.9189294888432463,1.0,9/34,21.02%,ROCK2;RTN1;EPHA4;EFNA1;RTN4;ABCA7;CASP3;ROCK1;GGA3
prerank,rRNA catabolic process (GO:0016075),0.33374435315094386,0.824100326909744,0.6717267552182163,0.9184821453863586,1.0,6/16,16.37%,XRN1;DIS3L;SLFN14;DIS3;ERN2;EXOSC10
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3110363560385571,-0.8239225221099858,0.7298474945533769,0.9566133153205767,1.0,5/15,19.50%,ELOVL5;PPARD;NR4A3;MID1IP1;SLC45A3
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2775625528122925,-0.8235126256014857,0.7215777262180975,0.9566629110220995,1.0,8/22,32.98%,MMS19;NDOR1;HSCB;CIAO3;IBA57;ISCU;GLRX5;NUBPL
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2894034430339997,0.8228838532563484,0.7120418848167539,0.9202234288084711,1.0,3/28,6.64%,PRKAG2;PRKAA2;CD47
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2239090846665595,0.8227407060814347,0.810958904109589,0.919958323321336,1.0,26/149,14.46%,EIF2AK2;FER;TRAF5;SLCO3A1;CFLAR;IL6;ROR1;TLR4;PRKCZ;MTDH;TRIM5;EDA;IL18;LGALS9;RIPK2;WNT5A;UBE2V1;TLR2;IRAK3;MAP3K7;TRIM21;CRNN;MAP3K13;TICAM1;FLOT2;ALK
prerank,lipoprotein transport (GO:0042953),-0.3555282762470694,-0.8226501157900571,0.6940451745379876,0.9575457324830925,1.0,2/10,8.69%,PRKCB;VMP1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.34474579951100864,0.8226091132481257,0.6900584795321637,0.9196611112232167,1.0,6/12,23.92%,UBE2C;BTRC;GOLGA2;PTEN;UBE2S;GORASP1
prerank,mitotic nuclear division (GO:0140014),0.24317817264105387,0.8224877261593272,0.7503852080123267,0.9193416857181015,1.0,22/71,23.03%,MAP9;STAG1;CLASP1;KLHL22;KLHDC8B;ESPL1;MISP;UBE2C;ZWINT;CHMP4B;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;RAN;CCDC61;OFD1;INO80;CHEK2;STAG2;SPAST;UBE2S
prerank,regulation of mitotic spindle organization (GO:0060236),0.27706843406861514,0.8224714274131882,0.7348353552859619,0.9188231398294039,1.0,8/35,16.64%,MAP9;PARP3;TPR;FSD1;CHMP3;CHMP4B;PSRC1;EML3
prerank,cochlea morphogenesis (GO:0090103),-0.351467779584192,-0.82233376450071,0.6960985626283368,0.957383293111544,1.0,2/10,11.27%,TBX1;PAX2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.271542256423452,0.8223304451130206,0.7244732576985413,0.9185438858377218,1.0,2/42,1.76%,PDPN;ECM2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.32135545211309,-0.8222782238024173,0.7278481012658228,0.956743593365902,1.0,4/14,19.85%,TMSB4X;MDFI;NFKBIB;CCDC22
prerank,cytoplasmic microtubule organization (GO:0031122),0.2546695184982578,0.8222752866578251,0.7496038034865293,0.9180934228358173,1.0,12/54,15.16%,CLASP1;CLIP4;KATNAL1;CCDC13;DLG1;TUBGCP4;FIGN;SLAIN2;FSD1;TUBGCP2;TUBGCP5;FIGNL1
prerank,microtubule polymerization (GO:0046785),0.29380183572132884,0.822174524471339,0.7011884550084889,0.9177416213478128,1.0,8/28,16.24%,CLASP1;HDGFL3;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.36382611077452787,0.8218259990593599,0.6863905325443787,0.9178540554254624,1.0,3/11,8.47%,TGFBR2;STAT1;WNT5A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.31976864794174226,-0.8216707903707015,0.7033898305084746,0.9571813184546928,1.0,8/14,37.29%,ENTPD1;ADPRM;NUDT18;NUDT16;NUDT1;ENTPD2;NUDT15;ENTPD3
prerank,regulation of protein ubiquitination (GO:0031396),0.2282938752872849,0.821595324547643,0.8220338983050848,0.9177518800638577,1.0,17/108,14.53%,SASH1;PRICKLE1;ANGPT1;CRY1;MYCBP2;TGFBR1;BIRC3;RIPK2;LRRK2;FBXO4;HUWE1;SPOPL;CENPX;CUL3;ARRB1;TBC1D7;RCHY1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.34310039456761066,-0.8215601850336104,0.6876267748478702,0.9566631983231241,1.0,5/11,30.44%,TIMM8B;TIMM22;NDUFA13;TIMM10;TIMM13
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.310572257075995,-0.8215164882413383,0.7145877378435518,0.9560182617796591,1.0,3/16,8.42%,ESR1;DDX54;DDX17
prerank,regulation of neuron projection arborization (GO:0150011),-0.30916464691331413,-0.8208549305189929,0.701098901098901,0.9565188840918066,1.0,7/15,20.67%,MACF1;GRIP1;DVL1;MFSD2A;FZD4;NTNG1;NTNG2
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3023688074645538,-0.8207382616270321,0.7096774193548387,0.9559805930108826,1.0,8/16,31.97%,SLC2A9;SLC50A1;SLC45A3;SLC2A2;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2469316181626558,0.8198254828282601,0.7852664576802508,0.9205268443167359,1.0,8/68,8.47%,IL16;IL17D;IL6;TLR4;NOS2;LGALS9;SETD4;WNT5A
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.23418401009986223,-0.8195245967805375,0.8154269972451791,0.9575575078415218,1.0,14/46,24.27%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;IL12RB2;MTAP
prerank,autophagosome assembly (GO:0000045),-0.22696408291610098,-0.8192609959749627,0.7931034482758621,0.9573166613818339,1.0,13/52,19.24%,GABARAP;NSFL1C;GABARAPL1;ATG16L1;VMP1;ATG9A;MFN2;TP53INP2;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3
prerank,negative regulation of hippo signaling (GO:0035331),-0.32941672630588126,-0.818753013239241,0.7222222222222222,0.9575669066417202,1.0,3/12,7.27%,CIT;SHANK2;WWC1
prerank,organelle assembly (GO:0070925),0.19894504120571221,0.8187524856887693,0.9190140845070423,0.9219723072833883,1.0,79/384,18.96%,DCDC2;TMOD3;PARVA;CYS1;ASAP1;DYNLL1;AMBRA1;SMIM22;ARL13B;RC3H1;RFX3;SYNPO;IFT88;ARL3;RAB43;TTC39C;HYLS1;ARF4;TMEM107;PLA2G4C;EXOC2;POGZ;DYNC2I1;DNAAF1;HAUS8;GOLGA8B;HPS1;TUBGCP4;NUDCD3;IFT81;CC2D2A;UBXN2A;ATG12;CDC14A;CCDC57;WDR19;UBAP2L;EIF4ENIF1;RAB3IP;CFAP221;IQCB1;DDX6;IFT20;TRAPPC14;WDR45B;TUBGCP2;FBF1;CCDC66;GORASP2;CHMP3;RFX2;RBM14;NPHP3;TUBGCP5;CEP250;CHMP4A;CHMP4B;CPLANE1;ATG2A;GBF1;AVIL;GOLGA2;TTBK2;SH3PXD2B;CENPC;EXOC7;EXOC1;CCDC61;OGFOD1;WIPI2;RPGR;PATL1;RAB19;MAPRE3;IFT52;PRRC2C;ARL6;FARP2;WDR11
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23420655391807227,-0.8183887870767346,0.7955112219451371,0.9574955373893321,1.0,10/45,23.15%,PIK3R1;LIN28B;SETX;BMP4;EGFR;HRAS;SIRT7;HNRNPLL;HEATR1;SLC38A2
prerank,histone H2A acetylation (GO:0043968),0.3352559957603003,0.8179235267449021,0.6927374301675978,0.9229285922453568,1.0,9/16,30.30%,EPC1;ACTL6A;BRD8;NAA40;SPHK2;EP400;ING3;RUVBL1;MORF4L1
prerank,gastrulation (GO:0007369),0.3346059822378103,0.8178286544525009,0.6972477064220184,0.9225797887937556,1.0,5/15,20.75%,LMBRD1;TASOR;NPHP3;SMAD2;MEGF8
prerank,positive regulation of cellular protein localization (GO:1903829),0.24687807479708168,0.8176747711661334,0.7752808988764045,0.9223130250708452,1.0,18/69,17.50%,PRKAA2;PARP9;PARD6A;DTX3L;NGFR;GSK3B;YAP1;GPD1L;ENTR1;RTN4;CROCC;EIF2AK3;CEP250;MEAK7;TM9SF4;WWTR1;GAS8;ABCA7
prerank,regulation of gene silencing by miRNA (GO:0060964),0.24496493467307492,0.8174420922113296,0.7643410852713178,0.9221838845133241,1.0,20/62,25.24%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;POU5F1;NUP37;WTIP;PUM2;NUP85;AJUBA;POLR2K;ELAVL1;DHX9;TGFB1;NUP160;NUP107;POLR2H
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3258625880137545,-0.8173162884047581,0.7377049180327869,0.9587566702728708,1.0,8/13,35.54%,FCER1G;SYK;LPL;ITGB2;CD81;LDLR;PPARG;CD9
prerank,cellular response to interferon-beta (GO:0035458),-0.31840172098301023,-0.8172870368213118,0.7440860215053764,0.9580640476052342,1.0,6/14,29.30%,AIM2;IFITM2;IRGM;NDUFA13;CDC34;UBE2G2
prerank,myelin assembly (GO:0032288),-0.3588895613216112,-0.8171930845154185,0.7068607068607069,0.9574919780063241,1.0,7/10,35.54%,TENM4;TPPP;NCMAP;DICER1;CNTNAP1;ABCA2;CD9
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.35088377641194507,0.8170994900085576,0.6590909090909091,0.9222638969453243,1.0,5/11,23.55%,IL6;MAP2K1;DDX5;RIPK1;TGFB1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.3176278883330285,-0.8168013906475762,0.7030567685589519,0.9575047761988947,1.0,8/14,34.38%,PHACTR4;EMP2;PRKD1;LIMS2;TIMP1;BST1;SLC2A10;ITGB1BP1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.33069255947434806,0.8166891067467403,0.7065420560747664,0.9224884236119429,1.0,2/16,9.14%,AMPD3;PAICS
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2588918859165224,-0.8165618844324235,0.7588832487309645,0.9572129004884841,1.0,7/33,18.39%,SETX;CSTF2;CPSF2;SYMPK;SNRPB;CSTF2T;SNRPF
prerank,mesenchymal cell development (GO:0014031),-0.29622727904846496,-0.8165385172166919,0.7266514806378133,0.9565027070334475,1.0,2/18,2.33%,CDH2;NOTCH1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.26644413675624296,-0.8164700389428233,0.7995391705069125,0.9558917955786393,1.0,14/30,33.90%,ACER2;HINT1;JMY;STK11;PPP1R13B;PYCARD;BCL3;E2F7;MYBBP1A;PMAIP1;TP53;POU4F1;PAXIP1;BOK
prerank,negative regulation of phosphatase activity (GO:0010923),-0.26632765547455367,-0.8158791506685553,0.7813267813267813,0.9562153711796307,1.0,4/25,8.46%,TGFB2;FKBP1A;SEMA4D;PPP1R11
prerank,regulation of cell projection organization (GO:0031344),-0.3219275749889432,-0.8157454736990187,0.7261663286004056,0.9556988355055891,1.0,7/13,20.67%,SEMA4D;MACF1;ERMN;MFSD2A;CCL19;NTNG1;NTNG2
prerank,receptor metabolic process (GO:0043112),-0.23371222628914756,-0.8156482232700245,0.7924050632911392,0.9551317228711086,1.0,10/53,14.30%,DNM3;TFRC;SNCA;LGMN;LDLRAP1;RAMP2;FCER1G;SYK;CAV1;KIF16B
prerank,positive regulation of lymphocyte migration (GO:2000403),0.354497376791175,0.8154547668305712,0.711864406779661,0.9241929039442778,1.0,2/12,7.90%,CXCL10;TNFRSF14
prerank,regulation of DNA replication (GO:0006275),0.26017611854905465,0.815425676527773,0.7402190923317684,0.9237018673558527,1.0,15/49,20.10%,ORC5;NUCKS1;GLI1;CDAN1;ANKRD17;GMNN;ESCO1;TSPYL2;ORC3;PDS5A;S100A11;PPP2CA;DSCC1;DNA2;CTC1
prerank,calcium ion import into cytosol (GO:1902656),-0.313290498021707,-0.8150909553258695,0.7118279569892473,0.9553893540704415,1.0,2/15,5.50%,SLC24A2;SLC8A1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2191336057519208,-0.8150330743417984,0.8060109289617486,0.9547656495035621,1.0,13/61,15.59%,USP29;CDK6;MAX;MAP3K11;CAMK2A;CCND1;BCAT1;ACVR1;HINFP;USP37;CDK2;CDKN1A;CDK4
prerank,embryonic axis specification (GO:0000578),0.3322286461757481,0.8150282863840924,0.6744639376218323,0.9238907863244109,1.0,4/15,18.82%,SMAD6;TASOR;SMAD2;PTCH1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.34288999985471125,0.8146933684631732,0.6826347305389222,0.9239443745632122,1.0,1/12,4.75%,BMP7
prerank,regulation of mitochondrial depolarization (GO:0051900),0.36627758704059765,0.8145500943124749,0.6994219653179191,0.9236729119214738,1.0,3/10,9.30%,DCN;BCL2;LRRK2
prerank,NAD biosynthetic process (GO:0009435),0.3081619162715602,0.8139646666404345,0.7250922509225092,0.9241954634088584,1.0,7/20,22.06%,PARP9;PARP10;PARP16;PTGS2;NADSYN1;QPRT;HAAO
prerank,glycogen catabolic process (GO:0005980),0.332985012694153,0.8137261596925462,0.7041984732824428,0.9240887614176144,1.0,5/15,20.05%,PYGB;PYGM;STBD1;PHKB;PHKA2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2726449302204453,0.8136504824083364,0.7462932454695222,0.9236977469713101,1.0,4/39,4.73%,ARFGAP3;STEAP3;RAB10;MIA3
prerank,cellular protein catabolic process (GO:0044257),-0.22478413964421762,-0.813522804108495,0.8276762402088773,0.9568197108276737,1.0,11/59,12.58%,CTSC;CTSB;DAB2IP;FAP;LGMN;CTSS;MALT1;CTSL;PSMA6;VLDLR;RAB12
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.34683705438281676,-0.8134393260537892,0.7013752455795678,0.9562286780804958,1.0,5/10,15.18%,GAS6;RAPGEF2;CXCL12;LYN;CCL19
prerank,peptide metabolic process (GO:0006518),0.24017692532656498,0.8133143311998927,0.7931034482758621,0.9237821160292656,1.0,13/75,14.02%,CPQ;ANPEP;AEBP1;MGAT3;NPEPPS;CLN5;SPPL3;GSTK1;ERAP1;NLN;GSTA3;CPXM2;LNPEP
prerank,regulation of macroautophagy (GO:0016241),-0.20100017292510328,-0.8127518130076864,0.8765822784810127,0.9567789551687343,1.0,29/105,22.76%,ATP6V0A1;KDR;MAPK8;SCOC;ATP6V1B2;EXOC4;SESN3;ATP6V0C;AKT1;SMCR8;HDAC6;PINK1;RRAGB;EPM2A;ATP6V1D;CAPN1;ULK1;CAPNS1;QSOX1;ATP6V0A2;RRAGC;ATP6V1G2;BNIP3L;ATP6V0E2;LAMTOR2;MLST8;ATP6V0D2;CLN3;PAFAH1B2
prerank,protein complex oligomerization (GO:0051259),0.23611131412412226,0.8125595291229294,0.8008849557522124,0.9246462493425648,1.0,23/85,23.12%,MCU;RNF213;MICU1;PRF1;CLDN1;DNM1L;CUTC;OPA1;TIFA;FUS;PKD2;ATL1;RNF135;IKZF4;JMJD6;ELAVL1;SLC9A1;NACC2;OXA1L;ZC3H12A;PNPT1;SPAST;PRMT1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.27756437705133513,-0.8124747903438312,0.7346491228070176,0.9565316815745691,1.0,13/22,41.54%,VPS37B;MVB12B;RNF126;VPS37A;VPS28;SNF8;PLAA;PTPN23;VPS4B;STAM;UBAP1L;UBAP1;VPS25
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2958053036657743,0.8123220419525763,0.7030965391621129,0.9245361124060367,1.0,5/24,19.81%,PLA2G4A;SERAC1;LPGAT1;PLA2G5;SLC27A1
prerank,organelle fission (GO:0048285),-0.27371408167613753,-0.8122246629759334,0.7535545023696683,0.9562544486311708,1.0,6/24,21.13%,DNM3;MFF;GDAP1;PEX19;PEX11A;MTFR1L
prerank,histone H2A ubiquitination (GO:0033522),0.32291513900156915,0.8119003404353087,0.7099644128113879,0.924726972483913,1.0,5/17,16.98%,BCOR;DTX3L;KDM2B;RING1;RNF2
prerank,epithelial cell differentiation (GO:0030855),0.23389153557526896,0.8118236921567734,0.7939481268011528,0.9243236270592956,1.0,9/88,8.12%,FSTL1;GATA6;MAF;ANXA1;RAB10;GLI1;ANXA4;GSTK1;ANXA7
prerank,steroid hormone biosynthetic process (GO:0120178),-0.25698647639182987,-0.8109355139013816,0.7687224669603524,0.9579252194354994,1.0,6/29,20.59%,STARD3NL;SRD5A3;FDXR;HSD17B7;DHCR7;HSD17B8
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.3170806183038799,0.8106726547168652,0.7058823529411765,0.9259162372862842,1.0,2/18,6.20%,SELP;VCAM1
prerank,snRNA processing (GO:0016180),-0.3127149014467351,-0.810308848705216,0.7307692307692307,0.9583552897278095,1.0,9/16,30.92%,INTS7;INTS10;INTS6L;INTS12;TOE1;INTS11;INTS1;INTS5;INTS2
prerank,regulation of platelet aggregation (GO:0090330),0.3225194250006623,0.8101195404503385,0.7222222222222222,0.9263966338013049,1.0,1/17,0.30%,PDPN
prerank,protein stabilization (GO:0050821),0.21559921547009447,0.8098520141920148,0.8675496688741722,0.9263363955389501,1.0,35/168,16.59%,PLPP3;PARVA;WNT10B;APOA2;LAMP2;AAK1;MORC3;CREBL2;USP27X;CTNND1;USP9X;EPHA4;PHB2;STK3;CCNH;NAA16;SUMO1;CDK7;ATF7IP;NAA15;ATP1B2;DVL3;EFNA1;RTN4;MDM4;USP36;FLOT2;VHL;STK4;MUL1;SOX4;PER3;TAF9;TBL1X;CCT6A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.23865628349864107,0.8094955474146063,0.8315301391035549,0.9264165654031866,1.0,11/80,12.46%,UACA;EPHA7;SH3RF1;DAPK1;SIAH2;NGFR;PDCD5;USP47;FNIP1;MAP2K5;RPS6KA3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.23402313425233554,0.8091664727692266,0.7994143484626647,0.9264994813019833,1.0,10/85,10.29%,PRICKLE1;SMURF2;FZD2;PARD6A;CELSR1;PSMB10;WNT5A;PSMA3;PSME4;PSMA5
prerank,heterochromatin assembly (GO:0031507),0.31221784967457256,0.8090772518046676,0.68760907504363,0.9261265899859146,1.0,10/20,27.81%,MBD2;BAZ2A;RRP8;ZNFX1;SIRT2;SMCHD1;EZH1;CENPV;SUV39H1;HMGA2
prerank,nucleocytoplasmic transport (GO:0006913),0.268068310246358,0.8089392418530656,0.7583465818759937,0.925852821021457,1.0,2/40,2.08%,ATXN1;GEMIN4
prerank,miRNA metabolic process (GO:0010586),0.3098414503764506,0.8087242681161051,0.7049180327868853,0.9257301523162381,1.0,9/20,21.47%,TUT4;SND1;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3280262943735893,0.8084262714668142,0.6918714555765595,0.9257124326835172,1.0,2/15,3.02%,FOXC1;NCOA3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.30361030131181393,0.8082700132027992,0.7041742286751361,0.9254473062490567,1.0,8/22,23.94%,MAN1C1;AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;EDEM1
prerank,RNA stabilization (GO:0043489),0.28151224696177957,0.8080781100841841,0.735,0.9252566154841302,1.0,10/33,20.84%,TENT5A;NOCT;EIF4ENIF1;TENT2;FUS;AXIN2;GDNF;DHX36;ELAVL1;PARN
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.2961989964208436,0.8078116971722389,0.7470817120622568,0.925212054734364,1.0,3/21,5.90%,CHST15;DCN;CHSY1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3374887876026632,-0.8077357454100602,0.7334669338677354,0.9622428546604528,1.0,3/11,14.81%,SMAD7;CEACAM1;PTPRC
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3386141060882543,-0.8076523944076824,0.7225806451612903,0.9616587898207857,1.0,1/11,1.55%,PLCG2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.29171953808021006,0.8074275786098714,0.7152899824253075,0.9253602831162338,1.0,4/26,9.25%,ADAMTS1;ANXA1;CCND3;ANKRD17
prerank,positive regulation of reproductive process (GO:2000243),0.2821210242882601,0.8071634080425681,0.7352445193929174,0.9252998971460685,1.0,3/31,3.59%,SMURF2;LHFPL2;FAM170B
prerank,nucleotide biosynthetic process (GO:0009165),0.31150323188200546,0.8069084671993336,0.6861702127659575,0.9252260315103622,1.0,4/18,11.67%,MTHFD1;RRM1;PRPSAP1;RRM2B
prerank,positive regulation of translation (GO:0045727),-0.20118271754571576,-0.8064857258575506,0.8716216216216216,0.9630466239045785,1.0,32/94,27.89%,THBS1;RPS9;RPL26;RPL5;PKM;RPS4X;EEF2;CNBP;NPM1;YTHDF2;EIF5A;EIF5AL1;CDC123;FASTKD2;PASK;EIF5A2;RBM3;BCL3;POLDIP3;C1QBP;UHMK1;NIBAN1;PYM1;EIF6;RCC1L;TRMT10C;POLR2G;HNRNPD;METTL14;RPUSD3;PRR16;BOLL
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3107159672917399,0.8062135952117863,0.726078799249531,0.925880112846138,1.0,3/19,7.85%,TLR4;LY96;LGALS9
prerank,cellular response to starvation (GO:0009267),0.21593825161643448,0.8061029417348947,0.85,0.925533066046877,1.0,27/147,16.27%,RNF152;PRKAG2;PRKAA2;EIF2AK2;GCGR;WRN;LAMP2;MTMR3;CARTPT;PPARA;STK24;LRRK2;NUPR2;FNIP1;RRP8;SESN1;FOXO3;SLC38A9;TCIRG1;WDR45B;NPRL3;ATP6V0B;NUAK2;EIF2AK3;ATP6V1E1;ATP6V1C1;LARS1
prerank,protein acetylation (GO:0006473),0.28200255042873895,0.80558069295598,0.7377049180327869,0.9259421844275719,1.0,10/30,20.13%,CREBBP;NAA16;ESCO1;NAA15;KAT6A;KAT2B;NAA35;DSCC1;CLOCK;NAA40
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.33919033823947925,-0.8053799580398028,0.7019027484143763,0.9642987955152306,1.0,4/10,35.52%,PDE6A;SAG;PDE6G;PDE6B
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2634092791131654,0.8052928447277756,0.751269035532995,0.9259379629142795,1.0,7/40,11.01%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.34797280369168493,0.8037401412174879,0.7200772200772201,0.9280931602429393,1.0,2/13,6.02%,NUPR1;NR1H3
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3031391594347977,0.8034574724539353,0.7302752293577982,0.9280606999969045,1.0,2/21,4.74%,ROCK2;ERRFI1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.2779145825390229,-0.8034546225567284,0.759493670886076,0.9670230265228269,1.0,5/21,16.37%,KDR;MAPK3;KARS1;EGF;HTR2B
prerank,dendritic cell differentiation (GO:0097028),0.29528355454191,0.8030570814805983,0.7414721723518851,0.9282554406422366,1.0,3/22,7.85%,AXL;TGFBR2;LGALS9
prerank,regulation of hippo signaling (GO:0035330),0.32001487202868334,0.8028790106663802,0.7204502814258912,0.9280189319695683,1.0,8/17,19.70%,NEK8;WWC2;MAPK14;VGLL4;NF2;WTIP;DLG5;AJUBA
prerank,positive regulation of cell cycle process (GO:0090068),-0.20424605429473947,-0.8019102818068696,0.8765060240963856,0.9690804410608128,1.0,36/91,33.33%,INSR;CIT;RCC2;NSFL1C;DDX11;DYNC1H1;MAP3K20;RANBP1;LRP5;RGCC;PLK4;EGF;ECT2;GEN1;KIF23;SPAG5;E2F7;PRKCE;WIZ;NUP62;RACGAP1;KIF14;CDC14B;RHNO1;EDN1;UBXN2B;RAD21;NUDT16;AURKA;CDC6;FEN1;E2F8;KIF20B;OPN1MW;DBF4;DRD3
prerank,protein modification by small protein removal (GO:0070646),-0.17494289749602493,-0.8010536748404257,0.9739130434782609,0.9698088748220262,1.0,73/252,25.03%,USP29;IL33;SMAD7;ACTB;ESR1;PSMC3;OTUD7A;SNX3;USP31;NFRKB;CLSPN;RAD23A;PSMD14;UBB;MBD5;PSMD3;YY1;BABAM1;EIF3F;USP13;COPS6;PSMD4;SMAD1;ZRANB1;PSMD6;BARD1;ADRB2;PSMA6;PSMA4;PSMB8;USP3;FOXO4;TFPT;USP46;USP37;UBA52;PSMA8;TAF9B;VCPIP1;OTUD1;CYLD;COPS5;COPS2;YOD1;USP38;SUDS3;BRCA1;UBE2D1;PSME1;GPS1;TOMM20;KAT2A;PSMD7;PSMC6;ASXL1;USP42;PSMB5;USP2;PSMC5;PSMB1;POLB;ATXN3;COPS4;OTUB2;USP22;KDM1B;PSMD11;DDB2;MCRS1;PSMD8;USP11;RAD23B;JOSD2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.31657194463310534,-0.8008116785295414,0.7295081967213115,0.9694998032979655,1.0,5/13,33.21%,CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.18572095010425632,-0.8005256046246478,0.9540229885057471,0.9692402938184274,1.0,51/148,27.66%,RPS15;RPL5;RPL11;TAF15;MRE11;JMY;RPS20;AKT1;PHF20;STK11;TAF3;SSRP1;RFFL;HDAC1;PPP1R13B;ATM;BARD1;RPL23;TAF9B;TAF11;CDK2;RMI2;BRCA1;RPL37;RAD1;CCNG1;PIP4P1;L3MBTL1;RFC4;CHEK1;NOC2L;PRMT5;MLST8;USP2;ATRIP;ATR;BRPF1;PRR5;SGK1;CDK5;RBBP7;EXO1;PIP4K2A;RHNO1;RFC5;HIPK2;RFC2;CSNK2B;BLM;CHD5;MAPK11
prerank,global genome nucleotide-excision repair (GO:0070911),0.28565995483233114,0.7999950917532287,0.7531083481349912,0.9325038382870715,1.0,7/26,19.03%,CUL4A;RNF111;GTF2H4;ERCC1;USP45;GTF2H2;XPC
prerank,positive regulation of T cell proliferation (GO:0042102),0.24583898036753765,0.7995582757924248,0.8048780487804879,0.9327591201348425,1.0,7/55,9.00%,IL6ST;ANXA1;IL6;VCAM1;IL18;CD274;IGF2
prerank,natural killer cell activation (GO:0030101),0.2925882044264254,0.7993744009289744,0.7275985663082437,0.9325361412737029,1.0,4/23,12.03%,AXL;ELF4;PBX1;SNX27
prerank,response to endoplasmic reticulum stress (GO:0034976),0.22239090723831983,0.7993482478156522,0.8561452513966481,0.9320521446503459,1.0,10/107,8.36%,RASGRF1;ITPR1;CREB3L2;UBA5;BCL2;CASP4;CREB3L3;GSK3B;QRICH1;BAX
prerank,exit from mitosis (GO:0010458),-0.32396804648357164,-0.7992307477658637,0.7148760330578512,0.9708387533553279,1.0,6/12,23.37%,EPS8;CTDP1;CLASP2;CHMP7;SIRT7;CHMP2A
prerank,regulation of interleukin-13 production (GO:0032656),-0.31973673525456603,-0.7991054828305346,0.726027397260274,0.9703240672296548,1.0,1/13,0.14%,LEF1
prerank,primary alcohol metabolic process (GO:0034308),0.29113491661241964,0.7986789481326521,0.7180451127819549,0.9327123805101503,1.0,5/25,16.06%,RDH10;RBP4;NAAA;PECR;NAPEPLD
prerank,mitotic spindle assembly (GO:0090307),0.2636562051737929,0.7983858686999229,0.7731788079470199,0.9326695815358188,1.0,12/42,22.73%,MAP9;STAG1;CLASP1;MISP;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;OFD1;CHEK2;STAG2
prerank,histone lysine demethylation (GO:0070076),-0.2638293094800711,-0.7981570698171817,0.7827102803738317,0.9712414998268484,1.0,8/25,17.19%,JMJD1C;RIOX2;KDM4D;KDM4C;KDM4A;KDM5C;PHF2;HR
prerank,regulation of protein transport (GO:0051223),-0.2582426611269977,-0.7980922851881939,0.8009708737864077,0.9706065282290366,1.0,7/27,19.62%,HSPA8;SNX3;STXBP5L;RHBDF2;LCP1;PPM1F;DISP1
prerank,sensory organ development (GO:0007423),-0.22905603657183668,-0.797058610874438,0.8279569892473119,0.9717203082073363,1.0,10/51,13.74%,MEIS2;TGFB2;PBX3;AHI1;ECE1;FREM2;ATF6;BMPR1B;SIPA1L3;SIX4
prerank,response to organonitrogen compound (GO:0010243),-0.24022416153663984,-0.7969658024097501,0.8114558472553699,0.9711371679560493,1.0,11/38,21.52%,GLRA3;SEL1L;BRSK2;CCDC47;RRAGC;KAT7;GLRA2;GLRA1;UBXN6;KYNU;TRPM2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.34318464995821363,-0.7963042764907928,0.7366336633663366,0.9715306373746302,1.0,3/10,11.66%,HMGB1;RUNX1;CBFB
prerank,peptidyl-lysine acetylation (GO:0018394),0.3552161879267845,0.7962185408147261,0.7125984251968503,0.9359335961732971,1.0,3/10,15.47%,CREBBP;ESCO1;KAT2B
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3123533211191535,-0.7959865348471258,0.7605321507760532,0.9713655909878419,1.0,6/13,28.13%,BAG6;USP13;CAV1;ATXN3;TMEM259;HERPUD1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.26789321942332817,0.7958264939694211,0.7628865979381443,0.9360864667501279,1.0,8/36,15.39%,NRP1;NCOA3;TGFA;CCL2;HFE;ADRA2C;HDAC2;ADRA2A
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.29042234170337233,-0.7944221325704398,0.7619047619047619,0.9733426912520705,1.0,4/17,13.08%,PDE3B;SORL1;AKT1;MFSD2A
prerank,regulation of phosphatase activity (GO:0010921),0.29105059542284306,0.7943000364035515,0.7544169611307421,0.9381332890219966,1.0,7/24,23.63%,BMP2;PPP1R35;PPP6R3;URI1;SH2D4A;CDK5RAP3;PPP1R2
prerank,establishment of mitotic spindle localization (GO:0040001),0.2756525876034014,0.7937304284741592,0.7535211267605634,0.938616624363011,1.0,5/28,12.79%,GJA1;CLASP1;ESPL1;MISP;FBXW11
prerank,plasma membrane repair (GO:0001778),0.33962862141078654,0.7934631908151198,0.7378640776699029,0.9385231072415391,1.0,1/13,1.42%,MYOF
prerank,glucose import (GO:0046323),-0.3158134998402078,-0.7931368596851848,0.7433264887063655,0.9747895710622762,1.0,4/13,19.14%,SLC2A1;SORT1;ZDHHC7;SLC2A4
prerank,regulation of myelination (GO:0031641),0.28890592786907743,0.7929369365445931,0.7546218487394958,0.938904091616005,1.0,1/25,0.48%,PTN
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.34110704049339924,0.7922512443561943,0.7163375224416517,0.9395205874446605,1.0,1/13,2.18%,GAB2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3395269319042883,-0.7899856486022188,0.7410358565737052,0.9792474941803667,1.0,3/10,13.69%,DIS3L2;UBB;UBA52
prerank,regulation of protein import into nucleus (GO:0042306),0.26448684503304154,0.789703810078926,0.7820299500831946,0.9432749621273491,1.0,3/36,5.83%,SMAD3;ZIC1;TPR
prerank,negative regulation of MAPK cascade (GO:0043409),0.22522253642073403,0.7894390244062074,0.8383233532934131,0.943215217627547,1.0,13/87,12.68%,TIMP3;DAG1;FBLN1;DUSP10;TLR4;BMP7;PTPN2;PPEF2;DLG1;IRAK3;SMAD4;SH2B3;PTPN1
prerank,endoplasmic reticulum organization (GO:0007029),-0.2103542314265942,-0.789188735936119,0.9083094555873925,0.979917293036009,1.0,31/72,31.46%,REEP1;DOP1B;LMAN2L;REEP5;SHTN1;SERP1;CAV2;TRAM1;LMAN1;VCPIP1;CCDC47;TOR1B;WDR83OS;SEC61A1;ATL2;SEC61G;RTN3;CYB5A;TOR1AIP2;RAB18;HMOX1;TRAM1L1;GET1;SEC61B;STX18;REEP4;VAMP2;SPTSSB;BNIP1;TRDN;LPCAT3
prerank,protein localization to chromatin (GO:0071168),-0.28334042102504486,-0.7886784059693979,0.7682119205298014,0.9800012732945106,1.0,8/18,32.69%,ESR1;MCM9;CHMP7;SGF29;RAD21;PLK1;PIH1D1;RUVBL2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24815787878620593,-0.7886568266858239,0.8197115384615384,0.9792869230690766,1.0,13/30,30.68%,NOS3;ARHGEF2;RFFL;FAS;TMBIM1;PARK7;BRCA1;BMP5;TNFRSF10B;HMOX1;FADD;TRAF2;TRADD
prerank,atrial septum development (GO:0003283),-0.3147881766151332,-0.7886076200382636,0.7505112474437627,0.9786276648977632,1.0,3/13,9.13%,TGFB2;BMPR2;ZFPM1
prerank,RNA splicing (GO:0008380),0.22555752343867472,0.7885005524548543,0.8584474885844748,0.9442530715513874,1.0,27/95,20.27%,SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RNPC3;SRSF4;DHX16;HNRNPH3;MAGOHB;USB1;DHX8;SRPK1;ZMAT5;FUS;TXNL4A;PPP2CA;WBP4;SCAF11;USP39;PRPF3;SNRNP40;KHSRP
prerank,outer dynein arm assembly (GO:0036158),0.327692417732357,0.7881571149001774,0.728440366972477,0.9442874468674194,1.0,3/14,10.13%,ODAD4;DNAAF1;DNAL1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3388696296001434,0.7878794086026661,0.7448015122873346,0.9442288967374998,1.0,3/12,15.67%,HEYL;SMARCA4;DAB2
prerank,keratan sulfate catabolic process (GO:0042340),0.343992540963824,0.7878710215213309,0.7195571955719557,0.9437051340391237,1.0,3/11,17.17%,OMD;PRELP;OGN
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.31704364743174396,-0.7874679641369079,0.7740667976424361,0.979738589227805,1.0,2/13,4.86%,CSPG4;HEXB
prerank,error-prone translesion synthesis (GO:0042276),0.29870476332088547,0.7867921731235108,0.7293103448275862,0.9449320220545828,1.0,4/21,9.92%,POLH;RFC1;REV1;RPA3
prerank,nucleosome organization (GO:0034728),-0.21893768010202724,-0.7867421152410369,0.8621621621621621,0.9802124386433628,1.0,12/55,16.30%,H3-3A;ZNHIT1;LIN54;NPM1;SART3;SMARCB1;ASF1A;H1-0;ANP32B;SPTY2D1;DMAP1;SET
prerank,response to interleukin-6 (GO:0070741),0.3597108038266266,0.7866850888546438,0.7378640776699029,0.9445722559739775,1.0,1/10,1.34%,PID1
prerank,regulation of T cell proliferation (GO:0042129),0.23495027786741426,0.7866393068827446,0.8322784810126582,0.9441074594869586,1.0,6/61,7.89%,IL6ST;ANXA1;IL6;FOXP3;VCAM1;CD274
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2960687194234065,-0.7860717812582403,0.7527114967462039,0.980573895088474,1.0,7/15,37.60%,CCT5;NOP10;RUVBL2;NHP2;CCT7;SHQ1;CCT8
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23245122898435647,0.7854529936628046,0.8462732919254659,0.9455816124735366,1.0,13/76,15.49%,LPAR1;FPR2;F2RL3;C5AR2;PLCE1;ACTN2;OPRD1;NMUR1;P2RY6;GPR65;P2RY1;ADRA2A;CCKBR
prerank,protein-containing complex disassembly (GO:0032984),-0.21751968658552692,-0.7851382442924628,0.8770053475935828,0.9814061404748717,1.0,11/54,12.95%,HSPA8;CTNNB1;GABARAP;GABARAPL1;LRP6;VPS33B;DVL1;PPP1CA;RPL23;TECPR1;CAV1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2963350413790239,-0.7840612154785861,0.7613882863340564,0.9824375279652373,1.0,6/15,23.13%,PPARD;AKT1;LDLRAP1;SLC45A3;PRKCE;IRS1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2348085759178911,0.7839977953297204,0.819047619047619,0.947460404242493,1.0,23/69,22.93%,POLR2D;RPRD2;INTS9;NABP1;CDK7;POLR2C;INTS14;POLR2F;POU2F1;INTS3;INTS8;SNAPC3;TAF9;INTS13;SNAPC5;RPRD1B;INTS6;NABP2;POLR2K;SNAPC4;SRRT;SP1;ELL
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.32515682535754853,-0.783912485202607,0.7478991596638656,0.9819253633071969,1.0,2/11,10.16%,PRKCQ;MALT1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.1915352129031947,-0.7833748833699855,0.9185667752442996,0.9820765521541931,1.0,20/104,17.66%,ACTB;CALM1;SNCA;CALM2;DAB2IP;SLC8A1;CALM3;AKT1;CCND1;LRP6;ADRB2;CNPPD1;LRP5;SERTAD1;CSF1R;CDKN1A;IRGM;CCNF;PYCARD;CCNG1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.28357411669233434,0.7829447571175071,0.7486910994764397,0.9486489999451859,1.0,11/26,26.28%,PPM1B;IRAK3;TRIM21;TRIB1;MUL1;PCBP2;SIRT2;NMI;MAPKBP1;CARD16;TYRO3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.29663513804566294,0.7818709955956072,0.7697974217311234,0.9498993688236904,1.0,4/22,10.29%,PSMB10;PSMA3;PSME4;PSMA5
prerank,lipoprotein biosynthetic process (GO:0042158),0.3444101098650069,0.78155139284549,0.7465069860279441,0.9498628410131783,1.0,6/11,26.21%,PORCN;WDR45B;ATG10;WIPI2;ATG7;APOE
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.24908381665100593,0.7814925325840217,0.8045977011494253,0.949418750986565,1.0,7/48,10.41%,DOCK5;NRP1;S100A10;MYADM;CUX1;TRIOBP;CUX2
prerank,B cell proliferation (GO:0042100),0.31033002221351813,0.7811844991055062,0.746031746031746,0.9493394222350083,1.0,2/17,4.91%,CTPS1;BCL2
prerank,positive regulation of lipid transport (GO:0032370),-0.3102751571520735,-0.7807305835260056,0.7478991596638656,0.9855379166773505,1.0,3/12,9.61%,ABCA3;PRELID1;SPP1
prerank,positive regulation of hormone secretion (GO:0046887),-0.28332796901995017,-0.7807164974277144,0.7858627858627859,0.9848224450970186,1.0,8/17,31.34%,C1QTNF3;SPP1;GRP;EDN1;SOX11;RASL10B;NMB;VAMP8
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.320319863814832,0.780596715752146,0.7486136783733827,0.9497805745588903,1.0,2/14,8.67%,OSR1;ZEB1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.21417242845556636,-0.7805671788469088,0.8904494382022472,0.9843100272322769,1.0,19/65,24.51%,PSMC3;PSMD14;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;PSMD8
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.31295345817633174,0.7803054957899602,0.7449908925318761,0.949708308588954,1.0,3/16,13.29%,WRN;MCM4;MCM6
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.22041732494255573,0.7802398245042989,0.8596237337192475,0.9492746895923992,1.0,29/101,23.55%,PLD1;SAMD4A;VIM;DACT1;IL6;NR1H3;ZCCHC4;CSF1;VGLL4;BTRC;FBXW11;HDAC2;SOX4;CPEB3;CYFIP2;UPF3A;ATG10;FXR2;PLXNB2;ASPH;ERBB2;ELAVL1;IST1;AGT;VPS35;ATG7;METTL5;YTHDF3;TGFB1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2587099740641424,0.7801593300358869,0.7851239669421488,0.9488834737951307,1.0,9/39,17.31%,CUL4A;RFC1;NTHL1;RPA3;OGG1;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2459178519719389,-0.7799256253157733,0.8032786885245902,0.984551340098271,1.0,10/29,21.35%,MRE11;HSP90AB1;TERF1;HSP90AA1;PPIA;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,mitotic sister chromatid segregation (GO:0000070),-0.19453389675521857,-0.7797183685706607,0.937125748502994,0.9841585731196897,1.0,50/98,37.68%,DIS3L2;MCPH1;KPNB1;NAA50;KIF18A;SMC2;CHMP1A;SET;CHMP1B;PRC1;CHMP7;CHMP2B;NCAPH2;TUBG1;KNSTRN;NCAPH;KIF23;SPAG5;TENT4A;TTN;NUP62;NSL1;KIF22;REC8;CHMP2A;DSN1;KIF14;SPDL1;TUBG2;CEP55;SGO1;RAD21;CSNK2B;NCAPD2;CHMP6;CHMP4C;PLK1;ZW10;DLGAP5;CDK1;SMC1A;MIS12;NCAPD3;KIFC1;VPS4B;NUDC;RAB11A;CDC23;KIF2C;CCNB1
prerank,nucleotide catabolic process (GO:0009166),0.30978819340152336,0.779666008080852,0.7409523809523809,0.9491205003248151,1.0,5/16,20.56%,NT5C;DERA;ITPA;NT5C1A;XDH
prerank,fatty acid oxidation (GO:0019395),-0.2105239182919088,-0.7794294104064601,0.898936170212766,0.9838733574466813,1.0,4/57,5.04%,ADIPOR2;ACAD10;ABCD4;PPARD
prerank,visual system development (GO:0150063),-0.23589035009453446,-0.7793701629756167,0.8214285714285714,0.9832299771255173,1.0,13/37,25.78%,MEIS2;TGFB2;PBX3;FREM2;ATF6;BMPR1B;SIPA1L3;SMOC1;SOX2;C3;RAB18;MAB21L2;HIPK2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3234594068405279,0.7792129918982864,0.7305605786618445,0.9493247579804865,1.0,1/15,0.46%,TEC
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3475432681251171,0.7791983022240717,0.7208835341365462,0.9488080957790127,1.0,1/10,1.61%,PRKAA2
prerank,protein heterotetramerization (GO:0051290),-0.3112289365482289,-0.7789085852431676,0.7515400410677618,0.9832469399834776,1.0,4/13,20.59%,GRIN2B;GRIN1;FARSB;HSD17B8
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3232738820589798,-0.7782567280436498,0.7510373443983402,0.9835337722100884,1.0,7/11,35.26%,ATF6;ATF4;HSPA5;CREB3L1;MBTPS2;TP53;DDIT3
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.32175571901689415,0.7782383309080868,0.769825918762089,0.9498393327198066,1.0,4/14,18.46%,PPP2R2B;NCK1;PPP2CA;PPP2R2A
prerank,proton transmembrane transport (GO:1902600),0.26210718515536807,0.7779272669100262,0.7819672131147541,0.9498003150819522,1.0,4/36,9.79%,ATP1A2;SLC4A11;NNT;OTOP1
prerank,acute inflammatory response (GO:0002526),0.2877577919059802,0.7778578848379268,0.7468805704099821,0.9493892376726044,1.0,4/23,13.70%,IL6;CRP;ANO6;IL22
prerank,"base-excision repair, gap-filling (GO:0006287)",0.26640486887302783,0.777426960755392,0.7822445561139029,0.9495378374700629,1.0,7/35,12.43%,RFC1;POLG;NTHL1;RPA3;XRCC1;ADPRS;OGG1
prerank,glial cell development (GO:0021782),-0.255561111382123,-0.7769166937360865,0.8129496402877698,0.9848610800982147,1.0,11/25,35.13%,CDK6;EIF2B2;TPPP;DLL1;CSPG5;SOX11;PICK1;PRDM8;MT3;S100A9;NRROS
prerank,regulation of endocytosis (GO:0030100),-0.21206808814741043,-0.776797183526124,0.8903394255874674,0.9843038265350834,1.0,15/61,20.22%,HIP1;RIT2;MCTP1;SNCA;SCAMP5;HIP1R;NEDD4L;RAB5C;CCL19;PRKD1;CBLL1;LRSAM1;MTMR2;SNX17;DLL1
prerank,regulation of leukocyte migration (GO:0002685),0.3083058868447843,0.7767446632316606,0.7379182156133829,0.9500985832419351,1.0,2/16,4.73%,ANXA1;MIA3
prerank,protein tetramerization (GO:0051262),0.23358987477605375,0.7763024964872342,0.8435054773082942,0.9502861250235671,1.0,4/67,6.33%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,heme biosynthetic process (GO:0006783),-0.27203974424509053,-0.7761488143380002,0.7969094922737306,0.9845668482013605,1.0,1/22,0.19%,ABCG2
prerank,negative regulation of transport (GO:0051051),-0.2180383332000494,-0.7758654630437601,0.8542199488491049,0.9842612308325134,1.0,12/51,19.10%,MCTP1;SNCA;SCAMP5;SNX3;DYSF;RACK1;PRKD1;EGF;LRSAM1;PPM1F;YRDC;MTMR2
prerank,chromatin remodeling at centromere (GO:0031055),-0.24783612470925773,-0.7758632003532683,0.8147208121827412,0.9835269294146202,1.0,11/31,26.66%,NPM1;HELLS;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,neuromuscular process (GO:0050905),-0.2892666117595502,-0.7755051497062025,0.8060344827586207,0.9833195484786103,1.0,6/16,22.59%,NRXN1;GCH1;SHANK1;KCNA1;DCTN1;CLN3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.29398675904689997,-0.775383530172283,0.776255707762557,0.9827755231175614,1.0,5/14,28.37%,AKT1;NNMT;SLC45A3;IRS1;PMAIP1
prerank,autophagy of mitochondrion (GO:0000422),0.2570698569315498,0.7751176980501334,0.8013355592654424,0.9516667798997026,1.0,8/38,17.87%,AMBRA1;SPATA18;PHB2;ATG12;WDR45B;ATG2A;FUNDC1;WIPI2
prerank,positive regulation of macroautophagy (GO:0016239),0.24498360136456773,0.7743559168638481,0.8032,0.9523350071233547,1.0,10/48,14.55%,PRKAA2;DCN;OPTN;WAC;UVRAG;SESN1;MAP3K7;PIP4K2B;SLC25A4;TBK1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.315999981586814,0.7741453505349697,0.7471698113207547,0.9521117826095206,1.0,4/15,12.58%,APOA2;FOXP3;IRAK3;HFE
prerank,Golgi organization (GO:0007030),-0.188458004237049,-0.7723155142552006,0.9415807560137457,0.9867416639024291,1.0,22/112,16.59%,SYNE1;CSNK1D;LMAN2L;ATP8B2;STX16;ARL1;NSFL1C;GCC2;ATP8B1;TMED2;VMP1;PI4K2A;LMAN1;ARHGEF7;CLASP2;VCPIP1;VPS51;PRKD1;VTI1A;MYO18A;VRK1;TMED7
prerank,histone deubiquitination (GO:0016578),0.3012521348495306,0.7722809815429664,0.7584905660377359,0.9545605140008938,1.0,6/18,19.95%,ATXN7;USP36;UIMC1;USP15;BRCC3;USP7
prerank,protein lipidation (GO:0006497),-0.21629827351586622,-0.7717949416550008,0.88268156424581,0.9867981341763931,1.0,19/59,26.19%,MPPE1;ZDHHC14;ZDHHC20;PIGM;PIGU;ZDHHC2;PIGQ;PIGH;DPM2;PIGO;ZDHHC7;PIK3C3;ZDHHC23;PIGB;ZDHHC9;WDR45;UGCG;ZDHHC5;SELENOK
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.20725082268117578,-0.7717632894296687,0.9032258064516129,0.9861138023040785,1.0,25/62,34.10%,TPT1;ARHGEF2;AKT1;PINK1;CXCL12;CCAR2;PTTG1IP;PLAUR;PPIA;PARK7;ENO1;NOC2L;CREB3L1;NDUFA13;EPO;DNAJA1;HERPUD1;CLU;VNN1;HSPB1;TMEM161A;SRC;MDM2;YBX3;CDKN2D
prerank,regulation of TOR signaling (GO:0032006),0.22984964731444343,0.7716458958885333,0.8369230769230769,0.9550437895568301,1.0,12/67,17.02%,DEPTOR;PRKAA2;ARAF;FBXO9;FNIP1;TTI1;SLC38A9;NPRL3;TBC1D7;MAPKAPK5;LARS1;RICTOR
prerank,mitotic metaphase plate congression (GO:0007080),-0.21552740922793212,-0.771383257858065,0.8624078624078624,0.9859812032467894,1.0,32/51,42.94%,KPNB1;KIF18A;CHMP1A;CHMP1B;CHMP7;CHMP2B;MAD1L1;NUP62;KIF22;CHMP2A;KIF14;SPDL1;CEP55;CHMP6;CHMP4C;ZW10;NUF2;MIS12;KIFC1;VPS4B;NUDC;RAB11A;CDC23;KIF2C;CCNB1;DCTN2;RRS1;BOD1;PINX1;CENPE;CHAMP1;CDT1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.27317598944899485,-0.7713812408349666,0.7911111111111111,0.9852532750078555,1.0,6/19,21.56%,MAF1;ZNF76;POLR3C;NAB2;POLR3G;ZC3H8
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.32196355327922055,0.7711252672198711,0.7433460076045627,0.9553586357704023,1.0,3/15,7.92%,FSTL3;DACT1;SKI
prerank,positive regulation of telomere maintenance (GO:0032206),-0.24452424245847293,-0.7708736544673473,0.7969543147208121,0.9852455832658883,1.0,9/31,19.98%,PRKCQ;NEK7;MRE11;MAPK3;ATM;PNKP;PKIB;GNL3;PPP1R10
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2861387899869672,0.7703172135683483,0.7893805309734513,0.956070480456363,1.0,3/23,6.16%,TPTE;MTMR11;MTMR3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.29102930559981366,0.769596303052319,0.7717996289424861,0.9567132472666727,1.0,2/20,9.14%,AMPD3;PAICS
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.26971884461706963,-0.7693339517542532,0.7891156462585034,0.9867975962398973,1.0,7/21,27.49%,ABCA3;EEPD1;CAV1;RXRA;TREM2;GPS2;NR1H2
prerank,protein K63-linked deubiquitination (GO:0070536),-0.24106435137105048,-0.7690598681153369,0.8479809976247031,0.9864828757008958,1.0,11/31,22.81%,OTUD7A;PSMD14;BABAM1;USP13;ZRANB1;OTUD1;CYLD;YOD1;ATXN3;OTUB2;SHMT2
prerank,snRNA transcription (GO:0009301),0.22922729505079004,0.7686469014606585,0.8436018957345972,0.9576348230286854,1.0,23/70,22.93%,POLR2D;RPRD2;INTS9;NABP1;CDK7;POLR2C;INTS14;POLR2F;POU2F1;INTS3;INTS8;SNAPC3;TAF9;INTS13;SNAPC5;RPRD1B;INTS6;NABP2;POLR2K;SNAPC4;SRRT;SP1;ELL
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.30771666698833067,-0.7680369086876206,0.776595744680851,0.9873018885714255,1.0,1/12,4.35%,PRKCQ
prerank,monocyte chemotaxis (GO:0002548),0.2664951629171309,0.7674974190791835,0.79,0.9588674795210865,1.0,4/32,7.71%,ANXA1;IL6;MSMP;CCL2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3250243182124833,-0.7674931056318706,0.7556935817805382,0.9873797543665402,1.0,4/10,18.00%,SNX3;TERF1;MAPT;PPM1F
prerank,smooth muscle tissue development (GO:0048745),-0.3291250492051776,-0.7674326809964257,0.7663157894736842,0.9867341415174323,1.0,2/10,8.07%,BMP4;MYLK
prerank,L-serine metabolic process (GO:0006563),0.34715729761670167,0.767291595001076,0.755859375,0.9586366981134693,1.0,2/10,4.11%,SHMT1;PHGDH
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3349325328026177,0.7671548183704953,0.7319778188539742,0.9583015268446569,1.0,4/12,15.27%,SGTA;SEC63;CHMP4A;CHMP4B
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.18399226595524362,-0.7670527913101556,0.9347826086956522,0.9865797561462553,1.0,8/112,5.88%,PTPRJ;PLCG2;IL33;THBS1;CD34;GAS6;HMGB1;ARHGEF2
prerank,endosome organization (GO:0007032),-0.22768407668544338,-0.7666699875144183,0.8759124087591241,0.9864408371090626,1.0,16/41,28.25%,RAB27A;CLCN3;SNX3;ALS2CL;VPS33B;PI4K2A;ALS2;CHMP2B;DNAJC13;SNX33;VPS18;LAPTM4B;PHETA2;PI4K2B;SNX10;SQSTM1
prerank,receptor recycling (GO:0001881),-0.3306004456102612,-0.7665109963507936,0.7931034482758621,0.9859412421607079,1.0,3/10,25.00%,SORL1;NSG1;PHETA2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.26718981612284787,-0.7661742840370067,0.8008948545861297,0.9857147471709482,1.0,5/21,13.56%,RPIA;PGM2L1;TKT;GPI;TALDO1
prerank,detection of visible light (GO:0009584),0.3053753492727063,0.765847429432032,0.7486238532110092,0.9598417041326168,1.0,1/16,1.89%,ABCA4
prerank,glycoprotein metabolic process (GO:0009100),0.23808790584528117,0.7655045277992508,0.834658187599364,0.9598535817645827,1.0,4/53,4.37%,MAN1C1;PRKCSH;MAN2A1;LARGE1
prerank,autophagosome organization (GO:1905037),-0.21752511891184073,-0.765259004412831,0.8604651162790697,0.98636969270817,1.0,19/50,30.65%,GABARAP;NSFL1C;GABARAPL1;ATG16L1;VMP1;ATG9A;TP53INP2;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3;WDR45;ULK3;UBXN2B;MAP1LC3B;STX12;RAB1A;WIPI1
prerank,negative regulation of bone remodeling (GO:0046851),0.3368302419111149,0.7651607351916677,0.7359223300970874,0.9598349750281858,1.0,2/11,6.29%,IL6;CARTPT
prerank,positive regulation of ion transport (GO:0043270),0.24258697360996975,0.7647747819492199,0.8428571428571429,0.9599001380090066,1.0,18/48,24.47%,ACTN2;SCN3B;KIF5B;DLG1;GPD1L;STIM2;ANO6;ATP2B1;ADRA2A;P2RX4;GDNF;ANK2;VAMP7;WNK3;SCN4B;CNKSR3;SCN5A;FHL1
prerank,regulation of autophagosome maturation (GO:1901096),-0.30181060302273566,-0.7644375410472668,0.7943722943722944,0.9868542671937763,1.0,5/13,22.59%,SMCR8;ADRB2;IRGM;UBQLN4;CLN3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.24003722656021687,0.7643132902950541,0.820919175911252,0.9600869774944436,1.0,7/52,14.94%,LEPROT;BCL2;NPEPPS;HUWE1;RHOU;USP36;CSNK2A2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.22651184563709076,-0.7640804460182294,0.8613861386138614,0.9866708697018335,1.0,12/40,28.40%,AKT1;MFF;PRELID1;PINK1;GHITM;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;CLU
prerank,regulation of tube diameter (GO:0035296),0.3185456202654293,0.763677791016895,0.7710196779964222,0.9599822655134858,1.0,1/13,0.67%,ROCK2
prerank,vascular process in circulatory system (GO:0003018),0.3185456202654293,0.763677791016895,0.7710196779964222,0.9599822655134858,1.0,1/13,0.67%,ROCK2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3244744974261466,0.7635170890867685,0.7601476014760148,0.9596836486608193,1.0,4/12,19.26%,ACSL1;SCP2;ELOVL1;ACOX1
prerank,regulation of membrane depolarization (GO:0003254),0.29406597631426307,0.7630912104230293,0.7735507246376812,0.9598360276522506,1.0,4/18,9.74%,PTPN3;SCN3B;LRRK2;GPD1L
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.33624152648757216,0.7630223017973532,0.7494692144373672,0.9594142437325514,1.0,10/10,66.40%,MYO9A;RAP2A;SH3BP1;CAMSAP3;RHOA;OPHN1;CDC42;EZR;SYNE4;MSN
prerank,positive regulation of organelle assembly (GO:1902117),-0.2245034170354843,-0.7629402027533061,0.8512396694214877,0.9875451649925527,1.0,15/44,27.63%,RAB3GAP1;CCDC88A;SDCBP;DYNC1H1;PLK4;CNOT2;LCP1;LRSAM1;SPAG5;NUP62;HTT;SDC4;PIP4K2A;SH3GLB1;STX18
prerank,autophagy of peroxisome (GO:0030242),-0.30385457536928695,-0.7628355654942145,0.7804878048780488,0.9869567596116078,1.0,4/12,28.25%,ATM;PIK3C3;MAP1LC3B;SQSTM1
prerank,hyaluronan metabolic process (GO:0030212),-0.26146441766995276,-0.7627581713232361,0.837378640776699,0.9863654310657539,1.0,10/23,28.58%,HEXB;CEMIP;FGF2;GUSB;ABCC5;HAS1;HMMR;HAS3;HYAL3;STAB2
prerank,negative regulation of ion transport (GO:0043271),-0.25740413440191795,-0.7625224512860773,0.7952941176470588,0.9859793287641926,1.0,5/24,10.30%,PTK2B;GPM6B;SNCA;INPP5K;NOS1
prerank,T cell differentiation in thymus (GO:0033077),0.3109714503933479,0.7622458699280275,0.7771428571428571,0.9600801485167437,1.0,1/14,2.82%,GLI3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2761105038897852,0.7621266110240719,0.7749546279491834,0.9597372017925958,1.0,4/25,11.03%,ITPR1;LRRK2;PLEK;CDH13
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.24048562256689926,0.7618109542259942,0.8404074702886248,0.959691706792228,1.0,7/55,10.27%,PID1;ARF4;PDGFRB;MPV17;TGFBR2;NOXO1;MAPK14
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.2951282520699555,-0.7616755229529584,0.7775467775467776,0.9864476876367724,1.0,4/14,13.22%,THBS1;MAPK3;CMKLR1;CSF1R
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.22469910953456043,0.7614494623528495,0.8688271604938271,0.9596954763279774,1.0,12/72,15.41%,ENPP1;RAD50;CUL4A;RFC1;FBH1;RPA3;SPO11;OGG1;GTF2H4;ERCC5;DNASE1L1;ERCC1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2314543792064353,-0.7612532656054605,0.8791773778920309,0.9863696910373345,1.0,15/38,29.85%,H3-3A;NPM1;ASF1A;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;IPO4;CENPA;RBBP7;ITGB3BP;ASF1B;OIP5
prerank,mitochondrion transport along microtubule (GO:0047497),-0.30054785685933266,-0.7608580030389589,0.775,0.9862170417278744,1.0,3/13,15.43%,SYBU;UBB;MAPT
prerank,organic cation transport (GO:0015695),-0.2719830324697714,-0.7607609910287627,0.7907488986784141,0.9856548305852318,1.0,4/20,15.72%,SLC47A1;SLC25A42;SLC22A5;SLC25A19
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.29372273341119925,-0.760700030951846,0.8073022312373225,0.985011996735523,1.0,9/14,41.00%,AKT1;MFSD2A;ABCD2;IRS1;LONP2;MTLN;TYSND1;PLIN5;ABCD1
prerank,neutrophil chemotaxis (GO:0030593),0.23694580711820545,0.7602555084324913,0.8551181102362204,0.9610040474692229,1.0,4/53,7.71%,CXADR;CXCL10;CKLF;CCL2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2698109378826511,-0.7597030801072038,0.7969432314410481,0.9857348105959955,1.0,3/18,10.36%,PIK3R1;BAG6;USP13
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3141187439986465,0.7592840003999699,0.7667844522968198,0.9619373415253972,1.0,4/14,13.63%,BAX;PTPN1;TMEM33;BFAR
prerank,response to acidic pH (GO:0010447),-0.29425617488009875,-0.7591278876966517,0.7927565392354124,0.9858082222555091,1.0,3/13,14.87%,LGMN;CTSS;RAB11FIP5
prerank,regulation of lamellipodium assembly (GO:0010591),-0.23136054259858574,-0.7588291503672984,0.8625,0.985532382129259,1.0,5/34,9.64%,SLIT2;PIK3R1;NCKAP1;ARPC2;ABI3
prerank,regulation of double-strand break repair (GO:2000779),0.24950412556311038,0.7584789551779644,0.8270799347471451,0.9625753485674027,1.0,14/39,22.07%,TRIP12;SPIDR;PPP4R2;SLF2;PML;FIGNL1;SHLD2;MGMT;KDM1A;UBR5;SETD2;SPIRE1;RTEL1;PPP4C
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.29645816456101,0.7582521788111339,0.7922794117647058,0.962373001249155,1.0,7/19,21.40%,DCP2;HNRNPC;XRN1;EXOSC10;TEN1;CTC1;TENT4B
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2575510167205539,-0.758130743804554,0.8163265306122449,0.9857885505290342,1.0,3/22,7.57%,PTPRJ;DGKZ;CEACAM1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.18751266604501618,0.7580133338974201,0.9711417816813049,0.9621935288328792,1.0,56/314,17.83%,SPSB1;TBL1XR1;SMURF2;FBXL17;NEDD4;NHLRC3;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;FBXO9;ANAPC11;KLHL15;FBXL3;PSMB10;SGTA;ANAPC1;AMFR;UBE2C;PSMA3;FBXL20;PSME4;FBXL7;FBXO4;PSMA5;WWP2;FBXO38;UBXN2A;HUWE1;SPOPL;UBXN4;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;CDC27;BFAR;RNF103-CHMP3;FBXL4;KCTD5;PML;FBXL13;FAF2;FBXL12;RNF185;ECPAS;TBL1X;AMN1;DNAJB2;UBE4B;PPP2R5C;TRIM3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3224377212490653,-0.7572604143503185,0.764344262295082,0.9863110824541832,1.0,2/10,5.14%,SEMA6A;DAB2IP
prerank,negative regulation of lymphocyte activation (GO:0051250),0.28820062269129426,0.7567778314211034,0.7942857142857143,0.9634243448341399,1.0,2/21,5.16%,TNFAIP8L2;PTPN22
prerank,intracellular cholesterol transport (GO:0032367),0.3043639068044566,0.7567216154113005,0.7906542056074767,0.9629794364227733,1.0,4/15,16.25%,NPC1;STAR;ABCA1;SERAC1
prerank,regulation of urine volume (GO:0035809),0.342628840217414,0.7567031280309957,0.7524950099800399,0.9624768676744135,1.0,4/10,20.35%,ADM;NPR3;ADCY6;HAS2
prerank,epithelial cell morphogenesis (GO:0003382),-0.2815291561692633,-0.7565447224311987,0.8049792531120332,0.9866106098547006,1.0,9/17,39.93%,MET;RILPL2;SIPA1L3;STC1;COL15A1;PKHD1;POF1B;GRHL2;RAB25
prerank,sulfur compound catabolic process (GO:0044273),-0.22798616978805517,-0.7562302235633585,0.8729016786570744,0.98632073333551,1.0,13/38,26.33%,CSPG4;HEXB;GGT5;TXN2;GGT7;CTH;ADO;LUM;GGT1;MPST;IDS;CSPG5;BGN
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3164160444330938,0.7560803794081703,0.7616279069767442,0.9628337157715852,1.0,1/13,0.97%,RNF152
prerank,regulation of TORC1 signaling (GO:1903432),-0.23261726490941653,-0.7558769888152204,0.8466981132075472,0.9861070011569258,1.0,9/33,18.16%,GPR137C;SESN3;STK11;SMCR8;RRAGB;ATM;SPAAR;RRAGC;PIP4P1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3149554362382129,0.7548304886744129,0.7853107344632768,0.9641588187015963,1.0,4/14,16.92%,RPL7L1;ZNHIT3;WDR12;DDX18
prerank,tRNA wobble uridine modification (GO:0002098),-0.2980295407245212,-0.754670748525344,0.8081896551724138,0.9870743001530651,1.0,7/14,32.68%,ELP1;TRMT9B;DPH3;KTI12;CTU2;ELP3;ALKBH8
prerank,protein kinase A signaling (GO:0010737),0.3221341722450045,0.7544020676804578,0.7677165354330708,0.9642746049155656,1.0,1/12,2.84%,TCP11X2
prerank,regulation of monocyte differentiation (GO:0045655),0.3095758618341373,0.7543690155896049,0.767578125,0.9637826369996887,1.0,3/14,12.04%,IL34;ACIN1;CSF1
prerank,cytosolic transport (GO:0016482),-0.183616515960851,-0.7543048630797042,0.9663299663299664,0.9868685664160989,1.0,31/108,26.43%,MYO1D;EMP2;DOP1B;RAB6B;STX16;WDR81;ARL1;GCC2;CORO7;KLHL20;RGP1;WASHC1;KIF16B;EVI5;RNF126;VPS51;SORT1;VTI1A;LAMP1;UBE2O;TBC1D5;PIK3C3;DCTN1;SNF8;CLN3;VPS13C;YKT6;TBC1D10B;PHETA2;AP2A1;SNX32
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2822376440019507,-0.7538717816370679,0.835920177383592,0.9867401855374777,1.0,6/16,22.51%,ACACA;ACLY;SCD;HSD17B8;FASN;GCDH
prerank,regulation of interleukin-1 beta production (GO:0032651),0.22549470532570218,0.7533845728800364,0.8663522012578616,0.9646405706380612,1.0,7/66,10.22%,IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,macrophage activation (GO:0042116),-0.23242022470351764,-0.7533517191691776,0.8982630272952854,0.9867689782380007,1.0,4/34,5.89%,PLCG2;CD93;SNCA;DYSF
prerank,glycogen biosynthetic process (GO:0005978),-0.30522243123273823,-0.7528402965853229,0.7775510204081633,0.9860374116351195,1.0,3/12,17.08%,PGM2L1;PPP1R3C;PER2
prerank,glucan biosynthetic process (GO:0009250),-0.30522243123273823,-0.7528402965853229,0.7775510204081633,0.9860374116351195,1.0,3/12,17.08%,PGM2L1;PPP1R3C;PER2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21721320627710403,0.7527281198035516,0.9047619047619048,0.9651219018622553,1.0,17/88,15.27%,FBXL17;CUL4A;FBXO9;FBXL3;PSMB10;PSMA3;FBXL20;PSME4;FBXL7;FBXO4;PSMA5;FBXO38;BTRC;FBXW11;FBXL4;FBXL13;FBXL12
prerank,regulation of DNA recombination (GO:0000018),0.2554779772995454,0.7525335278688615,0.811864406779661,0.9648829058395041,1.0,13/32,24.40%,RAD50;SPIDR;PPP4R2;FIGNL1;SHLD2;KDM1A;IL7R;SETD2;RTEL1;PPP4C;MSH2;ZCWPW1;ZRANB3
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2464212418657668,-0.7522604408181565,0.8286384976525821,0.9861069306831309,1.0,8/24,32.98%,MMS19;NDOR1;HSCB;CIAO3;IBA57;ISCU;GLRX5;NUBPL
prerank,negative regulation of chemokine production (GO:0032682),0.31471565138515145,0.7510292644679556,0.7845849802371542,0.9665129071256815,1.0,4/14,15.53%,IL6;LGALS9;MAP2K5;MUL1
prerank,carboxylic acid metabolic process (GO:0019752),0.25784013022928703,0.750962993515775,0.8324958123953099,0.9660746381360678,1.0,12/33,22.47%,PLA2G4A;DDO;LIPT1;SIRT4;PON3;HAO1;GRHPR;ST3GAL1;CARNMT1;AGXT;ST6GAL1;CYB5R3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.29402465546231615,0.7509281800930182,0.7568058076225045,0.965599365762939,1.0,2/18,5.14%,FPR2;C5AR2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.2802056981551484,-0.7503457112219989,0.81875,0.9880517732588521,1.0,7/17,36.75%,SEL1L;SEC61B;HERPUD1;UFD1;HM13;AUP1;DERL1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2921554163061023,-0.7499724177447764,0.8123620309050773,0.9878284969142946,1.0,7/14,33.09%,FASTKD2;C1QBP;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.31320550055736535,-0.7496509807290261,0.774468085106383,0.9875214342102632,1.0,6/12,33.60%,MBTPS1;KPNB1;MBTPS2;DGKQ;LPCAT3;ABCA2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.249407423694799,0.749484123638335,0.8224755700325733,0.9671374555109755,1.0,5/38,10.73%,SP100;CFLAR;SERPINE1;GSK3B;BCL2L1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3074186565920993,0.7494018594286852,0.7762645914396887,0.966724704393024,1.0,6/15,23.42%,NYNRIN;SLFN14;ZC3H12B;RNASEH1;ZC3H12A;KHNYN
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.34060539253559496,0.7492164744633921,0.7875243664717348,0.9659219285805005,1.0,4/10,20.47%,MYADM;MAP2K5;WNK1;MAPK7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.34060539253559496,0.7492164744633921,0.7875243664717348,0.9659219285805005,1.0,4/10,20.47%,MYADM;MAP2K5;WNK1;MAPK7
prerank,plasma membrane tubulation (GO:0097320),0.3141302950929528,0.7488002274373533,0.7899628252788105,0.9660178354787035,1.0,4/13,15.26%,PACSIN2;SNX9;MICALL1;CHMP4A
prerank,positive regulation of intracellular protein transport (GO:0090316),0.20152175719210708,0.7484481047151113,0.9265536723163842,0.9660015550735318,1.0,34/144,22.78%,TCF7L2;LEPROT;SMAD3;ZIC1;BCL2;TPR;NPEPPS;GSK3B;HUWE1;RHOU;USP36;MYO1C;CSNK2A2;MIEF1;TM9SF4;SAR1A;RAPGEF3;RAN;YWHAE;TENM1;EFCAB7;EMD;SEC16A;UBR5;CEP131;ERBB2;TFDP2;ZFAND1;TCAF1;FBXW7;ATG13;ZC3H12A;BAG3;HPS4
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3111490642197813,-0.7479474840386966,0.7925311203319502,0.9891806427568484,1.0,4/10,18.34%,ABCA3;PRELID1;TMEM30A;ABCB4
prerank,cellular component maintenance (GO:0043954),-0.30448868894041964,-0.7475981175371056,0.8008752735229759,0.9889109541346041,1.0,5/12,28.97%,INSR;ITGA3;MTMR2;TREM2;PICK1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2696605040696841,0.7473323046085465,0.8,0.9669956184571806,1.0,1/26,0.45%,ATP1A2
prerank,inner ear morphogenesis (GO:0042472),0.28372545157192935,0.7471142114155263,0.8099467140319716,0.9667639653308794,1.0,3/22,7.72%,ZIC1;TTC39C;TIFAB
prerank,melanosome organization (GO:0032438),0.27001618503791547,0.7459338341060039,0.8137082601054482,0.9678801509438455,1.0,3/26,9.35%,SHROOM2;DTNBP1;HPS1
prerank,histone H3-K9 demethylation (GO:0033169),0.332910748851341,0.745830950466715,0.7784200385356455,0.9674970203843145,1.0,2/11,5.61%,KDM7A;KDM3B
prerank,microtubule bundle formation (GO:0001578),-0.21749877822399405,-0.7457265038862261,0.874384236453202,0.990675209747375,1.0,19/42,34.12%,RP1;MTCL1;AAAS;NCKAP5;CFAP46;CFAP74;SPAG16;TPPP;NAV1;CDK5RAP2;GAS2L1;DCX;TTLL3;CLIP1;PLK1;KIF20A;CFAP206;FOXJ1;CCDC40
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2879742865308099,0.7457015467662197,0.7721280602636534,0.9671483726438279,1.0,2/18,3.73%,NELL1;DACT1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.236899322722135,-0.7453812709629808,0.8620689655172413,0.9904322946534604,1.0,7/31,18.10%,PEX26;PEX10;PEX16;DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.31950765769813216,-0.7453792543283222,0.8035320088300221,0.9897217489812057,1.0,5/10,20.65%,NOTCH1;PHACTR4;LRP6;DLL4;BMP5
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.2944911209214235,0.7450450807009403,0.8051470588235294,0.9675400930448727,1.0,2/15,13.17%,ANXA1;NR3C1
prerank,regulation of centriole replication (GO:0046599),-0.27556476725656687,-0.7444358163209438,0.8097165991902834,0.9902647087929846,1.0,8/17,26.43%,NPM1;PLK4;BRCA1;TRIM37;KAT2A;CDK5RAP2;NUP62;STIL
prerank,negative regulation of cellular component organization (GO:0051129),0.22159477000225583,0.7440661486614402,0.8975903614457831,0.9683594006371475,1.0,6/74,7.66%,BMP6;APOA2;EPHA3;PRKCZ;OPRD1;GSK3B
prerank,cellular response to interleukin-12 (GO:0071349),-0.20952829917144306,-0.7438662212095835,0.9086021505376344,0.9903247694448531,1.0,14/48,24.27%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;IL12RB2;MTAP
prerank,negative regulation of histone modification (GO:0031057),-0.2834986295806205,-0.7438622784856735,0.8121085594989561,0.9896217504730394,1.0,5/14,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,DNA replication (GO:0006260),0.20732029325831514,0.7438363927819379,0.9154727793696275,0.9681575203802825,1.0,18/105,15.44%,RBMS1;ORC5;WRN;TOP1;RAD50;POLA2;RFC1;POLG;REV1;MCMBP;RPA3;MCM4;BAZ1A;RBBP8;MCM6;ORC3;RAD9A;ORC4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2063442870169242,0.7437443677489415,0.9258202567760342,0.96775244221346,1.0,24/122,18.20%,PLD1;SAMD4A;VIM;SLC6A9;SORBS1;IL6;TLR4;GLI1;EPM2AIP1;PDGFRB;CCL2;IGF2;SLC25A37;TLR2;ZCCHC4;SMOC2;SOX4;PRKD2;CPEB3;NOX1;UPF3A;FXR2;HSPH1;PLXNB2
prerank,Rap protein signal transduction (GO:0032486),0.3293210162199964,0.7436457401330003,0.7669322709163346,0.9673589514829233,1.0,6/10,26.78%,RAP2C;RAPGEF3;RAP2B;RAP2A;RAPGEF1;RAP1B
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.21597107040942343,0.7434631052227365,0.9003021148036254,0.9670932173818022,1.0,12/87,10.29%,KANK2;DACT1;CDC73;CCL2;CDKN2B;PSMB10;PSMA3;DLG1;PSME4;USP47;FBXL7;PSMA5
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2216989181559277,0.74335683448691,0.8675078864353313,0.9667280844181905,1.0,10/76,13.07%,MTURN;TCEAL7;BMP7;FOXP3;ANXA4;PARP10;IRAK3;MAP2K5;TRIM21;ARRB1
prerank,protein K11-linked ubiquitination (GO:0070979),0.2661735341577285,0.7429704733887103,0.8152753108348135,0.966749691006134,1.0,5/27,13.48%,ANAPC11;ANAPC1;UBE2C;UBE2E3;CDC27
prerank,glycine transport (GO:0015816),-0.3210096157949127,-0.742801306406083,0.8016877637130801,0.9902360874044512,1.0,3/10,12.37%,SLC38A5;SLC36A1;SLC6A5
prerank,regulation of nervous system development (GO:0051960),0.2518113125997325,0.741906717897988,0.8262243285939969,0.9676976782749112,1.0,6/37,14.84%,PTN;YAP1;DOCK7;HEYL;BHLHE41;NPHP3
prerank,protein trimerization (GO:0070206),-0.2845457586688679,-0.741552587925041,0.8237791932059448,0.990462244359559,1.0,7/14,28.95%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;STEAP4;ALOX5AP
prerank,protein homotrimerization (GO:0070207),-0.2845457586688679,-0.741552587925041,0.8237791932059448,0.990462244359559,1.0,7/14,28.95%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;STEAP4;ALOX5AP
prerank,"phototransduction, visible light (GO:0007603)",0.30992982452880524,0.7415304591977855,0.783427495291902,0.9676991488013368,1.0,1/14,1.89%,ABCA4
prerank,cell projection assembly (GO:0030031),0.2738608847363544,0.7406385476790435,0.7967914438502673,0.9684524729448167,1.0,2/22,2.06%,PARVA;QRICH2
prerank,DNA conformation change (GO:0071103),0.2933793738215382,0.7397590937988714,0.7918968692449355,0.9691415238127293,1.0,3/17,13.90%,TOP1;TOP2B;KAT6A
prerank,regulation of inclusion body assembly (GO:0090083),-0.30330045303558967,-0.7395162451232402,0.8225108225108225,0.9924088471321995,1.0,4/11,24.43%,DNAJA4;SACS;SNCAIP;HSPA2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.22059100716562996,0.7391399501923166,0.8992125984251969,0.9694276175869697,1.0,7/63,7.89%,IL6ST;ANXA1;IL6;BCL2;VCAM1;IL18;CD274
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.23010171150481853,-0.738618233332197,0.8969849246231156,0.9928903891441907,1.0,11/33,21.35%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;RAD51;ANKRD28;TINF2;WRAP53;ZBTB48;PPP6C
prerank,sensory perception of chemical stimulus (GO:0007606),0.30120544597527266,0.7384665970118437,0.7936802973977695,0.9698058449259058,1.0,1/15,2.32%,BEST2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.22328153707597878,0.7383529369766025,0.8922610015174507,0.9694260417035188,1.0,26/68,27.68%,PCF11;POLR1C;CCNH;MNAT1;POLR1G;CDK7;MTERF2;POLR2F;GTF2H4;PABPN1;CSTF3;GTF2H2;CAVIN1;SLBP;TTF1;WDR33;POLR2K;UBTF;CLP1;PAPOLA;MAZ;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,positive regulation of cytokinesis (GO:0032467),-0.23120772838297093,-0.7381527376743919,0.8631840796019901,0.9927861603638363,1.0,19/32,45.95%,CIT;ECT2;KIF23;PRKCE;RACGAP1;KIF14;CDC14B;CDC6;KIF20B;OPN1MW;DRD3;GIPC1;MAP10;CDC42;AURKB;CXCR5;TAS1R2;AURKC;RXFP3
prerank,regulation of ATP metabolic process (GO:1903578),0.23013319615406005,0.737438458233374,0.8808049535603715,0.9701373516792453,1.0,15/54,25.39%,PRKAG2;RANBP2;TPR;JMJD8;POM121;NUP37;ATP5IF1;UQCC2;NUP85;SPHK2;HIF1A;COX7A2L;NUP160;NUP107;PRKAG1
prerank,regulation of neurogenesis (GO:0050767),0.2327826230296926,0.7372412907452882,0.8569254185692542,0.9698732778231541,1.0,8/55,13.10%,WNT3A;NUMB;IL6;APPL2;YAP1;DOCK7;HEYL;BHLHE41
prerank,positive regulation of lipid localization (GO:1905954),0.32479936846452784,0.7367454653424823,0.7712665406427222,0.97004118799542,1.0,4/11,24.41%,IKBKE;LRP1;ZC3H12A;HILPDA
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18548345702514363,0.7366708640812211,0.9698492462311558,0.9696109752446285,1.0,63/264,20.79%,GEMIN4;POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;SRPK1;STRAP;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;TGS1;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;CDK13;WBP4;SCAF11;PCBP2;USP39;PRPF3;WDR33;SNRNP40;DDX5;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,regulation of protein-containing complex assembly (GO:0043254),0.20228722301912033,0.7361159814065664,0.9279411764705883,0.9698051726659794,1.0,15/110,11.97%,SELP;EIF2AK2;CDH5;PRKCZ;SPIDR;FBLIM1;OPRD1;GSK3B;BAX;SUMO1;SLF2;ATF7IP;FNIP1;HJURP;RHOC
prerank,regulation of cellular catabolic process (GO:0031329),0.22308207353083548,0.7360237319895838,0.8789712556732224,0.9694155456297667,1.0,8/62,13.57%,ITPR1;NUPR1;DAPK1;MTMR3;LRRK2;KEAP1;DAPK2;PIP4K2B
prerank,autophagy of nucleus (GO:0044804),0.2915417974548249,0.7359317826933224,0.8074074074074075,0.9690137147082366,1.0,7/16,23.93%,ATG12;WDR45B;ATG2A;WIPI2;ATG13;ATG7;ATG3
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.28404394220247065,0.7357031193776539,0.8212290502793296,0.9687978837788733,1.0,7/22,18.40%,SLC16A2;APPL2;LRRK2;NES;DISP3;KDM2B;KDM1A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.24566757437239262,0.7356906681321085,0.8327868852459016,0.9682980408960105,1.0,8/37,17.31%,CUL4A;RFC1;NTHL1;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2618433354056753,-0.7347097081138781,0.8574468085106383,0.9963903602683838,1.0,7/19,23.43%,HDAC6;PINK1;PARK7;VDAC1;CAMKK2;FZD5;HTT
prerank,interstrand cross-link repair (GO:0036297),0.22842468572659283,0.7345793130624786,0.882258064516129,0.9692701285384655,1.0,8/53,12.36%,NUCKS1;SLX4;RPA3;FANCM;DCLRE1A;CENPX;RFWD3;FANCE
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.2775607114756663,-0.7342314423717207,0.8162393162393162,0.996270538838608,1.0,4/17,13.86%,AKT1;CCND1;EGFR;RGCC
prerank,synaptic vesicle transport (GO:0048489),0.3159121313923223,0.7339460771332662,0.7616161616161616,0.9696087392259761,1.0,3/11,11.84%,TMEM230;KIF5B;SPG11
prerank,positive regulation of coagulation (GO:0050820),-0.3118865197034614,-0.7335894044254306,0.8139059304703476,0.9956794480228678,1.0,2/10,14.61%,THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),-0.3118865197034614,-0.7335894044254306,0.8139059304703476,0.9956794480228678,1.0,2/10,14.61%,THBS1;ST3GAL4
prerank,protein methylation (GO:0006479),0.24199338835256545,0.7334663249946458,0.8464163822525598,0.9697146068546079,1.0,4/40,7.77%,NSD3;NSD1;METTL21C;ETFBKMT
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2296659712150125,0.7327399903870747,0.8811074918566775,0.9696110797614046,1.0,11/50,20.49%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;NUP85;POLR2K
prerank,regulation of gene silencing by RNA (GO:0060966),0.2296659712150125,0.7327399903870747,0.8811074918566775,0.9696110797614046,1.0,11/50,20.49%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;NUP85;POLR2K
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.28149407104157165,-0.7322898754700122,0.8485523385300668,0.996586146637784,1.0,7/15,31.46%,SCARB1;SIK1;MFSD2A;CTDNEP1;C3;NR1H2;LDLR
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2309296403982541,-0.7322346226973443,0.8597701149425288,0.9959514444421925,1.0,7/29,17.54%,THBS1;RET;CAV1;CYLD;LTBR;DEDD2;PYCARD
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3188123516192244,-0.7315912981253672,0.7922330097087379,0.9960295953681957,1.0,6/10,36.31%,E2F7;WIZ;E2F8;DBF4;CDC7;SSBP1
prerank,acyl-CoA metabolic process (GO:0006637),-0.22516148591266197,-0.7315277643062317,0.9033816425120773,0.9954115765770125,1.0,8/35,19.67%,HMGCS1;SUCLA2;HMGCS2;ACACA;ACBD6;MCEE;ACSF2;ACOT2
prerank,protein maturation (GO:0051604),-0.1850241420362911,-0.7312671008515331,0.9610027855153204,0.995025801814253,1.0,23/95,22.59%,F3;CPE;PCSK2;SORL1;TSPAN14;MMP16;ECE1;CTSS;CPD;NAA50;PCSK7;TASP1;PHEX;NNAT;MMS19;NAA10;PSENEN;ADAMTS3;CPXM1;TSPAN33;PCSK5;CPZ;CLN3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.1932135430073878,0.7312486089293323,0.9620081411126187,0.9710040685219798,1.0,16/175,9.21%,PID1;ADAMTS12;ZFAND6;GBP2;TRAF5;TNFSF15;GSDME;TNFRSF12A;BIRC3;EDA;STAT1;CCL2;TNFRSF14;PSMB10;PSMA3;PSME4
prerank,ureteric bud morphogenesis (GO:0060675),-0.27106402393436513,-0.7311890467797114,0.8340425531914893,0.9944218096754018,1.0,4/16,11.27%,SIX1;BMP4;FGF2;PAX2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.25798143637031146,-0.7310506331798653,0.8306997742663657,0.9938881315339088,1.0,8/20,30.54%,HSP90AB1;HSPA4;HSP90AA1;TMEM35A;HOPX;BBS10;CLU;PSMG2
prerank,regulation of protein localization to cell surface (GO:2000008),0.25117210280236707,0.7308432588050889,0.8508474576271187,0.970999564064135,1.0,8/33,17.50%,LEPROT;ACTN2;GPD1L;HFE;BDNF;TM9SF4;GBF1;ABCA7
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.29393260655736947,-0.7306425464544998,0.8133047210300429,0.9936891016256529,1.0,5/13,21.97%,RACK1;HSPA5;PPP1R15B;UFL1;PPP1R15A
prerank,negative regulation of intracellular protein transport (GO:0090317),0.2752932498370956,0.7298964263963001,0.8068965517241379,0.9717567777203776,1.0,3/22,10.14%,SP100;LRRK2;SUFU
prerank,apoptotic nuclear changes (GO:0030262),-0.24445687896059254,-0.7298940475408411,0.8834080717488789,0.9938824174999548,1.0,6/24,18.02%,HMGB1;KPNB1;H1-0;DEDD2;FOXL2;DICER1
prerank,cellular response to ATP (GO:0071318),0.29940010749666507,0.7298083203130998,0.8085501858736059,0.971345601612769,1.0,6/14,24.07%,SSH1;CIB2;P2RY1;P2RX4;TAF1;P2RX3
prerank,toll-like receptor signaling pathway (GO:0002224),0.2113671486999777,0.7291362491648281,0.9223880597014925,0.9716879249622697,1.0,13/84,13.97%,COLEC12;TLR4;MAP3K1;SCARA3;BIRC3;LY96;LGALS9;RIPK2;TLR2;IRAK3;MAP3K7;RPS6KA3;TICAM1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2325352673772528,0.7285998667197173,0.881619937694704,0.9718460271908446,1.0,8/48,15.00%,IKBKE;BCL2;MCL1;BAX;BCL2L1;EPHA2;HIC1;PML
prerank,adenine nucleotide transport (GO:0051503),0.2918723684273776,0.7280980267315406,0.8054474708171206,0.9719914316216365,1.0,4/17,14.25%,SLC19A1;SLC17A9;SLC25A24;SLC25A4
prerank,cellular response to estradiol stimulus (GO:0071392),0.28142136627587155,0.7271540612030802,0.8264014466546112,0.9726928749916771,1.0,2/18,8.37%,NCOA3;FAM210B
prerank,pseudouridine synthesis (GO:0001522),-0.2872774160969121,-0.7271522394934212,0.8258196721311475,0.9964699557860645,1.0,7/13,33.14%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;NOP10;NHP2
prerank,mRNA export from nucleus (GO:0006406),0.2043720171618224,0.7268351079238486,0.9355783308931186,0.9725779754356747,1.0,25/102,19.71%,NXF2;POLR2D;RANBP2;TPR;SLU7;SRSF4;IWS1;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;PABPN1;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.28867792705050044,0.7265130098352968,0.8210922787193974,0.9724631984391986,1.0,2/17,4.01%,EIF2AK2;TAOK3
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3056899538646312,0.7263558725182873,0.8041431261770244,0.9721370487450715,1.0,3/13,8.36%,NOS2;ALDH4A1;GLUL
prerank,negative regulation of histone methylation (GO:0031061),0.3283214126569059,0.7258566020110643,0.7857142857142857,0.9722298461711522,1.0,5/10,24.09%,BCOR;JARID2;KDM1A;PHF1;WDR5
prerank,positive regulation of cellular respiration (GO:1901857),0.31217966925495055,0.7255779046963734,0.7898832684824902,0.9720467491846848,1.0,2/11,10.66%,NUPR1;IFNLR1
prerank,epithelial cell development (GO:0002064),-0.255779153512659,-0.7253570213001818,0.8720682302771855,0.9979062825702225,1.0,5/20,16.60%,ACTA2;RILPL2;SIPA1L3;SLC4A7;EXPH5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.287457163708167,0.7252115964528747,0.8173258003766478,0.9720058322270946,1.0,3/17,5.66%,NRP1;BAIAP2L1;HAX1
prerank,negative regulation of T cell activation (GO:0050868),0.24214569270572506,0.725180663217349,0.8812056737588653,0.9715236354832346,1.0,4/35,7.89%,TNFAIP8L2;PTPN22;FOXP3;CD274
prerank,positive regulation of cholesterol transport (GO:0032376),-0.23968410293323394,-0.7249732362455479,0.8813559322033898,0.9976437786913535,1.0,9/27,27.49%,ABCA3;EEPD1;CAV1;RXRA;ABCB4;ABCA13;TREM2;GPS2;NR1H2
prerank,regulation of cell aging (GO:0090342),0.31698185239360704,0.7246423777913813,0.7895752895752896,0.9717095591814889,1.0,6/11,29.72%,NEK4;PNPT1;NEK6;RSL1D1;ING2;LMNA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.3217276224800018,0.7244736034388716,0.7802874743326489,0.9714045817259342,1.0,3/11,17.50%,NECAB1;SOAT1;ABCA7
prerank,defense response to fungus (GO:0050832),-0.26265758709103715,-0.7242936933855323,0.8418803418803419,0.9977427530167732,1.0,1/17,1.55%,PLCG2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2905461986263775,-0.7240900260912136,0.8317214700193424,0.9972755722945672,1.0,9/12,42.94%,KAT7;WRNIP1;BLM;WDR18;TICRR;NUGGC;NBN;METTL4;CDT1
prerank,purine ribonucleotide transport (GO:0015868),0.29563077354325384,0.7240821392769912,0.812133072407045,0.9713832952504572,1.0,4/16,14.25%,SLC19A1;SLC17A9;SLC25A24;SLC25A4
prerank,receptor catabolic process (GO:0032801),-0.24309604940567572,-0.7228530707454663,0.8699360341151386,0.9980326138965044,1.0,10/24,27.44%,LGMN;VLDLR;KIF16B;AP2B1;SNX25;AP2A2;AP2A1;SH3GLB1;CLTA;AP2M1
prerank,regulation of telomere maintenance (GO:0032204),0.25565586741385044,0.7228185161998955,0.8458904109589042,0.9723906368821668,1.0,9/26,21.48%,RAD50;SMG5;SMG6;PML;ERCC1;SMG1;DHX36;USP7;RTEL1
prerank,cellular response to estrogen stimulus (GO:0071391),0.2983033760173806,0.7226125356361099,0.8074766355140187,0.9721386640233672,1.0,4/14,20.36%,SFR1;TRIM24;RARA;ARID5A
prerank,negative regulation of type I interferon production (GO:0032480),0.23920551269465126,0.7224977179333522,0.871499176276771,0.9717486091834852,1.0,11/40,23.15%,IKBKE;RNF216;NLRX1;PPM1B;IFIH1;TBK1;RNF135;PCBP2;REL;OTUD5;TAX1BP1
prerank,nucleosome assembly (GO:0006334),-0.231436240427067,-0.7220518495341042,0.9,0.9982502515562152,1.0,6/31,14.79%,H3-3A;NPM1;SART3;ASF1A;ANP32B;SPTY2D1
prerank,positive regulation of catalytic activity (GO:0043085),0.24143732482177294,0.7216282355992639,0.8735632183908046,0.9723077370046659,1.0,6/37,10.27%,NHEJ1;WRN;AZIN2;XRCC4;IGF2;MAPK14
prerank,ruffle organization (GO:0031529),-0.2721855511028503,-0.7206057737542505,0.8755555555555555,0.9992037371048341,1.0,7/16,23.67%,PLEKHA1;INPP5K;CSF1R;RAC1;ARF6;CARMIL1;AIF1
prerank,methylguanosine-cap decapping (GO:0110156),0.31408331120549193,0.7205215566398327,0.7987927565392354,0.9731913333927548,1.0,2/10,7.46%,LSM1;DCP2
prerank,lysosome organization (GO:0007040),0.2431957331684622,0.7203960126780451,0.8525754884547069,0.9728241036608501,1.0,11/36,23.59%,CLN5;LRRK2;HPS1;TMEM165;ARSB;ABCA1;HOOK1;VPS33A;HPS4;TPCN2;LAMTOR1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2967432397957363,-0.7202603683647387,0.8167006109979633,0.9988739588007131,1.0,5/10,25.95%,HOMER1;CD84;SLC8B1;CASQ1;HOMER2
prerank,mRNA processing (GO:0006397),0.18114431348643914,0.7202344796282178,0.9900249376558603,0.9724924229587208,1.0,67/287,20.79%,POLR2D;PCF11;PRCC;RBM41;RPRD2;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;CCNH;DDX23;SLU7;CWF19L1;MNAT1;CDK7;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;THOC5;GTF2H4;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;GTF2H2;WBP4;SCAF11;PCBP2;USP39;PRPF3;WDR33;RPRD1B;SNRNP40;DDX5;RNGTT;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,protein insertion into ER membrane (GO:0045048),-0.21387412592516297,-0.7198688461157686,0.8973105134474327,0.9986135161414286,1.0,14/37,28.16%,BAG6;SERP1;TRAM1;CAMLG;CCDC47;EMC10;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;GET1;SEC61B;VAMP2
prerank,plasma membrane invagination (GO:0099024),-0.2258482317849887,-0.7194468380687944,0.8913043478260869,0.998349092507198,1.0,9/29,25.04%,ELMO1;DOCK1;SNX18;FCGR1A;ITGB2;SNX33;AIF1;BIN2;MSR1
prerank,nuclear pore organization (GO:0006999),0.2983063401512934,0.7186272441488963,0.821917808219178,0.9740008713885827,1.0,3/14,13.84%,TPR;AHCTF1;RTN4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.29470853019257887,0.7184224840914314,0.8398576512455516,0.9737370997747907,1.0,3/17,11.55%,EMC2;SGTA;EMC9
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.25749366038462845,-0.7178273803327267,0.8489702517162472,0.9995474239887541,1.0,10/18,45.03%,CEP135;CCT5;WRAP53;TREM2;CCT7;CCT8;CHP1;CEP295;TNF;CCT4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.23156454053208878,-0.7173570536299704,0.8978622327790974,0.999407872249866,1.0,10/28,28.83%,CTSC;PSMC3;DAB2IP;TMTC3;PSMC6;CCDC22;PSMC5;TREM2;CLU;LAPTM5
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3085653124540926,0.7173518773797056,0.8323586744639376,0.9744957732561346,1.0,3/11,15.98%,POMT2;UGGT2;RNF185
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.2749191163822784,-0.7148863961899566,0.8394308943089431,1.0,1.0,6/15,36.75%,SEL1L;SEC61B;HERPUD1;UFD1;AUP1;DERL1
prerank,ncRNA catabolic process (GO:0034661),0.25579087908148945,0.714344682744435,0.8677248677248677,0.9775812002340722,1.0,8/28,16.37%,TUT4;SND1;XRN1;DIS3L;SLFN14;DIS3;ERN2;EXOSC10
prerank,mRNA stabilization (GO:0048255),0.2391487446865607,0.7142814436981749,0.87,0.9771437127734129,1.0,9/40,17.71%,TENT5A;IGF2BP1;HNRNPC;NOCT;MAPK14;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,centromere complex assembly (GO:0034508),-0.22003763010709348,-0.7140831603834209,0.9033942558746736,1.0,1.0,17/36,35.40%,NPM1;HELLS;CENPU;CENPT;CENPQ;CENPL;CENPN;CENPF;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;DLGAP5;CENPW;MIS12;KNL1
prerank,melanosome localization (GO:0032400),-0.2433397642770011,-0.7140248313714305,0.893569844789357,1.0,1.0,4/21,11.54%,RAB27A;RAB27B;VPS33B;MLPH
prerank,negative regulation of RNA metabolic process (GO:0051253),0.27945878310158745,0.713510027647587,0.8403669724770643,0.9775380734829076,1.0,2/18,4.00%,PTBP3;TERT
prerank,endocytic recycling (GO:0032456),0.22641448434464054,0.7130757653935044,0.892018779342723,0.9775513173136603,1.0,9/50,14.31%,TRARG1;SNX12;DENND1A;VPS35L;ACAP2;MICALL1;SNX27;ENTR1;VPS26C
prerank,alcohol catabolic process (GO:0046164),0.31935764484321927,0.7128079687911365,0.8258317025440313,0.9773395421419212,1.0,1/10,3.22%,CYP27A1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.29883033020010846,-0.7124003345420611,0.8486140724946695,1.0,1.0,5/10,25.38%,ABCA3;MFSD2A;MTMR2;MTMR1;MTMR9
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.25717415220314077,-0.7105023671562286,0.864516129032258,1.0,1.0,3/18,13.96%,CCN3;KCNB1;INHBB
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20220659127600776,-0.71049232202065,0.953551912568306,1.0,1.0,11/51,18.29%,PRKCQ;NEK7;CTNNB1;MAPK3;TERF1;GNL3L;ATM;PNKP;PKIB;CCT5;TINF2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.2886120244386452,0.7104341294505813,0.8336520076481836,0.9796670982268137,1.0,4/16,20.45%,BMP7;FTO;NAPEPLD;PTGS2
prerank,electron transport chain (GO:0022900),0.2855761899097834,0.710375577849027,0.8385321100917431,0.9792157769278356,1.0,3/15,19.87%,POR;ETFA;UQCRFS1
prerank,postreplication repair (GO:0006301),0.23170729860680858,0.7100532138118024,0.8871473354231975,0.9790646350952975,1.0,6/45,10.87%,POLH;PARP10;RFC1;REV1;RPA3;UBE2V1
prerank,regulation of proteolysis (GO:0030162),-0.20307295439442918,-0.7100018473779044,0.9281914893617021,1.0,1.0,18/48,31.14%,CST3;PERP;AKT1;HDAC6;SPOP;BAG6;CAV1;PLAUR;AURKAIP1;BAD;FGFR4;CLN3;CDK5;GSAP;FADD;NEDD8;PLK1;LTBP4
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3210843811546421,0.7099473069182579,0.8273244781783681,0.9786886065390767,1.0,2/10,10.49%,ACTN2;PLEK
prerank,negative regulation of cell cycle process (GO:0010948),0.21779302960769364,0.7096016092870191,0.9216589861751152,0.9785620366177299,1.0,17/61,22.28%,SUZ12;BMP7;UXT;MGA;NANOS2;ESPL1;EPC1;RBBP8;TOM1L2;RING1;RNF2;BMI1;TOM1L1;TFDP2;PCGF2;APAF1;NME6
prerank,positive regulation of transmembrane transport (GO:0034764),-0.284647934744149,-0.7095334812086901,0.8651452282157677,1.0,1.0,6/13,21.34%,CA2;ACSL5;NR4A3;C2CD5;P2RX7;C3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.2664263056637568,-0.7086643278577465,0.8592750533049041,1.0,1.0,5/17,23.30%,NOS1AP;KCNQ1;KCNE4;GJA5;SCN1B
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.1845262972299876,0.7081647633981393,0.9809004092769441,0.9797192707910516,1.0,25/184,12.57%,NINL;DYNLL1;ALMS1;SDCCAG8;PLK5;CLASP1;APPL2;CEP152;ANAPC11;HAUS8;KLHL18;PSMB10;ANAPC1;UBE2C;PSMA3;PSME4;APPL1;PSMA5;PTPN6;NEDD1;CDC14A;CUL3;MAD2L1BP;BTRC;HECW2
prerank,response to gamma radiation (GO:0010332),-0.23560331747156826,-0.7081375288792299,0.8851351351351351,1.0,1.0,12/24,33.21%,RPL26;MAP3K20;ATM;HRAS;MEN1;ATR;DCUN1D3;XRCC6;MYC;TP53;TMEM109;MDM2
prerank,integrated stress response signaling (GO:0140467),0.2922451422144873,0.7078716404752551,0.8256880733944955,0.9795379153858246,1.0,3/14,15.09%,CCL2;QRICH1;EIF2AK3
prerank,cellular response to interleukin-15 (GO:0071350),-0.28216278605729095,-0.7077296001551769,0.8240343347639485,1.0,1.0,1/13,0.97%,PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.28216278605729095,-0.7077296001551769,0.8240343347639485,1.0,1.0,1/13,0.97%,PLCB1
prerank,negative regulation of translational initiation (GO:0045947),0.290570322727916,0.7070836953336413,0.8267716535433071,0.9799063910252633,1.0,1/13,5.83%,TPR
prerank,apoptotic mitochondrial changes (GO:0008637),0.24448375697488134,0.706247087876604,0.8794567062818336,0.9803836332858493,1.0,5/32,10.73%,IFIT2;BCL2;BAX;DNM1L;BCL2L1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.30789458649789014,0.7059629034054707,0.8234126984126984,0.9801888979669147,1.0,4/12,17.35%,PLA2G6;PPP3CB;BAIAP3;C2CD2L
prerank,negative regulation of RNA splicing (GO:0033119),-0.2466284239233228,-0.7058168060178601,0.8782201405152225,1.0,1.0,7/19,21.65%,PTBP1;RPS13;RPS26;RNPS1;SRSF9;C1QBP;SRSF6
prerank,COPII-coated vesicle budding (GO:0090114),-0.1843833222910734,-0.7048770348089832,0.9749303621169917,1.0,1.0,17/68,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.2996394732314452,0.7046976044443427,0.8170731707317073,0.9810975517389899,1.0,2/12,8.24%,MYCBP2;EPHA4
prerank,lymphocyte proliferation (GO:0046651),0.26101710889682384,0.7035697029800692,0.8414839797639123,0.9818369209256481,1.0,4/22,11.81%,CTPS1;BCL2;ELF4;PPP3CB
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.2925184962884961,0.7032886355430912,0.828125,0.9816130933764683,1.0,2/13,6.37%,NFATC4;PPARA
prerank,protein localization to mitochondrion (GO:0070585),-0.29830587226220984,-0.7032769530366562,0.8416833667334669,1.0,1.0,5/11,26.29%,AKT1;PINK1;MAIP1;MTCH2;DNAJA1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.17941779587053333,0.7031523274360553,0.9870801033591732,0.9812606988234596,1.0,57/241,20.79%,POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;WBP4;PCBP2;USP39;PRPF3;WDR33;SNRNP40;DDX5;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22657787006524263,-0.7024591448727184,0.9112709832134293,1.0,1.0,13/29,35.40%,NPM1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22657787006524263,-0.7024591448727184,0.9112709832134293,1.0,1.0,13/29,35.40%,NPM1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.2883685895424016,-0.7017831567779692,0.8347280334728033,1.0,1.0,11/11,71.19%,PRDX2;PRDX5;GPX1;GPX3;PRDX4;MPO;PXDNL;PRDX1;CAT;PRDX3;PXDN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2044115278005097,0.7016859858132853,0.9514978601997147,0.9823875788882254,1.0,6/80,7.41%,VPS54;DENND2A;SNX6;HEATR5A;SNX12;CLN5
prerank,vitamin D metabolic process (GO:0042359),-0.2750806748687653,-0.7015634465384465,0.8778947368421053,1.0,1.0,8/13,46.42%,LGMN;CYP2R1;VDR;CYP1A1;GC;CYP27B1;CYP24A1;FGF23
prerank,translesion synthesis (GO:0019985),0.22971396787885515,0.7012641502196959,0.88801261829653,0.9823445603261518,1.0,7/42,14.53%,POLH;PARP10;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.28185986304954125,-0.7012236682999179,0.853448275862069,1.0,1.0,6/12,33.36%,CTNNB1;DDX11;RAD21;CTCF;FEN1;BUB1
prerank,hyaluronan catabolic process (GO:0030214),-0.25538310777381246,-0.7011873406128099,0.8831460674157303,1.0,1.0,4/18,11.92%,HEXB;CEMIP;FGF2;GUSB
prerank,regulation of G0 to G1 transition (GO:0070316),0.23816432898015963,0.7000216688590504,0.875,0.9831976996636749,1.0,12/38,22.11%,SUZ12;UXT;MGA;CDKN2B;EPC1;RBBP8;RING1;RNF2;BMI1;TFDP2;PCGF2;APAF1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.30900281873641355,0.6999668828018023,0.8125,0.9827549351647407,1.0,2/11,11.18%,PPARA;TRAP1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24379132959058727,-0.6997289349664693,0.8822222222222222,1.0,1.0,13/21,39.62%,RCC2;NPM1;CCND1;ATAD5;CDK4;DTL;CDK1;DYRK3;VPS4B;CDC7;RAB11A;CCNB1;CDC25C
prerank,regulation of DNA recombination at telomere (GO:0072695),0.26866636790698334,0.6996481000314241,0.8587360594795539,0.9820822406815501,1.0,3/19,13.75%,POLR2D;POLR2C;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.26866636790698334,0.6996481000314241,0.8587360594795539,0.9820822406815501,1.0,3/19,13.75%,POLR2D;POLR2C;POLR2F
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2456753952316025,0.6996360022114003,0.8835125448028673,0.9815837134998897,1.0,8/31,21.20%,RBP4;IL6;PHB2;SHLD2;KMT5C;RIF1;KMT5B;XBP1
prerank,ncRNA 3'-end processing (GO:0043628),-0.27145350207194524,-0.6979571950256525,0.8556485355648535,1.0,1.0,7/14,30.92%,INTS7;INTS6L;INTS12;ERI1;TOE1;INTS5;INTS2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.2881726781973821,-0.6978941335426645,0.8453815261044176,1.0,1.0,3/11,15.14%,TGFB2;BMP4;ZFPM2
prerank,cellular response to ionizing radiation (GO:0071479),0.22504515939126887,0.6978748864082013,0.8983870967741936,0.9829949119497143,1.0,12/47,18.62%,PRAP1;NUCKS1;WRN;SPIDR;YAP1;TLK2;MAPK14;RAD9A;FIGNL1;NIPBL;KDM1A;CLOCK
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.26735119379567573,0.6967903429538886,0.8531073446327684,0.9835866177980898,1.0,6/18,21.69%,POR;GDNF;ABL2;SIRT3;AGT;PDP2
prerank,catecholamine metabolic process (GO:0006584),0.2861666148694382,0.6961849194835042,0.8368932038834952,0.9837399270386112,1.0,3/14,19.02%,COMT;RNF180;LRTOMT
prerank,negative regulation of DNA binding (GO:0043392),0.24452574136350522,0.695994581840694,0.900523560209424,0.9834392614562504,1.0,3/28,9.34%,SP100;CPNE1;SUMO1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.23234522695851023,-0.6951133638652082,0.8973214285714286,1.0,1.0,5/25,17.08%,DOT1L;H1-0;HEY1;PARK7;PER2
prerank,RNA transport (GO:0050658),0.20593658146262928,0.6947917482122032,0.9488372093023256,0.984183715851651,1.0,11/71,15.13%,SIDT1;NXF2;TPR;TGFBR2;SLU7;SRSF4;MAGOHB;DDX39A;THOC5;POM121;SRSF5
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.25283466777921826,-0.6945343743185927,0.881578947368421,1.0,1.0,7/18,28.69%,MAF1;ATF4;SIRT7;HEATR1;RASL11A;LYAR;WDR75
prerank,regulation of T cell migration (GO:2000404),0.274609828365045,0.6940662569625495,0.8557692307692307,0.9844446084023186,1.0,2/18,7.90%,CXCL10;TNFRSF14
prerank,sister chromatid segregation (GO:0000819),0.23853427797711588,0.6940264356073133,0.886986301369863,0.9839725439556839,1.0,4/31,9.26%,KLHL22;TOP2B;ESPL1;ZWINT
prerank,regulation of mitochondrial translation (GO:0070129),-0.23952624738996395,-0.6938125416946604,0.9066666666666666,1.0,1.0,9/21,33.09%,FASTKD2;MALSU1;C1QBP;SHMT2;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2679917977507116,-0.6927386493932524,0.8519269776876268,1.0,1.0,9/14,36.09%,HNRNPA0;ANGEL2;MYD88;BOLL;ZFP36;YBX3;TIRAP;TARDBP;DAZL
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.25635393103871557,0.6924399868737059,0.8492201039861352,0.9851202579677467,1.0,4/22,15.47%,CD55;FBXO38;MAP3K7;IL23R
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.23117497951886823,-0.6922311031306663,0.9170854271356784,1.0,1.0,11/26,29.51%,ST3GAL6;B3GNT2;B4GALT4;ST3GAL4;LUM;B3GNT3;B4GALT6;CHST5;B4GALT2;B4GAT1;ST3GAL2
prerank,intestinal absorption (GO:0050892),-0.2726254623381403,-0.6920128543195206,0.8796498905908097,1.0,1.0,5/13,28.35%,KCNQ1;F11R;TJP2;UGCG;SLC2A2
prerank,telomere maintenance via telomerase (GO:0007004),-0.22226911880789313,-0.6917792496439185,0.9088729016786571,1.0,1.0,9/28,21.35%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23869468778275543,0.6914318786742355,0.8856655290102389,0.9856813419534722,1.0,9/32,19.81%,APOA2;STARD10;CSNK2A2;PCYT1A;LPIN2;ABHD3;PEMT;SLC44A2;SLC27A1
prerank,cellular protein-containing complex assembly (GO:0034622),0.18201024248551548,0.6905040097065365,0.9875862068965517,0.9861617996310047,1.0,24/159,16.34%,TCF4;SMAD3;WNT3A;ANGPT1;PSMG1;TPR;PIK3C2A;POGZ;DNAAF1;SNX9;UVRAG;DNAI4;FCHO2;SMAD4;AHCTF1;DRC1;RTN4;CHMP3;NCK1;CHMP4A;CHMP4B;SRP19;SMAD2;TBCA
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2359687244710011,-0.6902503648838508,0.9144144144144144,1.0,1.0,6/24,19.11%,NOD1;UBB;UBA52;CYLD;NOD2;IRAK1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.30943137673383325,0.6892617743530457,0.8045540796963947,0.9869541765889287,1.0,3/10,11.59%,IRAK3;MAP2K5;SH2B3
prerank,negative regulation of ATPase activity (GO:0032780),0.27336625373374196,0.6890861204906877,0.8513513513513513,0.9866247512472686,1.0,6/16,25.84%,IFIT1;ATP5IF1;PXK;OXA1L;THADA;TNNI3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.31076677954093557,0.6889570898393511,0.844,0.9862466019437414,1.0,2/10,7.59%,TGFBR2;STAT1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2744691446614992,0.6889324690618503,0.8650646950092421,0.9857576200636549,1.0,1/17,1.32%,FGF1
prerank,regulation of dephosphorylation (GO:0035303),0.2823049261928801,0.6888325805864393,0.8562992125984252,0.9853444337714281,1.0,5/15,14.42%,MTMR3;PPP1R16A;SMG5;SMG6;SMG7
prerank,mitotic cytokinetic process (GO:1902410),-0.24674997772515905,-0.6887290765079537,0.8796498905908097,1.0,1.0,10/20,30.19%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CNTROB;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,regulation of cell cycle process (GO:0010564),-0.1722461342285401,-0.687977441337171,0.9938650306748467,1.0,1.0,24/104,20.81%,CALM1;CALM2;CTNNB1;RAB11FIP3;CALM3;YTHDF2;DYNC1H1;BORA;CAV2;CCDC8;CEP85;PLK4;RMI2;RAB11FIP4;PRC1;L3MBTL1;ECT2;CHEK1;PIK3C3;PRMT5;KNSTRN;MAD1L1;SPAG5;MKI67
prerank,covalent chromatin modification (GO:0016569),-0.2606794549246386,-0.6873009517698415,0.8599137931034483,1.0,1.0,6/14,21.95%,HDAC1;HELLS;PARK7;SIRT7;UFL1;PARP2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.21953804843385782,-0.6871129843523646,0.9054726368159204,1.0,1.0,13/31,33.92%,MAPK8;HIP1R;YWHAH;PPP1R13B;YWHAQ;BAD;CHCHD10;YWHAZ;PPP3CC;PMAIP1;TP53;BOK;E2F1
prerank,histone acetylation (GO:0016573),0.20443327893821173,0.6869910648752404,0.9339622641509434,0.9866846695355816,1.0,24/69,24.34%,APBB1;BRD1;CREBBP;KAT6B;EPC1;JADE2;ACTL6A;MAP3K7;BRD8;KAT6A;ZZZ3;KAT2B;PHF20L1;TAF9;TRIM16;ATF2;NAA40;CPA4;DR1;SUPT7L;WDR5;ING5;EP400;TAF6
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.1886530317125865,0.6867501623576447,0.9652567975830816,0.9864188268441738,1.0,19/113,15.41%,ASAP1;CDH5;TLR4;UNC13B;CUL4A;GBP5;SPIDR;GSK3B;BAX;SUMO1;SLF2;RPA3;PLEK;FNIP1;RHOC;GTF2H4;ERCC5;ABCA1;ERCC1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.25406328761761343,-0.6862842259002333,0.8980891719745223,1.0,1.0,2/16,9.32%,GPR137C;RRAGB
prerank,purine nucleotide catabolic process (GO:0006195),-0.26615579613922324,-0.6856694021156106,0.8821138211382114,1.0,1.0,3/13,15.69%,HINT1;PNP;NT5C2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2638115004703687,-0.6855643616362387,0.8553191489361702,1.0,1.0,3/15,19.53%,CPEB2;GSTO2;GSTO1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.25377961390470327,-0.6854268106819906,0.8858921161825726,1.0,1.0,8/17,35.92%,HDAC9;SORT1;LPL;PCSK5;NR1H2;LIPC;FURIN;APOH
prerank,response to reactive oxygen species (GO:0000302),0.2141145793529042,0.6853226670351837,0.9406919275123559,0.9873989157193461,1.0,5/54,8.57%,PDGFRA;FER;TPM1;MPV17;STK24
prerank,positive regulation of organelle organization (GO:0010638),0.2373143369348604,0.6850775443744528,0.9003378378378378,0.9871269277248954,1.0,7/32,18.72%,ANXA2;ANXA1;GSK3B;UVRAG;TMED9;KATNBL1;PLA2G5
prerank,regulation of gluconeogenesis (GO:0006111),-0.22008617209773013,-0.6850076994776908,0.9219858156028369,1.0,1.0,8/27,28.99%,C1QTNF3;SIK1;PGP;NNMT;SIRT7;ZNF692;DGKQ;GNMT
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3095364162740396,0.6847604103353305,0.8401559454191033,0.9869328360400662,1.0,3/10,17.53%,ZNHIT3;TAF9;NUFIP1
prerank,ERAD pathway (GO:0036503),-0.17514206114209657,-0.6846476016189463,0.9848942598187311,1.0,1.0,28/83,30.84%,SEL1L;ERLIN1;BAG6;USP13;UBXN8;BRSK2;CCDC47;HSPA5;TMUB2;YOD1;STT3B;FAM8A1;PSMC6;UBXN6;UBE2J1;SGTB;ATXN3;TMUB1;FBXO6;RNF121;FBXO2;SEC61B;HERPUD1;RNF5;UBE2G2;RHBDD2;UFD1;TOR1A
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.24713191309332905,0.6845733196772192,0.8812056737588653,0.9866185509049731,1.0,9/24,23.79%,NR1H3;LRRK2;BCL2L1;OPA1;UBXN1;XBP1;TXNDC12;SYVN1;USP25
prerank,regulation of Golgi organization (GO:1903358),0.2726031116943996,0.6844181414980627,0.845724907063197,0.9862673321507202,1.0,5/17,18.94%,ARMH3;MAP2K1;RAB33B;MYO5A;USP6NL
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.21452815645472204,0.6838456322653717,0.9345794392523364,0.9863210639025178,1.0,17/58,20.15%,NHEJ1;RAD50;XRCC4;SUMO1;UVRAG;DCLRE1A;NSMCE2;KDM2A;PRPF19;ERCC6;UIMC1;ERCC1;SMARCAL1;BRCC3;CYREN;RIF1;ERCC8
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.30531667817462826,0.681540979680721,0.8538011695906432,0.9880777659757224,1.0,11/11,69.49%,PKD1L3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;PKD2L1;RTP3;LPO
prerank,regulation of mitotic spindle assembly (GO:1901673),0.26123080319338465,0.6811317068072313,0.895117540687161,0.9879535599868401,1.0,5/19,19.77%,TPR;CHMP3;CHMP4B;EML3;CHMP5
prerank,positive regulation of DNA binding (GO:0043388),-0.2149069667756201,-0.6810754542480854,0.9339622641509434,1.0,1.0,7/31,17.72%,HMGB1;NGF;H1-0;PLAUR;PARK7;EGF;HES1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2127347939365526,0.680723584471408,0.941717791411043,0.987847569690228,1.0,5/54,6.52%,CFLAR;CASP4;CPNE1;BIRC3;PTPN2
prerank,response to nutrient levels (GO:0031667),0.2748266897241782,0.6791153787183883,0.8547486033519553,0.9889112784243909,1.0,1/17,1.61%,PRKAA2
prerank,response to fatty acid (GO:0070542),0.269736252578463,0.6790035889518914,0.8713235294117647,0.9885112774616097,1.0,1/17,1.34%,PID1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.24618994846191047,0.6785396901608072,0.884083044982699,0.988448307706564,1.0,2/22,6.03%,DUSP10;FOXP3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.25896914819566963,0.6776709959407067,0.9140767824497258,0.9887409040602019,1.0,3/21,9.26%,KLHL22;TPR;ZWINT
prerank,sensory perception of pain (GO:0019233),-0.23027866742084113,-0.6766379217998582,0.9264069264069265,1.0,1.0,5/21,17.66%,OPRM1;SCN9A;KCNA2;P2RX7;CHRNA4
prerank,tRNA modification (GO:0006400),-0.1844955112376115,-0.676447534249878,0.9726027397260274,1.0,1.0,22/62,33.01%,PUS7;TRMT13;THUMPD1;QTRT2;PUS3;ELP5;DTWD2;WDR4;TYW5;CDKAL1;TRMT6;TRMT9B;TRUB1;PUSL1;ADAT2;CTU2;TRMT61A;THUMPD2;BCDIN3D;ALKBH8;TRMT10A;TPRKB
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.23151195598730712,0.6757383869643734,0.9101694915254237,0.9900831208902048,1.0,4/33,6.52%,RC3H1;UBASH3A;PTPN22;PTPN2
prerank,DNA strand elongation (GO:0022616),0.2607765605700675,0.6755952141837009,0.8434163701067615,0.9897103879057004,1.0,3/18,10.21%,TERT;RAD50;MCM4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.25760904636689586,-0.6750591087367681,0.8966942148760331,1.0,1.0,1/14,2.14%,TFRC
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.19428512533910794,0.6745953823039035,0.9654631083202512,0.9901570870121852,1.0,20/78,23.09%,NR2F2;LATS2;CCND3;CDKN2B;CCNH;MNAT1;CDK7;IPO7;PKD2;PSRC1;CDKN3;MAPRE3;CCNY;CCNG2;PKMYT1;PTEN;PKD1;CDK5RAP3;CEBPA;HEXIM1
prerank,regulation of response to stress (GO:0080134),-0.2972883457042226,-0.6742661143638985,0.8458574181117534,1.0,1.0,5/10,26.67%,OPRM1;MLC1;ADCY8;SLC38A2;EIF4G1
prerank,organelle fusion (GO:0048284),-0.2355621434210839,-0.6738948148192097,0.900709219858156,1.0,1.0,4/22,11.20%,MFF;MFN2;GDAP1;MFN1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2488867229716092,0.6731501851784153,0.9055258467023173,0.9909971321224211,1.0,2/24,5.96%,RBPJ;CREB3L3
prerank,cholesterol metabolic process (GO:0008203),0.20242930240758208,0.6731454913218828,0.9630225080385852,0.9904939698359361,1.0,9/68,14.75%,APOA2;APOF;CYP27A1;INSIG2;SOAT1;LBR;CH25H;OSBPL5;ABCA1
prerank,regulation of vasculature development (GO:1901342),0.24111163308597794,0.6729863281454748,0.9087719298245615,0.9901322866707977,1.0,2/26,4.44%,SP100;IL6
prerank,protein palmitoylation (GO:0018345),-0.2159913071090906,-0.672688887110677,0.9383886255924171,1.0,1.0,13/30,33.48%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC5;SELENOK;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2596820900836383,0.672231292380099,0.9134438305709024,0.9892900237759494,1.0,3/20,9.26%,KLHL22;TPR;ZWINT
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2596820900836383,0.672231292380099,0.9134438305709024,0.9892900237759494,1.0,3/20,9.26%,KLHL22;TPR;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2596820900836383,0.672231292380099,0.9134438305709024,0.9892900237759494,1.0,3/20,9.26%,KLHL22;TPR;ZWINT
prerank,neuron remodeling (GO:0016322),-0.2974913906184057,-0.6721480496526308,0.8951781970649895,1.0,1.0,1/10,0.84%,ADGRB3
prerank,regulation of keratinocyte migration (GO:0051547),-0.2666902959043824,-0.6721202012601571,0.8611111111111112,1.0,1.0,3/12,18.62%,IQSEC1;EPB41L4B;ARF6
prerank,hexose metabolic process (GO:0019318),0.21975560873276567,0.6718582426361986,0.9117174959871589,0.9891347222742687,1.0,9/39,20.56%,CHST15;GALK2;FPGT;SLC37A4;KHK;HK1;GALM;PGM1;SORD
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22362530353572002,-0.6711252983571333,0.9063231850117096,1.0,1.0,9/25,31.64%,MFF;PINK1;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;TP53
prerank,tRNA transport (GO:0051031),-0.20525386682794064,-0.6708024501618649,0.9392405063291139,1.0,1.0,15/35,32.93%,YBX1;AAAS;NUP93;RAE1;XPOT;TOMM20;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.27000198643470075,-0.6700930323218756,0.8865979381443299,1.0,1.0,3/12,14.44%,RPL26;CD74;TAF9B
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.23664283139329978,-0.6698958925232882,0.9071274298056156,1.0,1.0,8/20,33.60%,MBTPS1;KPNB1;LDLRAP1;ACADVL;MBTPS2;DGKQ;LPCAT3;ABCA2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2079809685541812,0.6689668014206851,0.9487577639751553,0.990794050850922,1.0,20/51,25.35%,SUMO1;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,mitotic nuclear membrane organization (GO:0101024),0.2079809685541812,0.6689668014206851,0.9487577639751553,0.990794050850922,1.0,20/51,25.35%,SUMO1;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,chromatin organization (GO:0006325),0.18291321773811547,0.6687666197751311,0.9773049645390071,0.9904718580962446,1.0,32/132,21.55%,MYB;NUCKS1;BRWD1;TOP1;CDAN1;BAZ2A;FOXP3;HDAC4;TCF7L1;BAZ1B;JARID2;SETD7;BAZ1A;MYSM1;ACTL6A;KDM5B;BPTF;SUPV3L1;HDAC2;SETD5;SMARCA4;KAT2B;SMARCC1;LRWD1;INO80C;HCFC2;SETD2;SETDB1;PHF1;INO80;DR1;RSF1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2401203127388919,-0.6687340036533653,0.9047619047619048,1.0,1.0,4/17,18.61%,TGFB2;RET;SYK;RAC3
prerank,phagosome-lysosome fusion (GO:0090385),-0.2856504759247777,-0.6683870607935163,0.8843683083511777,1.0,1.0,3/10,22.59%,SYT7;RAB39A;CLN3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.2762146495506156,-0.6682200717323871,0.8729838709677419,1.0,1.0,8/11,47.79%,CAMK4;ITGB2;TYROBP;STAP1;ITGAM;MAVS;F2RL1;CD177
prerank,protein acylation (GO:0043543),-0.20232359302560932,-0.6679219663708267,0.9425837320574163,1.0,1.0,12/38,26.19%,FOXO1;ZDHHC14;ZDHHC20;ZDHHC2;NAA10;ZDHHC7;KAT2A;ZDHHC23;ZDHHC9;ING4;ZDHHC5;SELENOK
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.17671352451712502,-0.6677646837270084,0.9782016348773842,1.0,1.0,22/69,30.69%,SEL1L;ERLIN1;BAG6;UBXN8;HSPA5;TMUB2;YOD1;STT3B;FAM8A1;PSMC6;UBE2J1;SGTB;TMUB1;FBXO6;RNF121;FBXO2;SEC61B;HERPUD1;RNF5;UBE2G2;RHBDD2;UFD1
prerank,tRNA 5'-leader removal (GO:0001682),-0.2638065618984408,-0.6676810529036639,0.8922413793103449,1.0,1.0,4/13,26.42%,PRORP;RPP30;RPP25L;POP7
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2877358383708254,-0.6665048818489702,0.8730853391684902,1.0,1.0,2/10,20.96%,ASRGL1;KYNU
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.29929710006520127,0.6664958951386016,0.8482490272373541,0.9919855167674214,1.0,3/10,22.29%,ETFA;ACADS;IVD
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.24067654772184782,-0.6659035511876307,0.9349775784753364,1.0,1.0,6/19,18.69%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1;PMM2
prerank,regulation of actin nucleation (GO:0051125),0.2870128074665334,0.6657924717982567,0.865234375,0.9921108701720129,1.0,4/12,20.34%,ARPIN;ARF1;ARFIP2;CORO1B
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2636390461452686,-0.6653957985070054,0.9123173277661796,1.0,1.0,6/13,29.30%,BRSK2;YOD1;UBE2J1;UBAC2;SVIP;UBE2G2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.24299652392377738,0.6650772969969457,0.9125,0.9922420639479463,1.0,6/26,14.41%,RIPK2;MAP2K6;UBE2V1;MAP3K7;TIFA;IFIH1
prerank,lipoprotein catabolic process (GO:0042159),0.2899076412964948,0.6643694435763854,0.8686868686868687,0.9923711359539321,1.0,1/11,4.99%,ABHD10
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.23794501095965065,-0.6641780207379127,0.901565995525727,1.0,1.0,4/19,21.77%,PARK7;SOD1;MAOB;PRDX2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2672432937962016,0.663994354627487,0.8779527559055118,0.9921860838795201,1.0,7/15,26.52%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,fatty acid metabolic process (GO:0006631),-0.16226462961400998,-0.6626228615491832,1.0,1.0,1.0,37/115,30.40%,ADIPOR2;ACSL3;PPARD;ACSL5;GGT5;ACACA;ACLY;ABCD2;ACSBG1;CROT;AOAH;PER2;AASDH;LPL;LPIN3;ACSF2;ACOT2;GGT1;HSD17B8;PNPLA3;HPGD;FASN;MCAT;CPT1C;FAAH;FA2H;ACOT6;ALKBH7;ADIPOR1;LIPH;MSMO1;LIPC;SLC27A6;ALOX5AP;ACOX2;ALOX5;CPT1B
prerank,rRNA modification (GO:0000154),-0.2325268574432442,-0.6626113667900949,0.9011494252873563,1.0,1.0,7/21,33.14%,FTSJ3;THUMPD1;TFB2M;TFB1M;NOP10;FBL;NHP2
prerank,regulation of T cell activation (GO:0050863),0.21689075133299857,0.6621313547914677,0.9484193011647255,0.9932595324712254,1.0,4/42,7.71%,TNFAIP8L2;PTPN22;CD47;CCL2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.20894531242388664,-0.6619088793127996,0.9418886198547215,1.0,1.0,4/33,12.39%,LEF1;CD74;RUNX1;FES
prerank,fatty acid beta-oxidation (GO:0006635),0.20565183842503013,0.6618378569960908,0.9500831946755408,0.9929972876523863,1.0,11/51,19.43%,ACOXL;AMACR;SCP2;SLC27A2;ACAT1;ABCD3;ETFA;PEX2;ACADS;ACOX1;HADHA
prerank,protein localization to chromosome (GO:0034502),-0.20282558150456148,-0.6618029374298843,0.9440389294403893,1.0,1.0,10/34,26.32%,ESR1;MCM9;SLF1;CHMP7;TINF2;ATR;IFFO1;CENPA;RAD21;CTCF
prerank,proteasome assembly (GO:0043248),-0.2736525203545634,-0.6616423165400739,0.8893617021276595,1.0,1.0,5/11,30.81%,PSMD4;POMP;PSMD11;PSMG2;PSMD5
prerank,coenzyme A metabolic process (GO:0015936),0.2689439311356483,0.6615459519368707,0.8762088974854932,0.9927432461524806,1.0,2/14,11.27%,PANK2;ACAT1
prerank,early endosome to late endosome transport (GO:0045022),-0.23235563081511718,-0.6612263376810606,0.8982300884955752,1.0,1.0,5/20,22.00%,EMP2;WDR81;KIF16B;PIK3C3;SNF8
prerank,microglial cell activation (GO:0001774),-0.2287159578177047,-0.6609018327550386,0.9064748201438849,1.0,1.0,14/21,42.82%,SNCA;GRN;MAPT;ITGB2;AIF1;TREM2;CLU;TYROBP;C1QA;CX3CR1;IL4;C5AR1;TNF;ITGAM
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.27979390131619,-0.6608226978970623,0.8904109589041096,1.0,1.0,6/11,39.29%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.27979390131619,-0.6608226978970623,0.8904109589041096,1.0,1.0,6/11,39.29%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,regulation of establishment of protein localization (GO:0070201),-0.26132376500929555,-0.6596474085978826,0.9098712446351931,1.0,1.0,5/13,26.29%,CTSD;CEP135;CEP290;TREM2;DNAJA1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2072823677928774,-0.6592252052326704,0.9551122194513716,1.0,1.0,11/31,30.05%,RPS2;PINK1;DCUN1D2;DCUN1D5;DCUN1D1;SKP1;DCUN1D3;CDC14B;RAB1A;PLK1;UBE2L3
prerank,macroautophagy (GO:0016236),0.18087207138433728,0.6590980897701019,0.9826839826839827,0.9943249727104452,1.0,31/118,24.29%,PRKAG2;PRKAA2;DYNLL1;AMBRA1;LAMP2;MTMR3;UVRAG;SNX14;ATG12;VPS16;TCIRG1;PIP4K2B;CHMP3;CSNK2A2;CHMP4A;CHMP4B;FUNDC1;ATG10;WIPI2;RUBCNL;VPS33A;VPS39;ACBD5;VAMP7;ATG13;ATG7;PRKAA1;TOMM40;ATG3;TOMM70;VTA1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2769776763782134,-0.6590804611267689,0.880859375,1.0,1.0,3/11,13.40%,LYN;ATM;TNFRSF21
prerank,negative regulation of B cell activation (GO:0050869),0.24666595036621025,0.6579514117822601,0.9,0.9947766948930241,1.0,2/21,5.63%,RC3H1;PARP3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21931416731476833,-0.6575547078542266,0.9355555555555556,1.0,1.0,12/23,32.90%,NSFL1C;NDE1;INSC;CDK5RAP2;DCTN1;HTT;SPDL1;CENPA;UBXN2B;PLK1;ZW10;PKHD1
prerank,positive regulation of actin nucleation (GO:0051127),-0.2696178645162481,-0.6572199757258089,0.8920570264765784,1.0,1.0,1/11,3.12%,NCKAP1
prerank,positive regulation of macrophage migration (GO:1905523),-0.23553193268178219,-0.6571757138180363,0.8968421052631579,1.0,1.0,4/19,13.22%,THBS1;MAPK3;CMKLR1;CSF1R
prerank,protein hydroxylation (GO:0018126),-0.24277046158018173,-0.6568790507756654,0.9277899343544858,1.0,1.0,5/15,24.71%,VPS33B;PLOD2;VIPAS39;HIF1AN;JMJD7
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.20800410741656372,-0.6568394590431206,0.9445727482678984,0.9999985150299247,1.0,6/31,15.29%,GPHN;FDXR;GCH1;DHRS11;PRLR;PYCR2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2344405472530476,0.6564414199090538,0.9263157894736842,0.9955885472173844,1.0,5/28,12.26%,LACC1;RIPK2;MAP2K6;UBE2V1;MAP3K7
prerank,RNA interference (GO:0016246),0.26344267964123536,0.6563412087214836,0.8859813084112149,0.995160931044229,1.0,4/17,23.45%,TERT;TARBP2;CLP1;DHX9
prerank,axonemal dynein complex assembly (GO:0070286),0.23897190347600622,0.6562739016917933,0.9113043478260869,0.994716429491782,1.0,5/27,12.62%,ODAD4;DNAAF1;DNAL1;DNAI4;DRC1
prerank,Golgi inheritance (GO:0048313),0.28335448413936537,0.655731831062143,0.8648148148148148,0.9946808854369346,1.0,3/11,16.24%,PLK5;GBF1;GOLGA2
prerank,DNA alkylation (GO:0006305),-0.23257907721687004,-0.6552966619152341,0.9200913242009132,0.999847751596833,1.0,5/19,17.98%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,DNA methylation or demethylation (GO:0044728),-0.23257907721687004,-0.6552966619152341,0.9200913242009132,0.999847751596833,1.0,5/19,17.98%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,signal peptide processing (GO:0006465),-0.27836890834109684,-0.6547152617768225,0.889344262295082,0.9996168529952858,1.0,3/11,11.32%,SPCS2;SEC11C;SPCS1
prerank,negative regulation of cell division (GO:0051782),-0.2778578073677208,-0.6545537460284336,0.9188640973630832,0.9990730857321036,1.0,6/11,31.43%,ORC6;E2F7;BLM;CHMP4C;MYC;E2F8
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.25144196105589445,-0.6530322989743308,0.9088983050847458,0.9988980500968524,1.0,4/15,17.02%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.25144196105589445,-0.6530322989743308,0.9088983050847458,0.9988980500968524,1.0,4/15,17.02%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.287001430509499,0.6525095513624188,0.8806818181818182,0.9967723979956535,1.0,2/11,9.48%,NRP1;MST1R
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.20311995064571112,0.6514141273663883,0.9675850891410048,0.9971390043964907,1.0,5/53,7.71%,ANXA1;HRH3;MC2R;OPRD1;CCL2
prerank,regulation of lipase activity (GO:0060191),0.2772612887078747,0.6511737264546893,0.8714555765595463,0.996835631849947,1.0,1/13,2.03%,APOA2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.2820096700001774,0.6511274096793771,0.875,0.9963696902334279,1.0,2/11,10.73%,DLC1;BCL2L1
prerank,nuclear membrane reassembly (GO:0031468),0.20060086339102057,0.6498772951031114,0.9687010954616588,0.9968513799761299,1.0,21/54,25.35%,SUMO1;UBXN2A;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.21694642659803143,-0.648156744843581,0.9345372460496614,1.0,1.0,5/24,14.44%,TPT1;CXCL12;CD74;CCAR2;TAF9B
prerank,mismatch repair (GO:0006298),-0.210513088864042,-0.6481043268521325,0.9331797235023042,1.0,1.0,8/27,31.25%,MSH3;MCM9;PMS1;POLD2;POLD1;EXO1;PCNA;MSH5
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2034033166420122,-0.6474329226565005,0.955607476635514,1.0,1.0,9/33,20.04%,SESN3;RRAGB;CPEB4;UBR1;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2
prerank,histone exchange (GO:0043486),-0.199115653848243,-0.646726890648327,0.9523809523809523,1.0,1.0,13/37,26.66%,ZNHIT1;NPM1;SPTY2D1;DMAP1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,synaptonemal complex assembly (GO:0007130),0.2581691288315335,0.6461716116193096,0.900709219858156,0.9987703496117296,1.0,3/15,14.87%,SYCP2;TEX12;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.2581691288315335,0.6461716116193096,0.900709219858156,0.9987703496117296,1.0,3/15,14.87%,SYCP2;TEX12;P3H4
prerank,histone H3 deacetylation (GO:0070932),-0.24286571600855333,-0.6457043277562762,0.9157427937915743,1.0,1.0,4/15,18.56%,HDAC9;HDAC1;PER2;SIRT7
prerank,regulation of T cell differentiation (GO:0045580),0.22460310115625268,0.6453162361667506,0.9216354344122658,0.9989358432007095,1.0,2/33,6.03%,ZMIZ1;FOXP3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.21941446810541668,-0.6450924953112726,0.9276315789473685,1.0,1.0,11/21,46.72%,SETX;MED30;SRF;MED13;PAXIP1;SUB1;JUN;HNF1B;MED24;TWIST1;MED16
prerank,response to light stimulus (GO:0009416),0.20234769144810572,0.6448992225168145,0.96513470681458,0.9987398079637316,1.0,20/55,27.64%,CRY2;CRY1;FECH;REV1;ERCC5;ERCC6;OPN3;GTF2H2;UBE4B;UVSSA;CLOCK;ERCC8;TRIM32;ZRANB3;USP1;GPR52;SPRTN;ERCC2;ERCC4;ERCC3
prerank,regulation of endocytic recycling (GO:2001135),-0.2720958297350712,-0.6445544238657385,0.9090909090909091,1.0,1.0,2/11,11.13%,SORL1;ARHGAP1
prerank,positive regulation of chromosome organization (GO:2001252),-0.24254830485421242,-0.6441470630475725,0.9256756756756757,0.99984756127037,1.0,5/15,20.36%,MRE11;DDX11;GNL3;PPP1R10;SHCBP1L
prerank,cellular response to gamma radiation (GO:0071480),-0.23409469844785458,-0.6439969385616885,0.9256900212314225,0.9992838620321669,1.0,4/17,13.61%,RPL26;MAP3K20;ATM;HRAS
prerank,regulation of cytoplasmic transport (GO:1903649),0.28765443544204883,0.6429904910447047,0.88,0.9996772096978985,1.0,4/11,19.95%,LRRK2;MAP2K1;CHMP3;USP7
prerank,negative regulation of interleukin-10 production (GO:0032693),0.25320485436291207,0.6427482981797004,0.8925143953934741,0.9993654201777102,1.0,3/16,15.47%,FOXP3;CD274;IL23R
prerank,histone H4 deacetylation (GO:0070933),-0.27022238815932215,-0.6418308447254704,0.8977035490605428,1.0,1.0,2/10,9.20%,HDAC9;HDAC1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2198200817908323,0.6414229854692266,0.946551724137931,0.9998483311071472,1.0,11/36,22.11%,SUZ12;UXT;MGA;EPC1;RBBP8;RING1;RNF2;BMI1;TFDP2;PCGF2;APAF1
prerank,regulation of calcium ion import (GO:0090279),-0.22551165439751852,-0.6411545611309738,0.9389978213507625,0.9999242946571352,1.0,4/21,15.98%,CTNNB1;SLC30A1;CXCL12;EGF
prerank,inner dynein arm assembly (GO:0036159),0.2976399698719557,0.6405977332743613,0.8426501035196687,0.9999661904636643,1.0,10/10,70.25%,DNAAF1;CCDC39;DNAAF4;DNAAF5;ZMYND10;CFAP73;DNAI3;DNAH1;CCDC40;CFAP100
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.24607291756357152,-0.6397919482407891,0.8935281837160751,1.0,1.0,1/14,1.90%,ATP1B1
prerank,positive regulation of cell development (GO:0010720),0.2201863246593867,0.6394880854473718,0.9284525790349417,1.0,1.0,2/31,3.99%,NUMB;RFX3
prerank,mitochondrial membrane organization (GO:0007006),0.2233086559977103,0.6382854297070653,0.9410714285714286,1.0,1.0,7/32,18.47%,MICOS10;BCL2;BCL2L1;OPA1;SLC25A4;HSPA9;SLC25A31
prerank,positive regulation of protein deacetylation (GO:0090312),-0.25000570253693705,-0.6381291459227626,0.915948275862069,1.0,1.0,3/14,17.30%,CTBP1;APLNR;NNMT
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.2038500019736392,-0.6380013181704678,0.9557109557109557,0.9999473897258787,1.0,9/29,26.60%,SMAD7;DAB2IP;SPRED2;IL17RD;SPRED3;SPRED1;BMP5;ADIPOR1;SDHAF2
prerank,tryptophan catabolic process (GO:0006569),0.2812062001361084,0.6374459946814315,0.8768656716417911,1.0,1.0,1/11,5.60%,AFMID
prerank,protein prenylation (GO:0018342),-0.2712141545079724,-0.6371265857705303,0.8945147679324894,0.9998331702550977,1.0,5/10,29.21%,PGGT1B;CHML;RABGGTA;RABGGTB;PTAR1
prerank,indolalkylamine catabolic process (GO:0046218),-0.27582487145854384,-0.6369206112082034,0.8846960167714885,0.9993145384148823,1.0,7/10,53.66%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of vacuole organization (GO:0044090),0.2835765638326771,0.6361078564140188,0.8800738007380073,1.0,1.0,3/10,18.74%,ANXA2;PIP4K2B;PIP4K2C
prerank,glycosphingolipid metabolic process (GO:0006687),0.21142263595031494,0.6359905386910395,0.9451827242524917,1.0,1.0,4/42,7.76%,SMPD3;A4GALT;LARGE1;ESYT1
prerank,lipid droplet organization (GO:0034389),0.23847518238262383,0.6357256892427366,0.9208103130755064,1.0,1.0,4/22,15.17%,SMIM22;PLA2G4C;PPID;FAF2
prerank,protein catabolic process (GO:0030163),-0.17333348018384934,-0.6355311786361695,0.9828571428571429,0.999548577300368,1.0,8/59,14.25%,HSPA8;DAB2IP;CTSD;CEACAM1;BAG6;RAB12;HSP90AA1;PSMA8
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.21342474587937788,-0.6353534524363329,0.9514563106796117,0.9989957920518017,1.0,5/23,18.02%,HMGB1;KPNB1;H1-0;FOXL2;DICER1
prerank,mRNA transport (GO:0051028),-0.15752660804334007,-0.6346826719966472,0.9967213114754099,0.9987479013617329,1.0,35/101,30.55%,SRSF2;CPSF2;SRSF1;SYMPK;ZC3H11A;THOC2;HHEX;AAAS;NUP93;KIF5C;RAE1;RNPS1;SRSF9;POLDIP3;NXT1;RBM15B;UPF1;ALKBH5;NUP62;SRSF6;CHTOP;CPSF3;NUP188;U2AF1;CDC40;NUP54;NUP210;CPSF1;NUP42;NUP153;MCM3AP;UPF3B;ZFP36;NDC1;DDX25
prerank,ketone body metabolic process (GO:1902224),0.28183675712318457,0.6340163696328213,0.8972868217054264,1.0,1.0,3/10,17.44%,OXCT1;ACAT1;ACSS3
prerank,positive regulation of ATPase activity (GO:0032781),-0.18802925786342242,-0.6340134695661263,0.9720812182741116,0.9985151291145585,1.0,17/41,36.31%,ATP1B1;RYR2;MSH3;VMP1;DYNLL2;AHSA1;PFN2;CHTOP;TOR1AIP2;PFN1;UHRF1;FGF10;MYL4;DNAJB11;GABARAPL2;ALDOB;SSBP1
prerank,protein targeting to peroxisome (GO:0006625),0.22047868432947498,0.6329613657141602,0.94,1.0,1.0,5/29,13.46%,ZFAND6;PXMP2;HACL1;ABCD3;PEX2
prerank,tryptophan metabolic process (GO:0006568),-0.26840193128921214,-0.6329130996101232,0.8978260869565218,0.9985367038015374,1.0,7/11,53.66%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,mitotic spindle organization (GO:0007052),-0.14675877701582976,-0.632838031272964,1.0,0.9979376591068722,1.0,69/153,38.31%,RPS27;KPNB1;EFHC2;RCC2;DYNC1H1;PCNT;AAAS;KIF18A;XPO1;KIF3B;DYNC1I2;NDE1;CLASP2;PPP1CC;NEK9;CENPU;SKA2;BUB1B;DYNLL2;PRC1;ZWILCH;CENPT;CENPQ;CENPL;STMN1;TUBG1;KIF23;MAD1L1;NSL1;CENPN;CENPF;KIF4A;DSN1;KNTC1;SPDL1;TUBG2;DCTN6;CENPA;BCCIP;MAPRE1;SGO1;STIL;BIRC5;ITGB3BP;CLIP1;TBCE;PLK1;ZW10;DLGAP5;CEP192;NUF2;AURKA;SEC13;SMC1A;CDC20;BUB1;MIS12;ABRAXAS1;KIFC1;BUB3;KNL1;NUDC;INCENP;RAB11A;MZT1;KIF2C;CCNB1;CENPM;NDEL1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.21773508162452376,-0.6318944753075113,0.9579646017699115,0.9978676272220534,1.0,13/23,43.98%,ACSBG1;HPGD;FADS1;ALOX5;CYP2E1;ACOT7;GSTM4;GPX4;CYP1A1;LTC4S;GSTP1;ELOVL6;ALOX12
prerank,P-body assembly (GO:0033962),0.2730061463587593,0.6311964543292753,0.8969465648854962,1.0,1.0,4/12,18.25%,RC3H1;EIF4ENIF1;DDX6;PATL1
prerank,isotype switching (GO:0045190),-0.2688563362151646,-0.6307998145414248,0.9061224489795918,0.997890251590505,1.0,6/10,47.33%,RNF168;EXOSC3;CCR6;LIG4;BATF;HSPD1
prerank,linoleic acid metabolic process (GO:0043651),0.2540402412101132,0.6307188912266625,0.9061302681992337,1.0,1.0,2/17,8.37%,ACSL1;ALOXE3
prerank,axonal fasciculation (GO:0007413),0.27206886264979324,0.6305585874606258,0.916058394160584,1.0,1.0,3/12,13.84%,EPHA3;EPHA4;RTN4
prerank,regulation of exit from mitosis (GO:0007096),0.20923294026058797,0.6305369290949141,0.9612903225806452,1.0,1.0,7/38,13.48%,ANAPC11;PHB2;ANAPC1;UBE2C;CDC14A;MAD2L1BP;CDC27
prerank,intestinal lipid absorption (GO:0098856),0.2733717580489094,0.630185446563641,0.8781925343811395,1.0,1.0,4/11,28.26%,LIMA1;CD36;CEL;SOAT2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.20403964753674317,-0.6300401374405136,0.9647887323943662,0.997710407995752,1.0,3/28,6.43%,SH3KBP1;PRKCQ;CYRIB
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2368930816362254,-0.6299017509301459,0.9260042283298098,0.9971422611337818,1.0,7/16,35.44%,CLSPN;CDC45;HUS1B;TOPBP1;CDC6;TICRR;TIMELESS
prerank,regulation of coagulation (GO:0050818),-0.26377050874137997,-0.6268937070552412,0.9051724137931034,0.9983402081065157,1.0,2/11,12.95%,HS3ST5;CAV1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.2749807281816973,0.6268851111147729,0.8854368932038835,1.0,1.0,4/11,19.66%,FBH1;GMNN;SMARCAL1;TIPIN
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.19539199152899642,-0.6258232146590467,0.9763593380614657,0.9982928890023245,1.0,5/32,16.84%,GRM5;ATXN2;PUM3;PGAM1;RBM3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.16899660838019748,-0.624885086460766,0.9893333333333333,0.9981794409565385,1.0,11/63,17.56%,CRADD;RPL26;PLAGL1;CCND1;ATM;RGCC;CDK2;CDKN1A;RBL2;CNOT2;E2F4
prerank,regulation of isotype switching (GO:0045191),0.26166392113924575,0.6236474162930956,0.9132947976878613,1.0,1.0,5/14,20.40%,PARP3;SHLD2;KMT5C;RIF1;KMT5B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.17833967752795493,-0.6233004944318697,0.9807162534435262,0.998403558451085,1.0,11/54,21.16%,CRADD;RPL26;PLAGL1;ATM;RGCC;CDKN1A;RBL2;CNOT2;E2F4;CNOT8;E2F7
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.23025835105774334,0.6223421278903681,0.9466192170818505,1.0,1.0,2/24,5.56%,AUTS2;PLCE1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.27969596754608855,0.6220144255017389,0.897489539748954,1.0,1.0,9/10,50.16%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.27969596754608855,0.6220144255017389,0.897489539748954,1.0,1.0,9/10,50.16%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2294860974661157,-0.6214836269611361,0.9439834024896265,0.9987609304567877,1.0,7/17,28.40%,NTRK2;SORL1;CHRNA7;RTN3;HAP1;RTN2;CLU
prerank,regulation of translational initiation (GO:0006446),-0.16496269693025656,-0.6213139588341214,0.9921259842519685,0.9981949763444841,1.0,27/63,38.08%,EIF2B2;NPM1;YTHDF2;EIF5B;EIF1B;ATF4;CDC123;EIF1;PAIP2;PPP1R15B;EIF3H;EIF4A2;PAIP1;UHMK1;CSDE1;POLR2G;EIF4G1;BOLL;HSPB1;EIF4G3;CCL5;MTIF2;DDX1;DAZL;EIF5;EIF4EBP2;EIF4EBP1
prerank,DNA methylation (GO:0006306),-0.2062001474351039,-0.6198904082570349,0.9463414634146341,0.9983119515949116,1.0,8/23,28.97%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1;N6AMT1;FOS;PICK1
prerank,membrane lipid catabolic process (GO:0046466),0.2789182382448211,0.6193279742528012,0.8870056497175142,1.0,1.0,2/10,18.67%,ENPP2;SGPL1
prerank,regulation of histone methylation (GO:0031060),0.25862521057926335,0.6190946945346436,0.9146567717996289,1.0,1.0,3/13,13.47%,NSD1;JARID2;PAF1
prerank,RNA 3'-end processing (GO:0031123),0.18649129267665107,0.6176809101446664,0.9820627802690582,1.0,1.0,24/69,24.64%,TUT4;PCF11;RPRD2;SLU7;SRSF4;MAGOHB;SUPV3L1;DDX39A;THOC5;TENT2;PABPN1;SRSF5;CSTF3;TUT7;WDR33;RPRD1B;TENT4B;SRSF3;SRSF11;PNPT1;CLP1;DDX39B;PAPOLA;SRSF7
prerank,zymogen activation (GO:0031638),-0.18481930352932185,-0.6172694256022003,0.9697732997481109,0.9991265270003695,1.0,5/39,11.06%,GRIN2A;PERP;PGK1;LGMN;CTSL
prerank,lytic vacuole organization (GO:0080171),0.2099669651096844,0.616553312974286,0.953125,1.0,1.0,9/32,23.59%,CLN5;LRRK2;HPS1;ARSB;ABCA1;HOOK1;HPS4;TPCN2;LAMTOR1
prerank,axoneme assembly (GO:0035082),-0.19511430252691242,-0.6156234783379794,0.9695550351288056,0.9993866055884,1.0,14/30,34.12%,RP1;CFAP46;CFAP74;DNAAF3;SPAG16;SPAG1;SPAG17;DCX;TTLL3;CCDC65;DNAAF2;CFAP206;FOXJ1;CCDC40
prerank,mitotic recombination (GO:0006312),0.2501132223698057,0.6154173562000496,0.9029304029304029,1.0,1.0,5/15,21.67%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,pentose-phosphate shunt (GO:0006098),0.2777175369676313,0.61541534929888,0.9263565891472868,1.0,1.0,2/11,9.76%,PGD;DERA
prerank,phospholipid homeostasis (GO:0055091),0.2694118385537631,0.6133345940542834,0.8903846153846153,1.0,1.0,11/11,73.08%,ABCA1;ANGPTL3;RCN3;ABCG1;LIPG;ABCB11;APOA1;HNF4A;TLCD1;FABP3;TLCD2
prerank,mitochondrial transport (GO:0006839),0.19382375389257672,0.6129941648040189,0.9683544303797469,1.0,1.0,16/53,24.26%,BCL2;TIMM17A;SLC25A24;BCL2L1;COX18;TMEM14A;TIMM9;SLC25A4;TOMM34;SLC25A31;BCAP31;OXA1L;MTX2;TMEM14C;TOMM40;TOMM70
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.219384043947607,-0.6129139897859289,0.9398663697104677,1.0,1.0,4/18,11.83%,ZC3H11A;THOC2;HHEX;NUP93
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.25043179555027223,0.6127234543169842,0.8857677902621723,1.0,1.0,3/13,13.88%,ALG9;ALG11;ALG1
prerank,positive regulation of sodium ion transport (GO:0010765),0.26579265030770166,0.611573005068113,0.9066147859922179,1.0,1.0,6/12,24.16%,SCN3B;GPD1L;WNK3;SCN4B;CNKSR3;SCN5A
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.21623610471188504,-0.6103876856686263,0.9524886877828054,1.0,1.0,12/22,43.22%,RPS21;EXOSC2;FTSJ3;ERI1;ABT1;UTP20;EXOSC3;RRS1;EXOSC8;ERI2;EXOSC9;NOP14
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.24501984942413146,-0.6102328420590306,0.9394572025052192,1.0,1.0,4/13,22.46%,SORL1;TMEM30A;SAR1B;CD81
prerank,monocarboxylic acid catabolic process (GO:0072329),0.23225365434739756,0.6099668810224586,0.9257246376811594,1.0,1.0,8/21,23.01%,HAO1;LPIN2;ACOX1;HOGA1;ACBD5;AGXT;NUDT19;LPIN1
prerank,sterol biosynthetic process (GO:0016126),0.2084916147804604,0.6095947687649668,0.9601990049751243,1.0,1.0,4/33,12.53%,PRKAG2;INSIG2;LBR;CH25H
prerank,establishment of melanosome localization (GO:0032401),-0.21393027967031913,-0.6088906099281416,0.9409190371991247,1.0,1.0,12/19,41.98%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,UV-damage excision repair (GO:0070914),0.26031733345595753,0.6086374782618279,0.9209039548022598,1.0,1.0,4/12,21.08%,ERCC1;XPC;POLD3;INO80
prerank,transcription by RNA polymerase III (GO:0006383),-0.20163223948444653,-0.6084579030402211,0.9647058823529412,0.9998833588999712,1.0,6/27,24.22%,IVNS1ABP;RO60;GTF3C6;POLR3G;ZC3H8;SNAPC1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2473669664214245,-0.607883641033448,0.9290465631929047,0.999536236478838,1.0,5/12,28.70%,XPR1;SLC25A30;SLC20A2;SLC37A1;SLC37A2
prerank,Golgi to lysosome transport (GO:0090160),-0.25449309876993503,-0.6073244410295204,0.9206680584551148,0.9991709961535792,1.0,4/11,28.83%,SORT1;LAMP1;CLN3;LAPTM5
prerank,early endosome to Golgi transport (GO:0034498),-0.2574492283348923,-0.6071772435029877,0.9511201629327902,0.9985948629480143,1.0,2/11,14.01%,LMAN1;SNX8
prerank,regulation of mitotic nuclear division (GO:0007088),0.187025780174232,0.6070814223849353,0.9793650793650793,1.0,1.0,5/55,9.00%,PHIP;TGFA;BMP7;PDGFRB;IGF2
prerank,glycerol metabolic process (GO:0006071),-0.2579235855559757,-0.6068784739812048,0.9304703476482618,0.9980976032178661,1.0,4/10,24.38%,TPI1;PGP;COQ3;GK
prerank,male meiosis I (GO:0007141),0.24268491774456835,0.6057308245495774,0.9396092362344582,1.0,1.0,16/16,75.76%,ZSCAN21;SLC25A31;FOXJ3;ING2;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;HSF2BP;CCNA1;BRDT;FOXJ2;MOV10L1;TDRD9;SYCP3
prerank,purine nucleotide biosynthetic process (GO:0006164),0.2630082391774827,0.6050024598295194,0.9163498098859315,1.0,1.0,2/12,9.24%,MTHFD1;PRPSAP1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15941979681211407,-0.6044989007506231,0.9948586118251928,0.9986127618750408,1.0,12/72,17.85%,CRADD;ACER2;RPL26;PLAGL1;TFAP4;ATM;RGCC;CDKN1A;RBL2;CNOT2;E2F4;BCL3
prerank,natural killer cell mediated immunity (GO:0002228),-0.22917908915111906,-0.6044451570983926,0.9479166666666666,0.9979951097823666,1.0,3/15,15.54%,RAET1E;TUBB4B;LYST
prerank,regulation of cytokinesis (GO:0032465),0.17654245929887966,0.6042617091351974,0.9923076923076923,1.0,1.0,13/78,15.71%,MAP9;PLK5;KLHL21;UVRAG;BCL2L1;CDC14A;CUL3;KLHL13;AHCTF1;ENTR1;FSD1;BIRC6;PKN2
prerank,cellular macromolecule catabolic process (GO:0044265),0.19344718211607415,0.6033770004820088,0.9806763285024155,1.0,1.0,14/49,23.79%,SIAH2;MANBA;SND1;SUPV3L1;DNASE1L1;RNASEH1;RNASE3;DFFB;CHEK2;RIPK1;RNASEH2B;PNPT1;ADAMTS9;RNASEH2A
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2517650497138726,0.6029353321929604,0.9250493096646942,1.0,1.0,3/14,12.16%,FASTKD5;FOXO3;MTERF2
prerank,regulation of chromosome segregation (GO:0051983),-0.22926945583930058,-0.6024511923712317,0.9404255319148936,0.9983140538483354,1.0,9/16,41.47%,RMI2;MKI67;SMC5;RAD18;CDC6;BUB1;IHO1;KIF2C;AURKB
prerank,mitochondrion disassembly (GO:0061726),-0.1852651517210297,-0.6012764769042402,0.9853658536585366,0.998234995022591,1.0,5/34,11.76%,GABARAP;GABARAPL1;PINK1;ATG9A;ULK1
prerank,regulation of viral release from host cell (GO:1902186),0.22813318300699054,0.6004196529941547,0.9360902255639098,1.0,1.0,5/21,15.00%,TRIM5;TRIM21;TRIM26;CHMP3;PML
prerank,phagolysosome assembly (GO:0001845),-0.24281121508208894,-0.5998792098305372,0.9192139737991266,0.9982860639483224,1.0,3/12,22.59%,SYT7;RAB39A;CLN3
prerank,protein localization to microtubule organizing center (GO:1905508),-0.23237990644550177,-0.5998554328905306,0.9274725274725275,0.9976583274089552,1.0,6/15,30.50%,CSNK1D;CEP83;SPAG5;STIL;SNX10;CEP192
prerank,glutamine family amino acid metabolic process (GO:0009064),0.208740196628177,0.5994582161500323,0.9663299663299664,1.0,1.0,4/33,9.52%,ALDH4A1;GLUL;SIRT4;PYCR3
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.21173832465434878,0.5994237180502776,0.9598603839441536,1.0,1.0,6/27,15.59%,CREBBP;KAT6B;BRD8;KAT6A;KAT2B;PHF20L1
prerank,cellular response to hydroxyurea (GO:0072711),0.2722758224861296,0.5987592425558184,0.9251559251559252,1.0,1.0,4/10,25.09%,SPIDR;NSMCE3;ATRX;RTF2
prerank,phasic smooth muscle contraction (GO:0014821),0.26792805238377904,0.5983357950907303,0.9155206286836935,1.0,1.0,3/10,20.67%,TIFAB;GDNF;PTGER3
prerank,response to estrogen (GO:0043627),-0.19068418812154944,-0.5973727044801429,0.983451536643026,0.9981711325144317,1.0,7/31,23.73%,SERPINB9;ESR1;CAV1;BRCA1;ASH2L;RBBP5;KRT19
prerank,protein localization to phagophore assembly site (GO:0034497),-0.25146149670465817,-0.5965161125724184,0.922920892494929,0.9979408500192766,1.0,2/11,9.79%,ATG9A;MFN2
prerank,regulation of cholesterol storage (GO:0010885),0.24216396473716018,0.5960244630661079,0.9397363465160076,1.0,1.0,2/15,6.37%,NR1H3;PPARA
prerank,myelin maintenance (GO:0043217),-0.2578558575006638,-0.5948687054377225,0.9516129032258065,0.9980545194142452,1.0,5/10,41.27%,ABCD2;SOD1;CLU;ABCD1;DEGS1
prerank,lymphocyte migration (GO:0072676),0.20578465983011948,0.5946448013611942,0.9631490787269682,1.0,1.0,3/32,7.71%,CKLF;MSMP;CCL2
prerank,regulation of protein acetylation (GO:1901983),0.25369011700384647,0.5945361353230467,0.9201520912547528,1.0,1.0,2/12,16.82%,GSK3B;RAPGEF3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.22921844674584602,-0.5941489931467315,0.9557894736842105,0.9977423639241203,1.0,6/14,34.24%,RFK;ADSS2;ADSS1;IMPDH1;LHPP;PFAS
prerank,RNA export from nucleus (GO:0006405),0.16766934195395228,0.5937549836408865,0.9912917271407837,1.0,1.0,23/100,19.71%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;SRSF5;NUP37;HNRNPA2B1;RAN;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,protein localization to lysosome (GO:0061462),-0.191530364501682,-0.5936062456865068,0.9517241379310345,0.9973734030185553,1.0,5/28,12.02%,SORL1;GCC2;M6PR;SCARB2;GLMP
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.21098744666853783,0.5929695946487009,0.965,1.0,1.0,8/27,23.01%,ETNK2;PLA2G6;NAAA;NAPEPLD;LPIN2;SLC27A1;PLAAT5;LPIN1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.19203569769048606,-0.5929606323009781,0.9821428571428571,0.9970318528423087,1.0,6/25,20.14%,CCAR2;EAF2;EAF1;KAT7;CCNK;TCEA2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.20782900848813612,-0.5928701201783105,0.9582417582417583,0.9964385752995946,1.0,2/18,5.86%,RPS3;HMGB1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.21330648136433034,0.5924926773111859,0.9655172413793104,1.0,1.0,7/26,15.87%,TTL;KLHL18;CCDC57;CUL3;SMOC2;PKN2;APP
prerank,mitochondrial transcription (GO:0006390),-0.24757357502933827,-0.5918857558765253,0.9284294234592445,0.9962030550799967,1.0,4/10,23.04%,TWNK;TFB2M;TFB1M;POLRMT
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.19000866272255287,-0.5904733634567998,0.985981308411215,0.996143598744551,1.0,11/29,30.39%,EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EXOSC1;EDC3;LSM2;LSM3;DCPS
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.2610951516003007,0.5901653819066224,0.9383697813121272,1.0,1.0,4/10,22.43%,AMDHD2;ST3GAL1;NAGK;ST6GAL1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.23288069275809625,-0.589301400268295,0.9580838323353293,0.99600556746618,1.0,3/12,19.08%,LYN;ORMDL3;NOC2L
prerank,reticulophagy (GO:0061709),0.25283552505161594,0.5891119951143955,0.9085603112840467,1.0,1.0,2/12,15.66%,UBA5;ATG2A
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.18678134787214676,0.5881293199711365,0.9887640449438202,1.0,1.0,15/52,24.74%,KDELR3;SRPRA;CTDSP2;DNAJC3;TSPYL2;PARP16;EXTL2;ERN2;SEC31A;SHC1;XBP1;MYDGF;SYVN1;EDEM1;YIF1A
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.16711047809455815,0.5876256587884403,0.9941520467836257,1.0,1.0,22/96,19.71%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2093718097358518,-0.5875956765237839,0.9696356275303644,0.996106133146639,1.0,4/18,23.21%,LDLRAP1;PSENEN;CLN3;NSG1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.24855544100983606,-0.5873898389017759,0.9468085106382979,0.995569001513726,1.0,3/11,15.49%,SCARB1;MFSD2A;CTDNEP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.22270584540857694,0.5870547474698683,0.9457943925233645,1.0,1.0,4/18,15.67%,SNX12;MAP2K1;CHMP3;DAB2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.251771279522767,-0.5864540749713275,0.9343936381709742,0.9953145000477117,1.0,6/10,43.62%,CEACAM1;PTPRC;LILRB1;CX3CR1;FCGR2B;KLRD1
prerank,cilium-dependent cell motility (GO:0060285),0.22231799996516743,0.5863714406498307,0.9514925373134329,1.0,1.0,5/22,18.93%,RFX3;RSPH9;DRC1;GAS8;CCDC39
prerank,regulation of B cell differentiation (GO:0045577),0.2285741146641467,0.5863296811507945,0.9468864468864469,1.0,1.0,4/17,22.79%,MMP14;INHA;XBP1;ZFP36L2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.1832101887776943,0.586134413248894,0.9888535031847133,1.0,1.0,6/50,9.67%,STOX1;CCND3;CDKN2B;CCNH;MNAT1;CDK7
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.22967186428881048,-0.5860134912923047,0.9521829521829522,0.9948700771693443,1.0,3/13,23.52%,RPS21;BMS1;ABT1
prerank,protein-DNA complex disassembly (GO:0032986),-0.21874024591049143,-0.5859868048236178,0.9478079331941545,0.9942543873864756,1.0,8/16,37.35%,SMARCB1;RPL23;SET;SMARCC2;MYC;GRWD1;NFE2;HMGA1
prerank,spinal cord development (GO:0021510),0.24861625533821366,0.5850080761990998,0.9262759924385633,1.0,1.0,3/12,15.78%,LOXL3;SOX4;PKD2
prerank,lipoxygenase pathway (GO:0019372),0.24312132183624363,0.5849462907329905,0.9481037924151696,1.0,1.0,3/14,20.45%,ALOXE3;PON3;PTGS2
prerank,regulation of histone deacetylation (GO:0031063),0.24483858182432705,0.5845832226984661,0.9372623574144486,1.0,1.0,4/13,20.80%,FOXP3;SAP30BP;NIPBL;SPHK2
prerank,B cell activation involved in immune response (GO:0002312),0.24364366878021218,0.5833266336832129,0.9400386847195358,1.0,1.0,13/13,75.66%,MSH2;RNF8;GPR183;MSH6;CD40LG;CD180;GAPT;CD19;BATF;LIG4;FCGR2B;EXOSC3;RNF168
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24514621778652854,-0.5827684573985593,0.9420289855072463,0.9949139998679654,1.0,3/10,28.11%,YY1;PYCARD;LILRB1
prerank,maturation of LSU-rRNA (GO:0000470),0.2134674654044235,0.5826532569241796,0.9571428571428572,1.0,1.0,6/26,16.92%,NSA2;RPL7L1;ZNHIT3;WDR12;RPF1;DDX18
prerank,regulation of spindle assembly (GO:0090169),-0.1929556636525549,-0.5804507689299389,0.9782608695652174,0.9952080198978923,1.0,9/25,29.91%,DYNC1H1;RNF4;CHMP1A;CHMP1B;CHMP2B;SPAG5;CHMP2A;CHMP4C;PLK1
prerank,ncRNA export from nucleus (GO:0097064),-0.17440148202820982,-0.5795239621437839,0.9776674937965261,0.9949291188302818,1.0,14/36,32.93%,NPM1;AAAS;NUP93;RAE1;XPOT;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.2496289816374062,-0.5788468681023302,0.9572301425661914,0.9945710634131781,1.0,2/10,12.97%,GFPT2;GFPT1
prerank,lung epithelium development (GO:0060428),0.25428036934665077,0.57742679388098,0.9301397205588823,1.0,1.0,1/10,4.74%,ERRFI1
prerank,DNA recombination (GO:0006310),0.19602571865242052,0.5770188721345949,0.9743589743589743,1.0,1.0,6/37,15.41%,WRN;RAD50;FBH1;SUPV3L1;RAD51B;ERCC1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.23120450639047346,0.5768718973731604,0.9577981651376147,1.0,1.0,7/16,27.37%,KIF5B;PLEKHM2;VAMP7;KLRK1;CEBPG;ULBP1;ARL8B
prerank,mRNA metabolic process (GO:0016071),-0.14766838392251727,-0.5747902265675049,1.0,0.9954886722022591,1.0,27/90,31.64%,DIS3L2;PTBP1;DHX15;SRSF2;SRSF1;HNRNPA0;YTHDF2;SNRPB;NUDT16L1;AURKAIP1;SNRPF;SRSF9;RIDA;NONO;ALKBH5;CPSF3;U2AF1;LSM2;TBRG4;NUDT16;LSM3;RNH1;ZFP36;CPSF6;PRPF8;NUDT12;TP53
prerank,rRNA transcription (GO:0009303),-0.2105235322068763,-0.5737541142512284,0.9661016949152542,0.9952322516067001,1.0,7/17,33.60%,GTF3C6;SIRT7;SPIN1;POLR1E;TAF1B;NIFK;GTF3C4
prerank,determination of left/right symmetry (GO:0007368),0.19266941028772017,0.572626754363068,0.9686985172981878,1.0,1.0,10/36,20.83%,RFX3;ODAD4;DNAAF1;NPHP3;PKD2;ARL6;CCDC39;CITED2;MEGF8;OFD1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.23765300312288065,-0.571445014017902,0.9475890985324947,0.9954399335661772,1.0,2/11,10.21%,H3-3A;ASF1A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.25420651856123355,0.5709281977741825,0.9390962671905697,1.0,1.0,4/11,18.45%,STAT5B;JAK1;STAT5A;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.25420651856123355,0.5709281977741825,0.9390962671905697,1.0,1.0,4/11,18.45%,STAT5B;JAK1;STAT5A;SHC1
prerank,regulation of chromosome organization (GO:0033044),-0.1997288487064674,-0.570648085215153,0.9848484848484849,0.9950948097307569,1.0,14/22,45.15%,MAPT;RMI2;SHCBP1L;UPF1;HNRNPD;MYC;PIF1;BUB1;TERF2IP;HDAC8;CDT1;YLPM1;SETMAR;LIG4
prerank,peptidyl-proline hydroxylation (GO:0019511),0.2502474259174196,0.5706029896738884,0.9304174950298211,1.0,1.0,3/11,20.71%,P4HTM;OGFOD1;EGLN1
prerank,carboxylic acid catabolic process (GO:0046395),-0.2362584115546276,-0.5690398660957299,0.9613821138211383,0.9950171236233794,1.0,3/12,17.91%,BCKDK;RENBP;NPL
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.23687495929186184,0.5688164684175689,0.9375,1.0,1.0,2/14,12.26%,TNFSF15;MAP3K7
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22541660413551767,0.5674339669409718,0.9566003616636528,1.0,1.0,4/18,20.84%,DCP2;EXOSC10;CCT6A;PARN
prerank,kinetochore organization (GO:0051383),-0.22321651135781162,-0.5666739278934426,0.9572815533980582,0.9952518166826659,1.0,9/13,42.94%,CENPT;CENPF;CENPA;DLGAP5;NUF2;CENPW;MIS12;CENPE;CDT1
prerank,cytoplasmic translational initiation (GO:0002183),-0.2078526686811632,-0.5661046500616432,0.9703389830508474,0.994833496249256,1.0,7/17,36.64%,EIF4A1;EIF3A;EIF4A2;EIF3I;EIF4G1;DHX29;EIF5
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.23980973444026032,-0.5654726995684778,0.9557894736842105,0.9944260763546546,1.0,4/10,37.60%,CCT5;WRAP53;CCT7;CCT8
prerank,regulation of cholesterol efflux (GO:0010874),-0.18024962201119993,-0.563866323815122,0.9880668257756563,0.9943509495278213,1.0,7/30,27.49%,ABCA3;EEPD1;CAV1;RXRA;TREM2;GPS2;NR1H2
prerank,protein localization to vacuole (GO:0072665),-0.22287959665985385,-0.562781614810608,0.9656565656565657,0.9940842264051061,1.0,6/13,32.74%,GLMP;CD81;SH3GLB1;LAMTOR4;KPTN;SZT2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.23376624398586365,0.5604026187197173,0.9683426443202979,1.0,1.0,7/14,30.71%,TERT;TNKS2;NABP2;ATRX;TNKS;TERF2;ACD
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.19980209120195466,-0.5586731769751354,0.9616204690831557,0.9947718065556479,1.0,4/19,20.27%,RIC3;CHRNA4;CHRFAM7A;CHRNA7
prerank,positive regulation of viral transcription (GO:0050434),0.20054073546496654,0.5579884165406942,0.9714795008912656,1.0,1.0,8/25,26.80%,POLR2D;POLR2C;POLR2F;POLR2K;RSF1;DHX9;POLR2H;GTF2F1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.19121264553513262,0.5578394063005563,0.9779286926994907,1.0,1.0,7/31,20.30%,RC3H1;FOXP3;CD274;DLG5;VTCN1;CEBPB;BLK
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2230932065646117,-0.556757030679941,0.9637526652452025,0.9947431732548212,1.0,6/13,45.59%,NELFCD;RNF168;NELFA;SUPT4H1;NELFB;LARP7
prerank,regulation of cellular protein metabolic process (GO:0032268),0.18019831897153582,0.5560336818533494,0.9869067103109657,1.0,1.0,8/47,15.87%,PKP3;NR1H3;SSH1;FOXO3;CSF1;GEMIN5;MAPKAPK5;APP
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.21687192392798585,-0.5555750099880185,0.9606986899563319,0.9944715346480533,1.0,5/14,34.43%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,neuron maturation (GO:0042551),0.21619517343028244,0.5549258097246755,0.9647887323943662,1.0,1.0,5/18,19.86%,EPHA8;CLN5;APP;FARP2;MTCH1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.199272593846574,-0.5540828111494073,0.9780701754385965,0.9943197427838243,1.0,1/18,2.54%,KIF1B
prerank,amyloid precursor protein catabolic process (GO:0042987),0.22665561434008213,0.5534107775165593,0.9662921348314607,1.0,1.0,5/14,27.61%,ADAM19;ABCA7;PSEN1;NCSTN;ABCG1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2464730677772246,0.5515924498726631,0.9499036608863198,1.0,1.0,6/10,30.71%,DCLRE1A;RIF1;RTEL1;TFIP11;TERF2;ACD
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.20932908931008254,-0.5495869430805199,0.9609544468546638,0.995028049650634,1.0,3/16,14.21%,SRSF1;WBP11;SART1
prerank,protein alkylation (GO:0008213),0.2047614862119687,0.5484748576572154,0.9634369287020109,1.0,1.0,2/22,7.77%,METTL21C;ETFBKMT
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.23399731897113488,0.5479206660341797,0.9510204081632653,1.0,1.0,1/13,5.83%,TPR
prerank,erythrocyte development (GO:0048821),0.24327702377746283,0.5474148170445806,0.9541284403669725,1.0,1.0,3/10,18.98%,SH2B3;ALAS2;DMTN
prerank,double-strand break repair via break-induced replication (GO:0000727),0.23375532141772504,0.5466766191646223,0.9291338582677166,1.0,1.0,2/12,13.29%,MCM4;MCM6
prerank,phosphate ion transport (GO:0006817),-0.2057106210992332,-0.5421041079066636,0.9672489082969432,0.9964683875675419,1.0,4/16,22.81%,XPR1;SLC25A30;SLC20A2;SLC37A1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.18790286506281928,0.5412567923381694,0.9914965986394558,1.0,1.0,9/32,22.50%,AUTS2;PLCE1;ENPP2;AVIL;CORO1B;ACTR3;TWF2;FSCN1;CYFIP1
prerank,positive regulation of protein depolymerization (GO:1901881),0.2356852723361821,0.5410417375008117,0.9629629629629629,1.0,1.0,2/11,11.37%,PLEK;NES
prerank,lysosome localization (GO:0032418),0.17992704237961193,0.5396113667116305,0.9888178913738019,1.0,1.0,9/37,21.66%,KIT;MAP6;KIF5B;RAB34;PLEKHM2;VPS33A;BORCS5;DEF8;KXD1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.19695852714053236,-0.5393920671146663,0.9728033472803347,0.9965400122994975,1.0,3/18,12.81%,CTSC;PTTG1IP;HSP90AA1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.1889655338165997,-0.5392560179045405,0.9811764705882353,0.9959594477057975,1.0,4/20,15.04%,CAMK2D;TMCO1;ATP2A2;CCDC47
prerank,positive regulation of integrin activation (GO:0033625),-0.22615539489931644,-0.5351178389584509,0.9798792756539235,0.9963713143421683,1.0,1/11,5.36%,RASIP1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2126871617874097,0.535068352935125,0.9752380952380952,1.0,1.0,8/18,27.33%,AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;OS9;UGGT1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.20348100738210687,-0.5345521427342699,0.981404958677686,0.9959029158186381,1.0,7/15,38.24%,CD53;TREM2;ADGRB1;TYROBP;SCGB3A1;ADAM9;IL4
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.18222587712533522,0.534358440095293,0.9867549668874173,1.0,1.0,7/32,19.56%,RANBP2;TPR;POM121;SSB;NUP37;RAN;NUP85
prerank,tRNA export from nucleus (GO:0006409),0.18222587712533522,0.534358440095293,0.9867549668874173,1.0,1.0,7/32,19.56%,RANBP2;TPR;POM121;SSB;NUP37;RAN;NUP85
prerank,regulation of B cell activation (GO:0050864),-0.17760442034359972,-0.5342047585274342,0.9911894273127754,0.9953656398085089,1.0,10/25,40.67%,SH3KBP1;NOD2;SAMSN1;LAPTM5;IKZF3;THEMIS2;FOXJ1;IL4;FCGR2B;CD22
prerank,RNA catabolic process (GO:0006401),0.17071080840702196,0.533900710272091,0.9932203389830508,1.0,1.0,13/46,23.79%,NANOS2;DCP2;SND1;SLFN14;SUPV3L1;METTL16;RNASEH1;RNASE3;DNA2;RNASEH2B;PNPT1;ZFP36L2;RNASEH2A
prerank,regulation of mRNA metabolic process (GO:1903311),0.23355576222918473,0.5330787079522155,0.9585585585585585,1.0,1.0,2/11,13.16%,IWS1;SRPK1
prerank,telomere capping (GO:0016233),-0.199903549483667,-0.5325409215967244,0.9682539682539683,0.9951549134025851,1.0,8/16,35.38%,MRE11;TERF1;DCLRE1C;TINF2;STN1;DCLRE1B;PRKDC;TERF2IP
prerank,extracellular transport (GO:0006858),0.22994350282485856,0.5324180571757643,0.953307392996109,1.0,1.0,12/12,77.02%,WWP2;SPEF2;ROPN1L;DNAAF4;TSG101;SPA17;ARRDC1;CCDC40;DNAAF2;CABYR;SPAG17;ADCY10
prerank,amyloid-beta metabolic process (GO:0050435),0.2158895747101,0.5320237809361069,0.9662921348314607,1.0,1.0,5/16,25.82%,MGAT3;ABCA7;APEH;PSEN1;NCSTN
prerank,regulation of cilium movement (GO:0003352),0.24182573738427324,0.5307054960739147,0.9570552147239264,1.0,1.0,3/10,18.93%,DNAAF1;DRC1;CCDC39
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.21848317428427916,0.5288846440634848,0.9640831758034026,1.0,1.0,14/14,78.17%,CSF1;IL23R;TRAF6;POU4F2;IFNG;IL12B;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TYROBP;ATP6AP1
prerank,chromatin assembly or disassembly (GO:0006333),0.23759027810684802,0.5282557986343595,0.9621513944223108,1.0,1.0,1/11,5.72%,CDAN1
prerank,DNA modification (GO:0006304),0.19350157270571888,0.5275959288266417,0.9825174825174825,1.0,1.0,3/22,12.43%,PARP3;NTHL1;OGG1
prerank,alpha-amino acid metabolic process (GO:1901605),0.16995343763183773,0.5255451900482363,0.9936808846761453,1.0,1.0,11/45,22.85%,MTHFD1;ASPA;GLUL;PYCR3;THAP4;SRR;DPEP1;NAALAD2;ASS1;DDAH2;MMUT
prerank,regulation of pH (GO:0006885),0.2313172049494941,0.5243884392341409,0.966,1.0,1.0,3/11,20.72%,LACC1;SLC9A7;SLC9A1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2023985125974745,0.5214948543754937,0.9788732394366197,1.0,1.0,2/18,9.76%,MANBA;DERA
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.20352855775751494,0.5178475240992612,0.9760589318600368,1.0,1.0,3/18,13.34%,STOX1;BRD4;RAD51B
prerank,adipose tissue development (GO:0060612),0.22401883800223227,0.5177882756780329,0.9766081871345029,1.0,1.0,4/11,21.20%,DGAT2;ARID5B;SH3PXD2B;XBP1
prerank,regulation of centrosome duplication (GO:0010824),-0.16569389341710758,-0.5163417801415527,0.993006993006993,0.9979937385880188,1.0,12/29,35.00%,NPM1;CCNF;CHMP1A;CHMP1B;CHMP2B;GEN1;CHMP2A;STIL;CHMP4C;FBXW5;PKHD1;VPS4B
prerank,nuclear body organization (GO:0030575),-0.20879189384972502,-0.5160197609656044,0.9769392033542977,0.9974324119314285,1.0,5/12,34.85%,WRAP53;SRPK2;HIPK2;USPL1;DYRK3
prerank,regulation of phosphate metabolic process (GO:0019220),0.20268202151608114,0.5151987608100221,0.974609375,1.0,1.0,8/16,28.97%,SMG5;SMG6;SMG7;SIRT2;MCM7;PSEN1;IGBP1;GNB3
prerank,protein import into mitochondrial matrix (GO:0030150),-0.1869746178912201,-0.514029270075017,0.9931972789115646,0.9972272089893299,1.0,4/18,18.10%,DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,RNA methylation (GO:0001510),-0.13983009661403872,-0.5130745581398818,1.0,0.996776054283907,1.0,18/60,32.94%,TRMT13;FTSJ3;VIRMA;ZC3H13;CBLL1;RBM15B;TRMT6;TFB2M;TFB1M;METTL8;TRMT10C;METTL14;TRMT61A;THUMPD2;BCDIN3D;FBL;ALKBH8;TRMT10A
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.20242644719542158,-0.5129705790878853,0.9789029535864979,0.9961755209184731,1.0,8/13,50.38%,MMS19;YAE1;GLRX5;LTO1;CISD3;ISCA2;GLRX3;BOLA2
prerank,protein localization to centrosome (GO:0071539),0.20757571205124564,0.5127812591277753,0.9696428571428571,1.0,1.0,3/17,11.22%,C2CD3;NUDCD3;NEDD1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.20695738534333258,-0.5123733127847102,0.9779559118236473,0.9956781919171056,1.0,8/12,42.94%,MAD1L1;NUF2;MIS12;KIF2C;BOD1;CENPE;CHAMP1;CDT1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.19833634102305686,0.5113583989453395,0.9714828897338403,1.0,1.0,6/19,21.02%,RTN1;RTN4;FLOT2;ABCA7;ROCK1;GGA3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.19910196016773765,-0.5097592883000098,0.9777777777777777,0.9955597024515425,1.0,5/13,32.29%,SART3;LSM2;SRSF12;PRPF8;DDX20
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.19560329465627618,-0.5094830342614914,0.9783549783549783,0.9949872626230877,1.0,5/15,34.43%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,tRNA wobble base modification (GO:0002097),0.21245605223505767,0.5091169865686312,0.9739776951672863,1.0,1.0,14/14,78.77%,CTU1;ALKBH1;URM1;ELP4;GTPBP3;MTO1;MOCS3;ALKBH8;ELP3;CTU2;ADAT2;KTI12;DPH3;TRMT9B
prerank,transcription preinitiation complex assembly (GO:0070897),0.21893420391096025,0.5078517909501674,0.9712643678160919,1.0,1.0,4/12,23.90%,TAF7;BDP1;DR1;TAF1
prerank,placenta development (GO:0001890),0.22036912303750789,0.506055579650648,0.967479674796748,1.0,1.0,2/12,11.82%,PTK2;ADAM19
prerank,nuclear membrane organization (GO:0071763),0.19315947791091628,0.5050437635091385,0.9802158273381295,1.0,1.0,5/19,19.00%,TOR1AIP1;UBXN2A;NEMP1;CHMP4B;EMD
prerank,positive regulation of mRNA processing (GO:0050685),0.19241137926478452,0.5046157576024647,0.9895287958115183,1.0,1.0,11/21,29.35%,CDC73;PAF1;LEO1;DHX36;NCL;DAZAP1;RBMX;SF3B4;NUP98;TRA2B;THRAP3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.17033716114109843,0.5037889285182565,0.9932203389830508,1.0,1.0,12/37,23.96%,ENTPD7;SND1;SUPV3L1;DNASE1L1;RNASEH1;RNASE3;DFFB;RNASEH2B;PNPT1;ENTPD6;RNASEH2A;ENTPD5
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.2099156758099886,0.5036650631715814,0.9709302325581395,1.0,1.0,3/13,20.45%,BMP7;NAPEPLD;PTGS2
prerank,positive regulation of translational initiation (GO:0045948),0.1928177536553176,0.5004846295735929,0.981651376146789,1.0,1.0,1/18,3.35%,POLR2D
prerank,spliceosomal snRNP assembly (GO:0000387),0.16559411094955231,0.4987867462098595,0.9966887417218543,1.0,1.0,7/38,19.16%,GEMIN4;STRAP;PRPF19;GEMIN5;TGS1;PRPF3;USP4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.17598676182574052,0.49864705987990493,0.9918166939443536,1.0,1.0,4/29,14.87%,SYCP2;MAJIN;TEX12;P3H4
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.1816186224381638,-0.49643185782040544,0.987603305785124,0.9965670031618485,1.0,8/18,33.09%,COX20;COX19;BCS1L;PET100;TIMM21;COA5;SCO2;COA3
prerank,nuclear envelope organization (GO:0006998),0.19342360215333448,0.49516614718989665,0.9859649122807017,1.0,1.0,7/20,25.35%,TOR1AIP1;NEMP1;DMPK;EMD;LEMD3;SUN1;VPS4A
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19414903348401702,0.49442828404819134,0.9791666666666666,1.0,1.0,3/17,14.03%,NTHL1;OGG1;ERCC5
prerank,positive regulation of lipid storage (GO:0010884),0.18810367738619654,0.4943593321201769,0.9875444839857651,1.0,1.0,2/21,12.07%,IKBKE;PLIN3
prerank,respiratory chain complex IV assembly (GO:0008535),-0.17345540786210675,-0.4935368611576519,0.9936575052854123,0.9963881379832397,1.0,8/21,33.09%,COX20;COX19;BCS1L;PET100;TIMM21;COA5;SCO2;COA3
prerank,regulation of microglial cell activation (GO:1903978),0.1989621404846987,0.49275164098887747,0.975609756097561,1.0,1.0,1/15,4.44%,IL6
prerank,regulation of viral transcription (GO:0046782),0.16388178810558926,0.49133217165096216,0.9913494809688581,1.0,1.0,13/39,26.80%,POLR2D;POLR2C;TRIM21;POLR2F;TARBP2;POLR2K;RSF1;HEXIM1;DHX9;TRIM32;POLR2H;UBP1;GTF2F1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.1978028876333961,-0.4900413577734063,0.989451476793249,0.9963058905049245,1.0,12/12,80.24%,NELFCD;RNF168;NELFA;NELFB;LARP7;NELFE;RECQL5;HNRNPU;TCERG1;RNF8;HEXIM1;EAPP
prerank,cilium movement (GO:0003341),-0.139941507062479,-0.48941250721684393,1.0,0.9957752367227113,1.0,21/47,37.76%,CFAP251;DNAH11;CFAP54;CFAP70;ODAD2;ADCY10;SPAG17;CABYR;ODAD3;DNAAF2;CFAP100;DNAH17;DNAH9;CFAP206;CFAP61;CCDC40;CCDC63;TTC29;CFAP91;TEKT5;DNAH1
prerank,ncRNA transcription (GO:0098781),0.20533144762953526,0.4864120063607162,0.9810964083175804,1.0,1.0,3/13,17.70%,POLR1G;SNAPC3;CAVIN1
prerank,positive regulation of cilium assembly (GO:0045724),0.19317550556683113,0.4854060087534488,0.9892086330935251,1.0,1.0,3/18,14.44%,TAPT1;ENTR1;CROCC
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.19559496408528237,0.4786478957441305,0.9799270072992701,1.0,1.0,5/16,22.09%,NR1H3;ABHD5;SLC27A1;SREBF1;DAGLB
prerank,protein autoprocessing (GO:0016540),-0.17442260492676223,-0.4777757235753382,0.9898785425101214,0.9967263771798061,1.0,5/17,30.17%,FAM111A;CTSL;CASP1;OMA1;PIDD1
prerank,glutathione derivative metabolic process (GO:1901685),0.18158365066403923,0.4764753315763915,0.9911504424778761,1.0,1.0,2/20,11.84%,GSTK1;GSTA3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.18158365066403923,0.4764753315763915,0.9911504424778761,1.0,1.0,2/20,11.84%,GSTK1;GSTA3
prerank,mitochondrial protein processing (GO:0034982),0.2120675987264612,0.47515930457318356,0.9812382739212008,1.0,1.0,5/11,30.78%,PMPCB;AFG3L2;STOML2;PMPCA;YME1L1
prerank,regulation of rRNA processing (GO:2000232),0.18692108887629938,0.4724407638559816,0.9866412213740458,1.0,1.0,3/16,15.47%,UTP15;USP36;KAT2B
prerank,regulation of oxidoreductase activity (GO:0051341),-0.1874619914712629,-0.47073474753184746,0.9936974789915967,0.9969371867423229,1.0,2/13,15.58%,HDAC6;NOD2
prerank,cellular response to UV-A (GO:0071492),-0.18906520527446358,-0.4669108472021181,0.9920792079207921,0.9967459089074424,1.0,4/11,28.64%,MMP1;TIMP1;MMP2;MMP3
prerank,positive regulation of cell division (GO:0051781),0.1547450161209847,0.46555256895275976,0.9983277591973244,1.0,1.0,1/38,1.32%,FGF1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.20400096939877965,0.4622251838462386,0.984,1.0,1.0,4/12,24.58%,PAICS;GMPS;ADSL;ATIC
prerank,response to hydroxyurea (GO:0072710),0.20475294525752435,0.4584450500937,0.9897540983606558,1.0,1.0,4/11,25.09%,SPIDR;NSMCE3;ATRX;RTF2
prerank,rRNA methylation (GO:0031167),0.1715388954861802,0.4577789375447086,0.9927667269439421,1.0,1.0,6/22,23.92%,ZCCHC4;METTL16;FDXACB1;METTL15;METTL5;MTERF4
prerank,positive regulation of protein maturation (GO:1903319),0.19786819775754275,0.4515001342447954,0.9857142857142858,1.0,1.0,2/11,15.56%,CCBE1;SOX4
prerank,fatty acid transport (GO:0015908),0.17511028177343638,0.4466390302871139,0.9880239520958084,1.0,1.0,4/17,20.27%,ACSL1;SLC27A3;SLC27A1;CD36
prerank,nucleosome disassembly (GO:0006337),0.18359517269770342,0.4414405257854275,0.9925373134328358,1.0,1.0,7/14,26.18%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCE1;SMARCD1;ARID1A
prerank,chromatin disassembly (GO:0031498),0.18359517269770342,0.4414405257854275,0.9925373134328358,1.0,1.0,7/14,26.18%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCE1;SMARCD1;ARID1A
prerank,aromatic amino acid family catabolic process (GO:0009074),0.17851116953866214,0.43811847317075514,0.9961612284069098,1.0,1.0,1/15,7.97%,HGD
prerank,positive regulation of DNA recombination (GO:0045911),0.15911651958741457,0.43810529380297464,0.9964726631393298,1.0,1.0,11/27,27.20%,ERCC6;FUS;SHLD2;KMT5C;RIF1;KMT5B;ARID2;ZCWPW1;SHLD1;FANCB;ERCC2
prerank,tRNA metabolic process (GO:0006399),0.17677494160423457,0.4375189225616552,0.9981684981684982,1.0,1.0,3/17,16.10%,TRPT1;DTD2;SSB
prerank,eosinophil migration (GO:0072677),0.17708031386113426,0.4294444676251252,0.9946714031971581,1.0,1.0,1/14,7.71%,CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.17708031386113426,0.4294444676251252,0.9946714031971581,1.0,1.0,1/14,7.71%,CCL2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.1581506946950779,0.42820699660002776,0.996309963099631,1.0,1.0,4/22,19.03%,CUL4A;GTF2H4;GTF2H2;XPC
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.1838492907539535,0.42697737010020104,0.9940476190476191,1.0,1.0,1/12,6.37%,PPARA
prerank,tRNA methylation (GO:0030488),0.14457294986348895,0.425236907883222,0.9982698961937716,1.0,1.0,11/34,24.63%,THUMPD3;WDR6;TYW3;FTSJ1;METTL1;DALRD3;METTL2B;METTL2A;METTL6;TARBP1;THADA
prerank,regulation of lymphocyte proliferation (GO:0050670),0.17116615945901942,0.4231602817885476,0.996309963099631,1.0,1.0,1/16,5.16%,PTPN22
prerank,positive regulation of rRNA processing (GO:2000234),0.18560130554858137,0.4175695975687407,0.9899193548387096,1.0,1.0,10/10,81.45%,UTP15;RIOK2;RIOK1;TRMT112;BUD23;DIMT1;WDR43;WDR75;HEATR1;SIRT7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.1445860224395513,-0.4079651801173483,1.0,1.0,1.0,5/20,31.24%,MBTPS1;PSENEN;MBTPS2;RELA;HM13
prerank,regulation of amyloid-beta clearance (GO:1900221),0.16079058025249093,0.407811295688544,0.9925788497217068,1.0,1.0,4/16,20.25%,LRPAP1;ABCA7;LRP1;ROCK1
prerank,DNA packaging (GO:0006323),0.15792038778541706,0.3981103698002821,1.0,1.0,1.0,2/16,13.90%,CDAN1;KAT6A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.15062902259280142,-0.3957777157369757,0.9978260869565218,0.9998647414627452,1.0,5/15,32.57%,MRE11;MDC1;HUS1B;NEK11;MUS81
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.16376875274621805,-0.3950089094563028,0.9979123173277662,0.9992639370469129,1.0,11/11,83.64%,EXOSC2;EXOSC4;FBL;EXOSC3;FBLL1;LARP7;DKC1;EXOSC5;TENT4B;PARN;EXOSC10
prerank,regulation of protein localization to Cajal body (GO:1904869),0.17255665055552064,0.3866391560037566,0.998062015503876,0.9999270504638536,1.0,11/11,82.76%,CCT6A;CCT3;DKC1;TCP1;MEPCE;CCT2;LARP7;CCT4;CCT8;CCT7;CCT5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.17255665055552064,0.3866391560037566,0.998062015503876,0.9999270504638536,1.0,11/11,82.76%,CCT6A;CCT3;DKC1;TCP1;MEPCE;CCT2;LARP7;CCT4;CCT8;CCT7;CCT5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.1565796082370666,0.37401612363229686,1.0,0.9998181204624462,1.0,14/14,84.36%,ERCC6;FUS;ARID2;FANCB;WDR48;OOEP;PARP1;MRNIP;ACTR2;WAS;TIMELESS;RAD51AP1;WRAP53;MMS19
prerank,meiosis I (GO:0007127),0.11037071677127007,0.30130939206210156,1.0,0.9999858302879879,1.0,22/23,75.76%,ZSCAN21;SLC25A31;FOXJ3;ZCWPW1;ING2;MEIOB;BCL2L11;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;MEI1;HSF2BP;CCNA1;BRDT;FOXJ2;MEIKIN;MOV10L1;TDRD9;SGO1;SYCP3
